data_2gqk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gqk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.456 -0.728 0 N-CA-C 109.803 -0.883 . . . . 3.6800000000000002 109.803 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 5.5099999999999998 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 4.0800000000000001 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 3.4500000000000002 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 3.1099999999999999 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 2.3199999999999998 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 2.1800000000000002 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 3.1800000000000002 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.4300000000000002 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.9400000000000004 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 4.0899999999999999 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 4.1399999999999997 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.2599999999999998 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 7.3399999999999999 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.9500000000000002 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 4.1699999999999999 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 5.7699999999999996 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.6699999999999999 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.1400000000000001 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.8799999999999999 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 4.3899999999999997 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 3.2999999999999998 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 2.7799999999999998 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 4.3899999999999997 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 3.1299999999999999 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 5.0700000000000003 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.3899999999999997 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 9.3800000000000008 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.6499999999999999 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 5.0199999999999996 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.6499999999999999 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 3.6800000000000002 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.8500000000000001 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.77 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.3700000000000001 112.01 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.2799999999999998 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 3.71 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.3799999999999999 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 4.3600000000000003 111.202 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 4.4100000000000001 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 2.3399999999999999 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.457 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 2.5299999999999998 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 2.5299999999999998 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 3.3300000000000001 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 3.3700000000000001 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.6400000000000001 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 5.1100000000000003 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 4.2599999999999998 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.6200000000000001 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 4.0599999999999996 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 3.4100000000000001 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.4800000000000004 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 3.3700000000000001 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 2.0899999999999999 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 1.01 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 4.1100000000000003 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 3.5 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 3.0600000000000001 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 3.04 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.9399999999999999 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.2999999999999998 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.4399999999999999 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.8600000000000003 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 7.0800000000000001 117.962 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 3.27 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 6.0999999999999996 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 2.2999999999999998 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 2.8399999999999999 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.78 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 4.0700000000000003 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 5.2800000000000002 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 2.5 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 4.2999999999999998 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.3199999999999998 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 4.0599999999999996 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 3.27 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 2.0299999999999998 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 3.46 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 3.3999999999999999 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 2.3300000000000001 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.98999999999999999 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 3.79 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 3.1800000000000002 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.9399999999999999 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 4.0199999999999996 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 7.6600000000000001 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.1100000000000003 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.5299999999999998 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 2.8199999999999998 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.8799999999999999 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 5.3099999999999996 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 4.0800000000000001 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.6799999999999997 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.5 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 4.46 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 8.0299999999999994 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 5.0700000000000003 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 10.029999999999999 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 4.4199999999999999 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 4.0300000000000002 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.54 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.2999999999999998 113.493 -175.796 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 121.941 0.876 . . . . 5.7300000000000004 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 3.6600000000000001 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2000000000000002 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.9199999999999999 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.7599999999999998 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 4.1399999999999997 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 3.73 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 4.1799999999999997 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 4.2000000000000002 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.9900000000000002 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 3.7000000000000002 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.6299999999999999 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.6399999999999997 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.0700000000000003 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.6900000000000004 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.3899999999999997 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 4.7800000000000002 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 3.4500000000000002 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.5899999999999999 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 5.2199999999999998 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 4.5099999999999998 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.6699999999999999 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 6.7300000000000004 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.8899999999999997 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.483 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 9.1899999999999995 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 6.0499999999999998 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.457 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 2.8399999999999999 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 2.02 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.5099999999999998 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 2.29 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 2.3900000000000001 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 3.2799999999999998 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.9700000000000002 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 3.2000000000000002 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 3.0499999999999998 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 3.71 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 3.7999999999999998 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 5.9699999999999998 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 7.5700000000000003 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.5899999999999999 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 5.5999999999999996 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 11.65 108.161 -178.167 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 N-CA-C 111.966 -0.052 . . . . 3.5 111.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 3.4399999999999999 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.9700000000000002 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 3.3199999999999998 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 3.75 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 2.6499999999999999 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.8500000000000001 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 4.0899999999999999 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.1400000000000001 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.7800000000000002 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 6.8700000000000001 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.8300000000000001 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.8799999999999999 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.6600000000000001 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.7999999999999998 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 3.3199999999999998 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 4.2800000000000002 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 4.4699999999999998 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.53 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.4900000000000002 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.6200000000000001 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 3.1299999999999999 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 3.54 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 2.9900000000000002 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 4.7999999999999998 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 2.8599999999999999 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.8599999999999999 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 5.7400000000000002 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 5.2199999999999998 110.457 165.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 8.3200000000000003 111.866 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 4.0199999999999996 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 6.9500000000000002 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.1699999999999999 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 4.2800000000000002 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.3599999999999999 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.6600000000000001 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.2200000000000002 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.0099999999999998 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 3.4199999999999999 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.1100000000000003 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.6800000000000002 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 4.3099999999999996 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 2.3500000000000001 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.473 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 2.3300000000000001 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 2.5 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 3.6099999999999999 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.8900000000000001 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 2.77 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.3500000000000001 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 3.1000000000000001 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 192' ' ' THR . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 3.4100000000000001 111.411 174.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 3.46 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 190' ' ' ILE . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 3.7000000000000002 112.572 -173.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 3.6000000000000001 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.3500000000000001 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.5099999999999998 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 3.0499999999999998 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 2.3999999999999999 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.4399999999999999 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 4.3200000000000003 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 3.27 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 3.0099999999999998 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 2.1099999999999999 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.8799999999999999 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.0599999999999996 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.9199999999999999 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.3399999999999999 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 8.6999999999999993 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.5299999999999998 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 4.54 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 2.2400000000000002 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 3.0499999999999998 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 2.0299999999999998 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.9399999999999999 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 3.8900000000000001 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 2.3999999999999999 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.557 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 5.3499999999999996 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.557 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6000000000000001 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 4.0300000000000002 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 2.3999999999999999 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 2.1699999999999999 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 3.5499999999999998 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 3.3599999999999999 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 2.5499999999999998 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 1.04 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 3.8300000000000001 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 3.1099999999999999 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.1499999999999999 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 4.4800000000000004 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 8.1400000000000006 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.6299999999999999 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.8500000000000001 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 2.6299999999999999 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.0899999999999999 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 3.4399999999999999 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.8500000000000001 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 4.3300000000000001 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.7999999999999998 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.8599999999999999 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 8.4499999999999993 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 4.0300000000000002 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.415 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 6.54 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 4.3600000000000003 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 4.0800000000000001 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.6200000000000001 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.7200000000000002 115.645 -172.245 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.964 1.098 . . . . 6.0 113.964 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 3.3999999999999999 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.6499999999999999 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.98 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 4.21 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.7200000000000002 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 4.3799999999999999 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.7599999999999998 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 4.7300000000000004 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 3.96 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 3.77 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.54 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.8399999999999999 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.7400000000000002 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.1900000000000004 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 5.0099999999999998 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 3.79 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.6899999999999999 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 4.8099999999999996 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 4.4400000000000004 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 4.0800000000000001 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.0700000000000003 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 5.4000000000000004 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 9.4900000000000002 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 7.0899999999999999 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.473 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 2.46 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.6299999999999999 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 2.0600000000000001 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.9199999999999999 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 2.3199999999999998 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 2.73 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 3.4100000000000001 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 3.3599999999999999 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.8300000000000001 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 3.23 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 5.2699999999999996 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 6.5999999999999996 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 3.0 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 7.1600000000000001 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 11.220000000000001 112.285 -174.014 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.658 -0.555 . . . . 3.4900000000000002 110.658 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 3.9900000000000002 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.79 115.787 -172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.96 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 2.4199999999999999 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 2.0899999999999999 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 2.21 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 3.4500000000000002 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.1899999999999999 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 8.2300000000000004 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 4.1200000000000001 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 154' ' ' ASP . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 3.1400000000000001 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 7.2800000000000002 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.402 ' CG ' ' HG1' ' A' ' 151' ' ' THR . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.1600000000000001 111.332 164.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 4.54 114.311 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 4.6799999999999997 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.9700000000000002 110.331 167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.54 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 3.54 110.73 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 4.3499999999999996 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 2.8300000000000001 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 4.4000000000000004 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 4.1500000000000004 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.8899999999999999 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 6.46 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.9100000000000001 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 7.9100000000000001 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 3.0800000000000001 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 7.1299999999999999 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 4.04 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 2.0699999999999998 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.8100000000000001 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 4.2699999999999996 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.5899999999999999 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 4.29 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 2.7400000000000002 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 4.1299999999999999 110.781 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 2.3700000000000001 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 3.6899999999999999 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4000000000000004 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.6600000000000001 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 2.75 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.6600000000000001 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.8599999999999999 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 192' ' ' THR . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 4.5899999999999999 110.678 165.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 3.5800000000000001 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 190' ' ' ILE . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 4.8300000000000001 112.316 -175.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 6.2000000000000002 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.6699999999999999 110.912 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.9399999999999999 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 3.6400000000000001 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 2.2000000000000002 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 1.1399999999999999 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 3.6400000000000001 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 3.5699999999999998 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 2.71 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 2.4100000000000001 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 3.77 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.5499999999999998 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4000000000000004 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 7.8300000000000001 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.8600000000000003 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 3.8700000000000001 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 4.2999999999999998 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.1400000000000001 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 2.6899999999999999 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 2.8199999999999998 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 2.4500000000000002 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 4.5800000000000001 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 6.3499999999999996 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 2.5499999999999998 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 4.6799999999999997 112.904 -173.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.2999999999999998 112.347 174.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 3.5600000000000001 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 3.5699999999999998 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.9399999999999999 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 3.2999999999999998 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 3.6299999999999999 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 2.3500000000000001 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 1.01 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 3.0699999999999998 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 3.6000000000000001 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.6200000000000001 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 4.3099999999999996 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 6.7699999999999996 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.2999999999999998 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.2999999999999998 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 3.3399999999999999 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.4400000000000004 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.6299999999999999 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 4.3099999999999996 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.9399999999999999 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 5.1100000000000003 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.6699999999999999 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 4.25 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 11.199999999999999 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 4.4900000000000002 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 7.5499999999999998 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 6.4100000000000001 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.9399999999999999 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.5800000000000001 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.612 0.597 . . . . 5.6699999999999999 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 3.71 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.5099999999999998 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 5.25 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 5.3799999999999999 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 3.3399999999999999 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 3.9700000000000002 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 4.0 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 3.6400000000000001 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 3.29 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.5800000000000001 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.1699999999999999 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.9299999999999997 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.8100000000000001 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.4600000000000009 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 5.2199999999999998 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 5.2300000000000004 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.0699999999999998 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 5.2599999999999998 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 3.8900000000000001 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.0800000000000001 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.8200000000000003 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 7.0499999999999998 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.9199999999999999 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.8300000000000001 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 3.8100000000000001 113.622 -157.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.6399999999999999 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7000000000000002 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 2.6499999999999999 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 2.4300000000000002 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 2.2599999999999998 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 3.1499999999999999 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 3.1499999999999999 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 2.6499999999999999 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 2.46 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 4.7400000000000002 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.7999999999999998 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 5.21 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.5499999999999998 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 4.4900000000000002 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.7699999999999996 112.581 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 111.076 -0.394 . . . . 4.04 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 4.2599999999999998 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 3.6499999999999999 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 3.3399999999999999 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.4700000000000002 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.8900000000000001 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 2.5800000000000001 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 4.5499999999999998 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.0599999999999996 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 7.75 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 4.3600000000000003 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 4.5099999999999998 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.6799999999999997 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 8.2400000000000002 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.0499999999999998 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 3.3700000000000001 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 4.5300000000000002 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 2.04 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 3.1899999999999999 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 2.0899999999999999 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 3.5 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.98 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 3.2400000000000002 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 7.1100000000000003 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 4.46 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.8100000000000001 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 5.8399999999999999 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 5.54 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 3.0800000000000001 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 6.21 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.3399999999999999 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.62 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 4.1399999999999997 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.8799999999999999 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.8500000000000001 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7000000000000002 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.5299999999999998 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 4.4000000000000004 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.6499999999999999 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 3.9700000000000002 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 4.5499999999999998 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 2.79 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.8999999999999999 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 3.0099999999999998 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 4.3499999999999996 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.4100000000000001 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 2.8300000000000001 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.6400000000000001 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 3.8199999999999998 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.7400000000000002 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 4.0999999999999996 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 4.7699999999999996 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 5.4500000000000002 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.9500000000000002 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 3.3399999999999999 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 2.27 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 4.21 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 3.3900000000000001 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 3.1000000000000001 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 3.8199999999999998 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.6099999999999999 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.8599999999999999 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.5999999999999996 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 7.9000000000000004 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.6799999999999997 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.77 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 4.6699999999999999 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.8599999999999999 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 2.73 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 3.3199999999999998 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 2.73 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 5.8099999999999996 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 3.6200000000000001 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 2.6000000000000001 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.423 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 4.7000000000000002 114.227 -167.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.8099999999999996 112.851 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 3.8300000000000001 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.4700000000000002 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.4500000000000002 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 3.5800000000000001 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 3.3300000000000001 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 3.8700000000000001 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 3.7200000000000002 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 3.3999999999999999 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.2200000000000002 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.54 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 9.9199999999999999 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.1799999999999997 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.3099999999999996 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.8399999999999999 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.6400000000000001 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.6400000000000001 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 5.0 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 3.6600000000000001 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.5800000000000001 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.6099999999999999 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 4.1799999999999997 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 6.5899999999999999 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 4.79 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 7.3700000000000001 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 4.0800000000000001 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 3.3199999999999998 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.8700000000000001 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.9900000000000002 111.505 171.53 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.229 0.538 . . . . 4.7000000000000002 109.844 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 3.9399999999999999 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.8300000000000001 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 23.4 p80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.3799999999999999 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.8500000000000001 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 4.0800000000000001 111.447 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 3.3300000000000001 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 4.04 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 3.6699999999999999 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 3.5699999999999998 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 3.4700000000000002 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.95 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.1899999999999999 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.9699999999999998 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.1099999999999994 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 4.0199999999999996 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 3.1499999999999999 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.1899999999999999 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.9900000000000002 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 3.9500000000000002 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 3.54 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 4.2800000000000002 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.9199999999999999 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 9.5399999999999991 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 8.0299999999999994 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 3.0099999999999998 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.25 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.1799999999999997 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 2.0899999999999999 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 2.2799999999999998 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 3.0899999999999999 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 2.4399999999999999 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 3.4399999999999999 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 2.4100000000000001 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 3.0899999999999999 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 3.1499999999999999 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 4.3899999999999997 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 6.5499999999999998 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.8799999999999999 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.1299999999999999 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 10.33 116.081 -172.872 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 N-CA-C 110.811 -0.496 . . . . 3.2200000000000002 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 3.6600000000000001 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.5600000000000001 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.98 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 2.5699999999999998 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 2.2599999999999998 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 3.4199999999999999 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.2799999999999998 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.3499999999999996 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 7.5300000000000002 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 5.3700000000000001 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.4500000000000002 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.8300000000000001 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 8.4100000000000001 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 4.5300000000000002 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 4.9100000000000001 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 4.6600000000000001 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.2000000000000002 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.6299999999999999 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.8700000000000001 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 3.2000000000000002 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 4.7400000000000002 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 2.6299999999999999 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 4.3600000000000003 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 2.8999999999999999 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 5.5499999999999998 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.73 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 7.4900000000000002 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.49 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 4.5099999999999998 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 9.5500000000000007 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.49 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.6299999999999999 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 3.6699999999999999 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.0699999999999998 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 2.0699999999999998 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.1099999999999999 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.0899999999999999 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 3.8100000000000001 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.1099999999999999 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 4.2699999999999996 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 4.25 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 2.4900000000000002 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.0700000000000003 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 3.1400000000000001 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 3.6200000000000001 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.7400000000000002 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.5699999999999998 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 3.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.9399999999999999 111.409 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 3.6099999999999999 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 3.23 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.8399999999999999 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.8399999999999999 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 3.75 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 3.0099999999999998 108.474 158.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.9700000000000002 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 3.6699999999999999 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 2.5600000000000001 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.3400000000000001 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 4.1600000000000001 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 3.6299999999999999 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 2.3599999999999999 109.487 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 3.0099999999999998 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 3.2999999999999998 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7000000000000002 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 3.1299999999999999 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.2300000000000004 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 9.6400000000000006 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.6600000000000001 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.6600000000000001 106.249 146.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 4.4699999999999998 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.0499999999999998 113.993 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 3.3799999999999999 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 2.8300000000000001 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.78 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.416 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 4.8899999999999997 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 5.6500000000000004 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 2.3700000000000001 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 4.4000000000000004 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 5.46 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 4.4500000000000002 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.79 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.8199999999999998 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 3.7599999999999998 112.054 167.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 3.2400000000000002 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 2.73 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.95999999999999996 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 3.4399999999999999 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 3.4100000000000001 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.8999999999999999 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 3.9300000000000002 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 8.6799999999999997 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7000000000000002 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.5700000000000003 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 3.48 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.0700000000000003 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 3.1099999999999999 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 3.71 113.512 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.48 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.9100000000000001 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.8700000000000001 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 4.3899999999999997 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 9.5800000000000001 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 4.2000000000000002 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.7300000000000004 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 5.0999999999999996 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.75 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.52 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.7400000000000002 112.95 176.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 114.504 1.298 . . . . 5.5899999999999999 114.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 4.1299999999999999 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.4100000000000001 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 3.27 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 4.2199999999999998 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.478 ' H ' HD11 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 4.0 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 3.7200000000000002 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 4.2300000000000004 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 3.8999999999999999 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 3.0 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 3.8999999999999999 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.9100000000000001 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.1299999999999999 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.7999999999999998 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.5099999999999998 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.0800000000000001 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 4.8300000000000001 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 4.1600000000000001 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.1099999999999999 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.8799999999999999 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 4.3099999999999996 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.25 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 4.5099999999999998 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 6.4299999999999997 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.7599999999999998 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.8899999999999997 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.7999999999999998 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.8100000000000001 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.4900000000000002 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 2.1699999999999999 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 2.4500000000000002 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 2.5099999999999998 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 3.0099999999999998 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 4.0599999999999996 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 3.0899999999999999 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 2.29 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.8500000000000001 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 7.1699999999999999 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 7.1100000000000003 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.3199999999999998 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 4.1399999999999997 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 . . . . . 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 11.19 112.351 178.428 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 110.859 -0.477 . . . . 3.1099999999999999 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 3.4700000000000002 112.926 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.75 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 2.8700000000000001 112.841 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 2.3199999999999998 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.96 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.75 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.9399999999999999 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.79 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.0099999999999998 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 8.8699999999999992 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 4.5700000000000003 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.8900000000000001 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.4500000000000002 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 7.2400000000000002 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.6699999999999999 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 3.3599999999999999 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 4.8300000000000001 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.6200000000000001 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.5 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 4.6100000000000003 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 3.8700000000000001 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 2.5899999999999999 111.147 -172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HH ' ' HA ' ' A' ' 173' ' ' CYS . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.79 111.988 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 4.3799999999999999 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.4100000000000001 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 7.0199999999999996 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.6899999999999999 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 6.2999999999999998 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.9100000000000001 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 6.3799999999999999 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.5099999999999998 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 3.8100000000000001 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.502 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.0099999999999998 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.72 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.6499999999999999 112.106 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.3500000000000001 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 3.4300000000000002 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.2400000000000002 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 4.2800000000000002 111.87 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 4.4000000000000004 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.9399999999999999 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 2.2000000000000002 113.836 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 3.8199999999999998 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 3.5099999999999998 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.0999999999999996 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2000000000000002 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 3.48 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.8100000000000001 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 3.2400000000000002 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 3.21 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 3.9500000000000002 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 3.4900000000000002 114.378 -165.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 4.21 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.96 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.3700000000000001 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 3.5099999999999998 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.78 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.92000000000000004 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 3.6000000000000001 112.84 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 3.5499999999999998 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 2.4500000000000002 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 3.1899999999999999 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 3.1299999999999999 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.0199999999999996 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.0899999999999999 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.3799999999999999 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.53 ' HB3' HH11 ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 9.7200000000000006 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.8899999999999997 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.9300000000000002 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 4.7999999999999998 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.4199999999999999 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 2.4399999999999999 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 2.77 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 2.1800000000000002 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 5.8200000000000003 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 5.0999999999999996 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 2.3999999999999999 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.7999999999999998 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 3.4399999999999999 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.6099999999999999 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 3.29 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.72 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 4.3399999999999999 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 3.46 109.86 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 2.1800000000000002 111.811 173.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92000000000000004 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 2.8700000000000001 112.808 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 3.0600000000000001 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5299999999999998 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.8499999999999996 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.2599999999999998 113.028 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2000000000000002 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.8900000000000001 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.5499999999999998 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.9900000000000002 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 4.5300000000000002 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 3.0800000000000001 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 4.3099999999999996 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 3.6299999999999999 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.5 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 6.3899999999999997 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 5.2300000000000004 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.5399999999999991 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 4.7599999999999998 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 5.2699999999999996 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.3799999999999999 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.7599999999999998 113.619 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.285 -0.635 . . . . 4.4900000000000002 109.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 3.79 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.0599999999999996 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.462 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.8500000000000001 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 4.6699999999999999 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 5.7999999999999998 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 4.0 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 4.2199999999999998 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 3.98 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 3.2599999999999998 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 3.5699999999999998 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.45 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7000000000000002 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.8300000000000001 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.2599999999999998 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.5800000000000001 113.233 165.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 6.21 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 3.8199999999999998 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.8099999999999996 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 5.0199999999999996 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.3999999999999999 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.9400000000000004 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 6.7800000000000002 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 5.0700000000000003 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 7.2699999999999996 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 2.7200000000000002 113.504 -165.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.3999999999999999 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9000000000000004 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.96 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 1.76 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 2.27 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 2.9500000000000002 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.7599999999999998 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 2.1499999999999999 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 2.2000000000000002 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.6200000000000001 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 4.5300000000000002 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 5.1399999999999997 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.8700000000000001 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 3.8199999999999998 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 11.369999999999999 110.879 155.587 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 109.372 -1.049 . . . . 3.0899999999999999 109.372 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 3.5899999999999999 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.4700000000000002 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 3.0800000000000001 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 2.0800000000000001 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 2.3199999999999998 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.73 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 3.73 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.96 112.808 -155.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.8899999999999997 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.98 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 2.4100000000000001 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.1900000000000004 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 8.8000000000000007 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.8799999999999999 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 3.5499999999999998 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 5.6500000000000004 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.9099999999999999 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.3399999999999999 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 2.3100000000000001 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 3.2400000000000002 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 4.3399999999999999 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 2.9500000000000002 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 4.1900000000000004 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 4.1500000000000004 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 6.2599999999999998 109.724 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 4.2800000000000002 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 6.1399999999999997 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.9900000000000002 112.121 -157.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 172' ' ' VAL . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 7.4800000000000004 112.152 171.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.2999999999999998 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' PRO . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 3.9399999999999999 111.869 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.549 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.8899999999999999 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.0600000000000001 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.9100000000000001 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 3.2999999999999998 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.2400000000000002 109.501 169.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.9100000000000001 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 5.1200000000000001 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 183' ' ' VAL . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 3.6800000000000002 109.839 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.435 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 2.1099999999999999 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 181' ' ' ILE . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 3.0800000000000001 111.18 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 5.0800000000000001 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.6900000000000004 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.8799999999999999 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 4.1500000000000004 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.6800000000000002 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 3.7200000000000002 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 3.3799999999999999 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 4.9199999999999999 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 5.4400000000000004 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 4.5599999999999996 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 4.1900000000000004 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.8300000000000001 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 3.5699999999999998 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 2.0 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.85999999999999999 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 3.54 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 3.25 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 2.46 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 3.1899999999999999 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.77 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.1899999999999999 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.4199999999999999 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.6900000000000004 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 8.8100000000000005 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.8899999999999997 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 4.3499999999999996 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.79 114.294 -171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 2.4199999999999999 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 2.73 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 1.97 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 4.7400000000000002 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 4.1100000000000003 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 2.1899999999999999 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.8100000000000001 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.6600000000000001 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 4.0899999999999999 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.7599999999999998 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.8999999999999999 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 3.6499999999999999 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 3.1099999999999999 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 2.1600000000000001 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.73999999999999999 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 3.02 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 3.71 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.8300000000000001 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.2000000000000002 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 6.8099999999999996 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.3300000000000001 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.7599999999999998 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 2.7999999999999998 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.9300000000000002 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 3.5499999999999998 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 3.8599999999999999 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 3.3799999999999999 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 6.0999999999999996 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.7000000000000002 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 4.0700000000000003 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.9400000000000004 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 3.73 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 6.7000000000000002 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 5.5099999999999998 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 3.46 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.5800000000000001 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.9700000000000002 111.811 -174.333 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.439 0.638 . . . . 5.2400000000000002 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 3.9300000000000002 111.451 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.9700000000000002 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.549 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.8799999999999999 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 4.1799999999999997 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.8599999999999999 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 4.1900000000000004 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 3.6699999999999999 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 3.9100000000000001 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 3.0 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 2.7200000000000002 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.45 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.6699999999999999 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.6900000000000004 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.9100000000000001 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.8499999999999996 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 4.0499999999999998 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 3.3900000000000001 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.1400000000000001 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.6699999999999999 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 4.0099999999999998 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.6600000000000001 111.411 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 4.0199999999999996 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 6.2300000000000004 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 5.21 112.558 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.71 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.435 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 3.3599999999999999 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.6000000000000001 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 2.0499999999999998 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.8600000000000001 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.9199999999999999 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 3.1299999999999999 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 3.1899999999999999 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 2.1699999999999999 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 2.4199999999999999 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 4.7699999999999996 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 5.4699999999999998 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 5.0300000000000002 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.21 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 4.6100000000000003 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.9600000000000009 111.8 169.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 N-CA-C 110.754 -0.518 . . . . 4.0 110.754 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 4.0999999999999996 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 3.1299999999999999 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 3.5800000000000001 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 3.29 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 2.6200000000000001 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 2.0099999999999998 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 3.79 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 2.04 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2000000000000002 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 5.7999999999999998 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 6.1600000000000001 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 3.5 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.4100000000000001 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.8700000000000001 115.421 -156.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 3.6200000000000001 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.424 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 5.2000000000000002 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 5.2599999999999998 113.101 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.6400000000000001 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.4900000000000002 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.3300000000000001 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 3.3999999999999999 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 3.9700000000000002 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 3.25 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.8599999999999999 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.9700000000000002 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.0699999999999998 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CZ ' ' CD2' ' A' ' 260' ' ' HIS . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 6.3399999999999999 115.028 -159.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 3.27 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 7.5700000000000003 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.7200000000000002 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 5.79 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.0999999999999996 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 4.4900000000000002 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.0600000000000001 112.531 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.9299999999999999 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.0999999999999996 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 3.0 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 3.6499999999999999 111.518 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.3700000000000001 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.8300000000000001 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 4.4000000000000004 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 2.6800000000000002 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.469 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.4700000000000002 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 3.04 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 3.6299999999999999 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.0999999999999996 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.9700000000000002 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 3.54 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 3.1000000000000001 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 192' ' ' THR . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 3.9199999999999999 111.781 165.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 3.25 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 190' ' ' ILE . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 3.2200000000000002 111.768 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 4.0 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.6200000000000001 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.3399999999999999 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 3.5699999999999998 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 2.8900000000000001 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.2 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 3.6099999999999999 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 4.8600000000000003 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 2.7999999999999998 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 3.5299999999999998 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 2.25 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.2999999999999998 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.8799999999999999 112.181 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 8.5700000000000003 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 5.4400000000000004 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 5.5300000000000002 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 3.4199999999999999 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 2.75 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 2.2000000000000002 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 4.0599999999999996 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 4.9100000000000001 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 2.1000000000000001 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 6.4199999999999999 113.301 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.2300000000000004 113.748 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 3.2400000000000002 112.782 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 2.3900000000000001 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.5699999999999998 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 3.9399999999999999 113.74 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 4.2800000000000002 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 3.0099999999999998 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.1699999999999999 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 2.8599999999999999 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 3.0600000000000001 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.79 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 4.4800000000000004 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 9.1699999999999999 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.9900000000000002 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.1600000000000001 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 3.0899999999999999 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.5299999999999998 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 4.0 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 3.5600000000000001 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.8799999999999999 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 2.75 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 4.5599999999999996 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 6.8099999999999996 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 3.48 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 6.3600000000000003 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 4.8099999999999996 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 3.0800000000000001 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.79 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.3199999999999998 112.732 179.291 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.086 0.772 . . . . 5.75 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 4.3700000000000001 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.9900000000000002 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.0 OUTLIER -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.0499999999999998 112.522 -168.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 5.9000000000000004 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 4.0 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 3.4300000000000002 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 5.0800000000000001 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 4.1500000000000004 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 3.8799999999999999 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 4.1600000000000001 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.8500000000000001 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6000000000000001 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2000000000000002 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 4.3600000000000003 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.8899999999999997 113.794 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 4.8700000000000001 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 4.1500000000000004 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.6800000000000002 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 4.7199999999999998 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 4.1200000000000001 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 3.23 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 5.2400000000000002 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.71 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 6.04 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.474 ' H ' ' HD2' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 9.0 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.469 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 3.1299999999999999 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.1800000000000002 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 3.0099999999999998 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 2.3500000000000001 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 2.9500000000000002 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 3.9300000000000002 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 3.9100000000000001 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.5899999999999999 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.98 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.8300000000000001 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.71 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 7.0 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.8100000000000001 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.6100000000000003 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 8.1699999999999999 111.99 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 123.278 1.282 . . . . 4.7199999999999998 115.325 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 4.9299999999999997 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 5.4699999999999998 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 4.21 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 3.0 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 3.1400000000000001 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.21 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 5.0599999999999996 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.8100000000000001 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.0099999999999998 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 8.4399999999999995 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 5.46 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 5.0800000000000001 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.2400000000000002 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 8.0700000000000003 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.6500000000000004 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 4.5 113.405 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 5.0700000000000003 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.3399999999999999 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.6299999999999999 109.835 159.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.9199999999999999 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 3.8799999999999999 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 5.3600000000000003 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 3.6699999999999999 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 4.1399999999999997 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 3.1299999999999999 112.178 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.9500000000000002 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 6.5599999999999996 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.5300000000000002 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.6 m170 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 6.1900000000000004 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 260' ' ' HIS . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 4.0 109.869 159.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 7.2599999999999998 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.7400000000000002 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 3.5 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 3.1899999999999999 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 2.1299999999999999 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 3.9900000000000002 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.6499999999999999 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.9199999999999999 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.7999999999999998 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.6899999999999999 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 6.04 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 2.4300000000000002 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 2.23 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 2.8199999999999998 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 3.9199999999999999 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.547 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 3.1099999999999999 112.262 170.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 2.98 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 3.6000000000000001 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.477 ' C ' ' H ' ' A' ' 192' ' ' THR . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 3.1200000000000001 110.329 169.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 3.54 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 190' ' ' ILE . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 3.3999999999999999 110.692 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 3.5899999999999999 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.3900000000000001 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.2800000000000002 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 5.2999999999999998 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 2.0600000000000001 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 1.02 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.9100000000000001 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 4.1900000000000004 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 2.9900000000000002 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 2.25 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 3.6200000000000001 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.2300000000000004 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.2799999999999998 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.47 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.1900000000000004 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 10.220000000000001 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 4.54 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.7699999999999996 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.1499999999999999 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.8799999999999999 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 4.04 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 2.7400000000000002 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 5.9699999999999998 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 4.6100000000000003 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 2.25 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.7800000000000002 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 4.2999999999999998 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 5.5899999999999999 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 3.6600000000000001 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.9700000000000002 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 5.7699999999999996 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 3.3100000000000001 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 3.46 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.1499999999999999 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 3.0299999999999998 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 4.6299999999999999 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.1099999999999999 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.416 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 4.1299999999999999 109.003 157.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.47 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 7.2000000000000002 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.8899999999999997 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 230' ' ' THR . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.0599999999999996 111.705 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 3.6000000000000001 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.3300000000000001 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 3.7999999999999998 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.8200000000000003 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 4.0300000000000002 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 4.3099999999999996 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 3.25 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 5.3799999999999999 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 6.46 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 3.6400000000000001 111.959 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 6.7199999999999998 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 5.71 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.4299999999999997 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.6500000000000004 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 3.1200000000000001 114.882 -171.288 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 120.633 0.254 . . . . 4.4500000000000002 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 4.3399999999999999 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.424 ' NE2' ' SG ' ' A' ' 169' ' ' CYS . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 2.02 110.096 170.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.8399999999999999 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 4.1799999999999997 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.8300000000000001 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 4.7599999999999998 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 4.7000000000000002 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 3.9100000000000001 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 3.21 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.8900000000000001 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.9900000000000002 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.8600000000000003 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.6400000000000001 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 7.3899999999999997 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 5.6500000000000004 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.9199999999999999 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 6.0199999999999996 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 4.5199999999999996 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.8399999999999999 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 6.5800000000000001 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 5.5 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 5.7699999999999996 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 9.1699999999999999 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HZ3' ' CD ' ' A' ' 186' ' ' GLU . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 4.1399999999999997 114.072 -164.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 3.2200000000000002 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.0700000000000003 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.6299999999999999 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.6699999999999999 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 3.8999999999999999 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 4.3200000000000003 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 3.8599999999999999 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 3.3199999999999998 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 4.0499999999999998 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.9500000000000002 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 5.1200000000000001 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 6.2199999999999998 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.6299999999999999 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 5.8700000000000001 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 9.0999999999999996 113.298 -161.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 120.456 0.107 . . . . 3.8799999999999999 112.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 4.3099999999999996 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.4500000000000002 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 3.1200000000000001 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 4.1900000000000004 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 2.6699999999999999 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 2.5699999999999998 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 3.25 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1000000000000001 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.8200000000000003 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 6.6299999999999999 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.8799999999999999 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.8799999999999999 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.8700000000000001 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 8.4499999999999993 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.4500000000000002 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 3.9100000000000001 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 5.6200000000000001 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.9299999999999999 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.1200000000000001 109.375 165.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.9299999999999999 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 3.54 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 4.5 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 4.1500000000000004 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 4.04 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 4.4299999999999997 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7000000000000002 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 5.96 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 5.1799999999999997 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 6.75 111.929 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.5 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 5.1500000000000004 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.6699999999999999 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 4.3600000000000003 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.404 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.8400000000000001 112.355 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.8700000000000001 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.6600000000000001 111.672 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.1200000000000001 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 3.8100000000000001 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.5800000000000001 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 4.3399999999999999 112.175 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 3.5800000000000001 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 2.4399999999999999 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 3.0899999999999999 113.835 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 3.3100000000000001 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 3.4900000000000002 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7000000000000002 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6000000000000001 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 3.04 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.5299999999999998 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.8999999999999999 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 3.1800000000000002 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 4.04 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 3.3199999999999998 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 4.2000000000000002 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 3.1800000000000002 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.5600000000000001 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.9299999999999997 112.704 155.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 2.1000000000000001 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 1.0900000000000001 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 3.98 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 5.1200000000000001 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 2.52 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.9199999999999999 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 3.27 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.3599999999999999 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.3899999999999997 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.9699999999999998 113.029 -167.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.5700000000000003 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 5.04 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 5.6299999999999999 114.297 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 210' ' ' LYS . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 5.5199999999999996 113.48 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 3.1800000000000002 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 2.71 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 2.2000000000000002 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 5.6699999999999999 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 4.5 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 2.2200000000000002 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 7.1200000000000001 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.1100000000000003 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 4.5099999999999998 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 2.23 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 2.0 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 4.75 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 3.0299999999999998 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 2.3900000000000001 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.90000000000000002 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 2.73 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 3.8999999999999999 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.1499999999999999 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.77 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 9.6600000000000001 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.0099999999999998 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 3.2000000000000002 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 3.25 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 3.4900000000000002 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 3.6699999999999999 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 7.4699999999999998 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.7799999999999998 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 4.7599999999999998 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.9699999999999998 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 4.8399999999999999 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 7.1200000000000001 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 4.3399999999999999 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 3.1600000000000001 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.77 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.3700000000000001 112.194 175.078 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.434 0.159 . . . . 5.3499999999999996 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 3.2200000000000002 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.1600000000000001 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.404 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 2.0099999999999998 111.882 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 4.25 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 4.5899999999999999 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 3.5499999999999998 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.9100000000000001 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 3.9399999999999999 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 3.02 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 3.52 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.8700000000000001 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.0599999999999996 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 3.48 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.3600000000000003 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 5.25 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 4.1500000000000004 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.8399999999999999 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 4.3899999999999997 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 3.6400000000000001 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.41 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.2799999999999998 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 5.1600000000000001 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 9.1099999999999994 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.9699999999999998 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 6.2199999999999998 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 3.9300000000000002 112.726 -166.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 2.21 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.0199999999999996 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 3.0800000000000001 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.8799999999999999 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 2.71 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 2.3900000000000001 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 3.0099999999999998 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.27 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 3.1800000000000002 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 3.1499999999999999 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.6200000000000001 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 6.3799999999999999 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.1400000000000001 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 4.7000000000000002 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 10.01 109.726 166.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 CA-C-O 121.241 0.434 . . . . 3.77 111.629 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 4.1500000000000004 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.5099999999999998 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 3.6299999999999999 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 2.3500000000000001 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 2.4300000000000002 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.8300000000000001 112.565 161.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 3.48 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.8899999999999999 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.5700000000000003 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 9.1400000000000006 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 4.2400000000000002 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.8500000000000001 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.1899999999999999 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 7.79 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.7200000000000002 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.41 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 3.46 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 5.5099999999999998 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.6000000000000001 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.412 HE21 ' C ' ' A' ' 158' ' ' GLN . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 2.1800000000000002 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 3.4300000000000002 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 2.8700000000000001 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.8700000000000001 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 3.4900000000000002 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6000000000000001 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 5.2300000000000004 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.29 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 7.0700000000000003 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 3.0499999999999998 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 6.79 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 3.9199999999999999 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.1899999999999999 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 2.1299999999999999 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.8999999999999999 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4000000000000004 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 4.2999999999999998 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.445 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.8799999999999999 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 4.3499999999999996 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.9900000000000002 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 2.7000000000000002 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.445 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 2.0299999999999998 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 2.4500000000000002 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 3.6400000000000001 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.9300000000000002 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 3.1600000000000001 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.4700000000000002 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 2.77 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.8999999999999999 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 3.0800000000000001 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 3.2200000000000002 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 3.8399999999999999 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.6699999999999999 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.7800000000000002 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 4.1299999999999999 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 2.0899999999999999 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.83999999999999997 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 3.3399999999999999 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 4.4400000000000004 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 2.6299999999999999 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 3.98 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.6400000000000001 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.6699999999999999 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.9700000000000002 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.488 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 7.2800000000000002 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.4500000000000002 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 4.54 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 7.2000000000000002 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.9500000000000002 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 3.4900000000000002 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 3.6600000000000001 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.9399999999999999 111.414 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 4.6600000000000001 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 5.29 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 2.3599999999999999 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 7.8700000000000001 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.0599999999999996 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 3.75 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.6699999999999999 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.79 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.8100000000000001 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 3.3300000000000001 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 3.9500000000000002 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.95999999999999996 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 4.0899999999999999 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.52 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.5499999999999998 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 7.1100000000000003 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.2800000000000002 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.3499999999999996 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 4.5599999999999996 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.7999999999999998 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 3.46 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 3.5899999999999999 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 3.1499999999999999 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 7.1299999999999999 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 3.46 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 5.5700000000000003 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 9.5199999999999996 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 5.9400000000000004 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 16.420000000000002 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.9199999999999999 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.3899999999999997 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.9199999999999999 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.9100000000000001 112.966 174.396 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 4.8600000000000003 106.663 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 4.0199999999999996 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.9199999999999999 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.8200000000000003 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 4.4500000000000002 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 3.6800000000000002 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 4.0199999999999996 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 4.1100000000000003 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.9199999999999999 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 2.8599999999999999 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.54 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.3999999999999999 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.3200000000000003 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.9199999999999999 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.3300000000000001 112.387 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 4.5899999999999999 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 4.0 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.7799999999999998 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 6.2999999999999998 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 3.7799999999999998 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.8599999999999999 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 4.0099999999999998 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.9900000000000002 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.409 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.9299999999999997 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 6.6900000000000004 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 3.04 113.984 -165.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.8799999999999999 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.9199999999999999 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 2.4199999999999999 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 2.2599999999999998 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 2.79 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 3.3500000000000001 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 4.1299999999999999 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 2.4500000000000002 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.7200000000000002 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.7400000000000002 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 5.3399999999999999 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.8799999999999999 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.54 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 4.3200000000000003 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 10.949999999999999 110.813 -179.154 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.354 -1.056 . . . . 2.7999999999999998 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 3.8799999999999999 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 3.3199999999999998 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 3.48 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.7400000000000002 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 2.54 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 2.1000000000000001 113.025 168.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 4.3600000000000003 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 6.79 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 3.4700000000000002 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 3.1200000000000001 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.0199999999999996 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 8.2599999999999998 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.0099999999999998 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 4.6600000000000001 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 4.4800000000000004 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.6399999999999999 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.1899999999999999 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.8300000000000001 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 4.2800000000000002 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 3.4399999999999999 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 2.9500000000000002 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.8899999999999997 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 3.1000000000000001 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.8300000000000001 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 6.2999999999999998 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 4.2199999999999998 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 6.4400000000000004 111.344 161.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.7799999999999998 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 5.8700000000000001 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.2699999999999996 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 3.8999999999999999 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.549 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.9099999999999999 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.2200000000000002 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.4300000000000002 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 3.4500000000000002 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.1499999999999999 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 6.1600000000000001 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.96 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 2.6000000000000001 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 2.3100000000000001 113.278 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 2.6699999999999999 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 3.7400000000000002 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.3799999999999999 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 3.7200000000000002 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.3500000000000001 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.9700000000000002 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 192' ' ' THR . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 3.5499999999999998 112.728 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 4.04 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 190' ' ' ILE . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 3.9900000000000002 112.173 -161.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 4.6500000000000004 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.6899999999999999 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.3200000000000003 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 3.2000000000000002 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 2.04 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.1299999999999999 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 4.1600000000000001 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 4.0499999999999998 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 3.4900000000000002 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 2.0899999999999999 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 2.5699999999999998 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.1099999999999999 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.9199999999999999 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 8.3699999999999992 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9000000000000004 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 4.6200000000000001 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.8200000000000003 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.3200000000000003 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 3.5299999999999998 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 3.1400000000000001 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 2.6699999999999999 111.994 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 3.6699999999999999 111.416 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 3.98 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 2.5800000000000001 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 4.1299999999999999 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 3.4300000000000002 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 2.27 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 2.0800000000000001 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 3.6099999999999999 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 3.6000000000000001 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 3.0499999999999998 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 4.4100000000000001 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 4.1100000000000003 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.2200000000000002 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.9500000000000002 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 7.1900000000000004 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.9100000000000001 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.7400000000000002 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 3.6699999999999999 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.6200000000000001 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 3.3500000000000001 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 3.8900000000000001 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 3.7200000000000002 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 7.2300000000000004 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.75 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 4.4100000000000001 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.8899999999999997 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 3.3399999999999999 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 6.2999999999999998 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 4.0 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.8399999999999999 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 3.0299999999999998 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.9199999999999999 112.538 168.32 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 118.461 -0.781 . . . . 4.4900000000000002 109.923 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 3.7200000000000002 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.6800000000000002 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.549 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.7 p80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 2.2000000000000002 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 5.2999999999999998 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.96 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 3.9700000000000002 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 4.79 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 5.4199999999999999 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 3.3100000000000001 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 3.8700000000000001 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 2.29 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.8599999999999999 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.3399999999999999 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.1699999999999999 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.9100000000000001 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 6.3399999999999999 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 4.0800000000000001 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.71 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 4.21 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.5099999999999998 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.5099999999999998 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 10.58 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 5.4800000000000004 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 7.5800000000000001 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 2.4300000000000002 112.464 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.6299999999999999 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.0199999999999996 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 2.3700000000000001 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 2.23 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 2.1200000000000001 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 2.4900000000000002 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 3.1699999999999999 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 2.5299999999999998 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 4.75 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 4.5700000000000003 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 5.75 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 5.5300000000000002 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.3300000000000001 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 5.3099999999999996 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 9.3900000000000006 113.38 166.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 CA-C-O 121.976 0.74 . . . . 3.6099999999999999 111.673 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 4.0700000000000003 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 3.0600000000000001 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 3.7000000000000002 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 4.8099999999999996 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.3199999999999998 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.6200000000000001 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.79 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.3900000000000001 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.9100000000000001 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 9.4299999999999997 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.8999999999999999 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.581 ' HG1' ' HB2' ' A' ' 154' ' ' ASP . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 2.4399999999999999 105.957 166.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 7.1699999999999999 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.581 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.5299999999999998 112.203 163.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.458 ' HH ' HG23 ' A' ' 225' ' ' VAL . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.7400000000000002 114.959 -161.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 4.0999999999999996 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.49 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.3500000000000001 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 2.1400000000000001 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 3.2400000000000002 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 4.54 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 3.2799999999999998 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 4.0800000000000001 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 4.0099999999999998 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.3700000000000001 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 6.9800000000000004 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.1500000000000004 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 7.3099999999999996 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.2200000000000002 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 7.4299999999999997 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.5199999999999996 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 5.1500000000000004 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.6600000000000001 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.78 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.6400000000000001 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.5499999999999998 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 3.2999999999999998 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.9100000000000001 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.8799999999999999 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.6500000000000004 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 2.9900000000000002 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 3.6899999999999999 114.978 173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 3.6699999999999999 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 3.7599999999999998 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.4400000000000004 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 2.79 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.2999999999999998 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.8799999999999999 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 192' ' ' THR . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 4.1799999999999997 110.258 171.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.9900000000000002 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 190' ' ' ILE . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 3.1899999999999999 111.001 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 4.6100000000000003 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.7999999999999998 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.6100000000000003 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 5.2400000000000002 113.783 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 2.7999999999999998 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.3100000000000001 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 3.52 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 4.79 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 4.0499999999999998 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 3.3100000000000001 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 4.1699999999999999 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.6299999999999999 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.5699999999999998 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.8700000000000001 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 8.2300000000000004 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.7699999999999996 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 3.4700000000000002 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 4.1900000000000004 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.6099999999999999 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 2.6000000000000001 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 3.4700000000000002 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 2.4900000000000002 113.425 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 4.4400000000000004 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 4.8300000000000001 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 2.1099999999999999 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 6.7999999999999998 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.8999999999999999 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 4.9800000000000004 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.7400000000000002 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 3.0299999999999998 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 3.96 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 3.29 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.461 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 2.3100000000000001 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 3.1800000000000002 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 3.4900000000000002 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.8300000000000001 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 4.4299999999999997 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 10.44 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 5.1900000000000004 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.4400000000000004 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 3.25 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.2199999999999998 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 4.6200000000000001 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 4.25 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 3.1600000000000001 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 6.7999999999999998 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.8199999999999998 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 5.6799999999999997 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 6.54 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 4.3300000000000001 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 6.8300000000000001 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 5.71 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 3.1699999999999999 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.6899999999999999 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.3599999999999999 111.692 172.463 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.74 0.781 . . . . 5.46 111.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 4.46 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.7199999999999998 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.48 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 5.7400000000000002 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.423 HD13 HE21 ' A' ' 279' ' ' GLN 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 4.3399999999999999 119.655 155.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.8300000000000001 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 3.7599999999999998 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 5.2800000000000002 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 3.1699999999999999 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 3.46 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.53 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.5300000000000002 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 3.0699999999999998 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9000000000000004 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 4.9800000000000004 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 3.8300000000000001 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.6099999999999999 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 4.9900000000000002 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.465 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 3.4300000000000002 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.5499999999999998 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.423 HE21 HD13 ' A' ' 262' ' ' ILE . 4.5 mm-40 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.46 112.055 -171.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.6799999999999997 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.9000000000000004 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 8.2200000000000006 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 3.1099999999999999 113.451 -164.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.98 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4000000000000004 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 2.21 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.8899999999999999 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 2.4900000000000002 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 2.5899999999999999 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 3.1800000000000002 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 2.1899999999999999 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 2.5499999999999998 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 2.4300000000000002 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 5.4400000000000004 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 5.1299999999999999 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 2.0499999999999998 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 4.9500000000000002 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 7.5099999999999998 113.875 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.459 -0.502 0 N-CA-C 109.322 -1.069 . . . . 4.2999999999999998 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 3.8999999999999999 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.4700000000000002 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 3.8399999999999999 111.405 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 3.0800000000000001 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 3.2999999999999998 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.8799999999999999 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 4.1100000000000003 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.6899999999999999 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.7300000000000004 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 6.2800000000000002 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 3.8999999999999999 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.6600000000000001 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7000000000000002 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.7699999999999996 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.2799999999999998 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 4.5 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 5.1299999999999999 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.7999999999999998 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.2000000000000002 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.3300000000000001 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 4.1600000000000001 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 4.4500000000000002 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 2.7200000000000002 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 4.4500000000000002 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 3.21 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.8500000000000001 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 6.0099999999999998 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 4.3300000000000001 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 5.6699999999999999 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.6200000000000001 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 5.8600000000000003 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 4.6399999999999997 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.555 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.0899999999999999 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.7000000000000002 116.458 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.1299999999999999 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.3300000000000001 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 3.5600000000000001 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.3399999999999999 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 6.5099999999999998 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.98 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 4.0899999999999999 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 3.1000000000000001 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 4.1900000000000004 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 3.48 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.9699999999999998 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.4300000000000002 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 3.2200000000000002 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 5.0199999999999996 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 5.5199999999999996 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.9000000000000004 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 5.9299999999999997 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 5.4000000000000004 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.3999999999999999 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.3600000000000003 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 4.2699999999999996 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 3.4500000000000002 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.76 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 3.23 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 3.8900000000000001 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 2.5299999999999998 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 2.2999999999999998 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 2.25 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.9199999999999999 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.8499999999999996 110.286 -162.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.5800000000000001 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.409 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 7.8700000000000001 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.2800000000000002 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.8300000000000001 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 5.9100000000000001 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 2.3100000000000001 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 3.9700000000000002 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.75 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.448 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 3.77 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 4.5599999999999996 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 3.3500000000000001 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 4.3700000000000001 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 4.0 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 6.0599999999999996 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.3799999999999999 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.5099999999999998 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 3.3799999999999999 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 3.79 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 2.4300000000000002 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.0900000000000001 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 3.2999999999999998 111.299 -176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 3.21 109.072 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.6200000000000001 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 5.1699999999999999 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 10.0 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.1399999999999997 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.6400000000000001 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 2.8500000000000001 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.6299999999999999 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 3.3799999999999999 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 3.7000000000000002 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 6.1900000000000004 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 3.0499999999999998 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 5.04 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.8200000000000003 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 244' ' ' TYR . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 3.5800000000000001 112.104 -173.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.438 ' H ' HG21 ' A' ' 243' ' ' VAL . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 9.0500000000000007 111.141 166.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 5.3499999999999996 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.1399999999999997 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.7599999999999998 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.3599999999999999 113.883 178.308 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.837 0.827 . . . . 6.75 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 4.0300000000000002 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.3899999999999997 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.555 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 6.21 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 5.5599999999999996 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 5.3899999999999997 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 4.3499999999999996 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 4.75 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 3.8999999999999999 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 4.2199999999999998 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.5499999999999998 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.3100000000000001 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.412 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.9299999999999997 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.5600000000000001 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 6.9400000000000004 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 4.9800000000000004 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.4500000000000002 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 4.3799999999999999 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 3.8799999999999999 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.8900000000000001 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 4.3700000000000001 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 6.1200000000000001 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.8200000000000003 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 6.5899999999999999 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.8199999999999998 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 2.29 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.6500000000000004 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 3.1800000000000002 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 2.4500000000000002 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 2.4399999999999999 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 3.25 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 3.3999999999999999 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 2.4700000000000002 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 3.5 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.8700000000000001 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 5.3899999999999997 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 6.7300000000000004 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.77 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 5.2000000000000002 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 8.2899999999999991 110.51 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.46 -0.46 0 CA-C-O 121.241 0.434 . . . . 2.9300000000000002 111.994 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 3.6499999999999999 111.434 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 3.25 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 3.1200000000000001 110.154 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 2.6400000000000001 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 2.9900000000000002 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 2.3300000000000001 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.6600000000000001 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.5899999999999999 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.5999999999999996 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 6.8099999999999996 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 4.0300000000000002 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 3.1200000000000001 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.0800000000000001 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 8.2799999999999994 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 3.6600000000000001 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 4.3099999999999996 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.76 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.1400000000000001 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.8600000000000001 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 4.0499999999999998 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 3.77 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 2.5299999999999998 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' A' ' 173' ' ' CYS . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 5.8799999999999999 111.823 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 4.5700000000000003 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 2.0099999999999998 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 5.4000000000000004 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.8199999999999998 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 7.3799999999999999 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 4.0599999999999996 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 8.1500000000000004 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.3799999999999999 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 4.0599999999999996 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.0300000000000002 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.8100000000000001 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.4399999999999999 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.29 113.356 174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 3.5899999999999999 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.4900000000000002 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 4.0700000000000003 113.012 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 5.0099999999999998 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 2.5699999999999998 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.9900000000000002 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 2.3599999999999999 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 3.46 112.9 -170.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.5299999999999998 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 3.7000000000000002 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.5 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6000000000000001 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 3.1200000000000001 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 3.3300000000000001 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 4.6100000000000003 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 4.7999999999999998 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 4.8399999999999999 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 3.04 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.8799999999999999 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 4.1299999999999999 110.045 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 2.1299999999999999 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.6299999999999999 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 3.46 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 3.6499999999999999 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 3.0299999999999998 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 2.0499999999999998 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 2.4700000000000002 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.2199999999999998 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.3700000000000001 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.0300000000000002 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.9900000000000002 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.2699999999999996 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 5.6399999999999997 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.9900000000000002 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.6200000000000001 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 2.8999999999999999 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 3.3599999999999999 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 2.46 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 4.54 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 4.3799999999999999 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 2.02 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.542 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 4.2000000000000002 115.04 174.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.542 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 3.0099999999999998 113.658 168.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 3.2999999999999998 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 2.0499999999999998 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 2.0699999999999998 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.5 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 3.6200000000000001 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 3.1400000000000001 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 2.6899999999999999 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 3.7799999999999998 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 3.6499999999999999 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.8200000000000001 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 3.8700000000000001 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 7.7599999999999998 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.3799999999999999 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 2.6699999999999999 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 3.3599999999999999 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 3.73 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.96 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 5.3499999999999996 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.8399999999999999 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 5.3899999999999997 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 7.4000000000000004 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 3.8599999999999999 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 6.6900000000000004 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 4.2599999999999998 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.7000000000000002 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.4199999999999999 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.6099999999999999 114.486 -175.058 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 109.739 -0.467 . . . . 5.1600000000000001 109.739 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 3.75 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.2300000000000004 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 3.1099999999999999 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.8599999999999999 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 5.1799999999999997 109.808 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 3.8199999999999998 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.8300000000000001 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 4.0300000000000002 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 3.23 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 3.5899999999999999 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.6100000000000001 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.5499999999999998 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 4.8700000000000001 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.8099999999999996 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 5.0800000000000001 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 3.25 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.5899999999999999 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.79 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 3.5800000000000001 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.29 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 5.0800000000000001 118.667 -162.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 6.4900000000000002 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 6.3300000000000001 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.9900000000000002 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 2.7599999999999998 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.6299999999999999 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.8599999999999999 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 2.0699999999999998 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 2.2200000000000002 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 2.1200000000000001 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 2.8399999999999999 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 3.1099999999999999 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 2.3700000000000001 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 2.4300000000000002 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 3.2000000000000002 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 6.3300000000000001 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 6.25 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.96 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 4.0599999999999996 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.7300000000000004 113.474 156.602 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 N-CA-C 112.504 0.155 . . . . 2.9399999999999999 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 3.6699999999999999 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 4.1699999999999999 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 2.3100000000000001 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.6099999999999999 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 2.3199999999999998 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 3.6499999999999999 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.1099999999999999 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.7400000000000002 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 6.04 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.96 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 2.6000000000000001 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.0599999999999996 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.8699999999999992 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.6099999999999999 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 3.8999999999999999 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 5.0999999999999996 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.9099999999999999 113.688 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.3199999999999998 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.95 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 3.6200000000000001 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 3.5499999999999998 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 2.7599999999999998 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HH ' ' CB ' ' A' ' 173' ' ' CYS . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 6.6299999999999999 112.266 -167.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 3.1699999999999999 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 2.3399999999999999 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 6.4900000000000002 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 5.2999999999999998 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 6.2800000000000002 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 3.3599999999999999 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 5.5899999999999999 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 3.2599999999999998 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.479 ' CB ' ' HH ' ' A' ' 163' ' ' TYR . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.8300000000000001 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.51 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.7599999999999998 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 3.6299999999999999 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.3199999999999998 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.98 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 3.6000000000000001 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 3.04 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 2.4399999999999999 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 2.5499999999999998 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 3.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.4399999999999999 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.5299999999999998 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 3.3799999999999999 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.1299999999999999 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.5 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.96 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 5.2400000000000002 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 3.52 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 3.2599999999999998 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.3799999999999999 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 3.3100000000000001 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 2.29 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 1.05 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 3.46 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 3.6299999999999999 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 2.8999999999999999 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1000000000000001 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 2.77 113.693 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.6600000000000001 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 5.3799999999999999 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 9.25 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.9299999999999997 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 4.4900000000000002 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.8099999999999996 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.4399999999999999 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 2.8399999999999999 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 3.1699999999999999 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 2.0800000000000001 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 5.0199999999999996 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 4.0300000000000002 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 3.4199999999999999 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.6399999999999997 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.3399999999999999 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 4.6900000000000004 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.48 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 2.3700000000000001 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 3.7799999999999998 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 3.46 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 2.8500000000000001 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 3.1000000000000001 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 3.3300000000000001 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.1200000000000001 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 9.6899999999999995 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.5700000000000003 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 3.0699999999999998 112.633 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.9300000000000002 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.77 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 3.4900000000000002 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 3.52 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 6.2800000000000002 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 2.6899999999999999 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 4.4100000000000001 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 8.4700000000000006 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 4.2300000000000004 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 6.25 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 5.4100000000000001 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.48 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.7999999999999998 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 3.0299999999999998 114.071 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.007 0.373 . . . . 5.2800000000000002 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 3.9500000000000002 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.1699999999999999 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.6699999999999999 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 4.54 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 4.7599999999999998 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.9700000000000002 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 5.1200000000000001 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 4.1299999999999999 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 3.0299999999999998 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 3.2000000000000002 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 2.1600000000000001 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.0700000000000003 119.017 163.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.1799999999999997 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.3899999999999997 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 5.0800000000000001 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 3.6200000000000001 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.7200000000000002 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.3300000000000001 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 3.5 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.4100000000000001 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.1500000000000004 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.5800000000000001 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 6.1200000000000001 114.451 -166.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 6.5800000000000001 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 3.0 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.7200000000000002 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.4100000000000001 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 2.77 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 2.7200000000000002 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 2.5099999999999998 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 3.29 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 3.9199999999999999 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 2.5499999999999998 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 2.6800000000000002 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.5699999999999998 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 6.4500000000000002 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 6.1299999999999999 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.9700000000000002 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 4.6600000000000001 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 9.0500000000000007 110.057 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.533 0.432 0 N-CA-C 112.961 0.331 . . . . 3.6099999999999999 112.961 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 3.8500000000000001 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.8100000000000001 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 3.1299999999999999 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.9900000000000002 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 2.1400000000000001 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 2.1600000000000001 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 3.48 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.8399999999999999 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.1100000000000003 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 8.7599999999999998 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 4.0099999999999998 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.96 107.12 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.7799999999999998 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 8.2300000000000004 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.8399999999999999 111.9 173.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 4.3700000000000001 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 4.4800000000000004 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.6699999999999999 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 159' ' ' TRP . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.3399999999999999 109.845 175.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.433 ' H ' ' HG2' ' A' ' 158' ' ' GLN . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.8999999999999999 110.293 165.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 3.7599999999999998 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 3.46 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 3.9300000000000002 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 4.5099999999999998 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 4.2400000000000002 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 2.2999999999999998 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 8.8300000000000001 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 4.0800000000000001 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 6.2000000000000002 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.411 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.6000000000000001 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 172' ' ' VAL . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 8.8300000000000001 114.28 -142.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.1299999999999999 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 170' ' ' PRO . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 4.3399999999999999 110.241 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 3.5499999999999998 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.5700000000000001 111.795 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2000000000000002 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.557 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.1500000000000004 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 3.7799999999999998 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9000000000000004 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 4.2199999999999998 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 4.25 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 3.29 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.413 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 4.0700000000000003 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 2.52 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 3.9100000000000001 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.5599999999999996 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.5099999999999998 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 3.5600000000000001 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.2799999999999998 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 3.4900000000000002 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 3.6600000000000001 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.9100000000000001 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 4.1799999999999997 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 4.0899999999999999 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 3.4399999999999999 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.4500000000000002 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 4.0300000000000002 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 2.2200000000000002 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.3100000000000001 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 3.77 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 4.0899999999999999 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 2.2799999999999998 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.75 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 3.0 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.6600000000000001 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 9.0399999999999991 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9000000000000004 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 4.0 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 211' ' ' GLU . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 4.2000000000000002 113.687 -171.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' A' ' 210' ' ' LYS . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.7400000000000002 112.503 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 2.8500000000000001 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 3.3700000000000001 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 2.0699999999999998 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 5.5499999999999998 113.349 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 4.7699999999999996 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 2.29 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 4.0800000000000001 114.69 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 3.7200000000000002 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 3.0499999999999998 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 2.02 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 3.8199999999999998 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 3.1000000000000001 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 3.7599999999999998 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81000000000000005 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 3.3999999999999999 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 4.6900000000000004 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.9100000000000001 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 3.6499999999999999 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 7.3499999999999996 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.3799999999999999 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 3.3599999999999999 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.2799999999999998 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.6699999999999999 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 3.7400000000000002 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.8700000000000001 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 6.46 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.6499999999999999 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 4.1600000000000001 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 7.3899999999999997 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 4.2599999999999998 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 6.0599999999999996 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 4.8200000000000003 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 4.0899999999999999 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 3.2400000000000002 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 109.533 -0.543 . . . . 4.8499999999999996 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 4.2000000000000002 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.6200000000000001 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 5.5700000000000003 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 6.4199999999999999 113.144 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 3.02 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 4.5 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 4.4500000000000002 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 3.9300000000000002 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 3.6600000000000001 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.8200000000000001 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.8300000000000001 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.1200000000000001 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.9300000000000002 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.6299999999999999 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 4.7800000000000002 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 3.79 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.7999999999999998 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 4.3899999999999997 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.43 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 3.8399999999999999 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 4.9000000000000004 110.466 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 9.2599999999999998 113.002 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.43 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.7199999999999998 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 6.9000000000000004 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 3.2599999999999998 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.8400000000000001 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.3399999999999999 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 2.5099999999999998 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 2.7000000000000002 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 2.5899999999999999 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 2.9300000000000002 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 3.3500000000000001 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 2.6499999999999999 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 3.0299999999999998 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 3.5299999999999998 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 4.5700000000000003 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 7.1299999999999999 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.8700000000000001 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 4.1699999999999999 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 9.4800000000000004 113.835 -155.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.754 0 CA-C-O 121.368 0.486 . . . . 4.1100000000000003 112.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 4.4100000000000001 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 3.3500000000000001 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 3.73 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 2.3900000000000001 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 2.2799999999999998 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.9399999999999999 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 3.1499999999999999 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.9299999999999999 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.1200000000000001 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.9800000000000004 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 4.4800000000000004 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 3.23 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.8399999999999999 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 7.1799999999999997 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.3099999999999996 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 4.0800000000000001 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 4.7699999999999996 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.3199999999999998 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.5499999999999998 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.9399999999999999 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 2.9100000000000001 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 4.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 2.96 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.7599999999999998 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 4.0599999999999996 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.9399999999999999 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 5.6699999999999999 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.5199999999999996 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 6.46 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 3.5899999999999999 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.9299999999999997 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 4.4900000000000002 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.469 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 2.0099999999999998 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4000000000000004 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 3.0600000000000001 111.577 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 3.6600000000000001 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.8600000000000003 112.366 172.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.9199999999999999 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 2.4500000000000002 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 2.6899999999999999 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 2.54 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 4.0 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.1100000000000003 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1000000000000001 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 3.1899999999999999 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.1200000000000001 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 4.1500000000000004 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 4.3899999999999997 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 4.0800000000000001 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 5.4699999999999998 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 4.2999999999999998 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.8599999999999999 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.6099999999999999 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 5.21 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 2.1800000000000002 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.95999999999999996 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 3.5499999999999998 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.436 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 4.0300000000000002 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 2.7799999999999998 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.27 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 3.21 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.1900000000000004 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.5299999999999998 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.1200000000000001 113.112 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 8.8499999999999996 112.377 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 3.8300000000000001 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.402 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 4.5800000000000001 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.0899999999999999 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 2.2799999999999998 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 2.7200000000000002 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.8600000000000001 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 4.7400000000000002 112.377 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 4.5 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 2.0499999999999998 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 4.4199999999999999 114.843 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 4.0 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 2.27 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.5899999999999999 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 5.1799999999999997 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 3.5800000000000001 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 2.6400000000000001 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 2.8900000000000001 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 3.0600000000000001 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 3.5299999999999998 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 12.359999999999999 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 5.2400000000000002 110.667 -179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.46 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 4.0700000000000003 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.2599999999999998 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.413 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.9900000000000002 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 3.8700000000000001 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.7800000000000002 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.413 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.5500000000000007 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.4500000000000002 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.7699999999999996 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 6.0 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 4.6799999999999997 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 7.7199999999999998 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.96 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 5.1200000000000001 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.4199999999999999 113.512 -177.83 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 6.75 107.495 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 4.5099999999999998 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.0199999999999996 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.469 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.0899999999999999 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 6.6100000000000003 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 6.4500000000000002 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 4.1500000000000004 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 3.4700000000000002 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 4.1399999999999997 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.8599999999999999 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 3.27 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.48 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.7300000000000004 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.4900000000000002 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.0700000000000003 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 5.25 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 3.3500000000000001 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.7599999999999998 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 7.0199999999999996 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 3.77 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.6200000000000001 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 5.5199999999999996 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 7.9199999999999999 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.8200000000000003 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 6.71 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 2.9199999999999999 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.75 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.8300000000000001 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 2.0699999999999998 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 2.1499999999999999 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 2.2400000000000002 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 2.8399999999999999 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 3.7799999999999998 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 2.3500000000000001 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 2.6000000000000001 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.8900000000000001 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 5.7999999999999998 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 5.4299999999999997 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.5600000000000001 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 4.5 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.8499999999999996 113.13 -166.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 121.277 0.449 . . . . 2.8999999999999999 111.829 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 4.0099999999999998 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 3.3100000000000001 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 3.98 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 2.3599999999999999 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 2.1699999999999999 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 2.1299999999999999 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.9500000000000002 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.8999999999999999 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 9.8000000000000007 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 4.04 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 2.3399999999999999 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7000000000000002 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 7.3899999999999997 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.9700000000000002 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 3.25 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.8399999999999999 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.5600000000000001 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.1400000000000001 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.73 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 4.1399999999999997 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 4.96 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 2.6200000000000001 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 4.1600000000000001 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 4.04 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.5600000000000001 112.344 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 6.8600000000000003 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.6500000000000004 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 6.9100000000000001 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.422 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.9199999999999999 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 10.67 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.422 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.3499999999999996 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 4.0300000000000002 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 2.3799999999999999 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.6799999999999999 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.3700000000000001 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.8199999999999998 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 3.8900000000000001 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.1400000000000001 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.8499999999999996 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 4.0199999999999996 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 2.25 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 2.4500000000000002 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 2.6600000000000001 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 3.0099999999999998 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.9900000000000002 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.1400000000000001 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 2.8599999999999999 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.9500000000000002 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 3.27 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 192' ' ' THR . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 3.2799999999999998 112.788 169.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 4.25 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 190' ' ' ILE . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 4.5700000000000003 112.527 -173.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 4.8700000000000001 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6000000000000001 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.8399999999999999 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 3.5600000000000001 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 2.2999999999999998 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 1.05 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 3.6800000000000002 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 4.3399999999999999 108.508 -163.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 2.4700000000000002 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.7000000000000002 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 2.96 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.3599999999999999 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.5099999999999998 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 7.9800000000000004 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.8899999999999997 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 4.25 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 4.21 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.6400000000000001 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 2.6099999999999999 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 3.21 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 2.6400000000000001 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 5.5300000000000002 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 4.29 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 3.2200000000000002 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 5.8600000000000003 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.0700000000000003 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 3.9900000000000002 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 3.2200000000000002 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.8200000000000001 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 3.73 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 3.23 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 2.1600000000000001 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.1599999999999999 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 3.79 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 3.0499999999999998 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.8600000000000001 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 4.6699999999999999 107.392 169.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.9800000000000004 114.597 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.8399999999999999 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.4199999999999999 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 3.25 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.8500000000000001 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.6000000000000001 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 4.4500000000000002 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 3.2999999999999998 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 5.2599999999999998 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 3.0899999999999999 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.5700000000000003 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.9100000000000001 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 3.1699999999999999 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.7400000000000002 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 4.1799999999999997 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.6899999999999999 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.5899999999999999 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.4300000000000002 111.1 -179.509 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.825 -0.435 . . . . 4.79 109.825 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 4.0700000000000003 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.458 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 2.0499999999999998 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 4.1100000000000003 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 5.9299999999999997 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 3.54 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 4.04 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 4.1299999999999999 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 3.3300000000000001 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 4.5899999999999999 109.04 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 4.7400000000000002 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.9100000000000001 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.8100000000000001 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.0600000000000005 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 6.5099999999999998 111.836 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 5.54 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 4.3700000000000001 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 4.54 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.8799999999999999 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 4.3099999999999996 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 7.3899999999999997 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 5.0 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 6.1900000000000004 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.5699999999999998 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 2.2000000000000002 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.5599999999999996 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 2.5 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 2.21 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 2.3300000000000001 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.71 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 4.7300000000000004 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.2999999999999998 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 3.3700000000000001 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 3.0099999999999998 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 4.5099999999999998 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 7.1799999999999997 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.3199999999999998 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 4.4500000000000002 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.9900000000000002 110.791 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.458 -0.582 0 CA-C-O 121.172 0.405 . . . . 4.0999999999999996 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 3.8599999999999999 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.0800000000000001 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 3.4399999999999999 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.8999999999999999 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 2.25 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 2.3900000000000001 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.9700000000000002 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.1400000000000001 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.5099999999999998 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 7.5700000000000003 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 3.7200000000000002 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.96 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 153' ' ' LYS . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.1299999999999999 113.215 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 152' ' ' ASP . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 6.8499999999999996 114.012 171.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.2999999999999998 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 4.1500000000000004 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 3.75 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.6499999999999999 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.5499999999999998 111.535 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 2.1499999999999999 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 3.7599999999999998 112.567 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 3.75 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 3.2400000000000002 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.9500000000000002 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.98 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 5.8799999999999999 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.422 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 4.1100000000000003 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 6.2699999999999996 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 3.4100000000000001 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.9900000000000002 114.109 -137.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.3499999999999996 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 4.1299999999999999 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.0600000000000001 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.6899999999999999 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.8999999999999999 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.0299999999999998 113.222 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 3.9399999999999999 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.1200000000000001 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 4.1699999999999999 111.611 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 4.0499999999999998 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 2.6699999999999999 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.5800000000000001 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 2.5499999999999998 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 3.04 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.5999999999999996 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.3100000000000001 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 3.5299999999999998 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.5899999999999999 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 3.98 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 3.1200000000000001 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 4.8300000000000001 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 3.6400000000000001 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 4.3600000000000003 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.9500000000000002 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.4900000000000002 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 3.23 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.96 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 1.03 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 3.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 3.71 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 2.6299999999999999 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 2.7000000000000002 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 3.0899999999999999 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.3499999999999996 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.6899999999999999 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.422 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 10.380000000000001 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.4900000000000002 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 4.2199999999999998 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 5.4199999999999999 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 2.5499999999999998 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.79 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.76 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 4.0700000000000003 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 4.6699999999999999 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 2.6499999999999999 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 4.2400000000000002 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.3100000000000001 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 4.1200000000000001 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 2.29 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 2.0699999999999998 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 4.8300000000000001 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 3.0699999999999998 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 2.73 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.89000000000000001 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.9700000000000002 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 3.2400000000000002 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.0499999999999998 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 3.71 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 9.1500000000000004 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.4399999999999999 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.1900000000000004 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.8599999999999999 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.8399999999999999 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 4.3099999999999996 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 3.9500000000000002 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 3.3399999999999999 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.5800000000000001 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.3900000000000001 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.9100000000000001 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 9.2899999999999991 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 3.6000000000000001 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 7.0199999999999996 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 4.3300000000000001 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 4.0800000000000001 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.3500000000000001 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.3799999999999999 114.156 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 122.039 0.923 . . . . 4.9299999999999997 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.8799999999999999 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.4699999999999998 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.4700000000000002 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.9800000000000004 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 5.6699999999999999 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 3.75 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.7999999999999998 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 4.0700000000000003 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 2.9199999999999999 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 3.9700000000000002 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.6399999999999999 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.0600000000000001 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2000000000000002 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.4300000000000002 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 5.2400000000000002 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 4.3499999999999996 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 3.8900000000000001 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 3.04 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 4.25 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 4.0199999999999996 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.424 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.2200000000000002 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.8499999999999996 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 6.0499999999999998 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.7199999999999998 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 6.2699999999999996 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 3.2599999999999998 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.6499999999999999 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 2.5099999999999998 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 2.1899999999999999 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.98 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 3.27 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 3.4300000000000002 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 2.25 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 2.5699999999999998 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.5899999999999999 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 5.9100000000000001 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 7.2599999999999998 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.2599999999999998 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 4.6699999999999999 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 9.6600000000000001 111.173 175.349 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 CA-C-O 120.817 0.257 . . . . 3.3999999999999999 111.761 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 3.8700000000000001 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 4.0300000000000002 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 3.3900000000000001 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 2.3700000000000001 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 2.3599999999999999 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.79 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 3.6000000000000001 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.0299999999999998 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.8600000000000003 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 7.2400000000000002 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.9900000000000002 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 3.0600000000000001 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.3999999999999999 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.8399999999999999 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.0899999999999999 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.411 ' HH ' HG13 ' A' ' 225' ' ' VAL . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 3.5600000000000001 113.788 -177.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 6.0999999999999996 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.8899999999999999 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.5800000000000001 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.5900000000000001 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 3.6200000000000001 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.98 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 3.3999999999999999 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 4.0700000000000003 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 3.29 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 5.5899999999999999 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.0599999999999996 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 9.6699999999999999 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.8900000000000001 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 5.8600000000000003 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.3399999999999999 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 4.2599999999999998 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.427 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.9399999999999999 115.104 164.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.7599999999999998 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.5499999999999998 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.4399999999999999 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 3.7999999999999998 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.3100000000000001 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 6.3399999999999999 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 6.2800000000000002 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 5.04 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.4700000000000002 111.678 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 2.4900000000000002 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 3.4199999999999999 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.7599999999999998 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.2400000000000002 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 3.1800000000000002 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.6299999999999999 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 3.52 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 4.7400000000000002 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 4.0899999999999999 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.7999999999999998 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 5.04 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.2800000000000002 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 3.3799999999999999 108.877 135.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 2.8999999999999999 109.428 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 3.1499999999999999 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 3.6800000000000002 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 2.4100000000000001 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.9399999999999999 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 2.2599999999999998 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.1699999999999999 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.3500000000000001 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.3899999999999997 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 8.2699999999999996 110.951 -175.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.8399999999999999 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 4.21 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 4.0300000000000002 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.7400000000000002 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 3.1400000000000001 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 3.0600000000000001 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 2.1800000000000002 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 4.1699999999999999 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 4.1799999999999997 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 2.5600000000000001 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 4.0599999999999996 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.9500000000000002 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 4.3200000000000003 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 2.4300000000000002 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.3100000000000001 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 4.2400000000000002 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 3.5099999999999998 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.411 HG13 ' HH ' ' A' ' 155' ' ' TYR . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 2.3900000000000001 109.232 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.1299999999999999 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 3.0699999999999998 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 3.2400000000000002 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 3.8500000000000001 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 7.1699999999999999 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.5899999999999999 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.4700000000000002 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 3.0800000000000001 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 3.2000000000000002 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 4.6200000000000001 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 3.3399999999999999 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 4.5599999999999996 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 3.0299999999999998 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.8799999999999999 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 7.0 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 3.6499999999999999 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 6.1600000000000001 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.4100000000000001 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 3.1400000000000001 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.71 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.5699999999999998 113.763 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 112.917 0.71 . . . . 5.6799999999999997 112.917 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 4.3099999999999996 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.6299999999999999 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.427 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 20.0 p80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.3799999999999999 114.058 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.7000000000000002 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.8600000000000003 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 3.2400000000000002 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 5.1600000000000001 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 3.8500000000000001 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.8799999999999999 110.972 177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 3.0699999999999998 107.884 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.6599999999999999 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.4900000000000002 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.9500000000000002 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7000000000000002 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.1999999999999993 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 4.9100000000000001 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 4.1100000000000003 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.7400000000000002 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 5.1500000000000004 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 3.9500000000000002 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 3.7799999999999998 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 6.1799999999999997 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 7.7400000000000002 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 8.8499999999999996 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 6.0800000000000001 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.6499999999999999 113.161 -171.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 2.27 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.6699999999999999 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 2.5099999999999998 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 2.27 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 2.7200000000000002 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 3.27 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 3.9399999999999999 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 3.3599999999999999 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 3.0499999999999998 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 2.5499999999999998 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 6.6900000000000004 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 7.2400000000000002 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.6499999999999999 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 4.7300000000000004 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 9.0500000000000007 112.464 -165.392 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.412 -0.649 . . . . 3.9500000000000002 110.412 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 3.8300000000000001 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.5299999999999998 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 3.46 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 2.7200000000000002 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 2.21 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.9399999999999999 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 3.8900000000000001 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.3300000000000001 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 7.3200000000000003 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 3.5699999999999998 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.3700000000000001 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 8.0099999999999998 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.0800000000000001 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 4.4699999999999998 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 4.3099999999999996 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.76 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.0700000000000003 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 2.1699999999999999 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 3.5299999999999998 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 4.5499999999999998 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 2.4700000000000002 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 5.0199999999999996 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 3.7999999999999998 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.3300000000000001 115.567 -173.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.468 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 5.8899999999999997 110.164 162.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.3500000000000001 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 8.7100000000000009 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.75 111.846 -167.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.9900000000000002 114.275 -154.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.5699999999999998 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 4.5499999999999998 113.034 -174.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.533 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.27 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.98 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.4300000000000002 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.3300000000000001 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 3.8500000000000001 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.0899999999999999 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 7.6299999999999999 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 4.0300000000000002 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 2.21 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.6800000000000002 111.434 174.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 2.4399999999999999 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 3.48 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.3200000000000003 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.0499999999999998 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 3.5600000000000001 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.447 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.6699999999999999 110.887 172.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 3.21 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 192' ' ' THR . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 3.6000000000000001 111.501 171.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 3.6000000000000001 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 190' ' ' ILE . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 3.3700000000000001 110.398 176.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 3.6200000000000001 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.6200000000000001 113.308 -167.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.2999999999999998 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 4.0499999999999998 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 2.0699999999999998 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.91000000000000003 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 3.6000000000000001 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 3.7599999999999998 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 2.3500000000000001 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 2.2799999999999998 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 3.2799999999999998 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.4400000000000004 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.7200000000000002 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.0300000000000002 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 7.8200000000000003 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.3200000000000003 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 3.48 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 4.4000000000000004 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.7599999999999998 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 2.6899999999999999 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 2.54 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 2.1299999999999999 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 5.3300000000000001 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.9299999999999997 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.99 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 4.0599999999999996 115.658 -179.875 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.9399999999999999 110.064 170.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 4.0199999999999996 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 2.1600000000000001 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.25 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.447 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 4.0199999999999996 112.889 173.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 3.1800000000000002 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 3.0 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92000000000000004 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 2.8700000000000001 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 3.2400000000000002 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.4300000000000002 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 5.1500000000000004 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 6.1799999999999997 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.71 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.8200000000000003 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 3.6200000000000001 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.0600000000000001 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.0600000000000001 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 4.6799999999999997 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.6499999999999999 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 5.3700000000000001 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 3.4399999999999999 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 4.9400000000000004 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 6.2699999999999996 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.98 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 6.6399999999999997 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 4.5599999999999996 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.9300000000000002 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.5299999999999998 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.7000000000000002 115.279 -175.825 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.238 -0.652 . . . . 4.8600000000000003 109.238 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 5.4699999999999998 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.6800000000000002 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.533 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.5 p80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.5699999999999998 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 5.2699999999999996 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 4.0 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 4.8200000000000003 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 4.04 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 4.2199999999999998 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 3.3599999999999999 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 3.3199999999999998 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.6899999999999999 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.0999999999999996 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.4700000000000002 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 5.6900000000000004 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 3.8799999999999999 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.5099999999999998 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 4.7599999999999998 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 4.6500000000000004 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.9900000000000002 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.7199999999999998 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 10.5 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 6.2599999999999998 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 6.54 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 3.1099999999999999 112.733 -173.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.54 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.3099999999999996 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 3.4100000000000001 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.8500000000000001 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 3.73 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 4.46 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 4.3099999999999996 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.4300000000000002 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 3.8599999999999999 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 3.0800000000000001 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 5.2699999999999996 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 7.6299999999999999 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.1200000000000001 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 4.6600000000000001 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 8.3599999999999994 113.41 -166.924 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.458 -0.564 0 CA-C-O 119.887 -0.13 . . . . 4.0 111.935 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 4.1299999999999999 108.205 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 3.7200000000000002 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 3.8100000000000001 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.5899999999999999 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 2.5099999999999998 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 2.27 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 4.04 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.8300000000000001 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 6.7000000000000002 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.441 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 9.0899999999999999 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 6.0899999999999999 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.6799999999999997 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 9.0500000000000007 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.441 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 3.96 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 5.8300000000000001 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 3.0600000000000001 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.8999999999999999 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 3.1400000000000001 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 4.4900000000000002 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 4.3600000000000003 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 3.3500000000000001 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 6.5499999999999998 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 3.0800000000000001 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.3500000000000001 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 7.0599999999999996 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.6800000000000002 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 6.2199999999999998 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 3.5899999999999999 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 6.6399999999999997 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.568 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 4.3399999999999999 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 2.0899999999999999 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.3700000000000001 112.396 -168.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.6600000000000001 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 3.5600000000000001 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.6699999999999999 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 5.2999999999999998 110.656 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 4.9400000000000004 113.453 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 3.2599999999999998 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 2.6899999999999999 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 2.3199999999999998 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 3.6099999999999999 110.746 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.4400000000000004 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.3599999999999999 112.035 168.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 3.5 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.3900000000000001 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.6800000000000002 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.0700000000000003 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 5.7400000000000002 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 5.8899999999999997 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 5.6200000000000001 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.7000000000000002 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.3300000000000001 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 4.75 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 2.9199999999999999 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.9199999999999999 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 4.2800000000000002 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 4.5099999999999998 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 3.3199999999999998 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 2.23 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 2.6400000000000001 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.5300000000000002 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.73 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.9699999999999998 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 8.1899999999999995 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.1399999999999997 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 4.9199999999999999 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 8.75 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 3.1200000000000001 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 4.3600000000000003 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 2.3999999999999999 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 4.7599999999999998 111.705 170.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 5.5999999999999996 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 2.73 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 4.0499999999999998 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.2199999999999998 111.334 173.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 3.6499999999999999 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 3.5299999999999998 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.96 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 4.7400000000000002 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 3.6400000000000001 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 3.0800000000000001 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 3.7799999999999998 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 3.4399999999999999 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.4199999999999999 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.6600000000000001 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.9700000000000006 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.8300000000000001 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.0700000000000003 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.7599999999999998 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 239' ' ' ARG . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7000000000000002 111.86 167.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.9900000000000002 111.412 172.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 4.2800000000000002 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 3.2599999999999998 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 235' ' ' ASP . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.7999999999999998 113.22 170.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 3.1499999999999999 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 4.0899999999999999 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.8899999999999997 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 4.21 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 7.3200000000000003 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 5.1200000000000001 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 4.04 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 4.1299999999999999 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.516 -0.754 . . . . 6.3099999999999996 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 4.9299999999999997 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.7999999999999998 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.628 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 29.2 p80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.3799999999999999 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 4.2800000000000002 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 4.54 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 3.29 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 4.4199999999999999 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 4.9800000000000004 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 4.6500000000000004 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 4.5700000000000003 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.9399999999999999 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.6099999999999999 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.7699999999999996 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.3500000000000001 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.4100000000000001 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 5.0499999999999998 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 5.1799999999999997 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 4.5099999999999998 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.9000000000000004 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 4.0300000000000002 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.3999999999999999 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 5.0199999999999996 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 5.8499999999999996 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 6.3700000000000001 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 6.9299999999999997 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.519 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 2.54 113.636 -168.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.8999999999999999 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.6400000000000001 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 2.46 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 2.1099999999999999 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 2.25 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 3.0600000000000001 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 3.4100000000000001 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 2.9100000000000001 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 2.8399999999999999 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 3.2599999999999998 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.7800000000000002 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 6.8399999999999999 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.3700000000000001 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 5.1600000000000001 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.9199999999999999 110.666 172.466 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 110.827 -0.489 . . . . 4.29 110.827 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 5.0199999999999996 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.0199999999999996 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 3.3999999999999999 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 3.4900000000000002 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 2.48 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 2.5299999999999998 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 3.1899999999999999 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.8899999999999997 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.8399999999999999 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 4.5800000000000001 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 4.1299999999999999 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.8100000000000001 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.8599999999999994 114.548 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.7799999999999998 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' A' ' 227' ' ' LEU . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 4.7300000000000004 112.553 154.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 4.6100000000000003 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 2.25 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 3.5 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 3.5600000000000001 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 4.6600000000000001 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 2.8100000000000001 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.6100000000000003 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 3.9900000000000002 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.1699999999999999 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 6.4199999999999999 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 3.4199999999999999 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 6.25 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 4.4400000000000004 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 7.0300000000000002 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.4199999999999999 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 3.4399999999999999 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.414 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.3100000000000001 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 3.1800000000000002 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 179' ' ' LYS . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.4399999999999999 111.724 173.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.4700000000000002 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 4.4299999999999997 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.2699999999999996 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 175' ' ' GLU . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 4.5499999999999998 112.248 175.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.6699999999999999 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 3.1200000000000001 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 3.73 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 3.0099999999999998 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 3.6600000000000001 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.9399999999999999 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 2.9300000000000002 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.3399999999999999 110.288 167.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 3.73 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 3.7799999999999998 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 3.5 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 3.6400000000000001 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 4.0599999999999996 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.8700000000000001 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.8100000000000001 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 3.4399999999999999 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 2.1600000000000001 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.90000000000000002 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 3.79 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 4.3600000000000003 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 3.27 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.8599999999999999 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.5600000000000001 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.423 ' CG ' ' HE ' ' A' ' 207' ' ' ARG . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.79 110.105 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.8500000000000001 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.1500000000000004 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.423 ' HE ' ' CG ' ' A' ' 204' ' ' ASP . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 9.6600000000000001 115.411 -178.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 4.3399999999999999 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 5.4500000000000002 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.2699999999999996 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 2.6099999999999999 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 2.77 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 2.5800000000000001 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 3.8199999999999998 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 4.21 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 2.3599999999999999 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.509 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 4.1299999999999999 114.851 -177.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.509 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.8700000000000001 112.012 167.142 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 4.2599999999999998 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.5099999999999998 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 3.2200000000000002 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 3.77 112.621 168.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 3.0800000000000001 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 2.3399999999999999 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1000000000000001 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.461 HD11 ' HH ' ' A' ' 155' ' ' TYR . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 3.04 111.43 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 3.5299999999999998 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.8700000000000001 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.9600000000000009 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.6600000000000001 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.4500000000000002 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 3.0099999999999998 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.3300000000000001 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 3.3999999999999999 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 3.6000000000000001 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.7000000000000002 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.5899999999999999 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.8599999999999999 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 4.79 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 6.75 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 3.5499999999999998 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 7.0599999999999996 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 4.2999999999999998 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 4.4100000000000001 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.98 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.8900000000000001 110.942 164.555 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 110.306 -0.257 . . . . 5.3499999999999996 110.306 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 4.0099999999999998 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.0800000000000001 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.48 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.8900000000000001 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 4.6299999999999999 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 2.79 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 5.5199999999999996 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 4.3399999999999999 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 3.0600000000000001 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.8500000000000001 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.4699999999999998 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.5300000000000002 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 3.48 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 273' ' ' PHE . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.3399999999999999 114.155 -174.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.409 ' H ' ' HG3' ' A' ' 272' ' ' GLU . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 5.5999999999999996 113.253 -177.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 4.2599999999999998 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.8100000000000001 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 4.0199999999999996 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 4.6200000000000001 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 3.04 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 5.0 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 6.1799999999999997 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 5.04 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 9.2100000000000009 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 3.27 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.54 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 2.8799999999999999 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 2.1699999999999999 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 2.9300000000000002 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 3.9500000000000002 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 3.5699999999999998 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 2.46 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 3.54 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 4.1900000000000004 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.9100000000000001 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 6.0499999999999998 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.3199999999999998 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 6.0700000000000003 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 9.7400000000000002 111.386 179.406 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 111.023 -0.414 . . . . 3.8799999999999999 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 4.6699999999999999 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 3.3700000000000001 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 3.8700000000000001 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 3.5699999999999998 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 2.3999999999999999 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 2.1400000000000001 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 3.9399999999999999 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.4500000000000002 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.390000000000001 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 5.3300000000000001 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 4.4800000000000004 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 3.4399999999999999 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.8899999999999997 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 10.779999999999999 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.1299999999999999 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.558 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 4.9400000000000004 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 5.0499999999999998 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 2.3199999999999998 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 3.71 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.54 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 3.2000000000000002 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 3.9100000000000001 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 3.1000000000000001 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.2300000000000004 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 3.2400000000000002 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 5.5899999999999999 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.4699999999999998 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 7.3799999999999999 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 3.3199999999999998 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 6.0899999999999999 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.2300000000000004 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 6.4400000000000004 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.2400000000000002 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.7000000000000002 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 282' ' ' ARG . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.6699999999999999 111.449 177.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 4.6799999999999997 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.4800000000000004 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.7999999999999998 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 5.6699999999999999 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 2.1400000000000001 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.409 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.3599999999999999 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 4.2999999999999998 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 3.23 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.2999999999999998 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.1400000000000001 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 3.4500000000000002 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.5099999999999998 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.8300000000000001 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 3.3799999999999999 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.8999999999999999 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 4.71 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 3.4399999999999999 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 3.1699999999999999 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.3200000000000003 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 3.5099999999999998 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 2.54 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.3200000000000001 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 3.1699999999999999 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 3.8999999999999999 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 2.6699999999999999 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 2.5800000000000001 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.1699999999999999 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.8200000000000003 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.3799999999999999 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7000000000000002 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 7.0700000000000003 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.4100000000000001 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.8999999999999999 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 4.2599999999999998 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.9700000000000002 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 2.54 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 3.5099999999999998 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 2.4900000000000002 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 5.3099999999999996 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 5.3499999999999996 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 2.0899999999999999 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.9500000000000002 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 4.25 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 3.9199999999999999 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.54 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.8400000000000001 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 4.1100000000000003 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 3.1800000000000002 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 2.21 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76000000000000001 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 3.2799999999999998 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.6699999999999999 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.7400000000000002 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.3700000000000001 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 8.6199999999999992 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.6600000000000001 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.0199999999999996 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 3.6099999999999999 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.6400000000000001 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.9199999999999999 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 4.1100000000000003 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.8900000000000001 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.8300000000000001 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 3.3700000000000001 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 10.08 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 3.2200000000000002 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 6.3499999999999996 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 5.46 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.6699999999999999 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 5.2599999999999998 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.3499999999999996 111.194 176.565 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.894 0.854 . . . . 8.3100000000000005 112.303 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 6.2000000000000002 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.3600000000000003 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 6.6200000000000001 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.9699999999999998 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 5.71 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 4.1500000000000004 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 4.6299999999999999 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 5.1699999999999999 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 3.3399999999999999 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 3.4500000000000002 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 2.02 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.4900000000000002 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.0099999999999998 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 3.0899999999999999 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.0800000000000001 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 6.25 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 4.04 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 4.2300000000000004 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.8399999999999999 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 5.4100000000000001 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.3999999999999999 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.7000000000000002 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 7.25 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 7.1100000000000003 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 175' ' ' GLU . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 8.5299999999999994 110.524 156.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.409 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 3.4700000000000002 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.6899999999999999 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.8099999999999996 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 4.5099999999999998 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 2.8199999999999998 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 3.2400000000000002 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.96 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 4.3600000000000003 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 2.48 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 3.3700000000000001 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.9300000000000002 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.7999999999999998 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 6.4500000000000002 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.8799999999999999 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 4.7599999999999998 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 . . . . . 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 10.970000000000001 112.237 -166.382 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 110.032 -0.795 . . . . 3.2599999999999998 110.032 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 4.5199999999999996 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 3.25 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 3.3999999999999999 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 2.2999999999999998 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 2.3700000000000001 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 2.3500000000000001 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 3.1600000000000001 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.8499999999999996 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 5.5300000000000002 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 4.0599999999999996 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 3.5499999999999998 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.9900000000000002 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 6.3499999999999996 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 3.6800000000000002 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 4.0999999999999996 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 2.2200000000000002 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 3.5499999999999998 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.8400000000000001 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 3.8900000000000001 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 4.3099999999999996 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 3.9300000000000002 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.8899999999999997 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 3.1400000000000001 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.0800000000000001 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.456 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 5.6100000000000003 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.54 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 6.1900000000000004 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 3.4700000000000002 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 7.1200000000000001 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.2999999999999998 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.9900000000000002 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.8700000000000001 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.2400000000000002 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.476 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.9900000000000002 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 3.7200000000000002 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.9100000000000001 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 4.0199999999999996 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 5.1399999999999997 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 2.3199999999999998 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.414 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.3500000000000001 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 2.5 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 3.5600000000000001 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.1500000000000004 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.6400000000000001 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 3.3100000000000001 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.73 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 3.2000000000000002 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 3.6800000000000002 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.48 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 3.6299999999999999 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.3199999999999998 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 4.7999999999999998 110.801 153.131 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 2.46 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.04 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 3.6200000000000001 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 3.6600000000000001 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 2.3100000000000001 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.98 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.4900000000000002 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2000000000000002 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.8399999999999999 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.6900000000000004 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 8.4199999999999999 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 4.4000000000000004 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 5.3799999999999999 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 4.2599999999999998 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 3.27 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.9100000000000001 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 2.27 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 4.25 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 4.7400000000000002 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 2.1299999999999999 112.592 176.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 4.5 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.6499999999999999 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 4.0 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.9399999999999999 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.5899999999999999 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 3.3999999999999999 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 3.1600000000000001 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 3.8399999999999999 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.92000000000000004 112.603 -173.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 2.8599999999999999 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.75 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.4300000000000002 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 5.2999999999999998 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 6.0700000000000003 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.9300000000000002 113.384 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.6800000000000002 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 3.3500000000000001 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.3900000000000001 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 4.0899999999999999 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.9300000000000002 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 4.2300000000000004 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 3.0800000000000001 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.7200000000000002 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 8.5199999999999996 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 5.3499999999999996 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 6.2400000000000002 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 3.7400000000000002 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 3.4900000000000002 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.8599999999999999 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.71 111.767 173.04 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.557 0.947 . . . . 5.7999999999999998 113.557 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.7000000000000002 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.8399999999999999 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.476 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 2.0299999999999998 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 4.6600000000000001 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.8399999999999999 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 6.1799999999999997 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 3.5499999999999998 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 6.0199999999999996 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 4.2400000000000002 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 3.5299999999999998 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.8899999999999999 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.9199999999999999 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.4299999999999997 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.6200000000000001 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.6799999999999997 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 4.9100000000000001 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 4.3499999999999996 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.3900000000000001 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 4.3700000000000001 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 3.9900000000000002 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.4500000000000002 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 5.2699999999999996 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 5.9299999999999997 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 5.2300000000000004 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 8.0500000000000007 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.414 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 2.7999999999999998 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.8500000000000001 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.9300000000000002 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 2.3999999999999999 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 2.2200000000000002 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 2.7799999999999998 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 3.3999999999999999 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 3.4500000000000002 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 2.3799999999999999 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 2.5099999999999998 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 3.2000000000000002 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 5.7999999999999998 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.5800000000000001 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.0699999999999998 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 5.7599999999999998 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 9.1799999999999997 111.904 178.695 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.452 -0.939 0 N-CA-C 109.722 -0.915 . . . . 3.5800000000000001 109.722 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 3.6200000000000001 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 3.73 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 2.9199999999999999 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 2.4700000000000002 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 2.3700000000000001 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.3300000000000001 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 3.1000000000000001 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.2999999999999998 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.41 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.5800000000000001 109.793 -168.308 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 5.7000000000000002 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.96 113.22 -176.703 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.8599999999999999 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.9900000000000002 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 6.4500000000000002 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.5699999999999998 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 3.5899999999999999 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 3.7599999999999998 111.925 -178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.9199999999999999 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 2.2599999999999998 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 3.1600000000000001 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 4.4800000000000004 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 2.3900000000000001 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 4.2599999999999998 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 3.98 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 5.1600000000000001 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 4.1299999999999999 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 5.9400000000000004 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.73 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 6.1299999999999999 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.3200000000000003 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 3.6499999999999999 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.541 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6000000000000001 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.9299999999999999 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.0099999999999998 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 3.6200000000000001 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.478 ' N ' ' HZ1' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 5.4400000000000004 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 4.3099999999999996 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 2.9199999999999999 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.1800000000000002 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 2.8799999999999999 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 3.75 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 3.0600000000000001 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.4399999999999999 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.5800000000000001 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 192' ' ' THR . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.8999999999999999 111.455 169.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 4.2000000000000002 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 190' ' ' ILE . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 3.3199999999999998 109.823 177.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 3.4399999999999999 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.3599999999999999 110.811 170.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.2300000000000004 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 3.4700000000000002 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 2.0499999999999998 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.98999999999999999 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 3.6099999999999999 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 4.1500000000000004 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 2.54 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.71 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.6699999999999999 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.7400000000000002 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.1900000000000004 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.9500000000000002 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 16.510000000000002 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.9400000000000004 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.9199999999999999 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 7.0700000000000003 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.5499999999999998 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 3.1699999999999999 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 4.54 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 2.7799999999999998 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 5.6100000000000003 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.9000000000000004 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 2.2999999999999998 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 4.5499999999999998 114.913 -175.137 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.98 113.25 175.082 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 4.1900000000000004 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 3.6000000000000001 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.73 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 3.7000000000000002 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 3.71 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 3.98 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.94999999999999996 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 3.4700000000000002 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 3.1299999999999999 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.3300000000000001 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.9900000000000002 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 7.8600000000000003 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.0899999999999999 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.6800000000000002 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 2.5800000000000001 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.9300000000000002 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.6600000000000001 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 3.4700000000000002 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 3.4100000000000001 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 4.1600000000000001 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.3700000000000001 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 4.0800000000000001 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 6.54 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 4.2800000000000002 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 9.6500000000000004 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 4.5700000000000003 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.8100000000000001 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 3.3199999999999998 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.0800000000000001 112.888 173.018 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.559 0.207 . . . . 5.0099999999999998 111.559 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 4.3099999999999996 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.541 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 25.7 p80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.8500000000000001 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.4299999999999997 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 4.9000000000000004 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 3.3300000000000001 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 3.4100000000000001 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 4.8399999999999999 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 3.2000000000000002 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 2.6200000000000001 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.55 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.1200000000000001 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.9199999999999999 110.364 -153.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.4199999999999999 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.8200000000000003 113.324 -177.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 6.6200000000000001 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 5.0899999999999999 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 4.2400000000000002 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 3.9100000000000001 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.6099999999999999 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.447 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.1500000000000004 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.447 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 8.9499999999999993 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.46 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 6.0599999999999996 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 3.73 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.96 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 2.71 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.77 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 2.1200000000000001 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 2.8399999999999999 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 3.04 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.99 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 2.7599999999999998 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.7999999999999998 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 6.2300000000000004 114.247 172.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 5.29 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.0600000000000001 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 4.0700000000000003 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 9.1500000000000004 112.81 -172.143 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 121.506 0.544 . . . . 3.5 112.628 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 4.0 112.698 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.2200000000000002 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 4.54 111.662 -172.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 2.71 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 2.1499999999999999 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.3399999999999999 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 3.0600000000000001 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.3599999999999999 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.6399999999999997 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.9900000000000002 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 4.3399999999999999 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.8399999999999999 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.7599999999999998 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 7.4299999999999997 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.8399999999999999 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 3.48 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 4.2800000000000002 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.3700000000000001 113.666 -172.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.2400000000000002 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 2.1099999999999999 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 5.0099999999999998 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 3.4900000000000002 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 4.6699999999999999 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 4.5899999999999999 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 2.8399999999999999 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.6799999999999999 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 6.8499999999999996 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.75 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 10.31 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 3.3500000000000001 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 6.2199999999999998 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7000000000000002 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 4.1799999999999997 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 2.1400000000000001 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.6200000000000001 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.417 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.3100000000000001 112.541 178.258 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.5700000000000003 113.121 143.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 3.96 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.412 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.7200000000000002 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.417 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 4.5300000000000002 113.934 -176.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 5.5999999999999996 112.142 168.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 2.96 109.893 -174.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.412 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.71 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 3.6699999999999999 113.518 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 3.1000000000000001 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.3600000000000003 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.5499999999999998 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 3.1899999999999999 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.9500000000000002 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 3.0 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 3.1000000000000001 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.8799999999999999 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.4199999999999999 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 4.2800000000000002 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 4.3399999999999999 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.1500000000000004 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 4.0 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 2.5 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.98999999999999999 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 4.4900000000000002 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 3.73 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 3.6200000000000001 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.54 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 3.1600000000000001 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.4 ' CG ' HH11 ' A' ' 207' ' ' ARG . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.5899999999999999 111.067 -172.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.1800000000000002 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.4100000000000001 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.4 HH11 ' CG ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 7.9699999999999998 114.074 -177.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 3.8700000000000001 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 4.9000000000000004 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.8700000000000001 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 2.75 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 2.7599999999999998 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 2.4700000000000002 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.9700000000000002 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 4.2699999999999996 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 2.4500000000000002 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 6.1900000000000004 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.6299999999999999 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 3.8700000000000001 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 2.3900000000000001 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 3.0499999999999998 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 3.23 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.9700000000000002 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 2.7599999999999998 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 3.6899999999999999 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 3.73 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.9500000000000002 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.3399999999999999 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.8200000000000003 110.573 172.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.5300000000000002 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.7400000000000002 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 3.3199999999999998 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.7799999999999998 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 4.2599999999999998 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 4.6799999999999997 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.8799999999999999 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 6.21 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.7999999999999998 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 5.1699999999999999 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 7.2999999999999998 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 4.0999999999999996 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 6.1900000000000004 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 4.3799999999999999 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 3.6800000000000002 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.3900000000000001 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 3.1400000000000001 112.225 171.818 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 117.37 -1.3 . . . . 4.6200000000000001 112.165 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 4.3200000000000003 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 2.1000000000000001 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 4.2800000000000002 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 4.2999999999999998 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 4.6399999999999997 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 4.8899999999999997 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 4.9500000000000002 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 4.1299999999999999 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 3.2599999999999998 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.6200000000000001 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.0699999999999998 112.391 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.4299999999999997 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.0099999999999998 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.0800000000000001 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 5.2699999999999996 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 4.3600000000000003 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 4.8300000000000001 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 3.75 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.8100000000000001 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 6.3099999999999996 116.654 -169.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 7.8300000000000001 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 5.5599999999999996 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 6.71 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 3.3599999999999999 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.79 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.8100000000000001 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 3.0499999999999998 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 2.3500000000000001 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 2.0699999999999998 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 3.0299999999999998 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 4.0199999999999996 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.73 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 2.9500000000000002 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.6200000000000001 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.79 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.96 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.1299999999999999 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 5.29 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 11.02 109.923 -177.849 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 109.602 -0.961 . . . . 3.3799999999999999 109.602 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 3.9700000000000002 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 3.6800000000000002 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 3.54 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 3.2799999999999998 108.346 172.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 2.3100000000000001 108.801 163.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 3.02 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 3.8500000000000001 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.3199999999999998 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.119999999999999 115.158 -162.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 6.2199999999999998 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.489 ' HE3' ' CB ' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 5.04 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.6000000000000001 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.2400000000000002 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 8.1099999999999994 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 4.0499999999999998 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 5.4699999999999998 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.9099999999999999 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.7799999999999998 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.99 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 3.5600000000000001 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 3.7599999999999998 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 4.0199999999999996 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.447 ' HH ' ' HA ' ' A' ' 173' ' ' CYS . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 4.3399999999999999 111.697 -174.048 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 3.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.3100000000000001 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 8.9499999999999993 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 5.2800000000000002 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 7.8899999999999997 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 3.3599999999999999 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 7.5599999999999996 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.425 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.7999999999999998 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 3.4300000000000002 112.43 169.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.447 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.9199999999999999 114.286 -178.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.8100000000000001 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 3.2999999999999998 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.3399999999999999 112.873 174.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 3.98 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 7.4699999999999998 111.794 166.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 4.8700000000000001 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 3.8700000000000001 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 3.1000000000000001 113.213 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 2.4900000000000002 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 3.3500000000000001 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.5099999999999998 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.3300000000000001 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 2.6600000000000001 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.6800000000000002 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.73 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 4.6500000000000004 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.96 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.5099999999999998 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 4.3099999999999996 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.75 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 4.4000000000000004 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 2.3300000000000001 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.3999999999999999 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 3.1000000000000001 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 3.7799999999999998 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 2.9900000000000002 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 3.2000000000000002 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 4.25 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.2400000000000002 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.4500000000000002 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.3799999999999999 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 10.09 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.0700000000000003 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.7199999999999998 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 4.0700000000000003 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.9900000000000002 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 3.2999999999999998 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 3.1499999999999999 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 2.2599999999999998 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 5.1100000000000003 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.9100000000000001 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 3.0699999999999998 113.678 -173.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 3.4300000000000002 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 221' ' ' SER . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.1499999999999999 108.938 172.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 3.9199999999999999 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 219' ' ' GLU . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 2.3799999999999999 111.658 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.3199999999999998 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 4.0300000000000002 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 3.3199999999999998 108.84 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 3.5899999999999999 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.1799999999999999 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 3.2999999999999998 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 3.5699999999999998 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.3900000000000001 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 5.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.9900000000000002 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.3399999999999999 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.8799999999999999 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 3.9199999999999999 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.6399999999999997 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.9700000000000002 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 3.9100000000000001 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 3.73 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.7999999999999998 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 3.3599999999999999 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 4.4800000000000004 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 8.5399999999999991 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 3.4300000000000002 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 6.3099999999999996 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 4.7599999999999998 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 3.3199999999999998 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.8900000000000001 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.7799999999999998 116.031 178.633 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 112.547 0.573 . . . . 6.3499999999999996 112.547 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 3.54 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.6499999999999999 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.9099999999999999 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.75 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 4.0499999999999998 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.8300000000000001 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 4.7800000000000002 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 5.1600000000000001 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.9399999999999999 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 3.6899999999999999 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.8899999999999999 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.1800000000000002 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.6799999999999997 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.1899999999999999 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.0199999999999996 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 4.75 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 3.9500000000000002 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.5299999999999998 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 5.2300000000000004 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 4.2000000000000002 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.0299999999999998 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.8200000000000003 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 6.4900000000000002 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 6.1500000000000004 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 7.0499999999999998 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 2.48 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.8999999999999999 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.7799999999999998 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 2.5099999999999998 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.8899999999999999 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 2.5499999999999998 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 2.6499999999999999 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 3.1400000000000001 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 2.27 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 2.5600000000000001 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 3.2200000000000002 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 5.2599999999999998 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.71 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 4.6699999999999999 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 11.449999999999999 116.249 -163.345 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 CA-C-O 121.214 0.423 . . . . 2.6099999999999999 111.282 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 4.2400000000000002 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 3.5800000000000001 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 4.3499999999999996 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 3.1400000000000001 111.912 -169.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.9399999999999999 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.456 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 3.1600000000000001 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 4.6699999999999999 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 4.0499999999999998 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.9700000000000006 113.825 -171.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 8.2699999999999996 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 4.8099999999999996 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.77 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 8.7599999999999998 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.1699999999999999 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.52 ' HH ' HG12 ' A' ' 225' ' ' VAL . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 3.2999999999999998 114.602 -176.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 4.7999999999999998 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.3100000000000001 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.9900000000000002 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.6699999999999999 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 3.8500000000000001 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 4.04 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 2.5800000000000001 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.6799999999999997 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 2.7999999999999998 112.575 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.0699999999999998 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.444 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 5.2800000000000002 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.3999999999999999 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 5.7800000000000002 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.9300000000000002 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 5.5 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 4.3099999999999996 113.213 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.505 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.3199999999999998 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.6599999999999999 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 3.7999999999999998 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.0899999999999999 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 3.5600000000000001 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.8999999999999999 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 4.8700000000000001 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.6900000000000004 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 2.6000000000000001 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.6000000000000001 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 2.6499999999999999 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 3.7000000000000002 113.081 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.2300000000000004 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 3.3999999999999999 112.191 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.6299999999999999 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 3.02 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.8500000000000001 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.96 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.8300000000000001 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.8700000000000001 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.48 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 3.77 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 2.0899999999999999 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 1.02 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 3.0899999999999999 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 3.6400000000000001 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 2.3700000000000001 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 2.2799999999999998 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 3.0499999999999998 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.3700000000000001 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.7799999999999998 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.9100000000000001 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 7.5 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.2599999999999998 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 3.9199999999999999 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 4.4299999999999997 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 2.1299999999999999 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 2.71 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.9099999999999999 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 4.6799999999999997 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 3.8399999999999999 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 2.46 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.79 114.859 -177.377 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 4.1500000000000004 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 2.2999999999999998 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.78 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 4.1100000000000003 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 3.29 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.52 HG12 ' HH ' ' A' ' 155' ' ' TYR . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 2.1499999999999999 109.888 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.456 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.95999999999999996 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 3.7000000000000002 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.6200000000000001 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.6299999999999999 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.21 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 7.6900000000000004 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.7599999999999998 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 3.3300000000000001 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.6900000000000004 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.8199999999999998 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 4.25 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 3.0299999999999998 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 5.2000000000000002 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.54 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 3.5699999999999998 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 7.2300000000000004 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 4.3399999999999999 109.365 169.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 6.0599999999999996 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 4.5099999999999998 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 3.3500000000000001 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.9700000000000002 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.6400000000000001 110.808 163.84 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.841 0.311 . . . . 4.8700000000000001 111.841 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 3.7799999999999998 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.0899999999999999 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . 0.505 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.29 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 4.1799999999999997 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 4.2400000000000002 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 3.1899999999999999 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 4.3300000000000001 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 7.0599999999999996 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 3.9199999999999999 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 4.1100000000000003 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.8400000000000001 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.4500000000000002 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.3799999999999999 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.23 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.0299999999999994 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 4.3399999999999999 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 3.9700000000000002 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.8399999999999999 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 7.0700000000000003 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 5.46 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 2.2000000000000002 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.408 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 5.3200000000000003 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 9.6799999999999997 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 7.6299999999999999 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 5.5 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.9900000000000002 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.8200000000000001 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.3300000000000001 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 2.48 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 2.1899999999999999 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 2.4500000000000002 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 3.3900000000000001 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 3.5 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 2.6299999999999999 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.8700000000000001 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.79 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 6.2199999999999998 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 5.3899999999999997 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.2200000000000002 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 4.6200000000000001 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.6699999999999999 115.006 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.338 -0.839 . . . . 17.399999999999999 109.984 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -69.18 169.09 12.71 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.959 0.799 . . . . 17.699999999999999 111.363 168.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -167.49 -144.04 0.05 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.096 1.758 . . . . 14.74 109.733 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 58.38 6.99 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.347 1.451 . . . . 13.460000000000001 111.98 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 44.67 0.2 Allowed Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 116.448 2.018 . . . . 15.17 116.448 -163.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.25 164.78 34.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.703 2.268 . . . . 10.470000000000001 111.074 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.5 mt -128.61 143.67 51.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.188 1.395 . . . . 8.1699999999999999 108.502 167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.97 1.89 3.61 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.501 0.926 . . . . 10.32 113.501 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.64 -144.66 17.21 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.854 -1.298 . . . . 4.7699999999999996 109.854 -159.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.16 89.09 1.0 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.225 -1.55 . . . . 4.7000000000000002 109.225 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.65 102.08 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 3.6800000000000002 109.803 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 5.5099999999999998 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 4.0800000000000001 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 3.4500000000000002 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 3.1099999999999999 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 2.3199999999999998 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 2.1800000000000002 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 3.1800000000000002 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.4300000000000002 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.9400000000000004 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 4.0899999999999999 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 4.1399999999999997 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.2599999999999998 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 7.3399999999999999 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.9500000000000002 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 4.1699999999999999 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 5.7699999999999996 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.6699999999999999 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.1400000000000001 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.8799999999999999 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 4.3899999999999997 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 3.2999999999999998 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 2.7799999999999998 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 4.3899999999999997 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 3.1299999999999999 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 5.0700000000000003 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.3899999999999997 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 9.3800000000000008 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.6499999999999999 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 5.0199999999999996 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.6499999999999999 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 3.6800000000000002 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.8500000000000001 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.77 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.3700000000000001 112.01 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.2799999999999998 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 3.71 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.3799999999999999 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 4.3600000000000003 111.202 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 4.4100000000000001 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 2.3399999999999999 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.457 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 2.5299999999999998 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 2.5299999999999998 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 3.3300000000000001 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 3.3700000000000001 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.6400000000000001 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 5.1100000000000003 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 4.2599999999999998 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.6200000000000001 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 4.0599999999999996 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 3.4100000000000001 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.4800000000000004 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 3.3700000000000001 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 2.0899999999999999 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 1.01 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 4.1100000000000003 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 3.5 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 3.0600000000000001 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 3.04 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.9399999999999999 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.2999999999999998 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.4399999999999999 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.8600000000000003 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.437 HH21 ' CG ' ' A' ' 255' ' ' ASP . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 7.0800000000000001 117.962 -162.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 3.27 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 6.0999999999999996 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 2.2999999999999998 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 2.8399999999999999 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.78 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 4.0700000000000003 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 5.2800000000000002 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 2.5 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 4.2999999999999998 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.3199999999999998 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 4.0599999999999996 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 3.27 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 2.0299999999999998 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 3.46 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 3.3999999999999999 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 2.3300000000000001 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.98999999999999999 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 3.79 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 3.1800000000000002 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.9399999999999999 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 4.0199999999999996 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 7.6600000000000001 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.1100000000000003 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.5299999999999998 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 2.8199999999999998 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.8799999999999999 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 5.3099999999999996 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 4.0800000000000001 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.6799999999999997 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.5 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 4.46 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 8.0299999999999994 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 5.0700000000000003 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 10.029999999999999 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 4.4199999999999999 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 4.0300000000000002 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.54 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.84 83.89 0.34 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.2999999999999998 113.493 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 165.77 31.78 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.874 2.382 . . . . 6.2199999999999998 111.309 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.49 -63.54 1.23 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.086 -0.959 . . . . 10.01 113.343 170.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.5 t0 58.75 42.46 20.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.172 1.389 . . . . 7.9500000000000002 111.343 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -150.71 -50.5 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.604 1.162 . . . . 9.1500000000000004 111.336 -162.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -131.96 37.68 3.58 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.626 1.97 . . . . 8.8499999999999996 109.202 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 63.91 -74.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.818 2.847 . . . . 8.7100000000000009 113.309 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.437 ' CG ' HH21 ' A' ' 207' ' ' ARG . 39.7 t0 -66.75 136.73 55.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.999 1.851 . . . . 6.2199999999999998 115.999 -152.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -92.79 89.98 6.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.616 1.198 . . . . 6.8200000000000003 110.586 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm -72.09 68.47 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.356 1.863 . . . . 5.7300000000000004 110.467 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 3.6600000000000001 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2000000000000002 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.9199999999999999 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.7599999999999998 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 4.1399999999999997 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 3.73 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 4.1799999999999997 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 4.2000000000000002 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.9900000000000002 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 3.7000000000000002 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.6299999999999999 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.6399999999999997 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.0700000000000003 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.6900000000000004 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.3899999999999997 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 4.7800000000000002 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 3.4500000000000002 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.5899999999999999 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 5.2199999999999998 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 4.5099999999999998 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.6699999999999999 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 6.7300000000000004 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.8899999999999997 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.483 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 9.1899999999999995 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 6.0499999999999998 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.457 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 2.8399999999999999 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 2.02 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.5099999999999998 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 2.29 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 2.3900000000000001 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 3.2799999999999998 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.9700000000000002 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 3.2000000000000002 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 3.0499999999999998 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 3.71 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 3.7999999999999998 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 5.9699999999999998 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 7.5700000000000003 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.5899999999999999 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 5.5999999999999996 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 93.9 -142.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 11.65 108.161 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 57.33 -60.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 128.767 2.827 . . . . 9.6799999999999997 116.768 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 79.02 -41.59 0.28 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.585 2.754 . . . . 12.74 114.192 163.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--O 1.247 0.969 0 C-N-CA 125.206 1.402 . . . . 9.8599999999999994 111.397 178.035 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 118.159 -0.924 . . . . 15.890000000000001 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.18 153.04 42.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.13 0.877 . . . . 15.109999999999999 110.808 165.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.2 t -178.86 59.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.018 2.127 . . . . 11.289999999999999 110.812 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.19 71.84 1.18 Allowed Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.404 1.002 . . . . 10.710000000000001 113.388 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -149.69 77.54 8.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.72 1.208 . . . . 9.8300000000000001 112.949 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.52 173.0 13.15 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.765 2.31 . . . . 8.4900000000000002 110.508 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -145.93 156.19 43.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.545 2.338 . . . . 9.0800000000000001 106.691 162.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.7 -134.54 0.21 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.502 0.721 . . . . 7.2199999999999998 109.73 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.51 163.62 38.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.088 1.328 . . . . 3.79 111.829 -165.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -112.75 84.64 0.37 Allowed Glycine 0 N--CA 1.467 0.718 0 CA-C-O 117.914 -1.492 . . . . 3.98 111.684 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.48 115.96 3.21 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 CA-C-N 120.815 2.308 . . . . 3.5 111.966 -168.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 3.4399999999999999 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.9700000000000002 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 3.3199999999999998 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 3.75 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 2.6499999999999999 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.8500000000000001 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 4.0899999999999999 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.1400000000000001 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.7800000000000002 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 6.8700000000000001 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.8300000000000001 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.8799999999999999 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.6600000000000001 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.7999999999999998 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 3.3199999999999998 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 4.2800000000000002 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 4.4699999999999998 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.53 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.4900000000000002 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.6200000000000001 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 3.1299999999999999 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 3.54 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 2.9900000000000002 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 4.7999999999999998 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 2.8599999999999999 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.8599999999999999 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 5.7400000000000002 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 5.2199999999999998 110.457 165.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 8.3200000000000003 111.866 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 4.0199999999999996 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 6.9500000000000002 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.1699999999999999 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 4.2800000000000002 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.3599999999999999 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.6600000000000001 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.2200000000000002 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.0099999999999998 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 3.4199999999999999 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.1100000000000003 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.6800000000000002 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 4.3099999999999996 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 2.3500000000000001 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.473 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 2.3300000000000001 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 2.5 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 3.6099999999999999 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.8900000000000001 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 2.77 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.3500000000000001 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 3.1000000000000001 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 192' ' ' THR . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 3.4100000000000001 111.411 174.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 3.46 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 190' ' ' ILE . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 3.7000000000000002 112.572 -173.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 3.6000000000000001 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.3500000000000001 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.5099999999999998 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 3.0499999999999998 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 2.3999999999999999 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.4399999999999999 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 4.3200000000000003 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 3.27 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 3.0099999999999998 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 2.1099999999999999 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.8799999999999999 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.0599999999999996 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.9199999999999999 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.3399999999999999 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 8.6999999999999993 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.5299999999999998 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 4.54 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 2.2400000000000002 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 3.0499999999999998 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 2.0299999999999998 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.9399999999999999 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 3.8900000000000001 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 2.3999999999999999 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.557 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 5.3499999999999996 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.557 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6000000000000001 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 4.0300000000000002 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 2.3999999999999999 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 2.1699999999999999 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 3.5499999999999998 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 3.3599999999999999 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 2.5499999999999998 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 1.04 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 3.8300000000000001 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 3.1099999999999999 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.1499999999999999 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 4.4800000000000004 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 8.1400000000000006 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.6299999999999999 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.8500000000000001 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 2.6299999999999999 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.0899999999999999 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 3.4399999999999999 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.8500000000000001 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 4.3300000000000001 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.7999999999999998 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.8599999999999999 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 8.4499999999999993 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 4.0300000000000002 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.415 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 6.54 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 4.3600000000000003 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 4.0800000000000001 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.6200000000000001 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.33 36.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.7200000000000002 115.645 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.64 118.03 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.982 3.121 . . . . 5.5800000000000001 111.454 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.95 122.61 25.75 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.045 0.938 . . . . 8.1699999999999999 112.07 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.38 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 117.69 -1.148 . . . . 6.2400000000000002 111.812 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -170.28 -14.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.688 1.995 . . . . 9.9100000000000001 114.018 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -75.91 -32.49 59.65 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 121.695 2.043 . . . . 8.0 111.379 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -173.97 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.465 2.306 . . . . 7.75 109.912 157.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.38 161.27 16.4 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.916 1.817 . . . . 5.2800000000000002 115.812 -151.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.24 -26.26 3.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.51 3.124 . . . . 4.75 112.153 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp 54.05 166.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.613 2.765 . . . . 6.0 113.964 -166.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 3.3999999999999999 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.6499999999999999 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.98 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 4.21 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.7200000000000002 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 4.3799999999999999 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.7599999999999998 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 4.7300000000000004 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 3.96 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 3.77 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.54 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.8399999999999999 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.7400000000000002 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.1900000000000004 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 5.0099999999999998 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 3.79 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.6899999999999999 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 4.8099999999999996 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 4.4400000000000004 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 4.0800000000000001 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.0700000000000003 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 5.4000000000000004 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 9.4900000000000002 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 7.0899999999999999 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.473 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 2.46 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.6299999999999999 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 2.0600000000000001 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.9199999999999999 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 2.3199999999999998 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 2.73 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 3.4100000000000001 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 3.3599999999999999 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.8300000000000001 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 3.23 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 5.2699999999999996 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 6.5999999999999996 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 3.0 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 7.1600000000000001 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -65.6 75.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 11.220000000000001 112.285 -174.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . 0.297 55.2 mmtt 55.84 148.24 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.571 2.348 . . . . 7.4500000000000002 115.075 -159.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 109.85 5.7 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 130.394 3.477 . . . . 11.17 111.791 -135.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 C--O 1.247 0.938 0 C-N-CA 131.505 3.922 . . . . 11.01 107.449 -163.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.598 -1.667 . . . . 19.66 107.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.88 164.78 3.52 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.004 1.722 . . . . 18.09 109.746 -164.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -165.25 179.1 6.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.537 1.935 . . . . 14.630000000000001 109.202 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.55 164.14 38.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.8 1.19 . . . . 11.68 112.674 -175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -163.26 142.73 6.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.919 1.288 . . . . 12.94 111.074 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.72 174.07 13.31 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.846 2.364 . . . . 8.4399999999999995 110.133 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pp -151.46 179.37 8.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.575 1.55 . . . . 7.7199999999999998 110.796 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -142.6 162.94 34.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 7.75 111.022 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.36 152.28 20.36 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.821 1.201 . . . . 3.3399999999999999 112.461 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.42 157.53 52.8 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.264 0.935 . . . . 3.1600000000000001 113.642 -168.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -98.44 55.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.74 2.96 . . . . 3.4900000000000002 110.658 168.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 3.9900000000000002 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.79 115.787 -172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.96 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 2.4199999999999999 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 2.0899999999999999 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 2.21 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 3.4500000000000002 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.1899999999999999 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 8.2300000000000004 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 4.1200000000000001 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 154' ' ' ASP . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 3.1400000000000001 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 7.2800000000000002 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.402 ' CG ' ' HG1' ' A' ' 151' ' ' THR . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.1600000000000001 111.332 164.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 4.54 114.311 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 4.6799999999999997 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.9700000000000002 110.331 167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.54 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 3.54 110.73 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 4.3499999999999996 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 2.8300000000000001 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 4.4000000000000004 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 4.1500000000000004 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.8899999999999999 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 6.46 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.9100000000000001 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 7.9100000000000001 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 3.0800000000000001 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 7.1299999999999999 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 4.04 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 2.0699999999999998 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.8100000000000001 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 4.2699999999999996 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.5899999999999999 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 4.29 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 2.7400000000000002 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 4.1299999999999999 110.781 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 2.3700000000000001 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 3.6899999999999999 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4000000000000004 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.6600000000000001 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 2.75 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.6600000000000001 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.8599999999999999 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 192' ' ' THR . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 4.5899999999999999 110.678 165.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 3.5800000000000001 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 190' ' ' ILE . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 4.8300000000000001 112.316 -175.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 6.2000000000000002 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.435 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.6699999999999999 110.912 174.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.9399999999999999 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 3.6400000000000001 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 2.2000000000000002 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 1.1399999999999999 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 3.6400000000000001 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 3.5699999999999998 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 2.71 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 2.4100000000000001 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 3.77 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.5499999999999998 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4000000000000004 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 7.8300000000000001 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.8600000000000003 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 3.8700000000000001 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 4.2999999999999998 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.1400000000000001 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 2.6899999999999999 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 2.8199999999999998 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 2.4500000000000002 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 4.5800000000000001 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 6.3499999999999996 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 2.5499999999999998 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 4.6799999999999997 112.904 -173.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.2999999999999998 112.347 174.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 3.5600000000000001 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 3.5699999999999998 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.9399999999999999 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 3.2999999999999998 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 3.6299999999999999 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 2.3500000000000001 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 1.01 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 3.0699999999999998 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 3.6000000000000001 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.6200000000000001 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 4.3099999999999996 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 6.7699999999999996 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.2999999999999998 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.2999999999999998 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 3.3399999999999999 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.4400000000000004 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.6299999999999999 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 4.3099999999999996 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.9399999999999999 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 5.1100000000000003 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.6699999999999999 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 4.25 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 11.199999999999999 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 4.4900000000000002 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 7.5499999999999998 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 6.4100000000000001 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.9399999999999999 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.5800000000000001 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.0 -172.12 21.77 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.94 -176.45 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.904 3.736 . . . . 5.5300000000000002 110.328 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.62 11.13 1.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.725 1.75 . . . . 6.5300000000000002 115.725 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 3.96 1.17 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 129.693 3.197 . . . . 5.54 114.983 -165.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.66 -57.89 2.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.069 1.748 . . . . 11.210000000000001 112.21 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -165.5 51.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.092 1.357 . . . . 8.9399999999999995 113.043 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 72.39 -4.92 1.91 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.856 2.062 . . . . 7.5199999999999996 116.147 166.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -78.24 132.1 37.39 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.855 1.262 . . . . 5.96 111.977 171.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -76.24 -12.63 60.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.545 1.683 . . . . 6.1200000000000001 115.545 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt 41.3 64.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.284 2.233 . . . . 5.6699999999999999 112.612 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 3.71 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.5099999999999998 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 5.25 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 5.3799999999999999 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 3.3399999999999999 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 3.9700000000000002 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 4.0 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 3.6400000000000001 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 3.29 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.5800000000000001 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.1699999999999999 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.9299999999999997 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.8100000000000001 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.4600000000000009 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 5.2199999999999998 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 5.2300000000000004 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.0699999999999998 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 5.2599999999999998 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 3.8900000000000001 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.0800000000000001 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.8200000000000003 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 7.0499999999999998 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.9199999999999999 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.8300000000000001 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 3.8100000000000001 113.622 -157.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.6399999999999999 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7000000000000002 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 2.6499999999999999 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 2.4300000000000002 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 2.2599999999999998 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 3.1499999999999999 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 3.1499999999999999 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 2.6499999999999999 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 2.46 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 4.7400000000000002 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.7999999999999998 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 5.21 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.5499999999999998 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 4.4900000000000002 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -50.53 137.21 19.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.7699999999999996 112.581 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.523 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 47.9 tttt -72.65 -167.93 0.4 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.702 1.239 . . . . 7.7800000000000002 113.672 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.523 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 0.3 OUTLIER -131.64 -9.55 3.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.542 1.537 . . . . 12.59 114.723 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.485 1.288 1 C-N-CA 131.861 4.064 . . . . 10.4 108.081 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.551 -1.214 . . . . 15.6 108.838 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -57.34 -20.39 28.55 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.001 1.273 . . . . 17.07 113.07 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.7 m -138.94 170.69 15.53 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.798 2.039 . . . . 16.57 108.324 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.69 -153.87 22.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.25 1.405 . . . . 13.5 111.729 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.42 155.56 25.78 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.185 0.994 . . . . 10.039999999999999 112.452 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.59 -175.11 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.587 2.858 . . . . 10.35 112.331 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.16 170.7 17.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.304 . . . . 9.9199999999999999 111.96 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.57 -178.26 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.732 2.013 . . . . 7.8600000000000003 113.933 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.67 152.21 13.11 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.359 -1.097 . . . . 3.7999999999999998 110.359 -154.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.84 120.21 21.89 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.11 1.338 . . . . 3.6800000000000002 112.743 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -88.05 52.05 2.04 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.219 2.613 . . . . 4.04 111.076 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 4.2599999999999998 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 3.6499999999999999 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 3.3399999999999999 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.4700000000000002 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.8900000000000001 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 2.5800000000000001 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 4.5499999999999998 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.0599999999999996 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 7.75 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 4.3600000000000003 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 4.5099999999999998 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.6799999999999997 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 8.2400000000000002 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.0499999999999998 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 3.3700000000000001 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 4.5300000000000002 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 2.04 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 3.1899999999999999 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 2.0899999999999999 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 3.5 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.98 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 3.2400000000000002 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 7.1100000000000003 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 4.46 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.8100000000000001 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 5.8399999999999999 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 5.54 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 3.0800000000000001 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 6.21 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.3399999999999999 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.62 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 4.1399999999999997 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.584 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.8799999999999999 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.8500000000000001 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7000000000000002 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.5299999999999998 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 4.4000000000000004 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.6499999999999999 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 3.9700000000000002 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 4.5499999999999998 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 2.79 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.8999999999999999 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 3.0099999999999998 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 4.3499999999999996 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.4100000000000001 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 2.8300000000000001 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.6400000000000001 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 3.8199999999999998 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.7400000000000002 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 4.0999999999999996 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 4.7699999999999996 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 5.4500000000000002 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.9500000000000002 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 3.3399999999999999 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 2.27 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 4.21 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 3.3900000000000001 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 3.1000000000000001 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 3.8199999999999998 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.6099999999999999 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.8599999999999999 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.5999999999999996 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 7.9000000000000004 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.6799999999999997 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.77 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 4.6699999999999999 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.8599999999999999 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 2.73 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 3.3199999999999998 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 2.73 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 5.8099999999999996 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 3.6200000000000001 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 2.6000000000000001 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.423 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 4.7000000000000002 114.227 -167.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.8099999999999996 112.851 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 3.8300000000000001 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.4700000000000002 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.4500000000000002 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 3.5800000000000001 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 3.3300000000000001 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 3.8700000000000001 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 3.7200000000000002 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 3.3999999999999999 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.2200000000000002 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.54 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 9.9199999999999999 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.1799999999999997 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.3099999999999996 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.8399999999999999 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.6400000000000001 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.6400000000000001 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 5.0 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 3.6600000000000001 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.5800000000000001 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.6099999999999999 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 4.1799999999999997 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 6.5899999999999999 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 4.79 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 7.3700000000000001 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 4.0800000000000001 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 3.3199999999999998 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.8700000000000001 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.21 132.56 11.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.9900000000000002 111.505 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -85.28 53.13 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.015 3.144 . . . . 5.2699999999999996 110.657 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 83.64 149.39 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.6 3.16 . . . . 6.5999999999999996 110.393 -155.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -108.4 -39.64 5.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.319 1.448 . . . . 8.7100000000000009 110.199 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -136.95 -69.75 0.46 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.094 1.358 . . . . 10.800000000000001 110.745 166.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.62 144.88 13.98 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.424 1.107 . . . . 7.5300000000000002 113.303 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 55.75 23.13 6.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 128.542 2.737 . . . . 8.7300000000000004 114.24 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -115.48 172.88 6.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.166 2.587 . . . . 6.4199999999999999 111.872 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.54 127.4 2.37 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.58 1.152 . . . . 6.4199999999999999 111.972 158.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.62 160.54 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 121.546 -0.721 . . . . 4.7000000000000002 109.844 156.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 3.9399999999999999 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.8300000000000001 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.584 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 23.4 p80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.3799999999999999 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.8500000000000001 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 4.0800000000000001 111.447 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 3.3300000000000001 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 4.04 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 3.6699999999999999 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 3.5699999999999998 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 3.4700000000000002 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.95 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.1899999999999999 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.9699999999999998 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.1099999999999994 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 4.0199999999999996 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 3.1499999999999999 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.1899999999999999 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.9900000000000002 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 3.9500000000000002 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 3.54 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 4.2800000000000002 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.9199999999999999 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 9.5399999999999991 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 8.0299999999999994 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 3.0099999999999998 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.25 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.1799999999999997 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 2.0899999999999999 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 2.2799999999999998 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 3.0899999999999999 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 2.4399999999999999 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 3.4399999999999999 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 2.4100000000000001 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 3.0899999999999999 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 3.1499999999999999 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 4.3899999999999997 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 6.5499999999999998 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.8799999999999999 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.1299999999999999 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -70.48 -19.8 62.91 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 10.33 116.081 -172.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -106.74 166.37 10.63 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.448 1.099 . . . . 7.1299999999999999 109.248 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -138.5 163.57 31.64 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.455 1.025 . . . . 12.390000000000001 112.507 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.03 0 C-N-CA 129.606 3.162 . . . . 11.029999999999999 109.598 -179.191 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 106.587 -1.635 . . . . 19.789999999999999 106.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -67.51 -176.29 0.59 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.782 0.719 . . . . 18.859999999999999 109.738 144.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 t -125.75 173.75 8.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.948 1.299 . . . . 16.579999999999998 109.916 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -139.43 -152.15 5.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.239 1.399 . . . . 12.789999999999999 112.886 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.25 163.18 22.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.293 1.437 . . . . 14.279999999999999 112.081 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.22 162.31 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.421 2.747 . . . . 10.109999999999999 112.199 166.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.97 -26.1 7.44 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.913 1.285 . . . . 7.3099999999999996 112.909 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.33 -170.69 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.522 1.154 . . . . 6.9199999999999999 113.24 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.71 123.21 0.94 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.444 -1.862 . . . . 3.7799999999999998 108.444 -147.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.57 107.53 2.38 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 117.825 -1.542 . . . . 4.4699999999999998 109.559 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.38 145.03 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.056 2.504 . . . . 3.2200000000000002 110.811 -163.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 3.6600000000000001 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.5600000000000001 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.98 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 2.5699999999999998 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 2.2599999999999998 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 3.4199999999999999 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.2799999999999998 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.3499999999999996 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 7.5300000000000002 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 5.3700000000000001 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.4500000000000002 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.8300000000000001 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 8.4100000000000001 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 4.5300000000000002 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 4.9100000000000001 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 4.6600000000000001 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.2000000000000002 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.6299999999999999 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.8700000000000001 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 3.2000000000000002 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 4.7400000000000002 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 2.6299999999999999 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 4.3600000000000003 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 2.8999999999999999 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 5.5499999999999998 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.73 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 7.4900000000000002 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.49 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 4.5099999999999998 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 9.5500000000000007 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.49 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.6299999999999999 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 3.6699999999999999 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.0699999999999998 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 2.0699999999999998 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.1099999999999999 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.0899999999999999 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 3.8100000000000001 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.1099999999999999 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 4.2699999999999996 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 4.25 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 2.4900000000000002 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.0700000000000003 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 3.1400000000000001 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 3.6200000000000001 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.7400000000000002 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.5699999999999998 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 3.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.9399999999999999 111.409 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 3.6099999999999999 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 3.23 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.8399999999999999 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.8399999999999999 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 3.75 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.409 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 3.0099999999999998 108.474 158.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.9700000000000002 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 3.6699999999999999 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 2.5600000000000001 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.3400000000000001 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 4.1600000000000001 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 3.6299999999999999 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 2.3599999999999999 109.487 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 3.0099999999999998 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 3.2999999999999998 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7000000000000002 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 3.1299999999999999 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.2300000000000004 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 9.6400000000000006 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.6600000000000001 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.6600000000000001 106.249 146.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 4.4699999999999998 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.0499999999999998 113.993 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 3.3799999999999999 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 2.8300000000000001 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.78 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.416 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 4.8899999999999997 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 5.6500000000000004 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 2.3700000000000001 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 4.4000000000000004 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 5.46 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 4.4500000000000002 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.79 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.8199999999999998 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 3.7599999999999998 112.054 167.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 3.2400000000000002 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 2.73 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.95999999999999996 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 3.4399999999999999 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 3.4100000000000001 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.8999999999999999 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 3.9300000000000002 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 8.6799999999999997 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7000000000000002 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.5700000000000003 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 3.48 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.0700000000000003 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 3.1099999999999999 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 3.71 113.512 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.48 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.9100000000000001 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.8700000000000001 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 4.3899999999999997 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 9.5800000000000001 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 4.2000000000000002 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.7300000000000004 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 5.0999999999999996 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.75 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.52 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.63 -176.37 50.3 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.7400000000000002 112.95 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.15 157.63 60.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.743 1.629 . . . . 5.7999999999999998 108.6 159.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -90.9 156.31 18.09 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.487 0.551 . . . . 6.4500000000000002 112.487 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.42 -168.99 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.405 1.082 . . . . 9.1500000000000004 111.064 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.76 -37.68 59.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.551 -0.718 . . . . 11.57 111.533 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -86.79 24.17 1.54 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.126 1.37 . . . . 9.7200000000000006 111.486 168.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 83.12 -58.95 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.751 2.82 . . . . 7.0499999999999998 114.687 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -25.96 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.925 2.49 . . . . 6.0700000000000003 117.272 -153.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.19 21.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.639 2.376 . . . . 7.5999999999999996 115.836 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -24.47 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 128.45 2.7 . . . . 5.5899999999999999 114.504 -166.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 4.1299999999999999 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.4100000000000001 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 3.27 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 4.2199999999999998 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.478 ' H ' HD11 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 4.0 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 3.7200000000000002 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 4.2300000000000004 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 3.8999999999999999 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 3.0 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 3.8999999999999999 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.9100000000000001 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.1299999999999999 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.7999999999999998 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.5099999999999998 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.0800000000000001 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 4.8300000000000001 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 4.1600000000000001 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.1099999999999999 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.8799999999999999 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 4.3099999999999996 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.25 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 4.5099999999999998 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 6.4299999999999997 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.7599999999999998 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.8899999999999997 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.7999999999999998 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.8100000000000001 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.4900000000000002 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 2.1699999999999999 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 2.4500000000000002 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 2.5099999999999998 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 3.0099999999999998 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 4.0599999999999996 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 3.0899999999999999 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 2.29 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.8500000000000001 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 7.1699999999999999 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 7.1100000000000003 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.3199999999999998 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 4.1399999999999997 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -49.24 127.93 15.75 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 11.19 112.351 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 194' ' ' PRO . 14.9 ttmt -78.41 -61.3 2.05 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.715 1.606 . . . . 9.7599999999999998 111.507 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.9 140.23 21.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.504 0.928 . . . . 12.23 113.504 159.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.569 1.547 . . . . 8.3100000000000005 112.319 -174.322 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 118.316 -0.85 . . . . 18.41 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -65.56 151.5 46.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.399 0.68 . . . . 17.789999999999999 112.086 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 176.86 173.59 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 130.15 3.38 . . . . 16.030000000000001 108.308 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.33 50.05 62.11 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 115.646 1.019 . . . . 15.35 115.646 160.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 0.8 OUTLIER 41.2 67.47 3.0 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.119 1.768 . . . . 16.350000000000001 112.804 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -70.31 177.75 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.62 2.213 . . . . 10.5 112.256 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.64 71.85 3.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.504 1.122 . . . . 10.25 108.647 170.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.3 mt 139.28 142.62 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 1 C-N-CA 133.673 4.789 . . . . 11.109999999999999 107.645 -168.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.29 -51.29 6.19 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.539 -0.726 . . . . 5.3799999999999999 112.838 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -161.2 144.93 10.32 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.265 1.032 . . . . 3.3999999999999999 113.966 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.0 68.4 7.92 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.299 2.666 . . . . 3.1099999999999999 110.859 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 3.4700000000000002 112.926 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.75 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 2.8700000000000001 112.841 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 2.3199999999999998 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.96 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.75 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.9399999999999999 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.79 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.0099999999999998 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 8.8699999999999992 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 4.5700000000000003 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.8900000000000001 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.4500000000000002 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 7.2400000000000002 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.6699999999999999 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 3.3599999999999999 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 4.8300000000000001 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.6200000000000001 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.5 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 4.6100000000000003 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 3.8700000000000001 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 2.5899999999999999 111.147 -172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HH ' ' HA ' ' A' ' 173' ' ' CYS . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.79 111.988 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 4.3799999999999999 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.4100000000000001 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 7.0199999999999996 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.6899999999999999 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 6.2999999999999998 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.9100000000000001 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 6.3799999999999999 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.5099999999999998 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 3.8100000000000001 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.502 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.0099999999999998 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.72 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.6499999999999999 112.106 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.3500000000000001 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 3.4300000000000002 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.2400000000000002 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 4.2800000000000002 111.87 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 4.4000000000000004 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.9399999999999999 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 2.2000000000000002 113.836 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 3.8199999999999998 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 3.5099999999999998 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.0999999999999996 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2000000000000002 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 3.48 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.8100000000000001 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 3.2400000000000002 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 3.21 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 3.9500000000000002 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.485 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 3.4900000000000002 114.378 -165.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 4.21 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.96 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.3700000000000001 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 3.5099999999999998 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.78 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.92000000000000004 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 3.6000000000000001 112.84 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 3.5499999999999998 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 2.4500000000000002 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 3.1899999999999999 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 3.1299999999999999 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.0199999999999996 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.0899999999999999 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.3799999999999999 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.53 ' HB3' HH11 ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 9.7200000000000006 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.8899999999999997 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.9300000000000002 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 4.7999999999999998 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.4199999999999999 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 2.4399999999999999 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 2.77 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 2.1800000000000002 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 5.8200000000000003 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 5.0999999999999996 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 2.3999999999999999 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.7999999999999998 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 3.4399999999999999 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.6099999999999999 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 3.29 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.72 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 4.3399999999999999 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 3.46 109.86 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 2.1800000000000002 111.811 173.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92000000000000004 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 2.8700000000000001 112.808 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 3.0600000000000001 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5299999999999998 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.8499999999999996 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.2599999999999998 113.028 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2000000000000002 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.8900000000000001 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.5499999999999998 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.9900000000000002 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 4.5300000000000002 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 3.0800000000000001 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 4.3099999999999996 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 3.6299999999999999 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.5 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 6.3899999999999997 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 5.2300000000000004 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.5399999999999991 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 4.7599999999999998 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 5.2699999999999996 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.3799999999999999 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.89 177.5 29.11 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.7599999999999998 113.619 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.98 159.7 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.724 2.949 . . . . 4.5499999999999998 112.183 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -110.6 170.88 7.8 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.271 1.028 . . . . 5.8399999999999999 110.79 155.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -112.36 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.326 -0.99 . . . . 7.8799999999999999 108.326 156.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -121.08 -39.9 2.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.554 1.525 . . . . 8.6699999999999999 112.962 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.65 1.14 12.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.79 1.404 . . . . 9.3499999999999996 114.79 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.282 0.0 OUTLIER 142.05 -25.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.468 2.707 . . . . 9.1099999999999994 113.904 132.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -51.98 106.14 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.556 1.317 . . . . 6.54 114.556 -151.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.38 73.92 4.93 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.981 1.372 . . . . 5.54 111.404 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt -70.17 81.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.972 1.309 . . . . 4.4900000000000002 109.285 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 3.79 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.0599999999999996 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.461 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.8500000000000001 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 4.6699999999999999 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 5.7999999999999998 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 4.0 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 4.2199999999999998 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 3.98 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 3.2599999999999998 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 3.5699999999999998 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.45 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7000000000000002 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.8300000000000001 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.2599999999999998 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.5800000000000001 113.233 165.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 6.21 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 3.8199999999999998 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.8099999999999996 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 5.0199999999999996 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.3999999999999999 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.9400000000000004 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 6.7800000000000002 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 5.0700000000000003 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 7.2699999999999996 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 2.7200000000000002 113.504 -165.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.3999999999999999 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9000000000000004 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.96 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 1.76 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 2.27 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 2.9500000000000002 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.7599999999999998 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 2.1499999999999999 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 2.2000000000000002 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.6200000000000001 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 4.5300000000000002 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 5.1399999999999997 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.8700000000000001 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 3.8199999999999998 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -42.85 137.15 2.41 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 11.369999999999999 110.879 155.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -144.1 -83.68 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.653 0.781 . . . . 9.8800000000000008 111.646 -159.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 192' ' ' THR . 90.7 mttt -97.86 84.07 3.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.68 -1.23 . . . . 13.42 107.68 141.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 129.077 2.951 . . . . 10.58 110.127 -167.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 119.422 -0.323 . . . . 21.710000000000001 110.711 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 133' ' ' LYS . 76.9 t80 -78.69 175.81 10.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.643 1.177 . . . . 17.719999999999999 110.848 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.5 m -65.92 74.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.641 1.977 . . . . 13.94 110.328 167.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.58 -154.69 44.21 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.92 0.772 . . . . 10.25 112.97 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 130' ' ' PHE . 25.7 mtmt 82.41 149.45 0.11 Allowed Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 128.975 2.91 . . . . 11.83 111.672 -167.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.77 -38.86 7.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.722 2.281 . . . . 11.26 111.289 166.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.1 mt -100.83 100.64 11.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.703 1.601 . . . . 10.300000000000001 108.881 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.57 -45.56 71.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.802 0.841 . . . . 8.6999999999999993 112.572 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.77 -150.75 7.19 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.168 1.366 . . . . 3.77 113.483 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.3 114.54 5.01 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.711 -1.605 . . . . 3.9700000000000002 109.568 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.57 98.01 1.06 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.723 2.282 . . . . 3.0899999999999999 109.372 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 3.5899999999999999 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.4700000000000002 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 3.0800000000000001 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 2.0800000000000001 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 2.3199999999999998 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.73 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 3.73 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.96 112.808 -155.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.8899999999999997 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.98 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 2.4100000000000001 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.1900000000000004 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 8.8000000000000007 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.8799999999999999 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 3.5499999999999998 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 5.6500000000000004 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.9099999999999999 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.3399999999999999 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 2.3100000000000001 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 3.2400000000000002 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 4.3399999999999999 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 2.9500000000000002 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 4.1900000000000004 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 4.1500000000000004 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 6.2599999999999998 109.724 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 4.2800000000000002 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 6.1399999999999997 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.9900000000000002 112.121 -157.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 172' ' ' VAL . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 7.4800000000000004 112.152 171.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.2999999999999998 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' PRO . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 3.9399999999999999 111.869 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.8899999999999999 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.0600000000000001 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.9100000000000001 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 3.2999999999999998 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.2400000000000002 109.501 169.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.9100000000000001 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 5.1200000000000001 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 183' ' ' VAL . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 3.6800000000000002 109.839 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.435 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 2.1099999999999999 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 181' ' ' ILE . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 3.0800000000000001 111.18 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 5.0800000000000001 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.6900000000000004 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.8799999999999999 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 4.1500000000000004 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.6800000000000002 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 3.7200000000000002 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 3.3799999999999999 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 4.9199999999999999 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 5.4400000000000004 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 4.5599999999999996 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 4.1900000000000004 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.8300000000000001 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 3.5699999999999998 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 2.0 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.85999999999999999 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 3.54 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 3.25 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 2.46 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 3.1899999999999999 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.77 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.1899999999999999 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.4199999999999999 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.6900000000000004 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 8.8100000000000005 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.8899999999999997 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 4.3499999999999996 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.79 114.294 -171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 2.4199999999999999 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 2.73 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 1.97 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 4.7400000000000002 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 4.1100000000000003 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 2.1899999999999999 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.8100000000000001 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.6600000000000001 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 4.0899999999999999 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.7599999999999998 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.8999999999999999 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 3.6499999999999999 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 3.1099999999999999 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 2.1600000000000001 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.73999999999999999 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 3.02 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 3.71 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.8300000000000001 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.2000000000000002 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 6.8099999999999996 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.3300000000000001 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.7599999999999998 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 2.7999999999999998 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.9300000000000002 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 3.5499999999999998 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 3.8599999999999999 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 3.3799999999999999 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 6.0999999999999996 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.7000000000000002 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 4.0700000000000003 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.9400000000000004 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 3.73 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 6.7000000000000002 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 5.5099999999999998 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 3.46 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.5800000000000001 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.31 118.87 5.68 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.9700000000000002 111.811 -174.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.46 156.1 1.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.066 2.433 . . . . 4.3499999999999996 112.951 -174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.404 ' HZ2' ' HB3' ' A' ' 255' ' ' ASP . 33.9 mtmm -100.55 -65.46 0.97 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.57 -1.27 . . . . 8.4000000000000004 107.57 127.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -159.91 177.91 10.29 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 128.715 2.806 . . . . 7.9900000000000002 107.542 162.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -73.01 13.69 0.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.549 1.685 . . . . 14.949999999999999 115.549 -172.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -139.28 -40.73 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.476 -1.39 . . . . 9.3399999999999999 112.861 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.18 -33.85 59.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.628 1.571 . . . . 9.4700000000000006 113.505 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.404 ' HB3' ' HZ2' ' A' ' 250' ' ' LYS 0.283 1.6 t70 129.06 135.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 1 C-N-CA 132.086 4.154 . . . . 5.0899999999999999 112.884 171.738 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -88.36 100.35 12.95 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.391 2.276 . . . . 6.0199999999999996 109.932 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.97 63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.047 2.139 . . . . 5.2400000000000002 109.435 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 3.9300000000000002 111.451 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.9700000000000002 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.538 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.8799999999999999 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 4.1799999999999997 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.8599999999999999 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 4.1900000000000004 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 3.6699999999999999 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 3.9100000000000001 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 3.0 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 2.7200000000000002 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.45 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.6699999999999999 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.6900000000000004 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.9100000000000001 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.8499999999999996 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 4.0499999999999998 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 3.3900000000000001 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.1400000000000001 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.6699999999999999 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 4.0099999999999998 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.6600000000000001 111.411 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 4.0199999999999996 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 6.2300000000000004 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 5.21 112.558 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.71 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.435 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 3.3599999999999999 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.6000000000000001 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 2.0499999999999998 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.8600000000000001 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.9199999999999999 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 3.1299999999999999 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 3.1899999999999999 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 2.1699999999999999 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 2.4199999999999999 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 4.7699999999999996 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 5.4699999999999998 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 5.0300000000000002 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.21 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 4.6100000000000003 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 -29.31 129.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.9600000000000009 111.8 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -47.89 -39.69 19.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.367 0.877 . . . . 6.7000000000000002 113.367 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.293 0.1 OUTLIER -164.03 -18.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.964 1.705 . . . . 13.01 111.881 129.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 128.705 2.802 . . . . 7.29 109.854 156.008 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 117.532 -1.223 . . . . 19.800000000000001 109.592 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.58 -49.93 75.67 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.897 1.073 . . . . 18.469999999999999 113.897 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.12 -42.07 0.52 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 128.355 2.662 . . . . 13.44 114.251 171.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.87 158.5 21.95 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.022 1.296 . . . . 10.34 111.455 168.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 272' ' ' GLU . 60.9 pttt -67.62 123.23 86.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 118.418 -0.801 . . . . 12.26 111.47 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.8 165.12 17.92 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.453 2.769 . . . . 9.4499999999999993 110.676 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.75 163.88 37.64 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.79 1.636 . . . . 7.7699999999999996 111.044 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -132.57 145.1 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.479 1.111 . . . . 10.039999999999999 109.132 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.47 -143.77 16.76 Favored Glycine 0 N--CA 1.47 0.947 0 N-CA-C 110.381 -1.087 . . . . 6.3700000000000001 110.381 -167.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.05 -89.07 0.53 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.931 -1.483 . . . . 4.7999999999999998 111.975 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.18 83.8 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.298 2.665 . . . . 4.0 110.754 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 4.0999999999999996 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 3.1299999999999999 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 3.5800000000000001 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 3.29 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 2.6200000000000001 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 2.0099999999999998 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 3.79 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 2.04 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2000000000000002 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 5.7999999999999998 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 6.1600000000000001 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 3.5 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.4100000000000001 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.8700000000000001 115.421 -156.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 3.6200000000000001 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.424 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 5.2000000000000002 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 5.2599999999999998 113.101 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.6400000000000001 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.4900000000000002 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.3300000000000001 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 3.3999999999999999 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 3.9700000000000002 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 3.25 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.8599999999999999 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.9700000000000002 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.0699999999999998 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CZ ' ' CD2' ' A' ' 260' ' ' HIS . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 6.3399999999999999 115.028 -159.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 3.27 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 7.5700000000000003 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.7200000000000002 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 5.79 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.0999999999999996 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 4.4900000000000002 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.0600000000000001 112.531 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.9299999999999999 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.0999999999999996 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 3.0 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 3.6499999999999999 111.518 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.3700000000000001 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.8300000000000001 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 4.4000000000000004 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 2.6800000000000002 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.469 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.4700000000000002 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 3.04 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 3.6299999999999999 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.0999999999999996 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.9700000000000002 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 3.54 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 3.1000000000000001 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 192' ' ' THR . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 3.9199999999999999 111.781 165.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 3.25 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 190' ' ' ILE . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 3.2200000000000002 111.768 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 4.0 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.6200000000000001 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.3399999999999999 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 3.5699999999999998 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 2.8900000000000001 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.2 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 3.6099999999999999 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 4.8600000000000003 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 2.7999999999999998 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 3.5299999999999998 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 2.25 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.2999999999999998 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.8799999999999999 112.181 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 8.5700000000000003 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 5.4400000000000004 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 5.5300000000000002 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 3.4199999999999999 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 2.75 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 2.2000000000000002 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 4.0599999999999996 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 4.9100000000000001 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 2.1000000000000001 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 6.4199999999999999 113.301 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.2300000000000004 113.748 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 3.2400000000000002 112.782 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 2.3900000000000001 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.5699999999999998 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 3.9399999999999999 113.74 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 4.2800000000000002 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 3.0099999999999998 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.1699999999999999 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 2.8599999999999999 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 3.0600000000000001 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.79 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 4.4800000000000004 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 9.1699999999999999 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.9900000000000002 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.1600000000000001 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 3.0899999999999999 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.5299999999999998 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 4.0 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 3.5600000000000001 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.8799999999999999 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 2.75 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 4.5599999999999996 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 6.8099999999999996 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 3.48 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 6.3600000000000003 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 4.8099999999999996 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 3.0800000000000001 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.79 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.0 81.49 0.29 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.3199999999999998 112.732 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.42 129.09 13.43 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.186 2.591 . . . . 8.9299999999999997 109.802 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.493 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 26.1 pttt -169.56 -59.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.761 1.224 . . . . 9.9900000000000002 112.541 -168.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.7 t0 75.35 -168.95 0.09 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.781 1.632 . . . . 9.5700000000000003 110.902 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 77.32 -34.77 0.21 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.386 2.674 . . . . 10.83 115.096 161.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -160.18 -58.14 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.485 1.514 . . . . 8.9399999999999995 110.967 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.493 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -83.77 1.45 42.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.652 1.353 . . . . 12.640000000000001 114.652 -166.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.5 t0 91.32 158.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.793 2.516 . . . . 6.0700000000000003 117.793 147.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.25 95.75 1.33 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.787 1.235 . . . . 7.9400000000000004 110.71 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt -144.82 140.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.179 0.992 . . . . 5.75 113.086 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 4.3700000000000001 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.9900000000000002 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.0 OUTLIER -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.0499999999999998 112.522 -168.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 5.9000000000000004 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 4.0 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 3.4300000000000002 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 5.0800000000000001 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 4.1500000000000004 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 3.8799999999999999 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 4.1600000000000001 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.8500000000000001 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6000000000000001 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2000000000000002 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 4.3600000000000003 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 133' ' ' LYS . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.8899999999999997 113.794 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 4.8700000000000001 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 4.1500000000000004 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.6800000000000002 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 4.7199999999999998 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 4.1200000000000001 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 3.23 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 5.2400000000000002 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.71 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 6.04 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.474 ' H ' ' HD2' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 9.0 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.469 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 3.1299999999999999 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.1800000000000002 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 3.0099999999999998 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 2.3500000000000001 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 2.9500000000000002 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 3.9300000000000002 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 3.9100000000000001 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.5899999999999999 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.98 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.8300000000000001 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.71 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 7.0 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.8100000000000001 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.6100000000000003 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.25 178.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 8.1699999999999999 111.99 172.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.417 ' HE3' ' C ' ' A' ' 301' ' ' SER . 0.0 OUTLIER -133.31 -72.98 0.5 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.729 0.812 . . . . 6.2599999999999998 113.123 166.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -165.29 24.6 0.05 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.9 1.444 . . . . 12.74 114.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.417 ' C ' ' HE3' ' A' ' 299' ' ' LYS . 5.1 t . . . . . 0 C--O 1.252 1.219 0 C-N-CA 130.702 3.601 . . . . 8.1799999999999997 108.688 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.801 -1.095 . . . . 23.579999999999998 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -158.51 -173.86 4.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.636 1.174 . . . . 20.289999999999999 110.459 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 t -156.52 164.68 37.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.402 1.481 . . . . 19.719999999999999 111.394 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.36 4.7 57.59 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.597 1.094 . . . . 18.170000000000002 114.715 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt 173.11 152.69 0.24 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 129.502 3.121 . . . . 14.94 110.958 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.47 161.05 34.84 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.93 2.42 . . . . 14.07 109.794 161.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.3 146.65 48.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.429 1.092 . . . . 10.23 109.657 162.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.29 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 130.224 3.41 . . . . 9.4399999999999995 106.826 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.39 -156.45 24.11 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.143 1.338 . . . . 4.3600000000000003 113.669 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.42 -175.84 32.15 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 115.663 1.025 . . . . 4.2999999999999998 115.663 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -89.35 159.07 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.269 2.646 . . . . 4.7199999999999998 115.325 -155.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 4.9299999999999997 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 5.4699999999999998 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 4.21 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 3.0 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 3.1400000000000001 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.21 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 5.0599999999999996 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.8100000000000001 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.0099999999999998 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 8.4399999999999995 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 5.46 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 5.0800000000000001 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.2400000000000002 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 8.0700000000000003 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.6500000000000004 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 4.5 113.405 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 5.0700000000000003 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.3399999999999999 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.6299999999999999 109.835 159.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.9199999999999999 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 3.8799999999999999 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 5.3600000000000003 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 3.6699999999999999 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 4.1399999999999997 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 3.1299999999999999 112.178 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.9500000000000002 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 6.5599999999999996 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.5300000000000002 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.6 m170 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 6.1900000000000004 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 4.0 109.869 159.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 7.2599999999999998 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.7400000000000002 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 3.5 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 3.1899999999999999 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 2.1299999999999999 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 3.9900000000000002 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.6499999999999999 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.9199999999999999 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.7999999999999998 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.6899999999999999 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 6.04 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 2.4300000000000002 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 2.23 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 2.8199999999999998 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 3.9199999999999999 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.547 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 3.1099999999999999 112.262 170.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 2.98 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 3.6000000000000001 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.477 ' C ' ' H ' ' A' ' 192' ' ' THR . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 3.1200000000000001 110.329 169.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 3.54 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 190' ' ' ILE . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 3.3999999999999999 110.692 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 3.5899999999999999 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.3900000000000001 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.2800000000000002 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 5.2999999999999998 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 2.0600000000000001 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 1.02 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.9100000000000001 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 4.1900000000000004 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 2.9900000000000002 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 2.25 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 3.6200000000000001 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.2300000000000004 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.2799999999999998 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.47 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.1900000000000004 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 10.220000000000001 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 4.54 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.7699999999999996 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.1499999999999999 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.8799999999999999 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 4.04 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 2.7400000000000002 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 5.9699999999999998 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 4.6100000000000003 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 2.25 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.7800000000000002 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 4.2999999999999998 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 5.5899999999999999 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 3.6600000000000001 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.9700000000000002 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 5.7699999999999996 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 3.3100000000000001 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 3.46 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.1499999999999999 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 3.0299999999999998 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 4.6299999999999999 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.1099999999999999 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.416 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 4.1299999999999999 109.003 157.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.47 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 7.2000000000000002 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.8899999999999997 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 230' ' ' THR . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.0599999999999996 111.705 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 3.6000000000000001 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.3300000000000001 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 3.7999999999999998 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.8200000000000003 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 4.0300000000000002 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 4.3099999999999996 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 3.25 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 5.3799999999999999 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 6.46 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 3.6400000000000001 111.959 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 6.7199999999999998 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 5.71 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.4299999999999997 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.6500000000000004 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.11 143.93 25.59 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 3.1200000000000001 114.882 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.36 164.37 35.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.641 2.894 . . . . 5.3600000000000003 109.689 164.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HZ3' ' C ' ' A' ' 254' ' ' GLU . 14.7 mtmt -134.95 160.37 38.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.355 0.662 . . . . 5.9699999999999998 111.894 -174.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.23 -36.08 11.58 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.897 1.073 . . . . 6.5700000000000003 113.897 -156.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.75 -59.55 0.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.306 1.443 . . . . 10.16 109.395 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -156.7 -36.01 0.08 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.276 1.03 . . . . 8.0500000000000007 113.719 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.503 ' C ' ' HZ3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -72.21 161.85 30.28 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.003 2.121 . . . . 9.4900000000000002 115.042 -174.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 23.4 t70 93.55 -144.17 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 128.894 2.878 . . . . 5.9100000000000001 112.279 168.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.513 ' H ' ' CG ' ' A' ' 255' ' ' ASP 0.25 2.8 t80 132.39 50.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.868 1 C-N-CA 133.332 4.653 . . . . 6.4100000000000001 110.958 179.263 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.57 154.77 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 121.045 -1.034 . . . . 4.4500000000000002 111.65 163.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 4.3399999999999999 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 2.02 110.096 170.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.8399999999999999 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 4.1799999999999997 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.8300000000000001 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 4.7599999999999998 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 4.7000000000000002 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 3.9100000000000001 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 3.21 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.8900000000000001 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.9900000000000002 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.8600000000000003 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.6400000000000001 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 7.3899999999999997 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 5.6500000000000004 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.9199999999999999 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 6.0199999999999996 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 4.5199999999999996 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.8399999999999999 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 6.5800000000000001 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 5.5 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 5.7699999999999996 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 9.1699999999999999 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HZ3' ' CD ' ' A' ' 186' ' ' GLU . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 4.1399999999999997 114.072 -164.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 3.2200000000000002 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.0700000000000003 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.6299999999999999 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.6699999999999999 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 3.8999999999999999 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 4.3200000000000003 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 3.8599999999999999 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 3.3199999999999998 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 4.0499999999999998 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.9500000000000002 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 5.1200000000000001 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 6.2199999999999998 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.6299999999999999 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 5.8700000000000001 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.97 150.61 11.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 9.0999999999999996 113.298 -161.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? 75.26 -49.12 0.64 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.991 2.516 . . . . 8.5500000000000007 113.526 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.414 ' HZ2' ' C ' ' A' ' 301' ' ' SER 0.261 0.1 OUTLIER 71.49 -51.24 0.69 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 131.026 3.73 . . . . 13.5 112.614 -179.152 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.414 ' C ' ' HZ2' ' A' ' 300' ' ' LYS . 2.5 t . . . . . 0 C--O 1.243 0.75 0 C-N-CA 129.315 3.046 . . . . 10.58 110.246 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.516 -1.23 . . . . 19.469999999999999 108.563 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.99 111.53 2.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.851 -1.537 . . . . 17.449999999999999 106.851 152.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.1 m -161.58 152.22 17.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 17.359999999999999 108.424 -159.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.05 -136.44 15.17 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.626 0.631 . . . . 14.16 112.097 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.55 144.34 1.6 Allowed Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.37 1.468 . . . . 12.58 112.009 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.03 173.76 10.72 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.387 2.725 . . . . 8.8599999999999994 110.184 162.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.4 160.75 37.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.099 1.76 . . . . 9.1699999999999999 108.957 166.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -105.44 154.3 20.52 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.095 0.958 . . . . 8.3900000000000006 109.433 166.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.46 -170.98 39.44 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.522 1.058 . . . . 4.8499999999999996 111.221 -154.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.43 91.29 0.64 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 117.95 -1.472 . . . . 4.1600000000000001 110.498 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.98 109.98 2.29 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 CA-C-N 120.519 2.16 . . . . 3.8799999999999999 112.188 -169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 4.3099999999999996 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.4500000000000002 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 3.1200000000000001 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 4.1900000000000004 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 2.6699999999999999 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 2.5699999999999998 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 3.25 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1000000000000001 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.8200000000000003 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 6.6299999999999999 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.8799999999999999 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.8799999999999999 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.8700000000000001 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 8.4499999999999993 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.4500000000000002 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 3.9100000000000001 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 5.6200000000000001 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.9299999999999999 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.1200000000000001 109.375 165.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.9299999999999999 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 3.54 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 4.5 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 4.1500000000000004 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 4.04 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 4.4299999999999997 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7000000000000002 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 5.96 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 5.1799999999999997 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 6.75 111.929 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.5 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 5.1500000000000004 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.6699999999999999 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 4.3600000000000003 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.8400000000000001 112.355 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.8700000000000001 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.6600000000000001 111.672 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.1200000000000001 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 3.8100000000000001 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.5800000000000001 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 4.3399999999999999 112.175 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 3.5800000000000001 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 2.4399999999999999 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 3.0899999999999999 113.835 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 3.3100000000000001 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 3.4900000000000002 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7000000000000002 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6000000000000001 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 3.04 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.5299999999999998 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.8999999999999999 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 3.1800000000000002 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 4.04 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 3.3199999999999998 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 4.2000000000000002 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 3.1800000000000002 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.5600000000000001 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.9299999999999997 112.704 155.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 2.1000000000000001 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 1.0900000000000001 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 3.98 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 5.1200000000000001 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 2.52 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.9199999999999999 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 3.27 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.3599999999999999 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.3899999999999997 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.9699999999999998 113.029 -167.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.5700000000000003 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 5.04 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 5.6299999999999999 114.297 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 210' ' ' LYS . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 5.5199999999999996 113.48 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 3.1800000000000002 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 2.71 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 2.2000000000000002 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 5.6699999999999999 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 4.5 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 2.2200000000000002 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 7.1200000000000001 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.1100000000000003 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 4.5099999999999998 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 2.23 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 2.0 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 4.75 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 3.0299999999999998 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 2.3900000000000001 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.90000000000000002 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 2.73 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 3.8999999999999999 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.1499999999999999 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.77 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 9.6600000000000001 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.0099999999999998 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 3.2000000000000002 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 3.25 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 3.4900000000000002 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 3.6699999999999999 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 7.4699999999999998 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.7799999999999998 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 4.7599999999999998 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.9699999999999998 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 4.8399999999999999 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 7.1200000000000001 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 4.3399999999999999 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 3.1600000000000001 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.77 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.9 142.17 28.27 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.3700000000000001 112.194 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 89.54 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.979 2.453 . . . . 4.3200000000000003 109.569 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -5.13 30.94 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.194 -0.941 . . . . 5.9800000000000004 112.221 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -97.3 8.78 43.88 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.134 -1.603 . . . . 7.8499999999999996 110.983 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -91.99 -46.97 7.53 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.319 2.248 . . . . 12.09 110.617 166.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.31 53.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.269 1.828 . . . . 10.0 112.566 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 64.45 -9.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 128.524 2.73 . . . . 7.2699999999999996 117.387 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.78 115.34 7.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.508 1.299 . . . . 7.1200000000000001 114.508 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -113.08 60.15 0.64 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.215 1.806 . . . . 5.9699999999999998 112.264 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt -55.73 158.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 119.929 -1.732 . . . . 5.3499999999999996 111.252 152.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 3.2200000000000002 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.1600000000000001 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 2.0099999999999998 111.882 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 4.25 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 4.5899999999999999 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 3.5499999999999998 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.9100000000000001 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 3.9399999999999999 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 3.02 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 3.52 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.8700000000000001 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.0599999999999996 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 3.48 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.3600000000000003 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 5.25 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 4.1500000000000004 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.8399999999999999 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 4.3899999999999997 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 3.6400000000000001 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.41 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.2799999999999998 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 5.1600000000000001 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 9.1099999999999994 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.9699999999999998 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 6.2199999999999998 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 3.9300000000000002 112.726 -166.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 2.21 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.0199999999999996 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 3.0800000000000001 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.8799999999999999 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 2.71 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 2.3900000000000001 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 3.0099999999999998 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.27 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 3.1800000000000002 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 3.1499999999999999 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.6200000000000001 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 6.3799999999999999 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.1400000000000001 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 4.7000000000000002 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 94.26 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 10.01 109.726 166.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 62.43 172.88 0.14 Allowed 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 118.217 2.673 . . . . 7.3099999999999996 118.217 165.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -145.03 -66.87 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.813 1.645 . . . . 13.74 109.183 166.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.324 -1.322 . . . . 10.630000000000001 108.007 134.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.432 ' H1 ' ' CD ' ' A' ' 272' ' ' GLU . 1.4 m . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.543 0.571 . . . . 22.449999999999999 112.543 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.98 101.68 7.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.772 0.829 . . . . 19.0 109.977 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.7 t -174.52 -175.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.126 2.171 . . . . 15.17 109.773 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.27 -157.92 0.78 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.82 1.676 . . . . 11.93 112.391 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -134.89 130.8 19.72 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 120.366 -1.667 . . . . 9.5500000000000007 111.219 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -82.78 -41.03 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.027 2.485 . . . . 9.0299999999999994 113.446 -170.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.3 0.6 OUTLIER 47.61 6.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 129.87 3.268 . . . . 10.48 116.376 -170.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.0 tp -84.89 131.57 34.49 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.894 2.078 . . . . 11.99 108.989 164.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.01 -151.84 44.63 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 123.076 0.369 . . . . 8.0899999999999999 112.633 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.2 -119.9 6.61 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.234 -1.315 . . . . 4.04 113.055 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -71.99 104.92 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.212 2.608 . . . . 3.77 111.629 -166.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 4.1500000000000004 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.5099999999999998 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 3.6299999999999999 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 2.3500000000000001 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 2.4300000000000002 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.8300000000000001 112.565 161.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 3.48 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.8899999999999999 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.5700000000000003 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 9.1400000000000006 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 4.2400000000000002 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.8500000000000001 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.1899999999999999 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 7.79 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.7200000000000002 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.41 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 3.46 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 5.5099999999999998 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.6000000000000001 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.412 HE21 ' C ' ' A' ' 158' ' ' GLN . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 2.1800000000000002 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 3.4300000000000002 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 2.8700000000000001 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.8700000000000001 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 3.4900000000000002 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6000000000000001 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 5.2300000000000004 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.29 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 7.0700000000000003 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 3.0499999999999998 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 6.79 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 3.9199999999999999 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.1899999999999999 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 2.1299999999999999 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.8999999999999999 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4000000000000004 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 4.2999999999999998 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.445 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.8799999999999999 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 4.3499999999999996 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.9900000000000002 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 2.7000000000000002 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.445 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 2.0299999999999998 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 2.4500000000000002 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 3.6400000000000001 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.9300000000000002 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 3.1600000000000001 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.4700000000000002 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 2.77 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.8999999999999999 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 3.0800000000000001 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 3.2200000000000002 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 3.8399999999999999 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.6699999999999999 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.7800000000000002 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 4.1299999999999999 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 2.0899999999999999 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.83999999999999997 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 3.3399999999999999 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 4.4400000000000004 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 2.6299999999999999 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 3.98 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.6400000000000001 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.6699999999999999 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.9700000000000002 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.488 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 7.2800000000000002 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.4500000000000002 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 4.54 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 7.2000000000000002 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.9500000000000002 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 3.4900000000000002 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 3.6600000000000001 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.9399999999999999 111.414 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 4.6600000000000001 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 5.29 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 2.3599999999999999 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 7.8700000000000001 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.0599999999999996 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 3.75 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.6699999999999999 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.79 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.8100000000000001 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 3.3300000000000001 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 3.9500000000000002 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.95999999999999996 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 4.0899999999999999 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.52 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.5499999999999998 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 7.1100000000000003 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.2800000000000002 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.3499999999999996 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 4.5599999999999996 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.7999999999999998 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 3.46 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 3.5899999999999999 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 3.1499999999999999 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 7.1299999999999999 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 3.46 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 5.5700000000000003 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 9.5199999999999996 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 5.9400000000000004 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 16.420000000000002 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.9199999999999999 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.3899999999999997 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.9199999999999999 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.08 172.52 38.45 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.9100000000000001 112.966 174.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.56 39.12 0.81 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.623 3.549 . . . . 7.5499999999999998 110.967 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 158.4 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 1 C-N-CA 131.953 4.101 . . . . 8.0399999999999991 108.676 -162.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.76 -124.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 118.361 -0.828 . . . . 11.24 112.614 -164.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.59 58.58 2.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.301 1.441 . . . . 16.629999999999999 113.629 -159.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -162.98 -73.0 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.582 1.553 . . . . 13.210000000000001 110.517 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.19 13.68 0.86 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.5 1.52 . . . . 12.57 114.72 -168.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.5 t70 90.08 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.138 3.375 . . . . 6.2699999999999996 111.037 -164.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.55 139.51 17.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.067 0.937 . . . . 5.2000000000000002 113.452 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm -100.42 136.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 4.8600000000000003 106.663 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 4.0199999999999996 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.9199999999999999 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.8200000000000003 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 4.4500000000000002 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 3.6800000000000002 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 4.0199999999999996 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 4.1100000000000003 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.9199999999999999 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 2.8599999999999999 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.54 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.3999999999999999 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.3200000000000003 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.9199999999999999 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CD ' ' H1 ' ' A' ' 129' ' ' SER . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.3300000000000001 112.387 -171.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 4.5899999999999999 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 4.0 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.7799999999999998 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 6.2999999999999998 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 3.7799999999999998 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.8599999999999999 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 4.0099999999999998 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.9900000000000002 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.409 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.9299999999999997 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 6.6900000000000004 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 3.04 113.984 -165.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.8799999999999999 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.9199999999999999 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 2.4199999999999999 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 2.2599999999999998 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 2.79 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 3.3500000000000001 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 4.1299999999999999 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 2.4500000000000002 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.7200000000000002 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.7400000000000002 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 5.3399999999999999 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.8799999999999999 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.54 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 4.3200000000000003 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -72.68 79.32 1.1 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 10.949999999999999 110.813 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.519 ' HZ1' ' C ' ' A' ' 301' ' ' SER 0.306 10.1 pttp 38.34 -102.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.725 1.61 . . . . 6.9299999999999997 113.511 -164.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -146.46 35.0 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.817 1.647 . . . . 13.699999999999999 110.442 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.519 ' C ' ' HZ1' ' A' ' 299' ' ' LYS . 9.6 t . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.335 1.854 . . . . 9.1099999999999994 110.813 -146.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 117.879 -1.058 . . . . 18.030000000000001 109.265 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 174.28 161.99 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.292 1.837 . . . . 16.719999999999999 109.625 -160.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.4 t -87.34 -9.55 54.56 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.552 1.315 . . . . 13.92 114.552 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.88 -146.05 47.62 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 118.781 0.719 . . . . 12.06 112.364 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -174.54 134.56 0.54 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.864 2.066 . . . . 14.220000000000001 110.475 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.12 141.22 51.93 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.614 2.209 . . . . 8.2400000000000002 110.766 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.27 20.37 18.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.205 1.402 . . . . 10.220000000000001 114.54 -171.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.4 tp -105.52 -119.19 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.228 1.411 . . . . 8.4199999999999999 109.282 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.4 167.33 37.23 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 125.129 1.347 . . . . 4.1299999999999999 113.147 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.36 -55.75 0.5 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.986 1.279 . . . . 4.6399999999999997 113.583 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.2 128.11 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.623 2.211 . . . . 2.7999999999999998 109.354 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 3.8799999999999999 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 3.3199999999999998 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 3.48 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.7400000000000002 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 2.54 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 2.1000000000000001 113.025 168.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 4.3600000000000003 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 6.79 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 3.4700000000000002 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 3.1200000000000001 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.0199999999999996 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 8.2599999999999998 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.0099999999999998 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 4.6600000000000001 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 4.4800000000000004 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.6399999999999999 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.1899999999999999 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.8300000000000001 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 4.2800000000000002 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 3.4399999999999999 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 2.9500000000000002 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.8899999999999997 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 3.1000000000000001 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.8300000000000001 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 6.2999999999999998 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 4.2199999999999998 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 255' ' ' ASP . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 6.4400000000000004 111.344 161.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.7799999999999998 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 5.8700000000000001 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.2699999999999996 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 3.8999999999999999 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.539 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.9099999999999999 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.2200000000000002 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.4300000000000002 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 3.4500000000000002 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.1499999999999999 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 6.1600000000000001 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.96 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 2.6000000000000001 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 2.3100000000000001 113.278 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 2.6699999999999999 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 3.7400000000000002 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.3799999999999999 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 3.7200000000000002 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.3500000000000001 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.9700000000000002 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 192' ' ' THR . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 3.5499999999999998 112.728 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 4.04 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 190' ' ' ILE . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 3.9900000000000002 112.173 -161.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 4.6500000000000004 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.6899999999999999 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.3200000000000003 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 3.2000000000000002 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 2.04 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.1299999999999999 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 4.1600000000000001 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 4.0499999999999998 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 3.4900000000000002 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 2.0899999999999999 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 2.5699999999999998 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.1099999999999999 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.9199999999999999 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 8.3699999999999992 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9000000000000004 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 4.6200000000000001 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.8200000000000003 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.3200000000000003 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 3.5299999999999998 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 3.1400000000000001 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 2.6699999999999999 111.994 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 3.6699999999999999 111.416 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 3.98 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 2.5800000000000001 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 4.1299999999999999 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 3.4300000000000002 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 2.27 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 2.0800000000000001 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 3.6099999999999999 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 3.6000000000000001 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 3.0499999999999998 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 4.4100000000000001 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 4.1100000000000003 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.2200000000000002 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.9500000000000002 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 7.1900000000000004 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.9100000000000001 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.7400000000000002 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 3.6699999999999999 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.6200000000000001 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 3.3500000000000001 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 3.8900000000000001 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 3.7200000000000002 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 7.2300000000000004 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.75 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 4.4100000000000001 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.8899999999999997 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 3.3399999999999999 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 6.2999999999999998 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 4.0 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.8399999999999999 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 3.0299999999999998 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.1 -173.46 35.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.9199999999999999 112.538 168.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 166.14 30.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.675 2.25 . . . . 6.1299999999999999 111.819 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.88 -177.87 6.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.802 2.441 . . . . 6.2199999999999998 108.8 155.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 76.15 25.18 1.07 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.594 1.957 . . . . 7.5199999999999996 110.902 -162.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.01 -57.13 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.991 2.117 . . . . 9.5700000000000003 107.239 165.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -107.51 173.84 6.14 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.416 -1.328 . . . . 7.5599999999999996 107.416 136.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.31 -32.67 70.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.113 1.365 . . . . 7.8700000000000001 112.583 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.452 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.3 t0 -83.22 88.97 6.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.936 0.874 . . . . 6.6699999999999999 112.176 -163.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -60.69 168.57 2.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.114 1.524 . . . . 5.29 115.114 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt -115.31 157.17 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 119.923 -1.736 . . . . 4.4900000000000002 109.923 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 3.7200000000000002 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.6800000000000002 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.539 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.7 p80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 2.2000000000000002 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 5.2999999999999998 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.96 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 3.9700000000000002 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 4.79 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 5.4199999999999999 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 3.3100000000000001 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 3.8700000000000001 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 2.29 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.8599999999999999 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.3399999999999999 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.1699999999999999 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.9100000000000001 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 6.3399999999999999 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 4.0800000000000001 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.71 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 4.21 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.5099999999999998 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.5099999999999998 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 10.58 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 5.4800000000000004 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 7.5800000000000001 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 2.4300000000000002 112.464 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.6299999999999999 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.0199999999999996 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 2.3700000000000001 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 2.23 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 2.1200000000000001 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 2.4900000000000002 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 3.1699999999999999 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 2.5299999999999998 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 4.75 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 4.5700000000000003 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 5.75 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 5.5300000000000002 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.3300000000000001 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 5.3099999999999996 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 130.92 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 9.3900000000000006 113.38 166.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -135.69 -147.49 0.27 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.327 0.967 . . . . 8.9700000000000006 111.53 -163.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.59 -38.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.656 1.182 . . . . 11.859999999999999 109.872 157.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 129.109 2.964 . . . . 12.1 108.678 160.181 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 117.394 -1.289 . . . . 24.440000000000001 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 61.34 -157.25 0.34 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.995 0.918 . . . . 21.890000000000001 110.231 -166.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.0 m -159.53 164.38 34.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.613 1.965 . . . . 14.609999999999999 107.648 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.65 66.08 1.37 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.621 1.105 . . . . 11.92 111.815 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.9 127.82 2.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.026 1.73 . . . . 11.359999999999999 109.894 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.0 154.85 66.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.064 2.509 . . . . 7.1399999999999997 111.311 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.59 21.9 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.922 1.289 . . . . 8.4800000000000004 113.449 -167.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.45 129.63 34.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.658 0.783 . . . . 6.54 110.672 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.34 120.85 3.59 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.35 0.976 . . . . 4.0 111.602 -167.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.01 137.13 16.75 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 118.926 -0.93 . . . . 4.0 113.571 -166.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -82.74 55.02 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.479 3.453 . . . . 3.6099999999999999 111.673 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 4.0700000000000003 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 3.0600000000000001 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 3.7000000000000002 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 4.8099999999999996 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.3199999999999998 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.6200000000000001 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.79 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.3900000000000001 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.9100000000000001 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 9.4299999999999997 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.8999999999999999 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.581 ' HG1' ' HB2' ' A' ' 154' ' ' ASP . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 2.4399999999999999 105.957 166.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 7.1699999999999999 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.581 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.5299999999999998 112.203 163.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.458 ' HH ' HG23 ' A' ' 225' ' ' VAL . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.7400000000000002 114.959 -161.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 4.0999999999999996 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.49 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.3500000000000001 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 2.1400000000000001 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 3.2400000000000002 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 4.54 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 3.2799999999999998 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 4.0800000000000001 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 4.0099999999999998 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.3700000000000001 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 6.9800000000000004 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.1500000000000004 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 7.3099999999999996 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.2200000000000002 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 7.4299999999999997 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.5199999999999996 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 5.1500000000000004 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.6600000000000001 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.78 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.6400000000000001 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.5499999999999998 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 3.2999999999999998 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.9100000000000001 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.8799999999999999 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.6500000000000004 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 2.9900000000000002 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 3.6899999999999999 114.978 173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 3.6699999999999999 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 3.7599999999999998 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.4400000000000004 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 2.79 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.2999999999999998 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.8799999999999999 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 192' ' ' THR . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 4.1799999999999997 110.258 171.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.9900000000000002 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 190' ' ' ILE . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 3.1899999999999999 111.001 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 4.6100000000000003 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.7999999999999998 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.6100000000000003 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 5.2400000000000002 113.783 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 2.7999999999999998 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.3100000000000001 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 3.52 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 4.79 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 4.0499999999999998 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 3.3100000000000001 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 4.1699999999999999 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.6299999999999999 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.5699999999999998 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.8700000000000001 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 8.2300000000000004 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.7699999999999996 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 3.4700000000000002 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 4.1900000000000004 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.6099999999999999 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 2.6000000000000001 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 3.4700000000000002 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 2.4900000000000002 113.425 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 4.4400000000000004 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 4.8300000000000001 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 2.1099999999999999 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 6.7999999999999998 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.8999999999999999 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 4.9800000000000004 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.7400000000000002 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 3.0299999999999998 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 3.96 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 3.29 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.461 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 2.3100000000000001 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 3.1800000000000002 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 3.4900000000000002 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.8300000000000001 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 4.4299999999999997 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 10.44 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 5.1900000000000004 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.4400000000000004 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 3.25 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.2199999999999998 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 4.6200000000000001 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 4.25 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 3.1600000000000001 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 6.7999999999999998 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.8199999999999998 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 5.6799999999999997 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 6.54 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 4.3300000000000001 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 6.8300000000000001 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 5.71 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 3.1699999999999999 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.6899999999999999 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.55 175.09 38.15 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.3599999999999999 111.692 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.08 117.09 4.98 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.167 2.578 . . . . 5.96 111.626 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -49.9 4.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.631 1.572 . . . . 6.2699999999999996 112.336 167.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -107.29 -123.77 0.24 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 106.377 -1.712 . . . . 6.2300000000000004 106.377 161.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.35 31.6 6.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.494 1.517 . . . . 12.48 111.051 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -115.79 -40.14 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.726 2.01 . . . . 13.59 113.514 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.255 13.9 tt0 99.48 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 129.813 3.245 . . . . 17.100000000000001 108.583 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.7 t0 64.61 -167.81 0.21 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.89 1.676 . . . . 12.94 113.756 172.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.2 t80 58.27 -68.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.727 2.811 . . . . 8.4900000000000002 117.194 151.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.3 41.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 127.081 2.153 . . . . 5.46 111.474 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 4.46 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.7199999999999998 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.48 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 5.7400000000000002 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.423 HD13 HE21 ' A' ' 279' ' ' GLN 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 4.3399999999999999 119.655 155.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.8300000000000001 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 3.7599999999999998 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 5.2800000000000002 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 3.1699999999999999 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 3.46 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.53 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.5300000000000002 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 3.0699999999999998 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9000000000000004 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 4.9800000000000004 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 3.8300000000000001 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.6099999999999999 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 4.9900000000000002 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.465 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 3.4300000000000002 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.5499999999999998 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.423 HE21 HD13 ' A' ' 262' ' ' ILE . 4.5 mm-40 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.46 112.055 -171.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.6799999999999997 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.9000000000000004 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 8.2200000000000006 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 3.1099999999999999 113.451 -164.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.98 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4000000000000004 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 2.21 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.8899999999999999 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 2.4900000000000002 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 2.5899999999999999 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 3.1800000000000002 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 2.1899999999999999 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 2.5499999999999998 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 2.4300000000000002 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 5.4400000000000004 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 5.1299999999999999 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 2.0499999999999998 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 4.9500000000000002 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 -154.88 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 7.5099999999999998 113.875 -166.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -65.34 156.48 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.119 -1.613 . . . . 8.6799999999999997 113.481 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -119.42 1.57 11.23 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.949 1.7 . . . . 15.17 113.091 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.48 1.055 1 C-N-CA 131.739 4.015 . . . . 10.93 106.688 -155.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 116.491 -1.718 . . . . 24.690000000000001 107.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -75.47 83.19 2.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 121.312 1.869 . . . . 20.989999999999998 108.087 162.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.9 p -153.3 167.73 28.37 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.805 1.642 . . . . 19.41 110.324 -166.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.4 175.16 33.51 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 116.124 -0.489 . . . . 15.65 112.518 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.33 151.83 1.35 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.745 2.818 . . . . 11.84 109.809 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -82.27 -167.13 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.345 2.697 . . . . 12.09 112.726 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.06 -132.19 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.296 1.838 . . . . 7.9100000000000001 109.23 166.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.81 141.28 51.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.243 1.817 . . . . 10.51 108.432 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.48 -41.65 65.99 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 118.904 0.775 . . . . 4.4800000000000004 111.265 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -145.02 135.63 6.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 108.985 -1.646 . . . . 3.8999999999999999 108.985 157.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.81 119.59 5.19 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 CA-C-N 121.114 2.457 . . . . 4.2999999999999998 109.322 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 3.8999999999999999 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.4700000000000002 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 3.8399999999999999 111.405 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 3.0800000000000001 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 3.2999999999999998 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.8799999999999999 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 4.1100000000000003 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.6899999999999999 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.7300000000000004 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 6.2800000000000002 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 3.8999999999999999 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.6600000000000001 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7000000000000002 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.7699999999999996 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.2799999999999998 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 4.5 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 5.1299999999999999 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.7999999999999998 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.2000000000000002 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.3300000000000001 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 4.1600000000000001 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 4.4500000000000002 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 2.7200000000000002 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 4.4500000000000002 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 3.21 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.8500000000000001 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 6.0099999999999998 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 4.3300000000000001 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 5.6699999999999999 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.6200000000000001 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 5.8600000000000003 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 4.6399999999999997 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.54 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.0899999999999999 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.7000000000000002 116.458 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.1299999999999999 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.3300000000000001 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 3.5600000000000001 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.3399999999999999 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 6.5099999999999998 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.98 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 4.0899999999999999 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 3.1000000000000001 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 4.1900000000000004 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 3.48 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.9699999999999998 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.4300000000000002 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 3.2200000000000002 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 5.0199999999999996 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 5.5199999999999996 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.9000000000000004 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 5.9299999999999997 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 5.4000000000000004 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.3999999999999999 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.3600000000000003 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 4.2699999999999996 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 3.4500000000000002 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.76 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 3.23 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 3.8900000000000001 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 2.5299999999999998 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 2.2999999999999998 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 2.25 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.9199999999999999 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.8499999999999996 110.286 -162.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.5800000000000001 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.409 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 7.8700000000000001 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.2800000000000002 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.8300000000000001 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 5.9100000000000001 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 2.3100000000000001 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 3.9700000000000002 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.75 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.448 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 3.77 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 4.5599999999999996 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 3.3500000000000001 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 4.3700000000000001 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 4.0 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 6.0599999999999996 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.3799999999999999 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.5099999999999998 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 3.3799999999999999 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 3.79 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 2.4300000000000002 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.0900000000000001 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 3.2999999999999998 111.299 -176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 3.21 109.072 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.6200000000000001 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 5.1699999999999999 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 10.0 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.1399999999999997 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.6400000000000001 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 2.8500000000000001 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.6299999999999999 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 3.3799999999999999 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 3.7000000000000002 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 6.1900000000000004 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 3.0499999999999998 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 5.04 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.8200000000000003 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 244' ' ' TYR . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 3.5800000000000001 112.104 -173.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.438 ' H ' HG21 ' A' ' 243' ' ' VAL . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 9.0500000000000007 111.141 166.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 5.3499999999999996 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.1399999999999997 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.7599999999999998 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.98 162.09 26.01 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.3599999999999999 113.883 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -79.55 145.79 18.71 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.692 2.928 . . . . 5.5800000000000001 110.274 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -97.35 114.17 25.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.726 0.81 . . . . 6.4199999999999999 110.72 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -75.53 -18.31 59.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.053 1.131 . . . . 8.2899999999999991 114.053 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.262 11.4 tp10 121.42 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 1 C-N-CA 131.932 4.093 . . . . 8.8499999999999996 111.936 167.751 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -75.85 52.44 0.69 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.173 1.789 . . . . 8.75 111.181 168.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.335 4.1 pt-20 54.61 -33.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 132.276 4.231 . . . . 8.6400000000000006 117.94 -167.283 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.93 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.124 2.268 . . . . 6.1399999999999997 117.124 -157.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -99.31 102.99 14.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.489 1.116 . . . . 6.5300000000000002 109.95 161.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt -132.92 161.73 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.051 1.741 . . . . 6.75 110.57 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 4.0300000000000002 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.3899999999999997 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.54 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 6.21 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 5.5599999999999996 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 5.3899999999999997 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 4.3499999999999996 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 4.75 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 3.8999999999999999 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 4.2199999999999998 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.5499999999999998 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.3100000000000001 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.412 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.9299999999999997 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.5600000000000001 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 6.9400000000000004 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 4.9800000000000004 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.4500000000000002 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 4.3799999999999999 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 3.8799999999999999 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.8900000000000001 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 4.3700000000000001 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 6.1200000000000001 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.8200000000000003 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 6.5899999999999999 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.8199999999999998 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 2.29 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.6500000000000004 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 3.1800000000000002 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 2.4500000000000002 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 2.4399999999999999 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 3.25 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 3.3999999999999999 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 2.4700000000000002 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 3.5 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.8700000000000001 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 5.3899999999999997 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 6.7300000000000004 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.77 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 5.2000000000000002 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 126.7 28.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 8.2899999999999991 110.51 -175.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 1.0 OUTLIER -163.45 -179.77 6.74 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.404 1.882 . . . . 12.76 110.119 -162.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.496 ' HZ3' ' C ' ' A' ' 301' ' ' SER . 29.7 tttm -173.1 158.76 3.77 Favored 'General case' 0 CA--C 1.557 1.229 1 C-N-CA 132.985 4.514 . . . . 10.49 104.891 167.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.496 ' C ' ' HZ3' ' A' ' 300' ' ' LYS . 88.7 p . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.466 -0.939 . . . . 8.3599999999999994 108.466 152.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 118.152 -0.928 . . . . 15.32 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -76.48 -178.46 4.66 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.631 0.65 . . . . 15.4 110.201 157.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -94.62 -172.8 2.84 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.452 1.501 . . . . 12.34 110.915 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.91 -126.3 1.9 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.055 0.836 . . . . 9.7100000000000009 113.709 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.73 143.49 13.42 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.338 1.855 . . . . 11.58 110.699 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.23 157.21 57.76 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.508 2.139 . . . . 6.9500000000000002 109.974 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.52 -29.56 46.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.91 1.078 . . . . 9.0099999999999998 113.91 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 mt 68.95 179.48 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.138 2.175 . . . . 8.4600000000000009 112.048 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.51 -161.13 52.67 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.481 1.045 . . . . 3.3300000000000001 114.731 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.93 62.27 0.65 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 127.013 2.244 . . . . 3.5899999999999999 112.982 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.93 111.52 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.973 3.116 . . . . 2.9300000000000002 111.994 -166.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 3.6499999999999999 111.434 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 3.25 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 3.1200000000000001 110.154 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 2.6400000000000001 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 2.9900000000000002 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 2.3300000000000001 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.6600000000000001 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.5899999999999999 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.5999999999999996 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 6.8099999999999996 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 4.0300000000000002 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 3.1200000000000001 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.0800000000000001 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 8.2799999999999994 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 3.6600000000000001 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 4.3099999999999996 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.76 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.1400000000000001 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.8600000000000001 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 4.0499999999999998 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 3.77 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 2.5299999999999998 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' A' ' 173' ' ' CYS . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 5.8799999999999999 111.823 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 4.5700000000000003 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 2.0099999999999998 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 5.4000000000000004 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.8199999999999998 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 7.3799999999999999 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 4.0599999999999996 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 8.1500000000000004 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.3799999999999999 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 4.0599999999999996 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.0300000000000002 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.8100000000000001 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.4399999999999999 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.29 113.356 174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 3.5899999999999999 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.4900000000000002 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 4.0700000000000003 113.012 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 5.0099999999999998 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 2.5699999999999998 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.9900000000000002 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 2.3599999999999999 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 3.46 112.9 -170.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.5299999999999998 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 3.7000000000000002 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.5 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6000000000000001 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 3.1200000000000001 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 3.3300000000000001 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 4.6100000000000003 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 4.7999999999999998 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 4.8399999999999999 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 3.04 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.8799999999999999 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 4.1299999999999999 110.045 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 2.1299999999999999 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.6299999999999999 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 3.46 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 3.6499999999999999 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 3.0299999999999998 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 2.0499999999999998 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 2.4700000000000002 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.2199999999999998 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.3700000000000001 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.0300000000000002 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.9900000000000002 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.2699999999999996 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 5.6399999999999997 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.9900000000000002 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.6200000000000001 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 2.8999999999999999 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 3.3599999999999999 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 2.46 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 4.54 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 4.3799999999999999 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 2.02 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.542 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 4.2000000000000002 115.04 174.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.542 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 3.0099999999999998 113.658 168.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 3.2999999999999998 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 2.0499999999999998 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 2.0699999999999998 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.5 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 3.6200000000000001 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 3.1400000000000001 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 2.6899999999999999 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 3.7799999999999998 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 3.6499999999999999 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.8200000000000001 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 3.8700000000000001 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 7.7599999999999998 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.3799999999999999 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 2.6699999999999999 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 3.3599999999999999 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 3.73 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.96 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 5.3499999999999996 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.8399999999999999 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 5.3899999999999997 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 7.4000000000000004 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 3.8599999999999999 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 6.6900000000000004 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 4.2599999999999998 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.7000000000000002 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.4199999999999999 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.88 -173.16 18.8 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.6099999999999999 114.486 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.16 -178.69 4.59 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.41 3.407 . . . . 5.3700000000000001 112.951 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 34.7 mtpt -105.28 -86.15 0.47 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.338 -0.986 . . . . 6.7999999999999998 108.338 150.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 73.54 -39.56 0.44 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.811 2.844 . . . . 5.9000000000000004 116.173 151.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -88.16 -27.19 22.02 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.332 1.053 . . . . 11.75 113.322 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -154.06 -66.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.333 1.235 . . . . 9.0500000000000007 114.333 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.428 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 4.4 mm-40 163.08 2.45 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 131.154 3.782 . . . . 7.7999999999999998 113.867 -173.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.48 173.75 8.39 Favored 'General case' 0 CA--C 1.556 1.179 0 O-C-N 119.237 -2.164 . . . . 6.8499999999999996 110.759 159.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -125.2 152.03 45.07 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.128 -1.608 . . . . 5.8700000000000001 111.599 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -141.46 153.43 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.911 1.284 . . . . 5.1600000000000001 109.739 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 3.75 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.2300000000000004 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 3.1099999999999999 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.8599999999999999 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 5.1799999999999997 109.808 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 3.8199999999999998 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.8300000000000001 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 4.0300000000000002 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 3.23 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 3.5899999999999999 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.6100000000000001 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.5499999999999998 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 4.8700000000000001 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.8099999999999996 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 5.0800000000000001 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 3.25 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.5899999999999999 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.79 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 3.5800000000000001 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.29 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 5.0800000000000001 118.667 -162.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 6.4900000000000002 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 6.3300000000000001 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.9900000000000002 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 2.7599999999999998 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.6299999999999999 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.8599999999999999 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 2.0699999999999998 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 2.2200000000000002 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 2.1200000000000001 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 2.8399999999999999 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 3.1099999999999999 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 2.3700000000000001 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 2.4300000000000002 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 3.2000000000000002 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 6.3300000000000001 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 6.25 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.96 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 4.0599999999999996 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 89.99 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.7300000000000004 113.474 156.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.9 tttt 61.21 -145.66 0.45 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.345 1.458 . . . . 10.699999999999999 111.693 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.72 -10.68 0.2 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.139 1.903 . . . . 14.550000000000001 116.139 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 130.46 3.504 . . . . 9.4499999999999993 108.639 -153.815 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.636 -0.697 . . . . 18.129999999999999 110.044 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -169.45 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.906 2.483 . . . . 18.359999999999999 107.656 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -91.6 177.93 6.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.515 0.726 . . . . 13.48 109.336 140.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.26 9.28 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 117.157 1.623 . . . . 10.27 117.157 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -145.01 142.95 19.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.197 1.999 . . . . 12.869999999999999 112.454 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.47 170.77 19.3 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.124 2.55 . . . . 8.6899999999999995 110.044 161.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.58 32.0 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.44 1.896 . . . . 9.6500000000000004 111.885 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.6 mt -137.68 166.1 24.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 8.4600000000000009 110.653 -166.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.42 148.06 11.64 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 126.038 1.78 . . . . 4.29 112.401 -168.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.31 84.96 0.38 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.106 -1.941 . . . . 3.8399999999999999 111.073 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.28 128.38 7.15 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.342 2.694 . . . . 2.9399999999999999 112.504 -162.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 3.6699999999999999 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 4.1699999999999999 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 2.3100000000000001 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.6099999999999999 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 2.3199999999999998 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 3.6499999999999999 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.1099999999999999 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.7400000000000002 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 6.04 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.96 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 2.6000000000000001 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.0599999999999996 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.8699999999999992 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.6099999999999999 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 3.8999999999999999 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 5.0999999999999996 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.9099999999999999 113.688 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.3199999999999998 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.95 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 3.6200000000000001 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 3.5499999999999998 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 2.7599999999999998 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HH ' ' CB ' ' A' ' 173' ' ' CYS . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 6.6299999999999999 112.266 -167.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 3.1699999999999999 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 2.3399999999999999 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 6.4900000000000002 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 5.2999999999999998 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 6.2800000000000002 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 3.3599999999999999 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 5.5899999999999999 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 3.2599999999999998 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.479 ' CB ' ' HH ' ' A' ' 163' ' ' TYR . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.8300000000000001 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.51 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.7599999999999998 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 3.6299999999999999 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.3199999999999998 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.98 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 3.6000000000000001 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 3.04 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 2.4399999999999999 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 2.5499999999999998 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 3.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.4399999999999999 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.5299999999999998 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 3.3799999999999999 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.1299999999999999 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.5 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.96 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 5.2400000000000002 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 3.52 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 3.2599999999999998 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.3799999999999999 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 3.3100000000000001 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 2.29 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 1.05 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 3.46 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 3.6299999999999999 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 2.8999999999999999 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1000000000000001 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 2.77 113.693 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.6600000000000001 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 5.3799999999999999 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 9.25 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.9299999999999997 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 4.4900000000000002 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.8099999999999996 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.4399999999999999 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 2.8399999999999999 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 3.1699999999999999 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 2.0800000000000001 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 5.0199999999999996 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 4.0300000000000002 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 3.4199999999999999 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.6399999999999997 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.3399999999999999 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 4.6900000000000004 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.48 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 2.3700000000000001 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 3.7799999999999998 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 3.46 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 2.8500000000000001 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 3.1000000000000001 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 3.3300000000000001 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.1200000000000001 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 9.6899999999999995 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.5700000000000003 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 3.0699999999999998 112.633 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.9300000000000002 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.77 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 3.4900000000000002 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 3.52 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 6.2800000000000002 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 2.6899999999999999 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 4.4100000000000001 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 8.4700000000000006 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 4.2300000000000004 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 6.25 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 5.4100000000000001 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.48 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.7999999999999998 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.79 174.31 21.57 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 3.0299999999999998 114.071 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -82.66 -169.85 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.702 3.602 . . . . 4.9199999999999999 110.574 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -160.11 155.74 25.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.184 1.394 . . . . 6.1299999999999999 111.937 168.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.37 -93.49 0.29 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.119 1.367 . . . . 7.0599999999999996 111.281 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -115.47 -49.04 2.76 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.471 1.032 . . . . 10.75 113.536 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.32 -16.08 31.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 116.411 2.004 . . . . 8.5800000000000001 116.411 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.512 ' HA ' ' HE3' ' A' ' 250' ' ' LYS 0.289 5.3 mm-40 90.38 28.53 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 129.176 2.99 . . . . 7.6299999999999999 110.978 -174.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.84 25.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 134.276 5.03 . . . . 8.9000000000000004 115.891 177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.85 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.998 2.119 . . . . 5.1399999999999997 112.438 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.54 148.22 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.081 1.752 . . . . 5.2800000000000002 112.007 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 3.9500000000000002 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.1699999999999999 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.6699999999999999 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 4.54 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 4.7599999999999998 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.9700000000000002 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 5.1200000000000001 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 4.1299999999999999 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 3.0299999999999998 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 3.2000000000000002 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 2.1600000000000001 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.0700000000000003 119.017 163.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.1799999999999997 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.3899999999999997 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 5.0800000000000001 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 3.6200000000000001 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.7200000000000002 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.3300000000000001 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 3.5 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.4100000000000001 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.1500000000000004 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.5800000000000001 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 6.1200000000000001 114.451 -166.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 6.5800000000000001 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 3.0 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.7200000000000002 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.4100000000000001 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 2.77 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 2.7200000000000002 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 2.5099999999999998 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 3.29 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 3.9199999999999999 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 2.5499999999999998 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 2.6800000000000002 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.5699999999999998 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 6.4500000000000002 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 6.1299999999999999 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.9700000000000002 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 4.6600000000000001 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.444 ' CG ' ' H ' ' A' ' 299' ' ' LYS . 0.0 OUTLIER 82.22 -151.14 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 9.0500000000000007 110.057 177.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 298' ' ' ARG . 1.6 tmtm? 66.81 -44.67 0.44 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 130.407 3.483 . . . . 7.6100000000000003 115.95 169.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -73.46 -16.63 61.3 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.295 2.238 . . . . 12.609999999999999 112.197 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--O 1.253 1.28 0 C-N-CA 129.9 3.28 . . . . 9.6199999999999992 108.462 176.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 117.906 -1.045 . . . . 19.170000000000002 110.057 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -165.57 166.5 18.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 16.699999999999999 109.84 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 t -161.09 152.05 18.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.77 1.628 . . . . 14.119999999999999 109.646 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.77 -167.74 39.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.935 0.779 . . . . 12.84 111.272 163.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -157.72 153.48 22.84 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.265 1.426 . . . . 9.5500000000000007 111.259 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.77 174.05 12.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.2 2.6 . . . . 8.9199999999999999 111.679 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.7 mt -114.06 -174.56 2.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 8.4499999999999993 108.025 157.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.04 -146.57 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.718 0.69 . . . . 7.8600000000000003 110.113 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.65 -130.99 40.52 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.392 -1.483 . . . . 4.7400000000000002 109.392 -165.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -158.32 92.41 0.12 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.822 -1.544 . . . . 4.3700000000000001 111.5 170.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.22 150.69 76.89 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 3.6099999999999999 112.961 -166.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 3.8500000000000001 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.8100000000000001 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 3.1299999999999999 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.9900000000000002 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 2.1400000000000001 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 2.1600000000000001 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 3.48 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.8399999999999999 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.1100000000000003 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 8.7599999999999998 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 4.0099999999999998 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.96 107.12 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.7799999999999998 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 8.2300000000000004 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.8399999999999999 111.9 173.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 4.3700000000000001 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 4.4800000000000004 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.6699999999999999 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 159' ' ' TRP . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.3399999999999999 109.845 175.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.433 ' H ' ' HG2' ' A' ' 158' ' ' GLN . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.8999999999999999 110.293 165.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 3.7599999999999998 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 3.46 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 3.9300000000000002 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 4.5099999999999998 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 4.2400000000000002 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 2.2999999999999998 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 8.8300000000000001 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 4.0800000000000001 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 6.2000000000000002 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.6000000000000001 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 172' ' ' VAL . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 8.8300000000000001 114.28 -142.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.1299999999999999 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 170' ' ' PRO . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 4.3399999999999999 110.241 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 3.5499999999999998 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.5700000000000001 111.795 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2000000000000002 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.557 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.1500000000000004 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 3.7799999999999998 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9000000000000004 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 4.2199999999999998 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 4.25 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 3.29 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.413 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 4.0700000000000003 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 2.52 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 3.9100000000000001 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.5599999999999996 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.5099999999999998 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 3.5600000000000001 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.2799999999999998 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 3.4900000000000002 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 3.6600000000000001 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.9100000000000001 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 4.1799999999999997 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 4.0899999999999999 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 3.4399999999999999 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.4500000000000002 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 4.0300000000000002 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 2.2200000000000002 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.3100000000000001 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 3.77 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 4.0899999999999999 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 2.2799999999999998 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.75 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 3.0 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.6600000000000001 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 9.0399999999999991 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9000000000000004 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 4.0 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 211' ' ' GLU . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 4.2000000000000002 113.687 -171.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' A' ' 210' ' ' LYS . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.7400000000000002 112.503 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 2.8500000000000001 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 3.3700000000000001 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 2.0699999999999998 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 5.5499999999999998 113.349 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 4.7699999999999996 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 2.29 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 4.0800000000000001 114.69 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 3.7200000000000002 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 3.0499999999999998 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 2.02 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 3.8199999999999998 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 3.1000000000000001 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 3.7599999999999998 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81000000000000005 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 3.3999999999999999 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 4.6900000000000004 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.9100000000000001 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 3.6499999999999999 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 7.3499999999999996 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.3799999999999999 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 3.3599999999999999 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.2799999999999998 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.6699999999999999 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 3.7400000000000002 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.8700000000000001 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 6.46 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.6499999999999999 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 4.1600000000000001 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 7.3899999999999997 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 4.2599999999999998 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 6.0599999999999996 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 4.8200000000000003 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 4.0899999999999999 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 3.2400000000000002 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.86 43.57 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.68 -23.87 30.67 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.354 2.703 . . . . 5.1799999999999997 112.673 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.359 13.7 ptpt 66.26 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.288 3.435 . . . . 9.0700000000000003 118.29 170.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.94 -18.68 4.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.836 0.854 . . . . 5.71 113.238 -163.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -135.5 -60.4 0.75 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.486 0.714 . . . . 10.32 109.746 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -168.6 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.893 1.677 . . . . 13.65 109.172 154.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -85.52 3.72 39.16 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.061 1.874 . . . . 8.6400000000000006 116.061 -159.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -64.77 -12.07 43.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.196 2.198 . . . . 7.71 115.579 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -71.67 133.48 45.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 116.023 1.86 . . . . 5.7800000000000002 116.023 -145.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.95 165.28 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 125.947 1.699 . . . . 4.8499999999999996 109.533 161.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 4.2000000000000002 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.6200000000000001 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 5.5700000000000003 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 6.4199999999999999 113.144 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 3.02 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 4.5 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 4.4500000000000002 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 3.9300000000000002 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 3.6600000000000001 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.8200000000000001 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.8300000000000001 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.1200000000000001 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.9300000000000002 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.6299999999999999 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 4.7800000000000002 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 3.79 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.7999999999999998 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 4.3899999999999997 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.43 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 3.8399999999999999 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 4.9000000000000004 110.466 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 9.2599999999999998 113.002 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.43 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.7199999999999998 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 6.9000000000000004 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 3.2599999999999998 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.8400000000000001 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.3399999999999999 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 2.5099999999999998 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 2.7000000000000002 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 2.5899999999999999 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 2.9300000000000002 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 3.3500000000000001 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 2.6499999999999999 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 3.0299999999999998 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 3.5299999999999998 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 4.5700000000000003 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 7.1299999999999999 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.8700000000000001 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 4.1699999999999999 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 168.4 15.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 9.4800000000000004 113.835 -155.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.11 -41.89 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.217 3.407 . . . . 9.9399999999999995 110.789 -174.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -64.7 22.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.465 1.906 . . . . 10.1 115.32 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 131.411 3.884 . . . . 8.7400000000000002 109.042 -151.651 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.45 -0.786 . . . . 25.149999999999999 110.121 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -65.9 163.45 16.98 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.707 0.685 . . . . 22.719999999999999 110.217 155.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -107.25 -175.28 2.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.015 1.326 . . . . 16.989999999999998 109.506 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.79 14.14 82.86 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.119 1.208 . . . . 14.51 116.119 163.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -62.73 114.98 13.91 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 120.247 2.024 . . . . 19.16 108.78 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -82.28 -156.55 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.102 2.535 . . . . 11.34 110.558 -172.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.91 2.32 0.11 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.255 1.576 . . . . 12.98 115.255 -167.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 -10.04 2.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.39 1.626 . . . . 7.1799999999999997 115.39 -166.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 143.79 164.96 10.63 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.253 1.406 . . . . 3.6299999999999999 111.851 -163.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.03 -170.32 27.23 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.228 0.918 . . . . 4.7699999999999996 113.693 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.82 145.17 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.505 2.803 . . . . 4.1100000000000003 112.188 -172.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 4.4100000000000001 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 3.3500000000000001 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 3.73 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 2.3900000000000001 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 2.2799999999999998 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.9399999999999999 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 3.1499999999999999 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.9299999999999999 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.1200000000000001 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.9800000000000004 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 4.4800000000000004 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 3.23 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.8399999999999999 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 7.1799999999999997 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.3099999999999996 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 4.0800000000000001 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 4.7699999999999996 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.3199999999999998 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.5499999999999998 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.9399999999999999 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 2.9100000000000001 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 4.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 2.96 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.7599999999999998 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 4.0599999999999996 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.9399999999999999 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 5.6699999999999999 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.5199999999999996 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 6.46 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 3.5899999999999999 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.9299999999999997 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 4.4900000000000002 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 2.0099999999999998 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4000000000000004 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 3.0600000000000001 111.577 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 3.6600000000000001 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.8600000000000003 112.366 172.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.9199999999999999 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 2.4500000000000002 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 2.6899999999999999 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 2.54 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 4.0 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.1100000000000003 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1000000000000001 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 3.1899999999999999 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.1200000000000001 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 4.1500000000000004 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 4.3899999999999997 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 4.0800000000000001 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 5.4699999999999998 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 4.2999999999999998 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.8599999999999999 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.6099999999999999 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 5.21 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 2.1800000000000002 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.95999999999999996 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 3.5499999999999998 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.436 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 4.0300000000000002 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 2.7799999999999998 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.27 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 3.21 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.1900000000000004 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.5299999999999998 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.1200000000000001 113.112 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 8.8499999999999996 112.377 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 3.8300000000000001 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.402 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 4.5800000000000001 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.0899999999999999 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 2.2799999999999998 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 2.7200000000000002 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.8600000000000001 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 4.7400000000000002 112.377 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 4.5 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 2.0499999999999998 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 4.4199999999999999 114.843 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 4.0 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 2.27 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.5899999999999999 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 5.1799999999999997 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 3.5800000000000001 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 2.6400000000000001 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 2.8900000000000001 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 3.0600000000000001 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 3.5299999999999998 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 12.359999999999999 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 5.2400000000000002 110.667 -179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.46 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 4.0700000000000003 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.2599999999999998 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.413 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.9900000000000002 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 3.8700000000000001 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.7800000000000002 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.413 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.5500000000000007 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.4500000000000002 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.7699999999999996 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 6.0 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 4.6799999999999997 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 7.7199999999999998 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.96 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 5.1200000000000001 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.69 -172.49 18.1 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.4199999999999999 113.512 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.88 169.75 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.345 2.697 . . . . 5.0099999999999998 110.279 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -118.55 164.13 15.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.554 0.742 . . . . 6.5499999999999998 110.26 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.55 -169.31 2.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.018 0.927 . . . . 6.71 109.66 160.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -40.49 63.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.909 0.884 . . . . 9.9299999999999997 112.248 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.06 47.17 1.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.425 1.49 . . . . 7.6799999999999997 112.516 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 72.96 -20.73 0.27 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.049 2.94 . . . . 7.0800000000000001 117.077 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.55 124.95 20.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 122.468 2.395 . . . . 6.6699999999999999 116.048 -164.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.05 88.81 4.6 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.54 1.936 . . . . 5.7699999999999996 109.942 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.38 101.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 6.75 107.495 166.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 4.5099999999999998 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.0199999999999996 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.0899999999999999 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 6.6100000000000003 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 6.4500000000000002 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 4.1500000000000004 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 3.4700000000000002 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 4.1399999999999997 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.8599999999999999 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 3.27 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.48 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.7300000000000004 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.4900000000000002 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.0700000000000003 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 5.25 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 3.3500000000000001 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.7599999999999998 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 7.0199999999999996 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 3.77 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.6200000000000001 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 5.5199999999999996 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 7.9199999999999999 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.8200000000000003 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 6.71 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 2.9199999999999999 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.75 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.8300000000000001 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 2.0699999999999998 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 2.1499999999999999 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 2.2400000000000002 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 2.8399999999999999 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 3.7799999999999998 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 2.3500000000000001 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 2.6000000000000001 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.8900000000000001 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 5.7999999999999998 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 5.4299999999999997 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.5600000000000001 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 4.5 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.422 ' HE ' ' C ' ' A' ' 301' ' ' SER . 19.2 ptt-85 -60.41 120.41 9.84 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.8499999999999996 113.13 -166.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -19.14 13.48 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.008 1.855 . . . . 6.8499999999999996 116.008 -171.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER 148.23 135.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.914 4.486 . . . . 11.960000000000001 111.031 154.863 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.422 ' C ' ' HE ' ' A' ' 298' ' ' ARG . 28.7 t . . . . . 0 C--O 1.251 1.165 0 C-N-CA 131.38 3.872 . . . . 8.4199999999999999 105.82 -158.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 118.263 -0.875 . . . . 20.609999999999999 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -162.95 175.68 10.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.715 1.606 . . . . 16.850000000000001 109.591 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -134.27 155.49 50.11 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.722 1.209 . . . . 14.1 111.514 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.84 134.91 12.48 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.462 1.03 . . . . 11.43 111.903 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -151.18 71.14 8.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.003 0.921 . . . . 9.5500000000000007 112.73 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.96 -174.75 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.589 2.859 . . . . 7.7300000000000004 110.851 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.32 173.72 10.54 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.653 1.581 . . . . 7.2999999999999998 108.33 157.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -39.78 0.18 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.491 0.923 . . . . 8.0500000000000007 113.491 -165.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.99 -54.74 0.66 Allowed Glycine 0 N--CA 1.472 1.086 0 C-N-CA 125.039 1.304 . . . . 4.5 111.642 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.13 169.61 20.63 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.955 1.264 . . . . 4.1399999999999997 114.207 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -85.05 156.23 11.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.36 3.374 . . . . 2.8999999999999999 111.829 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 4.0099999999999998 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 3.3100000000000001 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 3.98 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 2.3599999999999999 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 2.1699999999999999 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 2.1299999999999999 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.9500000000000002 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.8999999999999999 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 9.8000000000000007 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 4.04 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 2.3399999999999999 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7000000000000002 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 7.3899999999999997 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.9700000000000002 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 3.25 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.8399999999999999 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.5600000000000001 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.1400000000000001 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.73 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 4.1399999999999997 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 4.96 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 2.6200000000000001 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 4.1600000000000001 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 4.04 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.5600000000000001 112.344 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 6.8600000000000003 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.6500000000000004 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 6.9100000000000001 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.422 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.9199999999999999 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 10.67 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.422 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.3499999999999996 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 4.0300000000000002 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 2.3799999999999999 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.6799999999999999 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.3700000000000001 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.8199999999999998 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 3.8900000000000001 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.1400000000000001 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.8499999999999996 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 4.0199999999999996 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 2.25 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 2.4500000000000002 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 2.6600000000000001 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 3.0099999999999998 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.9900000000000002 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.1400000000000001 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 2.8599999999999999 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.9500000000000002 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 3.27 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 192' ' ' THR . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 3.2799999999999998 112.788 169.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 4.25 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 190' ' ' ILE . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 4.5700000000000003 112.527 -173.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 4.8700000000000001 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6000000000000001 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.8399999999999999 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 3.5600000000000001 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 2.2999999999999998 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 1.05 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 3.6800000000000002 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 4.3399999999999999 108.508 -163.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 2.4700000000000002 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.7000000000000002 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 2.96 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.3599999999999999 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.5099999999999998 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 7.9800000000000004 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.8899999999999997 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 4.25 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 4.21 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.6400000000000001 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 2.6099999999999999 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 3.21 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 2.6400000000000001 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 5.5300000000000002 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 4.29 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 3.2200000000000002 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 5.8600000000000003 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.0700000000000003 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 3.9900000000000002 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 3.2200000000000002 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.8200000000000001 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 3.73 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 3.23 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 2.1600000000000001 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.1599999999999999 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 3.79 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 3.0499999999999998 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.8600000000000001 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 4.6699999999999999 107.392 169.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.9800000000000004 114.597 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.8399999999999999 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.4199999999999999 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 3.25 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.8500000000000001 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.6000000000000001 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 4.4500000000000002 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 3.2999999999999998 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 5.2599999999999998 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 3.0899999999999999 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.5700000000000003 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.9100000000000001 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 3.1699999999999999 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.7400000000000002 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 4.1799999999999997 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.6899999999999999 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.5899999999999999 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.56 113.46 4.39 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.4300000000000002 111.1 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.13 159.63 52.47 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.062 2.508 . . . . 5.3799999999999999 110.475 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 253' ' ' ASP . 25.6 mmmt -119.09 -173.94 2.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.271 1.952 . . . . 7.5499999999999998 116.271 -164.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.41 -89.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.985 0.914 . . . . 5.7800000000000002 111.546 -142.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.66 -26.29 6.62 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.115 1.766 . . . . 10.31 112.038 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.406 ' HB2' ' HE2' ' A' ' 250' ' ' LYS . 0.9 OUTLIER -81.1 136.05 35.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.913 1.233 . . . . 8.1099999999999994 109.476 157.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.05 -8.81 52.36 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.99 0.916 . . . . 8.4800000000000004 111.859 162.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.56 84.51 0.85 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.586 1.554 . . . . 5.5199999999999996 112.774 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.63 107.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.828 0.851 . . . . 7.9500000000000002 111.606 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -98.5 170.81 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.481 1.512 . . . . 4.79 109.825 -169.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 4.0700000000000003 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.458 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 2.0499999999999998 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 4.1100000000000003 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 5.9299999999999997 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 3.54 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 4.04 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 4.1299999999999999 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 3.3300000000000001 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 4.5899999999999999 109.04 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 4.7400000000000002 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.9100000000000001 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.8100000000000001 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.0600000000000005 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 6.5099999999999998 111.836 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 5.54 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 4.3700000000000001 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 4.54 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.8799999999999999 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 4.3099999999999996 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 7.3899999999999997 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 5.0 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 6.1900000000000004 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.5699999999999998 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 2.2000000000000002 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.5599999999999996 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 2.5 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 2.21 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 2.3300000000000001 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.71 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 4.7300000000000004 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.2999999999999998 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 3.3700000000000001 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 3.0099999999999998 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 4.5099999999999998 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 7.1799999999999997 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.3199999999999998 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 4.4500000000000002 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -55.03 118.38 4.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.9900000000000002 110.791 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -37.23 -74.57 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.235 1.814 . . . . 8.2300000000000004 114.55 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.425 ' HA ' ' HE2' ' A' ' 300' ' ' LYS . 9.0 mmpt? -144.32 20.0 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.127 1.771 . . . . 12.960000000000001 111.187 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.246 0.911 0 C-N-CA 130.998 3.719 . . . . 9.4299999999999997 106.274 -139.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.219 -0.896 . . . . 20.489999999999998 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.93 152.84 26.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.23 0.923 . . . . 16.710000000000001 110.46 163.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -167.06 30.15 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.416 1.487 . . . . 13.91 112.551 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.07 21.88 0.99 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 117.87 1.908 . . . . 10.949999999999999 117.87 -162.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 120.01 6.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.914 1.857 . . . . 11.43 110.444 162.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -80.53 -175.7 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.508 2.805 . . . . 7.4800000000000004 110.547 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.69 160.47 34.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.477 1.911 . . . . 7.6100000000000003 110.312 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.0 116.28 16.54 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.233 -1.025 . . . . 10.01 108.233 167.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.05 -130.86 19.98 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.223 0.916 . . . . 3.3500000000000001 113.751 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.53 141.72 6.02 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.361 1.458 . . . . 3.98 112.065 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.83 112.52 3.3 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.24 2.627 . . . . 4.0999999999999996 111.98 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 3.8599999999999999 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.0800000000000001 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 3.4399999999999999 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.8999999999999999 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 2.25 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 2.3900000000000001 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.9700000000000002 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.1400000000000001 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.5099999999999998 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 7.5700000000000003 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 3.7200000000000002 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.96 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 153' ' ' LYS . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.1299999999999999 113.215 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 152' ' ' ASP . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 6.8499999999999996 114.012 171.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.2999999999999998 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 4.1500000000000004 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 3.75 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.6499999999999999 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.5499999999999998 111.535 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 2.1499999999999999 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 3.7599999999999998 112.567 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 3.75 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 3.2400000000000002 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.9500000000000002 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.98 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 5.8799999999999999 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.422 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 4.1100000000000003 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 6.2699999999999996 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 3.4100000000000001 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.9900000000000002 114.109 -137.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.3499999999999996 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 4.1299999999999999 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.0600000000000001 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.6899999999999999 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.8999999999999999 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.0299999999999998 113.222 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 3.9399999999999999 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.1200000000000001 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 4.1699999999999999 111.611 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 4.0499999999999998 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 2.6699999999999999 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.5800000000000001 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 2.5499999999999998 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 3.04 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.5999999999999996 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.3100000000000001 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 3.5299999999999998 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.5899999999999999 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 3.98 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 3.1200000000000001 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 4.8300000000000001 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 3.6400000000000001 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 4.3600000000000003 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.9500000000000002 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.4900000000000002 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 3.23 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.96 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 1.03 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 3.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 3.71 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 2.6299999999999999 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 2.7000000000000002 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 3.0899999999999999 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.3499999999999996 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.6899999999999999 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.422 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 10.380000000000001 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.4900000000000002 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 4.2199999999999998 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 5.4199999999999999 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 2.5499999999999998 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.79 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.76 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 4.0700000000000003 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 4.6699999999999999 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 2.6499999999999999 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 4.2400000000000002 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.3100000000000001 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 4.1200000000000001 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 2.29 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 2.0699999999999998 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 4.8300000000000001 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 3.0699999999999998 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 2.73 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.89000000000000001 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.9700000000000002 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 3.2400000000000002 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.0499999999999998 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 3.71 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 9.1500000000000004 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.4399999999999999 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.1900000000000004 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.8599999999999999 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.8399999999999999 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 4.3099999999999996 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 3.9500000000000002 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 3.3399999999999999 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.5800000000000001 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.3900000000000001 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.9100000000000001 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 9.2899999999999991 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 3.6000000000000001 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 7.0199999999999996 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 4.3300000000000001 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 4.0800000000000001 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.3500000000000001 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -70.31 154.28 52.42 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.3799999999999999 114.156 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -100.82 -4.72 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.322 3.348 . . . . 4.9199999999999999 113.795 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.49 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 28.6 ttmt 103.13 113.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 131.934 4.094 . . . . 6.5499999999999998 108.048 -153.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.13 -46.41 5.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.821 -0.609 . . . . 8.7899999999999991 111.555 -166.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -151.64 135.48 16.42 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.656 0.662 . . . . 12.140000000000001 112.222 155.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 t70 60.55 -62.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 130.2 3.4 . . . . 8.7699999999999996 115.144 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.49 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 7.5 tp10 -154.31 10.42 0.38 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.975 2.11 . . . . 8.1600000000000001 112.281 175.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -78.64 156.59 28.97 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.262 -1.524 . . . . 6.0800000000000001 112.071 169.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.99 104.57 3.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.946 1.298 . . . . 6.5300000000000002 112.063 -170.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt -81.69 161.34 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 120.988 -1.07 . . . . 4.9299999999999997 112.439 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.8799999999999999 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.4699999999999998 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.4700000000000002 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.9800000000000004 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 5.6699999999999999 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 3.75 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.7999999999999998 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 4.0700000000000003 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 2.9199999999999999 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 3.9700000000000002 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.6399999999999999 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.0600000000000001 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2000000000000002 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.4300000000000002 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 5.2400000000000002 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 4.3499999999999996 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 3.8900000000000001 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 3.04 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 4.25 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 4.0199999999999996 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.424 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.2200000000000002 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.8499999999999996 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 6.0499999999999998 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.7199999999999998 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 6.2699999999999996 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 3.2599999999999998 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.6499999999999999 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 2.5099999999999998 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 2.1899999999999999 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.98 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 3.27 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 3.4300000000000002 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 2.25 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 2.5699999999999998 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.5899999999999999 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 5.9100000000000001 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 7.2599999999999998 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.2599999999999998 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 4.6699999999999999 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 79.04 -65.52 0.21 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 9.6600000000000001 111.173 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -173.72 147.41 1.38 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.061 1.134 . . . . 9.3300000000000001 114.061 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 8.74 35.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.938 2.095 . . . . 16.149999999999999 112.929 165.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 126.159 1.784 . . . . 11.34 110.536 -138.751 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 117.917 -1.04 . . . . 18.399999999999999 109.939 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -159.72 148.41 17.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.179 0.992 . . . . 16.039999999999999 111.091 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t 153.46 155.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 1 C-N-CA 132.032 4.133 . . . . 12.869999999999999 108.047 176.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 5.13 20.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.846 1.212 . . . . 10.630000000000001 113.179 166.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -146.08 142.31 17.56 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.755 1.277 . . . . 10.109999999999999 112.206 -171.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.27 164.06 35.01 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.628 . . . . 7.0199999999999996 109.834 163.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.6 mt -139.24 76.34 1.56 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.477 1.111 . . . . 8.9100000000000001 111.16 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.3 mt -141.93 114.98 8.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.473 1.909 . . . . 8.2899999999999991 106.82 170.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.87 149.31 1.92 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.195 0.902 . . . . 3.79 112.686 -166.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.73 -48.97 0.89 Allowed Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.113 -1.937 . . . . 6.2800000000000002 115.3 176.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -100.18 133.57 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.417 2.608 . . . . 3.3999999999999999 111.761 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 3.8700000000000001 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 4.0300000000000002 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 3.3900000000000001 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 2.3700000000000001 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 2.3599999999999999 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.79 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 3.6000000000000001 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.0299999999999998 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.8600000000000003 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 7.2400000000000002 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.9900000000000002 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 3.0600000000000001 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.3999999999999999 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.8399999999999999 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.0899999999999999 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.411 ' HH ' HG13 ' A' ' 225' ' ' VAL . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 3.5600000000000001 113.788 -177.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 6.0999999999999996 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.8899999999999999 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.5800000000000001 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.5900000000000001 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 3.6200000000000001 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.98 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 3.3999999999999999 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 4.0700000000000003 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 3.29 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 5.5899999999999999 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.0599999999999996 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 9.6699999999999999 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.8900000000000001 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 5.8600000000000003 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.3399999999999999 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 4.2599999999999998 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.427 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.9399999999999999 115.104 164.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.7599999999999998 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.5499999999999998 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.4399999999999999 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 3.7999999999999998 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.3100000000000001 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 6.3399999999999999 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 6.2800000000000002 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 5.04 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.4700000000000002 111.678 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 2.4900000000000002 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 3.4199999999999999 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.7599999999999998 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.2400000000000002 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 3.1800000000000002 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.6299999999999999 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 3.52 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 4.7400000000000002 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 4.0899999999999999 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.7999999999999998 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 5.04 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.2800000000000002 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 3.3799999999999999 108.877 135.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 2.8999999999999999 109.428 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 3.1499999999999999 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 3.6800000000000002 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 2.4100000000000001 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.9399999999999999 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 2.2599999999999998 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.1699999999999999 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.3500000000000001 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.3899999999999997 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.405 HH22 ' CG ' ' A' ' 255' ' ' ASP . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 8.2699999999999996 110.951 -175.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.8399999999999999 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 4.21 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 4.0300000000000002 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.7400000000000002 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 3.1400000000000001 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 3.0600000000000001 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 2.1800000000000002 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 4.1699999999999999 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 4.1799999999999997 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 2.5600000000000001 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 4.0599999999999996 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.9500000000000002 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 4.3200000000000003 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 2.4300000000000002 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.3100000000000001 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 4.2400000000000002 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 3.5099999999999998 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.411 HG13 ' HH ' ' A' ' 155' ' ' TYR . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 2.3900000000000001 109.232 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.1299999999999999 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 3.0699999999999998 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 3.2400000000000002 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 3.8500000000000001 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 7.1699999999999999 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.5899999999999999 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.4700000000000002 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 3.0800000000000001 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 3.2000000000000002 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 4.6200000000000001 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 3.3399999999999999 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 4.5599999999999996 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 3.0299999999999998 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.8799999999999999 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 7.0 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 3.6499999999999999 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 6.1600000000000001 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.4100000000000001 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 3.1400000000000001 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.71 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -130.92 156.61 21.82 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.5699999999999998 113.763 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -79.59 -159.35 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.336 3.357 . . . . 4.4299999999999997 110.194 175.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.26 177.07 9.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.183 2.193 . . . . 5.5499999999999998 111.301 172.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.25 -70.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.724 -1.584 . . . . 7.3300000000000001 106.724 154.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -168.02 167.6 12.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.668 1.987 . . . . 9.0899999999999999 109.922 164.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 77.61 -27.35 0.17 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 129.793 3.237 . . . . 8.5700000000000003 112.808 172.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -73.64 -32.72 64.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.869 1.268 . . . . 11.58 112.938 162.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.405 ' CG ' HH22 ' A' ' 207' ' ' ARG . 22.8 t0 62.25 165.58 0.1 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.747 2.419 . . . . 6.6699999999999999 113.614 -170.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -66.62 145.26 55.78 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.619 -1.926 . . . . 5.4400000000000004 112.013 -177.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.44 168.44 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.8 -1.188 . . . . 5.6799999999999997 112.917 -167.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 4.3099999999999996 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.6299999999999999 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.427 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 20.0 p80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.3799999999999999 114.058 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.7000000000000002 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.8600000000000003 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 3.2400000000000002 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 5.1600000000000001 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 3.8500000000000001 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.8799999999999999 110.972 177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 3.0699999999999998 107.884 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.6599999999999999 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.4900000000000002 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.9500000000000002 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7000000000000002 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.1999999999999993 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 4.9100000000000001 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 4.1100000000000003 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.7400000000000002 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 5.1500000000000004 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 3.9500000000000002 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 3.7799999999999998 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 6.1799999999999997 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 7.7400000000000002 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 8.8499999999999996 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 6.0800000000000001 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.6499999999999999 113.161 -171.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 2.27 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.6699999999999999 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 2.5099999999999998 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 2.27 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 2.7200000000000002 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 3.27 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 3.9399999999999999 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 3.3599999999999999 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 3.0499999999999998 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 2.5499999999999998 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 6.6900000000000004 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 7.2400000000000002 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.6499999999999999 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 4.7300000000000004 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -156.03 135.31 12.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 9.0500000000000007 112.464 -165.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt 124.82 175.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.469 4.308 . . . . 10.050000000000001 111.597 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -133.6 46.4 2.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.274 1.83 . . . . 11.949999999999999 108.302 160.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.246 0.888 0 C-N-CA 125.634 1.574 . . . . 11.91 111.663 -157.19 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.021 -0.99 . . . . 24.829999999999998 110.159 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -162.56 155.96 20.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.442 1.497 . . . . 19.75 109.812 -177.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t 179.08 166.65 0.96 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.327 2.651 . . . . 18.140000000000001 109.132 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.17 158.72 8.79 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.763 1.649 . . . . 13.82 112.667 -178.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -89.58 152.14 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 121.779 -0.836 . . . . 12.869999999999999 112.849 173.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -69.94 176.11 7.35 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.708 2.272 . . . . 9.0 109.604 157.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -126.0 160.39 30.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.895 1.278 . . . . 8.25 112.192 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.48 -124.69 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.911 2.085 . . . . 6.5199999999999996 108.82 -177.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.82 154.04 10.16 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.21 1.386 . . . . 3.4199999999999999 112.315 -168.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.71 111.64 3.33 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.893 -1.504 . . . . 3.8500000000000001 113.257 -167.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.13 94.09 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 120.742 2.271 . . . . 3.9500000000000002 110.412 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 3.8300000000000001 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.5299999999999998 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 3.46 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 2.7200000000000002 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 2.21 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.9399999999999999 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 3.8900000000000001 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.3300000000000001 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 7.3200000000000003 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 3.5699999999999998 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.3700000000000001 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 8.0099999999999998 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.0800000000000001 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 4.4699999999999998 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 4.3099999999999996 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.76 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.0700000000000003 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 2.1699999999999999 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 3.5299999999999998 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 4.5499999999999998 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 2.4700000000000002 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 5.0199999999999996 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 3.7999999999999998 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.3300000000000001 115.567 -173.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.468 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 5.8899999999999997 110.164 162.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.3500000000000001 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 8.7100000000000009 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.75 111.846 -167.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.9900000000000002 114.275 -154.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.5699999999999998 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 4.5499999999999998 113.034 -174.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.523 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.27 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.98 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.4300000000000002 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.3300000000000001 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 3.8500000000000001 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.0899999999999999 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 7.6299999999999999 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 4.0300000000000002 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 2.21 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.6800000000000002 111.434 174.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 2.4399999999999999 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 3.48 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.3200000000000003 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.0499999999999998 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 3.5600000000000001 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.447 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.6699999999999999 110.887 172.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 3.21 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 192' ' ' THR . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 3.6000000000000001 111.501 171.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 3.6000000000000001 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 190' ' ' ILE . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 3.3700000000000001 110.398 176.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 3.6200000000000001 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.403 ' HA ' ' HE2' ' A' ' 299' ' ' LYS . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.6200000000000001 113.308 -167.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.2999999999999998 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 4.0499999999999998 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 2.0699999999999998 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.91000000000000003 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 3.6000000000000001 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 3.7599999999999998 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 2.3500000000000001 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 2.2799999999999998 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 3.2799999999999998 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.4400000000000004 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.7200000000000002 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.0300000000000002 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 7.8200000000000003 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.3200000000000003 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 3.48 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 4.4000000000000004 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.7599999999999998 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 2.6899999999999999 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 2.54 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 2.1299999999999999 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 5.3300000000000001 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.9299999999999997 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.99 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 4.0599999999999996 115.658 -179.875 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.9399999999999999 110.064 170.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 4.0199999999999996 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 2.1600000000000001 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.25 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.447 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 4.0199999999999996 112.889 173.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 3.1800000000000002 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 3.0 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92000000000000004 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 2.8700000000000001 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 3.2400000000000002 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.4300000000000002 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 5.1500000000000004 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 6.1799999999999997 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.71 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.8200000000000003 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 3.6200000000000001 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.0600000000000001 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.0600000000000001 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 4.6799999999999997 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.6499999999999999 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 5.3700000000000001 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 3.4399999999999999 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 4.9400000000000004 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 6.2699999999999996 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.98 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 6.6399999999999997 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 4.5599999999999996 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.9300000000000002 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.5299999999999998 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.8 169.74 54.34 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.7000000000000002 115.279 -175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 -41.32 0.99 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.6 2.867 . . . . 6.6299999999999999 112.333 -168.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.327 16.7 ptpt 56.23 153.37 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.956 2.947 . . . . 7.0 118.956 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.0 -132.97 0.18 Allowed 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.601 -1.182 . . . . 7.5199999999999996 108.764 165.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -51.31 -33.48 29.17 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.935 1.698 . . . . 11.710000000000001 114.192 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -170.45 -30.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.229 1.412 . . . . 10.619999999999999 111.98 167.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.74 159.06 34.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.378 1.071 . . . . 8.6199999999999992 112.899 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . 0.279 16.2 t70 74.19 28.91 1.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.084 2.554 . . . . 8.4900000000000002 112.923 -164.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -68.74 58.12 0.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.837 1.255 . . . . 8.5800000000000001 111.967 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.24 151.55 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.564 -1.335 . . . . 4.8600000000000003 109.238 161.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 5.4699999999999998 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.6800000000000002 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.523 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.5 p80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.5699999999999998 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 5.2699999999999996 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 4.0 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 4.8200000000000003 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 4.04 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 4.2199999999999998 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 3.3599999999999999 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 3.3199999999999998 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.6899999999999999 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.0999999999999996 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.4700000000000002 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 5.6900000000000004 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 3.8799999999999999 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.5099999999999998 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 4.7599999999999998 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 4.6500000000000004 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.9900000000000002 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.7199999999999998 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 10.5 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 6.2599999999999998 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 6.54 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 3.1099999999999999 112.733 -173.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.54 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.3099999999999996 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 3.4100000000000001 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.8500000000000001 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 3.73 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 4.46 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 4.3099999999999996 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.4300000000000002 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 3.8599999999999999 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 3.0800000000000001 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 5.2699999999999996 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 7.6299999999999999 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.1200000000000001 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 4.6600000000000001 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.62 116.53 5.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 8.3599999999999994 113.41 -166.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 194' ' ' PRO . 1.2 tmtt? -60.26 -36.3 77.48 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.3 1.963 . . . . 8.4399999999999995 116.3 -157.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.45 ' HZ3' ' C ' ' A' ' 301' ' ' SER . 0.2 OUTLIER -135.45 5.01 3.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.765 1.024 . . . . 9.8599999999999994 113.765 -179.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.45 ' C ' ' HZ3' ' A' ' 300' ' ' LYS . 47.4 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.065 1.346 . . . . 9.0800000000000001 109.479 -149.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 118.275 -0.869 . . . . 26.41 109.98 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -72.56 176.27 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.279 0.49 . . . . 25.879999999999999 110.547 158.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.4 p -137.84 160.31 39.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.301 1.84 . . . . 20.850000000000001 110.325 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.19 -167.49 28.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.75 1.643 . . . . 16.940000000000001 112.375 -176.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 122.67 145.8 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 131.406 3.883 . . . . 14.81 110.871 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 130.45 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.713 2.276 . . . . 14.029999999999999 111.943 169.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.59 -40.82 11.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.766 1.226 . . . . 10.43 112.786 -171.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.15 133.17 2.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.02 1.328 . . . . 6.7599999999999998 111.113 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -119.76 145.97 17.92 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.571 -1.412 . . . . 4.1900000000000004 109.571 160.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.14 122.3 25.2 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.991 -1.45 . . . . 3.8100000000000001 109.689 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 121.79 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.221 2.011 . . . . 4.0 111.935 -166.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 4.1299999999999999 108.205 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 3.7200000000000002 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 3.8100000000000001 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.5899999999999999 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 2.5099999999999998 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 2.27 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 4.04 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.8300000000000001 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 6.7000000000000002 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.441 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 9.0899999999999999 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 6.0899999999999999 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.6799999999999997 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 9.0500000000000007 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.441 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 3.96 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 5.8300000000000001 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 3.0600000000000001 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.8999999999999999 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 3.1400000000000001 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 4.4900000000000002 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 4.3600000000000003 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 3.3500000000000001 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 6.5499999999999998 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 3.0800000000000001 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.3500000000000001 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 7.0599999999999996 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.6800000000000002 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 6.2199999999999998 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 3.5899999999999999 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 6.6399999999999997 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.568 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 4.3399999999999999 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 2.0899999999999999 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.3700000000000001 112.396 -168.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.6600000000000001 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 3.5600000000000001 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.6699999999999999 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 5.2999999999999998 110.656 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 4.9400000000000004 113.453 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 3.2599999999999998 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 2.6899999999999999 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 2.3199999999999998 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 3.6099999999999999 110.746 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.4400000000000004 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.3599999999999999 112.035 168.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 3.5 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.3900000000000001 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.6800000000000002 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.0700000000000003 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 5.7400000000000002 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 5.8899999999999997 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 5.6200000000000001 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.7000000000000002 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.3300000000000001 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 4.75 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 2.9199999999999999 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.9199999999999999 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 4.2800000000000002 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 4.5099999999999998 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 3.3199999999999998 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 2.23 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 2.6400000000000001 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.5300000000000002 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.73 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.9699999999999998 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 8.1899999999999995 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.1399999999999997 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 4.9199999999999999 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 8.75 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 3.1200000000000001 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 4.3600000000000003 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 2.3999999999999999 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 4.7599999999999998 111.705 170.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 5.5999999999999996 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 2.73 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 4.0499999999999998 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.2199999999999998 111.334 173.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 3.6499999999999999 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 3.5299999999999998 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.96 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 4.7400000000000002 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 3.6400000000000001 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 3.0800000000000001 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 3.7799999999999998 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 3.4399999999999999 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.4199999999999999 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.6600000000000001 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.9700000000000006 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.8300000000000001 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.0700000000000003 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.7599999999999998 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 239' ' ' ARG . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7000000000000002 111.86 167.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.9900000000000002 111.412 172.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 4.2800000000000002 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 3.2599999999999998 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 235' ' ' ASP . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.7999999999999998 113.22 170.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 3.1499999999999999 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 4.0899999999999999 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.8899999999999997 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 4.21 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 7.3200000000000003 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 5.1200000000000001 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 4.04 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 4.1299999999999999 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.18 155.01 29.46 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.93 -50.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.701 2.267 . . . . 4.8600000000000003 110.283 165.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.438 ' HZ1' ' CD ' ' A' ' 252' ' ' GLU 0.25 0.2 OUTLIER 63.36 -28.31 0.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 129.178 2.991 . . . . 10.390000000000001 116.871 177.202 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 74.65 -23.63 0.23 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.42 1.888 . . . . 6.0899999999999999 115.305 150.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.438 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 29.5 mt-10 -102.95 -36.73 8.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.97 2.508 . . . . 9.6799999999999997 112.994 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -160.3 138.86 10.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.392 1.877 . . . . 7.8700000000000001 106.211 -171.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -80.8 41.37 0.57 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.319 1.448 . . . . 7.5099999999999998 113.409 -163.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -146.01 152.97 40.23 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.848 1.259 . . . . 6.7000000000000002 113.237 -177.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -177.31 164.45 2.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.701 2.0 . . . . 5.8799999999999999 112.44 -155.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt -74.08 156.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.386 -1.446 . . . . 6.3099999999999996 109.412 163.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 4.9299999999999997 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.7999999999999998 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.628 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 29.2 p80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.3799999999999999 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 4.2800000000000002 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 4.54 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 3.29 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 4.4199999999999999 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 4.9800000000000004 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 4.6500000000000004 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 4.5700000000000003 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.9399999999999999 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.6099999999999999 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.7699999999999996 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.3500000000000001 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.4100000000000001 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 5.0499999999999998 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 5.1799999999999997 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 4.5099999999999998 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.9000000000000004 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 4.0300000000000002 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.3999999999999999 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 5.0199999999999996 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 5.8499999999999996 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 6.3700000000000001 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 6.9299999999999997 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.519 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 2.54 113.636 -168.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.8999999999999999 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.6400000000000001 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 2.46 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 2.1099999999999999 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 2.25 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 3.0600000000000001 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 3.4100000000000001 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 2.9100000000000001 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 2.8399999999999999 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 3.2599999999999998 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.7800000000000002 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 6.8399999999999999 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.3700000000000001 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 5.1600000000000001 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.416 HH12 ' C ' ' A' ' 301' ' ' SER . 17.4 ttt-85 -55.4 147.28 17.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.9199999999999999 110.666 172.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -59.61 164.83 3.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.992 -1.068 . . . . 8.9100000000000001 112.298 172.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.04 10.53 11.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.105 1.362 . . . . 14.789999999999999 113.4 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.416 ' C ' HH12 ' A' ' 298' ' ' ARG . 5.7 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 129.086 2.955 . . . . 10.85 107.953 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.194 -0.908 . . . . 20.460000000000001 109.997 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -64.38 152.66 40.78 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.597 0.635 . . . . 17.16 110.088 158.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t 179.09 153.78 0.41 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.378 2.671 . . . . 14.9 108.969 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.22 -179.15 49.71 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.38 -0.688 . . . . 12.25 111.38 162.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -163.4 150.51 10.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.493 1.517 . . . . 11.75 111.394 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.13 176.02 10.63 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.333 2.688 . . . . 10.0 111.095 172.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.23 152.98 45.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.351 1.46 . . . . 8.2100000000000009 109.267 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.88 143.52 49.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.745 1.218 . . . . 9.1999999999999993 108.482 178.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.91 -57.52 5.77 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.114 0.864 . . . . 5.5 111.882 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.37 58.81 0.51 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 117.318 -1.823 . . . . 4.7800000000000002 115.737 -176.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.04 128.44 13.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 120.716 2.258 . . . . 4.29 110.827 -173.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 5.0199999999999996 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.0199999999999996 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 3.3999999999999999 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 3.4900000000000002 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 2.48 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 2.5299999999999998 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 3.1899999999999999 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.8899999999999997 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.8399999999999999 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 4.5800000000000001 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 4.1299999999999999 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.8100000000000001 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.8599999999999994 114.548 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.7799999999999998 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' A' ' 227' ' ' LEU . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 4.7300000000000004 112.553 154.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 4.6100000000000003 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 2.25 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 3.5 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 3.5600000000000001 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 4.6600000000000001 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 2.8100000000000001 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.6100000000000003 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 3.9900000000000002 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.1699999999999999 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 6.4199999999999999 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 3.4199999999999999 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 6.25 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 4.4400000000000004 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 7.0300000000000002 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.4199999999999999 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 3.4399999999999999 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.3100000000000001 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 3.1800000000000002 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 179' ' ' LYS . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.4399999999999999 111.724 173.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.4700000000000002 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 4.4299999999999997 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.2699999999999996 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 175' ' ' GLU . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 4.5499999999999998 112.248 175.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.6699999999999999 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 3.1200000000000001 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 3.73 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 3.0099999999999998 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 3.6600000000000001 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.9399999999999999 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 2.9300000000000002 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.3399999999999999 110.288 167.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 3.73 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 3.7799999999999998 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 3.5 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 3.6400000000000001 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 4.0599999999999996 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.8700000000000001 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.8100000000000001 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 3.4399999999999999 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 2.1600000000000001 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.90000000000000002 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 3.79 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 4.3600000000000003 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 3.27 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.8599999999999999 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.5600000000000001 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.423 ' CG ' ' HE ' ' A' ' 207' ' ' ARG . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.79 110.105 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.8500000000000001 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.1500000000000004 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.423 ' HE ' ' CG ' ' A' ' 204' ' ' ASP . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 9.6600000000000001 115.411 -178.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 4.3399999999999999 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 5.4500000000000002 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.2699999999999996 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 2.6099999999999999 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 2.77 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 2.5800000000000001 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 3.8199999999999998 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 4.21 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 2.3599999999999999 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.509 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 4.1299999999999999 114.851 -177.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.509 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.8700000000000001 112.012 167.142 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 4.2599999999999998 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.5099999999999998 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 3.2200000000000002 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 3.77 112.621 168.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 3.0800000000000001 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 2.3399999999999999 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1000000000000001 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.461 HD11 ' HH ' ' A' ' 155' ' ' TYR . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 3.04 111.43 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 3.5299999999999998 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.8700000000000001 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.9600000000000009 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.6600000000000001 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.4500000000000002 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 3.0099999999999998 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.3300000000000001 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 3.3999999999999999 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 3.6000000000000001 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.7000000000000002 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.5899999999999999 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.8599999999999999 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 4.79 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 6.75 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 3.5499999999999998 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 7.0599999999999996 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 4.2999999999999998 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 4.4100000000000001 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.98 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.27 177.37 37.89 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.8900000000000001 110.942 164.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.34 162.03 41.28 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.967 2.445 . . . . 5.2400000000000002 111.43 177.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 26.5 mtpt -81.6 110.52 17.04 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.337 -1.357 . . . . 7.2699999999999996 107.337 161.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -164.7 -46.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.554 0.742 . . . . 8.1999999999999993 111.736 -152.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.76 -24.33 65.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.47 1.108 . . . . 14.35 113.767 168.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 254' ' ' GLU . 29.4 t70 161.28 -138.17 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 1 C-N-CA 133.676 4.79 . . . . 9.8399999999999999 103.316 175.11 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.411 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 14.4 mm-40 -98.82 -10.52 22.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.465 1.506 . . . . 8.0500000000000007 114.052 -174.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -84.6 52.9 2.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.299 1.047 . . . . 8.4100000000000001 113.627 -175.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -0.15 94.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 130.061 3.344 . . . . 5.1200000000000001 116.315 171.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.22 138.32 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 121.319 -0.863 . . . . 5.3499999999999996 110.306 175.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 4.0099999999999998 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.0800000000000001 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.411 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.48 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.8900000000000001 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 4.6299999999999999 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 2.79 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 5.5199999999999996 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 4.3399999999999999 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 3.0600000000000001 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.8500000000000001 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.4699999999999998 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.5300000000000002 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 3.48 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 273' ' ' PHE . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.3399999999999999 114.155 -174.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.409 ' H ' ' HG3' ' A' ' 272' ' ' GLU . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 5.5999999999999996 113.253 -177.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 4.2599999999999998 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.8100000000000001 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 4.0199999999999996 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 4.6200000000000001 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 3.04 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 5.0 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 6.1799999999999997 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 5.04 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 9.2100000000000009 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 3.27 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.54 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 2.8799999999999999 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 2.1699999999999999 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 2.9300000000000002 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 3.9500000000000002 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 3.5699999999999998 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 2.46 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 3.54 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 4.1900000000000004 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.9100000000000001 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 6.0499999999999998 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.3199999999999998 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 6.0700000000000003 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -48.13 133.67 14.93 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 9.7400000000000002 111.386 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 166.14 3.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.03 1.332 . . . . 6.3700000000000001 113.044 -175.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -108.1 -111.19 0.3 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.031 -1.1 . . . . 12.289999999999999 108.031 -172.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 116.125 -1.893 . . . . 11.17 111.216 130.354 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 118.185 -0.912 . . . . 18.890000000000001 109.968 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.45 168.05 13.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.682 0.674 . . . . 18.399999999999999 110.937 164.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.3 t -154.72 145.88 22.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.958 1.703 . . . . 13.970000000000001 109.075 173.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.46 -19.28 57.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.972 -0.904 . . . . 14.460000000000001 115.108 -169.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -104.05 105.62 49.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 119.49 1.645 . . . . 12.75 111.696 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.15 177.81 8.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.918 2.412 . . . . 10.33 110.368 166.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 155.26 21.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.363 1.865 . . . . 7.6600000000000001 110.093 175.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -161.47 -14.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.248 1.819 . . . . 8.0500000000000007 113.211 -171.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.92 122.21 25.35 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.082 1.325 . . . . 3.4100000000000001 113.428 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.81 136.73 15.24 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.62 -1.1 . . . . 4.2300000000000004 112.577 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.97 172.8 15.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.432 2.755 . . . . 3.8799999999999999 111.023 176.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 4.6699999999999999 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 3.3700000000000001 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 3.8700000000000001 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 3.5699999999999998 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 2.3999999999999999 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 2.1400000000000001 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 3.9399999999999999 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.4500000000000002 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.390000000000001 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 5.3300000000000001 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 4.4800000000000004 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 3.4399999999999999 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.8899999999999997 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 10.779999999999999 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.1299999999999999 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.558 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 4.9400000000000004 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 5.0499999999999998 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 2.3199999999999998 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 3.71 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.54 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 3.2000000000000002 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 3.9100000000000001 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 3.1000000000000001 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.2300000000000004 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 3.2400000000000002 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 5.5899999999999999 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.4699999999999998 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 7.3799999999999999 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 3.3199999999999998 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 6.0899999999999999 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.2300000000000004 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 6.4400000000000004 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.2400000000000002 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.7000000000000002 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 282' ' ' ARG . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.6699999999999999 111.449 177.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 4.6799999999999997 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.4800000000000004 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.7999999999999998 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 5.6699999999999999 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 2.1400000000000001 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.409 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.3599999999999999 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 4.2999999999999998 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 3.23 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.2999999999999998 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.1400000000000001 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 3.4500000000000002 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.5099999999999998 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.8300000000000001 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 3.3799999999999999 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.8999999999999999 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 4.71 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 3.4399999999999999 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 3.1699999999999999 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.3200000000000003 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 3.5099999999999998 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 2.54 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.3200000000000001 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 3.1699999999999999 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 3.8999999999999999 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 2.6699999999999999 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 2.5800000000000001 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.1699999999999999 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.8200000000000003 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.3799999999999999 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7000000000000002 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 7.0700000000000003 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.4100000000000001 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.8999999999999999 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 4.2599999999999998 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.9700000000000002 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 2.54 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 3.5099999999999998 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 2.4900000000000002 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 5.3099999999999996 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 5.3499999999999996 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 2.0899999999999999 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.9500000000000002 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 4.25 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 3.9199999999999999 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.54 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.8400000000000001 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 4.1100000000000003 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 3.1800000000000002 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 2.21 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76000000000000001 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 3.2799999999999998 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.6699999999999999 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.7400000000000002 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.3700000000000001 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 8.6199999999999992 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.6600000000000001 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.0199999999999996 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 3.6099999999999999 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.6400000000000001 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.9199999999999999 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 4.1100000000000003 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.8900000000000001 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.8300000000000001 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 3.3700000000000001 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 10.08 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 3.2200000000000002 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 6.3499999999999996 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 5.46 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.6699999999999999 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 5.2599999999999998 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.69 16.48 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.3499999999999996 111.194 176.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.79 -43.73 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.399 2.066 . . . . 6.6200000000000001 111.833 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt 67.42 110.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.428 2.691 . . . . 7.8799999999999999 114.24 -174.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.27 39.39 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.725 1.61 . . . . 6.3899999999999997 111.214 176.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 69.85 -49.76 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 130.094 3.358 . . . . 11.630000000000001 113.036 -178.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -79.99 46.26 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.948 2.099 . . . . 8.7799999999999994 113.558 -173.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 66.54 -21.29 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 129.16 2.984 . . . . 8.7400000000000002 118.08 170.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -74.35 144.48 44.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.638 2.017 . . . . 8.8100000000000005 111.463 170.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.24 122.06 5.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.558 1.171 . . . . 9.7400000000000002 113.332 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.03 76.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.753 -1.217 . . . . 8.3100000000000005 112.303 170.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 6.2000000000000002 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.3600000000000003 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 6.6200000000000001 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.9699999999999998 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 5.71 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 4.1500000000000004 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 4.6299999999999999 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 5.1699999999999999 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 3.3399999999999999 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 3.4500000000000002 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 2.02 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.4900000000000002 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.0099999999999998 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 3.0899999999999999 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.0800000000000001 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 6.25 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 4.04 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 4.2300000000000004 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.8399999999999999 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 5.4100000000000001 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.3999999999999999 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.7000000000000002 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 7.25 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 7.1100000000000003 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 175' ' ' GLU . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 8.5299999999999994 110.524 156.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.409 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 3.4700000000000002 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.6899999999999999 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.8099999999999996 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 4.5099999999999998 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 2.8199999999999998 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 3.2400000000000002 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.96 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 4.3600000000000003 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 2.48 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 3.3700000000000001 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.9300000000000002 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.7999999999999998 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 6.4500000000000002 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.8799999999999999 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 4.7599999999999998 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -77.18 92.0 3.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 10.970000000000001 112.237 -166.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -49.51 -40.82 39.11 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.414 2.005 . . . . 8.8499999999999996 116.414 -163.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -137.95 -37.1 0.59 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.726 1.38 . . . . 12.18 114.726 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.069 0 C-N-CA 128.608 2.763 . . . . 7.75 110.399 174.038 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 118.277 -0.868 . . . . 16.989999999999998 109.989 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -67.0 163.53 19.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.728 0.695 . . . . 16.649999999999999 111.152 168.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.4 -2.37 22.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.636 1.575 . . . . 10.949999999999999 114.434 -170.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.35 -1.63 33.9 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.635 1.414 . . . . 11.69 116.635 167.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.75 119.49 63.84 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 119.351 1.575 . . . . 11.52 112.305 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.97 154.29 47.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.595 2.197 . . . . 12.01 110.56 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.8 mt -142.77 162.17 36.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.205 1.802 . . . . 7.4699999999999998 108.994 175.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.26 -14.15 21.55 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.771 0.828 . . . . 10.85 113.101 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.67 -161.67 11.49 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.68 1.61 . . . . 5.5599999999999996 112.441 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.51 -32.96 6.07 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.726 -1.597 . . . . 5.21 115.03 178.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -104.79 65.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.207 3.271 . . . . 3.2599999999999998 110.032 167.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 4.5199999999999996 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 3.25 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 3.3999999999999999 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 2.2999999999999998 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 2.3700000000000001 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 2.3500000000000001 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 3.1600000000000001 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.8499999999999996 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 5.5300000000000002 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 4.0599999999999996 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 3.5499999999999998 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.9900000000000002 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 6.3499999999999996 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 3.6800000000000002 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 4.0999999999999996 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 2.2200000000000002 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 3.5499999999999998 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.8400000000000001 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 3.8900000000000001 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 4.3099999999999996 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 3.9300000000000002 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.8899999999999997 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 3.1400000000000001 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.0800000000000001 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.456 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 5.6100000000000003 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.54 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 6.1900000000000004 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 3.4700000000000002 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 7.1200000000000001 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.2999999999999998 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.9900000000000002 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.8700000000000001 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.2400000000000002 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.476 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.9900000000000002 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 3.7200000000000002 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.9100000000000001 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 4.0199999999999996 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 5.1399999999999997 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 2.3199999999999998 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.414 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.3500000000000001 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 2.5 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 3.5600000000000001 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.1500000000000004 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.6400000000000001 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 3.3100000000000001 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.73 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 3.2000000000000002 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 3.6800000000000002 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.48 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 3.6299999999999999 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.3199999999999998 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 4.7999999999999998 110.801 153.131 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 2.46 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.04 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 3.6200000000000001 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 3.6600000000000001 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 2.3100000000000001 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.98 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.4900000000000002 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2000000000000002 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.8399999999999999 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.6900000000000004 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 8.4199999999999999 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 4.4000000000000004 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 5.3799999999999999 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 4.2599999999999998 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 3.27 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.9100000000000001 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 2.27 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 4.25 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 4.7400000000000002 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 2.1299999999999999 112.592 176.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 4.5 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.6499999999999999 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 4.0 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.9399999999999999 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.5899999999999999 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 3.3999999999999999 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 3.1600000000000001 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 3.8399999999999999 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.92000000000000004 112.603 -173.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 2.8599999999999999 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.75 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.4300000000000002 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 5.2999999999999998 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 6.0700000000000003 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.9300000000000002 113.384 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.6800000000000002 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 3.3500000000000001 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.3900000000000001 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 4.0899999999999999 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.9300000000000002 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 4.2300000000000004 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 3.0800000000000001 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.7200000000000002 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 8.5199999999999996 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 5.3499999999999996 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 6.2400000000000002 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 3.7400000000000002 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 3.4900000000000002 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.8599999999999999 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -126.65 76.18 0.4 Allowed Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.71 111.767 173.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.72 150.8 24.48 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.292 2.661 . . . . 8.3800000000000008 112.799 -172.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 67.2 45.68 1.63 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.995 2.118 . . . . 6.5599999999999996 113.611 175.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -112.29 150.46 30.94 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.508 1.523 . . . . 7.3700000000000001 111.077 170.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 57.11 -68.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.812 2.845 . . . . 10.69 110.505 -157.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -157.03 -77.74 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 7.6799999999999997 109.429 154.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -132.85 38.85 3.36 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.075 1.509 . . . . 7.4500000000000002 115.075 -162.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -160.46 149.95 17.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.355 1.062 . . . . 6.5599999999999996 110.39 149.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -176.83 172.58 2.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.885 1.439 . . . . 5.7400000000000002 114.885 -152.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt -66.01 145.98 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.795 2.438 . . . . 5.7999999999999998 113.557 -175.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.7000000000000002 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.8399999999999999 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.476 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 2.0299999999999998 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 4.6600000000000001 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.8399999999999999 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 6.1799999999999997 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 3.5499999999999998 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 6.0199999999999996 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 4.2400000000000002 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 3.5299999999999998 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.8899999999999999 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.9199999999999999 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.4299999999999997 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.6200000000000001 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.6799999999999997 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 4.9100000000000001 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 4.3499999999999996 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.3900000000000001 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 4.3700000000000001 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 3.9900000000000002 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.4500000000000002 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 5.2699999999999996 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 5.9299999999999997 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 5.2300000000000004 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 8.0500000000000007 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.414 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 2.7999999999999998 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.8500000000000001 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.9300000000000002 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 2.3999999999999999 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 2.2200000000000002 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 2.7799999999999998 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 3.3999999999999999 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 3.4500000000000002 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 2.3799999999999999 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 2.5099999999999998 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 3.2000000000000002 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 5.7999999999999998 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.5800000000000001 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.0699999999999998 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 5.7599999999999998 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -58.33 103.23 0.14 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 9.1799999999999997 111.904 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 tttp 55.93 -89.65 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.1 1.36 . . . . 7.7599999999999998 112.622 -177.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 -15.26 14.51 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.812 1.645 . . . . 9.4800000000000004 115.001 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.487 1.419 1 C-N-CA 133.3 4.64 . . . . 10.16 110.445 -167.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 118.416 -0.802 . . . . 15.359999999999999 110.234 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -150.12 -155.44 0.63 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.597 1.559 . . . . 15.380000000000001 108.227 173.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -66.27 151.05 47.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.922 1.237 . . . . 11.779999999999999 111.173 172.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.59 -158.13 29.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.662 -0.975 . . . . 8.9000000000000004 110.662 159.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HZ3' ' CD ' ' A' ' 272' ' ' GLU . 17.9 tptt -55.48 117.8 16.47 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.053 0.941 . . . . 11.07 110.558 169.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.04 172.48 15.86 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.644 2.229 . . . . 7.5099999999999998 110.29 170.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.426 ' H ' ' CD2' ' A' ' 135' ' ' LEU . 1.7 pt? -74.78 -163.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.409 1.484 . . . . 8.1999999999999993 113.392 174.403 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -178.96 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.287 1.435 . . . . 9.1600000000000001 112.987 174.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.75 -13.09 30.76 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.116 1.207 . . . . 5.1600000000000001 116.116 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.54 129.77 1.19 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.327 1.918 . . . . 4.1500000000000004 111.326 173.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.24 159.3 40.65 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.572 2.181 . . . . 3.5800000000000001 109.722 170.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 3.6200000000000001 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 3.73 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 2.9199999999999999 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 2.4700000000000002 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 2.3700000000000001 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.3300000000000001 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 3.1000000000000001 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.2999999999999998 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.41 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.5800000000000001 109.793 -168.308 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 5.7000000000000002 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.96 113.22 -176.703 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.8599999999999999 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.9900000000000002 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 6.4500000000000002 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.5699999999999998 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 3.5899999999999999 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 3.7599999999999998 111.925 -178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.9199999999999999 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 2.2599999999999998 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 3.1600000000000001 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 4.4800000000000004 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 2.3900000000000001 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 4.2599999999999998 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 3.98 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 5.1600000000000001 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 4.1299999999999999 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 5.9400000000000004 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.73 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 6.1299999999999999 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.3200000000000003 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 3.6499999999999999 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.541 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6000000000000001 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.9299999999999999 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.0099999999999998 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 3.6200000000000001 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.478 ' N ' ' HZ1' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 5.4400000000000004 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 4.3099999999999996 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 2.9199999999999999 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.1800000000000002 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 2.8799999999999999 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 3.75 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 3.0600000000000001 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.4399999999999999 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.5800000000000001 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 192' ' ' THR . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.8999999999999999 111.455 169.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 4.2000000000000002 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 190' ' ' ILE . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 3.3199999999999998 109.823 177.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 3.4399999999999999 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.3599999999999999 110.811 170.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.2300000000000004 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 3.4700000000000002 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 2.0499999999999998 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.98999999999999999 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 3.6099999999999999 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 4.1500000000000004 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 2.54 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.71 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.6699999999999999 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.7400000000000002 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.1900000000000004 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.9500000000000002 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 16.510000000000002 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.9400000000000004 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.9199999999999999 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 7.0700000000000003 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.5499999999999998 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 3.1699999999999999 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 4.54 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 2.7799999999999998 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 5.6100000000000003 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.9000000000000004 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 2.2999999999999998 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 4.5499999999999998 114.913 -175.137 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.98 113.25 175.082 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 4.1900000000000004 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 3.6000000000000001 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.73 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 3.7000000000000002 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 3.71 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 3.98 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.94999999999999996 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 3.4700000000000002 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 3.1299999999999999 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.3300000000000001 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.9900000000000002 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 7.8600000000000003 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.0899999999999999 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.6800000000000002 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 2.5800000000000001 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.9300000000000002 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.6600000000000001 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 3.4700000000000002 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 3.4100000000000001 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 4.1600000000000001 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.3700000000000001 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 4.0800000000000001 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 6.54 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 4.2800000000000002 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 9.6500000000000004 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 4.5700000000000003 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.8100000000000001 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 3.3199999999999998 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.54 -169.55 25.61 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.0800000000000001 112.888 173.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -85.33 168.5 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.897 3.064 . . . . 4.4299999999999997 111.666 -179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -98.81 86.42 3.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.189 0.996 . . . . 7.0599999999999996 109.081 166.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -147.95 -5.14 0.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.477 1.511 . . . . 5.3499999999999996 112.612 -160.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 254' ' ' GLU . 14.7 tt0 -99.8 80.19 2.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 11.199999999999999 109.563 -171.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.5 t70 73.23 -25.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 129.231 3.013 . . . . 7.8899999999999997 113.451 -178.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 252' ' ' GLU . 8.5 mm-40 163.15 -17.49 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 1 C-N-CA 132.52 4.328 . . . . 7.8700000000000001 110.943 178.281 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -86.48 177.02 7.54 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.593 1.557 . . . . 6.0899999999999999 113.113 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.65 164.19 28.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.312 1.845 . . . . 7.0199999999999996 112.779 -177.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt -125.43 141.45 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.516 -0.74 . . . . 5.0099999999999998 111.559 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 4.3099999999999996 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.541 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 25.7 p80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.8500000000000001 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.4299999999999997 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 4.9000000000000004 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 3.3300000000000001 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 3.4100000000000001 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 4.8399999999999999 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 3.2000000000000002 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 2.6200000000000001 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.55 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.1200000000000001 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.9199999999999999 110.364 -153.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.4199999999999999 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.512 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.8200000000000003 113.324 -177.016 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 6.6200000000000001 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 5.0899999999999999 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 4.2400000000000002 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 3.9100000000000001 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.6099999999999999 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.447 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.1500000000000004 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.447 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 8.9499999999999993 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.46 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 6.0599999999999996 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 3.73 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.96 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 2.71 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.77 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 2.1200000000000001 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 2.8399999999999999 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 3.04 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.99 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 2.7599999999999998 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.7999999999999998 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 6.2300000000000004 114.247 172.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 5.29 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.0600000000000001 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 4.0700000000000003 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -58.66 145.88 38.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 9.1500000000000004 112.81 -172.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.99 72.24 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.764 1.394 . . . . 7.8099999999999996 114.764 -173.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -179.57 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 128.459 2.704 . . . . 12.32 111.232 148.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p . . . . . 0 C--O 1.257 1.452 0 CA-C-O 115.896 -2.002 . . . . 7.21 110.254 130.539 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 117.976 -1.011 . . . . 17.710000000000001 109.844 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -67.17 142.9 56.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.767 0.712 . . . . 19.34 110.666 172.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 152.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 1 C-N-CA 131.842 4.057 . . . . 12.77 107.509 -177.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.19 145.15 4.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.256 1.408 . . . . 10.1 113.487 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -175.24 141.5 0.66 Allowed Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.318 1.847 . . . . 11.460000000000001 111.012 177.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.8 161.03 30.69 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.89 2.393 . . . . 7.6900000000000004 110.243 167.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.57 139.31 4.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.679 1.992 . . . . 7.96 109.605 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tp -169.75 -162.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.36 1.864 . . . . 6.4500000000000002 109.766 -174.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.52 170.81 37.59 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.307 1.432 . . . . 3.7200000000000002 113.2 -175.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.77 93.79 0.75 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.756 -1.58 . . . . 4.0999999999999996 111.13 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.65 68.32 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.52 2.813 . . . . 3.5 112.628 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 4.0 112.698 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.2200000000000002 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 4.54 111.662 -172.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 2.71 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 2.1499999999999999 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.3399999999999999 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 3.0600000000000001 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.3599999999999999 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.6399999999999997 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.9900000000000002 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 4.3399999999999999 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.8399999999999999 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.7599999999999998 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 7.4299999999999997 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.8399999999999999 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 3.48 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 4.2800000000000002 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.3700000000000001 113.666 -172.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.2400000000000002 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 2.1099999999999999 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 5.0099999999999998 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 3.4900000000000002 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 4.6699999999999999 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 4.5899999999999999 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 2.8399999999999999 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.6799999999999999 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 6.8499999999999996 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.75 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 10.31 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 3.3500000000000001 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 6.2199999999999998 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7000000000000002 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 4.1799999999999997 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 2.1400000000000001 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.6200000000000001 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.417 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.3100000000000001 112.541 178.258 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.5700000000000003 113.121 143.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 3.96 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.412 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.7200000000000002 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.417 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 4.5300000000000002 113.934 -176.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 5.5999999999999996 112.142 168.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 2.96 109.893 -174.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.412 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.71 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 3.6699999999999999 113.518 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 3.1000000000000001 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.3600000000000003 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.5499999999999998 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 3.1899999999999999 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.9500000000000002 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 3.0 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 3.1000000000000001 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.8799999999999999 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.4199999999999999 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 4.2800000000000002 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 4.3399999999999999 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.1500000000000004 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 4.0 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 2.5 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.98999999999999999 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 4.4900000000000002 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 3.73 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 3.6200000000000001 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.54 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 3.1600000000000001 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.4 ' CG ' HH11 ' A' ' 207' ' ' ARG . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.5899999999999999 111.067 -172.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.1800000000000002 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.4100000000000001 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.4 HH11 ' CG ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 7.9699999999999998 114.074 -177.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 3.8700000000000001 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 4.9000000000000004 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.8700000000000001 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 2.75 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 2.7599999999999998 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 2.4700000000000002 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.9700000000000002 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 4.2699999999999996 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 2.4500000000000002 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 6.1900000000000004 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.6299999999999999 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 3.8700000000000001 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 2.3900000000000001 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 3.0499999999999998 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 3.23 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.9700000000000002 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 2.7599999999999998 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 3.6899999999999999 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 3.73 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.9500000000000002 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.3399999999999999 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.466 HH21 ' CG ' ' A' ' 253' ' ' ASP . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.8200000000000003 110.573 172.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.5300000000000002 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.7400000000000002 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 3.3199999999999998 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.7799999999999998 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 4.2599999999999998 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 4.6799999999999997 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.8799999999999999 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 6.21 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.7999999999999998 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 5.1699999999999999 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 7.2999999999999998 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 4.0999999999999996 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 6.1900000000000004 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 4.3799999999999999 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 3.6800000000000002 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.3900000000000001 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.99 171.01 54.66 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 3.1400000000000001 112.225 171.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 18.84 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.514 3.476 . . . . 5.3499999999999996 113.823 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 61.15 5.96 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.919 1.688 . . . . 6.5199999999999996 112.084 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -36.66 115.14 0.35 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.941 2.096 . . . . 9.6199999999999992 112.003 164.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 179.15 -55.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.395 2.278 . . . . 11.98 109.241 -164.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.466 ' CG ' HH21 ' A' ' 231' ' ' ARG . 27.4 t70 -172.16 48.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.15 1.78 . . . . 17.199999999999999 112.176 175.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.93 -8.75 0.22 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.353 1.861 . . . . 16.210000000000001 115.436 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 17.3 t70 -82.09 -171.46 3.41 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.249 1.82 . . . . 10.81 114.916 -169.161 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.55 ' H ' ' CG ' ' A' ' 255' ' ' ASP . 73.6 m-85 83.35 138.39 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.305 3.842 . . . . 7.6200000000000001 112.512 178.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt 77.47 -67.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 126.769 2.028 . . . . 4.6200000000000001 112.165 167.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 4.3200000000000003 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 2.1000000000000001 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 4.2800000000000002 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 4.2999999999999998 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 4.6399999999999997 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 4.8899999999999997 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 4.9500000000000002 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 4.1299999999999999 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 3.2599999999999998 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.6200000000000001 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.0699999999999998 112.391 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.4299999999999997 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.0099999999999998 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.0800000000000001 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 5.2699999999999996 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 4.3600000000000003 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 4.8300000000000001 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 3.75 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.8100000000000001 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 6.3099999999999996 116.654 -169.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 7.8300000000000001 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 5.5599999999999996 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 6.71 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 3.3599999999999999 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.79 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.8100000000000001 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 3.0499999999999998 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 2.3500000000000001 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 2.0699999999999998 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 3.0299999999999998 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 4.0199999999999996 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.73 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 2.9500000000000002 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.6200000000000001 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.79 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.96 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.1299999999999999 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 5.29 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -52.02 128.64 25.04 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 11.02 109.923 -177.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 132.94 53.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.267 1.21 . . . . 7.8399999999999999 114.267 -156.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 26.37 1.08 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 115.411 1.634 . . . . 13.82 115.411 -163.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 128.785 2.834 . . . . 11.460000000000001 110.768 -155.902 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 118.487 -0.768 . . . . 25.140000000000001 110.362 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.13 -179.59 8.15 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.241 1.382 . . . . 20.66 114.115 -171.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m 148.68 128.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 1 C-N-CA 132.32 4.248 . . . . 16.93 108.841 171.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.4 23.49 73.33 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.643 1.116 . . . . 12.51 115.863 170.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 161.11 63.89 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 119.058 1.429 . . . . 12.140000000000001 111.21 177.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.22 171.61 15.68 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.435 2.756 . . . . 7.3499999999999996 110.888 172.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.19 83.24 1.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.628 1.571 . . . . 11.15 108.486 -173.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.8 -29.19 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.547 2.054 . . . . 6.2400000000000002 116.547 -173.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.43 -167.85 31.44 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.858 1.218 . . . . 3.52 111.688 -171.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.89 -74.69 0.24 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.57 1.081 . . . . 5.4500000000000002 113.636 178.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -95.41 87.52 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.424 2.749 . . . . 3.3799999999999999 109.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 3.9700000000000002 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 3.6800000000000002 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 3.54 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 3.2799999999999998 108.346 172.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 2.3100000000000001 108.801 163.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 3.02 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 3.8500000000000001 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.3199999999999998 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.119999999999999 115.158 -162.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 6.2199999999999998 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.489 ' HE3' ' CB ' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 5.04 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.6000000000000001 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.2400000000000002 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 8.1099999999999994 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 4.0499999999999998 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 5.4699999999999998 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.9099999999999999 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.7799999999999998 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.99 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 3.5600000000000001 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 3.7599999999999998 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 4.0199999999999996 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.447 ' HH ' ' HA ' ' A' ' 173' ' ' CYS . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 4.3399999999999999 111.697 -174.048 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 3.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.3100000000000001 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 8.9499999999999993 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 5.2800000000000002 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 7.8899999999999997 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 3.3599999999999999 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 7.5599999999999996 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.425 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.7999999999999998 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 3.4300000000000002 112.43 169.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.447 ' HA ' ' HH ' ' A' ' 163' ' ' TYR . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.9199999999999999 114.286 -178.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.8100000000000001 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 3.2999999999999998 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.3399999999999999 112.873 174.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 3.98 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 7.4699999999999998 111.794 166.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 4.8700000000000001 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 3.8700000000000001 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 3.1000000000000001 113.213 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 2.4900000000000002 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 3.3500000000000001 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.5099999999999998 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.3300000000000001 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 2.6600000000000001 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.6800000000000002 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.73 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 4.6500000000000004 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.96 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.5099999999999998 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 4.3099999999999996 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.75 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 4.4000000000000004 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 2.3300000000000001 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.3999999999999999 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 3.1000000000000001 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 3.7799999999999998 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 2.9900000000000002 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 3.2000000000000002 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 4.25 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.2400000000000002 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.4500000000000002 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.3799999999999999 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 10.09 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.0700000000000003 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.7199999999999998 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 4.0700000000000003 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.9900000000000002 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 3.2999999999999998 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 3.1499999999999999 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 2.2599999999999998 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 5.1100000000000003 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.9100000000000001 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 3.0699999999999998 113.678 -173.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 3.4300000000000002 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 221' ' ' SER . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.1499999999999999 108.938 172.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 3.9199999999999999 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 219' ' ' GLU . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 2.3799999999999999 111.658 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.3199999999999998 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 4.0300000000000002 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 3.3199999999999998 108.84 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 3.5899999999999999 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.1799999999999999 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 3.2999999999999998 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 3.5699999999999998 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.3900000000000001 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 5.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.9900000000000002 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.3399999999999999 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.8799999999999999 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 3.9199999999999999 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.6399999999999997 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.9700000000000002 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 3.9100000000000001 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 3.73 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.7999999999999998 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 3.3599999999999999 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 4.4800000000000004 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 8.5399999999999991 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 3.4300000000000002 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 6.3099999999999996 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 4.7599999999999998 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 3.3199999999999998 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.8900000000000001 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.41 55.98 0.36 Allowed Glycine 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.7799999999999998 116.031 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.22 154.23 74.85 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.06 3.173 . . . . 7.54 113.27 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -160.08 -176.81 5.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.537 1.535 . . . . 6.3399999999999999 112.451 -167.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 60.49 12.77 3.72 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.611 2.078 . . . . 7.2300000000000004 116.611 159.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -34.17 0.28 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.286 2.634 . . . . 10.77 114.209 179.048 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.27 4.78 8.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.156 1.782 . . . . 10.43 113.105 170.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 77.39 -35.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.92 3.288 . . . . 11.199999999999999 113.636 177.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -30.02 134.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.515 2.326 . . . . 6.2999999999999998 116.262 -168.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.85 138.79 17.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.563 1.173 . . . . 7.1900000000000004 111.957 162.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt -70.19 58.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.149 1.78 . . . . 6.3499999999999996 112.547 175.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 3.54 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.6499999999999999 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.9099999999999999 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.75 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 4.0499999999999998 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.8300000000000001 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 4.7800000000000002 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 5.1600000000000001 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.9399999999999999 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 3.6899999999999999 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.8899999999999999 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.1800000000000002 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.6799999999999997 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.1899999999999999 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.0199999999999996 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 4.75 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 3.9500000000000002 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.5299999999999998 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 5.2300000000000004 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 4.2000000000000002 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.0299999999999998 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.8200000000000003 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 6.4900000000000002 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 6.1500000000000004 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 7.0499999999999998 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 2.48 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.8999999999999999 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.7799999999999998 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 2.5099999999999998 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.8899999999999999 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 2.5499999999999998 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 2.6499999999999999 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 3.1400000000000001 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 2.27 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 2.5600000000000001 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 3.2200000000000002 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 5.2599999999999998 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.71 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 4.6699999999999999 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -64.7 -35.0 79.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 11.449999999999999 116.249 -163.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -147.21 145.65 29.55 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.406 1.883 . . . . 8.6799999999999997 108.273 -179.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 36.6 pttt 174.15 171.04 0.21 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.603 1.161 . . . . 10.83 112.403 -146.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.249 1.074 0 C-N-CA 129.803 3.241 . . . . 10.44 108.46 173.603 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.192 -0.909 . . . . 20.260000000000002 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -161.18 -179.26 7.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.995 1.718 . . . . 20.120000000000001 109.157 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.1 t -78.46 160.25 27.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.531 0.732 . . . . 15.630000000000001 110.408 170.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.37 165.26 24.9 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.742 0.687 . . . . 11.720000000000001 111.419 163.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -121.61 141.35 33.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.513 1.525 . . . . 12.52 108.467 163.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.64 150.81 87.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.024 1.816 . . . . 8.5999999999999996 110.208 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -77.28 137.1 38.59 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.146 0.498 . . . . 7.0099999999999998 111.613 178.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -133.33 142.21 48.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.262 1.425 . . . . 7.6799999999999997 107.891 170.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 161.4 153.23 6.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.041 0.829 . . . . 3.9900000000000002 112.018 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.74 72.27 0.45 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.651 -1.639 . . . . 3.46 109.443 174.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.05 90.95 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.146 2.564 . . . . 2.6099999999999999 111.282 -164.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 4.2400000000000002 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 3.5800000000000001 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 4.3499999999999996 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 3.1400000000000001 111.912 -169.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.9399999999999999 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.456 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 3.1600000000000001 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 4.6699999999999999 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 4.0499999999999998 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.9700000000000006 113.825 -171.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 8.2699999999999996 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 4.8099999999999996 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.77 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 8.7599999999999998 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.1699999999999999 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.52 ' HH ' HG12 ' A' ' 225' ' ' VAL . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 3.2999999999999998 114.602 -176.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 4.7999999999999998 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.3100000000000001 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.9900000000000002 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.6699999999999999 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 3.8500000000000001 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 4.04 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 2.5800000000000001 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.6799999999999997 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 2.7999999999999998 112.575 -178.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.0699999999999998 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.444 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 5.2800000000000002 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.3999999999999999 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 5.7800000000000002 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.9300000000000002 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 5.5 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 4.3099999999999996 113.213 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.495 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.3199999999999998 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.6599999999999999 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 3.7999999999999998 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.0899999999999999 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 3.5600000000000001 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.8999999999999999 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 4.8700000000000001 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.6900000000000004 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 2.6000000000000001 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.6000000000000001 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 2.6499999999999999 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 3.7000000000000002 113.081 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.2300000000000004 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 3.3999999999999999 112.191 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.6299999999999999 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 3.02 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.8500000000000001 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.96 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.8300000000000001 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.8700000000000001 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.48 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 3.77 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 2.0899999999999999 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 1.02 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 3.0899999999999999 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 3.6400000000000001 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 2.3700000000000001 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 2.2799999999999998 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 3.0499999999999998 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.3700000000000001 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.7799999999999998 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.9100000000000001 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 7.5 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.2599999999999998 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 3.9199999999999999 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 4.4299999999999997 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 2.1299999999999999 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 2.71 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.9099999999999999 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 4.6799999999999997 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 3.8399999999999999 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 2.46 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.79 114.859 -177.377 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 4.1500000000000004 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 2.2999999999999998 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.78 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 4.1100000000000003 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 3.29 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.52 HG12 ' HH ' ' A' ' 155' ' ' TYR . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 2.1499999999999999 109.888 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.456 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.95999999999999996 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 3.7000000000000002 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.6200000000000001 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.6299999999999999 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.21 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 7.6900000000000004 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.7599999999999998 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 3.3300000000000001 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.6900000000000004 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.8199999999999998 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 4.25 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 3.0299999999999998 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 5.2000000000000002 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.54 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 3.5699999999999998 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 7.2300000000000004 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 4.3399999999999999 109.365 169.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 6.0599999999999996 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 4.5099999999999998 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 3.3500000000000001 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.9700000000000002 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.58 34.22 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.6400000000000001 110.808 163.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.65 163.55 34.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.261 1.974 . . . . 4.6500000000000004 110.965 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 23.3 ttmt -101.66 109.46 21.25 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.34 -0.615 . . . . 6.5999999999999996 109.34 162.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.14 49.23 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.654 1.982 . . . . 6.5 108.933 -177.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -172.72 -165.77 0.33 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 130.01 3.324 . . . . 11.02 107.047 -172.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -82.5 63.59 6.73 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.301 1.409 . . . . 9.3499999999999996 112.804 -165.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 74.02 -42.69 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.336 3.054 . . . . 7.3300000000000001 116.139 168.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.49 44.7 0.98 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.071 1.878 . . . . 6.75 116.071 -162.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.447 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 2.7 p90 -39.87 132.52 1.74 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.897 1.679 . . . . 4.7000000000000002 114.877 178.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt -100.38 149.08 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.352 1.061 . . . . 4.8700000000000001 111.841 -178.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 3.7799999999999998 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.0899999999999999 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.495 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.29 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 4.1799999999999997 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 4.2400000000000002 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 3.1899999999999999 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 4.3300000000000001 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 7.0599999999999996 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 3.9199999999999999 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 4.1100000000000003 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.8400000000000001 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.4500000000000002 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.3799999999999999 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.23 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.0299999999999994 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 4.3399999999999999 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 3.9700000000000002 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.8399999999999999 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 7.0700000000000003 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 5.46 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 2.2000000000000002 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.408 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 5.3200000000000003 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 9.6799999999999997 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 7.6299999999999999 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 5.5 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.9900000000000002 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.8200000000000001 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.3300000000000001 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 2.48 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 2.1899999999999999 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 2.4500000000000002 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 3.3900000000000001 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 3.5 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 2.6299999999999999 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.8700000000000001 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.79 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 6.2199999999999998 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 5.3899999999999997 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.2200000000000002 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 4.6200000000000001 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 31.27 -125.32 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.6699999999999999 115.006 177.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -108.84 167.9 9.74 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.378 1.471 . . . . 7.4000000000000004 111.25 170.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -54.82 -21.47 11.37 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.549 2.426 . . . . 12.17 117.549 -167.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.778 0 C-N-CA 126.142 1.777 . . . . 11.17 109.876 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.456 -0.728 0 N-CA-C 109.803 -0.883 . . . . 3.49 109.803 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 4.2 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 3.93 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 2.69 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 2.46 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 1.49 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 1.63 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 2.14 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.43 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.08 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 3.0 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 3.03 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.26 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 6.54 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.95 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 2.82 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 4.75 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.44 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.14 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.36 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 3.21 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 2.37 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 1.63 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 3.84 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 2.15 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 3.93 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.14 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 8.4 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.06 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 4.24 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.65 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 2.56 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.83 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.61 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.37 112.01 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.28 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 2.56 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.38 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 3.62 111.202 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 3.37 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 1.46 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 1.98 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 1.6 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 2.24 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 2.11 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.22 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 4.05 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 3.3 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.22 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 3.25 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 2.94 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.48 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 2.5 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 1.53 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 0.88 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 2.84 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 2.3 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 1.63 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 2.36 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.2 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.3 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.27 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.86 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 6.18 117.962 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 2.81 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 4.95 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 1.46 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 1.89 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.06 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 3.18 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 4.25 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 1.31 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 3.56 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.32 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 2.7 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 2.18 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 1.8 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 2.34 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 2.37 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 1.35 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.99 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 2.51 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 2.53 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.94 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 3.21 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 6.69 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.11 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.53 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 1.88 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.23 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 4.14 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 3.17 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.19 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.01 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 3.24 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 6.85 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 3.78 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 9.01 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 3.18 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 3.6 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.12 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.3 113.493 -175.796 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 121.941 0.876 . . . . 4.76 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 2.65 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.72 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.13 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 3.36 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 2.67 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 3.22 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 2.93 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.24 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 2.57 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.63 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.64 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.07 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.33 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.39 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 3.59 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 2.69 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.59 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 4.74 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 3.28 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.55 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 5.68 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.03 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 8.3 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 5.35 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 1.99 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 1.81 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.51 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 1.57 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 1.87 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 2.38 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.01 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 2.49 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 2.43 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 2.85 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 2.77 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 4.83 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 6.87 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.37 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 4.24 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 10.5 108.161 -178.167 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 N-CA-C 111.966 -0.052 . . . . 3.14 111.966 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 2.29 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.16 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 2.18 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 2.51 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 1.57 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.65 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 3.17 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.05 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.78 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 5.62 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.13 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.17 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.66 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.07 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 2.89 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 2.98 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 3.39 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.52 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.49 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.44 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 2.11 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 2.72 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 1.92 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 3.67 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 1.85 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.86 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 4.67 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 168' ' ' HIS 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 4.12 110.457 165.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.574 ' H ' HG23 ' A' ' 167' ' ' THR . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 7.51 111.866 -171.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 3.58 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 5.74 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.17 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 3.3 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.16 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.42 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.22 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.01 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 2.35 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.11 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.13 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 3.25 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 1.46 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.531 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 1.73 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 1.45 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 2.59 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.89 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 1.9 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.35 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 2.39 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 2.39 111.411 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 2.63 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 2.76 112.572 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 2.6 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.11 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.51 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 2.24 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 1.42 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.25 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 2.98 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 2.15 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 1.63 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 1.85 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.11 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.06 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.92 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.34 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 7.72 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 167' ' ' THR . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.21 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 3.82 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 1.5 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 2.05 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 1.37 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.66 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 2.87 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 1.31 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 4.75 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 2.71 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 1.79 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 1.97 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 2.63 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 2.21 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 1.8 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 0.99 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 2.69 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 2.29 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.15 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 3.27 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 7.08 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.63 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.85 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 1.81 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.09 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 2.39 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.25 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 3.83 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.51 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.1 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 7.19 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 3.02 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.624 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 5.62 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 3.6 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 3.37 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.43 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.67 115.645 -172.245 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.964 1.098 . . . . 5.22 113.964 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 2.42 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.65 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.85 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 3.34 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.01 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 3.06 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.0 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 3.34 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 2.66 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 2.68 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.36 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.84 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.74 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.19 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 3.73 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 2.78 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.69 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 3.47 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 3.2 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 3.09 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.07 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 4.7 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 8.5 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 6.2 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 1.74 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.49 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 1.3 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.24 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 1.68 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 1.88 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 2.49 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 2.14 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.19 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 2.6 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 4.45 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 5.33 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 2.94 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 5.76 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 10.3 112.285 -174.014 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.658 -0.555 . . . . 3.05 110.658 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 2.81 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 151' ' ' THR . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.6 115.787 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.15 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 1.75 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 1.25 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 1.67 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 2.34 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.19 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 6.95 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 3.24 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 141' ' ' SER . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 2.01 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 6.53 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.16 111.332 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 3.24 114.311 -178.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 3.77 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.471 HE22 HD23 ' A' ' 160' ' ' LEU . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.97 110.331 167.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.25 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.471 HD23 HE22 ' A' ' 158' ' ' GLN . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 2.64 110.73 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 1.84 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 3.74 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 2.61 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.89 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 5.24 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.62 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.448 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 6.57 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 2.55 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 5.98 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 3.07 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 1.98 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.81 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 3.28 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.11 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 3.51 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 1.93 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.443 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 3.36 110.781 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 1.56 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 2.49 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.52 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 1.93 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.66 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.13 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 3.72 110.678 165.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 2.92 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 3.92 112.316 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 5.02 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.67 110.912 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.94 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 2.85 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 1.44 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 0.95 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 2.42 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 2.36 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 1.52 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 1.99 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 2.79 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.55 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 6.82 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASP . . . . . 0.448 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.86 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 2.86 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 3.55 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.14 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 1.9 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 1.82 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 1.23 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 3.58 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 5.64 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 1.4 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 3.77 112.904 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.3 112.347 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 2.5 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 2.62 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.73 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 2.42 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 2.72 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 1.43 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 0.97 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 2.02 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 2.6 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.62 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 3.11 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 5.75 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.3 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.3 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 2.44 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.44 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.07 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 3.28 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.04 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 4.81 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.06 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 3.2 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 9.82 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 3.36 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 6.62 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 5.72 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.47 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.35 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.612 0.597 . . . . 4.83 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 2.7 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.51 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 4.13 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 4.34 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 2.63 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 2.64 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 2.79 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 2.59 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 2.39 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.56 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.17 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.93 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.81 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.46 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 4.04 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 4.11 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.07 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 3.87 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 2.73 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.08 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.35 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 5.95 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.33 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.08 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 2.81 113.622 -157.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.51 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 1.83 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 1.32 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 1.45 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 2.27 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 2.44 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 1.67 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 1.84 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 3.73 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.1 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 4.37 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.36 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 3.34 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.2 112.581 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 111.076 -0.394 . . . . 3.46 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 3.11 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 2.58 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 2.66 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.13 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.18 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 1.84 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 3.55 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.06 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 6.66 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 3.41 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 3.31 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.68 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 7.39 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.05 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 2.26 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 3.65 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 1.96 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 2.67 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 1.88 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 2.48 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.05 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 2.22 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 6.83 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 3.31 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.81 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 4.62 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 4.61 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 2.67 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 5.14 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.34 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.546 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 2.95 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.88 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.72 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.53 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 3.31 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.65 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 2.95 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 3.61 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 1.95 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.528 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.18 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 1.93 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 3.19 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.41 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 1.7 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.64 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 2.96 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.74 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 3.24 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 3.62 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 4.38 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.95 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 2.48 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 1.15 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 3.09 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 2.14 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 1.93 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 2.54 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.61 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.54 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.6 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 6.74 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.68 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.14 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 3.98 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.86 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 1.79 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 2.16 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 1.49 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 4.84 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 2.66 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 1.58 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 3.71 114.227 -167.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.81 112.851 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 2.8 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.01 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.16 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 2.52 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 2.35 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 2.35 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 2.4 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 2.48 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.22 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.24 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 8.69 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.18 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.31 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.12 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.64 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.09 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 3.8 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 2.66 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.0 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.02 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 3.0 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 5.75 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 3.63 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 6.63 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 3.01 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 2.79 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.75 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.97 111.505 171.53 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.229 0.538 . . . . 3.84 109.844 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 2.83 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.83 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 24.5 p-80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.12 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.21 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 262' ' ' ILE . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 3.36 111.447 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 2.36 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 3.13 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 2.49 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 2.71 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 2.21 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.77 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.19 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.97 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.11 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 2.96 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 2.3 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.19 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.51 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 2.78 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 2.6 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 3.32 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.07 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 8.46 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 6.98 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.528 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 2.25 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.01 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.18 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 1.43 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 1.53 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 2.06 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 1.69 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 2.45 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 1.5 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 2.22 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 2.2 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 3.53 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 5.85 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.75 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.13 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 9.38 116.081 -172.872 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 N-CA-C 110.811 -0.496 . . . . 3.06 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 2.49 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.18 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.08 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 1.72 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 1.28 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.21 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 2.4 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.28 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.35 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 6.85 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 4.49 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.05 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.83 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 7.64 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 3.18 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 3.5 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 3.74 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.12 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.63 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.54 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 2.27 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 3.58 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 1.78 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 3.61 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 1.91 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 4.4 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.51 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 6.15 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.492 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 3.7 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 7.89 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.63 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 2.77 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.07 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 1.89 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.11 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.453 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.09 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 2.97 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.11 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 3.53 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 3.14 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 1.78 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.07 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 2.04 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 2.62 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.74 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.57 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 2.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.94 111.409 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 2.64 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 2.41 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.34 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.56 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 2.66 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 2.81 108.474 158.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.97 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 2.72 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 1.88 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.25 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 3.05 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 2.37 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 237' ' ' VAL . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 1.31 109.487 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 2.01 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 2.14 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 2.5 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.23 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 8.79 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.66 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 211' ' ' GLU . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.08 106.249 146.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 3.67 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.05 113.993 -171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 2.33 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 1.97 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.23 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.421 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 3.94 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 4.59 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 1.69 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 3.47 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 4.4 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 3.33 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.25 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.54 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 2.89 112.054 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 2.29 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 1.66 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.96 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 2.2 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 2.54 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.9 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 2.91 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 7.48 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.57 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 2.36 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.07 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 2.54 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' CG2' ' A' ' 201' ' ' ILE . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 2.72 113.512 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.19 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.64 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.24 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 3.45 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 8.43 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 3.1 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.07 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 4.24 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.06 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.13 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.61 112.95 176.427 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 114.504 1.298 . . . . 4.93 114.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 2.89 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.41 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 2.52 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 3.58 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 2.86 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 2.98 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 3.12 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 2.72 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 2.13 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 2.55 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.91 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.13 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.8 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.51 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.08 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 3.64 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 2.97 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.11 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.33 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 3.04 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.02 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 3.66 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 5.35 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.06 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.2 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.02 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.57 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.49 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 1.5 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 1.43 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 1.48 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 2.16 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 3.13 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 2.05 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 1.63 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.32 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 6.08 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 5.9 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.25 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 3.18 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 . . . . . 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 9.88 112.351 178.428 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 110.859 -0.477 . . . . 3.11 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 2.27 112.926 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.71 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 1.87 112.841 -173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 1.59 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.22 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.24 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.09 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.78 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.01 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 7.81 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 3.75 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.03 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.45 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 6.56 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.67 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 2.18 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 3.87 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.38 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.32 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 3.18 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 2.6 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 199' ' ' LEU . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 1.77 111.147 -172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.3 111.988 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 3.06 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.41 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 5.57 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.38 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 5.17 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.82 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 5.28 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.51 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 2.79 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.462 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.01 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.59 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.65 112.106 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.08 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 2.59 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.24 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 3.64 111.87 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 3.55 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.07 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.416 ' O ' ' HE2' ' A' ' 283' ' ' LYS . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 1.99 113.836 172.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 2.55 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 2.6 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.1 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 2.43 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.81 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 2.17 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 2.3 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 2.87 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 2.5 114.378 -165.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 3.03 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.4 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.37 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 2.49 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.0 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.84 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 227' ' ' LEU . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 2.55 112.84 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 2.38 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 1.62 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 2.48 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.02 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.09 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.38 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.64 HH11 ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 8.63 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.89 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.0 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 3.95 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.42 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 1.47 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 1.86 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 1.08 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 4.73 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 4.17 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 1.27 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.16 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 2.78 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.43 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 2.34 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.53 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 3.16 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 225' ' ' VAL . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 2.52 109.86 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 224' ' ' LEU . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 1.32 111.811 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 199' ' ' LEU . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 1.91 112.808 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 2.57 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.0 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.26 113.028 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.08 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.55 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.0 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 3.43 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 2.1 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 3.83 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 2.7 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.08 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 5.4 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 3.88 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.22 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 3.41 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 4.86 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.08 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.32 113.619 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.285 -0.635 . . . . 3.44 109.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 2.94 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.06 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.462 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.5 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 3.69 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 4.73 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 3.06 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 3.33 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 2.72 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 2.09 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 2.5 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.24 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.83 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.26 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.13 113.233 165.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 4.62 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 2.79 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.24 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 3.65 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.4 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.53 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 5.86 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 4.41 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 6.51 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 182' ' ' GLN . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 1.81 113.504 -165.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.23 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.26 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 0.98 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 1.25 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 1.82 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.12 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 1.27 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 1.45 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.12 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 3.85 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 4.57 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.81 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 2.94 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 10.37 110.879 155.587 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 109.372 -1.049 . . . . 2.71 109.372 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 2.35 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.16 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 2.09 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 1.55 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 1.41 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.54 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 2.69 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.42 ' HA2' ' HE3' ' A' ' 210' ' ' LYS . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.9 112.808 -155.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.08 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.12 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 1.89 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.19 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 7.94 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.88 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 2.45 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 4.7 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.87 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.34 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 1.91 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 2.16 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 3.14 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 1.72 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 3.61 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 2.65 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.412 ' HE1' ' HG ' ' A' ' 169' ' ' CYS . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 4.95 109.724 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 3.63 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 5.25 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.412 ' HG ' ' HE1' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.64 112.121 -157.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 6.07 112.152 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.3 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 2.94 111.869 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.549 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.72 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.06 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.91 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 2.3 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.24 109.501 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.0 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 4.19 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 2.21 109.839 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.47 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 1.62 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 2.17 111.18 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 4.01 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.69 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.88 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 3.11 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.68 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 2.67 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 2.4 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 3.85 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 4.14 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 3.75 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 3.62 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.83 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 2.55 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 1.05 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.84 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 2.38 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 2.06 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 1.42 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 2.4 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.07 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.19 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.42 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.69 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 7.77 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.89 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 3.61 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.42 ' HE3' ' HA2' ' A' ' 147' ' ' GLY . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.17 114.294 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 1.52 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 1.76 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 0.96 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 3.72 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 2.85 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 1.22 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.03 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.66 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 3.24 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.16 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.71 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 2.8 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 1.88 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 1.32 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.74 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 1.97 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 2.75 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.83 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.05 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 5.81 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.33 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.76 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 1.85 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.93 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 2.44 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 2.73 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 2.45 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 5.2 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.6 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 3.02 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.23 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 2.82 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 5.93 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 4.44 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 2.99 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.0 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.97 111.811 -174.333 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.439 0.638 . . . . 4.47 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 166' ' ' PHE . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 2.86 111.451 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.97 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.549 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.65 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 3.31 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.07 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 2.91 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 2.8 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 2.62 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 1.9 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 1.89 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.25 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.67 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.69 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.91 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.85 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 3.11 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 2.6 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.14 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.07 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 2.77 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.66 111.411 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 3.93 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 5.32 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 4.57 112.558 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.06 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.47 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 2.22 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.4 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 1.31 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.16 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.22 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 2.17 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 2.23 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 1.36 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 1.66 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 3.81 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 4.79 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 4.26 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.17 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 3.71 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.27 111.8 169.848 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 N-CA-C 110.754 -0.518 . . . . 3.68 110.754 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 3.03 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 2.61 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 2.32 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 2.74 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 1.61 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 1.51 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 2.94 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 1.91 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 4.89 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 5.38 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 2.59 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.41 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 156' ' ' LEU . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.25 115.421 -156.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 2.97 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 4.13 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 153' ' ' LYS . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 4.18 113.101 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.31 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.49 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.06 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 2.65 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 2.78 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 2.2 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.57 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.01 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.07 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 5.1 115.028 -159.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 2.91 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 6.14 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.36 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 4.91 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.1 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 3.71 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.06 112.531 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.75 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.1 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 2.89 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 220' ' ' PHE . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 2.75 111.518 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.37 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.21 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 3.78 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 1.8 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.512 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.08 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 1.94 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 2.58 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.1 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.71 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 2.56 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 2.09 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 2.88 111.781 165.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 2.39 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 2.48 111.768 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 3.08 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.49 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.34 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 2.69 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 1.84 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.05 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 2.58 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 3.31 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 1.62 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 2.9 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 1.6 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.3 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 206' ' ' GLU . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.88 112.181 173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 7.58 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 4.52 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 4.67 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 2.38 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 1.94 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 1.26 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 3.11 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 3.7 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 1.37 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 5.51 113.301 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.23 113.748 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 177' ' ' LEU . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 2.16 112.782 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 1.82 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.21 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 2.94 113.74 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 3.03 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 1.97 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.17 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 1.75 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 2.78 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.74 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 3.79 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 8.33 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.99 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.16 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 2.1 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.53 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 3.18 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 2.58 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.2 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 1.87 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 3.41 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 5.93 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 2.54 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 5.2 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 3.8 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 2.65 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.47 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.26 112.732 179.291 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.086 0.772 . . . . 4.73 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 3.41 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.99 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.05 112.522 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 4.88 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 3.01 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 2.52 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 4.4 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 2.9 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 2.68 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 3.25 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.78 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 3.53 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.89 113.794 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 3.73 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 3.07 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.68 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 3.39 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 2.88 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 2.67 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 4.61 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.12 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 5.21 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.478 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 7.84 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.512 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 2.36 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.0 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 2.27 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 1.63 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 1.86 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 2.9 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 2.98 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.28 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.18 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.03 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.09 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 6.23 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.81 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.29 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 7.37 111.99 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 123.278 1.282 . . . . 4.11 115.325 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 3.89 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 4.78 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 2.95 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 2.51 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 2.25 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.09 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 3.9 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.47 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.01 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 7.68 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 4.58 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 4.28 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.24 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 7.21 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.65 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 3.52 113.405 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 3.72 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.26 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.63 109.835 159.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.65 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 2.79 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 4.33 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 2.71 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 3.32 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 243' ' ' VAL . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 2.15 112.178 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.95 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 5.14 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.05 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.6 m170 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 5.18 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.456 ' HG ' ' CD2' ' A' ' 260' ' ' HIS . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 3.38 109.869 159.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 6.17 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.74 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 2.67 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 2.51 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 1.99 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 2.72 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.65 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.08 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.8 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.12 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 4.86 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 1.62 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 1.9 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 1.87 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 2.79 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 2.93 112.262 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 1.8 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 2.6 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 2.35 110.329 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 2.8 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 2.93 110.692 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 2.74 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.17 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.28 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 4.17 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 1.3 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 0.91 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.14 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 2.99 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 1.75 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 1.6 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 2.55 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.23 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.28 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.19 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 8.95 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 3.7 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.17 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.15 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.02 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 2.8 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 1.43 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.487 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 4.79 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 3.33 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 1.48 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.21 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 3.75 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 4.16 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 2.91 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.64 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 4.67 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 2.32 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 2.31 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.03 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 1.81 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 3.92 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.11 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 3.21 109.003 157.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 6.38 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.89 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.06 111.705 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 2.91 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.33 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 2.59 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.09 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 3.11 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 3.74 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 2.84 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 4.46 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 5.53 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 164' ' ' PHE . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 2.69 111.959 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 5.89 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 4.48 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.11 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.23 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 2.85 114.882 -171.288 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 120.633 0.254 . . . . 3.82 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 3.24 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.456 ' CD2' ' HG ' ' A' ' 169' ' ' CYS . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 1.82 110.096 170.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.27 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 3.29 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.02 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 3.95 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 3.54 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 2.68 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 2.28 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.32 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.99 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.86 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.45 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 5.87 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 4.79 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.92 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 5.34 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 2.99 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.58 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 5.98 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 4.67 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 4.99 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 8.32 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 3.07 114.072 -164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 2.93 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.07 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.11 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.04 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 2.93 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 3.19 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 2.73 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 2.68 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 3.26 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.43 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 4.23 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 5.45 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.48 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 4.85 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 8.33 113.298 -161.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 120.456 0.107 . . . . 3.63 112.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 3.09 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.32 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 2.29 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 2.81 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 1.61 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 1.67 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 2.91 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.82 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 5.85 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.05 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.2 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.87 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 7.5 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.45 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 2.57 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 4.69 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.81 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.12 109.375 165.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.73 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 2.57 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 3.37 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 2.86 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 3.49 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 2.9 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 4.69 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 4.39 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.45 ' CE1' HH12 ' A' ' 207' ' ' ARG . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 5.57 111.929 169.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.05 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 4.28 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.67 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 3.23 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.404 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.7 112.355 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.68 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.1 111.672 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.12 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 2.66 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.58 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 3.58 112.175 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 2.91 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 1.43 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 2.55 113.835 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 2.32 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 2.24 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 1.97 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.53 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.23 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 2.53 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 3.23 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 2.77 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 3.23 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 2.84 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.56 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.1 112.704 155.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 1.06 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 0.93 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 2.71 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 3.53 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 1.32 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.63 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 2.34 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.36 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.39 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.45 HH12 ' CE1' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.09 113.029 -167.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.57 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 4.83 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 4.6 114.297 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 4.61 113.48 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 2.27 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 1.8 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 1.2 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 4.37 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 3.49 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 1.21 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 6.19 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.11 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 3.17 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 1.67 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 1.76 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 3.72 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 1.88 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 1.44 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.9 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 1.82 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 2.83 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.15 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.67 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 8.68 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.01 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 2.37 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 2.83 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 2.58 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 2.88 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 6.5 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.44 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 3.6 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.31 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 3.78 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 6.2 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 3.19 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 2.92 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.52 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.24 112.194 175.078 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.434 0.159 . . . . 4.54 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 2.32 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.16 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.404 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 1.77 111.882 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 3.36 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 3.68 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 2.36 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.02 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 2.73 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 2.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 2.1 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.72 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.06 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 2.97 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.18 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 3.82 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 3.15 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.84 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 3.56 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 2.5 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.17 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 4.54 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 7.97 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.07 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 5.43 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 2.67 112.726 -166.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 1.99 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.02 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 2.15 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.33 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 1.83 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 1.64 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 2.36 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.09 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 2.17 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 2.84 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.04 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 5.66 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.14 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 3.64 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 9.01 109.726 166.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 CA-C-O 121.241 0.434 . . . . 3.4 111.629 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 2.81 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.09 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 2.33 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 1.98 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 1.51 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.45 112.565 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 2.4 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.74 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.57 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 7.84 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 3.43 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.02 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.19 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 6.89 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.72 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 2.29 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 4.65 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.42 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 1.91 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 2.08 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 2.53 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 1.92 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.13 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 2.42 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 4.09 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.21 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 5.85 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 2.7 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 5.8 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 2.74 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.06 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 1.9 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.9 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 3.38 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.88 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 3.56 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.4 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 1.93 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.44 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 1.9 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 1.67 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 2.46 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.93 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.39 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 2.01 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.45 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 1.93 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.16 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 2.37 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 2.57 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 2.86 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.13 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.78 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 3.08 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 1.0 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.76 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 2.38 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 3.07 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 1.3 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 2.89 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.51 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.67 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.32 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 6.31 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.45 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 3.6 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 6.14 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.95 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.539 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 2.56 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 2.64 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.29 111.414 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 3.76 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 3.97 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 1.44 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 6.95 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.06 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 2.62 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.09 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.59 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.0 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 2.19 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 2.8 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.96 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 2.88 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.3 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.49 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 6.37 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.28 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.35 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 3.45 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.8 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 2.41 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 2.79 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 2.2 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 5.59 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 2.42 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 4.67 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 8.84 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 4.98 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 15.67 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.18 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.04 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.32 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.91 112.966 174.396 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 3.18 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.34 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.13 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 3.51 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 2.46 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 3.25 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 2.79 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.05 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 1.96 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.33 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.4 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.32 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.92 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.33 112.387 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 3.4 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 2.76 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.78 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 5.46 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 2.45 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.86 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 3.38 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.99 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.27 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 5.93 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 1.93 113.984 -165.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.68 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.92 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 1.47 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 1.55 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 1.75 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 2.32 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 3.21 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 1.8 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.1 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.12 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 4.69 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.2 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.41 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 3.85 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 9.61 110.813 -179.154 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.354 -1.056 . . . . 2.57 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 2.64 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 2.82 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 2.76 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.05 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 1.81 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 1.7 113.025 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 3.42 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 5.71 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 2.88 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 2.21 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.02 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 7.44 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.01 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 3.27 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 3.63 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.48 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.19 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.4 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 3.14 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 2.48 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 1.89 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.84 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 2.11 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.83 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 4.93 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 3.7 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 5.44 111.344 161.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.32 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 4.89 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.27 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 2.76 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.545 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.71 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.11 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.91 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.25 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 2.46 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.15 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 5.3 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.26 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 1.8 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.478 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 1.64 113.278 175.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 1.52 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 2.61 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.38 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 2.45 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.35 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.18 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 2.77 112.728 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 2.93 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 2.86 112.173 -161.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 3.53 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.11 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.32 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 2.43 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 1.18 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.12 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 2.92 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 2.76 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 2.22 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 1.49 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 1.85 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.11 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.92 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 7.4 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 3.55 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.04 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.32 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 2.46 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 2.14 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 1.72 111.994 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 2.76 111.416 173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 2.7 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 1.63 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 3.3 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 2.38 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 1.83 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 1.8 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 2.58 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 2.29 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 1.89 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 3.41 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 3.64 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.15 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.75 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 6.39 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.91 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.74 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 2.79 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.62 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 2.71 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 2.65 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 2.98 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 6.4 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.16 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 3.27 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.24 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 2.37 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 5.73 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 2.99 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.39 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 2.84 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.76 112.538 168.32 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 118.461 -0.781 . . . . 3.69 109.923 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 2.8 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.68 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.545 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 15.0 p-80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 1.89 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 4.48 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.22 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 2.84 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 3.64 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 4.02 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 2.4 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 2.72 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 1.82 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.86 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.34 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.17 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.91 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 5.22 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 3.14 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.01 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 3.02 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.28 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.51 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 9.26 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 4.9 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 6.8 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 1.65 112.464 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.43 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.02 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 1.42 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 1.38 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 1.58 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 1.86 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 2.18 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 1.92 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 3.69 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 3.65 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 4.87 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 4.9 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.13 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 4.15 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 8.59 113.38 166.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 CA-C-O 121.976 0.74 . . . . 3.61 111.673 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 2.85 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 2.74 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 2.53 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 3.62 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.11 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.62 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.17 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.39 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.401 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.78 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 8.24 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.16 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 1.88 105.957 166.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 6.34 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.53 112.203 163.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.27 114.959 -161.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 3.09 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.4 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.35 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 1.8 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 2.23 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 3.49 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 2.14 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 3.39 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 2.93 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.37 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 5.7 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.15 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 5.91 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.15 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 6.13 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.52 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 4.29 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.66 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.62 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.64 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.55 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 2.28 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.91 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.1 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.0 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 1.84 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 2.92 114.978 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 2.49 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 2.52 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.44 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 1.65 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.3 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.2 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 3.12 110.258 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.34 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 2.74 111.001 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 3.8 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.5 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.61 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 4.15 113.783 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 1.7 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.22 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 2.43 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 3.5 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 2.57 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 2.66 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 3.03 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.52 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.57 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.87 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 7.05 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.77 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 2.67 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 3.47 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.61 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 1.74 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 2.38 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 1.64 113.425 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 3.51 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 3.56 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 1.27 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 5.84 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.9 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 3.51 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.3 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 2.51 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 2.92 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 2.17 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 1.6 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 1.94 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 2.54 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.68 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 3.56 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 9.43 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 4.35 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.44 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 2.26 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.22 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 3.73 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 3.08 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 2.59 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 5.89 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.42 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 4.31 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 5.63 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 3.83 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.547 ' H ' HG22 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 5.51 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 4.38 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 2.7 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.69 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.18 111.692 172.463 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.74 0.781 . . . . 4.29 111.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 3.47 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.72 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.39 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 4.75 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 3.47 119.655 155.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.07 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 2.77 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 3.93 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 2.37 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 2.59 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.34 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.53 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 2.86 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 3.63 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 2.91 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.61 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 3.59 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.459 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 2.24 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.55 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.11 112.055 -171.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.36 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.22 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 7.17 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.403 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 2.17 113.451 -164.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.76 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 1.41 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.05 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 1.36 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 1.63 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 2.21 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 1.42 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 1.6 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 1.98 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 4.51 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 4.43 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 1.98 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 3.73 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 6.91 113.875 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.459 -0.502 0 N-CA-C 109.322 -1.069 . . . . 3.85 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 2.67 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.47 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 2.87 111.405 168.347 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 2.3 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 2.11 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.3 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 2.97 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.69 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.73 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 5.43 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 2.93 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.16 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.13 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.28 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 3.13 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 4.33 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.68 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.15 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.02 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 2.83 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 3.32 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 1.75 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 3.49 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 2.18 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.85 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 4.71 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 3.39 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 4.57 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.14 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 4.81 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 174' ' ' PRO 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 3.24 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.555 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.06 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 171' ' ' ASP . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.45 116.458 -173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.13 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.33 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 2.79 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.34 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 5.07 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.27 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 3.05 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 2.49 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 2.85 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 2.55 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.97 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.43 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 2.26 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 4.02 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 4.4 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.02 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 4.88 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 4.46 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.16 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.36 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 3.22 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 2.45 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.58 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 2.43 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 2.47 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 1.38 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 1.84 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 1.63 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.92 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB3' HG23 ' A' ' 228' ' ' THR . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.85 110.286 -162.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.58 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 6.95 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.28 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.26 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 4.96 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 1.58 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 2.83 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.23 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.471 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 2.86 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 3.31 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 2.48 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 3.6 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 3.81 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 4.63 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.14 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.24 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 2.36 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 2.75 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 1.67 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.08 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.402 ' HB3' HD13 ' A' ' 142' ' ' LEU . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 2.3 111.299 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 205' ' ' PRO . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 2.79 109.072 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.62 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 4.06 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 9.16 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.14 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.64 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 1.99 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.08 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 2.42 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 2.91 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 5.84 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 2.34 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 3.66 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.15 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 2.74 112.104 -173.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 8.07 111.141 166.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 4.53 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.12 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.56 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.04 113.883 178.308 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.837 0.827 . . . . 5.39 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 3.05 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.39 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.555 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 5.97 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 4.71 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 4.01 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 3.3 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 3.41 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 2.46 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 3.09 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.27 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.31 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.407 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.93 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.56 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 5.61 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 3.65 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.45 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 3.13 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 2.58 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.89 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 3.71 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 5.28 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.16 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 5.93 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.1 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 1.99 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.65 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 2.09 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 1.57 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 1.6 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 2.24 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 2.68 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 1.88 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 2.41 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.42 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 4.73 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 5.57 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.65 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 4.09 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 7.64 110.51 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.46 -0.46 0 CA-C-O 121.241 0.434 . . . . 2.52 111.994 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 2.48 111.434 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 2.97 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.405 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 2.31 110.154 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 1.93 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 1.84 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 1.67 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.13 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.36 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.6 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 5.93 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 3.31 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 2.08 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.08 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 7.41 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 2.55 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 3.55 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.52 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.14 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.66 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 2.92 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 2.75 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 1.53 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 4.54 111.823 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 2.98 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 1.97 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 4.15 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.39 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 6.14 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 3.23 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 6.85 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.38 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 3.21 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.03 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.25 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.44 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 262' ' ' ILE . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.25 113.356 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 2.67 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.49 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 176' ' ' GLU . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 3.43 113.012 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 4.05 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 1.6 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.36 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 1.49 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 196' ' ' LEU . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 2.5 112.9 -170.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.53 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 2.44 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.458 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 2.54 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 2.58 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 3.52 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 3.7 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 3.63 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 2.64 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.88 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 184' ' ' VAL . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 3.14 110.045 170.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 1.25 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.28 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 2.65 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 2.44 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 2.0 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 1.74 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 1.66 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.22 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.16 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.03 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.06 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.27 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 4.42 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.34 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.62 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 1.97 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 2.07 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 1.35 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 3.52 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 3.08 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 1.29 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 3.65 115.04 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 2.81 113.658 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 2.22 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 1.54 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 1.85 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 2.58 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 1.99 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 1.88 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 2.75 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 2.57 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.82 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 2.96 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 6.67 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.21 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 1.91 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 2.51 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 2.53 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.32 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 4.76 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.37 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 4.08 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 6.16 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 2.82 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 5.96 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 3.37 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.24 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.1 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.61 114.486 -175.058 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 109.739 -0.467 . . . . 4.02 109.739 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 2.69 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.23 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 2.64 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.04 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 279' ' ' GLN . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 4.08 109.808 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 2.84 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.12 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 2.77 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 2.25 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 2.66 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.46 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.55 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 3.65 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.81 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 3.99 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 2.6 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.59 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.14 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 2.43 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.17 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.465 ' HB3' HD13 ' A' ' 262' ' ' ILE . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 4.43 118.667 -162.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 5.44 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 5.48 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.29 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 1.79 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.43 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.86 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 1.26 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 1.14 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 1.3 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 1.84 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 2.36 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 1.89 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 1.65 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 2.52 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 5.06 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 5.45 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.93 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 2.93 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.1 113.474 156.602 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 N-CA-C 112.504 0.155 . . . . 2.75 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 2.45 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 3.03 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 1.66 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.07 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 1.75 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 2.62 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.0 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.74 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 5.39 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.35 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 1.99 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.06 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.13 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.61 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 2.6 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 4.21 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' H ' ' H ' ' A' ' 270' ' ' ASP . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.91 113.688 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.29 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.77 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 2.6 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 2.56 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 1.7 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 5.47 112.266 -167.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 2.15 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 1.73 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 5.2 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 4.05 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 5.39 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 2.75 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 4.64 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 2.51 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.83 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.39 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.76 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 2.62 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.32 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.32 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 2.93 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 1.84 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 1.72 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 1.44 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 2.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.44 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.53 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 2.28 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.13 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.22 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.11 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 4.24 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 2.85 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 2.49 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.24 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 2.44 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 1.35 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 0.93 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 2.35 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 2.38 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 1.48 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.488 HG22 HG13 ' A' ' 234' ' ' VAL . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 1.96 113.693 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.66 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 4.51 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 8.36 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.93 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 3.6 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.01 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.44 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 1.94 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 1.96 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 1.59 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 4.07 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 2.98 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 2.07 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.06 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.34 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 3.28 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.14 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 1.99 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 2.62 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 2.53 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 1.83 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 2.16 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 2.64 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.05 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 8.91 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.57 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 203' ' ' ILE . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 2.05 112.633 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.93 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.23 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 2.58 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 2.46 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 5.13 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 1.83 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 3.12 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 7.43 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 3.21 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 5.37 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 4.32 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.09 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.29 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 2.9 114.071 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.007 0.373 . . . . 4.42 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 2.78 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.17 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.67 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 3.44 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 3.99 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.02 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 3.91 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 2.91 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 2.07 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 2.43 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 1.92 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.55 ' H ' ' H ' ' A' ' 157' ' ' GLY . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.07 119.017 163.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.18 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.39 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 3.87 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 2.63 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.72 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.02 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 2.29 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.41 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.15 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.0 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 5.56 114.451 -166.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 5.41 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 2.4 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.19 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.41 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 1.62 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 1.71 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 1.64 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 2.5 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 2.97 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 1.89 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 1.98 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.21 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 5.41 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 5.26 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.97 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 3.64 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 8.36 110.057 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.533 0.432 0 N-CA-C 112.961 0.331 . . . . 3.34 112.961 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 2.59 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.64 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 2.19 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.24 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 1.45 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 1.53 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 2.79 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.84 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.11 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 7.54 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 3.19 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.35 107.12 163.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.78 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 7.3 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 151' ' ' THR . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.84 111.9 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 3.02 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 3.4 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.57 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.34 109.845 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.74 110.293 165.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 2.5 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 2.57 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 2.89 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 3.7 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 2.77 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 1.85 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 7.44 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 3.65 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 4.99 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.411 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.04 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 7.36 114.28 -142.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.13 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 3.35 110.241 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 2.39 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 173' ' ' CYS . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.42 111.795 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.601 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.15 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 2.75 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 3.44 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 3.31 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 2.05 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 2.93 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 1.51 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 2.72 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.56 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.51 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 2.33 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.28 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 2.97 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 2.6 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.32 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 3.09 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 3.1 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 2.98 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.45 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 3.23 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 1.34 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.17 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 2.56 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 2.65 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 1.2 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.03 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 2.17 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.66 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 8.0 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 3.07 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 3.56 113.687 -171.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.74 112.503 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 1.94 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 2.24 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 1.32 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.415 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 4.59 113.349 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 3.42 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 1.26 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 3.34 114.69 -175.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 2.61 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 2.25 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 1.79 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 2.78 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 2.03 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 2.55 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 2.31 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 3.96 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.91 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 2.73 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 6.58 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.38 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 2.4 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.28 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.07 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 2.83 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.19 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 5.71 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.55 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 3.8 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 6.3 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 3.48 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 5.7 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 3.72 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 3.73 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 2.92 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 109.533 -0.543 . . . . 3.81 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 3.13 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.49 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 4.51 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 279' ' ' GLN . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 5.26 113.144 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 2.29 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 3.57 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 3.25 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 2.85 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 2.63 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.62 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.83 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.12 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.55 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.63 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 3.48 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 2.69 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.8 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 3.44 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.433 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 2.64 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 3.99 110.466 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 8.1 113.002 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.17 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 5.97 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 2.27 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.66 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.34 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 1.51 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 1.37 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 1.56 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 1.96 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 2.29 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 1.84 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 2.18 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 2.68 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 3.71 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 6.2 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.64 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 3.38 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 8.58 113.835 -155.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.754 0 CA-C-O 121.368 0.486 . . . . 3.78 112.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 3.31 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 2.75 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 2.67 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 1.75 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.33 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.31 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 2.33 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.497 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.93 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.12 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.02 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 3.62 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 2.54 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.84 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 6.31 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.31 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 2.86 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 3.87 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.12 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.55 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.68 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 1.99 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 3.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 1.84 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.09 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 2.52 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.94 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 4.6 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.52 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 5.51 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 2.98 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.08 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 3.61 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.469 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 1.81 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 2.84 111.577 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 2.81 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.1 112.366 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.28 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 1.64 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 1.85 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 1.63 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 2.94 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.11 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 2.3 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.12 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 3.24 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 3.51 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 3.36 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 4.25 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 3.5 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.76 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.61 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 4.15 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 1.14 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.87 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 2.79 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 2.61 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 1.4 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.26 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 2.2 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.19 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.18 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 207' ' ' ARG . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.12 113.112 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 7.94 112.377 -178.102 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 2.94 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.497 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 3.75 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.09 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 1.39 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 1.81 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.0 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 3.81 112.377 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 3.14 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 1.08 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 3.56 114.843 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 2.76 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 1.65 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.36 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 4.38 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 2.39 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 1.84 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 1.94 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 2.6 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 2.73 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 11.09 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 3.9 110.667 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.03 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 2.8 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.26 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.539 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.21 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 2.9 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.78 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.539 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.13 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.22 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.77 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 5.32 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 3.72 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 6.64 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.79 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 4.66 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.04 113.512 -177.83 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 5.93 107.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 3.46 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.02 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.469 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.09 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 5.59 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 5.44 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 3.28 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 2.67 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 3.02 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 2.37 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.12 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.73 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.49 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.07 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 4.02 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 2.62 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.76 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 6.72 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 2.5 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.29 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 4.83 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 6.59 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.08 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 5.9 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 1.88 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.52 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.83 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 1.2 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 1.18 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 1.38 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 1.8 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 2.81 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 1.5 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 1.69 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.36 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 4.74 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 4.8 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.56 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 3.29 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.21 113.13 -166.801 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 121.277 0.449 . . . . 2.56 111.829 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 2.79 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 2.85 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 2.79 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 1.6 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 1.43 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 1.78 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.28 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.78 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 8.53 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 3.18 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 1.85 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 6.56 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.97 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 2.12 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.04 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.53 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.14 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.31 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 3.27 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 3.93 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 1.78 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 3.49 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 2.52 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.56 112.344 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 5.33 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.64 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 5.74 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.438 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.92 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 8.95 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.438 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.35 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 2.98 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 1.87 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.45 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.37 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.82 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 2.81 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.14 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.01 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 3.34 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 1.41 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 1.99 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 1.59 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 2.01 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.99 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.14 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 1.98 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.95 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 2.34 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 2.39 112.788 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 3.04 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 3.42 112.527 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 3.79 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.84 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 2.68 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 1.38 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 0.92 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 2.43 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 2.89 108.508 -163.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 1.49 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.33 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 1.89 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.36 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.51 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 6.93 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.89 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 3.53 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 3.54 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.64 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 1.77 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 2.08 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 1.62 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 4.58 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 3.25 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 2.12 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 4.95 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.07 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 2.83 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 2.09 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.61 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 2.81 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 2.08 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 1.36 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.06 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 2.61 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 2.67 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.86 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 231' ' ' ARG . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 3.97 107.392 169.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 230' ' ' THR . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.23 114.597 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.84 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.42 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 2.3 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.85 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.53 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 3.33 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 2.5 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 4.75 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 2.29 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.09 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.04 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 2.42 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.37 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 3.01 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.17 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.32 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.43 111.1 -179.509 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.825 -0.435 . . . . 3.67 109.825 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 2.88 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.447 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 1.95 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 3.16 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 4.79 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 2.59 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 3.02 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 2.92 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 2.12 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 3.42 109.04 -177.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 3.44 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.55 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.79 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.06 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 267' ' ' ILE . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 5.42 111.836 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 4.3 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 3.13 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 3.25 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.3 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 3.74 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 6.37 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 4.42 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 5.44 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.06 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 1.87 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.56 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 1.49 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 1.24 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 1.48 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.01 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 3.54 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.06 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 2.32 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 2.54 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 3.74 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 5.86 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.18 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 3.26 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.47 110.791 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.458 -0.582 0 CA-C-O 121.172 0.405 . . . . 3.67 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 2.69 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.08 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 2.42 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.25 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 1.32 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 1.68 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.12 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.14 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.51 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 6.28 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 2.89 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.16 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.13 113.215 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 5.98 114.012 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.11 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 2.79 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 2.89 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.47 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.417 HE22 ' CD2' ' A' ' 160' ' ' LEU . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.55 111.535 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 1.87 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.417 ' CD2' HE22 ' A' ' 158' ' ' GLN . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 2.74 112.567 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 2.79 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 2.32 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.38 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.06 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 4.78 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.436 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 3.29 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 5.15 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 2.9 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.13 114.109 -137.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.35 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 3.08 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.06 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.5 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.9 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.03 113.222 173.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 2.97 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.12 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 3.51 111.611 171.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 3.23 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 1.65 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.12 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 1.56 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 1.98 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.6 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.31 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 2.29 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.59 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 2.95 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 2.25 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 3.91 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 2.95 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 3.22 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.95 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.49 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 2.32 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.01 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 0.9 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 2.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 2.54 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 1.51 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 1.86 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 2.34 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.35 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.69 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.436 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 9.39 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.49 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 3.32 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 4.82 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 1.72 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.02 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.18 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 3.19 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 3.37 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 1.49 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 3.51 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.11 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 2.77 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 1.85 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 1.79 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 3.91 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 2.12 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 1.59 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.81 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.0 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 2.82 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.05 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 2.89 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 8.18 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.44 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.19 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.12 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.84 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 3.35 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 2.92 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 2.99 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.21 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 2.47 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.03 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 8.22 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 2.7 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 6.2 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 3.5 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 3.73 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.08 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.38 114.156 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 122.039 0.923 . . . . 3.99 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.05 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.47 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.26 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.12 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 4.73 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 2.84 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.01 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 2.8 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 1.98 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 2.93 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.37 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.06 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.27 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 4.75 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 3.14 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 2.94 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 2.84 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 3.09 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 2.78 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.22 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.04 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 5.72 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.08 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 5.66 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 1.93 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.49 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 1.48 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 1.26 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.28 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 2.25 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 2.56 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 1.55 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 1.68 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.12 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 4.9 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 6.01 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.26 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 3.6 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 8.88 111.173 175.349 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 CA-C-O 120.817 0.257 . . . . 3.36 111.761 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 2.79 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 3.05 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 2.27 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 1.69 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 1.42 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.38 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 2.6 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.03 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.86 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 6.35 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.21 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 2.31 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.4 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.14 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.09 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 2.38 113.788 -177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 5.1 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.82 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.58 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.41 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 2.44 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.08 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 2.28 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 3.7 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 2.2 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 4.6 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.06 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 8.36 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.43 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 4.76 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.34 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 3.37 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.88 115.104 164.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.35 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.55 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.44 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 2.79 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.31 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 5.2 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 4.98 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 3.75 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.07 111.678 -178.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 1.56 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 2.38 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.76 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.24 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 1.88 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.63 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 2.5 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 3.62 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 3.0 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.27 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 3.95 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.28 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 197' ' ' THR . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 2.43 108.877 135.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 196' ' ' LEU . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 1.75 109.428 -177.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 2.23 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 2.43 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 1.44 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.68 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 1.97 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.17 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.18 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.39 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 7.34 110.951 -175.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.84 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 3.2 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 3.41 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.74 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 2.18 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 2.15 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 1.48 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 3.31 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 3.34 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 1.44 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 3.39 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.7 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 3.16 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 1.94 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.05 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 3.25 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 2.29 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 1.48 109.232 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.13 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 2.13 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 2.32 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 2.84 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 6.12 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.59 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.47 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 2.15 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 2.64 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 3.7 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 2.98 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 3.98 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 2.57 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.04 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 6.06 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 2.65 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 5.86 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.07 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 2.74 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.49 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.26 113.763 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 112.917 0.71 . . . . 4.4 112.917 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 3.47 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.63 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.38 114.058 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.18 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.0 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 2.42 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 4.22 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 2.62 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 267' ' ' ILE . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.15 110.972 177.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 266' ' ' LEU . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 2.12 107.884 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.46 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.49 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.95 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.2 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 3.77 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 3.02 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.74 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 4.18 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 2.68 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 2.83 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 5.11 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 6.36 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 7.65 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 4.85 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.1 113.161 -171.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 1.86 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.67 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 1.79 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 1.5 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 1.85 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 2.24 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 2.77 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 2.2 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 2.3 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 1.92 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 5.76 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 6.67 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.41 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 3.54 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 8.37 112.464 -165.392 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.412 -0.649 . . . . 3.45 110.412 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 2.63 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.15 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 2.47 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 1.75 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 1.3 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.45 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 2.81 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.33 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 6.05 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 2.8 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.06 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 6.98 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.08 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 3.3 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 3.5 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.56 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.07 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 1.92 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 2.49 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 3.62 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 1.54 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 3.91 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 2.79 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 260' ' ' HIS . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.33 115.567 -173.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 4.65 110.164 162.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.25 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 7.47 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.72 111.846 -167.571 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.18 114.275 -154.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.57 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' ' 260' ' ' HIS . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 3.6 113.034 -174.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.25 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.76 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.43 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.06 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 2.64 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.09 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 6.96 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 3.19 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 1.42 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.25 111.434 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 1.54 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 2.4 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.32 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.05 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 2.5 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.67 110.887 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 2.57 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 2.68 111.501 171.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 2.91 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 2.64 110.398 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 2.67 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.16 113.308 -167.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.3 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 3.04 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 1.07 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.85 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 2.62 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 2.54 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 1.51 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 1.89 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 2.1 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.44 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.72 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.03 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 6.81 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.32 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 2.99 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 3.75 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.76 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 1.66 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 1.57 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 1.22 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 4.27 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.16 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.23 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 3.5 115.658 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.94 110.064 170.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 2.86 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 1.57 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.01 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 2.95 112.889 173.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 2.0 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 1.82 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 1.84 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 2.5 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.43 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 4.05 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 5.46 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.51 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.82 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 2.49 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.06 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.06 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 3.62 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.19 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 4.61 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 2.88 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 3.55 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 5.26 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.11 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 5.98 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 3.43 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.51 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.38 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.18 115.279 -175.825 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.238 -0.652 . . . . 4.3 109.238 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 4.44 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.68 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.464 ' CE1' HG23 ' A' ' 172' ' ' VAL . 33.2 p-80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.17 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 4.35 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 3.13 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 3.91 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 3.09 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 2.98 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 2.36 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 2.38 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.69 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.1 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.47 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 4.31 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 2.84 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.51 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 3.97 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 3.44 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.15 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.02 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 9.07 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 5.43 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 5.7 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 2.73 112.733 -173.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.44 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.31 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 2.36 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.23 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 2.77 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 3.57 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 3.34 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.07 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 2.95 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 2.72 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 4.26 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 6.37 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.01 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 3.81 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 7.91 113.41 -166.924 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.458 -0.564 0 CA-C-O 119.887 -0.13 . . . . 3.73 111.935 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 236' ' ' GLN . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 3.17 108.205 168.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 2.52 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 2.76 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.05 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 1.67 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 1.83 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 2.81 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.83 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 5.53 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 8.19 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 4.93 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.68 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 7.91 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.452 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 2.67 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 4.64 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 2.86 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.62 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 2.71 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 3.37 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 3.19 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 2.18 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 5.86 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 2.12 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.05 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 5.67 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.68 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 5.28 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 2.96 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 5.58 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.533 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 3.04 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.703 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 1.85 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.37 112.396 -168.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.66 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 2.78 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.67 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 3.87 110.656 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 184' ' ' VAL . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 3.94 113.453 174.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 2.0 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 1.95 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 1.46 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 180' ' ' MET . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 2.59 110.746 -178.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.44 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.36 112.035 168.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 2.48 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.39 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.68 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.07 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 4.76 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 4.83 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 4.45 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.44 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.28 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 3.86 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 1.89 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.76 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 3.34 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 3.08 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 1.9 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 1.83 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 1.94 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.53 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.47 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.97 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 7.07 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.14 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 3.89 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 7.71 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 2.37 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 2.95 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 1.83 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 3.71 111.705 170.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 4.39 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 1.94 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 3.22 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.22 111.334 173.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 2.65 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 2.72 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.66 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 3.12 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 2.49 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 2.15 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 2.39 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 2.75 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.42 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.41 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.09 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.68 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.07 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.05 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7 111.86 167.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' PHE . 5.5 tp-100 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.99 111.412 172.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 3.15 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 2.38 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.09 113.22 170.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 2.19 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 2.9 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.14 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 3.35 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 6.35 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 3.91 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 3.19 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 3.76 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.516 -0.754 . . . . 5.4 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 3.71 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.8 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.703 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 32.8 p-80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.13 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 3.3 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 3.83 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 2.48 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 3.55 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 3.73 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 3.22 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 3.74 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.69 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.61 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.77 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.35 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.41 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 4.11 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 4.41 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 3.18 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.14 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 2.83 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.4 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 4.47 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 4.87 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 5.62 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 5.95 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 1.67 113.636 -168.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.53 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.64 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 1.36 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 1.41 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 1.62 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 2.16 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 2.43 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 1.81 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 1.92 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 2.77 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.17 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 5.63 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.37 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 4.05 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.33 110.666 172.466 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 110.827 -0.489 . . . . 4.05 110.827 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 3.71 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.02 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 2.61 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 2.98 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 1.75 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 1.8 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 2.82 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.89 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.05 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 3.33 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 2.99 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.76 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.08 114.548 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.55 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 3.33 112.553 154.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 3.72 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 1.96 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 2.82 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.13 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 2.31 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 3.79 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 1.97 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.11 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 2.92 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.17 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 5.0 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 2.78 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 5.37 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 3.81 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 5.79 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.42 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 2.57 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.414 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.28 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 2.88 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.44 111.724 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.38 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 3.7 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.27 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 3.93 112.248 175.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.21 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 1.96 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 2.6 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 1.94 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 2.53 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.94 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 1.84 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.34 110.288 167.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 2.72 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 2.76 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 2.81 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 2.66 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 3.01 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.87 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.81 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 1.21 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.85 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 2.7 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 3.02 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 1.94 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.06 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.16 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.73 110.105 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.85 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.15 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 8.59 115.411 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 3.18 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 4.48 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.27 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 1.89 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 1.87 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 1.63 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 2.91 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 2.99 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 1.43 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 3.4 114.851 -177.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.87 112.012 167.142 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 3.02 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.13 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 2.77 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 2.59 112.621 168.242 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 1.98 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 1.45 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 2.18 111.43 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 2.48 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.79 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.1 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.66 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.45 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 1.98 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.33 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 2.7 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 2.58 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.28 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.14 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.19 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 3.47 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 5.54 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 2.67 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 6.55 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 3.13 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 3.8 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.47 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.89 110.942 164.555 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 110.306 -0.257 . . . . 4.37 110.306 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 2.91 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.08 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.19 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.37 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 3.65 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 1.98 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 4.47 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 3.02 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 1.94 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 2.1 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.81 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.47 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.53 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 2.76 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.34 114.155 -174.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 4.13 113.253 -177.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 3.43 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.81 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 3.21 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 3.28 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 2.4 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 4.4 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 5.43 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 4.45 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 8.11 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 2.37 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.24 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 1.95 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 1.41 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 1.95 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 2.96 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 2.4 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 1.91 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 2.55 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 3.29 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.14 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 5.35 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.19 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 4.94 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 8.99 111.386 179.406 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 111.023 -0.414 . . . . 3.33 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 3.4 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 2.54 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 2.68 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 2.96 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 1.61 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 1.49 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 2.94 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.45 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.39 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 4.5 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.596 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 3.41 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 2.94 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.89 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 9.92 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.13 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 3.7 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 4.12 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 1.8 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 2.84 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.26 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 2.4 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 2.92 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 1.87 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.13 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 2.22 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 4.39 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.04 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 6.42 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 2.91 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 5.08 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.23 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 5.43 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.24 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.51 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.67 111.449 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 3.52 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.48 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.03 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 4.65 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 1.42 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.425 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.03 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 3.2 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 2.28 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.3 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.14 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 2.48 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.51 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.07 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 2.4 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.08 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 3.78 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 2.76 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 2.85 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.32 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 2.57 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 1.48 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.15 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 2.24 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 2.51 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 1.53 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 1.85 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.17 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.82 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.38 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 6.22 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.41 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.19 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 3.57 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.97 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 1.84 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 2.35 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 1.35 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 4.21 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 4.17 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 1.26 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.01 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 3.42 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 2.61 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.01 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.63 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 3.16 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 2.09 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 1.35 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 2.12 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.04 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.74 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.37 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 7.63 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.66 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.02 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 2.46 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.64 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.92 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 3.05 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.48 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.3 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 2.52 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 8.59 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 2.46 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 5.53 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 4.64 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.1 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 4.85 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.28 111.194 176.565 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.894 0.854 . . . . 7.2 112.303 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 5.19 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.36 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 5.12 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.12 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 4.7 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 3.19 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 3.61 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 3.76 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 2.14 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 2.68 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 1.72 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.49 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.01 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 2.54 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.08 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 4.77 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 2.95 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 3.33 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.25 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 4.09 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.4 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.16 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 6.29 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 6.14 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 7.84 110.524 156.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 2.71 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.07 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.81 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 3.42 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 1.87 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 2.29 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.03 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 3.06 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 1.64 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 2.42 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.39 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.21 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 5.74 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.76 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 3.73 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 . . . . . 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 9.76 112.237 -166.382 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 110.032 -0.795 . . . . 3.08 110.032 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 3.17 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 2.97 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 2.38 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 1.72 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 1.88 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 1.83 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 2.46 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.85 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 4.86 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 3.22 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 2.5 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.99 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 5.6 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 2.52 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 3.29 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 1.84 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 2.71 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.62 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 2.85 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 3.28 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 2.58 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.82 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 2.26 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.08 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.597 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 4.41 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.26 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 5.25 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 2.8 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 6.04 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.3 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.15 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.71 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.24 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.99 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 2.55 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.91 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 3.35 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 4.21 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 1.53 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.453 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.02 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 1.55 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 2.46 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.15 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.64 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 2.03 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.45 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 2.66 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 2.9 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.03 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 2.82 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.32 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 3.84 110.801 153.131 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 1.28 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.0 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 2.45 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 2.41 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 1.34 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.61 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.08 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.84 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.69 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 7.37 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 3.14 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 4.46 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 3.15 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 2.51 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.15 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 1.49 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 3.38 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 3.5 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' A' ' 226' ' ' GLY . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 1.58 112.592 176.253 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 3.72 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.65 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 2.89 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.61 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.27 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 2.37 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 2.05 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 2.91 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.85 112.603 -173.259 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 1.99 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.2 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.43 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 4.58 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 5.33 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.93 113.384 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.68 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 2.3 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.39 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 3.15 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.15 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 3.9 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 2.31 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.31 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 7.28 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 4.15 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 5.57 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 2.97 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 2.98 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.53 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.63 111.767 173.04 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.557 0.947 . . . . 5.03 113.557 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.09 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.84 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 166' ' ' PHE . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 1.8 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 3.65 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.08 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 5.07 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.84 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 4.62 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 3.07 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 2.39 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.66 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.92 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.43 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.62 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.68 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 3.53 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 3.25 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.39 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 3.74 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 2.82 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.16 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 4.69 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 4.89 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 4.64 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 6.98 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 1.94 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.53 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.77 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 1.67 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 1.39 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 1.7 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 2.29 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 2.7 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 1.56 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 1.68 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 2.6 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 4.94 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.04 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.07 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 4.45 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 8.47 111.904 178.695 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.452 -0.939 0 N-CA-C 109.722 -0.915 . . . . 3.07 109.722 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 2.49 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 2.9 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 1.92 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 1.69 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 1.64 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.33 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 2.21 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.3 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.58 109.793 -168.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 4.89 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.11 113.22 -176.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.02 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.99 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 5.7 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.57 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 2.46 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.435 HD11 ' H ' ' A' ' 270' ' ' ASP . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 2.91 111.925 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.65 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 1.8 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 2.15 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 3.32 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 1.52 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 3.63 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 2.49 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 260' ' ' HIS . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 4.28 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 3.89 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 4.99 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.13 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 4.98 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.32 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 2.76 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.48 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.71 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.01 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 2.38 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.442 ' N ' ' HZ3' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 4.33 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 3.41 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 1.72 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.11 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 1.88 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 2.6 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 2.09 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.44 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.26 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.55 111.455 169.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 3.09 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 2.85 109.823 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 2.51 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 294' ' ' MET . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.36 110.811 170.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.23 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 2.58 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 1.09 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.95 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 2.55 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 2.86 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 1.35 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.45 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.3 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.74 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.19 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.95 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 15.38 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.94 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.15 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 6.25 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.55 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 2.09 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 3.1 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 1.74 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 4.49 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.17 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 1.54 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 3.99 114.913 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.38 113.25 175.082 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 2.94 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 2.87 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.25 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 2.8 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 2.64 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 2.68 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.95 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 2.29 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 2.31 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.26 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.69 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 6.98 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.09 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.68 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 1.71 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.93 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.66 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 2.69 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 2.67 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 3.78 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.0 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 3.22 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 5.78 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 3.27 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 8.72 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 3.74 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.41 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 2.98 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.08 112.888 173.018 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.559 0.207 . . . . 4.12 111.559 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 3.33 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.48 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 50.2 p-80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.73 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.02 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 3.84 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 2.52 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 2.6 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 3.75 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 2.31 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 1.91 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.5 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.12 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 156' ' ' LEU . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.92 110.364 -153.333 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.42 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.82 113.324 -177.016 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 5.2 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 4.06 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 3.24 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 2.68 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.61 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.464 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.15 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 7.83 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.45 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 5.1 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 2.64 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.72 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 1.68 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.1 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 1.39 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 1.9 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 2.42 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.4 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 1.88 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.33 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 194' ' ' PRO . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 5.03 114.247 172.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 4.57 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.06 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 3.09 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 8.27 112.81 -172.143 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 121.506 0.544 . . . . 3.49 112.628 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 142' ' ' LEU . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 2.78 112.698 -176.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.22 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.446 HD23 ' CD1' ' A' ' 140' ' ' PHE . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 3.55 111.662 -172.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 1.86 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 1.71 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.07 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 2.36 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.2 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.64 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.22 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 3.27 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.04 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.76 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 6.5 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.84 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 2.42 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 3.32 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 269' ' ' PRO . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.01 113.666 -172.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.18 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 1.74 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 4.04 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 2.58 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 3.35 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 3.93 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 1.89 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.68 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 5.52 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.11 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 8.78 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 2.7 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 5.33 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 3.12 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 1.98 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.3 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.31 112.541 178.258 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.57 113.121 143.795 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 2.83 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.401 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.72 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 3.54 113.934 -176.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.461 ' O ' HG22 ' A' ' 183' ' ' VAL . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 4.63 112.142 168.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 181' ' ' ILE . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 1.88 109.893 -174.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.401 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.25 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 180' ' ' MET . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 2.5 113.518 173.227 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 2.0 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.36 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.55 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 2.13 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.95 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 2.47 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 2.62 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.09 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.03 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 3.48 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 3.88 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.15 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 2.82 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 1.49 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.99 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 3.26 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 2.37 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 2.28 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 2.17 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.59 111.067 -172.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.18 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.41 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 6.98 114.074 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 2.85 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 3.97 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.87 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 1.68 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 1.74 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 1.89 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.46 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 3.22 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 1.45 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 5.14 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.63 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 2.8 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 1.82 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 2.68 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 2.43 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.1 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 1.68 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 2.7 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 2.74 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.95 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.2 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.01 110.573 172.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.53 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.28 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 2.2 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.78 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 3.33 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 3.61 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.25 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 5.36 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.41 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 3.78 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 6.46 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 3.02 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 5.48 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 3.21 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 2.93 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.08 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 2.7 112.225 171.818 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 117.37 -1.3 . . . . 4.62 112.165 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 3.44 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 3.29 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 3.39 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 3.53 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 3.8 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 3.6 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 2.93 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 2.27 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.51 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.411 ' HA ' ' H ' ' A' ' 157' ' ' GLY . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.07 112.391 169.133 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.43 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.01 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.08 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 4.09 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 3.46 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 3.95 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 2.68 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.45 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 176' ' ' GLU . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 5.74 116.654 -169.014 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 6.72 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 4.73 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 5.82 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 2.42 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.63 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.81 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 1.98 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 1.53 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 1.53 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 2.29 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 3.21 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.33 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 1.98 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.26 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.02 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.25 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.13 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 4.09 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 9.9 109.923 -177.849 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 109.602 -0.961 . . . . 3.17 109.602 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 2.69 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 2.96 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 2.63 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 2.38 108.346 172.726 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 150' ' ' LYS . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 1.54 108.801 163.411 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 2.16 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 2.66 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.32 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.12 115.158 -162.163 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 5.3 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 4.06 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.03 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.24 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 7.23 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 2.66 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 4.24 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.72 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.78 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.57 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 2.37 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 2.86 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 2.81 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 3.65 111.697 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 2.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.31 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 7.41 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 4.16 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 6.34 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 2.93 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 6.29 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.486 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.8 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 2.54 112.43 169.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.74 114.286 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.6 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 2.83 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.34 112.873 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 2.9 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 6.78 111.794 166.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 3.8 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 2.75 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 182' ' ' GLN . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 1.93 113.213 -175.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 1.42 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 2.27 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.51 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.33 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 1.61 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.68 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.02 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 3.45 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.12 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.14 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 3.26 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.3 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 3.49 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 1.61 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.2 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 2.08 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 2.44 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 1.82 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 2.54 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 3.11 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.24 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.42 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.38 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 8.87 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.07 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.09 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 3.34 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.99 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 2.14 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 2.12 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 1.58 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 4.18 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.04 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 224' ' ' LEU . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 2.24 113.678 -173.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 2.93 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.15 108.938 172.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 2.85 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 1.81 111.658 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.06 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 3.08 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 217' ' ' VAL . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 2.23 108.84 174.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 2.11 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.18 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 2.36 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 2.54 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.39 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 4.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.05 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.34 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.88 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 2.86 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.64 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.97 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 2.66 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 2.68 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.42 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 2.65 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 3.61 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 7.68 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 2.65 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 5.77 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 3.79 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 2.94 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.4 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.6 116.031 178.633 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 112.547 0.573 . . . . 5.38 112.547 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 2.59 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.65 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.59 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.03 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 3.38 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.08 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 3.8 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 3.89 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.08 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 2.42 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.48 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.18 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.68 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.19 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.02 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 3.64 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 2.93 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.53 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 4.93 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 2.92 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.03 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.01 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 5.55 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 5.38 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 5.97 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 1.61 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.64 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.78 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 1.54 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.09 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 1.37 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 1.75 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 2.05 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 1.48 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 1.61 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 2.34 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 4.18 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.09 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 3.4 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 10.57 116.249 -163.345 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 CA-C-O 121.214 0.423 . . . . 2.4 111.282 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 3.0 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 2.7 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 2.86 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 2.12 111.912 -169.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.06 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 2.32 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 3.62 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 2.66 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.97 113.825 -171.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 7.02 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 3.75 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.22 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 7.6 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.17 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 2.14 114.602 -176.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 3.69 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.09 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.99 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.3 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 2.66 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 3.01 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 1.59 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.13 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CZ ' HG22 ' A' ' 243' ' ' VAL . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 1.81 112.575 -178.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.07 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.463 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 4.12 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.18 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 4.79 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.26 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 4.58 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' A' ' 260' ' ' HIS . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 3.42 113.213 173.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.505 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.32 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.65 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 2.64 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.09 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 2.58 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.9 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 3.79 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.01 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 1.73 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.02 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 1.56 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 187' ' ' ILE . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 2.73 113.081 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.23 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 184' ' ' VAL . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 2.42 112.191 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.72 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.19 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 2.21 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.11 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.4 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.06 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.54 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.41 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 2.75 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 1.3 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 0.95 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 2.23 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 2.27 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 1.36 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 1.9 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 2.28 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.37 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.61 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.91 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 6.61 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.26 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 2.98 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 3.7 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 1.46 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 1.76 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.13 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 3.61 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 2.8 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 1.48 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.2 114.859 -177.377 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 3.06 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 1.69 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.56 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 2.82 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 2.31 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 1.45 109.888 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.442 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.96 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 2.65 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.01 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.63 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.04 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 6.46 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.76 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 2.2 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.69 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.2 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 3.27 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 2.23 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 4.48 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.14 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 2.52 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 6.33 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 164' ' ' PHE . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 3.33 109.365 169.006 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 5.29 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 3.29 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 2.88 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.74 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.45 110.808 163.84 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.841 0.311 . . . . 4.02 111.841 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 2.81 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.09 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' HG23 ' A' ' 172' ' ' VAL . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.04 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 3.19 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 3.36 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 2.36 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 3.33 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 6.4 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 2.61 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 3.12 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.64 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.45 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.38 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.01 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.03 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 3.42 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 2.98 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.84 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 6.1 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 4.02 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 1.9 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 4.48 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 8.74 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 6.61 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 4.83 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.12 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.59 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.33 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 1.73 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 1.37 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 1.71 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 2.5 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 2.51 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 1.91 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.17 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.32 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 5.52 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 4.85 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.16 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 3.44 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.2 115.006 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.338 -0.839 . . . . 16.85 109.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -69.18 169.09 12.71 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.959 0.799 . . . . 17.05 111.363 168.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -167.49 -144.04 0.05 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.096 1.758 . . . . 14.25 109.733 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 58.38 6.99 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.347 1.451 . . . . 12.59 111.98 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 44.67 0.2 Allowed Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 116.448 2.018 . . . . 14.28 116.448 -163.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.25 164.78 34.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.703 2.268 . . . . 9.36 111.074 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.5 mt -128.61 143.67 51.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.188 1.395 . . . . 7.36 108.502 167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.97 1.89 3.61 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.501 0.926 . . . . 9.32 113.501 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.64 -144.66 17.21 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.854 -1.298 . . . . 3.65 109.854 -159.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.16 89.09 1.0 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.225 -1.55 . . . . 4.04 109.225 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.65 102.08 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 3.49 109.803 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 4.2 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 3.93 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 2.69 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 2.46 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 1.49 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 1.63 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 2.14 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.43 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.08 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 3.0 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 3.03 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.26 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 6.54 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.95 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 2.82 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 4.75 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.44 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.14 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.36 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 3.21 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 2.37 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 1.63 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 3.84 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 2.15 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 3.93 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.14 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 8.4 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.06 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 4.24 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.65 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 2.56 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.83 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.61 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.37 112.01 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.28 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 2.56 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.38 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 3.62 111.202 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 3.37 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 1.46 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 1.98 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 1.6 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 2.24 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 2.11 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.22 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 4.05 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 3.3 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.22 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 3.25 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 2.94 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.48 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 2.5 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 1.53 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 0.88 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 2.84 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 2.3 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 1.63 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 2.36 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.2 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.3 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.27 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.86 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 255' ' ' ASP . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 6.18 117.962 -162.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 2.81 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 4.95 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 1.46 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 1.89 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.06 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 3.18 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 4.25 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 1.31 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 3.56 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.32 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 2.7 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 2.18 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 1.8 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 2.34 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 2.37 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 1.35 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.99 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 2.51 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 2.53 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.94 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 3.21 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 6.69 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.11 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.53 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 1.88 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.23 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 4.14 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 3.17 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.19 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.01 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 3.24 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 6.85 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 3.78 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 9.01 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 3.18 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 3.6 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.12 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.84 83.89 0.34 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.3 113.493 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 165.77 31.78 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.874 2.382 . . . . 5.03 111.309 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.49 -63.54 1.23 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.086 -0.959 . . . . 9.0 113.343 170.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.5 t0 58.75 42.46 20.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.172 1.389 . . . . 7.95 111.343 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -150.71 -50.5 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.604 1.162 . . . . 9.15 111.336 -162.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -131.96 37.68 3.58 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.626 1.97 . . . . 8.85 109.202 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 63.91 -74.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.818 2.847 . . . . 8.71 113.309 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.425 ' CG ' HH21 ' A' ' 207' ' ' ARG . 39.7 t0 -66.75 136.73 55.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.999 1.851 . . . . 6.22 115.999 -152.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -92.79 89.98 6.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.616 1.198 . . . . 6.43 110.586 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm -72.09 68.47 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.356 1.863 . . . . 4.76 110.467 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 2.65 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.72 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.13 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 3.36 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 2.67 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 3.22 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 2.93 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.24 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 2.57 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.63 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.64 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.07 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.33 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.39 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 3.59 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 2.69 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.59 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 4.74 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 3.28 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.55 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 5.68 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.03 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 8.3 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 5.35 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 1.99 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 1.81 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.51 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 1.57 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 1.87 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 2.38 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.01 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 2.49 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 2.43 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 2.85 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 2.77 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 4.83 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 6.87 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.37 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 4.24 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 93.9 -142.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 10.5 108.161 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 57.33 -60.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 128.767 2.827 . . . . 8.81 116.768 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 79.02 -41.59 0.28 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.585 2.754 . . . . 12.11 114.192 163.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--O 1.247 0.969 0 C-N-CA 125.206 1.402 . . . . 9.86 111.397 178.035 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 118.159 -0.924 . . . . 15.47 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.18 153.04 42.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.13 0.877 . . . . 14.49 110.808 165.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.2 t -178.86 59.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.018 2.127 . . . . 11.1 110.812 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.19 71.84 1.18 Allowed Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.404 1.002 . . . . 9.94 113.388 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -149.69 77.54 8.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.72 1.208 . . . . 9.07 112.949 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.52 173.0 13.15 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.765 2.31 . . . . 7.72 110.508 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -145.93 156.19 43.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.545 2.338 . . . . 7.95 106.691 162.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.7 -134.54 0.21 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.502 0.721 . . . . 6.54 109.73 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.51 163.62 38.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.088 1.328 . . . . 3.1 111.829 -165.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -112.75 84.64 0.37 Allowed Glycine 0 N--CA 1.467 0.718 0 CA-C-O 117.914 -1.492 . . . . 3.04 111.684 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.48 115.96 3.21 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 CA-C-N 120.815 2.308 . . . . 3.14 111.966 -168.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 2.29 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.16 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 2.18 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 2.51 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 1.57 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.65 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 3.17 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.05 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.78 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 5.62 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.13 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.17 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.66 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.07 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 2.89 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 2.98 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 3.39 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.52 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.49 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.44 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 2.11 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 2.72 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 1.92 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 3.67 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 1.85 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.86 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 4.67 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 168' ' ' HIS 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 4.12 110.457 165.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.574 ' H ' HG23 ' A' ' 167' ' ' THR . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 7.51 111.866 -171.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 3.58 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 5.74 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.17 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 3.3 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.16 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.42 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.22 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.01 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 2.35 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.11 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.13 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 3.25 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 1.46 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.531 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 1.73 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 1.45 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 2.59 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.89 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 1.9 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.35 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 2.39 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 2.39 111.411 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 2.63 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 2.76 112.572 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 2.6 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.11 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.51 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 2.24 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 1.42 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.25 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 2.98 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 2.15 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 1.63 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 1.85 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.11 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.06 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.92 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.34 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 7.72 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 167' ' ' THR . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.21 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 3.82 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 1.5 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 2.05 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 1.37 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.66 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 2.87 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 1.31 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 4.75 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 2.71 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 1.79 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 1.97 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 2.63 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 2.21 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 1.8 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 0.99 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 2.69 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 2.29 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.15 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 3.27 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 7.08 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.63 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.85 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 1.81 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.09 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 2.39 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.25 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 3.83 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.51 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.1 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 7.19 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 3.02 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.624 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 5.62 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 3.6 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 3.37 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.43 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.33 36.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.67 115.645 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.64 118.03 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.982 3.121 . . . . 4.74 111.454 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.95 122.61 25.75 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.045 0.938 . . . . 7.31 112.07 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.38 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 117.69 -1.148 . . . . 6.24 111.812 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -170.28 -14.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.688 1.995 . . . . 9.91 114.018 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -75.91 -32.49 59.65 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 121.695 2.043 . . . . 8.0 111.379 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -173.97 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.465 2.306 . . . . 7.75 109.912 157.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.38 161.27 16.4 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.916 1.817 . . . . 5.28 115.812 -151.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.24 -26.26 3.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.51 3.124 . . . . 4.44 112.153 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp 54.05 166.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.613 2.765 . . . . 5.22 113.964 -166.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 2.42 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.65 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.85 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 3.34 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.01 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 3.06 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.0 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 3.34 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 2.66 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 2.68 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.36 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.84 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.74 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.19 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 3.73 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 2.78 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.69 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 3.47 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 3.2 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 3.09 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.07 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 4.7 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 8.5 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 6.2 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 1.74 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.49 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 1.3 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.24 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 1.68 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 1.88 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 2.49 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 2.14 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.19 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 2.6 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 4.45 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 5.33 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 2.94 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 5.76 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -65.6 75.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 10.3 112.285 -174.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . 0.297 55.2 mmtt 55.84 148.24 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.571 2.348 . . . . 6.85 115.075 -159.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 109.85 5.7 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 130.394 3.477 . . . . 10.33 111.791 -135.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 C--O 1.247 0.938 0 C-N-CA 131.505 3.922 . . . . 10.23 107.449 -163.809 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.598 -1.667 . . . . 18.86 107.729 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.88 164.78 3.52 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.004 1.722 . . . . 17.15 109.746 -164.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -165.25 179.1 6.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.537 1.935 . . . . 13.85 109.202 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.55 164.14 38.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.8 1.19 . . . . 10.96 112.674 -175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -163.26 142.73 6.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.919 1.288 . . . . 12.23 111.074 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.72 174.07 13.31 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.846 2.364 . . . . 7.75 110.133 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pp -151.46 179.37 8.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.575 1.55 . . . . 7.11 110.796 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -142.6 162.94 34.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 6.86 111.022 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.36 152.28 20.36 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.821 1.201 . . . . 3.19 112.461 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.42 157.53 52.8 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.264 0.935 . . . . 2.8 113.642 -168.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -98.44 55.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.74 2.96 . . . . 3.05 110.658 168.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 2.81 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 151' ' ' THR . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.6 115.787 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.15 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 1.75 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 1.25 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 1.67 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 2.34 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.19 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 6.95 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 3.24 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 141' ' ' SER . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 2.01 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 6.53 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.16 111.332 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 3.24 114.311 -178.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 3.77 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.471 HE22 HD23 ' A' ' 160' ' ' LEU . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.97 110.331 167.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.25 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.471 HD23 HE22 ' A' ' 158' ' ' GLN . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 2.64 110.73 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 1.84 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 3.74 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 2.61 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.89 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 5.24 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.62 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.448 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 6.57 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 2.55 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 5.98 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 3.07 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 1.98 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.81 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 3.28 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.11 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 3.51 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 1.93 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.443 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 3.36 110.781 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 1.56 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 2.49 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.52 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 1.93 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.66 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.13 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 3.72 110.678 165.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 2.92 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 3.92 112.316 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 5.02 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.424 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.67 110.912 174.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.94 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 2.85 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 1.44 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 0.95 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 2.42 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 2.36 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 1.52 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 1.99 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 2.79 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.55 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 6.82 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASP . . . . . 0.448 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.86 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 2.86 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 3.55 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.14 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 1.9 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 1.82 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 1.23 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 3.58 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 5.64 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 1.4 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 3.77 112.904 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.3 112.347 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 2.5 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 2.62 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.73 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 2.42 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 2.72 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 1.43 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 0.97 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 2.02 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 2.6 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.62 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 3.11 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 5.75 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.3 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.3 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 2.44 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.44 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.07 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 3.28 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.04 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 4.81 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.06 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 3.2 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 9.82 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 3.36 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 6.62 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 5.72 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.47 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.35 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.0 -172.12 21.77 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.94 -176.45 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.904 3.736 . . . . 4.68 110.328 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.62 11.13 1.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.725 1.75 . . . . 6.01 115.725 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 3.96 1.17 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 129.693 3.197 . . . . 5.54 114.983 -165.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.66 -57.89 2.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.069 1.748 . . . . 11.21 112.21 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -165.5 51.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.092 1.357 . . . . 8.94 113.043 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 72.39 -4.92 1.91 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.856 2.062 . . . . 7.52 116.147 166.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -78.24 132.1 37.39 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.855 1.262 . . . . 5.96 111.977 171.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -76.24 -12.63 60.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.545 1.683 . . . . 5.95 115.545 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt 41.3 64.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.284 2.233 . . . . 4.83 112.612 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 2.7 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.51 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 4.13 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 4.34 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 2.63 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 2.64 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 2.79 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 2.59 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 2.39 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.56 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.17 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.93 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.81 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.46 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 4.04 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 4.11 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.07 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 3.87 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 2.73 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.08 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.35 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 5.95 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.33 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.08 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 2.81 113.622 -157.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.51 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 1.83 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 1.32 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 1.45 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 2.27 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 2.44 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 1.67 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 1.84 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 3.73 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.1 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 4.37 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.36 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 3.34 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -50.53 137.21 19.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.2 112.581 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.517 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 47.9 tttt -72.65 -167.93 0.4 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.702 1.239 . . . . 7.04 113.672 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.517 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 0.3 OUTLIER -131.64 -9.55 3.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.542 1.537 . . . . 11.89 114.723 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.485 1.288 1 C-N-CA 131.861 4.064 . . . . 10.4 108.081 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.551 -1.214 . . . . 15.34 108.838 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -57.34 -20.39 28.55 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.001 1.273 . . . . 16.5 113.07 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.7 m -138.94 170.69 15.53 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.798 2.039 . . . . 15.85 108.324 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.69 -153.87 22.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.25 1.405 . . . . 12.73 111.729 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.42 155.56 25.78 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.185 0.994 . . . . 9.83 112.452 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.59 -175.11 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.587 2.858 . . . . 9.05 112.331 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.16 170.7 17.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.304 . . . . 8.88 111.96 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.57 -178.26 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.732 2.013 . . . . 7.03 113.933 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.67 152.21 13.11 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.359 -1.097 . . . . 3.32 110.359 -154.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.84 120.21 21.89 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.11 1.338 . . . . 2.81 112.743 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -88.05 52.05 2.04 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.219 2.613 . . . . 3.46 111.076 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 3.11 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 2.58 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 2.66 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.13 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.18 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 1.84 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 3.55 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.06 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 6.66 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 3.41 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 3.31 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.68 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 7.39 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.05 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 2.26 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 3.65 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 1.96 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 2.67 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 1.88 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 2.48 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.05 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 2.22 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 6.83 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 3.31 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.81 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 4.62 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 4.61 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 2.67 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 5.14 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.34 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.546 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 2.95 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.584 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.88 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.72 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.53 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 3.31 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.65 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 2.95 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 3.61 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 1.95 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.528 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.18 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 1.93 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 3.19 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.41 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 1.7 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.64 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 2.96 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.74 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 3.24 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 3.62 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 4.38 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.95 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 2.48 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 1.15 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 3.09 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 2.14 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 1.93 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 2.54 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.61 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.54 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.6 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 6.74 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.68 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.14 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 3.98 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.86 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 1.79 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 2.16 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 1.49 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 4.84 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 2.66 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 1.58 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 3.71 114.227 -167.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.81 112.851 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 2.8 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.01 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.16 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 2.52 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 2.35 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 2.35 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 2.4 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 2.48 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.22 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.24 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 8.69 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.18 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.31 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.12 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.64 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.09 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 3.8 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 2.66 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.0 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.02 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 3.0 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 5.75 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 3.63 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 6.63 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 3.01 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 2.79 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.75 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.21 132.56 11.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.97 111.505 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -85.28 53.13 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.015 3.144 . . . . 4.86 110.657 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 83.64 149.39 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.6 3.16 . . . . 5.96 110.393 -155.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -108.4 -39.64 5.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.319 1.448 . . . . 8.71 110.199 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -136.95 -69.75 0.46 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.094 1.358 . . . . 10.8 110.745 166.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.62 144.88 13.98 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.424 1.107 . . . . 7.53 113.303 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 55.75 23.13 6.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 128.542 2.737 . . . . 8.73 114.24 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -115.48 172.88 6.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.166 2.587 . . . . 6.42 111.872 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.54 127.4 2.37 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.58 1.152 . . . . 6.17 111.972 158.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.62 160.54 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 121.546 -0.721 . . . . 3.84 109.844 156.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 2.83 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.83 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.584 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 23.4 p80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.12 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.21 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 262' ' ' ILE . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 3.36 111.447 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 2.36 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 3.13 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 2.49 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 2.71 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 2.21 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.77 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.19 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.97 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.11 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 2.96 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 2.3 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.19 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.51 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 2.78 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 2.6 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 3.32 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.07 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 8.46 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 6.98 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.528 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 2.25 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.01 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.18 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 1.43 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 1.53 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 2.06 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 1.69 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 2.45 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 1.5 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 2.22 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 2.2 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 3.53 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 5.85 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.75 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.13 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -70.48 -19.8 62.91 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 9.38 116.081 -172.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -106.74 166.37 10.63 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.448 1.099 . . . . 6.34 109.248 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -138.5 163.57 31.64 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.455 1.025 . . . . 11.55 112.507 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.03 0 C-N-CA 129.606 3.162 . . . . 10.7 109.598 -179.191 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 106.587 -1.635 . . . . 18.86 106.587 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -67.51 -176.29 0.59 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.782 0.719 . . . . 17.88 109.738 144.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 t -125.75 173.75 8.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.948 1.299 . . . . 15.74 109.916 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -139.43 -152.15 5.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.239 1.399 . . . . 12.11 112.886 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.25 163.18 22.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.293 1.437 . . . . 13.42 112.081 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.22 162.31 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.421 2.747 . . . . 9.26 112.199 166.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.97 -26.1 7.44 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.913 1.285 . . . . 6.6 112.909 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.33 -170.69 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.522 1.154 . . . . 6.37 113.24 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.71 123.21 0.94 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.444 -1.862 . . . . 3.29 108.444 -147.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.57 107.53 2.38 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 117.825 -1.542 . . . . 3.62 109.559 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.38 145.03 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.056 2.504 . . . . 3.06 110.811 -163.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 2.49 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.18 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.08 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 1.72 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 1.28 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.21 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 2.4 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.28 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.35 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 6.85 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 4.49 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.05 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.83 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 7.64 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 3.18 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 3.5 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 3.74 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.12 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.63 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.54 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 2.27 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 3.58 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 1.78 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 3.61 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 1.91 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 4.4 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.51 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 6.15 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.492 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 3.7 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 7.89 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.63 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 2.77 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.07 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 1.89 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.11 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.453 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.09 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 2.97 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.11 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 3.53 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 3.14 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 1.78 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.07 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 2.04 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 2.62 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.74 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.57 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 2.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.94 111.409 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 2.64 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 2.41 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.34 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.56 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 2.66 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 2.81 108.474 158.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.97 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 2.72 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 1.88 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.25 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 3.05 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 2.37 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 237' ' ' VAL . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 1.31 109.487 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 2.01 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 2.14 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 2.5 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.23 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 8.79 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.66 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 211' ' ' GLU . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.08 106.249 146.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 3.67 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.05 113.993 -171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 2.33 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 1.97 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.23 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.421 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 3.94 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 4.59 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 1.69 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 3.47 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 4.4 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 3.33 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.25 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.54 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 2.89 112.054 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 2.29 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 1.66 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.96 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 2.2 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 2.54 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.9 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 2.91 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 7.48 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.57 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 2.36 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.07 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 2.54 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' CG2' ' A' ' 201' ' ' ILE . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 2.72 113.512 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.19 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.64 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.24 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 3.45 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 8.43 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 3.1 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.07 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 4.24 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.06 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.13 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.63 -176.37 50.3 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.61 112.95 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.15 157.63 60.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.743 1.629 . . . . 4.97 108.6 159.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -90.9 156.31 18.09 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.487 0.551 . . . . 5.7 112.487 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.42 -168.99 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.405 1.082 . . . . 9.15 111.064 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.76 -37.68 59.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.551 -0.718 . . . . 11.57 111.533 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -86.79 24.17 1.54 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.126 1.37 . . . . 9.72 111.486 168.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 83.12 -58.95 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.751 2.82 . . . . 7.05 114.687 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -25.96 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.925 2.49 . . . . 6.07 117.272 -153.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.19 21.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.639 2.376 . . . . 6.82 115.836 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -24.47 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 128.45 2.7 . . . . 4.93 114.504 -166.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 2.89 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.41 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 2.52 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 3.58 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 2.86 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 2.98 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 3.12 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 2.72 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 2.13 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 2.55 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.91 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.13 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.8 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.51 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.08 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 3.64 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 2.97 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.11 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.33 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 3.04 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.02 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 3.66 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 5.35 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.06 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.2 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.02 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.57 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.49 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 1.5 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 1.43 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 1.48 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 2.16 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 3.13 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 2.05 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 1.63 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.32 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 6.08 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 5.9 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.25 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 3.18 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -49.24 127.93 15.75 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 9.88 112.351 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 194' ' ' PRO . 14.9 ttmt -78.41 -61.3 2.05 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.715 1.606 . . . . 8.91 111.507 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.9 140.23 21.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.504 0.928 . . . . 11.44 113.504 159.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.569 1.547 . . . . 8.31 112.319 -174.322 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 118.316 -0.85 . . . . 17.7 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -65.56 151.5 46.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.399 0.68 . . . . 17.17 112.086 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 176.86 173.59 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 130.15 3.38 . . . . 15.61 108.308 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.33 50.05 62.11 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 115.646 1.019 . . . . 14.65 115.646 160.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 0.8 OUTLIER 41.2 67.47 3.0 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.119 1.768 . . . . 15.39 112.804 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -70.31 177.75 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.62 2.213 . . . . 9.48 112.256 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.64 71.85 3.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.504 1.122 . . . . 9.57 108.647 170.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.3 mt 139.28 142.62 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 1 C-N-CA 133.673 4.789 . . . . 10.08 107.645 -168.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.29 -51.29 6.19 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.539 -0.726 . . . . 4.24 112.838 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -161.2 144.93 10.32 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.265 1.032 . . . . 2.55 113.966 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.0 68.4 7.92 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.299 2.666 . . . . 3.11 110.859 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 2.27 112.926 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.71 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 1.87 112.841 -173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 1.59 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.22 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.24 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.09 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.78 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.01 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 7.81 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 3.75 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.03 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.45 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 6.56 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.67 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 2.18 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 3.87 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.38 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.32 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 3.18 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 2.6 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 199' ' ' LEU . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 1.77 111.147 -172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.3 111.988 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 3.06 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.41 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 5.57 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.38 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 5.17 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.82 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 5.28 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.51 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 2.79 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.01 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.59 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.65 112.106 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.08 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 2.59 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.24 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 3.64 111.87 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 3.55 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.07 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.416 ' O ' ' HE2' ' A' ' 283' ' ' LYS . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 1.99 113.836 172.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 2.55 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 2.6 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.1 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 2.43 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.81 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 2.17 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 2.3 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 2.87 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.537 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 2.5 114.378 -165.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 3.03 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.4 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.37 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 2.49 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.0 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.84 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 227' ' ' LEU . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 2.55 112.84 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 2.38 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 1.62 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 2.48 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.02 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.09 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.38 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.64 HH11 ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 8.63 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.89 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.0 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 3.95 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.42 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 1.47 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 1.86 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 1.08 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 4.73 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 4.17 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 1.27 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.16 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 2.78 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.43 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 2.34 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.53 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 3.16 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 225' ' ' VAL . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 2.52 109.86 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 224' ' ' LEU . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 1.32 111.811 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 199' ' ' LEU . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 1.91 112.808 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 2.57 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.0 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.26 113.028 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.08 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.55 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.0 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 3.43 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 2.1 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 3.83 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 2.7 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.08 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 5.4 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 3.88 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.22 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 3.41 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 4.86 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.08 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.89 177.5 29.11 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.32 113.619 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.98 159.7 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.724 2.949 . . . . 4.55 112.183 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -110.6 170.88 7.8 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.271 1.028 . . . . 5.22 110.79 155.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -112.36 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.326 -0.99 . . . . 7.88 108.326 156.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -121.08 -39.9 2.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.554 1.525 . . . . 8.67 112.962 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.65 1.14 12.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.79 1.404 . . . . 9.35 114.79 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.282 0.0 OUTLIER 142.05 -25.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.468 2.707 . . . . 9.11 113.904 132.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -51.98 106.14 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.556 1.317 . . . . 6.54 114.556 -151.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.38 73.92 4.93 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.981 1.372 . . . . 4.88 111.404 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt -70.17 81.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.972 1.309 . . . . 3.44 109.285 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 2.94 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.06 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.461 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.5 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 3.69 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 4.73 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 3.06 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 3.33 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 2.72 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 2.09 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 2.5 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.24 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.83 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.26 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.13 113.233 165.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 4.62 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 2.79 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.24 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 3.65 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.4 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.53 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 5.86 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 4.41 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 6.51 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 182' ' ' GLN . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 1.81 113.504 -165.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.23 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.26 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 0.98 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 1.25 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 1.82 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.12 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 1.27 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 1.45 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.12 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 3.85 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 4.57 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.81 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 2.94 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -42.85 137.15 2.41 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 10.37 110.879 155.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -144.1 -83.68 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.653 0.781 . . . . 8.75 111.646 -159.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 192' ' ' THR . 90.7 mttt -97.86 84.07 3.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.68 -1.23 . . . . 12.67 107.68 141.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 129.077 2.951 . . . . 10.58 110.127 -167.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 119.422 -0.323 . . . . 20.89 110.711 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 133' ' ' LYS . 76.9 t80 -78.69 175.81 10.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.643 1.177 . . . . 17.08 110.848 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.5 m -65.92 74.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.641 1.977 . . . . 13.54 110.328 167.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.58 -154.69 44.21 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.92 0.772 . . . . 9.69 112.97 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 130' ' ' PHE . 25.7 mtmt 82.41 149.45 0.11 Allowed Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 128.975 2.91 . . . . 11.05 111.672 -167.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.77 -38.86 7.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.722 2.281 . . . . 9.79 111.289 166.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.1 mt -100.83 100.64 11.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.703 1.601 . . . . 9.47 108.881 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.57 -45.56 71.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.802 0.841 . . . . 7.84 112.572 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.77 -150.75 7.19 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.168 1.366 . . . . 3.19 113.483 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.3 114.54 5.01 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.711 -1.605 . . . . 3.25 109.568 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.57 98.01 1.06 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.723 2.282 . . . . 2.71 109.372 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 2.35 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.16 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 2.09 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 1.55 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 1.41 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.54 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 2.69 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' HA2' ' HE3' ' A' ' 210' ' ' LYS . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.9 112.808 -155.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.08 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.12 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 1.89 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.19 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 7.94 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.88 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 2.45 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 4.7 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.87 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.34 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 1.91 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 2.16 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 3.14 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 1.72 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 3.61 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 2.65 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.41 ' CE1' HG23 ' A' ' 258' ' ' VAL . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 4.95 109.724 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 3.63 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 5.25 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.64 112.121 -157.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 6.07 112.152 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.3 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 2.94 111.869 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.72 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.06 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.91 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 2.3 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.24 109.501 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.0 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 4.19 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 2.21 109.839 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.47 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 1.62 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 2.17 111.18 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 4.01 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.69 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.88 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 3.11 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.68 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 2.67 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 2.4 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 3.85 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 4.14 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 3.75 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 3.62 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.83 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 2.55 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 1.05 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.84 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 2.38 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 2.06 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 1.42 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 2.4 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.07 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.19 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.42 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.69 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 7.77 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.89 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 3.61 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.42 ' HE3' ' HA2' ' A' ' 147' ' ' GLY . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.17 114.294 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 1.52 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 1.76 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 0.96 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 3.72 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 2.85 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 1.22 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.03 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.66 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 3.24 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.16 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.71 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 2.8 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 1.88 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 1.32 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.74 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 1.97 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 2.75 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.83 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.05 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 5.81 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.33 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.76 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 1.85 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.93 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 2.44 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 2.73 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 2.45 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 5.2 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.6 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 3.02 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.23 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 2.82 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 5.93 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 4.44 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 2.99 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.0 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.31 118.87 5.68 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.97 111.811 -174.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.46 156.1 1.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.066 2.433 . . . . 3.95 112.951 -174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -100.55 -65.46 0.97 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.57 -1.27 . . . . 7.32 107.57 127.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -159.91 177.91 10.29 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 128.715 2.806 . . . . 7.99 107.542 162.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -73.01 13.69 0.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.549 1.685 . . . . 14.95 115.549 -172.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -139.28 -40.73 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.476 -1.39 . . . . 8.98 112.861 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.18 -33.85 59.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.628 1.571 . . . . 9.47 113.505 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . 0.283 1.6 t70 129.06 135.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 1 C-N-CA 132.086 4.154 . . . . 5.09 112.884 171.738 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -88.36 100.35 12.95 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.391 2.276 . . . . 5.71 109.932 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.97 63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.047 2.139 . . . . 4.47 109.435 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 166' ' ' PHE . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 2.86 111.451 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.97 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.538 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.65 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 3.31 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.07 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 2.91 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 2.8 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 2.62 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 1.9 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 1.89 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.25 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.67 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.69 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.91 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.85 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 3.11 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 2.6 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.14 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.07 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 2.77 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.66 111.411 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 3.93 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 5.32 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 4.57 112.558 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.06 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.47 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 2.22 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.4 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 1.31 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.16 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.22 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 2.17 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 2.23 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 1.36 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 1.66 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 3.81 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 4.79 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 4.26 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.17 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 3.71 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 -29.31 129.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.27 111.8 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -47.89 -39.69 19.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.367 0.877 . . . . 6.3 113.367 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.293 0.1 OUTLIER -164.03 -18.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.964 1.705 . . . . 12.28 111.881 129.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 128.705 2.802 . . . . 7.29 109.854 156.008 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 117.532 -1.223 . . . . 19.07 109.592 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.58 -49.93 75.67 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.897 1.073 . . . . 17.58 113.897 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.12 -42.07 0.52 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 128.355 2.662 . . . . 13.09 114.251 171.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.87 158.5 21.95 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.022 1.296 . . . . 10.21 111.455 168.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 272' ' ' GLU . 60.9 pttt -67.62 123.23 86.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 118.418 -0.801 . . . . 11.77 111.47 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.8 165.12 17.92 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.453 2.769 . . . . 8.51 110.676 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.75 163.88 37.64 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.79 1.636 . . . . 6.73 111.044 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -132.57 145.1 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.479 1.111 . . . . 9.36 109.132 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.47 -143.77 16.76 Favored Glycine 0 N--CA 1.47 0.947 0 N-CA-C 110.381 -1.087 . . . . 5.45 110.381 -167.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.05 -89.07 0.53 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.931 -1.483 . . . . 3.64 111.975 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.18 83.8 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.298 2.665 . . . . 3.68 110.754 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 3.03 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 2.61 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 2.32 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 2.74 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 1.61 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 1.51 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 2.94 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 1.91 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 4.89 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 5.38 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 2.59 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.41 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 156' ' ' LEU . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.25 115.421 -156.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 2.97 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 4.13 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 153' ' ' LYS . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 4.18 113.101 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.31 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.49 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.06 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 2.65 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 2.78 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 2.2 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.57 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.01 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.07 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CZ ' ' CD2' ' A' ' 260' ' ' HIS . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 5.1 115.028 -159.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 2.91 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 6.14 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.36 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 4.91 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.1 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 3.71 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.06 112.531 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.75 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.1 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 2.89 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 220' ' ' PHE . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 2.75 111.518 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.37 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.21 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 3.78 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 1.8 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.512 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.08 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 1.94 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 2.58 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.1 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.71 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 2.56 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 2.09 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 2.88 111.781 165.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 2.39 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 2.48 111.768 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 3.08 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.49 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.34 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 2.69 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 1.84 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.05 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 2.58 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 3.31 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 1.62 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 2.9 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 1.6 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.3 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 206' ' ' GLU . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.88 112.181 173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 7.58 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 4.52 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 4.67 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 2.38 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 1.94 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 1.26 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 3.11 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 3.7 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 1.37 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 5.51 113.301 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.23 113.748 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 177' ' ' LEU . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 2.16 112.782 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 1.82 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.21 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 2.94 113.74 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 3.03 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 1.97 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.17 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 1.75 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 2.78 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.74 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 3.79 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 8.33 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.99 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.16 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 2.1 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.53 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 3.18 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 2.58 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.2 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 1.87 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 3.41 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 5.93 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 2.54 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 5.2 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 3.8 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 2.65 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.47 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.0 81.49 0.29 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.26 112.732 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.42 129.09 13.43 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.186 2.591 . . . . 7.74 109.802 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -169.56 -59.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.761 1.224 . . . . 8.93 112.541 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.7 t0 75.35 -168.95 0.09 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.781 1.632 . . . . 9.57 110.902 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 77.32 -34.77 0.21 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.386 2.674 . . . . 10.83 115.096 161.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -160.18 -58.14 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.485 1.514 . . . . 8.94 110.967 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 1.45 42.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.652 1.353 . . . . 12.64 114.652 -166.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.5 t0 91.32 158.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.793 2.516 . . . . 6.07 117.793 147.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.25 95.75 1.33 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.787 1.235 . . . . 7.41 110.71 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt -144.82 140.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.179 0.992 . . . . 4.73 113.086 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 3.41 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.99 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.0 OUTLIER -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.05 112.522 -168.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 4.88 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 3.01 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 2.52 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 4.4 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 2.9 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 2.68 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 3.25 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.78 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 3.53 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 133' ' ' LYS . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.89 113.794 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 3.73 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 3.07 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.68 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 3.39 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 2.88 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 2.67 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 4.61 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.12 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 5.21 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.478 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 7.84 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.512 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 2.36 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.0 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 2.27 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 1.63 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 1.86 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 2.9 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 2.98 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.28 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.18 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.03 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.09 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 6.23 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.81 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.29 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.25 178.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 7.37 111.99 172.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 301' ' ' SER . 0.0 OUTLIER -133.31 -72.98 0.5 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.729 0.812 . . . . 5.78 113.123 166.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -165.29 24.6 0.05 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.9 1.444 . . . . 12.04 114.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.421 ' C ' ' HE3' ' A' ' 299' ' ' LYS . 5.1 t . . . . . 0 C--O 1.252 1.219 0 C-N-CA 130.702 3.601 . . . . 7.77 108.688 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.801 -1.095 . . . . 22.84 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -158.51 -173.86 4.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.636 1.174 . . . . 19.51 110.459 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 t -156.52 164.68 37.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.402 1.481 . . . . 19.29 111.394 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.36 4.7 57.59 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.597 1.094 . . . . 17.14 114.715 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt 173.11 152.69 0.24 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 129.502 3.121 . . . . 14.74 110.958 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.47 161.05 34.84 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.93 2.42 . . . . 12.76 109.794 161.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.3 146.65 48.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.429 1.092 . . . . 9.22 109.657 162.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.29 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 130.224 3.41 . . . . 8.41 106.826 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.39 -156.45 24.11 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.143 1.338 . . . . 3.52 113.669 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.42 -175.84 32.15 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 115.663 1.025 . . . . 3.3 115.663 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -89.35 159.07 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.269 2.646 . . . . 4.11 115.325 -155.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 3.89 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 4.78 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 2.95 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 2.51 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 2.25 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.09 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 3.9 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.47 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.01 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 7.68 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 4.58 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 4.28 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.24 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 7.21 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.65 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 3.52 113.405 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 3.72 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.26 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.63 109.835 159.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.65 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 2.79 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 4.33 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 2.71 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 3.32 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 243' ' ' VAL . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 2.15 112.178 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.95 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 5.14 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.05 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 5.18 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 3.38 109.869 159.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 6.17 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.74 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 2.67 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 2.51 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 1.99 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 2.72 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.65 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.08 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.8 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.12 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 4.86 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 1.62 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 1.9 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 1.87 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 2.79 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 2.93 112.262 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 1.8 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 2.6 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 2.35 110.329 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 2.8 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 2.93 110.692 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 2.74 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.17 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.28 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 4.17 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 1.3 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 0.91 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.14 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 2.99 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 1.75 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 1.6 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 2.55 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.23 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.28 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.19 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 8.95 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 3.7 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.17 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.15 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.02 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 2.8 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 1.43 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.487 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 4.79 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 3.33 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 1.48 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.21 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 3.75 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 4.16 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 2.91 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.64 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 4.67 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 2.32 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 2.31 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.03 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 1.81 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 3.92 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.11 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 3.21 109.003 157.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 6.38 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.89 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.06 111.705 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 2.91 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.33 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 2.59 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.09 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 3.11 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 3.74 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 2.84 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 4.46 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 5.53 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 164' ' ' PHE . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 2.69 111.959 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 5.89 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 4.48 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.11 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.23 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.11 143.93 25.59 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 2.85 114.882 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.36 164.37 35.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.641 2.894 . . . . 4.57 109.689 164.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.427 ' HZ2' ' C ' ' A' ' 255' ' ' ASP . 14.7 mtmt -134.95 160.37 38.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.355 0.662 . . . . 4.99 111.894 -174.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.23 -36.08 11.58 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.897 1.073 . . . . 6.57 113.897 -156.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.75 -59.55 0.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.306 1.443 . . . . 10.16 109.395 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -156.7 -36.01 0.08 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.276 1.03 . . . . 7.36 113.719 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.21 161.85 30.28 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.003 2.121 . . . . 9.49 115.042 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 23.4 t70 93.55 -144.17 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 128.894 2.878 . . . . 5.91 112.279 168.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' A' ' 255' ' ' ASP 0.25 2.8 t80 132.39 50.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.868 1 C-N-CA 133.332 4.653 . . . . 5.86 110.958 179.263 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.57 154.77 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 121.045 -1.034 . . . . 3.82 111.65 163.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 3.24 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 1.82 110.096 170.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.27 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 3.29 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.02 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 3.95 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 3.54 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 2.68 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 2.28 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.32 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.99 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.86 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.45 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 5.87 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 4.79 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.92 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 5.34 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 2.99 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.58 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 5.98 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 4.67 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 4.99 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 8.32 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 3.07 114.072 -164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 2.93 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.07 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.11 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.04 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 2.93 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 3.19 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 2.73 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 2.68 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 3.26 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.43 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 4.23 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 5.45 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.48 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 4.85 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.97 150.61 11.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 8.33 113.298 -161.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? 75.26 -49.12 0.64 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.991 2.516 . . . . 8.03 113.526 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.261 0.1 OUTLIER 71.49 -51.24 0.69 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 131.026 3.73 . . . . 12.86 112.614 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.243 0.75 0 C-N-CA 129.315 3.046 . . . . 10.15 110.246 -179.005 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.519 ' N ' ' HG1' ' A' ' 131' ' ' THR . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.516 -1.23 . . . . 19.18 108.563 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.99 111.53 2.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.851 -1.537 . . . . 16.59 106.851 152.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.519 ' HG1' ' N ' ' A' ' 129' ' ' SER . 51.1 m -161.58 152.22 17.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 16.43 108.424 -159.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.05 -136.44 15.17 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.626 0.631 . . . . 13.58 112.097 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.55 144.34 1.6 Allowed Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.37 1.468 . . . . 11.7 112.009 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.03 173.76 10.72 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.387 2.725 . . . . 8.0 110.184 162.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.4 160.75 37.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.099 1.76 . . . . 8.12 108.957 166.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -105.44 154.3 20.52 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.095 0.958 . . . . 7.64 109.433 166.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.46 -170.98 39.44 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.522 1.058 . . . . 4.4 111.221 -154.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.43 91.29 0.64 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 117.95 -1.472 . . . . 3.41 110.498 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.98 109.98 2.29 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 CA-C-N 120.519 2.16 . . . . 3.63 112.188 -169.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 3.09 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.32 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 2.29 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 2.81 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 1.61 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 1.67 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 2.91 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.82 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 5.85 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.05 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.2 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.87 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 7.5 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.45 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 2.57 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 4.69 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.81 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.12 109.375 165.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.73 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 2.57 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 3.37 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 2.86 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 3.49 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 2.9 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 4.69 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 4.39 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.45 ' CE1' HH12 ' A' ' 207' ' ' ARG . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 5.57 111.929 169.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.05 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 4.28 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.67 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 3.23 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.7 112.355 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.68 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.1 111.672 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.12 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 2.66 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.58 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 3.58 112.175 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 2.91 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 1.43 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 2.55 113.835 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 2.32 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 2.24 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 1.97 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.53 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.23 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 2.53 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 3.23 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 2.77 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 3.23 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 2.84 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.56 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.1 112.704 155.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 1.06 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 0.93 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 2.71 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 3.53 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 1.32 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.63 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 2.34 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.36 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.39 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.45 HH12 ' CE1' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.09 113.029 -167.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.57 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 4.83 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 4.6 114.297 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 4.61 113.48 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 2.27 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 1.8 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 1.2 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 4.37 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 3.49 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 1.21 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 6.19 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.11 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 3.17 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 1.67 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 1.76 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 3.72 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 1.88 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 1.44 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.9 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 1.82 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 2.83 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.15 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.67 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 8.68 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.01 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 2.37 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 2.83 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 2.58 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 2.88 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 6.5 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.44 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 3.6 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.31 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 3.78 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 6.2 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 3.19 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 2.92 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.52 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.9 142.17 28.27 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.24 112.194 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 89.54 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.979 2.453 . . . . 3.74 109.569 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -5.13 30.94 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.194 -0.941 . . . . 5.08 112.221 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -97.3 8.78 43.88 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.134 -1.603 . . . . 7.85 110.983 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -91.99 -46.97 7.53 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.319 2.248 . . . . 12.09 110.617 166.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.31 53.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.269 1.828 . . . . 10.0 112.566 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 64.45 -9.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 128.524 2.73 . . . . 7.27 117.387 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.78 115.34 7.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.508 1.299 . . . . 7.12 114.508 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -113.08 60.15 0.64 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.215 1.806 . . . . 5.49 112.264 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt -55.73 158.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 119.929 -1.732 . . . . 4.54 111.252 152.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 2.32 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.16 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 1.77 111.882 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 3.36 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 3.68 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 2.36 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.02 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 2.73 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 2.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 2.1 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.72 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.06 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 2.97 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.18 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 3.82 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 3.15 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.84 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 3.56 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 2.5 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.17 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 4.54 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 7.97 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.07 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 5.43 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 2.67 112.726 -166.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 1.99 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.02 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 2.15 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.33 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 1.83 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 1.64 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 2.36 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.09 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 2.17 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 2.84 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.04 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 5.66 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.14 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 3.64 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 94.26 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 9.01 109.726 166.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 62.43 172.88 0.14 Allowed 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 118.217 2.673 . . . . 7.31 118.217 165.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -145.03 -66.87 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.813 1.645 . . . . 12.91 109.183 166.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.324 -1.322 . . . . 10.57 108.007 134.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.543 0.571 . . . . 22.45 112.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.98 101.68 7.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.772 0.829 . . . . 18.21 109.977 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.7 t -174.52 -175.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.126 2.171 . . . . 14.21 109.773 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.27 -157.92 0.78 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.82 1.676 . . . . 10.98 112.391 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -134.89 130.8 19.72 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 120.366 -1.667 . . . . 8.98 111.219 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -82.78 -41.03 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.027 2.485 . . . . 9.03 113.446 -170.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.3 0.6 OUTLIER 47.61 6.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 129.87 3.268 . . . . 9.63 116.376 -170.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.0 tp -84.89 131.57 34.49 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.894 2.078 . . . . 11.18 108.989 164.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.01 -151.84 44.63 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 123.076 0.369 . . . . 7.0 112.633 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.2 -119.9 6.61 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.234 -1.315 . . . . 3.48 113.055 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -71.99 104.92 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.212 2.608 . . . . 3.4 111.629 -166.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 2.81 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.09 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 2.33 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 1.98 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 1.51 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.45 112.565 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 2.4 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.74 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.57 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 7.84 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 3.43 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.02 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.19 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 6.89 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.72 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 2.29 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 4.65 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.42 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 1.91 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 2.08 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 2.53 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 1.92 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.13 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 2.42 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 4.09 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.21 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 5.85 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 2.7 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 5.8 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 2.74 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.06 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 1.9 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.9 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 3.38 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.88 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 3.56 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.4 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 1.93 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.44 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 1.9 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 1.67 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 2.46 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.93 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.39 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 2.01 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.45 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 1.93 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.16 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 2.37 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 2.57 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 2.86 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.13 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.78 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 3.08 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 1.0 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.76 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 2.38 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 3.07 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 1.3 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 2.89 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.51 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.67 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.32 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 6.31 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.45 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 3.6 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 6.14 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.95 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.539 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 2.56 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 2.64 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.29 111.414 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 3.76 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 3.97 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 1.44 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 6.95 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.06 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 2.62 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.09 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.59 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.0 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 2.19 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 2.8 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.96 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 2.88 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.3 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.49 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 6.37 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.28 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.35 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 3.45 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.8 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 2.41 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 2.79 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 2.2 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 5.59 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 2.42 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 4.67 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 8.84 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 4.98 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 15.67 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.18 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.04 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.32 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.08 172.52 38.45 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.91 112.966 174.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.56 39.12 0.81 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.623 3.549 . . . . 7.25 110.967 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 158.4 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 1 C-N-CA 131.953 4.101 . . . . 7.26 108.676 -162.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.76 -124.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 118.361 -0.828 . . . . 11.24 112.614 -164.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.59 58.58 2.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.301 1.441 . . . . 16.63 113.629 -159.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -162.98 -73.0 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.582 1.553 . . . . 13.21 110.517 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.19 13.68 0.86 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.5 1.52 . . . . 12.57 114.72 -168.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.5 t70 90.08 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.138 3.375 . . . . 6.03 111.037 -164.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.55 139.51 17.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.067 0.937 . . . . 4.52 113.452 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm -100.42 136.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 3.18 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.34 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.13 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 3.51 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 2.46 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 3.25 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 2.79 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.05 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 1.96 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.33 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.4 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.32 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.92 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.33 112.387 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 3.4 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 2.76 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.78 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 5.46 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 2.45 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.86 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 3.38 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.99 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.27 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 5.93 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 1.93 113.984 -165.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.68 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.92 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 1.47 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 1.55 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 1.75 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 2.32 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 3.21 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 1.8 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.1 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.12 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 4.69 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.2 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.41 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 3.85 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -72.68 79.32 1.1 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 9.61 110.813 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . 0.306 10.1 pttp 38.34 -102.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.725 1.61 . . . . 6.38 113.511 -164.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -146.46 35.0 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.817 1.647 . . . . 13.02 110.442 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.335 1.854 . . . . 8.41 110.813 -146.769 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 117.879 -1.058 . . . . 17.44 109.265 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 174.28 161.99 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.292 1.837 . . . . 15.87 109.625 -160.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.4 t -87.34 -9.55 54.56 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.552 1.315 . . . . 13.38 114.552 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.88 -146.05 47.62 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 118.781 0.719 . . . . 11.19 112.364 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -174.54 134.56 0.54 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.864 2.066 . . . . 13.61 110.475 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.12 141.22 51.93 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.614 2.209 . . . . 7.47 110.766 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 135' ' ' LEU . 1.7 pt? -109.27 20.37 18.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.205 1.402 . . . . 9.58 114.54 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.4 tp -105.52 -119.19 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.228 1.411 . . . . 7.82 109.282 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.4 167.33 37.23 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 125.129 1.347 . . . . 3.91 113.147 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.36 -55.75 0.5 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.986 1.279 . . . . 3.25 113.583 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.2 128.11 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.623 2.211 . . . . 2.57 109.354 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 2.64 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 2.82 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 2.76 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.05 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 1.81 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 1.7 113.025 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 3.42 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 5.71 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 2.88 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 2.21 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.02 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 7.44 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.01 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 3.27 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 3.63 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.48 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.19 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.4 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 3.14 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 2.48 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 1.89 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.84 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 2.11 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.83 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 4.93 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 3.7 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 5.44 111.344 161.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.32 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 4.89 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.27 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 2.76 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.539 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.71 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.11 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.91 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.25 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 2.46 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.15 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 5.3 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.26 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 1.8 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.478 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 1.64 113.278 175.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 1.52 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 2.61 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.38 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 2.45 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.35 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.18 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 2.77 112.728 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 2.93 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 2.86 112.173 -161.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 3.53 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.11 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.32 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 2.43 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 1.18 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.12 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 2.92 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 2.76 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 2.22 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 1.49 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 1.85 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.11 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.92 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 7.4 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 3.55 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.04 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.32 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 2.46 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 2.14 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 1.72 111.994 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 2.76 111.416 173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 2.7 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 1.63 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 3.3 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 2.38 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 1.83 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 1.8 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 2.58 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 2.29 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 1.89 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 3.41 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 3.64 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.15 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.75 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 6.39 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.91 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.74 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 2.79 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.62 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 2.71 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 2.65 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 2.98 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 6.4 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.16 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 3.27 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.24 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 2.37 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 5.73 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 2.99 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.39 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 2.84 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.1 -173.46 35.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.76 112.538 168.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 166.14 30.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.675 2.25 . . . . 5.2 111.819 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.88 -177.87 6.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.802 2.441 . . . . 5.45 108.8 155.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 76.15 25.18 1.07 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.594 1.957 . . . . 7.52 110.902 -162.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.01 -57.13 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.991 2.117 . . . . 9.57 107.239 165.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -107.51 173.84 6.14 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.416 -1.328 . . . . 7.56 107.416 136.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.31 -32.67 70.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.113 1.365 . . . . 7.87 112.583 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.22 88.97 6.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.936 0.874 . . . . 6.67 112.176 -163.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -60.69 168.57 2.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.114 1.524 . . . . 5.11 115.114 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt -115.31 157.17 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 119.923 -1.736 . . . . 3.69 109.923 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 2.8 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.68 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.539 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.7 p80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 1.89 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 4.48 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.22 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 2.84 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 3.64 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 4.02 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 2.4 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 2.72 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 1.82 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.86 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.34 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.17 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.91 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 5.22 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 3.14 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.01 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 3.02 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.28 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.51 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 9.26 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 4.9 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 6.8 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 1.65 112.464 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.43 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.02 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 1.42 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 1.38 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 1.58 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 1.86 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 2.18 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 1.92 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 3.69 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 3.65 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 4.87 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 4.9 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.13 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 4.15 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 130.92 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 8.59 113.38 166.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -135.69 -147.49 0.27 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.327 0.967 . . . . 8.31 111.53 -163.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.59 -38.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.656 1.182 . . . . 11.27 109.872 157.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 129.109 2.964 . . . . 12.1 108.678 160.181 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 117.394 -1.289 . . . . 23.58 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 61.34 -157.25 0.34 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.995 0.918 . . . . 20.92 110.231 -166.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.0 m -159.53 164.38 34.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.613 1.965 . . . . 14.54 107.648 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.65 66.08 1.37 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.621 1.105 . . . . 11.43 111.815 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.9 127.82 2.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.026 1.73 . . . . 10.65 109.894 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.0 154.85 66.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.064 2.509 . . . . 6.39 111.311 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.59 21.9 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.922 1.289 . . . . 7.6 113.449 -167.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.45 129.63 34.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.658 0.783 . . . . 5.9 110.672 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.34 120.85 3.59 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.35 0.976 . . . . 3.55 111.602 -167.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.01 137.13 16.75 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 118.926 -0.93 . . . . 3.21 113.571 -166.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -82.74 55.02 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.479 3.453 . . . . 3.61 111.673 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 2.85 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 2.74 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 2.53 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 3.62 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.11 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.62 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.17 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.39 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.401 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.78 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 8.24 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.16 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 1.88 105.957 166.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 6.34 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.53 112.203 163.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.27 114.959 -161.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 3.09 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.4 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.35 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 1.8 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 2.23 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 3.49 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 2.14 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 3.39 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 2.93 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.37 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 5.7 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.15 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 5.91 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.15 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 6.13 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.52 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 4.29 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.66 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.62 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.64 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.55 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 2.28 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.91 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.1 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.0 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 1.84 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 2.92 114.978 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 2.49 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 2.52 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.44 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 1.65 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.3 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.2 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 3.12 110.258 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.34 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 2.74 111.001 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 3.8 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.5 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.61 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 4.15 113.783 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 1.7 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.22 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 2.43 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 3.5 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 2.57 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 2.66 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 3.03 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.52 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.57 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.87 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 7.05 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.77 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 2.67 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 3.47 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.61 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 1.74 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 2.38 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 1.64 113.425 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 3.51 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 3.56 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 1.27 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 5.84 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.9 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 3.51 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.3 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 2.51 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 2.92 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 2.17 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 1.6 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 1.94 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 2.54 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.68 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 3.56 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 9.43 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 4.35 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.44 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 2.26 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.22 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 3.73 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 3.08 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 2.59 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 5.89 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.42 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 4.31 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 5.63 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 3.83 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.547 ' H ' HG22 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 5.51 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 4.38 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 2.7 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.69 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.55 175.09 38.15 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.18 111.692 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.08 117.09 4.98 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.167 2.578 . . . . 5.3 111.626 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.481 ' HE2' ' H ' ' A' ' 251' ' ' ASP . 0.0 OUTLIER -96.95 -49.9 4.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.631 1.572 . . . . 5.39 112.336 167.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.481 ' H ' ' HE2' ' A' ' 250' ' ' LYS . 79.2 m-20 -107.29 -123.77 0.24 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 106.377 -1.712 . . . . 6.23 106.377 161.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.35 31.6 6.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.494 1.517 . . . . 12.48 111.051 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -115.79 -40.14 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.726 2.01 . . . . 13.59 113.514 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.255 13.9 tt0 99.48 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 129.813 3.245 . . . . 17.1 108.583 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.7 t0 64.61 -167.81 0.21 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.89 1.676 . . . . 12.91 113.756 172.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.2 t80 58.27 -68.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.727 2.811 . . . . 7.35 117.194 151.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.3 41.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 127.081 2.153 . . . . 4.29 111.474 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 3.47 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.72 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.39 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 4.75 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 3.47 119.655 155.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.07 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 2.77 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 3.93 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 2.37 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 2.59 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.34 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.53 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 2.86 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 3.63 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 2.91 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.61 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 3.59 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.459 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 2.24 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.55 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.11 112.055 -171.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.36 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.22 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 7.17 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.403 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 2.17 113.451 -164.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.76 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 1.41 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.05 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 1.36 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 1.63 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 2.21 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 1.42 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 1.6 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 1.98 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 4.51 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 4.43 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 1.98 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 3.73 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 -154.88 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 6.91 113.875 -166.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -65.34 156.48 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.119 -1.613 . . . . 8.12 113.481 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -119.42 1.57 11.23 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.949 1.7 . . . . 14.39 113.091 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.48 1.055 1 C-N-CA 131.739 4.015 . . . . 10.93 106.688 -155.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.634 ' N ' ' HG1' ' A' ' 131' ' ' THR . 12.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 116.491 -1.718 . . . . 23.86 107.161 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -75.47 83.19 2.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 121.312 1.869 . . . . 19.94 108.087 162.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 129' ' ' SER . 63.9 p -153.3 167.73 28.37 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.805 1.642 . . . . 18.75 110.324 -166.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.4 175.16 33.51 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 116.124 -0.489 . . . . 14.66 112.518 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.33 151.83 1.35 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.745 2.818 . . . . 11.7 109.809 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -82.27 -167.13 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.345 2.697 . . . . 10.86 112.726 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.06 -132.19 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.296 1.838 . . . . 7.29 109.23 166.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.81 141.28 51.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.243 1.817 . . . . 9.31 108.432 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.48 -41.65 65.99 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 118.904 0.775 . . . . 4.43 111.265 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -145.02 135.63 6.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 108.985 -1.646 . . . . 3.17 108.985 157.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.81 119.59 5.19 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 CA-C-N 121.114 2.457 . . . . 3.85 109.322 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 2.67 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.47 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 2.87 111.405 168.347 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 2.3 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 2.11 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.3 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 2.97 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.69 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.73 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 5.43 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 2.93 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.16 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.13 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.28 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 3.13 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 4.33 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.68 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.15 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.02 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 2.83 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 3.32 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 1.75 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 3.49 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 2.18 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.85 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 4.71 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 3.39 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 4.57 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.14 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 4.81 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 174' ' ' PRO 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 3.24 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.54 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.06 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 171' ' ' ASP . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.45 116.458 -173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.13 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.33 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 2.79 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.34 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 5.07 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.27 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 3.05 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 2.49 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 2.85 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 2.55 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.97 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.43 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 2.26 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 4.02 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 4.4 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.02 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 4.88 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 4.46 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.16 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.36 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 3.22 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 2.45 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.58 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 2.43 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 2.47 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 1.38 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 1.84 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 1.63 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.92 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB3' HG23 ' A' ' 228' ' ' THR . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.85 110.286 -162.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.58 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 6.95 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.28 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.26 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 4.96 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 1.58 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 2.83 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.23 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.471 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 2.86 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 3.31 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 2.48 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 3.6 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 3.81 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 4.63 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.14 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.24 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 2.36 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 2.75 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 1.67 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.08 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.402 ' HB3' HD13 ' A' ' 142' ' ' LEU . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 2.3 111.299 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 205' ' ' PRO . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 2.79 109.072 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.62 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 4.06 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 9.16 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.14 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.64 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 1.99 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.08 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 2.42 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 2.91 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 5.84 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 2.34 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 3.66 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.15 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 2.74 112.104 -173.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 8.07 111.141 166.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 4.53 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.12 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.56 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.98 162.09 26.01 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.04 113.883 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -79.55 145.79 18.71 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.692 2.928 . . . . 4.89 110.274 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -97.35 114.17 25.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.726 0.81 . . . . 5.84 110.72 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -75.53 -18.31 59.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.053 1.131 . . . . 8.29 114.053 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.262 11.4 tp10 121.42 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 1 C-N-CA 131.932 4.093 . . . . 8.85 111.936 167.751 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -75.85 52.44 0.69 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.173 1.789 . . . . 8.75 111.181 168.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.335 4.1 pt-20 54.61 -33.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 132.276 4.231 . . . . 8.64 117.94 -167.283 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.93 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.124 2.268 . . . . 6.14 117.124 -157.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -99.31 102.99 14.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.489 1.116 . . . . 5.62 109.95 161.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt -132.92 161.73 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.051 1.741 . . . . 5.39 110.57 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 3.05 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.39 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.54 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 5.97 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 4.71 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 4.01 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 3.3 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 3.41 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 2.46 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 3.09 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.27 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.31 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.407 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.93 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.56 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 5.61 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 3.65 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.45 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 3.13 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 2.58 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.89 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 3.71 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 5.28 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.16 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 5.93 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.1 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 1.99 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.65 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 2.09 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 1.57 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 1.6 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 2.24 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 2.68 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 1.88 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 2.41 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.42 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 4.73 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 5.57 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.65 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 4.09 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 126.7 28.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 7.64 110.51 -175.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 1.0 OUTLIER -163.45 -179.77 6.74 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.404 1.882 . . . . 11.72 110.119 -162.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 29.7 tttm -173.1 158.76 3.77 Favored 'General case' 0 CA--C 1.557 1.229 1 C-N-CA 132.985 4.514 . . . . 9.7 104.891 167.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.466 -0.939 . . . . 8.29 108.466 152.254 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 118.152 -0.928 . . . . 14.98 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -76.48 -178.46 4.66 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.631 0.65 . . . . 14.6 110.201 157.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -94.62 -172.8 2.84 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.452 1.501 . . . . 11.73 110.915 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.91 -126.3 1.9 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.055 0.836 . . . . 9.4 113.709 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.73 143.49 13.42 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.338 1.855 . . . . 10.91 110.699 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.23 157.21 57.76 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.508 2.139 . . . . 6.38 109.974 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.52 -29.56 46.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.91 1.078 . . . . 8.03 113.91 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 mt 68.95 179.48 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.138 2.175 . . . . 7.57 112.048 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.51 -161.13 52.67 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.481 1.045 . . . . 2.86 114.731 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.93 62.27 0.65 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 127.013 2.244 . . . . 3.11 112.982 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.93 111.52 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.973 3.116 . . . . 2.52 111.994 -166.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 2.48 111.434 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 2.97 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.405 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 2.31 110.154 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 1.93 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 1.84 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 1.67 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.13 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.36 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.6 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 5.93 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 3.31 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 2.08 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.08 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 7.41 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 2.55 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 3.55 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.52 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.14 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.66 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 2.92 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 2.75 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 1.53 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 4.54 111.823 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 2.98 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 1.97 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 4.15 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.39 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 6.14 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 3.23 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 6.85 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.38 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 3.21 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.03 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.25 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.44 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 262' ' ' ILE . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.25 113.356 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 2.67 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.49 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 176' ' ' GLU . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 3.43 113.012 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 4.05 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 1.6 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.36 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 1.49 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 196' ' ' LEU . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 2.5 112.9 -170.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.53 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 2.44 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.458 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 2.54 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 2.58 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 3.52 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 3.7 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 3.63 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 2.64 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.88 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 184' ' ' VAL . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 3.14 110.045 170.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 1.25 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.28 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 2.65 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 2.44 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 2.0 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 1.74 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 1.66 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.22 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.16 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.03 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.06 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.27 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 4.42 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.34 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.62 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 1.97 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 2.07 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 1.35 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 3.52 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 3.08 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 1.29 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 3.65 115.04 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 2.81 113.658 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 2.22 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 1.54 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 1.85 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 2.58 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 1.99 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 1.88 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 2.75 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 2.57 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.82 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 2.96 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 6.67 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.21 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 1.91 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 2.51 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 2.53 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.32 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 4.76 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.37 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 4.08 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 6.16 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 2.82 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 5.96 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 3.37 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.24 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.1 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.88 -173.16 18.8 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.61 114.486 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.16 -178.69 4.59 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.41 3.407 . . . . 4.63 112.951 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -105.28 -86.15 0.47 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.338 -0.986 . . . . 6.34 108.338 150.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 73.54 -39.56 0.44 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.811 2.844 . . . . 5.9 116.173 151.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -88.16 -27.19 22.02 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.332 1.053 . . . . 11.75 113.322 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -154.06 -66.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.333 1.235 . . . . 9.05 114.333 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 163.08 2.45 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 131.154 3.782 . . . . 7.8 113.867 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.48 173.75 8.39 Favored 'General case' 0 CA--C 1.556 1.179 0 O-C-N 119.237 -2.164 . . . . 6.85 110.759 159.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -125.2 152.03 45.07 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.128 -1.608 . . . . 5.24 111.599 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -141.46 153.43 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.911 1.284 . . . . 4.02 109.739 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 2.69 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.23 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 2.64 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.04 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 279' ' ' GLN . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 4.08 109.808 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 2.84 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.12 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 2.77 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 2.25 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 2.66 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.46 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.55 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 3.65 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.81 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 3.99 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 2.6 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.59 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.14 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 2.43 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.17 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.465 ' HB3' HD13 ' A' ' 262' ' ' ILE . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 4.43 118.667 -162.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 5.44 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 5.48 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.29 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 1.79 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.43 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.86 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 1.26 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 1.14 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 1.3 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 1.84 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 2.36 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 1.89 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 1.65 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 2.52 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 5.06 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 5.45 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.93 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 2.93 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 89.99 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.1 113.474 156.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.9 tttt 61.21 -145.66 0.45 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.345 1.458 . . . . 10.16 111.693 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.72 -10.68 0.2 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.139 1.903 . . . . 13.65 116.139 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 130.46 3.504 . . . . 8.55 108.639 -153.815 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.636 -0.697 . . . . 17.58 110.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -169.45 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.906 2.483 . . . . 17.64 107.656 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -91.6 177.93 6.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.515 0.726 . . . . 13.15 109.336 140.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.26 9.28 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 117.157 1.623 . . . . 10.16 117.157 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -145.01 142.95 19.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.197 1.999 . . . . 12.13 112.454 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.47 170.77 19.3 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.124 2.55 . . . . 7.59 110.044 161.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.58 32.0 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.44 1.896 . . . . 8.83 111.885 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.6 mt -137.68 166.1 24.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 7.66 110.653 -166.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.42 148.06 11.64 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 126.038 1.78 . . . . 3.61 112.401 -168.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.31 84.96 0.38 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.106 -1.941 . . . . 2.91 111.073 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.28 128.38 7.15 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.342 2.694 . . . . 2.75 112.504 -162.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 2.45 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 3.03 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 1.66 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.07 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 1.75 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 2.62 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.0 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.74 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 5.39 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.35 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 1.99 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.06 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.13 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.61 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 2.6 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 4.21 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' H ' ' H ' ' A' ' 270' ' ' ASP . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.91 113.688 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.29 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.77 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 2.6 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 2.56 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 1.7 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 5.47 112.266 -167.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 2.15 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 1.73 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 5.2 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 4.05 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 5.39 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 2.75 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 4.64 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 2.51 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.83 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.39 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.76 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 2.62 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.32 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.32 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 2.93 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 1.84 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 1.72 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 1.44 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 2.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.44 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.53 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 2.28 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.13 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.22 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.11 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 4.24 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 2.85 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 2.49 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.24 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 2.44 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 1.35 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 0.93 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 2.35 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 2.38 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 1.48 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.488 HG22 HG13 ' A' ' 234' ' ' VAL . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 1.96 113.693 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.66 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 4.51 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 8.36 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.93 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 3.6 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.01 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.44 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 1.94 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 1.96 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 1.59 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 4.07 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 2.98 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 2.07 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.06 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.34 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 3.28 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.14 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 1.99 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 2.62 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 2.53 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 1.83 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 2.16 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 2.64 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.05 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 8.91 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.57 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 203' ' ' ILE . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 2.05 112.633 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.93 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.23 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 2.58 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 2.46 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 5.13 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 1.83 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 3.12 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 7.43 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 3.21 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 5.37 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 4.32 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.09 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.29 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.79 174.31 21.57 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 2.9 114.071 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -82.66 -169.85 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.702 3.602 . . . . 4.21 110.574 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -160.11 155.74 25.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.184 1.394 . . . . 5.57 111.937 168.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.37 -93.49 0.29 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.119 1.367 . . . . 7.06 111.281 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -115.47 -49.04 2.76 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.471 1.032 . . . . 10.75 113.536 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.32 -16.08 31.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 116.411 2.004 . . . . 8.58 116.411 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 250' ' ' LYS 0.289 5.3 mm-40 90.38 28.53 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 129.176 2.99 . . . . 7.63 110.978 -174.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.84 25.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 134.276 5.03 . . . . 8.9 115.891 177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.85 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.998 2.119 . . . . 4.73 112.438 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.54 148.22 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.081 1.752 . . . . 4.42 112.007 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 2.78 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.17 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.67 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 3.44 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 3.99 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.02 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 3.91 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 2.91 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 2.07 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 2.43 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 1.92 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.55 ' H ' ' H ' ' A' ' 157' ' ' GLY . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.07 119.017 163.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.18 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.39 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 3.87 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 2.63 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.72 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.02 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 2.29 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.41 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.15 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.0 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 5.56 114.451 -166.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 5.41 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 2.4 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.19 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.41 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 1.62 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 1.71 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 1.64 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 2.5 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 2.97 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 1.89 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 1.98 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.21 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 5.41 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 5.26 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.97 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 3.64 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 82.22 -151.14 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 8.36 110.057 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? 66.81 -44.67 0.44 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 130.407 3.483 . . . . 6.8 115.95 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -73.46 -16.63 61.3 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.295 2.238 . . . . 11.71 112.197 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--O 1.253 1.28 0 C-N-CA 129.9 3.28 . . . . 9.62 108.462 176.634 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 117.906 -1.045 . . . . 18.9 110.057 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -165.57 166.5 18.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 16.17 109.84 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 t -161.09 152.05 18.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.77 1.628 . . . . 13.66 109.646 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.77 -167.74 39.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.935 0.779 . . . . 12.15 111.272 163.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -157.72 153.48 22.84 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.265 1.426 . . . . 9.16 111.259 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.77 174.05 12.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.2 2.6 . . . . 7.72 111.679 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.7 mt -114.06 -174.56 2.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 7.74 108.025 157.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.04 -146.57 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.718 0.69 . . . . 7.19 110.113 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.65 -130.99 40.52 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.392 -1.483 . . . . 4.74 109.392 -165.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -158.32 92.41 0.12 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.822 -1.544 . . . . 3.54 111.5 170.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.22 150.69 76.89 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 3.34 112.961 -166.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 2.59 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.64 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 2.19 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.24 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 1.45 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 1.53 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 2.79 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.84 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.11 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 7.54 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 3.19 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.35 107.12 163.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.78 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 7.3 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 151' ' ' THR . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.84 111.9 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 3.02 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 3.4 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.57 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.34 109.845 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.74 110.293 165.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 2.5 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 2.57 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 2.89 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 3.7 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 2.77 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 1.85 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 7.44 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 3.65 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 4.99 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.04 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 7.36 114.28 -142.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.13 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 3.35 110.241 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 2.39 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 173' ' ' CYS . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.42 111.795 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.601 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.15 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 2.75 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 3.44 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 3.31 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 2.05 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 2.93 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 1.51 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 2.72 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.56 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.51 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 2.33 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.28 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 2.97 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 2.6 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.32 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 3.09 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 3.1 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 2.98 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.45 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 3.23 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 1.34 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.17 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 2.56 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 2.65 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 1.2 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.03 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 2.17 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.66 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 8.0 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 3.07 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 3.56 113.687 -171.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.74 112.503 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 1.94 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 2.24 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 1.32 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.415 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 4.59 113.349 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 3.42 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 1.26 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 3.34 114.69 -175.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 2.61 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 2.25 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 1.79 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 2.78 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 2.03 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 2.55 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 2.31 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 3.96 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.91 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 2.73 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 6.58 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.38 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 2.4 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.28 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.07 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 2.83 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.19 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 5.71 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.55 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 3.8 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 6.3 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 3.48 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 5.7 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 3.72 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 3.73 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 2.92 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.86 43.57 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.68 -23.87 30.67 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.354 2.703 . . . . 4.94 112.673 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.359 13.7 ptpt 66.26 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.288 3.435 . . . . 8.38 118.29 170.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.94 -18.68 4.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.836 0.854 . . . . 5.71 113.238 -163.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -135.5 -60.4 0.75 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.486 0.714 . . . . 10.32 109.746 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -168.6 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.893 1.677 . . . . 13.65 109.172 154.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -85.52 3.72 39.16 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.061 1.874 . . . . 8.59 116.061 -159.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -64.77 -12.07 43.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.196 2.198 . . . . 7.71 115.579 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -71.67 133.48 45.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 116.023 1.86 . . . . 5.6 116.023 -145.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.95 165.28 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 125.947 1.699 . . . . 3.81 109.533 161.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 3.13 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.49 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 4.51 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 279' ' ' GLN . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 5.26 113.144 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 2.29 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 3.57 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 3.25 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 2.85 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 2.63 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.62 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.83 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.12 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.55 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.63 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 3.48 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 2.69 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.8 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 3.44 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.433 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 2.64 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 3.99 110.466 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 8.1 113.002 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.17 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 5.97 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 2.27 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.66 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.34 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 1.51 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 1.37 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 1.56 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 1.96 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 2.29 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 1.84 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 2.18 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 2.68 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 3.71 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 6.2 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.64 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 3.38 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.45 ' HG3' ' H ' ' A' ' 299' ' ' LYS . 0.0 OUTLIER -127.66 168.4 15.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 8.58 113.835 -155.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.45 ' H ' ' HG3' ' A' ' 298' ' ' ARG . 1.0 OUTLIER 76.11 -41.89 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.217 3.407 . . . . 9.47 110.789 -174.034 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -64.7 22.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.465 1.906 . . . . 9.54 115.32 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 131.411 3.884 . . . . 8.43 109.042 -151.651 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.45 -0.786 . . . . 24.74 110.121 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -65.9 163.45 16.98 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.707 0.685 . . . . 21.78 110.217 155.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -107.25 -175.28 2.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.015 1.326 . . . . 16.9 109.506 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.79 14.14 82.86 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.119 1.208 . . . . 14.12 116.119 163.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -62.73 114.98 13.91 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 120.247 2.024 . . . . 18.0 108.78 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -82.28 -156.55 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.102 2.535 . . . . 10.62 110.558 -172.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.91 2.32 0.11 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.255 1.576 . . . . 12.25 115.255 -167.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 -10.04 2.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.39 1.626 . . . . 6.59 115.39 -166.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 143.79 164.96 10.63 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.253 1.406 . . . . 3.63 111.851 -163.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.03 -170.32 27.23 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.228 0.918 . . . . 3.75 113.693 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.82 145.17 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.505 2.803 . . . . 3.78 112.188 -172.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 3.31 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 2.75 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 2.67 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 1.75 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.33 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.31 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 2.33 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.497 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.93 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.12 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.02 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 3.62 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 2.54 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.84 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 6.31 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.31 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 2.86 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 3.87 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.12 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.55 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.68 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 1.99 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 3.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 1.84 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.09 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 2.52 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.94 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 4.6 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.52 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 5.51 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 2.98 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.08 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 3.61 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 1.81 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 2.84 111.577 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 2.81 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.1 112.366 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.28 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 1.64 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 1.85 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 1.63 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 2.94 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.11 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 2.3 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.12 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 3.24 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 3.51 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 3.36 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 4.25 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 3.5 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.76 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.61 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 4.15 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 1.14 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.87 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 2.79 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 2.61 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 1.4 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.26 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 2.2 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.19 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.18 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 207' ' ' ARG . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.12 113.112 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 7.94 112.377 -178.102 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 2.94 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.497 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 3.75 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.09 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 1.39 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 1.81 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.0 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 3.81 112.377 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 3.14 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 1.08 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 3.56 114.843 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 2.76 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 1.65 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.36 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 4.38 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 2.39 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 1.84 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 1.94 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 2.6 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 2.73 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 11.09 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 3.9 110.667 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.03 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 2.8 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.26 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.539 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.21 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 2.9 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.78 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.539 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.13 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.22 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.77 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 5.32 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 3.72 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 6.64 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.79 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 4.66 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.69 -172.49 18.1 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.04 113.512 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.88 169.75 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.345 2.697 . . . . 4.43 110.279 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -118.55 164.13 15.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.554 0.742 . . . . 5.47 110.26 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.55 -169.31 2.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.018 0.927 . . . . 6.71 109.66 160.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -40.49 63.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.909 0.884 . . . . 9.93 112.248 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.06 47.17 1.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.425 1.49 . . . . 7.68 112.516 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 72.96 -20.73 0.27 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.049 2.94 . . . . 7.08 117.077 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.55 124.95 20.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 122.468 2.395 . . . . 6.67 116.048 -164.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.05 88.81 4.6 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.54 1.936 . . . . 5.17 109.942 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.38 101.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 5.93 107.495 166.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 3.46 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.02 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.09 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 5.59 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 5.44 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 3.28 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 2.67 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 3.02 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 2.37 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.12 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.73 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.49 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.07 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 4.02 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 2.62 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.76 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 6.72 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 2.5 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.29 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 4.83 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 6.59 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.08 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 5.9 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 1.88 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.52 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.83 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 1.2 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 1.18 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 1.38 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 1.8 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 2.81 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 1.5 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 1.69 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.36 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 4.74 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 4.8 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.56 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 3.29 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -60.41 120.41 9.84 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.21 113.13 -166.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -19.14 13.48 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.008 1.855 . . . . 6.25 116.008 -171.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER 148.23 135.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.914 4.486 . . . . 11.12 111.031 154.863 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 C--O 1.251 1.165 0 C-N-CA 131.38 3.872 . . . . 8.33 105.82 -158.635 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 118.263 -0.875 . . . . 19.99 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -162.95 175.68 10.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.715 1.606 . . . . 16.13 109.591 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -134.27 155.49 50.11 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.722 1.209 . . . . 13.42 111.514 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.84 134.91 12.48 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.462 1.03 . . . . 10.57 111.903 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -151.18 71.14 8.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.003 0.921 . . . . 8.87 112.73 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.96 -174.75 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.589 2.859 . . . . 6.84 110.851 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.32 173.72 10.54 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.653 1.581 . . . . 6.42 108.33 157.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -39.78 0.18 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.491 0.923 . . . . 7.18 113.491 -165.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.99 -54.74 0.66 Allowed Glycine 0 N--CA 1.472 1.086 0 C-N-CA 125.039 1.304 . . . . 4.02 111.642 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.13 169.61 20.63 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.955 1.264 . . . . 3.12 114.207 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -85.05 156.23 11.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.36 3.374 . . . . 2.56 111.829 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 2.79 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 2.85 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 2.79 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 1.6 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 1.43 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 1.78 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.28 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.78 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 8.53 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 3.18 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 1.85 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 6.56 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.97 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 2.12 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.04 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.53 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.14 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.31 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 3.27 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 3.93 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 1.78 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 3.49 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 2.52 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.56 112.344 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 5.33 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.64 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 5.74 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.438 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.92 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 8.95 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.438 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.35 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 2.98 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 1.87 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.45 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.37 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.82 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 2.81 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.14 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.01 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 3.34 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 1.41 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 1.99 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 1.59 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 2.01 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.99 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.14 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 1.98 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.95 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 2.34 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 2.39 112.788 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 3.04 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 3.42 112.527 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 3.79 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.84 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 2.68 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 1.38 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 0.92 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 2.43 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 2.89 108.508 -163.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 1.49 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.33 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 1.89 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.36 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.51 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 6.93 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.89 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 3.53 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 3.54 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.64 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 1.77 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 2.08 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 1.62 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 4.58 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 3.25 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 2.12 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 4.95 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.07 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 2.83 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 2.09 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.61 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 2.81 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 2.08 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 1.36 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.06 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 2.61 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 2.67 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.86 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 231' ' ' ARG . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 3.97 107.392 169.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 230' ' ' THR . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.23 114.597 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.84 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.42 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 2.3 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.85 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.53 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 3.33 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 2.5 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 4.75 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 2.29 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.09 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.04 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 2.42 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.37 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 3.01 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.17 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.32 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.56 113.46 4.39 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.43 111.1 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.13 159.63 52.47 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.062 2.508 . . . . 4.45 110.475 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 253' ' ' ASP . 25.6 mmmt -119.09 -173.94 2.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.271 1.952 . . . . 6.92 116.271 -164.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.41 -89.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.985 0.914 . . . . 5.78 111.546 -142.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.66 -26.29 6.62 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.115 1.766 . . . . 10.31 112.038 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 250' ' ' LYS . 0.9 OUTLIER -81.1 136.05 35.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.913 1.233 . . . . 8.11 109.476 157.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.05 -8.81 52.36 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.99 0.916 . . . . 8.48 111.859 162.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.56 84.51 0.85 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.586 1.554 . . . . 5.52 112.774 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.63 107.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.828 0.851 . . . . 7.4 111.606 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -98.5 170.81 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.481 1.512 . . . . 3.67 109.825 -169.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 2.88 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.447 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 1.95 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 3.16 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 4.79 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 2.59 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 3.02 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 2.92 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 2.12 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 3.42 109.04 -177.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 3.44 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.55 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.79 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.06 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 267' ' ' ILE . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 5.42 111.836 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 4.3 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 3.13 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 3.25 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.3 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 3.74 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 6.37 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 4.42 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 5.44 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.06 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 1.87 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.56 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 1.49 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 1.24 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 1.48 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.01 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 3.54 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.06 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 2.32 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 2.54 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 3.74 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 5.86 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.18 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 3.26 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -55.03 118.38 4.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.47 110.791 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -37.23 -74.57 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.235 1.814 . . . . 7.49 114.55 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 300' ' ' LYS . 9.0 mmpt? -144.32 20.0 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.127 1.771 . . . . 12.11 111.187 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.246 0.911 0 C-N-CA 130.998 3.719 . . . . 8.98 106.274 -139.574 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.219 -0.896 . . . . 20.07 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.93 152.84 26.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.23 0.923 . . . . 16.18 110.46 163.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -167.06 30.15 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.416 1.487 . . . . 13.28 112.551 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.07 21.88 0.99 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 117.87 1.908 . . . . 10.24 117.87 -162.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 120.01 6.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.914 1.857 . . . . 10.49 110.444 162.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -80.53 -175.7 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.508 2.805 . . . . 6.73 110.547 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.69 160.47 34.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.477 1.911 . . . . 6.65 110.312 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.0 116.28 16.54 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.233 -1.025 . . . . 9.3 108.233 167.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.05 -130.86 19.98 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.223 0.916 . . . . 3.04 113.751 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.53 141.72 6.02 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.361 1.458 . . . . 3.21 112.065 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.83 112.52 3.3 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.24 2.627 . . . . 3.67 111.98 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 2.69 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.08 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 2.42 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.25 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 1.32 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 1.68 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.12 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.14 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.51 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 6.28 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 2.89 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.16 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.13 113.215 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 5.98 114.012 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.11 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 2.79 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 2.89 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.47 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.417 HE22 ' CD2' ' A' ' 160' ' ' LEU . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.55 111.535 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 1.87 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.417 ' CD2' HE22 ' A' ' 158' ' ' GLN . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 2.74 112.567 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 2.79 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 2.32 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.38 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.06 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 4.78 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.436 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 3.29 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 5.15 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 2.9 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.13 114.109 -137.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.35 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 3.08 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.06 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.5 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.9 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.03 113.222 173.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 2.97 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.12 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 3.51 111.611 171.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 3.23 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 1.65 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.12 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 1.56 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 1.98 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.6 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.31 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 2.29 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.59 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 2.95 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 2.25 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 3.91 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 2.95 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 3.22 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.95 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.49 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 2.32 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.01 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 0.9 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 2.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 2.54 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 1.51 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 1.86 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 2.34 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.35 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.69 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.436 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 9.39 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.49 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 3.32 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 4.82 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 1.72 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.02 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.18 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 3.19 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 3.37 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 1.49 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 3.51 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.11 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 2.77 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 1.85 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 1.79 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 3.91 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 2.12 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 1.59 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.81 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.0 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 2.82 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.05 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 2.89 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 8.18 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.44 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.19 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.12 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.84 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 3.35 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 2.92 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 2.99 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.21 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 2.47 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.03 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 8.22 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 2.7 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 6.2 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 3.5 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 3.73 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.08 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -70.31 154.28 52.42 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.38 114.156 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -100.82 -4.72 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.322 3.348 . . . . 4.92 113.795 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt 103.13 113.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 131.934 4.094 . . . . 5.96 108.048 -153.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.13 -46.41 5.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.821 -0.609 . . . . 8.79 111.555 -166.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -151.64 135.48 16.42 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.656 0.662 . . . . 12.14 112.222 155.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 t70 60.55 -62.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 130.2 3.4 . . . . 8.77 115.144 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -154.31 10.42 0.38 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.975 2.11 . . . . 8.16 112.281 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -78.64 156.59 28.97 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.262 -1.524 . . . . 6.08 112.071 169.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.99 104.57 3.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.946 1.298 . . . . 6.13 112.063 -170.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt -81.69 161.34 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 120.988 -1.07 . . . . 3.99 112.439 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.05 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.47 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.26 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.12 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 4.73 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 2.84 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.01 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 2.8 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 1.98 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 2.93 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.37 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.06 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.27 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 4.75 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 3.14 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 2.94 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 2.84 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 3.09 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 2.78 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.22 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.04 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 5.72 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.08 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 5.66 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 1.93 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.49 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 1.48 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 1.26 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.28 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 2.25 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 2.56 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 1.55 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 1.68 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.12 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 4.9 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 6.01 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.26 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 3.6 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 79.04 -65.52 0.21 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 8.88 111.173 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -173.72 147.41 1.38 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.061 1.134 . . . . 8.71 114.061 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 8.74 35.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.938 2.095 . . . . 15.31 112.929 165.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 126.159 1.784 . . . . 10.72 110.536 -138.751 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 117.917 -1.04 . . . . 18.06 109.939 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -159.72 148.41 17.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.179 0.992 . . . . 15.33 111.091 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t 153.46 155.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 1 C-N-CA 132.032 4.133 . . . . 12.58 108.047 176.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 5.13 20.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.846 1.212 . . . . 10.15 113.179 166.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -146.08 142.31 17.56 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.755 1.277 . . . . 9.61 112.206 -171.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.27 164.06 35.01 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.628 . . . . 6.41 109.834 163.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.6 mt -139.24 76.34 1.56 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.477 1.111 . . . . 8.31 111.16 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.3 mt -141.93 114.98 8.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.473 1.909 . . . . 7.31 106.82 170.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.87 149.31 1.92 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.195 0.902 . . . . 3.79 112.686 -166.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.73 -48.97 0.89 Allowed Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.113 -1.937 . . . . 5.02 115.3 176.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -100.18 133.57 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.417 2.608 . . . . 3.36 111.761 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 2.79 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 3.05 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 2.27 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 1.69 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 1.42 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.38 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 2.6 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.03 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.86 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 6.35 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.21 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 2.31 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.4 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.14 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.09 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 2.38 113.788 -177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 5.1 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.82 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.58 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.41 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 2.44 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.08 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 2.28 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 3.7 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 2.2 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 4.6 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.06 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 8.36 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.43 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 4.76 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.34 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 3.37 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.427 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.88 115.104 164.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.35 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.55 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.44 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 2.79 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.31 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 5.2 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 4.98 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 3.75 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.07 111.678 -178.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 1.56 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 2.38 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.76 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.24 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 1.88 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.63 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 2.5 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 3.62 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 3.0 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.27 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 3.95 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.28 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 197' ' ' THR . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 2.43 108.877 135.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 196' ' ' LEU . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 1.75 109.428 -177.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 2.23 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 2.43 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 1.44 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.68 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 1.97 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.17 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.18 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.39 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.418 HH22 ' CG ' ' A' ' 255' ' ' ASP . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 7.34 110.951 -175.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.84 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 3.2 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 3.41 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.74 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 2.18 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 2.15 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 1.48 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 3.31 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 3.34 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 1.44 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 3.39 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.7 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 3.16 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 1.94 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.05 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 3.25 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 2.29 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 1.48 109.232 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.13 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 2.13 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 2.32 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 2.84 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 6.12 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.59 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.47 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 2.15 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 2.64 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 3.7 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 2.98 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 3.98 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 2.57 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.04 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 6.06 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 2.65 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 5.86 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.07 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 2.74 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.49 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -130.92 156.61 21.82 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.26 113.763 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -79.59 -159.35 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.336 3.357 . . . . 3.68 110.194 175.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.26 177.07 9.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.183 2.193 . . . . 4.92 111.301 172.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.25 -70.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.724 -1.584 . . . . 7.33 106.724 154.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -168.02 167.6 12.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.668 1.987 . . . . 9.09 109.922 164.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 77.61 -27.35 0.17 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 129.793 3.237 . . . . 8.57 112.808 172.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -73.64 -32.72 64.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.869 1.268 . . . . 11.58 112.938 162.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.418 ' CG ' HH22 ' A' ' 207' ' ' ARG . 22.8 t0 62.25 165.58 0.1 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.747 2.419 . . . . 6.67 113.614 -170.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -66.62 145.26 55.78 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.619 -1.926 . . . . 5.03 112.013 -177.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.44 168.44 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.8 -1.188 . . . . 4.4 112.917 -167.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 3.47 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.63 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.427 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 20.0 p80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.38 114.058 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.18 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.0 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 2.42 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 4.22 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 2.62 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 267' ' ' ILE . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.15 110.972 177.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 266' ' ' LEU . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 2.12 107.884 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.46 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.49 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.95 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.2 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 3.77 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 3.02 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.74 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 4.18 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 2.68 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 2.83 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 5.11 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 6.36 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 7.65 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 4.85 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.1 113.161 -171.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 1.86 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.67 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 1.79 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 1.5 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 1.85 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 2.24 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 2.77 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 2.2 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 2.3 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 1.92 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 5.76 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 6.67 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.41 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 3.54 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -156.03 135.31 12.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 8.37 112.464 -165.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt 124.82 175.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.469 4.308 . . . . 9.38 111.597 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -133.6 46.4 2.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.274 1.83 . . . . 11.11 108.302 160.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.246 0.888 0 C-N-CA 125.634 1.574 . . . . 11.41 111.663 -157.19 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.021 -0.99 . . . . 24.04 110.159 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -162.56 155.96 20.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.442 1.497 . . . . 19.1 109.812 -177.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t 179.08 166.65 0.96 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.327 2.651 . . . . 17.1 109.132 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.17 158.72 8.79 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.763 1.649 . . . . 13.22 112.667 -178.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -89.58 152.14 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 121.779 -0.836 . . . . 12.17 112.849 173.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -69.94 176.11 7.35 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.708 2.272 . . . . 8.23 109.604 157.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 135' ' ' LEU . 2.1 pt? -126.0 160.39 30.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.895 1.278 . . . . 7.2 112.192 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.48 -124.69 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.911 2.085 . . . . 5.86 108.82 -177.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.82 154.04 10.16 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.21 1.386 . . . . 2.82 112.315 -168.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.71 111.64 3.33 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.893 -1.504 . . . . 2.91 113.257 -167.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.13 94.09 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 120.742 2.271 . . . . 3.45 110.412 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 2.63 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.15 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 2.47 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 1.75 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 1.3 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.45 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 2.81 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.33 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 6.05 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 2.8 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.06 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 6.98 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.08 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 3.3 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 3.5 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.56 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.07 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 1.92 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 2.49 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 3.62 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 1.54 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 3.91 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 2.79 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.33 115.567 -173.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.428 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 4.65 110.164 162.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.25 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 7.47 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.72 111.846 -167.571 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.18 114.275 -154.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.57 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 3.6 113.034 -174.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.523 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.25 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.76 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.43 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.06 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 2.64 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.09 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 6.96 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 3.19 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 1.42 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.25 111.434 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 1.54 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 2.4 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.32 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.05 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 2.5 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.67 110.887 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 2.57 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 2.68 111.501 171.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 2.91 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 2.64 110.398 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 2.67 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.418 ' HA ' ' HE2' ' A' ' 299' ' ' LYS . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.16 113.308 -167.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.3 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 3.04 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 1.07 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.85 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 2.62 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 2.54 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 1.51 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 1.89 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 2.1 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.44 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.72 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.03 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 6.81 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.32 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 2.99 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 3.75 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.76 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 1.66 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 1.57 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 1.22 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 4.27 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.16 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.23 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 3.5 115.658 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.94 110.064 170.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 2.86 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 1.57 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.01 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 2.95 112.889 173.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 2.0 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 1.82 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 1.84 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 2.5 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.43 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 4.05 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 5.46 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.51 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.82 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 2.49 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.06 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.06 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 3.62 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.19 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 4.61 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 2.88 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 3.55 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 5.26 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.11 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 5.98 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 3.43 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.51 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.38 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.8 169.74 54.34 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.18 115.279 -175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 -41.32 0.99 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.6 2.867 . . . . 5.53 112.333 -168.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.327 16.7 ptpt 56.23 153.37 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.956 2.947 . . . . 5.96 118.956 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.0 -132.97 0.18 Allowed 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.601 -1.182 . . . . 7.52 108.764 165.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -51.31 -33.48 29.17 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.935 1.698 . . . . 11.71 114.192 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -170.45 -30.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.229 1.412 . . . . 10.62 111.98 167.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.74 159.06 34.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.378 1.071 . . . . 8.62 112.899 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . 0.279 16.2 t70 74.19 28.91 1.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.084 2.554 . . . . 8.49 112.923 -164.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -68.74 58.12 0.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.837 1.255 . . . . 8.0 111.967 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.24 151.55 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.564 -1.335 . . . . 4.3 109.238 161.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 4.44 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.68 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.523 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.5 p80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.17 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 4.35 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 3.13 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 3.91 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 3.09 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 2.98 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 2.36 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 2.38 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.69 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.1 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.47 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 4.31 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 2.84 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.51 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 3.97 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 3.44 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.15 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.02 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 9.07 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 5.43 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 5.7 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 2.73 112.733 -173.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.44 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.31 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 2.36 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.23 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 2.77 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 3.57 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 3.34 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.07 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 2.95 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 2.72 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 4.26 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 6.37 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.01 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 3.81 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.62 116.53 5.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 7.91 113.41 -166.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 194' ' ' PRO . 1.2 tmtt? -60.26 -36.3 77.48 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.3 1.963 . . . . 7.59 116.3 -157.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.45 5.01 3.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.765 1.024 . . . . 9.32 113.765 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.065 1.346 . . . . 8.86 109.479 -149.418 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 118.275 -0.869 . . . . 25.53 109.98 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -72.56 176.27 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.279 0.49 . . . . 25.04 110.547 158.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.4 p -137.84 160.31 39.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.301 1.84 . . . . 20.35 110.325 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.19 -167.49 28.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.75 1.643 . . . . 16.58 112.375 -176.056 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 122.67 145.8 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 131.406 3.883 . . . . 14.02 110.871 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 130.45 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.713 2.276 . . . . 12.63 111.943 169.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.59 -40.82 11.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.766 1.226 . . . . 9.87 112.786 -171.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.15 133.17 2.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.02 1.328 . . . . 6.08 111.113 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -119.76 145.97 17.92 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.571 -1.412 . . . . 3.54 109.571 160.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.14 122.3 25.2 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.991 -1.45 . . . . 2.99 109.689 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 121.79 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.221 2.011 . . . . 3.73 111.935 -166.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 236' ' ' GLN . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 3.17 108.205 168.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 2.52 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 2.76 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.05 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 1.67 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 1.83 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 2.81 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.83 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 5.53 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 8.19 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 4.93 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.68 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 7.91 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.452 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 2.67 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 4.64 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 2.86 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.62 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 2.71 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 3.37 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 3.19 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 2.18 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 5.86 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 2.12 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.05 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 5.67 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.68 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 5.28 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 2.96 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 5.58 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.533 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 3.04 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 1.85 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.37 112.396 -168.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.66 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 2.78 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.67 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 3.87 110.656 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 184' ' ' VAL . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 3.94 113.453 174.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 2.0 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 1.95 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 1.46 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 180' ' ' MET . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 2.59 110.746 -178.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.44 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.36 112.035 168.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 2.48 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.39 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.68 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.07 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 4.76 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 4.83 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 4.45 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.44 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.28 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 3.86 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 1.89 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.76 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 3.34 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 3.08 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 1.9 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 1.83 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 1.94 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.53 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.47 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.97 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 7.07 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.14 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 3.89 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 7.71 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 2.37 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 2.95 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 1.83 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 3.71 111.705 170.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 4.39 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 1.94 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 3.22 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.22 111.334 173.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 2.65 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 2.72 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.66 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 3.12 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 2.49 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 2.15 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 2.39 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 2.75 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.42 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.41 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.09 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.68 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.07 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.05 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7 111.86 167.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' PHE . 5.5 tp-100 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.99 111.412 172.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 3.15 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 2.38 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.09 113.22 170.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 2.19 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 2.9 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.14 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 3.35 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 6.35 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 3.91 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 3.19 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 3.76 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.18 155.01 29.46 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.93 -50.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.701 2.267 . . . . 4.84 110.283 165.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 252' ' ' GLU 0.25 0.2 OUTLIER 63.36 -28.31 0.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 129.178 2.991 . . . . 9.58 116.871 177.202 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 74.65 -23.63 0.23 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.42 1.888 . . . . 6.09 115.305 150.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 29.5 mt-10 -102.95 -36.73 8.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.97 2.508 . . . . 9.68 112.994 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -160.3 138.86 10.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.392 1.877 . . . . 7.87 106.211 -171.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -80.8 41.37 0.57 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.319 1.448 . . . . 7.51 113.409 -163.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -146.01 152.97 40.23 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.848 1.259 . . . . 6.7 113.237 -177.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -177.31 164.45 2.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.701 2.0 . . . . 5.11 112.44 -155.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt -74.08 156.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.386 -1.446 . . . . 5.4 109.412 163.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 3.71 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.8 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.628 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 29.2 p80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.13 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 3.3 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 3.83 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 2.48 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 3.55 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 3.73 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 3.22 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 3.74 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.69 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.61 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.77 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.35 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.41 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 4.11 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 4.41 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 3.18 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.14 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 2.83 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.4 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 4.47 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 4.87 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 5.62 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 5.95 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 1.67 113.636 -168.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.53 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.64 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 1.36 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 1.41 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 1.62 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 2.16 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 2.43 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 1.81 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 1.92 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 2.77 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.17 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 5.63 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.37 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 4.05 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.45 HH12 ' C ' ' A' ' 301' ' ' SER . 17.4 ttt-85 -55.4 147.28 17.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.33 110.666 172.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -59.61 164.83 3.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.992 -1.068 . . . . 8.14 112.298 172.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.04 10.53 11.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.105 1.362 . . . . 14.05 113.4 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.45 ' C ' HH12 ' A' ' 298' ' ' ARG . 5.7 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 129.086 2.955 . . . . 10.76 107.953 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.194 -0.908 . . . . 19.9 109.997 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -64.38 152.66 40.78 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.597 0.635 . . . . 16.35 110.088 158.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t 179.09 153.78 0.41 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.378 2.671 . . . . 13.97 108.969 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.22 -179.15 49.71 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.38 -0.688 . . . . 11.52 111.38 162.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -163.4 150.51 10.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.493 1.517 . . . . 11.15 111.394 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.13 176.02 10.63 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.333 2.688 . . . . 8.86 111.095 172.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.23 152.98 45.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.351 1.46 . . . . 7.13 109.267 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.441 HD12 ' HE3' ' A' ' 153' ' ' LYS . 1.0 OUTLIER -122.88 143.52 49.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.745 1.218 . . . . 8.06 108.482 178.148 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.91 -57.52 5.77 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.114 0.864 . . . . 4.45 111.882 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.37 58.81 0.51 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 117.318 -1.823 . . . . 4.06 115.737 -176.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.04 128.44 13.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 120.716 2.258 . . . . 4.05 110.827 -173.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 3.71 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.02 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 2.61 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 2.98 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 1.75 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 1.8 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 2.82 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.89 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.05 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 3.33 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 2.99 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.76 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.441 ' HE3' HD12 ' A' ' 136' ' ' LEU . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.08 114.548 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.55 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 3.33 112.553 154.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 3.72 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 1.96 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 2.82 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.13 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 2.31 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 3.79 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 1.97 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.11 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 2.92 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.17 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 5.0 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 2.78 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 5.37 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 3.81 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 5.79 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.42 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 2.57 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.28 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 2.88 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.44 111.724 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.38 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 3.7 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.27 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 3.93 112.248 175.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.21 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 1.96 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 2.6 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 1.94 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 2.53 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.94 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 1.84 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.34 110.288 167.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 2.72 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 2.76 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 2.81 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 2.66 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 3.01 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.87 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.81 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 1.21 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.85 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 2.7 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 3.02 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 1.94 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.06 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.16 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.73 110.105 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.85 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.15 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 8.59 115.411 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 3.18 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 4.48 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.27 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 1.89 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 1.87 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 1.63 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 2.91 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 2.99 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 1.43 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 3.4 114.851 -177.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.87 112.012 167.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 3.02 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.13 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 2.77 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 2.59 112.621 168.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 1.98 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 1.45 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 2.18 111.43 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 2.48 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.79 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.1 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.66 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.45 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 1.98 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.33 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 2.7 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 2.58 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.28 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.14 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.19 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 3.47 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 5.54 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 2.67 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 6.55 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 3.13 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 3.8 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.47 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.27 177.37 37.89 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.89 110.942 164.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.34 162.03 41.28 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.967 2.445 . . . . 4.9 111.43 177.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -81.6 110.52 17.04 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.337 -1.357 . . . . 6.69 107.337 161.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -164.7 -46.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.554 0.742 . . . . 8.2 111.736 -152.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.76 -24.33 65.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.47 1.108 . . . . 14.35 113.767 168.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 161.28 -138.17 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 1 C-N-CA 133.676 4.79 . . . . 9.48 103.316 175.11 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -98.82 -10.52 22.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.465 1.506 . . . . 7.7 114.052 -174.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -84.6 52.9 2.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.299 1.047 . . . . 8.41 113.627 -175.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -0.15 94.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 130.061 3.344 . . . . 4.8 116.315 171.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.22 138.32 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 121.319 -0.863 . . . . 4.37 110.306 175.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 2.91 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.08 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.411 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.19 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.37 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 3.65 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 1.98 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 4.47 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 3.02 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 1.94 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 2.1 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.81 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.47 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.53 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 2.76 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.34 114.155 -174.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 4.13 113.253 -177.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 3.43 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.81 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 3.21 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 3.28 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 2.4 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 4.4 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 5.43 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 4.45 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 8.11 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 2.37 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.24 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 1.95 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 1.41 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 1.95 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 2.96 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 2.4 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 1.91 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 2.55 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 3.29 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.14 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 5.35 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.19 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 4.94 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -48.13 133.67 14.93 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 8.99 111.386 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 166.14 3.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.03 1.332 . . . . 5.88 113.044 -175.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -108.1 -111.19 0.3 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.031 -1.1 . . . . 11.39 108.031 -172.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 116.125 -1.893 . . . . 11.17 111.216 130.354 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 118.185 -0.912 . . . . 18.17 109.968 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.45 168.05 13.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.682 0.674 . . . . 17.86 110.937 164.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.3 t -154.72 145.88 22.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.958 1.703 . . . . 13.9 109.075 173.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.46 -19.28 57.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.972 -0.904 . . . . 13.6 115.108 -169.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -104.05 105.62 49.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 119.49 1.645 . . . . 11.95 111.696 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.15 177.81 8.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.918 2.412 . . . . 9.55 110.368 166.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 155.26 21.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.363 1.865 . . . . 6.61 110.093 175.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -161.47 -14.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.248 1.819 . . . . 7.13 113.211 -171.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.92 122.21 25.35 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.082 1.325 . . . . 3.28 113.428 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.81 136.73 15.24 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.62 -1.1 . . . . 3.37 112.577 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.97 172.8 15.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.432 2.755 . . . . 3.33 111.023 176.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 3.4 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 2.54 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 2.68 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 2.96 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 1.61 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 1.49 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 2.94 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.45 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.39 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 4.5 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.596 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 3.41 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 2.94 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.89 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 9.92 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.13 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 3.7 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 4.12 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 1.8 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 2.84 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.26 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 2.4 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 2.92 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 1.87 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.13 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 2.22 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 4.39 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.04 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 6.42 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 2.91 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 5.08 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.23 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 5.43 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.24 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.51 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.67 111.449 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 3.52 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.48 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.03 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 4.65 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 1.42 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.425 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.03 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 3.2 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 2.28 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.3 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.14 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 2.48 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.51 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.07 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 2.4 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.08 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 3.78 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 2.76 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 2.85 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.32 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 2.57 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 1.48 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.15 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 2.24 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 2.51 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 1.53 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 1.85 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.17 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.82 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.38 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 6.22 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.41 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.19 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 3.57 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.97 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 1.84 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 2.35 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 1.35 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 4.21 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 4.17 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 1.26 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.01 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 3.42 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 2.61 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.01 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.63 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 3.16 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 2.09 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 1.35 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 2.12 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.04 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.74 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.37 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 7.63 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.66 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.02 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 2.46 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.64 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.92 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 3.05 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.48 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.3 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 2.52 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 8.59 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 2.46 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 5.53 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 4.64 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.1 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 4.85 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.69 16.48 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.28 111.194 176.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.79 -43.73 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.399 2.066 . . . . 6.62 111.833 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt 67.42 110.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.428 2.691 . . . . 6.83 114.24 -174.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.27 39.39 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.725 1.61 . . . . 6.39 111.214 176.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 69.85 -49.76 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 130.094 3.358 . . . . 11.63 113.036 -178.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -79.99 46.26 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.948 2.099 . . . . 8.78 113.558 -173.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 66.54 -21.29 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 129.16 2.984 . . . . 8.74 118.08 170.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -74.35 144.48 44.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.638 2.017 . . . . 8.81 111.463 170.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.24 122.06 5.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.558 1.171 . . . . 9.07 113.332 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.03 76.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.753 -1.217 . . . . 7.2 112.303 170.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 5.19 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.36 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 5.12 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.12 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 4.7 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 3.19 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 3.61 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 3.76 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 2.14 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 2.68 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 1.72 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.49 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.01 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 2.54 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.08 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 4.77 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 2.95 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 3.33 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.25 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 4.09 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.4 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.16 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 6.29 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 6.14 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 7.84 110.524 156.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 2.71 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.07 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.81 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 3.42 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 1.87 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 2.29 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.03 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 3.06 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 1.64 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 2.42 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.39 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.21 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 5.74 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.76 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 3.73 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -77.18 92.0 3.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 9.76 112.237 -166.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -49.51 -40.82 39.11 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.414 2.005 . . . . 8.0 116.414 -163.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -137.95 -37.1 0.59 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.726 1.38 . . . . 11.6 114.726 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.069 0 C-N-CA 128.608 2.763 . . . . 7.34 110.399 174.038 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 118.277 -0.868 . . . . 16.48 109.989 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -67.0 163.53 19.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.728 0.695 . . . . 15.71 111.152 168.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.4 -2.37 22.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.636 1.575 . . . . 10.95 114.434 -170.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.35 -1.63 33.9 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.635 1.414 . . . . 11.67 116.635 167.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.75 119.49 63.84 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 119.351 1.575 . . . . 10.74 112.305 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.97 154.29 47.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.595 2.197 . . . . 10.76 110.56 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.8 mt -142.77 162.17 36.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.205 1.802 . . . . 7.33 108.994 175.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.26 -14.15 21.55 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.771 0.828 . . . . 10.05 113.101 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.67 -161.67 11.49 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.68 1.61 . . . . 4.92 112.441 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.51 -32.96 6.07 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.726 -1.597 . . . . 4.74 115.03 178.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -104.79 65.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.207 3.271 . . . . 3.08 110.032 167.042 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 3.17 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 2.97 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 2.38 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 1.72 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 1.88 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 1.83 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 2.46 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.85 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 4.86 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 3.22 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 2.5 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.99 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 5.6 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 2.52 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 3.29 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 1.84 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 2.71 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.62 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 2.85 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 3.28 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 2.58 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.82 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 2.26 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.08 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.597 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 4.41 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.26 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 5.25 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 2.8 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 6.04 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.3 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.15 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.71 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.24 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.99 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 2.55 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.91 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 3.35 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 4.21 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 1.53 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.453 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.02 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 1.55 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 2.46 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.15 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.64 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 2.03 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.45 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 2.66 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 2.9 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.03 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 2.82 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.32 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 3.84 110.801 153.131 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 1.28 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.0 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 2.45 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 2.41 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 1.34 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.61 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.08 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.84 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.69 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 7.37 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 3.14 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 4.46 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 3.15 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 2.51 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.15 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 1.49 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 3.38 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 3.5 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' A' ' 226' ' ' GLY . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 1.58 112.592 176.253 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 3.72 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.65 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 2.89 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.61 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.27 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 2.37 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 2.05 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 2.91 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.85 112.603 -173.259 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 1.99 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.2 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.43 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 4.58 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 5.33 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.93 113.384 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.68 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 2.3 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.39 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 3.15 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.15 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 3.9 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 2.31 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.31 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 7.28 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 4.15 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 5.57 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 2.97 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 2.98 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.53 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -126.65 76.18 0.4 Allowed Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.63 111.767 173.04 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.72 150.8 24.48 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.292 2.661 . . . . 6.87 112.799 -172.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 67.2 45.68 1.63 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.995 2.118 . . . . 5.84 113.611 175.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -112.29 150.46 30.94 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.508 1.523 . . . . 7.37 111.077 170.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 57.11 -68.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.812 2.845 . . . . 10.69 110.505 -157.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -157.03 -77.74 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 7.68 109.429 154.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -132.85 38.85 3.36 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.075 1.509 . . . . 7.45 115.075 -162.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -160.46 149.95 17.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.355 1.062 . . . . 6.56 110.39 149.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -176.83 172.58 2.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.885 1.439 . . . . 4.98 114.885 -152.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt -66.01 145.98 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.795 2.438 . . . . 5.03 113.557 -175.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.09 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.84 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 166' ' ' PHE . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 1.8 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 3.65 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.08 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 5.07 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.84 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 4.62 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 3.07 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 2.39 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.66 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.92 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.43 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.62 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.68 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 3.53 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 3.25 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.39 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 3.74 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 2.82 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.16 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 4.69 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 4.89 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 4.64 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 6.98 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 1.94 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.53 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.77 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 1.67 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 1.39 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 1.7 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 2.29 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 2.7 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 1.56 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 1.68 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 2.6 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 4.94 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.04 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.07 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 4.45 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -58.33 103.23 0.14 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 8.47 111.904 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 tttp 55.93 -89.65 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.1 1.36 . . . . 7.13 112.622 -177.111 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 -15.26 14.51 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.812 1.645 . . . . 9.07 115.001 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.487 1.419 1 C-N-CA 133.3 4.64 . . . . 9.79 110.445 -167.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 118.416 -0.802 . . . . 14.92 110.234 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -150.12 -155.44 0.63 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.597 1.559 . . . . 14.59 108.227 173.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -66.27 151.05 47.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.922 1.237 . . . . 11.09 111.173 172.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.59 -158.13 29.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.662 -0.975 . . . . 8.61 110.662 159.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -55.48 117.8 16.47 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.053 0.941 . . . . 10.46 110.558 169.124 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.04 172.48 15.86 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.644 2.229 . . . . 6.55 110.29 170.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' A' ' 135' ' ' LEU . 1.7 pt? -74.78 -163.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.409 1.484 . . . . 7.23 113.392 174.403 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -178.96 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.287 1.435 . . . . 8.2 112.987 174.508 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.75 -13.09 30.76 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.116 1.207 . . . . 4.37 116.116 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.54 129.77 1.19 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.327 1.918 . . . . 3.22 111.326 173.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.24 159.3 40.65 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.572 2.181 . . . . 3.07 109.722 170.022 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 2.49 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 2.9 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 1.92 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 1.69 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 1.64 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.33 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 2.21 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.3 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.58 109.793 -168.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 4.89 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.11 113.22 -176.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.02 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.99 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 5.7 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.57 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 2.46 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.435 HD11 ' H ' ' A' ' 270' ' ' ASP . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 2.91 111.925 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.65 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 1.8 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 2.15 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 3.32 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 1.52 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 3.63 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 2.49 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 4.28 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 3.89 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 4.99 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.13 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 4.98 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.32 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 2.76 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.541 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.71 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.01 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 2.38 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.442 ' N ' ' HZ3' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 4.33 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 3.41 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 1.72 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.11 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 1.88 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 2.6 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 2.09 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.44 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.26 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.55 111.455 169.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 3.09 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 2.85 109.823 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 2.51 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 294' ' ' MET . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.36 110.811 170.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.23 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 2.58 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 1.09 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.95 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 2.55 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 2.86 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 1.35 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.45 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.3 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.74 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.19 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.95 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 15.38 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.94 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.15 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 6.25 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.55 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 2.09 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 3.1 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 1.74 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 4.49 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.17 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 1.54 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 3.99 114.913 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.38 113.25 175.082 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 2.94 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 2.87 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.25 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 2.8 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 2.64 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 2.68 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.95 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 2.29 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 2.31 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.26 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.69 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 6.98 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.09 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.68 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 1.71 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.93 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.66 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 2.69 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 2.67 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 3.78 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.0 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 3.22 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 5.78 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 3.27 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 8.72 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 3.74 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.41 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 2.98 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.54 -169.55 25.61 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.08 112.888 173.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -85.33 168.5 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.897 3.064 . . . . 4.16 111.666 -179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -98.81 86.42 3.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.189 0.996 . . . . 6.48 109.081 166.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -147.95 -5.14 0.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.477 1.511 . . . . 5.35 112.612 -160.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -99.8 80.19 2.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 11.2 109.563 -171.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.5 t70 73.23 -25.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 129.231 3.013 . . . . 7.89 113.451 -178.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 163.15 -17.49 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 1 C-N-CA 132.52 4.328 . . . . 7.87 110.943 178.281 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -86.48 177.02 7.54 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.593 1.557 . . . . 6.09 113.113 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.65 164.19 28.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.312 1.845 . . . . 6.48 112.779 -177.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt -125.43 141.45 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.516 -0.74 . . . . 4.12 111.559 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 3.33 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.541 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 25.7 p80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.73 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.02 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 3.84 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 2.52 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 2.6 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 3.75 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 2.31 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 1.91 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.5 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.12 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 156' ' ' LEU . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.92 110.364 -153.333 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.42 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.82 113.324 -177.016 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 5.2 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 4.06 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 3.24 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 2.68 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.61 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.464 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.15 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 7.83 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.45 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 5.1 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 2.64 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.72 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 1.68 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.1 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 1.39 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 1.9 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 2.42 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.4 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 1.88 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.33 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 194' ' ' PRO . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 5.03 114.247 172.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 4.57 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.06 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 3.09 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -58.66 145.88 38.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 8.27 112.81 -172.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.99 72.24 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.764 1.394 . . . . 7.1 114.764 -173.258 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -179.57 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 128.459 2.704 . . . . 11.58 111.232 148.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p . . . . . 0 C--O 1.257 1.452 0 CA-C-O 115.896 -2.002 . . . . 7.21 110.254 130.539 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 117.976 -1.011 . . . . 17.3 109.844 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -67.17 142.9 56.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.767 0.712 . . . . 18.22 110.666 172.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 152.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 1 C-N-CA 131.842 4.057 . . . . 12.17 107.509 -177.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.19 145.15 4.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.256 1.408 . . . . 9.81 113.487 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -175.24 141.5 0.66 Allowed Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.318 1.847 . . . . 10.74 111.012 177.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.8 161.03 30.69 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.89 2.393 . . . . 6.93 110.243 167.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.57 139.31 4.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.679 1.992 . . . . 7.36 109.605 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tp -169.75 -162.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.36 1.864 . . . . 5.87 109.766 -174.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.52 170.81 37.59 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.307 1.432 . . . . 3.19 113.2 -175.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.77 93.79 0.75 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.756 -1.58 . . . . 3.44 111.13 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.65 68.32 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.52 2.813 . . . . 3.49 112.628 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 142' ' ' LEU . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 2.78 112.698 -176.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.22 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.446 HD23 ' CD1' ' A' ' 140' ' ' PHE . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 3.55 111.662 -172.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 1.86 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 1.71 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.07 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 2.36 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.2 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.64 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.22 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 3.27 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.04 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.76 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 6.5 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.84 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 2.42 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 3.32 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 269' ' ' PRO . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.01 113.666 -172.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.18 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 1.74 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 4.04 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 2.58 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 3.35 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 3.93 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 1.89 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.68 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 5.52 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.11 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 8.78 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 2.7 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 5.33 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 3.12 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 1.98 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.3 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.31 112.541 178.258 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.57 113.121 143.795 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 2.83 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.401 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.72 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 3.54 113.934 -176.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.461 ' O ' HG22 ' A' ' 183' ' ' VAL . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 4.63 112.142 168.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 181' ' ' ILE . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 1.88 109.893 -174.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.401 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.25 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 180' ' ' MET . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 2.5 113.518 173.227 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 2.0 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.36 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.55 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 2.13 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.95 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 2.47 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 2.62 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.09 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.03 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 3.48 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 3.88 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.15 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 2.82 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 1.49 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.99 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 3.26 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 2.37 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 2.28 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 2.17 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.59 111.067 -172.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.18 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.41 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 6.98 114.074 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 2.85 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 3.97 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.87 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 1.68 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 1.74 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 1.89 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.46 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 3.22 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 1.45 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 5.14 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.63 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 2.8 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 1.82 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 2.68 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 2.43 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.1 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 1.68 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 2.7 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 2.74 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.95 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.2 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.456 HH21 ' CG ' ' A' ' 253' ' ' ASP . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.01 110.573 172.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.53 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.28 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 2.2 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.78 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 3.33 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 3.61 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.25 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 5.36 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.41 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 3.78 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 6.46 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 3.02 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 5.48 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 3.21 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 2.93 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.08 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.99 171.01 54.66 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 2.7 112.225 171.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 18.84 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.514 3.476 . . . . 4.39 113.823 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 61.15 5.96 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.919 1.688 . . . . 5.84 112.084 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -36.66 115.14 0.35 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.941 2.096 . . . . 9.62 112.003 164.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 179.15 -55.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.395 2.278 . . . . 11.98 109.241 -164.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.456 ' CG ' HH21 ' A' ' 231' ' ' ARG . 27.4 t70 -172.16 48.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.15 1.78 . . . . 17.2 112.176 175.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.93 -8.75 0.22 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.353 1.861 . . . . 16.21 115.436 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 17.3 t70 -82.09 -171.46 3.41 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.249 1.82 . . . . 9.35 114.916 -169.161 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.464 ' H ' ' CG ' ' A' ' 255' ' ' ASP . 73.6 m-85 83.35 138.39 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.305 3.842 . . . . 7.54 112.512 178.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt 77.47 -67.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 126.769 2.028 . . . . 4.62 112.165 167.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 3.44 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 3.29 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 3.39 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 3.53 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 3.8 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 3.6 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 2.93 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 2.27 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.51 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.411 ' HA ' ' H ' ' A' ' 157' ' ' GLY . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.07 112.391 169.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.43 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.01 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.08 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 4.09 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 3.46 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 3.95 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 2.68 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.45 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 176' ' ' GLU . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 5.74 116.654 -169.014 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 6.72 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 4.73 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 5.82 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 2.42 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.63 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.81 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 1.98 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 1.53 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 1.53 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 2.29 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 3.21 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.33 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 1.98 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.26 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.02 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.25 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.13 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 4.09 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -52.02 128.64 25.04 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 9.9 109.923 -177.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 132.94 53.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.267 1.21 . . . . 7.18 114.267 -156.093 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 26.37 1.08 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 115.411 1.634 . . . . 13.11 115.411 -163.218 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 128.785 2.834 . . . . 11.45 110.768 -155.902 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 118.487 -0.768 . . . . 24.35 110.362 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.13 -179.59 8.15 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.241 1.382 . . . . 20.3 114.115 -171.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m 148.68 128.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 1 C-N-CA 132.32 4.248 . . . . 16.3 108.841 171.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.4 23.49 73.33 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.643 1.116 . . . . 12.22 115.863 170.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 161.11 63.89 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 119.058 1.429 . . . . 11.6 111.21 177.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.22 171.61 15.68 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.435 2.756 . . . . 6.71 110.888 172.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.19 83.24 1.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.628 1.571 . . . . 10.22 108.486 -173.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.8 -29.19 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.547 2.054 . . . . 5.62 116.547 -173.391 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.43 -167.85 31.44 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.858 1.218 . . . . 3.03 111.688 -171.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.89 -74.69 0.24 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.57 1.081 . . . . 4.31 113.636 178.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -95.41 87.52 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.424 2.749 . . . . 3.17 109.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 2.69 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 2.96 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 2.63 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 2.38 108.346 172.726 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 150' ' ' LYS . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 1.54 108.801 163.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 2.16 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 2.66 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.32 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.12 115.158 -162.163 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 5.3 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 4.06 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.03 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.24 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 7.23 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 2.66 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 4.24 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.72 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.78 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.57 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 2.37 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 2.86 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 2.81 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 3.65 111.697 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 2.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.31 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 7.41 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 4.16 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 6.34 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 2.93 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 6.29 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.486 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.8 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 2.54 112.43 169.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.74 114.286 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.6 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 2.83 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.34 112.873 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 2.9 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 6.78 111.794 166.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 3.8 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 2.75 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 182' ' ' GLN . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 1.93 113.213 -175.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 1.42 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 2.27 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.51 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.33 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 1.61 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.68 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.02 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 3.45 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.12 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.14 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 3.26 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.3 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 3.49 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 1.61 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.2 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 2.08 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 2.44 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 1.82 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 2.54 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 3.11 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.24 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.42 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.38 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 8.87 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.07 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.09 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 3.34 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.99 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 2.14 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 2.12 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 1.58 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 4.18 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.04 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 224' ' ' LEU . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 2.24 113.678 -173.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 2.93 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.15 108.938 172.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 2.85 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 1.81 111.658 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.06 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 3.08 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 217' ' ' VAL . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 2.23 108.84 174.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 2.11 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.18 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 2.36 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 2.54 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.39 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 4.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.05 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.34 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.88 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 2.86 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.64 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.97 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 2.66 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 2.68 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.42 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 2.65 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 3.61 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 7.68 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 2.65 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 5.77 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 3.79 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 2.94 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.4 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.41 55.98 0.36 Allowed Glycine 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.6 116.031 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.22 154.23 74.85 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.06 3.173 . . . . 6.08 113.27 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -160.08 -176.81 5.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.537 1.535 . . . . 5.75 112.451 -167.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 60.49 12.77 3.72 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.611 2.078 . . . . 7.23 116.611 159.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -34.17 0.28 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.286 2.634 . . . . 10.77 114.209 179.048 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.27 4.78 8.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.156 1.782 . . . . 10.43 113.105 170.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 77.39 -35.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.92 3.288 . . . . 11.2 113.636 177.06 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -30.02 134.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.515 2.326 . . . . 5.57 116.262 -168.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.85 138.79 17.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.563 1.173 . . . . 7.1 111.957 162.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt -70.19 58.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.149 1.78 . . . . 5.38 112.547 175.119 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 2.59 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.65 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.59 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.03 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 3.38 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.08 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 3.8 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 3.89 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.08 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 2.42 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.48 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.18 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.68 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.19 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.02 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 3.64 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 2.93 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.53 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 4.93 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 2.92 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.03 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.01 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 5.55 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 5.38 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 5.97 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 1.61 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.64 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.78 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 1.54 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.09 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 1.37 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 1.75 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 2.05 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 1.48 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 1.61 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 2.34 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 4.18 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.09 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 3.4 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -64.7 -35.0 79.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 10.57 116.249 -163.345 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -147.21 145.65 29.55 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.406 1.883 . . . . 7.83 108.273 -179.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 36.6 pttt 174.15 171.04 0.21 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.603 1.161 . . . . 10.12 112.403 -146.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.249 1.074 0 C-N-CA 129.803 3.241 . . . . 10.32 108.46 173.603 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.192 -0.909 . . . . 19.88 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -161.18 -179.26 7.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.995 1.718 . . . . 19.08 109.157 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.1 t -78.46 160.25 27.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.531 0.732 . . . . 14.91 110.408 170.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.37 165.26 24.9 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.742 0.687 . . . . 11.31 111.419 163.678 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -121.61 141.35 33.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.513 1.525 . . . . 11.62 108.467 163.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.64 150.81 87.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.024 1.816 . . . . 7.97 110.208 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -77.28 137.1 38.59 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.146 0.498 . . . . 6.16 111.613 178.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -133.33 142.21 48.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.262 1.425 . . . . 6.99 107.891 170.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 161.4 153.23 6.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.041 0.829 . . . . 3.18 112.018 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.74 72.27 0.45 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.651 -1.639 . . . . 2.9 109.443 174.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.05 90.95 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.146 2.564 . . . . 2.4 111.282 -164.01 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 3.0 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 2.7 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 2.86 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 2.12 111.912 -169.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.06 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 2.32 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 3.62 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 2.66 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.97 113.825 -171.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 7.02 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 3.75 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.22 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 7.6 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.17 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 2.14 114.602 -176.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 3.69 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.09 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.99 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.3 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 2.66 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 3.01 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 1.59 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.13 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CZ ' HG22 ' A' ' 243' ' ' VAL . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 1.81 112.575 -178.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.07 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.463 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 4.12 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.18 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 4.79 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.26 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 4.58 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' A' ' 260' ' ' HIS . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 3.42 113.213 173.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.495 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.32 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.65 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 2.64 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.09 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 2.58 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.9 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 3.79 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.01 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 1.73 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.02 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 1.56 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 187' ' ' ILE . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 2.73 113.081 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.23 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 184' ' ' VAL . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 2.42 112.191 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.72 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.19 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 2.21 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.11 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.4 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.06 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.54 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.41 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 2.75 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 1.3 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 0.95 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 2.23 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 2.27 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 1.36 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 1.9 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 2.28 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.37 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.61 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.91 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 6.61 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.26 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 2.98 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 3.7 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 1.46 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 1.76 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.13 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 3.61 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 2.8 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 1.48 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.2 114.859 -177.377 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 3.06 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 1.69 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.56 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 2.82 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 2.31 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 1.45 109.888 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.442 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.96 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 2.65 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.01 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.63 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.04 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 6.46 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.76 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 2.2 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.69 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.2 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 3.27 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 2.23 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 4.48 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.14 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 2.52 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 6.33 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 164' ' ' PHE . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 3.33 109.365 169.006 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 5.29 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 3.29 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 2.88 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.74 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.58 34.22 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.45 110.808 163.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.65 163.55 34.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.261 1.974 . . . . 3.98 110.965 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.473 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 23.3 ttmt -101.66 109.46 21.25 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.34 -0.615 . . . . 5.92 109.34 162.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.14 49.23 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.654 1.982 . . . . 6.5 108.933 -177.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -172.72 -165.77 0.33 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 130.01 3.324 . . . . 11.02 107.047 -172.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -82.5 63.59 6.73 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.301 1.409 . . . . 9.35 112.804 -165.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 74.02 -42.69 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.336 3.054 . . . . 7.33 116.139 168.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.49 44.7 0.98 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.071 1.878 . . . . 6.75 116.071 -162.057 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.473 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 2.7 p90 -39.87 132.52 1.74 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.897 1.679 . . . . 4.28 114.877 178.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt -100.38 149.08 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.352 1.061 . . . . 4.02 111.841 -178.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 2.81 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.09 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' HG23 ' A' ' 172' ' ' VAL . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.04 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 3.19 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 3.36 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 2.36 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 3.33 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 6.4 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 2.61 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 3.12 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.64 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.45 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.38 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.01 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.03 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 3.42 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 2.98 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.84 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 6.1 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 4.02 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 1.9 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 4.48 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 8.74 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 6.61 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 4.83 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.12 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.59 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.33 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 1.73 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 1.37 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 1.71 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 2.5 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 2.51 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 1.91 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.17 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.32 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 5.52 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 4.85 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.16 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 3.44 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 31.27 -125.32 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.2 115.006 177.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -108.84 167.9 9.74 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.378 1.471 . . . . 6.62 111.25 170.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -54.82 -21.47 11.37 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.549 2.426 . . . . 11.29 117.549 -167.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.778 0 C-N-CA 126.142 1.777 . . . . 10.88 109.876 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.456 -0.728 0 N-CA-C 109.803 -0.883 . . . . 3.49 109.803 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 4.2 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 3.93 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 2.69 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 2.46 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 1.49 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 1.63 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 2.14 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.43 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.08 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 3.0 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 3.03 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.26 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 6.54 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.95 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 2.82 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 4.75 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.44 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.14 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.36 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 3.21 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 2.37 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 1.63 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 3.84 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 2.15 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 3.93 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.14 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 8.4 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.06 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 4.24 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.65 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 2.56 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.83 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.61 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.37 112.01 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.28 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 2.56 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.38 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 3.62 111.202 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 3.37 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 1.46 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 1.98 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 1.6 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 2.24 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 2.11 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.22 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 4.05 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 3.3 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.22 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 3.25 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 2.94 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.48 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 2.5 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 1.53 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 0.88 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 2.84 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 2.3 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 1.63 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 2.36 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.2 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.3 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.27 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.86 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 6.18 117.962 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 2.81 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 4.95 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 1.46 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 1.89 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.06 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 3.18 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 4.25 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 1.31 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 3.56 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.32 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 2.7 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 2.18 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 1.8 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 2.34 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 2.37 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 1.35 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.99 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 2.51 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 2.53 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.94 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 3.21 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 6.69 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.11 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.53 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 1.88 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.23 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 4.14 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 3.17 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.19 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.01 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 3.24 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 6.85 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 3.78 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 9.01 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 3.18 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 3.6 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.12 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.3 113.493 -175.796 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 121.941 0.876 . . . . 4.76 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 2.65 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.72 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.13 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 3.36 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 2.67 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 3.22 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 2.93 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.24 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 2.57 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.63 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.64 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.07 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.33 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.39 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 3.59 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 2.69 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.59 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 4.74 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 3.28 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.55 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 5.68 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.03 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 8.3 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 5.35 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 1.99 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 1.81 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.51 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 1.57 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 1.87 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 2.38 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.01 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 2.49 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 2.43 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 2.85 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 2.77 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 4.83 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 6.87 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.37 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 4.24 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 10.5 108.161 -178.167 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 N-CA-C 111.966 -0.052 . . . . 3.14 111.966 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 2.29 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.16 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 2.18 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 2.51 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 1.57 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.65 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 3.17 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.05 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.78 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 5.62 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.13 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.17 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.66 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.07 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 2.89 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 2.98 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 3.39 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.52 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.49 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.44 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 2.11 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 2.72 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 1.92 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 3.67 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 1.85 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.86 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 4.67 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 168' ' ' HIS 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 4.12 110.457 165.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.574 ' H ' HG23 ' A' ' 167' ' ' THR . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 7.51 111.866 -171.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 3.58 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 5.74 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.17 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 3.3 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.16 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.42 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.22 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.01 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 2.35 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.11 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.13 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 3.25 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 1.46 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.531 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 1.73 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 1.45 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 2.59 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.89 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 1.9 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.35 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 2.39 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 2.39 111.411 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 2.63 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 2.76 112.572 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 2.6 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.11 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.51 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 2.24 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 1.42 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.25 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 2.98 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 2.15 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 1.63 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 1.85 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.11 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.06 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.92 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.34 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 7.72 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 167' ' ' THR . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.21 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 3.82 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 1.5 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 2.05 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 1.37 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.66 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 2.87 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 1.31 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 4.75 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 2.71 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 1.79 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 1.97 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 2.63 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 2.21 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 1.8 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 0.99 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 2.69 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 2.29 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.15 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 3.27 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 7.08 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.63 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.85 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 1.81 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.09 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 2.39 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.25 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 3.83 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.51 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.1 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 7.19 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 3.02 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.624 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 5.62 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 3.6 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 3.37 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.43 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.67 115.645 -172.245 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.964 1.098 . . . . 5.22 113.964 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 2.42 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.65 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.85 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 3.34 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.01 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 3.06 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.0 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 3.34 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 2.66 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 2.68 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.36 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.84 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.74 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.19 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 3.73 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 2.78 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.69 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 3.47 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 3.2 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 3.09 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.07 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 4.7 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 8.5 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 6.2 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 1.74 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.49 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 1.3 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.24 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 1.68 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 1.88 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 2.49 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 2.14 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.19 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 2.6 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 4.45 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 5.33 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 2.94 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 5.76 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 10.3 112.285 -174.014 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.658 -0.555 . . . . 3.05 110.658 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 2.81 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 151' ' ' THR . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.6 115.787 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.15 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 1.75 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 1.25 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 1.67 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 2.34 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.19 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 6.95 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 3.24 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 141' ' ' SER . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 2.01 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 6.53 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.16 111.332 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 3.24 114.311 -178.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 3.77 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.471 HE22 HD23 ' A' ' 160' ' ' LEU . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.97 110.331 167.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.25 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.471 HD23 HE22 ' A' ' 158' ' ' GLN . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 2.64 110.73 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 1.84 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 3.74 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 2.61 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.89 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 5.24 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.62 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.448 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 6.57 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 2.55 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 5.98 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 3.07 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 1.98 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.81 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 3.28 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.11 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 3.51 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 1.93 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.443 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 3.36 110.781 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 1.56 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 2.49 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.52 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 1.93 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.66 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.13 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 3.72 110.678 165.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 2.92 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 3.92 112.316 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 5.02 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.67 110.912 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.94 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 2.85 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 1.44 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 0.95 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 2.42 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 2.36 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 1.52 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 1.99 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 2.79 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.55 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 6.82 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . 0.448 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.86 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 2.86 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 3.55 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.14 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 1.9 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 1.82 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 1.23 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 3.58 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 5.64 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 1.4 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 3.77 112.904 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.3 112.347 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 2.5 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 2.62 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.73 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 2.42 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 2.72 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 1.43 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 0.97 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 2.02 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 2.6 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.62 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 3.11 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 5.75 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.3 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.3 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 2.44 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.44 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.07 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 3.28 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.04 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 4.81 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.06 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 3.2 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 9.82 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 3.36 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 6.62 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 5.72 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.47 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.35 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.612 0.597 . . . . 4.83 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 2.7 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.51 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 4.13 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 4.34 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 2.63 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 2.64 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 2.79 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 2.59 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 2.39 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.56 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.17 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.93 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.81 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.46 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 4.04 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 4.11 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.07 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 3.87 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 2.73 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.08 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.35 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 5.95 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.33 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.08 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 2.81 113.622 -157.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.51 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 1.83 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 1.32 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 1.45 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 2.27 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 2.44 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 1.67 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 1.84 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 3.73 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.1 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 4.37 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.36 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 3.34 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.2 112.581 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 111.076 -0.394 . . . . 3.46 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 3.11 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 2.58 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 2.66 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.13 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.18 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 1.84 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 3.55 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.06 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 6.66 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 3.41 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 3.31 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.68 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 7.39 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.05 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 2.26 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 3.65 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 1.96 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 2.67 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 1.88 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 2.48 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.05 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 2.22 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 6.83 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 3.31 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.81 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 4.62 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 4.61 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 2.67 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 5.14 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.34 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.546 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 2.95 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.88 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.72 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.53 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 3.31 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.65 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 2.95 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 3.61 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 1.95 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.528 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.18 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 1.93 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 3.19 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.41 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 1.7 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.64 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 2.96 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.74 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 3.24 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 3.62 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 4.38 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.95 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 2.48 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 1.15 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 3.09 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 2.14 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 1.93 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 2.54 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.61 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.54 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.6 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 6.74 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.68 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.14 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 3.98 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.86 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 1.79 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 2.16 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 1.49 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 4.84 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 2.66 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 1.58 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 3.71 114.227 -167.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.81 112.851 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 2.8 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.01 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.16 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 2.52 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 2.35 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 2.35 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 2.4 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 2.48 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.22 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.24 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 8.69 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.18 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.31 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.12 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.64 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.09 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 3.8 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 2.66 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.0 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.02 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 3.0 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 5.75 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 3.63 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 6.63 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 3.01 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 2.79 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.75 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.97 111.505 171.53 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.229 0.538 . . . . 3.84 109.844 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 2.83 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.83 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 23.4 p80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.12 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.21 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 262' ' ' ILE . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 3.36 111.447 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 2.36 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 3.13 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 2.49 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 2.71 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 2.21 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.77 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.19 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.97 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.11 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 2.96 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 2.3 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.19 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.51 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 2.78 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 2.6 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 3.32 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.07 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 8.46 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 6.98 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.528 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 2.25 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.01 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.18 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 1.43 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 1.53 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 2.06 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 1.69 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 2.45 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 1.5 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 2.22 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 2.2 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 3.53 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 5.85 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.75 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.13 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 9.38 116.081 -172.872 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 N-CA-C 110.811 -0.496 . . . . 3.06 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 2.49 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.18 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.08 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 1.72 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 1.28 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.21 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 2.4 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.28 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.35 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 6.85 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 4.49 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.05 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.83 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 7.64 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 3.18 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 3.5 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 3.74 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.12 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.63 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.54 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 2.27 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 3.58 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 1.78 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 3.61 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 1.91 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 4.4 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.51 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 6.15 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.492 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 3.7 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 7.89 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.63 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 2.77 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.07 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 1.89 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.11 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.453 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.09 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 2.97 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.11 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 3.53 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 3.14 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 1.78 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.07 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 2.04 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 2.62 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.74 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.57 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 2.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.94 111.409 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 2.64 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 2.41 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.34 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.56 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 2.66 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 2.81 108.474 158.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.97 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 2.72 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 1.88 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.25 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 3.05 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 2.37 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 237' ' ' VAL . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 1.31 109.487 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 2.01 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 2.14 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 2.5 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.23 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 8.79 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.66 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 211' ' ' GLU . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.08 106.249 146.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 3.67 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.05 113.993 -171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 2.33 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 1.97 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.23 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.421 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 3.94 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 4.59 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 1.69 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 3.47 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 4.4 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 3.33 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.25 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.54 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 2.89 112.054 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 2.29 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 1.66 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.96 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 2.2 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 2.54 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.9 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 2.91 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 7.48 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.57 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 2.36 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.07 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 2.54 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' CG2' ' A' ' 201' ' ' ILE . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 2.72 113.512 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.19 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.64 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.24 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 3.45 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 8.43 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 3.1 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.07 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 4.24 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.06 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.13 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.61 112.95 176.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 114.504 1.298 . . . . 4.93 114.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 2.89 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.41 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 2.52 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 3.58 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 2.86 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 2.98 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 3.12 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 2.72 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 2.13 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 2.55 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.91 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.13 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.8 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.51 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.08 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 3.64 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 2.97 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.11 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.33 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 3.04 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.02 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 3.66 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 5.35 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.06 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.2 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.02 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.57 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.49 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 1.5 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 1.43 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 1.48 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 2.16 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 3.13 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 2.05 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 1.63 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.32 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 6.08 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 5.9 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.25 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 3.18 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 . . . . . 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 9.88 112.351 178.428 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 110.859 -0.477 . . . . 3.11 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 2.27 112.926 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.71 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 1.87 112.841 -173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 1.59 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.22 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.24 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.09 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.78 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.01 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 7.81 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 3.75 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.03 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.45 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 6.56 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.67 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 2.18 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 3.87 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.38 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.32 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 3.18 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 2.6 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 199' ' ' LEU . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 1.77 111.147 -172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.3 111.988 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 3.06 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.41 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 5.57 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.38 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 5.17 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.82 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 5.28 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.51 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 2.79 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.462 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.01 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.59 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.65 112.106 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.08 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 2.59 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.24 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 3.64 111.87 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 3.55 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.07 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.416 ' O ' ' HE2' ' A' ' 283' ' ' LYS . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 1.99 113.836 172.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 2.55 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 2.6 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.1 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 2.43 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.81 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 2.17 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 2.3 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 2.87 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 2.5 114.378 -165.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 3.03 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.4 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.37 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 2.49 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.0 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.84 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 227' ' ' LEU . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 2.55 112.84 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 2.38 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 1.62 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 2.48 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.02 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.09 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.38 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.64 HH11 ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 8.63 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.89 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.0 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 3.95 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.42 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 1.47 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 1.86 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 1.08 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 4.73 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 4.17 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 1.27 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.16 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 2.78 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.43 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 2.34 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.53 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 3.16 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 225' ' ' VAL . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 2.52 109.86 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 224' ' ' LEU . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 1.32 111.811 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 199' ' ' LEU . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 1.91 112.808 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 2.57 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.0 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.26 113.028 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.08 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.55 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.0 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 3.43 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 2.1 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 3.83 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 2.7 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.08 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 5.4 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 3.88 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.22 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 3.41 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 4.86 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.08 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.32 113.619 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.285 -0.635 . . . . 3.44 109.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 2.94 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.06 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.462 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.5 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 3.69 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 4.73 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 3.06 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 3.33 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 2.72 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 2.09 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 2.5 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.24 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.83 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.26 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.13 113.233 165.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 4.62 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 2.79 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.24 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 3.65 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.4 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.53 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 5.86 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 4.41 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 6.51 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 182' ' ' GLN . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 1.81 113.504 -165.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.23 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.26 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 0.98 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 1.25 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 1.82 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.12 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 1.27 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 1.45 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.12 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 3.85 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 4.57 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.81 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 2.94 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 10.37 110.879 155.587 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 109.372 -1.049 . . . . 2.71 109.372 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 2.35 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.16 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 2.09 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 1.55 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 1.41 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.54 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 2.69 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.42 ' HA2' ' HE3' ' A' ' 210' ' ' LYS . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.9 112.808 -155.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.08 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.12 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 1.89 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.19 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 7.94 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.88 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 2.45 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 4.7 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.87 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.34 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 1.91 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 2.16 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 3.14 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 1.72 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 3.61 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 2.65 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.412 ' HE1' ' HG ' ' A' ' 169' ' ' CYS . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 4.95 109.724 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 3.63 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 5.25 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.412 ' HG ' ' HE1' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.64 112.121 -157.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 6.07 112.152 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.3 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 2.94 111.869 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.549 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.72 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.06 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.91 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 2.3 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.24 109.501 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.0 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 4.19 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 2.21 109.839 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.47 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 1.62 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 2.17 111.18 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 4.01 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.69 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.88 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 3.11 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.68 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 2.67 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 2.4 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 3.85 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 4.14 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 3.75 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 3.62 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.83 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 2.55 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 1.05 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.84 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 2.38 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 2.06 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 1.42 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 2.4 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.07 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.19 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.42 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.69 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 7.77 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.89 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 3.61 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.42 ' HE3' ' HA2' ' A' ' 147' ' ' GLY . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.17 114.294 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 1.52 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 1.76 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 0.96 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 3.72 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 2.85 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 1.22 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.03 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.66 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 3.24 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.16 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.71 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 2.8 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 1.88 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 1.32 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.74 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 1.97 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 2.75 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.83 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.05 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 5.81 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.33 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.76 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 1.85 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.93 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 2.44 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 2.73 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 2.45 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 5.2 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.6 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 3.02 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.23 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 2.82 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 5.93 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 4.44 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 2.99 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.0 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.97 111.811 -174.333 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.439 0.638 . . . . 4.47 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 166' ' ' PHE . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 2.86 111.451 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.97 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.549 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.65 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 3.31 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.07 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 2.91 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 2.8 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 2.62 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 1.9 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 1.89 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.25 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.67 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.69 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.91 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.85 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 3.11 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 2.6 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.14 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.07 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 2.77 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.66 111.411 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 3.93 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 5.32 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 4.57 112.558 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.06 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.47 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 2.22 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.4 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 1.31 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.16 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.22 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 2.17 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 2.23 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 1.36 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 1.66 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 3.81 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 4.79 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 4.26 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.17 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 3.71 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.27 111.8 169.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 N-CA-C 110.754 -0.518 . . . . 3.68 110.754 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 3.03 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 2.61 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 2.32 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 2.74 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 1.61 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 1.51 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 2.94 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 1.91 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 4.89 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 5.38 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 2.59 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.41 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 156' ' ' LEU . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.25 115.421 -156.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 2.97 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 4.13 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 153' ' ' LYS . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 4.18 113.101 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.31 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.49 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.06 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 2.65 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 2.78 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 2.2 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.57 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.01 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.07 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CZ ' ' CD2' ' A' ' 260' ' ' HIS . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 5.1 115.028 -159.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 2.91 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 6.14 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.36 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 4.91 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.1 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 3.71 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.06 112.531 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.75 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.1 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 2.89 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 220' ' ' PHE . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 2.75 111.518 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.37 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.21 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 3.78 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 1.8 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.512 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.08 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 1.94 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 2.58 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.1 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.71 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 2.56 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 2.09 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 2.88 111.781 165.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 2.39 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 2.48 111.768 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 3.08 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.49 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.34 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 2.69 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 1.84 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.05 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 2.58 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 3.31 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 1.62 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 2.9 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 1.6 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.3 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 206' ' ' GLU . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.88 112.181 173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 7.58 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 4.52 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 4.67 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 2.38 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 1.94 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 1.26 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 3.11 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 3.7 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 1.37 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 5.51 113.301 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.23 113.748 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 177' ' ' LEU . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 2.16 112.782 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 1.82 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.21 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 2.94 113.74 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 3.03 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 1.97 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.17 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 1.75 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 2.78 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.74 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 3.79 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 8.33 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.99 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.16 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 2.1 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.53 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 3.18 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 2.58 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.2 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 1.87 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 3.41 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 5.93 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 2.54 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 5.2 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 3.8 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 2.65 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.47 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.26 112.732 179.291 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.086 0.772 . . . . 4.73 113.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 3.41 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.99 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.0 OUTLIER -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.05 112.522 -168.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 4.88 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 3.01 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 2.52 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 4.4 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 2.9 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 2.68 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 3.25 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.78 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 3.53 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.89 113.794 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 3.73 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 3.07 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.68 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 3.39 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 2.88 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 2.67 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 4.61 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.12 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 5.21 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.478 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 7.84 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.512 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 2.36 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.0 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 2.27 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 1.63 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 1.86 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 2.9 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 2.98 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.28 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.18 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.03 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.09 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 6.23 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.81 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.29 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 7.37 111.99 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 123.278 1.282 . . . . 4.11 115.325 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 3.89 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 4.78 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 2.95 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 2.51 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 2.25 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.09 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 3.9 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.47 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.01 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 7.68 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 4.58 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 4.28 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.24 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 7.21 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.65 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.426 ' HB3' HE22 ' A' ' 158' ' ' GLN . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 3.52 113.405 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 3.72 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.26 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.426 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.63 109.835 159.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.65 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 2.79 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 4.33 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 2.71 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 3.32 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 243' ' ' VAL . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 2.15 112.178 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.95 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 5.14 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.05 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.6 m170 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 5.18 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.456 ' HG ' ' CD2' ' A' ' 260' ' ' HIS . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 3.38 109.869 159.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 6.17 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.74 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 2.67 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 2.51 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 1.99 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 2.72 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.65 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.08 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.8 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.12 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 4.86 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 1.62 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 1.9 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 1.87 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 2.79 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 2.93 112.262 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 1.8 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 2.6 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 2.35 110.329 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 2.8 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 2.93 110.692 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 2.74 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.17 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.28 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 4.17 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 1.3 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 0.91 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.14 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 2.99 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 1.75 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 1.6 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 2.55 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.23 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.28 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.19 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 8.95 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 3.7 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.17 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.15 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.02 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 2.8 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 1.43 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.487 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 4.79 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 3.33 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 1.48 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.21 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 3.75 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 4.16 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 2.91 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.64 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 4.67 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 2.32 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 2.31 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.03 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 1.81 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 3.92 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.11 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 3.21 109.003 157.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 6.38 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.89 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.06 111.705 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 2.91 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.33 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 2.59 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.09 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 3.11 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 3.74 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 2.84 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 4.46 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 5.53 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 164' ' ' PHE . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 2.69 111.959 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 5.89 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 4.48 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.11 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.23 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 2.85 114.882 -171.288 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 120.633 0.254 . . . . 3.82 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 3.24 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.456 ' CD2' ' HG ' ' A' ' 169' ' ' CYS . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 1.82 110.096 170.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.27 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 3.29 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.02 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 3.95 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 3.54 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 2.68 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 2.28 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.32 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.99 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.86 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.45 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 5.87 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 4.79 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.92 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 5.34 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 2.99 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.58 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 5.98 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 4.67 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 4.99 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 8.32 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 3.07 114.072 -164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 2.93 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.07 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.11 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.04 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 2.93 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 3.19 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 2.73 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 2.68 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 3.26 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.43 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 4.23 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 5.45 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.48 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 4.85 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 8.33 113.298 -161.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 120.456 0.107 . . . . 3.63 112.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 3.09 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.32 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 2.29 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 2.81 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 1.61 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 1.67 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 2.91 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.82 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 5.85 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.05 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.2 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.87 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 7.5 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.45 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 2.57 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 4.69 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.81 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.12 109.375 165.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.73 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 2.57 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 3.37 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 2.86 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 3.49 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 2.9 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 4.69 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 4.39 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.45 ' CE1' HH12 ' A' ' 207' ' ' ARG . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 5.57 111.929 169.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.05 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 4.28 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.67 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 3.23 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.404 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.7 112.355 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.68 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.1 111.672 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.12 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 2.66 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.58 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 3.58 112.175 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 2.91 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 1.43 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 2.55 113.835 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 2.32 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 2.24 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 1.97 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.53 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.23 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 2.53 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 3.23 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 2.77 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 3.23 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 2.84 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.56 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.1 112.704 155.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 1.06 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 0.93 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 2.71 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 3.53 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 1.32 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.63 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 2.34 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.36 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.39 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.45 HH12 ' CE1' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.09 113.029 -167.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.57 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 4.83 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 4.6 114.297 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 4.61 113.48 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 2.27 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 1.8 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 1.2 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 4.37 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 3.49 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 1.21 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 6.19 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.11 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 3.17 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 1.67 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 1.76 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 3.72 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 1.88 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 1.44 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.9 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 1.82 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 2.83 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.15 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.67 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 8.68 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.01 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 2.37 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 2.83 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 2.58 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 2.88 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 6.5 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.44 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 3.6 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.31 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 3.78 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 6.2 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 3.19 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 2.92 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.52 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.24 112.194 175.078 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.434 0.159 . . . . 4.54 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 2.32 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.16 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.404 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 1.77 111.882 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 3.36 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 3.68 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 2.36 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.02 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 2.73 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 2.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 2.1 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.72 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.06 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 2.97 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.18 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 3.82 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 3.15 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.84 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 3.56 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 2.5 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.17 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 4.54 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 7.97 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.07 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 5.43 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 2.67 112.726 -166.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 1.99 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.02 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 2.15 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.33 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 1.83 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 1.64 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 2.36 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.09 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 2.17 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 2.84 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.04 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 5.66 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.14 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 3.64 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 9.01 109.726 166.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 CA-C-O 121.241 0.434 . . . . 3.4 111.629 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 2.81 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.09 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 2.33 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 1.98 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 1.51 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.45 112.565 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 2.4 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.74 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.57 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 7.84 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 3.43 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.02 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.19 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 6.89 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.72 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 2.29 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 4.65 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.42 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 1.91 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 2.08 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 2.53 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 1.92 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.13 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 2.42 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 4.09 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.21 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 5.85 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 2.7 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 5.8 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 2.74 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.06 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 1.9 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.9 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 3.38 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.88 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 3.56 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.4 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 1.93 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.44 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 1.9 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 1.67 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 2.46 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.93 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.39 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 2.01 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.45 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 1.93 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.16 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 2.37 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 2.57 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 2.86 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.13 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.78 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 3.08 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 1.0 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.76 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 2.38 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 3.07 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 1.3 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 2.89 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.51 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.67 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.32 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 6.31 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.45 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 3.6 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 6.14 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.95 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.539 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 2.56 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 2.64 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.29 111.414 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 3.76 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 3.97 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 1.44 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 6.95 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.06 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 2.62 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.09 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.59 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.0 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 2.19 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 2.8 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.96 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 2.88 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.3 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.49 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 6.37 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.28 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.35 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 3.45 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.8 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 2.41 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 2.79 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 2.2 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 5.59 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 2.42 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 4.67 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 8.84 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 4.98 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 15.67 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.18 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.04 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.32 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.91 112.966 174.396 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 3.18 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.34 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.13 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 3.51 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 2.46 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 3.25 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 2.79 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.05 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 1.96 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.33 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.4 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.32 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.92 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.33 112.387 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 3.4 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 2.76 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.78 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 5.46 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 2.45 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.86 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 3.38 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.99 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.27 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 5.93 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 1.93 113.984 -165.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.68 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.92 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 1.47 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 1.55 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 1.75 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 2.32 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 3.21 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 1.8 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.1 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.12 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 4.69 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.2 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.41 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 3.85 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 9.61 110.813 -179.154 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.354 -1.056 . . . . 2.57 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 2.64 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 2.82 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 2.76 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.05 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 1.81 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 1.7 113.025 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 3.42 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 5.71 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 2.88 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 2.21 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.02 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 7.44 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.01 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 3.27 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 3.63 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.48 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.19 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.4 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 3.14 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 2.48 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 1.89 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.84 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 2.11 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.83 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 4.93 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 3.7 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 5.44 111.344 161.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.32 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 4.89 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.27 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 2.76 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.549 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.71 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.11 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.91 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.25 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 2.46 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.15 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 5.3 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.26 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 1.8 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.478 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 1.64 113.278 175.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 1.52 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 2.61 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.38 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 2.45 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.35 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.18 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 2.77 112.728 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 2.93 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 2.86 112.173 -161.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 3.53 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.11 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.32 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 2.43 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 1.18 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.12 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 2.92 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 2.76 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 2.22 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 1.49 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 1.85 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.11 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.92 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 7.4 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 3.55 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.04 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.32 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 2.46 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 2.14 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 1.72 111.994 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 2.76 111.416 173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 2.7 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 1.63 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 3.3 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 2.38 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 1.83 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 1.8 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 2.58 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 2.29 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 1.89 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 3.41 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 3.64 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.15 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.75 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 6.39 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.91 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.74 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 2.79 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.62 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 2.71 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 2.65 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 2.98 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 6.4 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.16 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 3.27 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.24 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 2.37 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 5.73 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 2.99 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.39 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 2.84 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.76 112.538 168.32 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 118.461 -0.781 . . . . 3.69 109.923 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 2.8 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.68 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.549 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.7 p80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 1.89 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 4.48 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.22 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 2.84 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 3.64 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 4.02 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 2.4 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 2.72 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 1.82 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.86 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.34 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.17 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.91 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 5.22 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 3.14 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.01 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 3.02 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.28 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.51 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 9.26 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 4.9 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 6.8 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 1.65 112.464 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.43 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.02 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 1.42 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 1.38 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 1.58 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 1.86 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 2.18 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 1.92 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 3.69 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 3.65 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 4.87 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 4.9 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.13 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 4.15 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 8.59 113.38 166.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 CA-C-O 121.976 0.74 . . . . 3.61 111.673 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 2.85 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 2.74 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 2.53 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 3.62 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.11 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.62 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.17 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.39 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.401 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.78 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 8.24 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.16 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 1.88 105.957 166.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 6.34 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.53 112.203 163.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.27 114.959 -161.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 3.09 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.4 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.35 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 1.8 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 2.23 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 3.49 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 2.14 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 3.39 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 2.93 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.37 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 5.7 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.15 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 5.91 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.15 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 6.13 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.52 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 4.29 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.66 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.62 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.64 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.55 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 2.28 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.91 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.1 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.0 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 1.84 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 2.92 114.978 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 2.49 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 2.52 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.44 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 1.65 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.3 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.2 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 3.12 110.258 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.34 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 2.74 111.001 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 3.8 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.5 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.61 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 4.15 113.783 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 1.7 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.22 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 2.43 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 3.5 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 2.57 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 2.66 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 3.03 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.52 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.57 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.87 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 7.05 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.77 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 2.67 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 3.47 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.61 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 1.74 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 2.38 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 1.64 113.425 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 3.51 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 3.56 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 1.27 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 5.84 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.9 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 3.51 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.3 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 2.51 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 2.92 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 2.17 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 1.6 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 1.94 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 2.54 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.68 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 3.56 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 9.43 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 4.35 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.44 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 2.26 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.22 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 3.73 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 3.08 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 2.59 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 5.89 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.42 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 4.31 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 5.63 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 3.83 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.547 ' H ' HG22 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 5.51 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 4.38 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 2.7 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.69 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.18 111.692 172.463 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.74 0.781 . . . . 4.29 111.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 3.47 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.72 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.39 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 4.75 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.662 HD11 HE21 ' A' ' 279' ' ' GLN 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 3.47 119.655 155.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.07 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 2.77 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 3.93 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 2.37 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 2.59 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.34 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.53 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 2.86 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 3.63 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 2.91 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.61 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 3.59 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.459 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 2.24 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.55 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.662 HE21 HD11 ' A' ' 262' ' ' ILE . 4.5 mm-40 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.11 112.055 -171.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.36 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.22 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 7.17 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.403 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 2.17 113.451 -164.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.76 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 1.41 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.05 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 1.36 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 1.63 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 2.21 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 1.42 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 1.6 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 1.98 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 4.51 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 4.43 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 1.98 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 3.73 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 6.91 113.875 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.459 -0.502 0 N-CA-C 109.322 -1.069 . . . . 3.85 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 2.67 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.47 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 2.87 111.405 168.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 2.3 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 2.11 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.3 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 2.97 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.69 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.73 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 5.43 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 2.93 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.16 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.13 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.28 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 3.13 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 4.33 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.68 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.15 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.02 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 2.83 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 3.32 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 1.75 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 3.49 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 2.18 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.85 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 4.71 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 3.39 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 4.57 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.14 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 4.81 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 174' ' ' PRO 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 3.24 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.555 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.06 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 171' ' ' ASP . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.45 116.458 -173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.13 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.33 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 2.79 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.34 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 5.07 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.27 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 3.05 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 2.49 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 2.85 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 2.55 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.97 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.43 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 2.26 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 4.02 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 4.4 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.02 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 4.88 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 4.46 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.16 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.36 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 3.22 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 2.45 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.58 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 2.43 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 2.47 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 1.38 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 1.84 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 1.63 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.92 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB3' HG23 ' A' ' 228' ' ' THR . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.85 110.286 -162.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.58 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 6.95 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.28 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.26 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 4.96 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 1.58 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 2.83 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.23 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.471 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 2.86 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 3.31 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 2.48 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 3.6 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 3.81 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 4.63 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.14 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.24 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 2.36 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 2.75 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 1.67 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.08 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.402 ' HB3' HD13 ' A' ' 142' ' ' LEU . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 2.3 111.299 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 205' ' ' PRO . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 2.79 109.072 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.62 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 4.06 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 9.16 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.14 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.64 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 1.99 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.08 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 2.42 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 2.91 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 5.84 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 2.34 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 3.66 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.15 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 2.74 112.104 -173.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 8.07 111.141 166.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 4.53 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.12 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.56 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.04 113.883 178.308 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.837 0.827 . . . . 5.39 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 3.05 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.39 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.555 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 5.97 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 4.71 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 4.01 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 3.3 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 3.41 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 2.46 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 3.09 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.27 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.31 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.407 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.93 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.56 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 5.61 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 3.65 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.45 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 3.13 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 2.58 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.89 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 3.71 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 5.28 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.16 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 5.93 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.1 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 1.99 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.65 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 2.09 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 1.57 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 1.6 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 2.24 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 2.68 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 1.88 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 2.41 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.42 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 4.73 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 5.57 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.65 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 4.09 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 7.64 110.51 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.46 -0.46 0 CA-C-O 121.241 0.434 . . . . 2.52 111.994 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 2.48 111.434 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 2.97 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.405 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 2.31 110.154 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 1.93 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 1.84 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 1.67 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.13 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.36 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.6 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 5.93 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 3.31 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 2.08 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.08 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 7.41 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 2.55 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 3.55 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.52 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.14 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.66 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 2.92 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 2.75 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 1.53 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 4.54 111.823 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 2.98 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 1.97 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 4.15 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.39 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 6.14 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 3.23 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 6.85 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.38 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 3.21 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.03 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.25 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.44 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 262' ' ' ILE . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.25 113.356 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 2.67 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.49 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 176' ' ' GLU . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 3.43 113.012 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 4.05 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 1.6 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.36 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 1.49 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 196' ' ' LEU . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 2.5 112.9 -170.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.53 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 2.44 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.458 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 2.54 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 2.58 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 3.52 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 3.7 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 3.63 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 2.64 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.88 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 184' ' ' VAL . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 3.14 110.045 170.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 1.25 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.28 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 2.65 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 2.44 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 2.0 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 1.74 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 1.66 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.22 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.16 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.03 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.06 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.27 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 4.42 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.34 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.62 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 1.97 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 2.07 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 1.35 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 3.52 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 3.08 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 1.29 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 3.65 115.04 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 2.81 113.658 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 2.22 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 1.54 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 1.85 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 2.58 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 1.99 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 1.88 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 2.75 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 2.57 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.82 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 2.96 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 6.67 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.21 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 1.91 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 2.51 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 2.53 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.32 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 4.76 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.37 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 4.08 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 6.16 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 2.82 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 5.96 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 3.37 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.24 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.1 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.61 114.486 -175.058 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 109.739 -0.467 . . . . 4.02 109.739 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 2.69 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.23 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 2.64 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.04 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 279' ' ' GLN . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 4.08 109.808 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 2.84 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.12 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 2.77 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 2.25 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 2.66 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.46 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.55 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 3.65 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.81 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 3.99 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 2.6 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.59 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.14 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 2.43 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.17 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.465 ' HB3' HD13 ' A' ' 262' ' ' ILE . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 4.43 118.667 -162.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 5.44 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 5.48 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.29 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 1.79 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.43 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.86 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 1.26 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 1.14 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 1.3 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 1.84 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 2.36 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 1.89 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 1.65 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 2.52 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 5.06 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 5.45 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.93 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 2.93 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.1 113.474 156.602 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 N-CA-C 112.504 0.155 . . . . 2.75 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 2.45 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 3.03 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 1.66 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.07 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 1.75 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 2.62 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.0 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.74 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 5.39 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.35 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 1.99 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.06 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.13 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.61 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 2.6 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 4.21 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' H ' ' H ' ' A' ' 270' ' ' ASP . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.91 113.688 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.29 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.77 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 2.6 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 2.56 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 1.7 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 5.47 112.266 -167.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 2.15 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 1.73 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 5.2 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 4.05 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 5.39 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 2.75 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 4.64 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 2.51 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.83 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.39 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.76 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 2.62 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.32 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.32 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 2.93 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 1.84 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 1.72 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 1.44 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 2.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.44 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.53 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 2.28 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.13 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.22 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.11 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 4.24 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 2.85 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 2.49 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.24 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 2.44 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 1.35 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 0.93 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 2.35 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 2.38 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 1.48 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.488 HG22 HG13 ' A' ' 234' ' ' VAL . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 1.96 113.693 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.66 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 4.51 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 8.36 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.93 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 3.6 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.01 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.44 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 1.94 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 1.96 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 1.59 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 4.07 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 2.98 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 2.07 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.06 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.34 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 3.28 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.14 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 1.99 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 2.62 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 2.53 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 1.83 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 2.16 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 2.64 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.05 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 8.91 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.57 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 203' ' ' ILE . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 2.05 112.633 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.93 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.23 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 2.58 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 2.46 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 5.13 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 1.83 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 3.12 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 7.43 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 3.21 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 5.37 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 4.32 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.09 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.29 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 2.9 114.071 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.007 0.373 . . . . 4.42 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 2.78 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.17 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.67 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 3.44 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 3.99 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.02 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 3.91 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 2.91 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 2.07 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 2.43 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 1.92 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.55 ' H ' ' H ' ' A' ' 157' ' ' GLY . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.07 119.017 163.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.18 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.39 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 3.87 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 2.63 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.72 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.02 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 2.29 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.41 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.15 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.0 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 5.56 114.451 -166.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 5.41 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 2.4 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.19 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.41 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 1.62 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 1.71 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 1.64 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 2.5 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 2.97 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 1.89 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 1.98 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.21 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 5.41 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 5.26 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.97 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 3.64 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 8.36 110.057 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.533 0.432 0 N-CA-C 112.961 0.331 . . . . 3.34 112.961 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 2.59 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.64 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 2.19 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.24 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 1.45 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 1.53 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 2.79 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.84 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.11 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 7.54 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 3.19 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.35 107.12 163.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.78 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 7.3 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 151' ' ' THR . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.84 111.9 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 3.02 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 3.4 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.57 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.34 109.845 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.74 110.293 165.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 2.5 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 2.57 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 2.89 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 3.7 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 2.77 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 1.85 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 7.44 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 3.65 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 4.99 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.411 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.04 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 7.36 114.28 -142.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.13 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 3.35 110.241 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 2.39 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 173' ' ' CYS . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.42 111.795 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.601 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.15 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 2.75 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 3.44 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 3.31 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 2.05 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 2.93 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 1.51 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 2.72 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.56 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.51 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 2.33 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.28 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 2.97 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 2.6 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.32 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 3.09 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 3.1 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 2.98 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.45 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 3.23 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 1.34 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.17 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 2.56 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 2.65 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 1.2 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.03 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 2.17 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.66 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 8.0 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 3.07 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 3.56 113.687 -171.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.74 112.503 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 1.94 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 2.24 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 1.32 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.415 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 4.59 113.349 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 3.42 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 1.26 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 3.34 114.69 -175.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 2.61 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 2.25 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 1.79 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 2.78 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 2.03 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 2.55 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 2.31 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 3.96 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.91 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 2.73 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 6.58 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.38 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 2.4 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.28 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.07 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 2.83 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.19 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 5.71 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.55 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 3.8 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 6.3 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 3.48 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 5.7 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 3.72 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 3.73 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 2.92 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 109.533 -0.543 . . . . 3.81 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 3.13 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.49 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 4.51 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 279' ' ' GLN . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 5.26 113.144 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 2.29 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 3.57 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 3.25 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 2.85 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 2.63 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.62 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.83 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.12 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.55 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.63 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 3.48 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 2.69 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.8 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 3.44 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.433 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 2.64 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 3.99 110.466 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 8.1 113.002 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.17 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 5.97 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 2.27 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.66 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.34 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 1.51 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 1.37 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 1.56 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 1.96 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 2.29 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 1.84 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 2.18 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 2.68 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 3.71 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 6.2 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.64 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 3.38 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 8.58 113.835 -155.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.754 0 CA-C-O 121.368 0.486 . . . . 3.78 112.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 3.31 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 2.75 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 2.67 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 1.75 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.33 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.31 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 2.33 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.497 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.93 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.12 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.02 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 3.62 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 2.54 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.84 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 6.31 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.31 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 2.86 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 3.87 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.12 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.55 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.68 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 1.99 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 3.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 1.84 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.09 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 2.52 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.94 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 4.6 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.52 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 5.51 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 2.98 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.08 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 3.61 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.469 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 1.81 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 2.84 111.577 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 2.81 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.1 112.366 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.28 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 1.64 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 1.85 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 1.63 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 2.94 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.11 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 2.3 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.12 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 3.24 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 3.51 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 3.36 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 4.25 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 3.5 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.76 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.61 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 4.15 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 1.14 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.87 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 2.79 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 2.61 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 1.4 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.26 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 2.2 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.19 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.18 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 207' ' ' ARG . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.12 113.112 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 7.94 112.377 -178.102 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 2.94 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.497 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 3.75 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.09 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 1.39 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 1.81 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.0 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 3.81 112.377 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 3.14 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 1.08 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 3.56 114.843 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 2.76 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 1.65 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.36 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 4.38 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 2.39 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 1.84 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 1.94 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 2.6 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 2.73 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 11.09 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 3.9 110.667 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.03 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 2.8 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.26 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.539 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.21 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 2.9 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.78 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.539 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.13 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.22 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.77 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 5.32 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 3.72 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 6.64 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.79 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 4.66 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.04 113.512 -177.83 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 5.93 107.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 3.46 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.02 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.469 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.09 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 5.59 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 5.44 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 3.28 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 2.67 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 3.02 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 2.37 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.12 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.73 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.49 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.07 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 4.02 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 2.62 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.76 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 6.72 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 2.5 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.29 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 4.83 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 6.59 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.08 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 5.9 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 1.88 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.52 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.83 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 1.2 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 1.18 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 1.38 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 1.8 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 2.81 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 1.5 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 1.69 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.36 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 4.74 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 4.8 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.56 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 3.29 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.21 113.13 -166.801 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 121.277 0.449 . . . . 2.56 111.829 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 2.79 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 2.85 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 2.79 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 1.6 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 1.43 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 1.78 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.28 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.78 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 8.53 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 3.18 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 1.85 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 6.56 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.97 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 2.12 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.04 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.53 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.14 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.31 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 3.27 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 3.93 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 1.78 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 3.49 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 2.52 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.56 112.344 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 5.33 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.64 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 5.74 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.438 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.92 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 8.95 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.438 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.35 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 2.98 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 1.87 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.45 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.37 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.82 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 2.81 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.14 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.01 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 3.34 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 1.41 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 1.99 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 1.59 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 2.01 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.99 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.14 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 1.98 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.95 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 2.34 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 2.39 112.788 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 3.04 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 3.42 112.527 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 3.79 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.84 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 2.68 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 1.38 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 0.92 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 2.43 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 2.89 108.508 -163.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 1.49 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.33 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 1.89 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.36 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.51 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 6.93 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.89 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 3.53 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 3.54 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.64 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 1.77 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 2.08 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 1.62 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 4.58 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 3.25 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 2.12 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 4.95 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.07 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 2.83 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 2.09 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.61 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 2.81 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 2.08 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 1.36 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.06 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 2.61 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 2.67 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.86 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 231' ' ' ARG . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 3.97 107.392 169.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 230' ' ' THR . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.23 114.597 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.84 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.42 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 2.3 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.85 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.53 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 3.33 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 2.5 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 4.75 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 2.29 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.09 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.04 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 2.42 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.37 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 3.01 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.17 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.32 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.43 111.1 -179.509 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.825 -0.435 . . . . 3.67 109.825 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 2.88 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.447 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 1.95 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 3.16 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 4.79 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 2.59 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 3.02 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 2.92 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 2.12 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 3.42 109.04 -177.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 3.44 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.55 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.79 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.06 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 267' ' ' ILE . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 5.42 111.836 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 4.3 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 3.13 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 3.25 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.3 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 3.74 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 6.37 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 4.42 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 5.44 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.06 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 1.87 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.56 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 1.49 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 1.24 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 1.48 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.01 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 3.54 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.06 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 2.32 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 2.54 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 3.74 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 5.86 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.18 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 3.26 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.47 110.791 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.458 -0.582 0 CA-C-O 121.172 0.405 . . . . 3.67 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 2.69 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.08 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 2.42 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.25 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 1.32 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 1.68 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.12 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.14 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.51 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 6.28 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 2.89 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.16 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.13 113.215 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 5.98 114.012 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.11 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 2.79 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 2.89 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.47 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.417 HE22 ' CD2' ' A' ' 160' ' ' LEU . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.55 111.535 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 1.87 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.417 ' CD2' HE22 ' A' ' 158' ' ' GLN . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 2.74 112.567 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 2.79 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 2.32 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.38 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.06 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 4.78 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.436 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 3.29 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 5.15 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 2.9 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.13 114.109 -137.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.35 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 3.08 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.06 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.5 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.9 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.03 113.222 173.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 2.97 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.12 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 3.51 111.611 171.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 3.23 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 1.65 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.12 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 1.56 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 1.98 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.6 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.31 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 2.29 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.59 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 2.95 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 2.25 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 3.91 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 2.95 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 3.22 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.95 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.49 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 2.32 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.01 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 0.9 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 2.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 2.54 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 1.51 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 1.86 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 2.34 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.35 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.69 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.436 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 9.39 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.49 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 3.32 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 4.82 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 1.72 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.02 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.18 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 3.19 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 3.37 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 1.49 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 3.51 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.11 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 2.77 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 1.85 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 1.79 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 3.91 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 2.12 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 1.59 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.81 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.0 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 2.82 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.05 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 2.89 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 8.18 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.44 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.19 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.12 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.84 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 3.35 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 2.92 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 2.99 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.21 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 2.47 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.03 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 8.22 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 2.7 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 6.2 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 3.5 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 3.73 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.08 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.38 114.156 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 122.039 0.923 . . . . 3.99 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.05 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.47 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.26 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.12 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 4.73 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 2.84 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.01 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 2.8 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 1.98 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 2.93 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.37 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.06 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.27 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 4.75 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 3.14 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 2.94 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 2.84 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 3.09 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 2.78 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.22 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.04 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 5.72 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.08 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 5.66 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 1.93 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.49 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 1.48 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 1.26 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.28 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 2.25 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 2.56 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 1.55 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 1.68 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.12 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 4.9 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 6.01 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.26 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 3.6 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 8.88 111.173 175.349 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 CA-C-O 120.817 0.257 . . . . 3.36 111.761 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 2.79 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 3.05 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 2.27 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 1.69 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 1.42 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.38 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 2.6 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.03 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.86 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 6.35 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.21 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 2.31 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.4 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.14 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.09 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 2.38 113.788 -177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 5.1 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.82 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.58 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.41 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 2.44 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.08 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 2.28 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 3.7 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 2.2 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 4.6 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.06 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 8.36 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.43 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 4.76 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.34 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 3.37 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.427 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.88 115.104 164.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.35 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.55 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.44 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 2.79 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.31 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 5.2 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 4.98 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 3.75 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.07 111.678 -178.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 1.56 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 2.38 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.76 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.24 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 1.88 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.63 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 2.5 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 3.62 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 3.0 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.27 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 3.95 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.28 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 197' ' ' THR . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 2.43 108.877 135.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 196' ' ' LEU . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 1.75 109.428 -177.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 2.23 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 2.43 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 1.44 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.68 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 1.97 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.17 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.18 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.39 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 7.34 110.951 -175.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.84 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 3.2 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 3.41 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.74 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 2.18 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 2.15 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 1.48 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 3.31 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 3.34 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 1.44 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 3.39 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.7 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 3.16 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 1.94 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.05 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 3.25 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 2.29 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 1.48 109.232 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.13 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 2.13 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 2.32 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 2.84 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 6.12 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.59 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.47 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 2.15 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 2.64 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 3.7 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 2.98 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 3.98 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 2.57 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.04 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 6.06 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 2.65 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 5.86 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.07 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 2.74 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.49 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.26 113.763 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 112.917 0.71 . . . . 4.4 112.917 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 3.47 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.63 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.427 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 20.0 p80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.38 114.058 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.18 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.0 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 2.42 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 4.22 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 2.62 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 267' ' ' ILE . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.15 110.972 177.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 266' ' ' LEU . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 2.12 107.884 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.46 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.49 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.95 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.2 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 3.77 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 3.02 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.74 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 4.18 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 2.68 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 2.83 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 5.11 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 6.36 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 7.65 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 4.85 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.1 113.161 -171.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 1.86 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.67 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 1.79 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 1.5 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 1.85 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 2.24 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 2.77 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 2.2 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 2.3 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 1.92 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 5.76 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 6.67 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.41 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 3.54 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 8.37 112.464 -165.392 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.412 -0.649 . . . . 3.45 110.412 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 2.63 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.15 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 2.47 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 1.75 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 1.3 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.45 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 2.81 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.33 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 6.05 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 2.8 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.06 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 6.98 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.08 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 3.3 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 3.5 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.56 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.07 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 1.92 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 2.49 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 3.62 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 1.54 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 3.91 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 2.79 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.33 115.567 -173.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.428 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 4.65 110.164 162.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.25 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 7.47 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.72 111.846 -167.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.18 114.275 -154.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.57 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 3.6 113.034 -174.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.533 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.25 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.76 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.43 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.06 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 2.64 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.09 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 6.96 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 3.19 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 1.42 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.25 111.434 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 1.54 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 2.4 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.32 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.05 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 2.5 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.67 110.887 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 2.57 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 2.68 111.501 171.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 2.91 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 2.64 110.398 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 2.67 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.16 113.308 -167.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.3 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 3.04 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 1.07 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.85 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 2.62 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 2.54 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 1.51 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 1.89 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 2.1 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.44 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.72 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.03 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 6.81 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.32 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 2.99 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 3.75 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.76 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 1.66 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 1.57 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 1.22 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 4.27 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.16 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.23 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 3.5 115.658 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.94 110.064 170.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 2.86 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 1.57 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.01 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 2.95 112.889 173.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 2.0 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 1.82 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 1.84 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 2.5 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.43 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 4.05 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 5.46 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.51 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.82 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 2.49 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.06 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.06 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 3.62 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.19 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 4.61 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 2.88 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 3.55 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 5.26 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.11 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 5.98 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 3.43 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.51 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.38 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.18 115.279 -175.825 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.238 -0.652 . . . . 4.3 109.238 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 4.44 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.68 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.533 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.5 p80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.17 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 4.35 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 3.13 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 3.91 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 3.09 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 2.98 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 2.36 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 2.38 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.69 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.1 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.47 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 4.31 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 2.84 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.51 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 3.97 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 3.44 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.15 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.02 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 9.07 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 5.43 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 5.7 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 2.73 112.733 -173.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.44 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.31 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 2.36 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.23 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 2.77 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 3.57 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 3.34 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.07 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 2.95 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 2.72 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 4.26 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 6.37 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.01 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 3.81 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 7.91 113.41 -166.924 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.458 -0.564 0 CA-C-O 119.887 -0.13 . . . . 3.73 111.935 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 236' ' ' GLN . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 3.17 108.205 168.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 2.52 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 2.76 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.05 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 1.67 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 1.83 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 2.81 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.83 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 5.53 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 8.19 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 4.93 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.68 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 7.91 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.452 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 2.67 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 4.64 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 2.86 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.62 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 2.71 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 3.37 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 3.19 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 2.18 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 5.86 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 2.12 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.05 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 5.67 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.68 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 5.28 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 2.96 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 5.58 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.533 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 3.04 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 1.85 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.37 112.396 -168.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.66 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 2.78 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.67 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 3.87 110.656 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 184' ' ' VAL . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 3.94 113.453 174.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 2.0 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 1.95 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 1.46 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 180' ' ' MET . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 2.59 110.746 -178.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.44 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.36 112.035 168.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 2.48 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.39 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.68 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.07 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 4.76 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 4.83 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 4.45 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.44 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.28 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 3.86 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 1.89 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.76 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 3.34 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 3.08 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 1.9 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 1.83 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 1.94 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.53 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.47 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.97 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 7.07 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.14 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 3.89 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 7.71 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 2.37 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 2.95 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 1.83 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 3.71 111.705 170.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 4.39 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 1.94 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 3.22 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.22 111.334 173.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 2.65 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 2.72 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.66 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 3.12 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 2.49 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 2.15 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 2.39 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 2.75 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.42 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.41 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.09 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.68 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.07 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.05 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7 111.86 167.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' PHE . 25.5 tp60 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.99 111.412 172.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 3.15 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 2.38 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.09 113.22 170.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 2.19 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 2.9 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.14 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 3.35 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 6.35 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 3.91 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 3.19 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 3.76 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.516 -0.754 . . . . 5.4 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 3.71 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.8 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.628 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 29.2 p80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.13 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 3.3 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 3.83 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 2.48 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 3.55 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 3.73 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 3.22 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 3.74 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.69 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.61 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.77 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.35 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.41 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 4.11 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 4.41 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 3.18 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.14 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 2.83 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.4 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 4.47 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 4.87 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 5.62 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 5.95 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 1.67 113.636 -168.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.53 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.64 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 1.36 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 1.41 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 1.62 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 2.16 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 2.43 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 1.81 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 1.92 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 2.77 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.17 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 5.63 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.37 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 4.05 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.33 110.666 172.466 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 N-CA-C 110.827 -0.489 . . . . 4.05 110.827 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 3.71 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.02 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 2.61 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 2.98 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 1.75 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 1.8 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 2.82 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.89 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.05 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 3.33 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 2.99 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.76 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.08 114.548 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.55 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 3.33 112.553 154.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 3.72 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 1.96 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 2.82 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.13 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 2.31 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 3.79 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 1.97 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.11 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 2.92 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.17 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 5.0 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 2.78 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 5.37 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 3.81 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 5.79 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.42 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 2.57 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.414 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.28 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 2.88 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.44 111.724 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.38 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 3.7 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.27 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 3.93 112.248 175.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.21 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 1.96 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 2.6 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 1.94 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 2.53 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.94 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 1.84 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.34 110.288 167.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 2.72 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 2.76 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 2.81 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 2.66 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 3.01 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.87 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.81 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 1.21 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.85 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 2.7 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 3.02 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 1.94 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.06 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.16 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.73 110.105 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.85 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.15 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 8.59 115.411 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 3.18 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 4.48 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.27 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 1.89 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 1.87 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 1.63 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 2.91 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 2.99 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 1.43 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 3.4 114.851 -177.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.87 112.012 167.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 3.02 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.13 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 2.77 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 2.59 112.621 168.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 1.98 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 1.45 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 2.18 111.43 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 2.48 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.79 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.1 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.66 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.45 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 1.98 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.33 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 2.7 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 2.58 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.28 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.14 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.19 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 3.47 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 5.54 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 2.67 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 6.55 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 3.13 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 3.8 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.47 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.89 110.942 164.555 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 110.306 -0.257 . . . . 4.37 110.306 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 2.91 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.08 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.19 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.37 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 3.65 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 1.98 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 4.47 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 3.02 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 1.94 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 2.1 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.81 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.47 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.53 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 2.76 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.34 114.155 -174.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 4.13 113.253 -177.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 3.43 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.81 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 3.21 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 3.28 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 2.4 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 4.4 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 5.43 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 4.45 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 8.11 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 2.37 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.24 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 1.95 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 1.41 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 1.95 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 2.96 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 2.4 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 1.91 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 2.55 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 3.29 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.14 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 5.35 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.19 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 4.94 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 8.99 111.386 179.406 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 111.023 -0.414 . . . . 3.33 111.023 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 3.4 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 2.54 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 2.68 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 2.96 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 1.61 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 1.49 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 2.94 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.45 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.39 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 4.5 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.596 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 3.41 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 2.94 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.89 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 9.92 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.13 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 3.7 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 4.12 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 1.8 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 2.84 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.26 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 2.4 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 2.92 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 1.87 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.13 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 2.22 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 4.39 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.04 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 6.42 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 2.91 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 5.08 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.23 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 5.43 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.24 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.51 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.67 111.449 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 3.52 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.48 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.03 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 4.65 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 1.42 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.425 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.03 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 3.2 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 2.28 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.3 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.14 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 2.48 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.51 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.07 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 2.4 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.08 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 3.78 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 2.76 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 2.85 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.32 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 2.57 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 1.48 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.15 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 2.24 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 2.51 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 1.53 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 1.85 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.17 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.82 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.38 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 6.22 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.41 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.19 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 3.57 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.97 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 1.84 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 2.35 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 1.35 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 4.21 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 4.17 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 1.26 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.01 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 3.42 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 2.61 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.01 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.63 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 3.16 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 2.09 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 1.35 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 2.12 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.04 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.74 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.37 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 7.63 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.66 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.02 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 2.46 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.64 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.92 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 3.05 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.48 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.3 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 2.52 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 8.59 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 2.46 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 5.53 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 4.64 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.1 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 4.85 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.28 111.194 176.565 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.894 0.854 . . . . 7.2 112.303 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 5.19 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.36 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 5.12 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.12 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 4.7 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 3.19 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 3.61 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 3.76 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 2.14 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 2.68 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 1.72 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.49 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.01 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 2.54 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.08 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 4.77 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 2.95 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 3.33 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.25 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 4.09 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.4 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.16 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 6.29 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 6.14 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 7.84 110.524 156.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 2.71 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.07 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.81 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 3.42 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 1.87 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 2.29 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.03 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 3.06 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 1.64 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 2.42 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.39 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.21 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 5.74 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.76 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 3.73 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 . . . . . 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 9.76 112.237 -166.382 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 110.032 -0.795 . . . . 3.08 110.032 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 3.17 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 2.97 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 2.38 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 1.72 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 1.88 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 1.83 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 2.46 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.85 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 4.86 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 3.22 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 2.5 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.99 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 5.6 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 2.52 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 3.29 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 1.84 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 2.71 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.62 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 2.85 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 3.28 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 2.58 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.82 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 2.26 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.08 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.597 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 4.41 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.26 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 5.25 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 2.8 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 6.04 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.3 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.15 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.71 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.24 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.99 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 2.55 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.91 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 3.35 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 4.21 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 1.53 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.453 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.02 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 1.55 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 2.46 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.15 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.64 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 2.03 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.45 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 2.66 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 2.9 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.03 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 2.82 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.32 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 3.84 110.801 153.131 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 1.28 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.0 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 2.45 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 2.41 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 1.34 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.61 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.08 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.84 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.69 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 7.37 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 3.14 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 4.46 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 3.15 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 2.51 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.15 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 1.49 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 3.38 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 3.5 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' A' ' 226' ' ' GLY . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 1.58 112.592 176.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 3.72 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.65 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 2.89 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.61 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.27 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 2.37 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 2.05 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 2.91 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.85 112.603 -173.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 1.99 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.2 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.43 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 4.58 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 5.33 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.93 113.384 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.68 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 2.3 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.39 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 3.15 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.15 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 3.9 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 2.31 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.31 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 7.28 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 4.15 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 5.57 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 2.97 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 2.98 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.53 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.63 111.767 173.04 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.557 0.947 . . . . 5.03 113.557 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.09 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.84 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 166' ' ' PHE . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 1.8 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 3.65 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.08 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 5.07 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.84 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 4.62 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 3.07 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 2.39 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.66 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.92 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.43 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.62 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.68 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 3.53 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 3.25 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.39 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 3.74 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 2.82 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.16 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 4.69 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 4.89 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 4.64 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 6.98 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 1.94 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.53 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.77 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 1.67 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 1.39 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 1.7 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 2.29 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 2.7 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 1.56 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 1.68 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 2.6 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 4.94 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.04 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.07 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 4.45 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 8.47 111.904 178.695 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.452 -0.939 0 N-CA-C 109.722 -0.915 . . . . 3.07 109.722 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 2.49 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 2.9 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 1.92 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 1.69 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 1.64 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.33 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 2.21 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.3 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.58 109.793 -168.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 4.89 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.11 113.22 -176.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.02 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.99 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 5.7 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.57 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 2.46 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.435 HD11 ' H ' ' A' ' 270' ' ' ASP . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 2.91 111.925 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.65 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 1.8 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 2.15 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 3.32 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 1.52 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 3.63 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 2.49 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 4.28 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 3.89 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 4.99 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.13 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 4.98 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.32 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 2.76 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.541 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.71 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.01 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 2.38 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.442 ' N ' ' HZ3' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 4.33 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 3.41 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 1.72 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.11 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 1.88 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 2.6 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 2.09 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.44 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.26 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.55 111.455 169.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 3.09 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 2.85 109.823 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 2.51 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 294' ' ' MET . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.36 110.811 170.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.23 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 2.58 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 1.09 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.95 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 2.55 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 2.86 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 1.35 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.45 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.3 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.74 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.19 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.95 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 15.38 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.94 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.15 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 6.25 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.55 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 2.09 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 3.1 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 1.74 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 4.49 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.17 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 1.54 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 3.99 114.913 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.38 113.25 175.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 2.94 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 2.87 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.25 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 2.8 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 2.64 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 2.68 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.95 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 2.29 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 2.31 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.26 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.69 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 6.98 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.09 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.68 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 1.71 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.93 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.66 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 2.69 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 2.67 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 3.78 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.0 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 3.22 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 5.78 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 3.27 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 8.72 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 3.74 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.41 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 2.98 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.08 112.888 173.018 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.559 0.207 . . . . 4.12 111.559 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 3.33 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.541 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 25.7 p80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.73 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.02 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 3.84 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 2.52 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 2.6 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 3.75 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 2.31 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 1.91 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.5 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.12 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 156' ' ' LEU . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.92 110.364 -153.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.42 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.82 113.324 -177.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 5.2 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 4.06 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 3.24 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 2.68 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.61 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.464 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.15 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 7.83 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.45 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 5.1 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 2.64 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.72 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 1.68 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.1 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 1.39 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 1.9 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 2.42 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.4 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 1.88 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.33 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 194' ' ' PRO . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 5.03 114.247 172.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 4.57 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.06 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 3.09 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 8.27 112.81 -172.143 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 121.506 0.544 . . . . 3.49 112.628 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 142' ' ' LEU . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 2.78 112.698 -176.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.22 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.446 HD23 ' CD1' ' A' ' 140' ' ' PHE . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 3.55 111.662 -172.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 1.86 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 1.71 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.07 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 2.36 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.2 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.64 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.22 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 3.27 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.04 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.76 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 6.5 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.84 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 2.42 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 3.32 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 269' ' ' PRO . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.01 113.666 -172.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.18 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 1.74 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 4.04 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 2.58 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 3.35 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 3.93 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 1.89 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.68 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 5.52 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.11 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 8.78 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 2.7 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 5.33 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 3.12 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 1.98 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.3 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.31 112.541 178.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.57 113.121 143.795 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 2.83 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.401 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.72 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 3.54 113.934 -176.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.461 ' O ' HG22 ' A' ' 183' ' ' VAL . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 4.63 112.142 168.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 181' ' ' ILE . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 1.88 109.893 -174.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.401 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.25 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 180' ' ' MET . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 2.5 113.518 173.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 2.0 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.36 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.55 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 2.13 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.95 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 2.47 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 2.62 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.09 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.03 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 3.48 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 3.88 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.15 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 2.82 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 1.49 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.99 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 3.26 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 2.37 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 2.28 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 2.17 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.59 111.067 -172.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.18 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.41 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 6.98 114.074 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 2.85 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 3.97 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.87 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 1.68 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 1.74 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 1.89 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.46 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 3.22 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 1.45 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 5.14 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.63 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 2.8 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 1.82 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 2.68 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 2.43 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.1 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 1.68 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 2.7 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 2.74 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.95 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.2 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.01 110.573 172.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.53 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.28 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 2.2 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.78 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 3.33 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 3.61 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.25 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 5.36 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.41 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 3.78 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 6.46 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 3.02 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 5.48 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 3.21 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 2.93 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.08 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 2.7 112.225 171.818 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 117.37 -1.3 . . . . 4.62 112.165 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 3.44 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 3.29 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 3.39 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 3.53 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 3.8 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 3.6 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 2.93 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 2.27 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.51 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.411 ' HA ' ' H ' ' A' ' 157' ' ' GLY . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.07 112.391 169.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.43 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.01 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.08 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 4.09 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 3.46 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 3.95 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 2.68 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.45 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 176' ' ' GLU . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 5.74 116.654 -169.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 6.72 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 4.73 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 5.82 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 2.42 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.63 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.81 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 1.98 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 1.53 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 1.53 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 2.29 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 3.21 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.33 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 1.98 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.26 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.02 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.25 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.13 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 4.09 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 9.9 109.923 -177.849 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 109.602 -0.961 . . . . 3.17 109.602 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 2.69 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 2.96 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 2.63 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 2.38 108.346 172.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 150' ' ' LYS . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 1.54 108.801 163.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 2.16 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 2.66 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.32 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.12 115.158 -162.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 5.3 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 4.06 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.03 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.24 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 7.23 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 2.66 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 4.24 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.72 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.78 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.57 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 2.37 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 2.86 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 2.81 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 3.65 111.697 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 2.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.31 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 7.41 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 4.16 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 6.34 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 2.93 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 6.29 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.486 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.8 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 2.54 112.43 169.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.74 114.286 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.6 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 2.83 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.34 112.873 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 2.9 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 6.78 111.794 166.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 3.8 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 2.75 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 182' ' ' GLN . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 1.93 113.213 -175.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 1.42 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 2.27 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.51 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.33 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 1.61 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.68 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.02 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 3.45 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.12 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.14 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 3.26 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.3 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 3.49 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 1.61 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.2 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 2.08 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 2.44 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 1.82 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 2.54 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 3.11 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.24 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.42 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.38 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 8.87 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.07 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.09 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 3.34 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.99 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 2.14 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 2.12 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 1.58 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 4.18 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.04 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 224' ' ' LEU . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 2.24 113.678 -173.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 2.93 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.15 108.938 172.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 2.85 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 1.81 111.658 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.06 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 3.08 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 217' ' ' VAL . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 2.23 108.84 174.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 2.11 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.18 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 2.36 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 2.54 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.39 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 4.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.05 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.34 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.88 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 2.86 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.64 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.97 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 2.66 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 2.68 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.42 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 2.65 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 3.61 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 7.68 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 2.65 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 5.77 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 3.79 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 2.94 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.4 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.6 116.031 178.633 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 112.547 0.573 . . . . 5.38 112.547 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 2.59 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.65 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.59 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.03 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 3.38 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.08 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 3.8 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 3.89 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.08 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 2.42 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.48 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.18 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.68 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.19 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.02 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 3.64 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 2.93 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.53 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 4.93 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 2.92 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.03 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.01 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 5.55 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 5.38 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 5.97 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 1.61 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.64 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.78 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 1.54 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.09 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 1.37 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 1.75 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 2.05 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 1.48 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 1.61 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 2.34 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 4.18 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.09 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 3.4 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 10.57 116.249 -163.345 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 CA-C-O 121.214 0.423 . . . . 2.4 111.282 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 3.0 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 2.7 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 2.86 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 2.12 111.912 -169.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.06 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 2.32 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 3.62 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 2.66 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.97 113.825 -171.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 7.02 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 3.75 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.22 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 7.6 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.17 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 2.14 114.602 -176.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 3.69 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.09 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.99 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.3 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 2.66 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 3.01 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 1.59 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.13 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CZ ' HG22 ' A' ' 243' ' ' VAL . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 1.81 112.575 -178.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.07 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.463 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 4.12 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.18 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 4.79 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.26 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 4.58 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' A' ' 260' ' ' HIS . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 3.42 113.213 173.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.505 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.32 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.65 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 2.64 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.09 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 2.58 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.9 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 3.79 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.01 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 1.73 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.02 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 1.56 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 187' ' ' ILE . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 2.73 113.081 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.23 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 184' ' ' VAL . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 2.42 112.191 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.72 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.19 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 2.21 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.11 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.4 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.06 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.54 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.41 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 2.75 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 1.3 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 0.95 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 2.23 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 2.27 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 1.36 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 1.9 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 2.28 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.37 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.61 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.91 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 6.61 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.26 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 2.98 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 3.7 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 1.46 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 1.76 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.13 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 3.61 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 2.8 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 1.48 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.2 114.859 -177.377 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 3.06 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 1.69 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.56 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 2.82 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 2.31 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 1.45 109.888 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.442 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.96 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 2.65 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.01 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.63 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.04 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 6.46 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.76 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 2.2 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.69 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.2 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 3.27 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 2.23 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 4.48 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.14 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 2.52 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 6.33 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 164' ' ' PHE . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 3.33 109.365 169.006 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 5.29 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 3.29 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 2.88 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.74 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.45 110.808 163.84 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.841 0.311 . . . . 4.02 111.841 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 2.81 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.09 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' HG23 ' A' ' 172' ' ' VAL . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.04 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 3.19 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 3.36 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 2.36 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 3.33 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 6.4 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 2.61 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 3.12 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.64 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.45 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.38 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.01 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.03 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 3.42 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 2.98 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.84 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 6.1 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 4.02 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 1.9 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 4.48 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 8.74 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 6.61 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 4.83 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.12 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.59 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.33 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 1.73 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 1.37 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 1.71 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 2.5 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 2.51 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 1.91 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.17 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.32 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 5.52 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 4.85 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.16 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 3.44 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.2 115.006 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.338 -0.839 . . . . 16.85 109.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -69.18 169.09 12.71 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.959 0.799 . . . . 17.05 111.363 168.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -167.49 -144.04 0.05 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.096 1.758 . . . . 14.25 109.733 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 58.38 6.99 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.347 1.451 . . . . 12.59 111.98 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 44.67 0.2 Allowed Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 116.448 2.018 . . . . 14.28 116.448 -163.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.25 164.78 34.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.703 2.268 . . . . 9.36 111.074 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.5 mt -128.61 143.67 51.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.188 1.395 . . . . 7.36 108.502 167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.97 1.89 3.61 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.501 0.926 . . . . 9.32 113.501 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.64 -144.66 17.21 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.854 -1.298 . . . . 3.65 109.854 -159.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.16 89.09 1.0 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.225 -1.55 . . . . 4.04 109.225 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.65 102.08 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 3.49 109.803 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -85.58 150.96 24.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.934 0.397 . . . . 4.2 109.961 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -137.5 123.38 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.128 -1.064 . . . . 3.93 108.128 162.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.53 159.19 42.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.714 0.769 . . . . 2.69 111.294 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.6 m -100.55 134.93 42.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.401 1.88 . . . . 2.46 110.023 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.4 p -81.54 159.14 24.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.468 1.907 . . . . 1.49 112.635 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -58.13 -25.83 61.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.843 1.257 . . . . 1.63 113.027 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -75.43 -23.57 56.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.566 1.946 . . . . 2.14 112.189 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.54 51.67 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.181 1.372 . . . . 2.43 114.172 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.87 41.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.01 1.324 . . . . 5.5 109.61 164.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -127.54 138.81 53.0 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.548 1.539 . . . . 6.08 107.158 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.21 174.32 13.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.279 1.214 . . . . 3.0 114.279 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -121.69 175.87 6.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.813 2.045 . . . . 3.03 109.752 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.18 -41.02 96.07 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.036 0.754 . . . . 5.26 113.036 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -2.74 14.83 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.478 1.288 . . . . 6.54 114.478 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -105.12 -14.78 15.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.569 1.948 . . . . 3.95 112.62 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -90.85 -30.74 16.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.417 1.887 . . . . 2.82 114.133 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.07 153.12 38.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.057 1.132 . . . . 4.75 114.057 -168.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.47 -27.32 2.99 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.889 1.709 . . . . 2.44 112.403 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.71 158.22 43.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.893 2.477 . . . . 3.14 108.485 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -60.55 145.77 47.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.184 0.902 . . . . 2.36 112.632 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.68 158.79 24.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.402 0.681 . . . . 3.21 111.948 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 30.7 mt -139.33 122.15 16.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.667 1.187 . . . . 2.37 109.269 168.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.72 134.3 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.823 1.249 . . . . 1.63 109.881 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -144.49 142.85 30.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.71 1.604 . . . . 3.84 112.284 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -98.99 107.21 19.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.207 1.003 . . . . 2.15 112.048 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.57 -11.94 11.08 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 117.226 1.651 . . . . 3.77 117.226 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.4 t80 65.59 166.14 0.18 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.454 1.901 . . . . 3.93 110.29 -165.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -37.01 -61.68 0.54 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.061 1.745 . . . . 5.14 113.741 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -150.99 -1.42 0.36 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.398 1.879 . . . . 8.4 114.99 -166.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 p -78.12 134.39 63.61 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 121.551 1.978 . . . . 3.06 110.267 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -114.34 0.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 O-C-N 123.165 1.087 . . . . 4.24 113.986 -106.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.81 -57.09 1.91 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.768 1.227 . . . . 3.65 112.738 -156.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.21 -28.23 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.108 0.867 . . . . 2.56 110.737 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.59 -52.84 70.37 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 116.294 -1.812 . . . . 1.83 114.992 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.97 -28.52 49.89 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 CA-C-N 122.916 2.077 . . . . 1.61 113.006 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -66.74 -37.39 84.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.141 1.337 . . . . 3.37 112.01 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 281' ' ' LYS . 7.1 mm-40 -73.84 -44.42 55.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.714 1.605 . . . . 3.28 113.326 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -77.73 -19.63 54.88 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.565 -1.207 . . . . 2.56 112.75 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.08 -52.08 65.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.005 1.73 . . . . 3.38 110.038 161.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -56.06 -46.5 78.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 3.62 111.202 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 mtt -64.56 -50.14 68.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.797 0.726 . . . . 3.37 112.888 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.84 -44.66 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.848 1.204 . . . . 1.46 108.985 -164.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.487 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 61.0 mt-30 -66.31 -24.63 66.57 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.203 0.456 . . . . 1.98 111.905 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.01 -45.16 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.138 -0.976 . . . . 1.6 111.645 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.7 m -76.23 -18.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.415 1.007 . . . . 2.24 112.478 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.37 -55.32 18.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.807 2.043 . . . . 3.98 111.235 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -56.06 -39.3 71.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 2.75 112.32 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.24 -29.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.234 0.827 . . . . 2.11 113.234 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.22 -44.54 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.376 1.07 . . . . 3.52 109.581 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.6 t -72.14 -29.09 63.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.74 1.216 . . . . 2.22 113.819 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.82 57.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 4.05 108.172 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 6.12 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.386 2.675 . . . . 3.3 115.945 -169.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.8 m -67.35 -21.49 65.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.251 1.42 . . . . 3.22 110.681 159.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.27 143.61 26.42 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.835 1.254 . . . . 3.25 109.958 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.35 160.31 32.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.052 3.168 . . . . 2.94 111.047 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.81 147.39 11.96 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.943 1.831 . . . . 4.48 115.943 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -115.9 115.31 25.98 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.268 -1.333 . . . . 2.5 109.985 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -95.71 106.08 25.01 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.952 1.701 . . . . 1.53 109.268 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.98 156.62 30.58 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.424 2.082 . . . . 0.88 111.525 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.16 135.85 24.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 123.246 1.498 . . . . 2.84 112.545 175.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -104.02 120.03 40.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.966 1.706 . . . . 2.3 109.651 -168.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mm -100.67 122.2 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.335 0.588 . . . . 1.63 111.938 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.0 t -80.71 152.66 28.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.911 0.863 . . . . 2.36 110.605 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -126.35 22.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.11 1.764 . . . . 2.2 110.886 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -164.25 89.73 1.09 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.771 0.828 . . . . 4.3 111.563 -149.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -95.46 -16.07 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.124 2.549 . . . . 2.27 114.176 -169.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.82 5.7 1.43 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.661 1.726 . . . . 5.86 115.661 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 255' ' ' ASP . 0.0 OUTLIER -156.05 20.4 0.37 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.962 2.578 . . . . 6.18 117.962 -162.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.0 179.6 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 121.472 1.942 . . . . 4.21 116.034 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.0 m -141.05 146.67 37.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.249 1.42 . . . . 2.81 110.351 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -50.36 -42.66 53.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.092 1.145 . . . . 4.95 114.092 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 211' ' ' GLU . 3.4 mp0 -68.74 -33.11 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.612 1.165 . . . . 3.73 112.683 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.49 57.15 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.328 -0.857 . . . . 1.46 111.833 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.11 -47.21 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.79 -1.194 . . . . 1.89 110.213 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.1 69.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.914 1.286 . . . . 1.06 112.933 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -59.24 -55.95 28.32 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.808 0.731 . . . . 3.18 111.93 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -54.83 -40.04 69.16 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.608 -0.683 . . . . 4.25 111.795 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.52 -54.04 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.744 0.818 . . . . 1.31 111.497 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.265 0.1 OUTLIER -70.05 -21.45 63.16 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.359 1.244 . . . . 3.56 114.359 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -28.02 66.28 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.147 0.885 . . . . 3.32 112.429 171.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -92.17 -54.2 3.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.68 0.622 . . . . 2.7 112.68 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.4 p -179.63 152.91 0.66 Allowed Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.69 1.196 . . . . 2.18 111.369 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 -16.53 46.81 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.315 2.01 . . . . 1.8 113.802 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.53 0.02 57.39 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.164 1.172 . . . . 2.34 114.164 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.05 138.93 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.362 -1.347 . . . . 2.37 107.362 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.6 129.85 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 119.245 0.929 . . . . 1.35 110.581 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.9 126.71 8.94 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.05 0.841 . . . . 0.99 111.364 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.21 141.74 50.57 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.689 0.796 . . . . 2.51 112.419 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -149.99 -167.89 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.17 2.988 . . . . 2.53 107.924 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.71 -139.66 2.86 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 119.947 -1.721 . . . . 1.94 112.94 160.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -89.56 171.67 9.52 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.197 0.999 . . . . 3.21 108.465 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -58.73 -26.89 64.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.601 1.56 . . . . 6.69 112.778 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.43 -28.46 61.99 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.946 2.098 . . . . 4.11 112.731 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.66 -42.82 40.44 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.648 -1.283 . . . . 3.53 110.232 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.3 t -55.36 -28.31 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 N-CA-C 113.21 0.818 . . . . 1.88 113.21 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.86 -37.97 33.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.117 1.767 . . . . 3.54 111.988 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -55.56 -35.1 65.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.464 -1.398 . . . . 2.23 112.937 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 52.7 t -51.95 -50.46 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.65 1.18 . . . . 4.14 113.031 166.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.17 71.7 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.884 1.273 . . . . 3.17 111.65 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -68.38 -35.02 77.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.339 1.456 . . . . 4.19 112.701 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.33 -98.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.72 1.208 . . . . 2.01 111.419 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.29 31.93 0.34 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.451 -1.406 . . . . 3.24 114.35 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? 68.12 -57.86 0.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.917 2.887 . . . . 6.85 112.637 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 63.96 158.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 128.412 2.685 . . . . 3.78 113.511 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -164.22 32.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.093 1.757 . . . . 9.01 112.973 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -62.42 162.91 9.39 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.728 1.01 . . . . 3.18 113.728 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 36.8 m -104.77 98.83 16.11 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.891 1.277 . . . . 3.6 112.019 -163.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.02 101.16 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.711 2.274 . . . . 3.12 111.68 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.84 83.89 0.34 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.916 1.722 . . . . 3.3 113.493 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 165.77 31.78 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.874 2.382 . . . . 5.03 111.309 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.49 -63.54 1.23 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.086 -0.959 . . . . 9.0 113.343 170.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.5 t0 58.75 42.46 20.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.172 1.389 . . . . 7.95 111.343 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -150.71 -50.5 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.604 1.162 . . . . 9.15 111.336 -162.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -131.96 37.68 3.58 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.626 1.97 . . . . 8.85 109.202 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 63.91 -74.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.818 2.847 . . . . 8.71 113.309 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.425 ' CG ' HH21 ' A' ' 207' ' ' ARG . 39.7 t0 -66.75 136.73 55.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.999 1.851 . . . . 6.22 115.999 -152.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -92.79 89.98 6.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.616 1.198 . . . . 6.43 110.586 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.0 mm -72.09 68.47 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.356 1.863 . . . . 4.76 110.467 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.9 119.63 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 127.443 2.297 . . . . 2.65 108.654 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 152.23 26.92 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.802 1.287 . . . . 3.2 112.265 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -130.09 139.61 50.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 123.116 1.436 . . . . 1.72 113.777 -166.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -69.7 121.34 16.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.997 1.719 . . . . 4.13 109.862 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.23 57.94 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.895 1.331 . . . . 3.36 110.693 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 13.7 mm -123.67 133.7 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.887 2.075 . . . . 2.67 109.243 -167.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 54.5 ttp -123.1 131.53 53.73 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.97 0.908 . . . . 3.22 110.515 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -90.41 127.92 36.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.988 1.315 . . . . 2.93 110.387 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.24 110.29 20.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.874 1.67 . . . . 3.24 107.613 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 60.5 mt -111.01 130.77 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.094 -1.447 . . . . 2.57 107.094 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.88 172.04 33.68 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 123.987 0.803 . . . . 2.63 112.765 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.37 -18.62 13.87 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.197 1.931 . . . . 4.64 112.973 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 16.5 3.0 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 129.683 3.193 . . . . 7.07 113.113 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -149.27 127.52 2.5 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.914 -1.116 . . . . 4.33 114.823 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.8 -31.17 69.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.868 2.067 . . . . 7.39 114.504 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -132.05 139.96 48.72 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.316 -0.865 . . . . 3.59 110.706 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.48 -53.83 1.09 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.508 1.123 . . . . 2.69 110.065 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -165.21 174.72 9.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.206 1.403 . . . . 3.59 111.674 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.06 138.54 13.94 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.457 -1.402 . . . . 4.74 113.707 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.36 148.44 41.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.563 0.949 . . . . 3.28 113.563 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.49 141.48 11.13 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 115.842 1.097 . . . . 3.55 115.842 -155.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 49.81 -92.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.542 1.937 . . . . 5.68 109.972 -162.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -50.55 126.29 15.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.673 1.189 . . . . 5.03 112.661 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 8.4 ptpp? 176.98 161.75 0.43 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.76 3.624 . . . . 8.3 108.759 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -158.05 158.39 34.7 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.83 -1.169 . . . . 5.35 110.882 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 10.5 tmtt? -52.84 -58.29 7.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.608 1.163 . . . . 1.99 112.842 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -41.41 69.06 Favored Glycine 0 N--CA 1.471 0.998 0 CA-C-N 118.459 0.572 . . . . 1.81 112.645 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -68.29 -34.63 76.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.322 1.449 . . . . 5.51 111.27 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.59 -48.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.109 -0.994 . . . . 1.57 110.512 166.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.22 86.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.51 1.05 . . . . 1.87 112.125 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -34.67 76.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 2.38 112.79 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.2 m -70.33 -45.27 66.52 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.509 -0.744 . . . . 3.01 111.751 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.92 -36.46 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.298 0.954 . . . . 2.49 110.891 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.88 73.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.678 1.126 . . . . 2.43 112.807 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.9 m -71.77 -55.77 7.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.034 1.334 . . . . 2.85 110.807 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -63.95 -24.94 67.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.632 1.173 . . . . 2.77 113.216 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.12 71.26 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 4.83 113.14 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -64.84 -38.21 28.35 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 116.371 -1.776 . . . . 6.87 114.312 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.98 -44.25 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.318 2.679 . . . . 2.37 112.95 166.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -86.44 65.47 9.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.123 0.969 . . . . 4.24 111.864 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 93.9 -142.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.483 3.113 . . . . 10.5 108.161 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 57.33 -60.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 128.767 2.827 . . . . 8.81 116.768 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 79.02 -41.59 0.28 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.585 2.754 . . . . 12.11 114.192 163.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--O 1.247 0.969 0 C-N-CA 125.206 1.402 . . . . 9.86 111.397 178.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 118.159 -0.924 . . . . 15.47 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.18 153.04 42.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.13 0.877 . . . . 14.49 110.808 165.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.2 t -178.86 59.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.018 2.127 . . . . 11.1 110.812 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.19 71.84 1.18 Allowed Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.404 1.002 . . . . 9.94 113.388 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -149.69 77.54 8.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.72 1.208 . . . . 9.07 112.949 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.52 173.0 13.15 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.765 2.31 . . . . 7.72 110.508 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -145.93 156.19 43.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.545 2.338 . . . . 7.95 106.691 162.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.7 -134.54 0.21 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.502 0.721 . . . . 6.54 109.73 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.51 163.62 38.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.088 1.328 . . . . 3.1 111.829 -165.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -112.75 84.64 0.37 Allowed Glycine 0 N--CA 1.467 0.718 0 CA-C-O 117.914 -1.492 . . . . 3.04 111.684 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.48 115.96 3.21 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 CA-C-N 120.815 2.308 . . . . 3.14 111.966 -168.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -157.39 157.49 34.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.535 1.534 . . . . 2.29 113.117 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.6 t -139.1 115.21 10.27 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.856 1.262 . . . . 3.16 107.709 161.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.6 163.36 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.806 1.642 . . . . 2.18 110.313 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -99.05 148.45 24.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.383 0.673 . . . . 2.51 110.252 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.09 163.45 14.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.658 2.383 . . . . 1.57 111.34 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -62.7 -25.38 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.405 0.891 . . . . 1.65 113.405 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -72.26 -48.39 42.88 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.916 2.086 . . . . 3.17 110.746 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.38 13.95 3.05 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 116.951 1.54 . . . . 2.05 116.951 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -81.38 -145.9 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.461 1.63 . . . . 6.78 111.058 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.07 140.03 39.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.203 1.401 . . . . 5.62 109.873 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.85 154.84 48.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.189 1.396 . . . . 3.13 111.457 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.6 p -140.34 158.84 43.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.536 1.535 . . . . 2.17 110.158 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -49.76 -30.7 9.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.248 1.419 . . . . 3.66 112.722 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -92.68 -5.22 51.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.599 1.703 . . . . 6.07 115.599 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -3.74 4.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.489 1.516 . . . . 2.89 114.584 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -75.94 -14.21 60.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.278 1.031 . . . . 2.98 112.936 144.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.36 157.19 20.45 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.577 1.951 . . . . 3.39 112.743 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.01 75.89 Favored Glycine 0 N--CA 1.479 1.551 0 C-N-CA 124.385 0.993 . . . . 1.52 114.725 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -141.5 169.57 17.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.783 2.033 . . . . 3.49 107.78 168.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -84.22 153.8 23.41 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.227 -0.92 . . . . 1.44 113.402 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -132.11 135.2 46.25 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.016 -1.052 . . . . 2.11 112.762 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.24 99.88 6.98 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 105.134 -2.173 . . . . 2.72 105.134 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.36 107.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.751 -0.833 . . . . 1.92 108.751 -164.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -103.6 137.35 41.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.859 1.664 . . . . 3.67 112.384 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.77 115.68 30.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.275 0.63 . . . . 1.85 112.453 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.95 176.17 24.58 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 127.388 2.423 . . . . 2.86 112.269 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -70.05 0.68 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.566 -2.013 . . . . 4.67 105.566 148.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 168' ' ' HIS 0.25 9.8 t 171.63 -81.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.964 2.106 . . . . 4.12 110.457 165.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.574 ' H ' HG23 ' A' ' 167' ' ' THR . 40.9 m170 -84.34 46.57 1.23 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.87 0.868 . . . . 7.51 111.866 -171.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 19.9 p -135.36 83.48 37.77 Favored Pre-proline 0 CA--C 1.562 1.408 0 C-N-CA 123.806 0.843 . . . . 3.58 109.267 -169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 97.31 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.29 2.66 . . . . 5.74 108.489 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.01 -87.28 0.49 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.122 1.369 . . . . 5.17 109.153 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.0 t -98.79 -9.78 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.561 1.544 . . . . 3.3 109.795 166.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 67.7 m -45.62 -53.65 18.68 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.922 -1.514 . . . . 2.16 114.206 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.69 -51.54 2.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.799 1.678 . . . . 2.42 111.395 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -41.4 88.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.142 1.377 . . . . 3.22 112.697 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.67 -43.35 20.54 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.021 -1.049 . . . . 3.01 112.859 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.0 -25.52 62.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.106 -1.426 . . . . 2.35 113.033 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.27 -58.33 3.36 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.0 1.273 . . . . 4.11 110.305 162.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -55.48 -42.61 74.61 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.387 -0.821 . . . . 3.13 110.88 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.3 mmm -68.38 -41.03 81.15 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.308 1.043 . . . . 3.25 112.769 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mm -71.23 -50.3 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 C-N-CA 123.849 0.86 . . . . 1.46 108.814 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.531 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 66.0 mt-30 -67.52 -23.88 65.5 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.196 -0.315 . . . . 1.73 110.598 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.24 -51.38 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 1.45 111.709 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.36 -41.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.503 1.501 . . . . 2.59 112.325 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.73 -36.69 81.7 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.439 0.696 . . . . 3.89 110.674 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.63 -48.61 59.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.033 1.333 . . . . 2.21 112.311 172.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.8 mt -55.43 -42.93 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.641 1.176 . . . . 1.9 111.313 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.69 -53.72 42.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.344 1.458 . . . . 2.35 110.528 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.8 t -66.11 -25.73 67.13 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.001 -1.062 . . . . 2.39 113.257 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mm -61.69 -24.35 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.175 0.898 . . . . 2.39 111.411 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m 71.67 -24.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.126 2.17 . . . . 2.63 113.804 164.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 85.4 m -80.97 -13.26 59.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.167 2.987 . . . . 2.76 112.572 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -100.29 162.76 19.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.116 1.366 . . . . 2.6 110.349 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.05 165.64 27.57 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.507 2.138 . . . . 2.11 109.324 158.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -61.88 156.67 20.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.105 0.955 . . . . 3.51 112.876 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.8 tt -142.79 127.63 18.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.738 2.415 . . . . 2.24 109.759 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.6 m -111.32 109.14 56.63 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.141 1.776 . . . . 1.42 110.178 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 147.53 45.88 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.673 1.582 . . . . 1.25 111.649 163.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.94 151.68 39.02 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.696 0.999 . . . . 2.98 113.696 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.96 115.44 20.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.556 1.943 . . . . 2.15 109.104 -167.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.74 128.05 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.774 0.83 . . . . 1.63 110.793 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.1 t -95.15 160.97 14.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.206 1.002 . . . . 1.85 112.334 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -141.83 0.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.846 2.058 . . . . 2.11 113.767 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -137.44 89.24 16.09 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.275 1.83 . . . . 4.06 108.503 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -88.36 -28.61 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.764 2.309 . . . . 2.92 113.954 -166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -60.19 -16.12 30.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.849 1.204 . . . . 5.34 113.882 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.69 20.37 3.31 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.824 1.046 . . . . 7.72 113.824 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 167' ' ' THR . 41.3 t0 -120.79 77.24 1.27 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.028 1.394 . . . . 5.21 113.614 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 m -54.49 130.53 39.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 113.766 -1.561 . . . . 3.21 109.347 169.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -49.45 -41.18 39.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.805 0.842 . . . . 3.82 112.891 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -60.4 -37.29 80.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.377 2.271 . . . . 2.96 113.51 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.66 -28.57 64.9 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.846 0.859 . . . . 1.5 112.696 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.25 -42.65 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.12 0.568 . . . . 2.05 109.689 166.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.25 86.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.941 0.792 . . . . 1.37 112.181 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -60.96 -46.88 88.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.014 0.526 . . . . 3.66 111.568 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -66.11 -42.07 89.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.237 0.615 . . . . 2.87 111.872 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.4 t -60.17 -40.61 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.137 1.375 . . . . 1.31 111.513 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -63.96 -15.42 59.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.484 1.513 . . . . 4.75 114.101 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 50.7 mm-40 -80.82 -16.32 54.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.131 1.332 . . . . 3.6 114.497 171.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -96.75 -59.87 1.72 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.812 1.041 . . . . 2.71 113.812 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t 171.47 149.68 0.18 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.715 1.606 . . . . 1.79 111.355 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.01 -12.2 31.97 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.719 2.946 . . . . 1.97 114.752 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -88.13 -5.4 58.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.035 0.834 . . . . 2.63 113.075 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.66 134.41 33.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.831 1.252 . . . . 2.21 109.489 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.12 139.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-N 118.368 0.531 . . . . 1.8 111.964 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.31 144.6 15.85 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.487 1.041 . . . . 0.99 112.99 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.79 141.57 48.56 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.566 1.146 . . . . 2.69 112.62 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.4 t -157.49 168.87 26.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.798 1.239 . . . . 2.29 112.789 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.18 -130.78 1.37 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.474 1.511 . . . . 2.15 111.034 158.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -119.56 -160.78 0.83 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.715 1.206 . . . . 3.27 109.8 161.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.255 5.2 ptm180 -60.72 -31.21 70.52 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 120.039 1.29 . . . . 7.08 113.251 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.72 -56.51 6.06 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.499 1.499 . . . . 4.63 110.601 168.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -72.09 -42.4 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 114.899 1.444 . . . . 3.85 114.899 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.34 -40.28 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.486 . . . . 1.81 112.149 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.4 -47.79 69.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.355 1.062 . . . . 5.09 108.688 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -52.43 -45.55 66.01 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 119.113 0.87 . . . . 2.54 112.918 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.72 -38.41 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.586 0.754 . . . . 2.39 112.794 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.41 92.97 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.105 0.866 . . . . 2.25 111.022 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -70.02 -42.43 73.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.259 1.824 . . . . 3.83 112.527 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.95 -61.41 1.88 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.413 1.485 . . . . 2.51 113.604 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -92.8 6.59 47.05 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.907 0.706 . . . . 3.1 112.907 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.15 47.99 23.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.954 1.702 . . . . 7.19 111.481 -170.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 244' ' ' TYR . 8.1 p -92.9 -172.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.009 1.324 . . . . 3.02 110.029 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.624 ' H ' HG22 ' A' ' 243' ' ' VAL . 37.7 p90 -162.18 162.35 28.34 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.057 1.743 . . . . 5.62 111.29 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -121.31 177.67 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 3.6 111.887 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -120.45 83.16 33.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.771 0.829 . . . . 3.37 111.148 -166.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.91 142.78 15.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.109 2.539 . . . . 2.43 111.387 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.33 36.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.645 1.018 . . . . 2.67 115.645 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.64 118.03 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.982 3.121 . . . . 4.74 111.454 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.95 122.61 25.75 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.045 0.938 . . . . 7.31 112.07 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.38 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 117.69 -1.148 . . . . 6.24 111.812 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -170.28 -14.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.688 1.995 . . . . 9.91 114.018 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -75.91 -32.49 59.65 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 121.695 2.043 . . . . 8.0 111.379 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -173.97 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.465 2.306 . . . . 7.75 109.912 157.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.38 161.27 16.4 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.916 1.817 . . . . 5.28 115.812 -151.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.24 -26.26 3.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.51 3.124 . . . . 4.44 112.153 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.262 2.5 tp 54.05 166.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.613 2.765 . . . . 5.22 113.964 -166.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.47 132.19 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 120.899 -1.126 . . . . 2.42 108.614 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -97.46 156.83 16.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.005 2.122 . . . . 3.65 110.501 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -141.84 111.96 6.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.974 1.31 . . . . 1.85 109.589 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -70.08 28.05 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.093 2.557 . . . . 3.34 116.116 -170.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.283 1.1 mp 42.19 34.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 129.291 3.036 . . . . 3.01 114.449 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.26 133.73 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.319 1.448 . . . . 3.06 109.023 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.6 ttp -124.79 131.08 53.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.139 1.376 . . . . 4.0 109.985 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.68 133.58 42.03 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.731 0.812 . . . . 3.34 110.74 165.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.94 118.28 35.34 Favored 'General case' 0 C--N 1.335 -0.023 0 N-CA-C 106.49 -1.67 . . . . 2.66 106.49 171.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.5 mm -121.92 134.23 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.059 -1.089 . . . . 2.68 108.059 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.17 170.5 35.99 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.375 0.988 . . . . 1.36 111.483 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -60.04 -25.46 79.79 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.878 3.052 . . . . 2.84 113.147 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.85 -18.51 1.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.173 2.989 . . . . 5.74 114.272 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.38 -69.28 3.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.167 1.842 . . . . 2.54 114.301 167.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.93 -30.97 68.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.897 1.443 . . . . 5.19 114.897 -151.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -172.73 161.85 4.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.694 2.398 . . . . 3.73 110.298 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -147.95 -60.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.294 -0.86 . . . . 2.78 112.124 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -163.17 -179.35 6.59 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.303 1.441 . . . . 2.69 111.402 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -163.29 148.87 11.54 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 119.827 -1.795 . . . . 3.47 113.777 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.03 146.05 51.1 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.054 0.942 . . . . 3.2 111.22 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.93 -160.98 33.24 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.404 -1.078 . . . . 3.09 110.404 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -73.06 56.89 0.45 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.302 1.051 . . . . 5.07 111.917 167.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.96 86.85 0.43 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.184 1.394 . . . . 4.7 111.524 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.96 167.48 18.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.401 1.881 . . . . 8.5 109.986 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -149.96 157.41 43.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.804 1.242 . . . . 6.2 110.622 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 6.9 tmtt? -52.76 -60.19 3.57 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.379 1.072 . . . . 1.74 112.433 -163.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.12 72.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.539 -0.624 . . . . 1.49 111.539 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -72.42 -28.97 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.35 1.86 . . . . 5.25 112.862 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.69 -46.46 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.926 -1.109 . . . . 1.3 109.884 167.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.51 93.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.77 0.428 . . . . 1.24 111.393 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.24 81.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.285 1.034 . . . . 1.68 112.947 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.9 t -69.0 -50.03 52.51 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.043 -1.036 . . . . 1.88 110.908 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 8.7 tt -68.95 -19.81 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.848 0.684 . . . . 2.49 112.848 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.12 -31.99 53.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.936 1.244 . . . . 2.14 112.583 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -54.46 -56.01 23.1 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.137 1.775 . . . . 2.19 110.744 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -89.47 -15.7 32.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.42 1.888 . . . . 2.6 113.415 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -64.82 -41.65 95.58 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.434 1.494 . . . . 4.45 112.005 167.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 -46.0 -49.83 38.25 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 116.605 -1.664 . . . . 5.33 114.54 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.42 -10.33 28.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.637 2.891 . . . . 2.94 115.109 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.56 0.18 13.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.582 1.553 . . . . 5.76 114.743 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -65.6 75.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.665 2.386 . . . . 10.3 112.285 -174.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . 0.297 55.2 mmtt 55.84 148.24 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.571 2.348 . . . . 6.85 115.075 -159.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 109.85 5.7 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 130.394 3.477 . . . . 10.33 111.791 -135.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 C--O 1.247 0.938 0 C-N-CA 131.505 3.922 . . . . 10.23 107.449 -163.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.598 -1.667 . . . . 18.86 107.729 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.88 164.78 3.52 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.004 1.722 . . . . 17.15 109.746 -164.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -165.25 179.1 6.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.537 1.935 . . . . 13.85 109.202 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.55 164.14 38.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.8 1.19 . . . . 10.96 112.674 -175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -163.26 142.73 6.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.919 1.288 . . . . 12.23 111.074 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.72 174.07 13.31 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.846 2.364 . . . . 7.75 110.133 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pp -151.46 179.37 8.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.575 1.55 . . . . 7.11 110.796 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -142.6 162.94 34.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 6.86 111.022 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.36 152.28 20.36 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.821 1.201 . . . . 3.19 112.461 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.42 157.53 52.8 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.264 0.935 . . . . 2.8 113.642 -168.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -98.44 55.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.74 2.96 . . . . 3.05 110.658 168.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -94.97 149.44 21.24 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.037 -0.506 . . . . 2.81 110.223 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 151' ' ' THR . 12.7 p -138.53 33.39 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.787 1.773 . . . . 2.6 115.787 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.87 149.65 35.51 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.203 1.557 . . . . 2.15 115.203 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -85.65 146.05 27.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.005 1.722 . . . . 1.75 109.916 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -87.11 163.59 16.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.756 1.622 . . . . 1.25 111.274 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -56.35 -33.68 65.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 1.67 112.173 171.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 m -60.53 -46.22 90.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.274 2.23 . . . . 2.34 112.062 170.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.27 -6.01 21.43 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.698 1.142 . . . . 2.19 115.221 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.05 156.44 39.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.562 1.181 . . . . 5.5 109.803 159.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.23 142.44 30.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.492 0.587 . . . . 6.95 111.261 170.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -128.94 118.95 23.48 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.332 1.053 . . . . 3.24 108.855 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 141' ' ' SER . 56.3 p -94.28 168.41 10.92 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.426 1.89 . . . . 2.01 109.286 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -37.33 -41.72 0.43 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.268 2.227 . . . . 3.52 113.856 166.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -102.34 -8.98 20.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.865 1.266 . . . . 6.53 113.903 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -81.97 -24.95 35.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.714 0.688 . . . . 3.16 111.332 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -86.73 -11.98 49.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.842 1.657 . . . . 3.24 114.311 -178.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 tt -52.26 144.03 13.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.221 2.609 . . . . 3.77 111.543 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.08 41.01 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 115.849 1.1 . . . . 1.71 115.849 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.471 HE22 HD23 ' A' ' 160' ' ' LEU . 2.3 pp0? -147.64 177.2 9.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.006 1.403 . . . . 3.97 110.331 167.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -82.62 116.91 22.23 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.972 0.805 . . . . 2.25 112.498 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.471 HD23 HE22 ' A' ' 158' ' ' GLN . 51.4 mt -88.98 131.17 35.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.774 0.83 . . . . 2.64 110.73 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.08 100.56 5.47 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.7 mt -112.33 108.5 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.117 0.967 . . . . 1.84 109.735 -156.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.59 148.99 23.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.632 1.173 . . . . 3.74 112.166 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -121.85 104.29 9.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.4 0.546 . . . . 2.61 110.632 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -138.04 148.71 20.05 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.71 1.044 . . . . 1.89 115.71 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.23 -14.7 61.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.361 1.064 . . . . 5.24 112.852 166.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 m 76.43 -55.67 0.58 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.499 1.92 . . . . 3.62 111.06 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.448 ' HE2' ' CG ' ' A' ' 208' ' ' ASP . 57.6 m-70 -69.58 -3.3 14.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.219 1.808 . . . . 6.57 114.788 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.2 75.11 0.88 Allowed Pre-proline 0 CA--C 1.57 1.725 0 CA-C-N 119.435 1.016 . . . . 2.55 108.874 160.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -79.52 65.91 8.83 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.742 3.628 . . . . 5.98 108.011 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.25 -87.34 0.6 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.677 1.991 . . . . 4.0 107.005 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.94 -29.1 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.428 0.899 . . . . 3.07 113.428 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.524 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 72.1 m -61.96 -63.76 3.87 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 125.457 1.503 . . . . 1.98 112.534 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.15 -27.31 64.91 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.658 2.239 . . . . 1.95 112.873 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -52.23 -50.04 62.78 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 120.514 1.506 . . . . 2.75 111.651 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.18 -40.59 21.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.728 1.211 . . . . 3.81 113.823 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.9 tt -68.34 -30.81 69.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.833 -1.08 . . . . 3.28 112.548 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -59.89 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.381 1.472 . . . . 3.54 109.271 166.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -56.93 -36.48 70.27 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.364 -0.835 . . . . 3.11 110.547 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.3 tpp -60.75 -31.29 70.63 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.135 1.374 . . . . 3.51 113.155 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.6 mm -66.56 -43.21 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 120.326 1.421 . . . . 1.93 108.948 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.443 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 27.9 mm-40 -62.31 -45.65 92.29 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.34 0.973 . . . . 3.36 110.781 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.1 -37.09 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.067 0.947 . . . . 1.56 112.009 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 t -67.71 -43.64 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.389 0.995 . . . . 2.49 110.969 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.69 -43.4 84.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.901 0.881 . . . . 4.4 110.973 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.47 -32.71 74.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.3 1.04 . . . . 2.52 112.759 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.9 -38.28 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.028 1.286 . . . . 1.93 112.952 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -40.21 96.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.617 1.167 . . . . 2.66 110.554 169.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t -70.63 -14.94 62.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.116 1.366 . . . . 3.13 113.74 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.1 mt -81.94 -34.13 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.712 1.205 . . . . 3.72 110.678 165.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.9 m 68.8 -19.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.995 2.518 . . . . 2.92 113.78 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.6 m -83.43 -0.74 51.38 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.437 3.095 . . . . 3.92 112.316 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.73 164.84 40.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.911 -1.118 . . . . 5.02 110.582 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.424 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 52.6 Cg_endo -69.8 -55.12 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.97 2.447 . . . . 3.67 110.912 174.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -174.18 156.65 2.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.469 3.108 . . . . 3.94 108.148 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.1 104.02 9.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.08 0.952 . . . . 2.85 111.058 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.2 m -105.04 102.13 34.15 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.1 1.36 . . . . 1.44 109.932 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.4 154.07 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.643 2.229 . . . . 0.95 112.672 170.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 143.04 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.502 -0.772 . . . . 2.42 111.182 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.59 118.93 37.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.595 1.158 . . . . 2.36 108.862 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mm -83.64 115.84 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.534 -1.284 . . . . 1.52 107.534 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.5 t -75.8 112.78 12.55 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.239 -1.023 . . . . 1.99 108.239 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.5 pt -71.61 -9.81 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.21 0.819 . . . . 2.79 113.21 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.7 111.7 56.71 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.132 1.773 . . . . 4.0 107.952 163.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -103.44 0.3 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.905 3.736 . . . . 2.55 112.907 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.29 -30.96 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.026 1.331 . . . . 5.4 111.808 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -90.23 -37.4 14.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 6.82 113.429 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . 0.448 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 0.9 OUTLIER -123.07 136.92 55.01 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.881 1.273 . . . . 4.86 111.626 -173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -84.61 166.78 16.85 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.242 1.017 . . . . 2.86 111.503 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -60.08 -34.74 73.86 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.606 -0.725 . . . . 3.55 111.767 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -70.4 -33.85 71.86 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.013 1.725 . . . . 3.14 113.294 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.4 70.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.513 1.052 . . . . 1.9 110.375 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.39 -29.74 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.967 1.307 . . . . 1.82 111.727 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.71 -28.09 8.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.361 1.064 . . . . 1.23 113.442 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -71.59 -57.17 4.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.03 0.832 . . . . 3.58 111.552 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -53.75 -36.02 61.88 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.937 -1.102 . . . . 5.64 112.709 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.96 -59.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.011 1.324 . . . . 1.4 111.577 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.11 -31.98 71.07 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.904 0.705 . . . . 3.77 112.904 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -27.62 66.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.251 . . . . 3.3 112.347 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -80.53 -57.02 3.77 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.356 0.873 . . . . 2.5 113.356 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.5 p -178.92 156.67 0.9 Allowed Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 120.537 1.517 . . . . 2.62 112.644 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.68 -9.74 21.38 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.123 2.549 . . . . 1.73 115.117 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -91.8 -5.51 53.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.957 1.095 . . . . 2.42 113.957 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -80.84 134.91 35.85 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.052 -1.03 . . . . 2.72 108.918 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.51 127.49 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 118.746 0.703 . . . . 1.43 111.02 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.16 130.98 10.51 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.065 -1.022 . . . . 0.97 111.998 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.67 139.02 53.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.938 1.295 . . . . 2.02 113.702 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.9 p -154.34 159.27 41.1 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 127.569 2.348 . . . . 2.6 111.148 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -159.6 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 112.281 -0.328 . . . . 2.62 112.281 164.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t 179.82 160.59 0.84 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.651 2.78 . . . . 3.11 107.829 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -54.0 -35.27 61.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.66 1.184 . . . . 5.75 111.954 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.9 mp0 -71.28 -34.61 70.83 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 126.442 1.897 . . . . 4.3 110.972 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.06 -41.19 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.997 0.919 . . . . 4.3 111.735 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.52 -36.41 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 2.44 112.062 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.65 -54.0 19.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.638 1.175 . . . . 4.44 110.643 167.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -46.21 -52.18 12.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.07 113.313 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.38 -26.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.868 1.213 . . . . 3.28 113.232 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.66 42.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.235 . . . . 3.04 114.088 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -119.35 -15.54 9.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.206 2.202 . . . . 4.81 113.148 -165.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.32 -31.0 69.88 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.583 -0.698 . . . . 2.06 111.137 150.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -102.87 -128.63 0.23 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.708 1.203 . . . . 3.2 110.606 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 104.98 2.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.705 1.202 . . . . 9.82 111.919 165.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 78.2 t -132.71 150.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.848 1.659 . . . . 3.36 108.934 165.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -129.71 160.39 33.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.659 1.984 . . . . 6.62 110.515 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.1 166.67 16.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.295 1.038 . . . . 5.72 111.906 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.7 m -116.63 74.34 6.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.535 1.134 . . . . 3.47 111.154 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.62 136.09 35.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.994 2.462 . . . . 2.35 111.56 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.0 -172.12 21.77 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.898 1.237 . . . . 2.29 115.593 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.94 -176.45 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.904 3.736 . . . . 4.68 110.328 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.62 11.13 1.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.725 1.75 . . . . 6.01 115.725 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 3.96 1.17 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 129.693 3.197 . . . . 5.54 114.983 -165.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.66 -57.89 2.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.069 1.748 . . . . 11.21 112.21 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -165.5 51.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.092 1.357 . . . . 8.94 113.043 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 72.39 -4.92 1.91 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.856 2.062 . . . . 7.52 116.147 166.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -78.24 132.1 37.39 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.855 1.262 . . . . 5.96 111.977 171.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -76.24 -12.63 60.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.545 1.683 . . . . 5.95 115.545 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.1 mt 41.3 64.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.284 2.233 . . . . 4.83 112.612 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.84 124.92 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.886 0.874 . . . . 2.7 111.391 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.77 161.11 19.3 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.405 1.482 . . . . 3.51 111.885 173.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 7.3 p80 -145.47 120.81 10.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.88 1.272 . . . . 2.04 111.87 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.39 43.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.43 2.292 . . . . 4.13 114.305 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.291 3.4 tp 50.11 3.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 129.751 3.22 . . . . 4.34 118.298 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.8 mt -60.08 142.45 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.352 -1.468 . . . . 2.63 112.711 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -151.16 150.98 31.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.386 1.874 . . . . 2.64 110.929 167.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -110.17 153.39 24.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.398 1.079 . . . . 2.79 112.972 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 17.9 tp -119.43 134.83 55.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 2.59 110.606 166.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.5 146.74 29.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.149 1.38 . . . . 2.39 108.367 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.91 171.41 55.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 124.424 1.011 . . . . 1.56 114.698 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.71 -36.62 40.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 125.188 3.925 . . . . 3.17 112.774 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.32 -30.23 64.6 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 130.554 3.542 . . . . 5.93 115.025 164.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 101.75 6.75 49.22 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.002 -1.443 . . . . 2.81 115.554 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.11 122.58 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.388 2.094 . . . . 8.46 111.633 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.27 108.44 4.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.653 -0.869 . . . . 4.04 108.653 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -38.45 8.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.002 0.921 . . . . 4.11 112.772 -166.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.16 151.81 10.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.551 1.14 . . . . 3.07 109.163 -161.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.06 145.44 32.89 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.951 -1.093 . . . . 3.87 111.757 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.52 179.7 5.66 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.873 1.669 . . . . 2.73 110.404 -161.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.91 73.25 0.06 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.933 1.254 . . . . 3.08 111.723 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 77.5 -24.11 0.23 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.282 2.633 . . . . 5.35 113.302 165.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -77.31 20.92 0.27 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.826 1.65 . . . . 5.95 112.729 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -137.93 -157.6 0.79 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.078 . . . . 4.33 109.489 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -166.81 158.51 12.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.202 1.401 . . . . 6.08 108.341 -168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 14.5 tmtt? -55.57 -56.02 25.21 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.877 -1.139 . . . . 2.81 113.622 -157.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.98 -29.13 72.49 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 118.208 0.458 . . . . 1.51 112.531 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -75.39 -28.64 59.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.364 2.265 . . . . 5.7 111.482 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.51 -46.79 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.72 1.208 . . . . 1.83 110.396 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.39 -47.41 81.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.558 0.617 . . . . 1.32 110.929 171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.02 69.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.313 1.045 . . . . 1.45 113.34 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.4 m -63.25 -58.77 6.06 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.507 1.049 . . . . 2.27 110.539 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.7 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.114 -0.991 . . . . 2.44 112.083 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.97 63.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.851 1.261 . . . . 1.67 113.523 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.6 m -74.79 -47.46 30.69 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.427 1.012 . . . . 1.84 109.225 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -65.27 -26.9 68.29 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 3.73 113.716 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.2 ttp -50.37 -29.94 11.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.735 1.614 . . . . 4.1 113.537 164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -74.14 -50.57 5.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.018 -1.944 . . . . 4.37 114.037 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.52 -44.35 8.75 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.552 1.947 . . . . 2.36 110.833 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -93.05 51.18 1.63 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.714 0.806 . . . . 3.34 111.875 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -50.53 137.21 19.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.733 1.213 . . . . 8.2 112.581 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.517 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 47.9 tttt -72.65 -167.93 0.4 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.702 1.239 . . . . 7.04 113.672 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.517 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 0.3 OUTLIER -131.64 -9.55 3.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.542 1.537 . . . . 11.89 114.723 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.485 1.288 1 C-N-CA 131.861 4.064 . . . . 10.4 108.081 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.551 -1.214 . . . . 15.34 108.838 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -57.34 -20.39 28.55 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.001 1.273 . . . . 16.5 113.07 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.7 m -138.94 170.69 15.53 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.798 2.039 . . . . 15.85 108.324 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.69 -153.87 22.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.25 1.405 . . . . 12.73 111.729 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.42 155.56 25.78 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.185 0.994 . . . . 9.83 112.452 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.59 -175.11 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.587 2.858 . . . . 9.05 112.331 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.16 170.7 17.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.304 . . . . 8.88 111.96 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.57 -178.26 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.732 2.013 . . . . 7.03 113.933 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.67 152.21 13.11 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.359 -1.097 . . . . 3.32 110.359 -154.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.84 120.21 21.89 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.11 1.338 . . . . 2.81 112.743 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -88.05 52.05 2.04 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.219 2.613 . . . . 3.46 111.076 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -93.14 163.65 13.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 3.11 111.846 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.4 t -134.39 62.71 1.64 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.216 -0.928 . . . . 2.58 111.418 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.95 142.16 27.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.326 1.05 . . . . 2.66 111.402 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 m -74.88 126.78 31.68 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.947 1.299 . . . . 2.13 108.994 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 p -82.35 151.96 26.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.854 0.861 . . . . 2.18 109.567 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -63.17 -10.98 17.35 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.86 1.43 . . . . 1.84 114.86 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -80.89 -23.59 38.88 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.814 -1.179 . . . . 3.55 113.205 170.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.15 -28.57 4.06 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.747 1.642 . . . . 2.96 114.729 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.42 141.31 46.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.459 1.129 . . . . 6.06 110.282 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 160.99 14.6 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.031 1.332 . . . . 6.66 112.199 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.24 -179.2 5.46 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.06 -1.025 . . . . 3.41 113.501 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.9 p -114.01 176.05 5.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.922 2.089 . . . . 3.31 108.996 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.8 -36.09 71.73 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.492 1.139 . . . . 4.68 111.852 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -72.3 -20.3 61.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.18 1.392 . . . . 7.39 112.081 -170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.26 -19.47 63.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.426 1.49 . . . . 4.05 113.399 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -104.75 -1.45 26.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.821 1.248 . . . . 2.26 113.964 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -68.85 129.09 38.92 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.082 -1.011 . . . . 3.65 110.469 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.12 -30.24 2.84 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 124.947 1.261 . . . . 1.96 113.704 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -104.77 174.68 5.77 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 2.67 110.629 163.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.87 134.9 34.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.53 -0.731 . . . . 1.88 110.661 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.2 mt -116.96 120.69 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.099 0.952 . . . . 2.48 111.801 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 102.17 10.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.248 -2.131 . . . . 3.05 105.248 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.9 mt -100.05 125.11 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.355 1.862 . . . . 2.22 107.397 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.65 156.77 43.12 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.102 0.779 . . . . 6.83 113.102 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.56 127.44 39.22 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 3.31 111.395 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.78 163.76 20.57 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.407 1.956 . . . . 1.81 112.673 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -153.09 147.3 25.68 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.03 0.752 . . . . 4.62 113.03 -168.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.62 24.06 11.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.483 1.29 . . . . 3.98 114.483 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -124.31 -31.02 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 115.316 -2.278 . . . . 4.61 115.165 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 p -118.47 108.17 41.96 Favored Pre-proline 0 CA--C 1.563 1.467 0 CA-C-N 122.554 2.433 . . . . 2.67 109.504 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.75 85.29 0.91 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.044 3.163 . . . . 5.14 108.889 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 11.0 p-10 -128.71 -99.62 0.35 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.394 1.878 . . . . 4.34 108.926 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.546 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 27.4 t -54.44 -35.56 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.326 1.451 . . . . 2.95 112.308 163.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.584 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 13.0 m -53.7 -54.94 40.69 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 117.445 -1.264 . . . . 1.88 113.454 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.76 -31.74 8.14 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.621 2.881 . . . . 1.72 113.483 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -64.3 -47.53 79.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.763 1.165 . . . . 2.7 111.919 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.87 -30.24 66.56 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.345 -0.847 . . . . 3.53 111.125 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -40.45 68.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.78 -1.2 . . . . 3.31 112.289 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -49.75 56.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.484 1.114 . . . . 3.65 111.343 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -46.86 85.66 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.921 -1.112 . . . . 2.95 109.873 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.84 -38.4 75.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.391 -0.814 . . . . 3.61 113.035 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.3 -47.7 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 120.025 1.284 . . . . 1.95 109.661 -171.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.528 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 64.3 mt-30 -64.54 -27.25 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.116 0.166 . . . . 2.18 111.26 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.7 t -72.15 -48.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 117.49 -1.243 . . . . 1.93 111.576 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.42 -25.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 121.48 1.945 . . . . 3.19 113.645 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.25 -52.03 51.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.059 1.744 . . . . 3.98 111.261 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.5 -50.09 74.1 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.275 1.03 . . . . 2.41 111.6 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.6 tt -75.47 -18.95 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.596 0.961 . . . . 1.7 113.596 -163.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -70.15 -38.78 75.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.513 1.125 . . . . 2.64 111.237 168.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.5 t -70.3 -19.78 63.06 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.918 -1.114 . . . . 2.96 112.464 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.2 59.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.179 0.991 . . . . 3.74 108.607 165.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 7.96 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.382 1.873 . . . . 3.24 114.154 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.5 m -51.69 -31.49 26.15 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.536 1.534 . . . . 3.62 111.0 150.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.88 172.75 7.66 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 120.519 1.509 . . . . 4.38 113.168 173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.59 -54.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.951 3.101 . . . . 3.98 110.183 156.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -178.16 164.23 1.77 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.322 3.049 . . . . 3.95 108.752 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.85 113.83 19.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.107 0.963 . . . . 2.48 108.727 160.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.5 m -99.42 113.08 64.61 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.435 1.094 . . . . 1.15 108.799 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.81 133.15 4.96 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.929 2.419 . . . . 1.03 112.564 172.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.82 101.82 9.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.982 1.313 . . . . 3.09 109.834 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -77.18 103.63 7.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.548 1.139 . . . . 2.14 108.0 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.5 mm -93.15 116.96 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.621 -0.881 . . . . 1.93 108.621 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.2 t -77.96 140.44 39.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.914 0.339 . . . . 2.46 111.914 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.14 7.31 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.113 1.365 . . . . 2.54 112.664 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.02 79.49 73.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.278 2.631 . . . . 3.61 108.326 -160.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -90.46 -25.97 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.59 2.86 . . . . 2.54 113.765 -169.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -75.74 41.82 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.261 1.391 . . . . 5.6 112.393 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -78.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.657 1.183 . . . . 6.74 112.206 -166.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -169.22 -174.6 2.03 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.978 1.311 . . . . 6.68 110.692 -156.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.1 p -62.5 149.73 42.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.511 1.924 . . . . 3.14 111.287 167.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -27.39 68.44 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.13 -0.981 . . . . 3.98 112.334 174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -54.36 -38.19 65.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.596 2.358 . . . . 3.86 113.737 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.85 82.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.287 0.949 . . . . 1.79 111.686 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.49 -43.44 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.094 0.558 . . . . 2.16 110.66 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.73 -51.37 65.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.672 1.189 . . . . 1.49 111.104 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -64.93 -29.25 70.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.297 0.851 . . . . 4.84 113.297 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -70.21 -49.9 45.48 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.671 1.123 . . . . 2.66 111.589 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.86 -46.35 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.125 1.37 . . . . 1.58 113.205 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -27.94 65.83 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.227 1.195 . . . . 3.71 114.227 -167.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.31 -20.0 63.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.851 0.685 . . . . 4.81 112.851 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -78.55 -35.65 45.73 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.909 0.777 . . . . 2.8 112.287 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 169.76 140.3 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 126.746 2.019 . . . . 2.01 111.835 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.04 -16.28 32.23 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.251 2.634 . . . . 2.16 114.414 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -75.0 -20.6 59.58 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.607 1.094 . . . . 2.52 113.19 171.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.0 139.12 34.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.694 0.798 . . . . 2.35 108.933 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.73 147.09 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.858 1.059 . . . . 2.35 113.858 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.12 129.03 9.5 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.642 1.592 . . . . 1.2 112.511 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.83 145.69 40.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 2.4 111.694 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 51.6 m -153.69 154.16 33.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.324 1.45 . . . . 2.48 109.581 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -139.58 -159.72 8.09 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 110.85 -0.9 . . . . 2.22 110.85 159.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.5 t -86.16 -177.62 6.31 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.385 1.088 . . . . 3.24 108.389 154.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -58.1 -22.12 49.23 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.021 -1.049 . . . . 8.69 113.116 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -69.56 -42.93 73.9 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.091 2.156 . . . . 4.18 110.9 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.76 -30.4 36.09 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.921 -1.112 . . . . 4.31 112.359 172.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.22 -35.04 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.327 -0.858 . . . . 2.12 111.799 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.24 -49.7 74.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.627 1.103 . . . . 3.64 110.063 159.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -54.24 -31.8 54.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.443 1.474 . . . . 3.09 114.069 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.39 -47.56 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.202 1.401 . . . . 3.8 112.054 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.29 68.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.955 1.302 . . . . 2.66 113.799 174.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -95.34 -25.14 16.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.21 2.204 . . . . 4.0 111.438 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.13 -59.55 2.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.228 1.411 . . . . 2.02 112.772 164.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.49 -45.48 3.87 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.084 1.142 . . . . 3.0 114.084 -169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 100.29 139.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.224 3.41 . . . . 5.75 112.99 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.78 162.11 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.774 2.03 . . . . 3.63 108.621 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -137.46 146.89 44.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.972 1.309 . . . . 6.63 109.437 164.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.13 143.39 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.196 1.398 . . . . 3.01 111.932 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.8 m -116.88 91.46 35.59 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.979 1.312 . . . . 2.79 111.849 -170.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.0 142.58 12.47 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.934 2.423 . . . . 2.75 113.045 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.21 132.56 11.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.451 1.024 . . . . 2.97 111.505 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -85.28 53.13 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.015 3.144 . . . . 4.86 110.657 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 83.64 149.39 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.6 3.16 . . . . 5.96 110.393 -155.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -108.4 -39.64 5.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.319 1.448 . . . . 8.71 110.199 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -136.95 -69.75 0.46 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.094 1.358 . . . . 10.8 110.745 166.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.62 144.88 13.98 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.424 1.107 . . . . 7.53 113.303 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 55.75 23.13 6.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 128.542 2.737 . . . . 8.73 114.24 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -115.48 172.88 6.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.166 2.587 . . . . 6.42 111.872 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.54 127.4 2.37 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.58 1.152 . . . . 6.17 111.972 158.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.62 160.54 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 121.546 -0.721 . . . . 3.84 109.844 156.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.6 p -171.33 118.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 127.545 2.338 . . . . 2.83 105.898 165.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.58 171.31 3.35 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.046 0.451 . . . . 3.83 112.0 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.584 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 23.4 p80 -150.39 113.03 4.73 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.697 -1.252 . . . . 2.12 113.483 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.7 t -59.82 130.32 46.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.524 1.13 . . . . 3.21 112.234 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 262' ' ' ILE . 3.0 mp -84.31 48.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 126.4 1.88 . . . . 3.36 111.447 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.6 mm -88.29 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.905 -1.122 . . . . 2.36 110.971 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 14.4 ttm -140.11 124.49 17.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.768 1.627 . . . . 3.13 110.393 167.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -95.49 136.9 35.27 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.987 1.715 . . . . 2.49 110.732 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -103.3 119.8 39.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.199 1.4 . . . . 2.71 109.669 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 50.9 mt -120.76 139.75 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.818 1.247 . . . . 2.21 107.988 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.55 166.95 44.09 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 119.718 -0.49 . . . . 1.77 112.595 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -59.17 154.18 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.948 1.765 . . . . 3.19 108.56 160.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 72.53 -17.2 0.4 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.248 1.419 . . . . 5.97 113.837 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.8 21.49 7.81 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 117.224 1.65 . . . . 2.79 117.224 162.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -74.81 135.62 41.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.7 1.75 . . . . 9.11 112.447 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -80.68 123.43 28.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.409 1.083 . . . . 2.96 108.738 166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.45 -52.03 2.78 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.153 0.797 . . . . 2.3 113.153 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -165.96 164.6 18.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.835 1.254 . . . . 3.19 110.492 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -151.4 88.45 1.43 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.682 1.193 . . . . 4.51 112.691 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.06 133.51 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.009 1.323 . . . . 2.78 112.699 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -99.95 -118.16 4.13 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.528 1.537 . . . . 2.6 112.485 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.58 166.0 9.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.989 0.915 . . . . 3.32 112.495 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 74.29 -10.56 1.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.645 1.978 . . . . 5.07 114.051 168.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -62.25 154.65 26.97 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.946 -1.096 . . . . 8.46 112.471 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -169.11 165.14 11.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.041 1.337 . . . . 6.98 110.939 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.528 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.7 tmtt? -54.5 -65.7 0.53 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.821 1.649 . . . . 2.25 113.559 -161.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.64 -26.27 74.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 117.832 0.287 . . . . 2.01 112.433 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -71.24 -47.59 56.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.782 2.433 . . . . 6.18 110.575 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.3 mt -60.2 -44.74 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.884 1.273 . . . . 1.43 110.239 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.82 67.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.871 0.76 . . . . 1.53 112.058 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.91 76.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.003 0.921 . . . . 2.06 112.834 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.7 t -70.46 -45.72 65.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.173 0.989 . . . . 1.69 111.926 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.48 -41.17 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.636 1.107 . . . . 2.45 110.019 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.65 -29.36 70.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.926 0.891 . . . . 1.5 113.09 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.5 m -69.73 -48.74 58.39 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.338 1.055 . . . . 2.22 110.095 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.44 -23.34 62.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.822 1.249 . . . . 2.2 114.187 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.1 ttp -71.07 -37.22 72.48 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.42 -1.425 . . . . 3.53 112.213 169.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -55.17 -40.44 84.37 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 115.55 1.685 . . . . 5.85 115.55 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.23 -20.7 32.27 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.023 2.482 . . . . 2.75 113.529 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 -166.16 1.17 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 116.189 1.922 . . . . 4.13 116.189 -165.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -70.48 -19.8 62.91 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 116.081 1.882 . . . . 9.38 116.081 -172.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -106.74 166.37 10.63 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.448 1.099 . . . . 6.34 109.248 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -138.5 163.57 31.64 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.455 1.025 . . . . 11.55 112.507 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.249 1.03 0 C-N-CA 129.606 3.162 . . . . 10.7 109.598 -179.191 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 106.587 -1.635 . . . . 18.86 106.587 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -67.51 -176.29 0.59 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.782 0.719 . . . . 17.88 109.738 144.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 t -125.75 173.75 8.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.948 1.299 . . . . 15.74 109.916 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -139.43 -152.15 5.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.239 1.399 . . . . 12.11 112.886 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.25 163.18 22.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.293 1.437 . . . . 13.42 112.081 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -59.22 162.31 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.421 2.747 . . . . 9.26 112.199 166.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.97 -26.1 7.44 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.913 1.285 . . . . 6.6 112.909 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.33 -170.69 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.522 1.154 . . . . 6.37 113.24 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.71 123.21 0.94 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.444 -1.862 . . . . 3.29 108.444 -147.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.57 107.53 2.38 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 117.825 -1.542 . . . . 3.62 109.559 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.38 145.03 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.056 2.504 . . . . 3.06 110.811 -163.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -157.74 166.33 33.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.255 1.022 . . . . 2.49 110.431 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -130.5 107.21 9.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.029 -1.1 . . . . 2.18 108.029 156.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.3 mt -122.24 143.39 49.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.15 0.886 . . . . 2.08 108.963 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.9 m -73.93 128.16 34.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.856 -1.164 . . . . 1.72 107.856 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 61.2 p -75.9 158.82 31.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.463 1.505 . . . . 1.28 110.643 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -56.98 -24.78 55.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.782 1.233 . . . . 1.21 113.396 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 m -70.94 -57.78 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.636 1.574 . . . . 2.4 110.855 167.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 144.85 -9.82 1.83 Allowed Glycine 0 N--CA 1.476 1.301 0 N-CA-C 116.477 1.351 . . . . 2.28 116.477 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.57 146.41 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.833 1.316 . . . . 5.35 110.978 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.22 49.62 0.8 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.828 1.651 . . . . 6.85 112.096 -156.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -65.89 158.37 28.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.852 2.061 . . . . 4.49 114.147 -159.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -116.13 150.21 37.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.493 1.117 . . . . 2.05 112.274 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -37.62 15.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.03 1.732 . . . . 3.83 112.599 166.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -44.26 66.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.003 -0.999 . . . . 7.64 112.905 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.95 -4.29 58.07 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.55 1.523 . . . . 3.18 113.326 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -76.28 -11.79 59.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.445 -1.41 . . . . 3.5 113.784 159.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -81.68 116.75 21.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.042 1.292 . . . . 3.74 111.467 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.86 -25.42 0.24 Allowed Glycine 0 N--CA 1.472 1.092 0 C-N-CA 125.257 1.408 . . . . 2.12 113.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -124.75 -178.39 4.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.981 1.713 . . . . 3.63 109.76 170.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -76.71 123.48 26.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.18 0.514 . . . . 2.54 111.304 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.59 138.33 40.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.799 1.24 . . . . 2.27 110.157 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.72 116.32 18.61 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.268 -1.382 . . . . 3.58 107.268 171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.23 106.91 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.993 0.917 . . . . 1.78 108.632 -160.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -114.85 143.12 45.62 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.291 1.437 . . . . 3.61 112.235 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.89 125.87 39.84 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.362 -0.836 . . . . 1.91 111.983 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.95 155.67 15.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.944 2.211 . . . . 2.04 114.802 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -142.42 -13.8 0.78 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.636 1.174 . . . . 4.4 114.01 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 m 77.15 -41.34 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.511 1.925 . . . . 3.51 112.528 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -68.73 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.677 1.991 . . . . 6.15 109.233 160.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.492 ' CB ' ' H ' ' A' ' 171' ' ' ASP . 6.4 t 62.77 175.4 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 127.412 2.285 . . . . 3.7 112.976 -167.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.65 1.55 1.71 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.602 2.868 . . . . 7.89 114.148 142.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 15.7 t70 121.04 6.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 129.813 3.245 . . . . 4.63 113.421 158.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -12.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 119.976 -1.703 . . . . 2.77 111.774 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.86 -61.05 8.17 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 116.552 -1.69 . . . . 2.07 112.098 169.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.55 -32.24 79.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.62 1.546 . . . . 1.89 112.74 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -60.97 -58.02 10.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.991 1.269 . . . . 3.11 112.555 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.453 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 21.4 tp10 -62.64 -32.74 73.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.571 -1.331 . . . . 4.09 112.47 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.6 mt -67.59 -22.46 65.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.258 -1.353 . . . . 2.97 114.008 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -74.04 -58.88 3.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.274 1.397 . . . . 3.11 109.573 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 3.8 ptpt -60.93 -24.79 66.3 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.771 -1.205 . . . . 3.53 112.509 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.0 tpp -56.09 -32.27 64.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.801 1.241 . . . . 3.14 113.591 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.7 mm -71.66 -60.97 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.542 1.065 . . . . 1.78 109.053 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -56.19 -28.42 58.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.512 -1.232 . . . . 4.07 113.476 170.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.51 -52.27 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.996 1.725 . . . . 2.04 111.536 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.64 -42.17 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.808 1.186 . . . . 2.62 112.701 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -69.02 -29.69 67.91 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.126 0.965 . . . . 3.74 113.452 -167.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.24 -36.91 84.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.146 1.778 . . . . 2.57 111.965 170.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.47 -43.25 72.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.567 1.147 . . . . 2.04 110.886 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.19 -40.75 82.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.072 0.549 . . . . 2.94 111.409 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 75.5 m -70.45 -35.93 73.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.221 1.009 . . . . 2.64 113.109 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.29 -28.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.144 -0.973 . . . . 2.41 111.136 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 68.52 -17.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.948 2.203 . . . . 3.34 116.948 149.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.5 p -72.28 -25.08 61.46 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.051 2.141 . . . . 3.56 110.778 162.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.95 149.38 73.82 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.647 1.979 . . . . 2.66 112.626 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HA ' ' HE3' ' A' ' 299' ' ' LYS . 62.3 Cg_endo -66.29 150.54 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.179 1.92 . . . . 2.81 108.474 158.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.43 141.19 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.145 0.974 . . . . 3.97 111.842 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.72 117.23 34.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.393 -1.276 . . . . 2.72 108.784 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.9 m -99.22 101.98 14.47 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.854 1.261 . . . . 1.88 108.781 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.75 147.58 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.696 1.597 . . . . 1.25 111.589 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.259 3.4 pp -145.78 149.73 34.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.614 1.197 . . . . 3.05 113.009 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -117.77 106.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.499 1.92 . . . . 2.37 107.846 -167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 237' ' ' VAL . 36.8 mm -89.19 105.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.482 1.113 . . . . 1.31 109.487 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 m -68.48 119.97 13.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.719 . . . . 2.01 110.113 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.5 pt -87.75 -14.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 115.196 1.554 . . . . 2.14 115.196 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.69 139.85 20.55 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.171 0.988 . . . . 4.7 108.757 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.5 -10.55 8.64 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.249 2.633 . . . . 2.5 113.852 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 139.37 54.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.387 1.075 . . . . 7.23 108.745 169.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 153.09 -6.09 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 131.741 4.016 . . . . 8.79 113.714 -161.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 20.7 t0 173.21 169.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.122 3.369 . . . . 5.66 107.492 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 211' ' ' GLU . 1.9 t -69.89 -116.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.249 -1.76 . . . . 3.08 106.249 146.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -121.5 -16.07 7.88 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.792 -1.192 . . . . 3.67 113.035 158.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 16.5 mp0 -65.32 -34.13 77.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.413 2.285 . . . . 3.05 113.993 -171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.08 67.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.586 1.539 . . . . 2.33 111.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.49 -44.98 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.661 0.664 . . . . 1.97 109.896 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.57 75.47 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.97 0.908 . . . . 1.23 111.968 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.421 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 27.1 m-80 -64.55 -34.56 78.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.669 0.988 . . . . 3.94 113.669 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.11 -53.5 17.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.371 0.987 . . . . 4.59 111.178 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.67 -39.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.694 1.598 . . . . 1.69 112.315 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -64.89 -19.47 65.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.807 1.41 . . . . 3.47 114.807 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -97.5 -27.45 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.133 0.973 . . . . 4.4 112.463 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.32 -56.33 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.489 1.116 . . . . 3.33 111.378 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 t -179.3 129.91 0.26 Allowed Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 121.028 -1.045 . . . . 2.25 112.331 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.93 -9.16 25.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.356 2.704 . . . . 2.54 113.426 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -71.34 -23.65 61.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.937 0.895 . . . . 2.89 112.054 167.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.5 tt -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.646 1.178 . . . . 2.29 109.525 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.9 t -115.15 135.71 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.753 0.421 . . . . 1.66 111.647 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.49 125.19 8.49 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 124.42 1.01 . . . . 0.96 112.235 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.87 142.87 46.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.603 1.161 . . . . 2.2 113.236 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 36.6 p -147.71 154.4 40.52 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.925 2.09 . . . . 2.54 110.674 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.53 -164.94 12.01 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.165 0.888 . . . . 1.9 111.287 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.1 -176.18 2.05 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.383 1.473 . . . . 2.91 108.541 168.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.04 64.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.789 0.835 . . . . 7.48 111.279 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -77.2 -46.66 22.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.899 2.08 . . . . 3.7 110.875 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.57 -27.27 58.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.064 0.847 . . . . 4.57 112.26 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.75 -46.29 79.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 118.493 -0.765 . . . . 2.36 111.711 159.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.41 -53.28 59.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.108 1.322 . . . . 4.07 109.372 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -40.46 -61.43 0.92 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.678 1.591 . . . . 2.54 112.589 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' CG2' ' A' ' 201' ' ' ILE . 27.4 m -79.37 -36.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.512 0.93 . . . . 2.72 113.512 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.05 97.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.704 1.138 . . . . 3.19 111.089 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -77.18 -44.93 28.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.428 1.891 . . . . 5.64 112.803 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.29 82.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.007 1.276 . . . . 3.24 112.363 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.38 12.44 18.41 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.543 0.942 . . . . 3.45 113.543 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 48.21 43.03 18.46 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.189 2.196 . . . . 8.43 113.991 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.5 t -79.46 114.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.927 1.291 . . . . 3.1 110.023 -168.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -84.5 127.73 34.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.494 0.664 . . . . 6.07 112.289 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.79 169.31 24.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.428 1.491 . . . . 4.24 111.707 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -147.25 137.21 12.16 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.156 -0.926 . . . . 4.06 110.698 162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.67 157.91 58.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.52 2.147 . . . . 3.13 110.496 162.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.63 -176.37 50.3 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.513 -0.767 . . . . 2.61 112.95 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.15 157.63 60.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.743 1.629 . . . . 4.97 108.6 159.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -90.9 156.31 18.09 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.487 0.551 . . . . 5.7 112.487 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.42 -168.99 1.63 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.405 1.082 . . . . 9.15 111.064 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.76 -37.68 59.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.551 -0.718 . . . . 11.57 111.533 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -86.79 24.17 1.54 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.126 1.37 . . . . 9.72 111.486 168.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 83.12 -58.95 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.751 2.82 . . . . 7.05 114.687 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -25.96 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.925 2.49 . . . . 6.07 117.272 -153.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.19 21.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.639 2.376 . . . . 6.82 115.836 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -24.47 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 128.45 2.7 . . . . 4.93 114.504 -166.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.76 140.69 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 127.041 2.136 . . . . 2.89 112.852 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.95 147.22 26.81 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.374 1.07 . . . . 3.41 109.815 152.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.95 126.35 10.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.615 0.598 . . . . 2.52 112.615 -174.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -62.4 114.72 3.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.665 -1.235 . . . . 3.58 107.665 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.2 OUTLIER -72.18 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.764 0.792 . . . . 2.86 109.63 -179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 51.1 mt -107.19 148.76 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.102 2.161 . . . . 2.98 107.534 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 45.3 ttp -145.74 118.73 8.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.258 1.423 . . . . 3.12 109.99 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.12 142.48 27.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.95 -1.094 . . . . 2.72 112.032 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.6 tp -101.78 130.22 48.15 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.516 1.127 . . . . 2.13 108.613 170.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.4 mt -123.9 120.2 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.872 -1.158 . . . . 2.55 107.872 170.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.84 153.03 30.74 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.083 -0.843 . . . . 2.91 111.069 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.47 99.08 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.743 2.295 . . . . 3.13 111.798 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -178.34 -39.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.325 3.05 . . . . 5.8 111.348 159.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.85 -25.96 2.65 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 117.767 1.867 . . . . 3.51 117.767 162.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -78.73 40.7 0.39 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.231 2.016 . . . . 6.08 115.132 -165.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 274' ' ' LEU . 2.8 t80 62.51 -172.67 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.669 1.187 . . . . 3.64 110.149 -168.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.41 ' N ' ' CG ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -157.45 -58.88 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.015 -1.678 . . . . 2.97 112.378 175.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -161.07 166.11 28.63 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.604 1.562 . . . . 3.11 110.0 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -144.46 144.95 31.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.932 1.825 . . . . 3.33 115.11 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -129.74 -174.94 3.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.821 2.848 . . . . 3.04 109.362 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 152.71 -143.69 10.6 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 121.412 -0.805 . . . . 2.02 112.534 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -46.23 129.48 10.23 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.69 1.196 . . . . 3.66 112.821 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 94.18 -8.14 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 130.264 3.426 . . . . 5.35 114.166 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 21.2 mmtt -69.15 141.92 54.49 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.859 -1.15 . . . . 4.06 113.384 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -142.02 147.38 36.79 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.64 1.976 . . . . 6.2 111.411 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -41.68 -63.46 0.71 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.504 1.921 . . . . 2.02 112.573 -169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.33 -19.16 74.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.265 0.484 . . . . 1.57 113.98 -169.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.57 -39.61 11.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.38 1.872 . . . . 4.49 110.125 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.65 -49.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.965 0.906 . . . . 1.5 109.617 164.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.78 83.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.973 0.909 . . . . 1.43 110.95 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.67 84.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.42 1.009 . . . . 1.48 113.696 174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 34.4 m -64.04 -60.31 3.4 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 2.16 110.263 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.66 -39.16 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 3.13 110.875 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.12 -15.83 58.02 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.746 -1.221 . . . . 2.05 113.57 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.4 m -71.08 -55.97 7.12 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.314 1.416 . . . . 1.63 109.978 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -68.27 -18.63 64.58 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.478 1.288 . . . . 2.32 114.478 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 77.7 mtm -81.9 -19.54 40.62 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 119.947 -1.721 . . . . 6.08 114.422 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -50.93 -45.44 87.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-O 116.65 -1.643 . . . . 5.9 113.123 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.45 2.74 3.1 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.34 2.693 . . . . 2.25 115.485 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -135.38 30.86 3.2 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 120.569 1.531 . . . . 3.18 114.817 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -49.24 127.93 15.75 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.63 -1.294 . . . . 9.88 112.351 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 194' ' ' PRO . 14.9 ttmt -78.41 -61.3 2.05 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.715 1.606 . . . . 8.91 111.507 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.9 140.23 21.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.504 0.928 . . . . 11.44 113.504 159.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.569 1.547 . . . . 8.31 112.319 -174.322 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 118.316 -0.85 . . . . 17.7 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -65.56 151.5 46.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.399 0.68 . . . . 17.17 112.086 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 176.86 173.59 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 130.15 3.38 . . . . 15.61 108.308 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.33 50.05 62.11 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 115.646 1.019 . . . . 14.65 115.646 160.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 0.8 OUTLIER 41.2 67.47 3.0 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.119 1.768 . . . . 15.39 112.804 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -70.31 177.75 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.62 2.213 . . . . 9.48 112.256 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.64 71.85 3.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.504 1.122 . . . . 9.57 108.647 170.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.3 mt 139.28 142.62 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 1 C-N-CA 133.673 4.789 . . . . 10.08 107.645 -168.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.29 -51.29 6.19 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.539 -0.726 . . . . 4.24 112.838 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -161.2 144.93 10.32 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.265 1.032 . . . . 2.55 113.966 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.0 68.4 7.92 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.299 2.666 . . . . 3.11 110.859 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 16.3 p90 -103.07 163.53 12.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.102 1.361 . . . . 2.27 112.926 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.3 p -139.97 56.4 1.63 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.435 1.112 . . . . 2.71 113.83 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 19.9 mt -70.52 149.3 47.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.772 2.029 . . . . 1.87 112.841 -173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 140.85 35.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.946 1.298 . . . . 1.59 109.936 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.3 p -97.13 155.06 16.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.49 1.138 . . . . 1.22 111.834 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -59.08 -21.62 59.48 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.915 2.086 . . . . 1.24 113.959 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 m -82.52 -21.8 35.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.867 1.667 . . . . 2.09 111.318 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.09 -37.38 2.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.96 1.267 . . . . 1.78 114.053 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 159.93 32.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.436 1.894 . . . . 5.01 110.838 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.74 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.367 1.067 . . . . 7.81 113.266 168.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -140.2 158.34 44.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.178 1.791 . . . . 3.75 110.731 -170.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.1 p -129.65 161.12 31.31 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.958 1.703 . . . . 2.03 110.171 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -54.46 -34.15 60.98 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.848 0.459 . . . . 3.45 110.88 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -71.82 -19.41 61.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 117.433 2.383 . . . . 6.56 117.433 173.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.14 -40.92 71.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.413 1.006 . . . . 2.67 111.242 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -83.57 -36.21 24.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.383 0.883 . . . . 2.18 113.383 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.07 115.92 11.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.191 -0.943 . . . . 3.87 111.062 -171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.36 5.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.006 1.765 . . . . 1.38 113.239 -168.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -119.67 173.6 6.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.761 1.624 . . . . 3.0 107.669 152.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.91 140.87 44.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.249 0.62 . . . . 1.32 111.381 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.92 150.85 46.38 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.489 -0.757 . . . . 3.18 112.946 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -133.32 106.9 7.79 Favored 'General case' 0 CA--C 1.527 0.066 0 C-N-CA 124.734 1.214 . . . . 2.6 109.016 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 199' ' ' LEU . 30.3 mt -111.79 112.87 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.445 0.698 . . . . 1.77 111.147 -172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.73 133.81 52.29 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.34 1.456 . . . . 4.3 111.988 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.83 85.78 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.601 1.16 . . . . 3.06 110.711 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.19 177.99 21.12 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.987 1.756 . . . . 2.41 114.136 -171.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -159.73 139.19 11.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 115.257 1.577 . . . . 5.57 115.257 166.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.0 m -72.97 -39.07 66.43 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.115 2.966 . . . . 3.38 114.402 -166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -51.42 -28.88 14.14 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.846 1.659 . . . . 5.17 113.823 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . 0.257 21.0 p -126.1 85.39 59.75 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.104 1.762 . . . . 2.82 107.162 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.81 63.72 7.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.535 3.49 . . . . 5.28 108.747 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.84 -87.54 0.64 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.954 1.702 . . . . 4.51 108.513 -170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.15 -29.87 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.608 1.095 . . . . 2.79 112.265 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 71.2 m -50.41 -69.02 0.31 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-O 116.224 -1.846 . . . . 2.01 113.282 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.34 -38.82 41.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.904 2.403 . . . . 1.59 112.913 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -60.72 -36.45 78.88 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.845 0.748 . . . . 3.65 112.106 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.08 -30.85 18.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.696 0.999 . . . . 3.08 113.696 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.77 -44.41 93.9 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.541 1.064 . . . . 2.59 111.128 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.88 75.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.042 0.837 . . . . 5.24 111.484 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -62.57 -37.41 86.08 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 119.806 -1.809 . . . . 3.64 111.87 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.2 mtt -70.77 -44.32 66.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.574 1.15 . . . . 3.55 113.322 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.38 -40.53 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 119.587 -1.946 . . . . 2.07 109.051 -166.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.416 ' O ' ' HE2' ' A' ' 283' ' ' LYS . 79.4 mt-30 -53.9 -28.27 35.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.934 1.294 . . . . 1.99 113.836 172.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.16 -36.51 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.936 1.698 . . . . 2.55 112.97 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.96 -29.24 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.552 1.978 . . . . 2.6 111.243 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -56.31 -59.99 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.25 1.82 . . . . 4.1 111.586 161.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.37 -33.41 72.41 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.321 1.23 . . . . 2.2 114.321 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.21 -49.65 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.883 1.673 . . . . 2.43 111.189 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.71 -45.87 87.99 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.193 0.933 . . . . 2.81 109.67 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.1 t -61.78 -39.86 93.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.124 0.97 . . . . 2.17 112.751 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.94 -17.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.345 -1.472 . . . . 2.3 112.767 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 76.1 m 62.57 13.7 6.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.844 1.202 . . . . 2.87 111.822 166.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.537 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 89.0 m -140.21 -11.55 1.09 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.194 1.398 . . . . 2.5 114.378 -165.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.34 155.83 83.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.904 -0.776 . . . . 3.03 108.904 160.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.12 133.92 9.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 N-CA-C 106.139 -2.293 . . . . 2.4 106.139 153.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.8 166.74 22.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.622 1.712 . . . . 3.37 115.622 -159.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.55 119.45 20.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.62 -1.173 . . . . 2.49 112.569 -160.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 m -93.32 108.07 30.62 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.897 1.279 . . . . 1.0 111.693 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.12 150.88 29.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.444 2.096 . . . . 0.84 111.806 165.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 227' ' ' LEU . 2.2 pp -147.21 151.0 35.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.62 1.2 . . . . 2.55 112.84 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -114.94 115.3 26.68 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.803 1.641 . . . . 2.38 108.201 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 23.1 mt -100.09 119.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.176 0.898 . . . . 1.62 109.919 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.0 m -65.35 137.0 57.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 163.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.6 pt -121.77 14.75 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 115.027 1.491 . . . . 2.48 115.027 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -123.91 59.7 18.57 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 125.447 1.499 . . . . 5.02 109.176 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.58 80.67 2.67 Favored 'Trans proline' 0 C--N 1.362 1.255 1 C-N-CA 125.835 4.357 . . . . 4.09 112.231 -155.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -165.14 -6.08 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.211 1.189 . . . . 5.38 114.211 -162.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.64 HH11 ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -163.27 1.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.962 1.838 . . . . 8.63 115.962 -175.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.95 86.6 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 129.479 3.112 . . . . 6.89 108.388 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.5 p -65.07 140.82 58.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.626 0.726 . . . . 3.0 110.135 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -59.62 -24.26 63.68 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 119.057 -0.496 . . . . 3.95 112.235 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -71.63 -43.16 66.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.652 2.381 . . . . 3.42 112.923 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.07 72.85 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.842 -1.162 . . . . 1.47 111.915 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.49 -44.81 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.612 0.765 . . . . 1.86 110.085 166.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.1 -34.89 61.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 118.255 -0.879 . . . . 1.08 113.305 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.01 -49.59 69.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.85 1.205 . . . . 4.73 112.232 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.578 -0.701 . . . . 4.17 111.329 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.75 -56.51 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.287 0.635 . . . . 1.27 112.091 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -21.16 66.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.991 1.108 . . . . 3.16 113.991 -173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.05 -34.21 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.046 0.938 . . . . 2.78 110.799 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.03 18.57 0.06 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.683 0.994 . . . . 3.43 113.683 162.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.8 p 100.81 151.86 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 130.146 3.378 . . . . 2.34 114.104 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.11 -4.97 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.565 . . . . 1.53 114.012 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -90.28 -11.02 42.06 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.164 0.986 . . . . 3.16 112.981 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 225' ' ' VAL . 1.6 tm? -80.08 143.43 33.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 2.52 109.86 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 224' ' ' LEU . 4.0 t -121.43 130.56 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 111.811 0.3 . . . . 1.32 111.811 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.08 116.14 5.47 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-O 119.255 -0.747 . . . . 0.92 112.205 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 199' ' ' LEU . 9.9 mp -111.48 139.26 47.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.507 1.523 . . . . 1.91 112.808 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.7 t -160.89 158.68 28.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.157 2.183 . . . . 2.57 109.626 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.72 -106.29 0.28 Allowed Glycine 0 N--CA 1.462 0.423 0 O-C-N 120.548 -1.345 . . . . 1.96 110.861 170.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -129.98 174.26 9.93 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.138 1.375 . . . . 3.5 109.09 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -48.43 -36.79 15.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.245 1.818 . . . . 6.0 112.185 172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -77.4 -36.88 52.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.217 1.407 . . . . 3.26 113.028 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.16 -45.4 63.56 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.313 -0.867 . . . . 4.2 111.152 172.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 38.2 t -55.87 -40.7 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 118.66 -0.686 . . . . 2.08 111.758 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.9 -53.02 62.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.187 -1.387 . . . . 3.55 110.811 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -47.27 -51.29 19.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.901 1.682 . . . . 3.0 113.374 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.36 -42.26 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.896 0.702 . . . . 3.43 112.896 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.42 83.11 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.485 1.039 . . . . 2.1 111.844 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -77.91 -47.84 17.75 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.667 2.787 . . . . 3.83 112.083 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.65 -38.82 67.55 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.233 1.197 . . . . 2.7 114.233 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -78.21 -19.06 54.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.742 0.817 . . . . 3.08 112.919 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.99 55.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.293 2.237 . . . . 5.4 111.877 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -77.19 -175.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.242 1.017 . . . . 3.88 112.558 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -156.3 138.31 14.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.133 1.773 . . . . 8.22 110.768 167.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -169.63 174.94 5.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.218 1.807 . . . . 3.41 110.206 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.4 t -147.53 150.3 36.65 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 119.645 1.112 . . . . 4.86 113.272 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.77 125.16 3.67 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.83 2.353 . . . . 3.08 109.995 167.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.89 177.5 29.11 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.926 0.774 . . . . 2.32 113.619 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.98 159.7 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.724 2.949 . . . . 4.55 112.183 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -110.6 170.88 7.8 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.271 1.028 . . . . 5.22 110.79 155.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.07 -112.36 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.326 -0.99 . . . . 7.88 108.326 156.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -121.08 -39.9 2.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.554 1.525 . . . . 8.67 112.962 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.65 1.14 12.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.79 1.404 . . . . 9.35 114.79 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.282 0.0 OUTLIER 142.05 -25.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.468 2.707 . . . . 9.11 113.904 132.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -51.98 106.14 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.556 1.317 . . . . 6.54 114.556 -151.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.38 73.92 4.93 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.981 1.372 . . . . 4.88 111.404 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 56.8 mt -70.17 81.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.972 1.309 . . . . 3.44 109.285 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.21 135.43 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.342 -0.614 . . . . 2.94 109.342 158.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.14 76.99 8.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.591 1.556 . . . . 5.06 107.89 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.461 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 14.5 p80 -81.44 115.25 20.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.132 -0.94 . . . . 2.5 109.671 169.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.5 t -64.57 163.46 13.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.111 0.957 . . . . 3.69 111.474 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 tp -100.14 93.56 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.417 1.103 . . . . 4.73 111.225 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.94 132.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.832 -1.173 . . . . 3.06 107.832 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -129.71 131.74 46.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.794 1.238 . . . . 3.33 109.933 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -105.14 127.16 52.78 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.094 1.758 . . . . 2.72 111.4 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.36 114.17 26.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.455 -1.313 . . . . 2.09 107.455 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mt -112.71 139.17 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.818 -1.549 . . . . 2.5 106.818 169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -74.55 -174.48 32.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.418 -0.673 . . . . 1.24 111.418 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.76 163.56 36.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 N-CA-C 108.382 -1.43 . . . . 2.7 108.382 153.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 78.96 -16.16 0.7 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.563 1.69 . . . . 5.83 115.563 158.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.65 47.49 0.21 Allowed Glycine 0 N--CA 1.479 1.531 0 N-CA-C 119.91 2.724 . . . . 4.26 119.91 159.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -153.55 161.52 42.14 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.465 2.133 . . . . 5.13 113.233 165.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.73 144.77 56.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.277 2.231 . . . . 4.62 110.666 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.33 -38.52 2.78 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.431 0.901 . . . . 2.79 113.431 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -158.65 152.61 23.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.451 1.023 . . . . 2.73 113.612 -161.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -122.56 121.81 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.228 1.811 . . . . 7.24 110.162 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.87 147.18 29.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.883 -1.154 . . . . 3.65 107.883 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.14 74.48 0.06 OUTLIER Glycine 0 N--CA 1.467 0.716 0 O-C-N 121.566 -0.709 . . . . 3.4 111.925 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 59.4 177.56 0.08 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.399 1.48 . . . . 4.53 110.574 -155.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.41 -44.15 0.57 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.385 2.274 . . . . 5.86 113.141 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.9 136.44 55.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.476 1.91 . . . . 4.41 111.091 163.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -147.52 148.85 31.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.14 1.776 . . . . 6.51 108.854 -170.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 182' ' ' GLN . 18.7 tptp -39.64 -61.44 0.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.962 1.705 . . . . 1.81 113.504 -165.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.39 -17.33 76.07 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.015 0.766 . . . . 1.23 115.015 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.5 -38.42 13.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 4.9 110.327 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.76 -44.68 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.004 0.922 . . . . 1.26 109.692 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.31 80.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.411 0.684 . . . . 0.98 112.496 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.52 73.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.825 1.193 . . . . 1.25 113.132 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -56.74 17.84 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.88 1.272 . . . . 1.82 110.328 167.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.04 -38.63 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.355 -0.841 . . . . 2.12 111.613 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.63 -34.61 78.25 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.151 -0.968 . . . . 1.27 112.708 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 54.2 m -64.84 -47.26 78.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 1.45 110.093 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -75.75 -27.52 58.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.452 1.101 . . . . 2.12 113.483 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.1 ttp -64.56 -34.2 77.7 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.042 -1.661 . . . . 3.85 111.49 167.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.44 -52.82 46.32 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 115.998 -1.954 . . . . 4.57 112.998 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.91 -22.79 17.02 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.283 3.322 . . . . 1.81 115.118 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.93 177.6 5.84 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 120.257 1.389 . . . . 2.94 113.106 -162.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -42.85 137.15 2.41 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.883 -1.508 . . . . 10.37 110.879 155.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -144.1 -83.68 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.653 0.781 . . . . 8.75 111.646 -159.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 192' ' ' THR . 90.7 mttt -97.86 84.07 3.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.68 -1.23 . . . . 12.67 107.68 141.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 129.077 2.951 . . . . 10.58 110.127 -167.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 119.422 -0.323 . . . . 20.89 110.711 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 133' ' ' LYS . 76.9 t80 -78.69 175.81 10.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.643 1.177 . . . . 17.08 110.848 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.5 m -65.92 74.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.641 1.977 . . . . 13.54 110.328 167.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.58 -154.69 44.21 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.92 0.772 . . . . 9.69 112.97 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 130' ' ' PHE . 25.7 mtmt 82.41 149.45 0.11 Allowed Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 128.975 2.91 . . . . 11.05 111.672 -167.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.77 -38.86 7.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.722 2.281 . . . . 9.79 111.289 166.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.1 mt -100.83 100.64 11.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.703 1.601 . . . . 9.47 108.881 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.57 -45.56 71.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.802 0.841 . . . . 7.84 112.572 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.77 -150.75 7.19 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.168 1.366 . . . . 3.19 113.483 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.3 114.54 5.01 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.711 -1.605 . . . . 3.25 109.568 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.57 98.01 1.06 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.723 2.282 . . . . 2.71 109.372 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -96.01 164.7 12.6 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.27 1.428 . . . . 2.35 110.999 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 p -144.53 60.24 1.33 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.339 1.542 . . . . 2.16 113.245 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.31 164.13 27.11 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.587 -1.321 . . . . 2.09 112.036 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -99.72 145.19 27.94 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.615 1.566 . . . . 1.55 108.022 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.2 p -86.76 165.5 15.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.491 0.716 . . . . 1.41 111.674 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -55.52 -30.0 59.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.187 0.995 . . . . 1.54 112.825 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -62.14 -53.64 52.44 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.522 1.529 . . . . 2.69 110.751 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' HA2' ' HE3' ' A' ' 210' ' ' LYS . . . 110.41 18.69 8.41 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 123.898 0.761 . . . . 1.9 112.808 -155.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 172.18 8.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 4.71 108.018 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.92 108.51 5.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.697 -1.252 . . . . 5.08 110.775 -161.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -122.46 147.86 45.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.79 1.404 . . . . 3.12 114.79 -161.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 45.6 p -135.63 178.56 6.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.31 2.244 . . . . 1.89 110.335 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.18 -21.91 62.29 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.601 0.76 . . . . 5.19 112.886 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -92.39 -26.84 17.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.113 1.365 . . . . 7.94 112.325 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.13 -38.84 75.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.429 1.092 . . . . 2.88 111.058 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -89.32 3.76 51.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.508 1.299 . . . . 2.45 114.508 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 63.0 tp -68.53 109.32 3.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.423 1.011 . . . . 4.7 111.027 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.89 -14.77 2.86 Favored Glycine 0 N--CA 1.475 1.247 0 N-CA-C 117.662 1.825 . . . . 1.87 117.662 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.21 153.54 50.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.251 2.025 . . . . 3.34 111.105 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -63.57 136.05 57.26 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.79 0.723 . . . . 1.91 112.39 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.29 149.86 35.31 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.981 0.912 . . . . 2.16 111.343 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -142.01 112.46 7.12 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.412 -1.329 . . . . 3.14 107.412 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.63 109.2 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.128 0.971 . . . . 1.72 109.083 -157.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -102.41 141.01 35.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.634 1.174 . . . . 3.61 111.705 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -105.69 111.91 24.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.612 0.765 . . . . 2.65 112.001 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -148.35 -179.24 24.14 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.697 1.039 . . . . 1.71 115.697 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.41 ' CE1' HG23 ' A' ' 258' ' ' VAL . 11.7 p90 169.58 154.98 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.829 3.252 . . . . 4.95 109.724 -176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.5 p -116.48 54.36 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.679 1.192 . . . . 3.63 112.711 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -89.39 -19.67 24.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.076 -0.964 . . . . 5.25 110.838 155.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.22 177.28 1.21 Allowed Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 118.928 0.785 . . . . 2.64 112.121 -157.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 -169.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.475 2.783 . . . . 6.07 112.152 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.74 23.38 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.452 1.901 . . . . 5.3 111.768 -159.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.11 -9.79 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.759 2.424 . . . . 2.94 111.869 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 1.3 m -76.42 -62.46 0.68 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.462 2.305 . . . . 1.8 111.88 164.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.84 -27.94 11.89 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.394 2.062 . . . . 1.72 115.218 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -51.38 -61.64 2.12 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.742 2.064 . . . . 3.06 115.766 -160.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -82.7 -16.68 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.103 -0.998 . . . . 3.91 112.702 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.69 -42.88 85.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.593 1.157 . . . . 2.3 110.457 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -54.66 44.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.047 1.739 . . . . 3.24 109.501 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -63.81 -25.12 68.03 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.62 -1.925 . . . . 4.0 113.027 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -72.39 -36.7 68.75 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.384 1.874 . . . . 4.19 113.068 165.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 tp -71.48 -44.02 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 120.523 1.511 . . . . 2.21 109.839 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.47 ' CB ' ' HE2' ' A' ' 283' ' ' LYS . 68.1 mt-30 -56.69 -0.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.72 2.008 . . . . 1.62 114.701 164.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.15 -49.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.676 1.591 . . . . 2.17 111.18 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.98 -15.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 121.025 1.739 . . . . 4.01 114.066 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -92.93 -39.37 11.18 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.151 0.797 . . . . 4.69 113.151 164.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.71 -33.99 76.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.327 1.451 . . . . 2.88 112.244 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.7 -36.73 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 123.96 0.904 . . . . 3.11 112.115 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -57.56 -36.97 72.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.787 1.635 . . . . 3.68 110.087 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.3 m -60.88 -10.46 5.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.465 1.283 . . . . 2.67 114.465 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.56 -4.78 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.692 1.197 . . . . 2.4 111.433 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.267 1.6 t 64.94 -34.21 0.17 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 130.437 3.495 . . . . 3.85 118.069 157.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -30.89 44.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.512 -1.368 . . . . 4.14 110.012 161.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.75 154.39 26.8 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.382 -0.824 . . . . 3.75 110.513 162.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.0 154.65 22.72 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.571 2.18 . . . . 3.62 112.772 -164.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.7 145.78 53.55 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.422 0.629 . . . . 3.83 110.017 158.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.0 tt -144.28 126.87 16.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 2.55 111.407 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.1 m -99.33 104.87 29.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 125.535 1.534 . . . . 1.05 109.004 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.94 144.85 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.159 1.906 . . . . 0.84 111.095 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.08 130.14 17.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 122.297 1.046 . . . . 2.38 112.191 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -102.08 107.42 18.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.493 1.917 . . . . 2.06 108.393 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mt -87.72 119.56 35.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.331 -0.989 . . . . 1.42 108.331 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -83.21 151.32 25.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.65 -1.159 . . . . 2.4 111.083 164.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.43 27.43 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 114.759 -1.11 . . . . 2.07 110.522 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -122.08 75.06 39.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 128.317 2.647 . . . . 3.19 109.539 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -88.38 61.47 3.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.813 3.009 . . . . 2.42 112.901 -152.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -179.77 -75.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.327 2.251 . . . . 5.69 108.721 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -45.4 83.35 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.903 1.681 . . . . 7.77 112.086 -171.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.32 71.35 7.12 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 123.413 1.578 . . . . 5.89 109.688 169.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 m -59.28 140.16 56.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 113.106 -1.861 . . . . 3.61 108.906 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.42 ' HE3' ' HA2' ' A' ' 147' ' ' GLY . 9.1 ptmm? -53.84 -32.09 51.74 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.294 1.22 . . . . 3.17 114.294 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -66.46 -42.96 86.78 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.668 1.587 . . . . 2.77 113.105 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.05 89.03 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.079 -1.013 . . . . 1.52 110.913 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 59.1 mt -60.08 -43.2 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.121 0.568 . . . . 1.76 110.593 171.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.76 68.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.006 0.821 . . . . 0.96 112.94 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -70.47 -31.93 69.26 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.899 0.772 . . . . 3.72 112.83 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.33 -44.16 53.63 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.42 1.088 . . . . 2.85 111.704 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -54.96 -47.69 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.975 2.11 . . . . 1.22 112.747 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -61.58 -28.0 69.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.33 0.863 . . . . 3.03 113.33 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.71 -37.77 76.7 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.114 0.566 . . . . 3.66 110.27 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -79.97 36.8 0.35 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.308 1.043 . . . . 3.24 113.036 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.0 t 83.19 141.05 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.976 2.511 . . . . 2.16 112.14 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.04 -10.04 27.17 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.904 2.403 . . . . 1.71 114.715 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -79.06 -9.23 59.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.7 1.37 . . . . 2.8 114.7 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tt -80.83 145.97 31.14 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.105 1.775 . . . . 1.88 112.517 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.4 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.19 0.996 . . . . 1.32 109.522 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -108.96 148.45 16.91 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 124.108 0.861 . . . . 0.74 111.943 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.3 mp -139.61 149.32 43.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.145 0.978 . . . . 1.97 113.424 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.1 p -140.3 153.55 46.5 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 128.353 2.661 . . . . 2.75 109.899 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -141.54 -162.09 9.0 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.744 -1.743 . . . . 1.83 108.744 161.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.2 p -89.52 179.36 6.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.617 0.709 . . . . 3.05 109.635 163.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -56.03 -29.89 61.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.944 0.898 . . . . 5.81 112.352 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.0 -38.71 66.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.589 1.555 . . . . 3.33 112.119 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -73.19 -42.42 62.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.655 1.182 . . . . 3.76 110.472 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.37 -44.89 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.606 1.162 . . . . 1.85 112.2 165.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.53 -38.94 88.25 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.211 -0.93 . . . . 2.93 112.044 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.46 -37.61 78.61 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.931 -1.106 . . . . 2.44 112.882 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.58 -41.3 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.556 1.071 . . . . 2.73 111.546 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.39 70.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.448 0.699 . . . . 2.45 112.561 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -24.22 37.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.738 1.615 . . . . 5.2 113.738 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.76 -49.39 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.988 1.107 . . . . 2.6 113.988 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.98 -45.18 1.27 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.704 0.631 . . . . 3.02 112.704 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 46.0 mtt-85 125.91 149.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 1 C-N-CA 133.15 4.58 . . . . 5.23 108.966 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.05 153.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.025 1.73 . . . . 2.82 107.813 165.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -139.91 148.21 41.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 5.93 111.019 172.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -135.27 145.89 48.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 4.44 110.247 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.0 t -72.83 126.49 90.58 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.006 -0.997 . . . . 2.99 109.386 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -89.41 61.26 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.839 3.026 . . . . 3.0 110.695 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.31 118.87 5.68 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.343 -1.254 . . . . 2.97 111.811 -174.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.46 156.1 1.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.066 2.433 . . . . 3.95 112.951 -174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -100.55 -65.46 0.97 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.57 -1.27 . . . . 7.32 107.57 127.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -159.91 177.91 10.29 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 128.715 2.806 . . . . 7.99 107.542 162.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -73.01 13.69 0.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.549 1.685 . . . . 14.95 115.549 -172.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -139.28 -40.73 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.476 -1.39 . . . . 8.98 112.861 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.18 -33.85 59.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.628 1.571 . . . . 9.47 113.505 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . 0.283 1.6 t70 129.06 135.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 1 C-N-CA 132.086 4.154 . . . . 5.09 112.884 171.738 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -88.36 100.35 12.95 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.391 2.276 . . . . 5.71 109.932 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.97 63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.047 2.139 . . . . 4.47 109.435 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 166' ' ' PHE . 16.6 m -72.37 156.81 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.545 1.538 . . . . 2.86 111.451 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.63 163.53 37.63 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.056 2.142 . . . . 3.97 110.242 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.538 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.3 p80 -148.37 131.85 16.7 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.902 -1.749 . . . . 1.65 113.804 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -64.99 10.38 0.07 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.493 2.717 . . . . 3.31 117.471 -165.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.3 mt 57.98 48.97 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.479 1.512 . . . . 3.07 112.376 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.01 153.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.607 1.163 . . . . 2.91 110.466 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -152.44 137.59 17.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.519 1.127 . . . . 2.8 110.703 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -100.93 136.47 40.73 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.374 -0.829 . . . . 2.62 112.388 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.09 123.43 46.64 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.835 0.854 . . . . 1.9 109.52 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.15 129.42 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.23 1.412 . . . . 1.89 107.389 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.19 160.96 52.86 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.607 -0.552 . . . . 1.25 112.512 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.87 -41.79 42.73 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.253 3.302 . . . . 3.67 113.509 -168.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -70.21 4.43 2.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.697 1.599 . . . . 5.69 115.25 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 135.59 -66.53 0.56 Allowed Glycine 0 N--CA 1.476 1.303 0 N-CA-C 118.013 1.965 . . . . 2.91 118.013 157.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.58 -64.04 0.97 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.8 1.778 . . . . 4.85 115.8 -162.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -175.01 170.33 3.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.924 -1.11 . . . . 3.11 112.197 -151.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -150.81 -68.77 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.96 1.304 . . . . 2.6 110.881 160.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -158.98 -176.71 6.02 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.748 1.619 . . . . 3.14 112.538 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.65 143.51 48.65 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.294 1.045 . . . . 3.07 112.274 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -112.18 170.48 8.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.825 2.05 . . . . 2.77 108.862 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 125.46 120.14 2.41 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 124.332 0.968 . . . . 2.66 111.411 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 85.28 120.23 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.944 2.898 . . . . 3.93 111.166 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.9 14.76 5.47 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.326 1.051 . . . . 5.32 112.997 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 18.7 mmtt -76.44 -21.15 56.3 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.234 -1.541 . . . . 4.57 112.558 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 63.95 -148.3 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.664 1.986 . . . . 5.06 111.868 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.47 ' HE2' ' CB ' ' A' ' 182' ' ' GLN . 18.2 tptp -105.85 -89.48 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.996 1.319 . . . . 2.22 112.113 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.19 -16.61 58.09 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.601 0.62 . . . . 1.4 112.632 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -71.43 -29.18 64.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.708 1.603 . . . . 5.21 111.346 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 15.6 mt -70.75 -41.44 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.643 -1.286 . . . . 1.31 110.504 168.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.64 -42.75 99.77 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.806 -0.559 . . . . 1.16 111.308 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.18 -35.07 79.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.974 1.31 . . . . 1.22 112.595 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.4 m -63.33 -51.17 67.1 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.91 0.777 . . . . 2.17 111.269 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.37 -32.89 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.307 -0.87 . . . . 2.23 111.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.68 71.03 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.264 -1.522 . . . . 1.36 113.079 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.0 m -67.83 -49.05 64.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.964 0.906 . . . . 1.66 109.465 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -61.82 -27.73 68.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.635 1.174 . . . . 3.81 113.584 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.252 -1.53 . . . . 4.79 111.592 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -57.39 -51.92 78.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.011 -1.471 . . . . 4.26 112.347 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 -45.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.515 2.81 . . . . 2.17 113.164 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.83 11.4 28.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.415 1.086 . . . . 3.71 113.197 -158.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 20.8 ptt85 -29.31 129.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.242 1.817 . . . . 8.27 111.8 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -47.89 -39.69 19.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.367 0.877 . . . . 6.3 113.367 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.293 0.1 OUTLIER -164.03 -18.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.964 1.705 . . . . 12.28 111.881 129.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.476 0.87 0 C-N-CA 128.705 2.802 . . . . 7.29 109.854 156.008 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 117.532 -1.223 . . . . 19.07 109.592 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.58 -49.93 75.67 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.897 1.073 . . . . 17.58 113.897 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.12 -42.07 0.52 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 128.355 2.662 . . . . 13.09 114.251 171.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.87 158.5 21.95 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.022 1.296 . . . . 10.21 111.455 168.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 272' ' ' GLU . 60.9 pttt -67.62 123.23 86.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 118.418 -0.801 . . . . 11.77 111.47 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.8 165.12 17.92 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.453 2.769 . . . . 8.51 110.676 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.75 163.88 37.64 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.79 1.636 . . . . 6.73 111.044 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -132.57 145.1 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.479 1.111 . . . . 9.36 109.132 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.47 -143.77 16.76 Favored Glycine 0 N--CA 1.47 0.947 0 N-CA-C 110.381 -1.087 . . . . 5.45 110.381 -167.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.05 -89.07 0.53 Allowed Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.931 -1.483 . . . . 3.64 111.975 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.18 83.8 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.298 2.665 . . . . 3.68 110.754 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.86 148.62 25.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.351 0.661 . . . . 3.03 110.545 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.7 p -146.01 80.41 1.57 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.445 -0.784 . . . . 2.61 110.154 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.03 143.13 29.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.973 0.909 . . . . 2.32 108.99 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -75.27 132.16 40.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.238 -0.653 . . . . 2.74 109.238 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.5 p -63.93 173.09 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.635 1.207 . . . . 1.61 110.828 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -58.85 -33.93 71.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.552 1.541 . . . . 1.51 112.187 166.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -32.44 59.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.619 2.368 . . . . 2.94 112.168 171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.73 -8.48 13.03 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.759 1.647 . . . . 1.91 116.113 167.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 138.49 51.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.603 2.202 . . . . 6.2 111.649 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -83.01 64.6 7.71 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.976 -1.078 . . . . 4.89 113.02 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 155' ' ' TYR . 9.1 tmtt? -61.87 152.38 31.96 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.788 2.035 . . . . 5.38 112.541 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -117.22 -163.23 0.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.012 1.725 . . . . 2.59 110.55 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.29 -56.98 12.03 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.265 -1.522 . . . . 4.41 110.675 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 156' ' ' LEU . 17.8 mmtt -65.58 -21.43 66.59 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.421 1.637 . . . . 5.25 115.421 -156.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -19.3 65.47 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.928 1.24 . . . . 2.97 113.944 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.44 ' CD1' ' HE3' ' A' ' 150' ' ' LYS . 18.2 m-30 -109.72 12.31 24.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.658 1.355 . . . . 4.13 114.658 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 153' ' ' LYS . 5.2 mp -53.96 147.85 11.64 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.768 -1.208 . . . . 4.18 113.101 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.56 -19.45 54.62 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.806 1.193 . . . . 2.31 114.113 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -122.42 -179.41 4.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.451 1.125 . . . . 3.49 110.639 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -103.9 123.31 46.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.516 1.127 . . . . 2.06 111.819 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.88 126.29 37.89 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.708 -0.62 . . . . 2.65 109.865 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.39 123.38 48.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.915 -0.772 . . . . 2.78 108.915 163.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.73 123.02 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.987 1.715 . . . . 2.2 109.61 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -121.05 137.85 54.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.594 1.157 . . . . 3.57 113.095 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.19 93.07 6.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.503 0.668 . . . . 2.01 110.546 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.77 143.17 14.66 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.781 1.658 . . . . 2.07 110.142 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CZ ' ' CD2' ' A' ' 260' ' ' HIS . 0.0 OUTLIER -139.17 20.99 2.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.028 1.492 . . . . 5.1 115.028 -159.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m 70.25 -44.5 0.57 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.218 2.207 . . . . 2.91 114.815 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -82.99 -26.68 31.04 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.721 1.748 . . . . 6.14 115.721 -155.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.85 103.97 32.41 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.227 -1.768 . . . . 2.36 106.227 160.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.24 -16.64 3.19 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.45 2.1 . . . . 4.91 114.494 -143.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -99.16 -38.58 8.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.948 2.499 . . . . 4.1 113.116 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.14 -32.99 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.298 1.439 . . . . 3.71 113.019 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 54.3 m -68.86 -60.11 4.77 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 117.074 -1.441 . . . . 2.06 112.531 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 -28.74 16.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.509 2.806 . . . . 1.75 115.792 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.9 -60.25 3.5 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.903 2.138 . . . . 5.1 111.796 -171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -50.51 -45.96 56.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.619 1.168 . . . . 2.89 111.145 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 220' ' ' PHE . 1.5 tm? -64.32 -34.05 77.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.514 -0.755 . . . . 2.75 111.518 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.21 -50.92 69.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.774 1.23 . . . . 3.37 109.496 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -56.88 -39.41 74.32 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.673 -1.267 . . . . 5.21 110.678 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 44.9 mtt -69.43 -22.1 63.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.594 1.158 . . . . 3.78 113.39 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -65.05 -51.21 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.783 1.629 . . . . 1.8 108.9 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.512 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 49.0 mt-30 -60.53 -24.77 65.63 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.234 0.457 . . . . 2.08 112.234 -172.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.87 -44.97 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.609 1.163 . . . . 1.94 110.929 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.41 -19.7 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 111.818 0.303 . . . . 2.58 111.818 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -68.79 -44.83 72.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.118 1.367 . . . . 4.1 110.5 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -58.36 -46.14 86.86 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.234 0.827 . . . . 2.71 113.234 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.18 -41.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.208 -0.933 . . . . 2.56 112.855 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.57 -39.32 53.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.903 1.681 . . . . 2.21 111.122 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.3 t -73.0 -19.56 61.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.218 1.407 . . . . 2.09 113.081 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 23.1 mm -84.69 -28.65 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.818 -1.176 . . . . 2.88 111.781 165.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.3 m 67.42 -17.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 128.081 2.552 . . . . 2.39 114.394 166.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 32.4 m -84.28 -9.31 58.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.376 2.27 . . . . 2.48 111.768 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.65 173.27 4.93 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 126.391 1.876 . . . . 3.08 109.559 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 150.35 40.15 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.073 1.849 . . . . 2.49 109.876 167.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.11 147.65 24.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.116 1.367 . . . . 3.34 112.614 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 tt -131.24 109.64 10.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.356 1.062 . . . . 2.69 109.826 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.6 m -100.45 95.07 3.9 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 125.287 1.435 . . . . 1.84 109.934 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.33 153.12 50.52 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.261 3.308 . . . . 1.05 112.215 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.17 148.29 31.39 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 116.132 1.901 . . . . 2.58 116.132 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.9 137.08 48.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.878 1.271 . . . . 3.31 110.615 167.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.3 mm -106.24 123.6 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.696 -1.224 . . . . 1.62 107.696 155.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 89.9 p -81.22 147.13 30.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.643 0.777 . . . . 2.9 112.436 165.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.7 pt -137.42 -1.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 115.9 1.815 . . . . 1.6 115.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.32 66.32 4.48 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.542 1.137 . . . . 4.21 108.978 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.6 -10.8 29.25 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.247 3.298 . . . . 2.3 114.356 -162.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 206' ' ' GLU . 4.8 mp0 -77.59 1.75 18.64 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.09 1.756 . . . . 4.88 112.181 173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.94 -27.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.54 1.936 . . . . 7.58 113.246 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.16 81.98 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.905 1.682 . . . . 7.0 110.523 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 86.8 m -74.45 117.77 16.65 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.272 -1.381 . . . . 4.52 107.272 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -54.64 -32.03 58.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.081 0.771 . . . . 4.67 113.081 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -75.99 -36.38 59.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.075 2.15 . . . . 6.25 113.32 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.54 -40.02 85.01 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.635 -1.291 . . . . 2.38 110.269 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 60.0 mt -57.68 -46.82 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 117.657 -1.163 . . . . 1.94 110.098 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.71 82.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.484 1.493 . . . . 1.26 113.184 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -58.58 -46.4 87.0 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 118.702 0.683 . . . . 3.11 111.662 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -53.71 54.76 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.645 -0.66 . . . . 3.7 111.114 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.57 -44.52 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.839 2.056 . . . . 1.37 112.07 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -60.6 -36.34 78.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.264 1.026 . . . . 5.51 113.301 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -91.07 -24.13 20.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.748 1.018 . . . . 5.23 113.748 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 177' ' ' LEU . 4.6 m-85 -57.92 -45.63 86.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.368 0.985 . . . . 2.16 112.782 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -175.42 150.22 1.18 Allowed Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 125.293 1.437 . . . . 1.82 110.285 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -64.76 -16.86 57.48 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.526 2.151 . . . . 3.21 112.978 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -97.87 3.64 49.75 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.726 1.211 . . . . 2.94 113.74 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.53 135.74 33.7 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.833 -1.167 . . . . 3.03 109.937 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.35 168.86 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.89 1.676 . . . . 1.97 109.815 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -145.4 150.63 22.85 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 119.454 -2.029 . . . . 1.17 113.606 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.03 143.69 50.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.861 2.064 . . . . 1.75 112.233 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 27.5 m -146.75 148.77 32.29 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.851 2.46 . . . . 2.78 110.896 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.44 -166.17 14.34 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.449 1.023 . . . . 1.74 110.723 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -177.97 6.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.832 2.053 . . . . 3.79 109.255 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -66.04 -27.76 68.34 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.599 -1.191 . . . . 8.33 113.964 -170.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 33.8 mp0 -65.23 -46.44 80.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.729 1.604 . . . . 3.99 111.527 170.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.99 -42.46 69.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.632 1.173 . . . . 4.16 111.2 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.26 -36.58 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.524 1.13 . . . . 2.1 111.837 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -60.91 -54.37 45.93 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.814 1.188 . . . . 3.53 109.316 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -45.18 -55.73 5.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.653 1.115 . . . . 3.25 112.526 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 -19.83 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 114.682 1.364 . . . . 3.18 114.682 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.67 -45.01 16.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.871 1.214 . . . . 2.58 111.273 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -68.4 -36.9 79.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.564 2.346 . . . . 4.2 112.766 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.21 -58.76 4.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.189 1.395 . . . . 1.87 112.893 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -80.3 -9.42 59.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.877 0.871 . . . . 3.41 112.571 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 53.0 51.36 15.98 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.528 1.931 . . . . 5.93 110.024 -161.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 143.87 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.728 0.811 . . . . 2.54 111.204 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -81.45 129.3 34.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.78 0.8 . . . . 5.2 111.224 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -153.72 154.46 34.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.889 1.675 . . . . 3.8 110.392 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 27.6 t -115.1 86.41 13.84 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.761 0.824 . . . . 2.65 110.73 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 133.28 14.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.899 2.399 . . . . 3.47 110.728 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.0 81.49 0.29 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.765 -1.575 . . . . 3.26 112.732 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.42 129.09 13.43 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.186 2.591 . . . . 7.74 109.802 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -169.56 -59.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.761 1.224 . . . . 8.93 112.541 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.7 t0 75.35 -168.95 0.09 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.781 1.632 . . . . 9.57 110.902 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 77.32 -34.77 0.21 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.386 2.674 . . . . 10.83 115.096 161.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -160.18 -58.14 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.485 1.514 . . . . 8.94 110.967 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 1.45 42.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.652 1.353 . . . . 12.64 114.652 -166.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.5 t0 91.32 158.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.793 2.516 . . . . 6.07 117.793 147.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.25 95.75 1.33 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.787 1.235 . . . . 7.41 110.71 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 pt -144.82 140.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.179 0.992 . . . . 4.73 113.086 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 66.2 t -87.36 160.77 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 126.744 2.018 . . . . 3.41 109.988 157.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -118.4 146.36 44.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.666 1.986 . . . . 3.99 111.04 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.0 OUTLIER -124.59 99.1 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.662 1.985 . . . . 2.05 112.522 -168.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 m -74.4 70.67 1.73 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.77 1.228 . . . . 4.88 109.923 169.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -3.01 116.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 1 C-N-CA 131.915 4.086 . . . . 3.01 118.099 -177.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.9 mt -141.62 141.72 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.817 1.247 . . . . 2.52 108.698 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 mtt -111.24 148.15 33.47 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.754 1.622 . . . . 4.4 110.328 159.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -116.48 142.21 47.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.953 0.901 . . . . 2.9 111.883 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -101.76 128.79 47.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.285 1.434 . . . . 2.68 109.753 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.05 134.65 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.378 1.471 . . . . 3.25 108.997 166.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.47 -179.01 42.51 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.927 1.251 . . . . 1.78 113.459 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.57 156.43 65.6 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.745 2.296 . . . . 2.6 110.935 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.4 t0 69.47 -11.44 0.5 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.067 2.547 . . . . 7.2 113.227 -156.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.22 18.89 32.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.266 1.412 . . . . 3.53 114.048 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 133' ' ' LYS . 18.7 mt-10 -82.53 145.43 29.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.748 1.274 . . . . 5.89 113.794 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.36 136.28 56.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.63 1.172 . . . . 3.73 110.79 167.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.54 -63.35 1.46 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.64 0.776 . . . . 3.07 111.98 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -174.02 -179.18 1.64 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 3.68 111.17 -159.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -141.69 146.71 36.41 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.02 1.328 . . . . 3.39 113.967 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -135.8 179.57 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.401 1.881 . . . . 2.88 112.829 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.78 158.3 10.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.272 2.368 . . . . 2.67 112.303 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 45.78 -86.81 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.323 2.649 . . . . 4.61 115.649 166.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -56.07 -35.15 66.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.078 0.951 . . . . 6.12 113.246 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 9.5 mmpt? -88.66 101.25 13.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.855 1.662 . . . . 5.21 109.882 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.478 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 4.9 mpt_? -70.7 154.86 41.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.698 0.799 . . . . 7.84 111.06 -168.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.512 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 13.5 tmtt? -47.2 -50.33 21.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.33 1.452 . . . . 2.36 113.335 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.37 64.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 114.281 0.472 . . . . 2.0 114.281 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -70.75 -38.0 73.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.984 0.913 . . . . 5.5 110.996 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.01 -49.56 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.963 0.905 . . . . 2.27 110.187 172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.67 68.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.728 0.811 . . . . 1.63 111.844 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.97 91.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.429 -0.794 . . . . 1.86 113.08 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 13.2 t -68.47 -47.35 67.34 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.21 1.004 . . . . 2.9 111.184 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 10.1 tt -73.65 -27.55 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 2.98 112.364 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.55 73.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.415 -1.428 . . . . 2.28 111.854 165.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 59.2 m -70.19 -44.3 68.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.11 -0.947 . . . . 2.18 110.52 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -65.65 -26.01 67.61 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.297 1.221 . . . . 3.03 114.297 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.4 tmm? -70.32 -36.65 74.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.674 -1.266 . . . . 4.09 111.312 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -50.18 -48.36 79.9 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 115.813 -2.041 . . . . 6.23 114.22 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.69 -39.77 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.201 3.267 . . . . 2.81 114.142 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -29.58 28.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.017 1.28 . . . . 4.29 111.44 -170.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.25 178.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.199 2.6 . . . . 7.37 111.99 172.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 301' ' ' SER . 0.0 OUTLIER -133.31 -72.98 0.5 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.729 0.812 . . . . 5.78 113.123 166.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -165.29 24.6 0.05 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.9 1.444 . . . . 12.04 114.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.421 ' C ' ' HE3' ' A' ' 299' ' ' LYS . 5.1 t . . . . . 0 C--O 1.252 1.219 0 C-N-CA 130.702 3.601 . . . . 7.77 108.688 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.801 -1.095 . . . . 22.84 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -158.51 -173.86 4.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.636 1.174 . . . . 19.51 110.459 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 t -156.52 164.68 37.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.402 1.481 . . . . 19.29 111.394 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.36 4.7 57.59 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.597 1.094 . . . . 17.14 114.715 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt 173.11 152.69 0.24 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 129.502 3.121 . . . . 14.74 110.958 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.47 161.05 34.84 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.93 2.42 . . . . 12.76 109.794 161.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.3 146.65 48.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.429 1.092 . . . . 9.22 109.657 162.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.29 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 130.224 3.41 . . . . 8.41 106.826 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.39 -156.45 24.11 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.143 1.338 . . . . 3.52 113.669 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.42 -175.84 32.15 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 115.663 1.025 . . . . 3.3 115.663 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -89.35 159.07 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.269 2.646 . . . . 4.11 115.325 -155.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.37 166.04 25.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.986 -1.915 . . . . 3.89 111.187 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 t -146.6 112.96 5.9 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.531 1.132 . . . . 4.78 108.453 158.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.74 153.32 50.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.144 0.978 . . . . 2.95 111.377 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 121.79 20.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.98 -1.489 . . . . 2.51 106.98 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.8 p -59.2 153.06 19.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.706 -0.85 . . . . 2.25 108.706 161.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -49.51 -38.28 29.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.032 1.333 . . . . 2.09 112.769 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.8 m -62.72 -48.9 77.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.024 1.729 . . . . 3.9 111.533 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.77 -8.6 3.35 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.844 1.498 . . . . 2.47 116.844 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 136.76 44.8 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.263 1.531 . . . . 5.01 109.918 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -88.1 82.12 7.24 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.01 1.724 . . . . 7.68 110.102 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.06 145.87 33.59 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.151 -0.968 . . . . 4.58 112.03 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.6 p -99.67 170.5 8.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.02 1.328 . . . . 4.28 110.431 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.3 -58.51 5.49 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.374 0.421 . . . . 5.24 110.805 162.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -71.97 -10.58 59.97 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.363 1.986 . . . . 7.21 116.363 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -61.61 -50.56 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.221 0.918 . . . . 4.65 110.576 164.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.426 ' HB3' HE22 ' A' ' 158' ' ' GLN . 68.7 m-85 -83.48 -42.81 16.48 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.405 0.891 . . . . 3.52 113.405 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.92 114.79 3.57 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.417 0.687 . . . . 3.72 109.894 -165.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.03 -23.9 3.66 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.114 1.34 . . . . 2.26 114.039 -159.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.426 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -118.65 159.37 23.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.728 1.764 . . . . 3.63 109.835 159.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -62.92 142.11 58.44 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.531 -0.731 . . . . 2.65 112.833 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.5 mt -130.65 126.81 37.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.865 0.866 . . . . 2.79 111.477 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 97.26 5.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.86 -1.533 . . . . 4.33 106.86 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp -94.15 122.36 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.11 -1.441 . . . . 2.71 107.11 -171.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 165' ' ' GLY . 55.8 t80 -130.91 137.51 49.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.823 0.82 . . . . 3.32 112.964 -169.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 243' ' ' VAL . 97.0 m-85 -108.52 53.91 0.67 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 2.15 112.178 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 163' ' ' TYR . . . -101.11 56.12 0.75 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.875 1.226 . . . . 3.95 112.71 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -71.93 159.5 34.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.96 0.504 . . . . 5.14 111.866 171.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.2 t -85.87 -140.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.708 2.003 . . . . 5.05 112.436 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.6 m170 68.49 -24.52 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.575 3.15 . . . . 5.18 114.347 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 163.57 18.01 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-N 119.874 1.215 . . . . 3.38 109.869 159.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -58.15 -175.04 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.958 1 C-N-CA 125.32 4.014 . . . . 6.17 115.221 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.69 20.62 2.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.457 1.903 . . . . 4.74 113.094 -128.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.84 -16.61 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 115.02 -0.991 . . . . 2.67 111.344 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -54.55 22.6 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 127.237 2.215 . . . . 2.51 111.811 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.15 -28.81 12.33 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.978 2.452 . . . . 1.99 114.461 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -47.48 -57.63 5.14 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.337 1.606 . . . . 2.72 115.337 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.32 -21.59 45.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.774 -1.829 . . . . 3.65 112.663 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.54 -35.89 63.13 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.719 1.208 . . . . 3.08 111.976 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -53.75 -52.41 60.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.952 1.301 . . . . 3.8 109.502 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -58.68 -36.46 74.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.065 -1.022 . . . . 3.12 111.472 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.2 mmm -70.36 -23.39 62.79 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.765 1.394 . . . . 4.86 114.765 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.35 -50.91 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 120.691 1.587 . . . . 1.62 107.665 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -56.63 -41.95 78.01 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.856 -1.069 . . . . 1.9 110.751 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 t -54.93 -39.92 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.703 1.138 . . . . 1.87 113.453 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 18.0 m -79.59 -28.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.744 1.156 . . . . 2.79 111.869 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -39.12 66.71 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.862 1.21 . . . . 3.23 113.174 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.79 -23.66 65.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.788 2.035 . . . . 2.93 112.262 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 31.6 mt -92.3 -52.03 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 1.8 111.766 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -55.04 -40.79 70.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 2.98 111.135 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 m -68.09 -11.98 60.04 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.196 1.399 . . . . 2.6 113.841 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 78.6 mt -91.21 -30.41 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.529 -0.732 . . . . 2.35 110.329 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.7 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.02 2.528 . . . . 2.8 114.68 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -96.52 -6.35 37.27 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.716 3.206 . . . . 2.93 110.692 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.93 157.66 40.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.49 1.116 . . . . 2.74 108.423 166.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.11 139.53 32.77 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.368 2.046 . . . . 2.17 110.104 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.28 139.31 58.18 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.208 2.603 . . . . 4.28 113.709 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.64 119.55 17.4 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.946 1.461 . . . . 4.17 114.946 -169.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 m -99.53 114.73 65.79 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.722 1.609 . . . . 1.3 110.746 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.76 136.72 7.36 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.683 2.255 . . . . 0.91 111.989 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.33 107.04 9.64 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.822 1.249 . . . . 3.14 110.231 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -83.69 118.61 23.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 2.99 109.357 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.78 118.2 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.132 -1.062 . . . . 1.75 108.132 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.8 t -70.07 98.84 1.37 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.716 -0.846 . . . . 1.6 108.716 159.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -1.7 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.724 1.009 . . . . 2.55 113.724 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -122.51 130.33 24.7 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.523 1.929 . . . . 4.23 108.879 169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -86.45 -26.99 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.592 2.861 . . . . 2.28 112.939 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 231' ' ' ARG . 12.9 mt-10 -92.95 45.61 1.19 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.762 1.625 . . . . 5.19 111.735 -169.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.8 -55.01 3.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.398 1.479 . . . . 8.95 113.674 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.5 t0 170.82 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.906 1.682 . . . . 5.75 110.299 -141.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.5 t -90.44 156.77 17.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.588 1.155 . . . . 3.7 112.278 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -56.76 -30.19 63.35 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.89 1.07 . . . . 4.17 113.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -62.48 -37.47 86.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.708 1.603 . . . . 3.15 111.773 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -80.7 -19.99 43.89 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.013 -1.054 . . . . 2.02 112.255 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.51 -46.06 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.215 -0.897 . . . . 2.8 109.41 160.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.29 -39.49 72.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.028 1.285 . . . . 1.43 112.301 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.487 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 12.7 t30 -57.9 -53.83 53.74 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.204 0.602 . . . . 4.79 112.347 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -62.5 -33.89 75.78 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.155 0.982 . . . . 3.33 112.378 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.76 -52.58 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.029 1.732 . . . . 1.48 111.575 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -66.55 -25.66 66.76 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.575 1.08 . . . . 4.21 113.144 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.5 -40.52 83.05 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.531 1.533 . . . . 3.75 111.463 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -75.07 -43.1 55.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.174 0.59 . . . . 4.16 110.997 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 176.04 156.01 0.39 Allowed Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.404 1.882 . . . . 2.91 112.592 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -23.55 43.58 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.626 2.218 . . . . 2.64 113.049 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -91.17 4.03 53.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.316 1.228 . . . . 4.67 114.316 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.03 136.63 33.49 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.969 -1.123 . . . . 2.32 107.969 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -119.64 129.92 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.486 0.714 . . . . 2.31 109.619 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.22 144.15 15.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.067 0.841 . . . . 1.03 113.363 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.47 140.22 48.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.225 1.41 . . . . 1.81 112.248 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 70.2 p -137.74 135.33 36.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.3 2.24 . . . . 3.92 110.084 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -134.35 -165.6 10.97 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.864 -1.695 . . . . 2.11 108.864 168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 p -81.34 -179.49 7.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.001 0.9 . . . . 3.21 109.003 157.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 206' ' ' GLU . 9.9 ttm180 -54.86 -27.44 42.53 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.853 -1.067 . . . . 6.38 112.122 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -71.24 -50.29 34.45 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.05 1.34 . . . . 4.89 113.233 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.41 -33.21 62.93 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.435 -1.415 . . . . 4.06 111.705 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.08 -36.83 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.571 1.148 . . . . 2.91 110.969 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -55.82 -60.56 3.28 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.309 -0.853 . . . . 3.33 109.274 161.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -50.95 -42.28 59.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 116.969 -1.491 . . . . 2.59 114.917 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.6 -40.36 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 120.888 1.677 . . . . 4.09 113.087 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.3 -23.16 61.9 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.08 0.854 . . . . 3.11 113.222 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -80.54 -55.09 5.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.003 2.921 . . . . 3.74 111.261 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.68 -56.05 26.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 2.84 112.156 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -91.02 56.32 3.15 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.313 1.045 . . . . 4.46 109.674 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -40.17 102.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.491 1.916 . . . . 5.53 115.648 -157.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 164' ' ' PHE . 1.5 p -102.14 167.37 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.667 0.787 . . . . 2.69 111.959 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -102.75 139.13 38.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.006 0.922 . . . . 5.89 110.155 159.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.76 156.67 3.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.101 2.161 . . . . 4.48 110.409 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.4 t -156.83 114.03 2.0 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 121.467 -0.77 . . . . 5.11 112.069 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.16 140.23 24.8 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.991 2.46 . . . . 4.23 111.475 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.11 143.93 25.59 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 114.882 0.713 . . . . 2.85 114.882 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.36 164.37 35.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.641 2.894 . . . . 4.57 109.689 164.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.427 ' HZ2' ' C ' ' A' ' 255' ' ' ASP . 14.7 mtmt -134.95 160.37 38.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.355 0.662 . . . . 4.99 111.894 -174.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.23 -36.08 11.58 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.897 1.073 . . . . 6.57 113.897 -156.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.75 -59.55 0.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.306 1.443 . . . . 10.16 109.395 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -156.7 -36.01 0.08 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.276 1.03 . . . . 7.36 113.719 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.21 161.85 30.28 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.003 2.121 . . . . 9.49 115.042 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 23.4 t70 93.55 -144.17 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 128.894 2.878 . . . . 5.91 112.279 168.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' A' ' 255' ' ' ASP 0.25 2.8 t80 132.39 50.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.868 1 C-N-CA 133.332 4.653 . . . . 5.86 110.958 179.263 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.57 154.77 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 121.045 -1.034 . . . . 3.82 111.65 163.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.5 m -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.083 1.353 . . . . 3.24 109.336 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 118.44 19.92 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.617 0.767 . . . . 5.54 109.314 162.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -120.32 90.45 3.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.76 1.224 . . . . 1.82 110.096 170.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 19.29 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.792 2.145 . . . . 3.27 116.792 -157.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.2 mp 55.32 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 127.106 2.162 . . . . 3.29 112.29 168.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.28 147.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.123 1.369 . . . . 3.02 109.42 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 6.0 ttp -127.09 129.86 48.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.947 1.699 . . . . 3.95 110.932 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -95.97 139.49 32.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.217 . . . . 3.54 111.336 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.86 115.76 30.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.582 1.153 . . . . 2.68 109.175 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.95 145.83 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.282 -1.377 . . . . 2.28 107.282 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.93 -176.63 8.06 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.778 0.704 . . . . 2.32 113.871 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.43 -92.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 105.241 -2.638 . . . . 3.99 105.241 158.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.76 73.06 5.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 119.342 0.974 . . . . 7.86 111.918 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.52 35.68 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.275 -0.891 . . . . 3.45 114.072 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -70.47 -162.08 0.06 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.792 1.237 . . . . 8.0 110.926 166.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -66.51 138.82 57.79 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.437 -1.415 . . . . 5.87 112.94 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.8 -40.19 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.795 1.638 . . . . 4.79 110.959 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -151.9 179.33 8.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.592 1.157 . . . . 3.92 112.443 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.77 155.94 44.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.22 1.009 . . . . 5.34 112.044 160.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -148.69 -161.55 1.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.327 1.851 . . . . 2.99 109.876 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -177.12 -130.39 1.36 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.882 -1.136 . . . . 2.58 111.874 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.39 140.82 32.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.34 0.867 . . . . 5.98 113.34 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 84.78 2.2 0.76 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.053 2.541 . . . . 4.67 114.245 168.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -54.48 116.66 2.78 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.88 -1.138 . . . . 4.99 111.014 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 31.3 mtt85 -80.5 132.87 35.75 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.544 -1.348 . . . . 8.32 109.285 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -55.33 7.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.072 1.138 . . . . 3.07 114.072 -164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.15 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 121.012 -0.613 . . . . 2.93 113.325 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -76.01 -9.4 58.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.192 1.797 . . . . 6.07 112.256 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.0 mt -76.77 -56.17 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.845 -1.785 . . . . 2.11 109.658 159.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.38 73.96 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.266 1.027 . . . . 2.04 112.256 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.76 -28.57 69.12 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.791 1.034 . . . . 2.93 113.791 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -55.18 7.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.812 1.245 . . . . 3.19 110.523 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.69 -32.63 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.054 -1.029 . . . . 2.73 112.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.11 -15.03 63.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.855 1.057 . . . . 2.68 113.855 168.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.8 m -91.21 -30.25 16.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.773 -1.108 . . . . 3.26 111.831 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -74.17 -27.32 60.77 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.591 1.087 . . . . 3.43 113.187 163.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.5 ttp -57.35 -45.48 84.31 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 119.826 -1.796 . . . . 4.23 110.734 166.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -47.92 -49.01 60.85 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.358 1.863 . . . . 5.45 115.303 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.64 -21.79 45.04 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.69 2.927 . . . . 3.48 114.729 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.59 -27.74 10.68 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.777 1.399 . . . . 4.85 114.777 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.97 150.61 11.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.599 1.091 . . . . 8.33 113.298 -161.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? 75.26 -49.12 0.64 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.991 2.516 . . . . 8.03 113.526 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.261 0.1 OUTLIER 71.49 -51.24 0.69 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 131.026 3.73 . . . . 12.86 112.614 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.243 0.75 0 C-N-CA 129.315 3.046 . . . . 10.15 110.246 -179.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.519 ' N ' ' HG1' ' A' ' 131' ' ' THR . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.516 -1.23 . . . . 19.18 108.563 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.99 111.53 2.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.851 -1.537 . . . . 16.59 106.851 152.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.519 ' HG1' ' N ' ' A' ' 129' ' ' SER . 51.1 m -161.58 152.22 17.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 16.43 108.424 -159.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.05 -136.44 15.17 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.626 0.631 . . . . 13.58 112.097 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.55 144.34 1.6 Allowed Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.37 1.468 . . . . 11.7 112.009 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.03 173.76 10.72 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.387 2.725 . . . . 8.0 110.184 162.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.4 160.75 37.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.099 1.76 . . . . 8.12 108.957 166.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -105.44 154.3 20.52 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.095 0.958 . . . . 7.64 109.433 166.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.46 -170.98 39.44 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.522 1.058 . . . . 4.4 111.221 -154.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.43 91.29 0.64 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 117.95 -1.472 . . . . 3.41 110.498 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.98 109.98 2.29 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 CA-C-N 120.519 2.16 . . . . 3.63 112.188 -169.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -140.04 164.09 30.94 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.934 1.694 . . . . 3.09 111.249 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 t -135.62 147.4 48.63 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.582 1.153 . . . . 3.32 108.463 160.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -151.07 149.19 29.24 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.883 0.873 . . . . 2.29 111.041 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -77.03 144.12 38.86 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.904 -0.498 . . . . 2.81 110.402 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.1 p -100.11 157.65 16.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.863 1.665 . . . . 1.61 111.31 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -20.37 57.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.658 1.183 . . . . 1.67 113.927 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -78.4 -5.34 52.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.123 2.569 . . . . 2.91 115.087 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.18 5.58 67.51 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.989 1.268 . . . . 2.1 114.712 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 -158.98 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.653 1.581 . . . . 4.82 110.556 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 233' ' ' GLU . 56.2 ttt180 -160.18 108.8 1.7 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.493 -1.379 . . . . 5.85 112.501 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -116.24 165.05 13.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.695 1.369 . . . . 3.05 114.695 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.9 p -125.88 167.1 15.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.045 1.738 . . . . 2.2 111.415 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -43.28 -37.71 2.31 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 3.87 114.339 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -116.85 8.53 13.6 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.606 1.335 . . . . 7.5 114.606 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -70.78 -39.8 72.96 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.112 -1.07 . . . . 3.45 108.112 149.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.56 20.44 0.9 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.15 1.78 . . . . 2.57 114.662 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.02 150.08 44.34 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.033 -1.042 . . . . 4.69 109.999 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.25 -23.96 21.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.162 1.225 . . . . 1.81 116.162 164.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -116.93 168.87 9.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.131 1.372 . . . . 3.12 109.375 165.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -70.01 137.02 51.02 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.301 -0.874 . . . . 1.73 111.257 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.6 122.83 43.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.18 0.992 . . . . 2.57 112.826 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.29 86.78 2.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.187 1.395 . . . . 3.37 108.907 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tt -102.75 107.1 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.159 0.984 . . . . 2.86 112.375 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -112.46 147.03 37.36 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.63 1.572 . . . . 3.49 113.576 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -89.43 103.4 16.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.563 0.745 . . . . 2.9 111.531 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.57 112.97 0.55 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.43 1.014 . . . . 2.7 113.538 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.53 21.33 13.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.074 0.95 . . . . 4.69 112.536 167.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.364 10.2 t 54.91 -113.03 0.76 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 116.973 -1.489 . . . . 4.39 110.054 -171.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.45 ' CE1' HH12 ' A' ' 207' ' ' ARG . 37.4 m170 62.9 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.823 3.249 . . . . 5.57 111.929 169.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.1 p -70.93 109.42 5.16 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 126.291 1.836 . . . . 2.05 106.385 167.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.79 23.39 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.986 3.124 . . . . 4.28 112.792 -150.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -59.05 1.91 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.306 1.842 . . . . 3.67 111.267 -164.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.77 -29.29 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.131 1.372 . . . . 3.23 112.945 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 60.0 m -70.96 -60.84 2.65 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.516 1.526 . . . . 1.7 112.355 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.76 -32.57 46.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.441 2.094 . . . . 1.68 113.47 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.52 -61.26 2.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.812 1.187 . . . . 3.1 111.672 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -76.89 -38.71 53.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.574 -0.727 . . . . 3.12 111.773 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.12 -48.61 78.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.346 0.976 . . . . 2.66 113.177 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -49.87 -63.06 1.23 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.909 0.777 . . . . 4.58 109.309 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -66.63 -26.97 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.696 -0.628 . . . . 3.58 112.175 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 43.6 mtt -67.09 -44.47 79.94 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.503 1.121 . . . . 2.91 112.822 166.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.72 -53.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 120.832 1.651 . . . . 1.43 107.816 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.448 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 54.2 mt-30 -54.22 -17.2 2.62 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.437 1.895 . . . . 2.55 113.835 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.1 t -99.59 -39.36 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.781 1.633 . . . . 2.32 112.349 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 m -65.8 -30.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 120.426 1.466 . . . . 2.24 110.576 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.47 -32.36 60.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.825 1.25 . . . . 3.7 112.747 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.75 -44.57 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.248 1.019 . . . . 2.6 112.376 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -77.06 -31.6 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.208 -0.932 . . . . 1.97 112.307 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.35 -48.68 25.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.868 1.267 . . . . 2.53 109.762 161.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.0 t -69.05 -14.46 63.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.434 0.902 . . . . 2.23 113.434 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.03 -22.63 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.242 0.928 . . . . 2.53 110.447 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m 71.98 -29.78 0.2 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.422 2.289 . . . . 3.23 113.276 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.2 m -85.74 -22.84 27.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.592 2.757 . . . . 2.77 111.215 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.66 144.33 85.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.226 1.01 . . . . 3.23 109.73 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -76.04 170.29 20.4 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 2.84 109.686 167.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -48.77 140.88 7.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.179 1.791 . . . . 3.56 113.815 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.4 pt? -121.67 115.05 22.03 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.356 -1.293 . . . . 4.1 112.704 155.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.4 m -93.65 115.78 65.56 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.436 1.895 . . . . 1.06 110.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -95.33 157.6 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.029 3.153 . . . . 0.93 113.936 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.25 148.2 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.652 1.353 . . . . 2.71 114.652 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.49 122.33 39.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.936 2.094 . . . . 3.53 109.118 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.59 110.14 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.04 1.336 . . . . 1.32 109.352 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -96.3 112.31 24.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.254 0.55 . . . . 1.63 111.22 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.2 pt -96.47 5.72 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.672 0.99 . . . . 2.34 113.672 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -120.28 88.25 41.52 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.684 1.594 . . . . 3.52 109.155 171.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.452 3.435 . . . . 2.36 114.162 -168.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -25.05 27.12 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.23 1.937 . . . . 5.39 116.23 -163.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.45 HH12 ' CE1' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -163.17 -59.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.821 -1.174 . . . . 6.09 113.029 -167.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.2 78.45 3.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.267 1.508 . . . . 4.57 109.68 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 t -63.9 168.88 4.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 129.059 2.944 . . . . 4.83 112.798 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -33.94 49.05 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.297 1.221 . . . . 4.6 114.297 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.44 -19.34 50.13 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.564 1.529 . . . . 4.61 113.48 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.09 -45.56 23.11 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.655 -1.278 . . . . 2.27 110.849 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 71.7 mt -56.82 -27.79 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.796 1.638 . . . . 1.8 111.843 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -44.98 -45.9 10.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.431 1.493 . . . . 1.2 112.579 171.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -70.31 -45.78 65.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.352 1.061 . . . . 4.37 111.124 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.38 -44.81 95.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.021 0.915 . . . . 3.49 112.044 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.75 -40.11 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.994 1.317 . . . . 1.21 111.49 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -66.8 -25.21 66.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.647 1.579 . . . . 6.19 113.943 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.56 -35.21 80.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.71 1.141 . . . . 4.11 111.914 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -83.91 -54.89 4.55 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.511 0.56 . . . . 3.17 112.511 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 t -169.31 137.69 1.6 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 121.193 -0.942 . . . . 1.67 111.574 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.23 -13.25 39.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.185 2.59 . . . . 1.76 113.532 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.77 -25.03 68.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.702 1.001 . . . . 3.72 113.702 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 tt -87.05 138.28 31.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.719 -0.613 . . . . 1.88 112.021 -165.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.81 140.49 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.239 0.615 . . . . 1.44 111.866 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.08 124.71 7.24 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.363 0.982 . . . . 0.9 111.54 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.88 147.31 48.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.405 1.102 . . . . 1.82 112.183 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.3 p -145.38 164.79 30.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 127.292 2.237 . . . . 2.83 110.276 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -145.59 -161.88 9.37 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.37 -1.892 . . . . 2.15 108.37 156.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 35.8 p -81.88 177.85 8.63 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.977 -0.749 . . . . 3.67 108.977 160.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -57.65 -33.02 67.86 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.207 -0.452 . . . . 8.68 110.963 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.4 mp0 -62.08 -45.01 95.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.241 1.816 . . . . 3.5 111.644 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 149' ' ' ARG . 4.6 mm-40 -69.68 -43.27 72.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.061 0.945 . . . . 4.01 110.946 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.4 -35.07 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.486 1.114 . . . . 2.37 112.764 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.26 -35.49 71.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.338 1.455 . . . . 3.23 109.811 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -65.83 -38.65 89.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 117.844 -1.074 . . . . 2.83 112.411 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.55 -37.6 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.961 1.255 . . . . 2.58 112.565 168.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.72 -31.07 70.75 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.909 -1.119 . . . . 2.88 112.477 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -84.44 -19.92 32.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.858 2.063 . . . . 6.5 112.815 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.78 -70.51 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.286 1.435 . . . . 2.44 112.32 166.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.29 -55.59 2.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.535 1.309 . . . . 3.6 114.535 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 142.66 134.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 131.519 3.928 . . . . 5.31 110.1 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.0 t -139.32 143.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.944 1.698 . . . . 3.78 108.04 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.15 146.93 19.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.671 1.988 . . . . 6.2 109.627 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -161.45 164.53 29.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.879 1.271 . . . . 3.19 111.649 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.06 117.07 25.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 2.92 110.112 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -94.09 150.25 2.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.295 2.663 . . . . 2.52 112.574 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.9 142.17 28.27 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.051 1.31 . . . . 2.24 112.194 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 89.54 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.979 2.453 . . . . 3.74 109.569 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -5.13 30.94 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.194 -0.941 . . . . 5.08 112.221 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -97.3 8.78 43.88 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.134 -1.603 . . . . 7.85 110.983 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -91.99 -46.97 7.53 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.319 2.248 . . . . 12.09 110.617 166.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.31 53.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.269 1.828 . . . . 10.0 112.566 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 64.45 -9.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 128.524 2.73 . . . . 7.27 117.387 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.78 115.34 7.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.508 1.299 . . . . 7.12 114.508 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -113.08 60.15 0.64 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.215 1.806 . . . . 5.49 112.264 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.9 pt -55.73 158.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 119.929 -1.732 . . . . 4.54 111.252 152.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.6 t -149.16 124.59 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.166 1.386 . . . . 2.32 107.933 167.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -88.53 105.08 17.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.484 1.514 . . . . 4.16 111.413 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -103.12 123.01 45.88 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.802 0.841 . . . . 1.77 111.882 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 70.8 p -67.9 135.5 52.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.05 0.94 . . . . 3.36 110.799 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.8 pt -69.27 95.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.73 1.212 . . . . 3.68 110.366 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.2 mp -143.84 133.4 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.089 1.756 . . . . 2.36 110.278 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.2 ttm -117.58 116.22 26.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.407 1.883 . . . . 4.02 110.165 166.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.6 132.87 45.25 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.434 -0.791 . . . . 2.73 110.647 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 68.5 tp -101.1 115.14 29.79 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.818 1.247 . . . . 2.0 109.741 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.55 137.94 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.391 1.077 . . . . 2.1 108.439 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.74 168.89 38.25 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.2 -0.778 . . . . 1.72 112.916 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.86 -41.17 65.17 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.34 3.36 . . . . 3.29 113.102 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.56 -10.72 1.04 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.262 1.825 . . . . 6.06 113.941 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.33 27.27 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.77 -1.572 . . . . 2.97 116.324 156.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -138.55 171.29 14.59 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.567 1.684 . . . . 5.18 111.203 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -88.32 157.3 18.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.483 1.29 . . . . 3.82 114.483 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 -37.42 1.88 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.105 1.762 . . . . 3.15 111.693 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -162.46 175.81 11.11 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.218 1.807 . . . . 2.84 109.768 -173.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -142.56 81.9 1.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.558 1.543 . . . . 3.56 111.755 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -63.56 152.66 38.1 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.216 1.406 . . . . 2.5 113.441 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 281' ' ' LYS . . . 174.33 163.09 27.1 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.288 0.947 . . . . 2.17 113.214 167.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 101.25 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 130.404 3.482 . . . . 4.54 110.962 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.2 29.45 19.02 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.84 1.256 . . . . 7.97 112.536 168.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 278' ' ' GLY . 5.3 mmtm -58.37 110.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.654 -1.279 . . . . 6.07 112.59 -162.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -66.52 151.02 48.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.326 1.051 . . . . 5.43 110.694 -174.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 17.3 tptp -46.63 -67.63 0.26 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.839 -1.163 . . . . 2.67 112.726 -166.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.58 0.76 68.98 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 119.167 -0.796 . . . . 1.99 114.605 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.58 -44.98 48.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.936 1.368 . . . . 4.02 110.649 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.4 mt -58.97 -47.49 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.158 0.583 . . . . 2.15 109.562 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.21 1.004 . . . . 1.33 112.49 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.04 95.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.777 1.171 . . . . 1.83 112.789 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.0 t -66.15 -52.89 44.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.179 0.445 . . . . 1.64 111.698 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.97 -41.08 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.892 -1.13 . . . . 2.36 111.781 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.72 -5.38 24.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.918 1.236 . . . . 2.09 113.708 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 61.4 m -97.33 -51.3 4.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.628 1.571 . . . . 2.17 109.3 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.57 -26.71 67.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.95 2.1 . . . . 2.84 114.195 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 63.1 ttp -51.33 -37.98 50.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.661 1.984 . . . . 4.04 112.965 167.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -70.97 -41.69 11.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.62 1.568 . . . . 5.66 114.811 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.48 -25.46 21.24 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.946 1.764 . . . . 3.14 112.319 168.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -94.38 40.7 1.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.105 1.362 . . . . 3.64 110.86 173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.4 ttm105 94.26 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.963 2.505 . . . . 9.01 109.726 166.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 62.43 172.88 0.14 Allowed 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 118.217 2.673 . . . . 7.31 118.217 165.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -145.03 -66.87 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.813 1.645 . . . . 12.91 109.183 166.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.324 -1.322 . . . . 10.57 108.007 134.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.543 0.571 . . . . 22.45 112.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.98 101.68 7.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.772 0.829 . . . . 18.21 109.977 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.7 t -174.52 -175.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.126 2.171 . . . . 14.21 109.773 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.27 -157.92 0.78 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.82 1.676 . . . . 10.98 112.391 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -134.89 130.8 19.72 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 120.366 -1.667 . . . . 8.98 111.219 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -82.78 -41.03 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.027 2.485 . . . . 9.03 113.446 -170.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.3 0.6 OUTLIER 47.61 6.25 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 129.87 3.268 . . . . 9.63 116.376 -170.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.0 tp -84.89 131.57 34.49 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.894 2.078 . . . . 11.18 108.989 164.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.01 -151.84 44.63 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 123.076 0.369 . . . . 7.0 112.633 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.2 -119.9 6.61 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.234 -1.315 . . . . 3.48 113.055 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -71.99 104.92 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.212 2.608 . . . . 3.4 111.629 -166.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -105.82 167.59 9.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.335 1.454 . . . . 2.81 111.22 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.3 p -132.49 23.64 4.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.561 1.144 . . . . 3.09 113.777 -166.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.12 133.16 45.03 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.808 -1.182 . . . . 2.33 111.597 -162.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 141.0 56.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.265 -1.013 . . . . 1.98 108.265 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 p -74.12 158.7 33.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.572 1.177 . . . . 1.51 110.167 164.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 9.7 p-80 -49.21 -32.57 10.76 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.677 1.991 . . . . 1.45 112.565 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -79.63 -19.36 49.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 2.4 113.619 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.18 -12.99 31.34 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.129 1.212 . . . . 1.74 116.129 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 135.61 37.39 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.206 1.503 . . . . 4.57 110.171 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 118.42 24.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.367 0.985 . . . . 7.84 110.987 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -106.05 163.3 12.88 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.981 1.372 . . . . 3.43 111.701 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.68 5.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.786 2.834 . . . . 2.02 107.171 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.83 -72.12 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.09 0.556 . . . . 3.19 111.969 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -86.84 26.32 1.15 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.329 -1.482 . . . . 6.89 114.427 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.45 -43.57 93.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.408 0.623 . . . . 2.72 110.122 142.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' HE22 ' A' ' 158' ' ' GLN . 81.2 m-85 -92.48 -43.63 9.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.546 1.313 . . . . 2.29 114.546 -167.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.77 103.43 0.56 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.073 0.949 . . . . 4.65 111.372 -165.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 157.6 -36.32 0.54 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 128.073 2.749 . . . . 1.42 110.186 -164.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -95.48 168.99 10.36 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.403 -0.962 . . . . 2.75 108.403 144.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -83.92 153.73 23.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.741 1.216 . . . . 1.91 112.237 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.0 mt -121.86 146.0 47.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.438 0.903 . . . . 2.08 113.438 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 tp -115.21 115.32 26.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.729 -1.952 . . . . 2.53 105.729 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.4 mt -122.1 124.75 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.557 1.071 . . . . 1.92 109.682 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.98 161.14 38.54 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.54 0.941 . . . . 5.13 113.54 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -99.22 115.3 28.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.616 1.166 . . . . 2.42 111.422 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.57 150.48 18.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.899 1.238 . . . . 1.6 113.752 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -135.07 119.04 17.4 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.554 1.142 . . . . 4.09 109.557 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -67.93 -35.59 78.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.897 2.479 . . . . 3.21 112.198 -168.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -70.43 -1.72 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.257 1.206 . . . . 5.85 114.257 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.78 94.35 34.91 Favored Pre-proline 0 CA--C 1.569 1.704 0 C-N-CA 125.126 1.37 . . . . 2.7 108.326 160.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.7 53.03 3.65 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.889 3.726 . . . . 5.8 110.561 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -125.16 -85.4 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.431 1.492 . . . . 3.96 108.407 -168.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 86.6 t -43.89 -41.44 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.301 1.441 . . . . 2.74 113.165 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -54.74 -68.2 0.54 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.738 -1.601 . . . . 2.06 111.462 -177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -34.87 90.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.928 1.752 . . . . 1.9 113.012 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -65.02 -41.68 95.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.813 1.642 . . . . 2.9 112.222 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -84.03 -34.9 24.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.495 -1.378 . . . . 4.4 113.118 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 tt -69.55 -30.24 68.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.36 1.064 . . . . 3.38 112.512 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CD ' HE21 ' A' ' 182' ' ' GLN . 1.0 OUTLIER -49.94 -53.94 23.04 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.449 1.1 . . . . 2.88 110.536 166.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -52.22 -38.2 57.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.371 -0.831 . . . . 3.56 111.527 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 13.9 mtt -69.74 -45.35 68.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.058 1.343 . . . . 3.4 113.08 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.89 -47.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.344 0.975 . . . . 1.93 109.456 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.44 HE21 ' CD ' ' A' ' 178' ' ' GLU . 66.7 mt-30 -62.12 -25.95 68.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.602 -0.713 . . . . 1.9 112.822 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.02 -45.88 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.92 1.237 . . . . 1.67 111.591 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.72 -41.24 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.407 1.003 . . . . 2.46 111.264 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.75 -36.84 81.26 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.205 0.911 . . . . 3.93 112.663 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -20.04 64.62 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.355 1.062 . . . . 2.39 112.726 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 mt -86.71 -53.56 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.191 1.796 . . . . 2.01 110.938 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.3 -44.84 96.55 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.262 2.625 . . . . 2.45 111.42 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.0 t -72.92 -6.75 47.29 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.315 1.228 . . . . 1.93 114.315 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 24.3 mt -88.69 -31.87 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 119.913 1.233 . . . . 2.16 110.807 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.8 m 69.26 -24.68 0.14 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 127.905 2.482 . . . . 2.37 114.326 164.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.4 m -71.29 -12.72 61.6 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 129.475 3.11 . . . . 2.57 111.365 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.74 166.82 10.02 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 128.83 2.852 . . . . 2.86 111.037 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.95 157.71 34.6 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.095 2.53 . . . . 3.13 114.078 -163.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.27 119.9 20.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.48 0.657 . . . . 4.78 110.524 169.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.91 102.73 6.42 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.117 1.367 . . . . 3.08 110.929 -168.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -90.23 126.14 57.82 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 121.167 -0.958 . . . . 1.0 111.175 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.28 131.64 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.096 2.531 . . . . 0.76 114.69 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.65 112.65 21.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.163 2.185 . . . . 2.38 110.365 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.98 98.95 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.289 1.436 . . . . 3.07 108.215 173.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.51 106.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 105.585 -2.006 . . . . 1.3 105.585 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.8 t -106.45 100.54 10.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.926 -0.768 . . . . 2.89 108.926 -161.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.8 pt -82.16 35.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 3.51 113.284 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.46 21.96 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.468 0 C-N-CA 126.787 2.035 . . . . 5.67 115.968 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.73 79.34 3.39 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 124.168 2.524 . . . . 3.32 109.315 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 207' ' ' ARG . 2.9 tm-20 -161.24 -129.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 103.107 -2.923 . . . . 5.25 103.107 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.467 ' H ' ' CD ' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -56.17 139.73 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.212 -1.555 . . . . 6.31 110.554 158.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 110.23 -157.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 131.028 3.731 . . . . 5.45 108.923 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 212' ' ' ALA . 1.9 t -162.65 141.63 8.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.837 1.303 . . . . 3.6 111.408 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -56.82 -25.73 56.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.311 -1.313 . . . . 6.14 113.082 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -66.62 -53.22 36.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.643 1.977 . . . . 4.95 114.052 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.539 ' H ' HG23 ' A' ' 209' ' ' THR . . . -65.17 -37.26 86.79 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 119.989 -1.694 . . . . 2.56 111.501 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.62 -34.68 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.339 1.055 . . . . 2.64 111.348 166.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -61.99 -40.21 94.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.974 1.261 . . . . 1.29 111.414 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -63.76 -39.94 95.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 0.665 . . . . 3.76 111.991 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.4 -40.4 81.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.364 -0.835 . . . . 3.97 112.039 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.09 -33.17 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 1.44 112.224 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -65.39 -28.27 69.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.367 0.876 . . . . 6.95 113.367 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.81 -57.22 4.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.9 1.28 . . . . 5.06 110.155 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -44.86 -45.63 10.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.758 1.623 . . . . 2.62 114.032 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 154.78 151.47 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 129.194 2.998 . . . . 3.09 111.413 166.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.08 -17.37 50.81 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.022 2.481 . . . . 1.59 114.221 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.65 -12.66 60.03 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.657 0.984 . . . . 3.0 113.657 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.09 131.87 35.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.868 0.867 . . . . 2.19 109.226 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.26 136.92 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.281 0.475 . . . . 2.8 112.281 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.97 124.05 8.03 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.653 1.596 . . . . 0.96 111.181 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.61 113.37 24.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.647 1.179 . . . . 2.88 109.366 -171.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.8 m -142.32 110.86 6.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.701 1.601 . . . . 3.3 108.868 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -86.83 -132.59 3.41 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 124.361 0.981 . . . . 3.29 112.25 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.5 t -95.39 167.19 11.48 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.545 -1.28 . . . . 3.49 107.545 123.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.51 -24.21 63.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.56 1.544 . . . . 6.37 112.548 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -68.66 -55.85 10.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.161 1.785 . . . . 5.28 109.686 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -47.76 -40.91 21.99 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.057 1.753 . . . . 4.35 113.663 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.15 -16.06 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.386 1.874 . . . . 3.45 112.196 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.59 -48.61 63.12 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.288 -1.339 . . . . 2.8 110.337 169.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.31 -42.78 53.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.32 1.418 . . . . 2.41 113.288 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.8 t -72.77 -39.93 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.722 0.809 . . . . 2.79 110.705 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.54 -35.65 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.923 1.082 . . . . 2.2 113.923 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -65.41 -37.02 85.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 129.128 2.971 . . . . 5.59 110.587 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -46.98 -30.99 2.89 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.17 1.174 . . . . 2.42 114.17 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -121.97 -6.9 8.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.628 1.171 . . . . 4.67 113.69 -176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 68.05 28.03 6.83 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.509 2.324 . . . . 8.84 112.63 -171.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.31 122.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.615 1.566 . . . . 4.98 109.969 -163.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.13 -65.42 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.858 1.263 . . . . 15.67 111.701 -172.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.62 164.53 38.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.416 2.287 . . . . 4.18 111.037 -177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 126.46 89.43 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.412 1.085 . . . . 4.04 110.117 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -85.53 150.52 10.22 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.043 2.495 . . . . 4.32 110.889 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.08 172.52 38.45 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 123.455 0.55 . . . . 5.91 112.966 174.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.56 39.12 0.81 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.623 3.549 . . . . 7.25 110.967 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 158.4 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 1 C-N-CA 131.953 4.101 . . . . 7.26 108.676 -162.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.76 -124.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 118.361 -0.828 . . . . 11.24 112.614 -164.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.59 58.58 2.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.301 1.441 . . . . 16.63 113.629 -159.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -162.98 -73.0 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.582 1.553 . . . . 13.21 110.517 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.19 13.68 0.86 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.5 1.52 . . . . 12.57 114.72 -168.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.5 t70 90.08 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.138 3.375 . . . . 6.03 111.037 -164.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.55 139.51 17.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.067 0.937 . . . . 4.52 113.452 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 49.8 mm -100.42 136.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.31 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.444 1.498 . . . . 3.18 108.155 -161.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.99 130.96 44.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.938 1.352 . . . . 5.21 111.949 -172.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 1.5 p80 -65.23 160.84 20.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.047 1.404 . . . . 2.34 113.182 170.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 p -89.88 -13.1 37.13 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 115.54 1.682 . . . . 5.13 115.54 -162.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 61.58 45.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.474 1.607 . . . . 3.51 111.561 169.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.8 mt -135.25 139.95 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.433 2.293 . . . . 2.46 107.0 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.1 ttp -140.67 142.47 34.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.29 1.036 . . . . 3.25 111.467 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -122.32 132.36 54.36 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.25 1.42 . . . . 2.79 111.224 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.7 tp -95.9 128.66 42.97 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.959 -1.497 . . . . 2.05 106.959 164.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.8 mt -133.51 138.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.561 1.144 . . . . 1.96 108.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.46 -159.78 33.47 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.416 1.007 . . . . 1.33 113.861 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.91 -26.34 4.56 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.041 3.161 . . . . 3.4 114.046 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.6 -73.7 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 6.32 110.892 169.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 133.08 -26.31 3.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.623 1.582 . . . . 2.92 116.236 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -82.5 57.77 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.193 1.497 . . . . 5.33 112.387 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 t80 80.55 -176.63 0.06 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.229 2.612 . . . . 3.4 112.131 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.9 tt -162.44 -49.39 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.86 1.264 . . . . 2.76 112.904 160.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -164.38 152.16 12.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.985 1.314 . . . . 2.78 111.473 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -110.55 143.55 40.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.868 1.667 . . . . 5.46 113.439 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 94.8 m-85 -155.17 -177.05 6.26 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.471 1.908 . . . . 2.45 111.527 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 94.58 123.95 4.0 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.511 1.529 . . . . 2.86 109.961 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 57.75 -3.06 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.356 1.462 . . . . 3.38 114.559 -166.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -138.84 148.17 43.39 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.896 -1.753 . . . . 6.99 111.785 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 47.6 mtmt 69.92 111.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.341 2.656 . . . . 5.27 111.69 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.21 -177.4 4.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.169 1.788 . . . . 5.93 109.499 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 14.4 tptp -52.17 -65.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.871 -1.768 . . . . 1.93 113.984 -165.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.68 -19.55 79.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.561 -0.352 . . . . 1.68 112.814 -173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -76.48 -27.23 56.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.863 2.065 . . . . 4.92 111.516 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 53.5 mt -65.9 -51.18 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.107 -0.996 . . . . 1.47 110.085 163.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.67 81.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 1.55 112.027 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.08 -31.82 72.29 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.933 1.086 . . . . 1.75 113.933 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -56.85 8.22 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.125 0.97 . . . . 2.32 108.953 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.55 -31.17 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.414 -0.804 . . . . 3.21 112.683 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.33 -18.65 64.83 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.881 -1.137 . . . . 1.8 113.018 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.7 m -74.02 -48.83 27.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.712 0.687 . . . . 2.1 110.609 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.7 -21.61 63.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.369 1.068 . . . . 3.12 113.452 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -61.29 -28.98 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 4.69 112.845 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -58.21 -50.18 89.52 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 115.995 -1.955 . . . . 5.2 112.142 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.3 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.978 3.118 . . . . 2.41 111.729 167.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.11 68.72 8.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.162 1.385 . . . . 3.85 111.583 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -72.68 79.32 1.1 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.692 1.597 . . . . 9.61 110.813 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . 0.306 10.1 pttp 38.34 -102.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.725 1.61 . . . . 6.38 113.511 -164.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -146.46 35.0 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.817 1.647 . . . . 13.02 110.442 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.335 1.854 . . . . 8.41 110.813 -146.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 117.879 -1.058 . . . . 17.44 109.265 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 174.28 161.99 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.292 1.837 . . . . 15.87 109.625 -160.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.4 t -87.34 -9.55 54.56 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.552 1.315 . . . . 13.38 114.552 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.88 -146.05 47.62 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 118.781 0.719 . . . . 11.19 112.364 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -174.54 134.56 0.54 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.864 2.066 . . . . 13.61 110.475 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.12 141.22 51.93 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.614 2.209 . . . . 7.47 110.766 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 135' ' ' LEU . 1.7 pt? -109.27 20.37 18.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.205 1.402 . . . . 9.58 114.54 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.4 tp -105.52 -119.19 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.228 1.411 . . . . 7.82 109.282 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.4 167.33 37.23 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 125.129 1.347 . . . . 3.91 113.147 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.36 -55.75 0.5 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.986 1.279 . . . . 3.25 113.583 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.2 128.11 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.623 2.211 . . . . 2.57 109.354 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.03 169.53 23.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.297 1.439 . . . . 2.64 108.539 166.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.297 1.4 p -137.48 36.79 2.47 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.622 1.201 . . . . 2.82 113.538 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.81 152.55 39.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.15 1.38 . . . . 2.76 111.423 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -99.29 142.9 30.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.166 1.386 . . . . 2.05 110.902 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.2 p -83.43 160.55 21.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.508 1.147 . . . . 1.81 112.183 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 3.7 p-80 -60.7 -29.22 69.21 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.304 1.441 . . . . 1.7 113.025 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 t -84.73 8.2 17.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.2 1.8 . . . . 3.42 113.443 169.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.39 -3.91 50.91 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 117.309 1.683 . . . . 2.21 117.309 156.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -80.51 179.73 7.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.361 1.465 . . . . 5.21 113.071 -167.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -100.58 129.96 46.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.253 -1.388 . . . . 5.71 107.253 154.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -129.05 157.62 41.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.323 1.449 . . . . 2.88 111.798 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.82 164.9 29.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.048 1.739 . . . . 2.21 109.097 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.47 -36.74 83.43 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.161 1.346 . . . . 4.02 111.665 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -69.55 -4.71 20.18 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.871 1.804 . . . . 7.44 115.871 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -68.59 -46.49 69.23 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.569 1.176 . . . . 4.01 109.953 162.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.84 -37.88 29.22 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.858 1.663 . . . . 3.27 113.56 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.0 tp -65.72 97.45 0.33 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.002 1.321 . . . . 3.63 112.241 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.34 -16.05 1.48 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.142 1.353 . . . . 1.48 113.385 -169.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -109.56 -170.52 1.67 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.286 1.043 . . . . 3.19 108.645 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -95.78 134.72 38.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.338 0.655 . . . . 2.4 111.303 170.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.92 146.06 46.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.109 1.364 . . . . 3.14 112.156 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.72 120.09 32.59 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.057 -2.201 . . . . 2.48 105.057 156.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.57 132.22 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.743 1.217 . . . . 1.89 107.726 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.36 143.24 22.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.466 0.65 . . . . 7.84 112.539 -169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.54 107.39 19.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.555 -0.906 . . . . 2.11 108.555 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.02 141.19 11.02 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.002 1.287 . . . . 1.83 110.731 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -167.56 147.81 5.24 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.627 1.343 . . . . 4.93 114.627 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 t -98.09 -9.23 26.23 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 117.53 2.419 . . . . 3.7 117.53 -152.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -52.55 -32.51 41.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 122.095 2.225 . . . . 5.44 111.344 161.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.32 86.51 38.67 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 126.108 1.763 . . . . 2.32 106.935 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -90.43 43.71 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 124.447 3.431 . . . . 4.89 110.991 -167.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -113.72 -61.34 1.76 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.744 . . . . 4.27 111.942 -166.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.38 -37.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.424 0.556 . . . . 2.76 109.966 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.539 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 86.3 m -54.73 -63.59 2.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.868 2.067 . . . . 1.71 113.621 -172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.85 -34.93 28.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 122.01 1.754 . . . . 2.11 112.109 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.69 -52.8 61.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.683 0.793 . . . . 4.91 112.229 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -36.97 75.4 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.815 0.846 . . . . 3.25 112.085 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -46.82 86.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.654 1.181 . . . . 2.46 110.976 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.68 -48.56 79.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.747 0.819 . . . . 3.15 110.62 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -62.66 -26.91 68.88 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.665 -1.272 . . . . 5.3 113.401 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 mtm -70.16 -29.0 65.78 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.772 1.027 . . . . 3.26 113.772 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.22 -48.05 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.1 1.318 . . . . 1.8 108.585 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.478 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 60.0 mt-30 -56.06 -27.38 53.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.278 0.844 . . . . 1.64 113.278 175.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.36 -39.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.503 1.521 . . . . 1.52 111.561 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.8 t -72.68 -43.44 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.166 0.987 . . . . 2.61 110.172 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.05 -38.85 90.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.131 0.972 . . . . 3.38 111.514 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.8 -37.56 87.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.627 1.571 . . . . 2.71 111.87 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.93 -49.64 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.163 1.385 . . . . 2.45 112.343 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.57 -41.35 94.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.388 1.075 . . . . 2.35 109.99 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.2 t -68.74 -34.03 74.92 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.301 1.04 . . . . 2.18 112.261 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.54 -18.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.503 -1.373 . . . . 2.77 112.728 170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m 69.28 -17.02 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.608 1.963 . . . . 2.93 113.446 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 90.0 m -92.53 -39.48 11.35 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.364 1.466 . . . . 2.86 112.173 -161.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.9 151.52 64.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 118.84 0.745 . . . . 3.53 110.598 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.59 155.67 65.85 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.243 1.962 . . . . 3.11 108.855 160.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.44 135.58 10.7 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 115.853 1.798 . . . . 4.32 115.853 -164.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -95.3 121.07 36.58 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.424 -0.807 . . . . 2.43 110.71 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -100.46 117.46 62.88 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.678 1.991 . . . . 1.18 109.399 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.56 135.38 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.507 2.804 . . . . 1.12 111.88 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.91 108.97 11.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.021 1.329 . . . . 2.92 112.782 -165.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -80.98 104.24 11.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.623 1.969 . . . . 2.76 109.999 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.8 mt -80.26 109.31 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.597 -0.89 . . . . 2.22 108.597 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.0 t -82.23 104.43 12.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.413 0.685 . . . . 1.49 109.336 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.9 pt -80.44 -21.29 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 115.167 1.543 . . . . 1.85 115.167 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -94.49 122.02 61.98 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 3.73 107.954 169.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -104.46 -2.02 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.733 3.622 . . . . 2.11 113.664 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -91.83 -32.82 15.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.444 1.098 . . . . 4.92 111.877 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -29.33 70.35 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.637 1.575 . . . . 7.4 114.204 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.47 164.89 19.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.802 0.841 . . . . 4.9 113.202 -160.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 59.3 m -110.61 154.56 23.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.306 1.042 . . . . 3.55 111.329 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -53.2 -40.38 64.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.084 1.513 . . . . 5.04 115.084 -171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -68.83 -36.78 78.61 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.918 1.69 . . . . 4.32 112.903 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.32 67.22 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.464 -1.398 . . . . 2.46 112.012 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.16 -38.51 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.408 -0.807 . . . . 2.14 110.054 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -58.07 -40.83 82.02 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.158 0.983 . . . . 1.72 111.994 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.3 t30 -57.57 -53.45 57.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.739 0.699 . . . . 2.76 111.416 173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -57.0 -39.28 74.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.455 0.702 . . . . 2.7 112.044 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.36 -42.86 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.634 1.574 . . . . 1.63 112.922 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -74.06 -16.32 61.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.145 1.339 . . . . 3.3 114.372 -176.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.54 -19.72 65.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.186 0.903 . . . . 3.77 111.989 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.39 -43.41 12.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.275 0.843 . . . . 2.38 113.275 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.6 t 176.72 147.98 0.3 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.522 1.529 . . . . 1.83 110.239 -172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.58 -26.35 69.53 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.488 2.125 . . . . 1.8 112.931 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -74.75 -8.58 56.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.885 1.068 . . . . 2.58 113.885 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 120.2 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.618 1.099 . . . . 2.29 108.933 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.69 140.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.666 1.187 . . . . 1.89 109.922 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.26 145.72 17.66 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.01 0.814 . . . . 1.55 111.986 171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mt -129.68 150.95 50.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.875 1.67 . . . . 3.41 111.507 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.7 t -157.0 166.24 33.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.436 1.495 . . . . 3.64 111.078 155.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.23 -132.36 3.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.845 -1.302 . . . . 2.15 109.845 164.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -109.0 179.47 4.16 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.731 1.212 . . . . 3.75 108.958 163.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -49.7 -33.53 16.14 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.031 1.332 . . . . 6.39 112.748 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -66.13 -36.83 84.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 3.91 112.015 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.52 -34.84 47.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.416 1.087 . . . . 4.74 111.945 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.4 t -56.8 -44.47 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.168 -0.958 . . . . 2.79 110.502 165.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -40.0 96.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.017 1.327 . . . . 3.62 111.724 170.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -58.51 -44.53 89.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.06 -0.971 . . . . 2.71 113.087 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.16 -19.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.627 1.103 . . . . 2.65 113.679 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.38 -34.95 65.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.498 0.719 . . . . 2.98 111.567 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -74.58 -33.43 62.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.09 1.756 . . . . 6.4 112.534 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.73 -92.58 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.899 0.88 . . . . 2.16 112.434 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -84.3 -23.43 30.3 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.366 1.247 . . . . 3.27 114.366 -168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 85.65 139.5 0.05 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.704 2.802 . . . . 6.24 112.41 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.77 156.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.55 1.54 . . . . 2.37 110.127 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -136.04 150.57 49.24 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.612 1.965 . . . . 5.73 109.155 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.7 133.83 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.218 1.007 . . . . 2.99 111.908 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.6 m -94.76 105.09 16.71 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.847 1.259 . . . . 3.39 110.99 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.17 142.53 30.8 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.136 1.89 . . . . 2.84 110.735 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.1 -173.46 35.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.129 1.347 . . . . 2.76 112.538 168.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 166.14 30.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.675 2.25 . . . . 5.2 111.819 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.88 -177.87 6.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.802 2.441 . . . . 5.45 108.8 155.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 76.15 25.18 1.07 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.594 1.957 . . . . 7.52 110.902 -162.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.01 -57.13 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.991 2.117 . . . . 9.57 107.239 165.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -107.51 173.84 6.14 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.416 -1.328 . . . . 7.56 107.416 136.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.31 -32.67 70.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.113 1.365 . . . . 7.87 112.583 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.22 88.97 6.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.936 0.874 . . . . 6.67 112.176 -163.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -60.69 168.57 2.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.114 1.524 . . . . 5.11 115.114 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.9 pt -115.31 157.17 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 119.923 -1.736 . . . . 3.69 109.923 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.36 112.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.659 0.783 . . . . 2.8 109.649 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.43 178.6 1.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.381 1.073 . . . . 3.68 113.493 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.539 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 11.7 p80 -164.75 129.75 2.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.774 1.63 . . . . 1.89 111.26 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.7 p -38.91 -16.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.106 3.743 . . . . 4.48 121.106 -162.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.0 mt 64.83 53.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.377 1.471 . . . . 3.22 109.057 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.6 mt -140.8 134.81 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 2.84 110.872 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.7 mtp -99.81 121.48 41.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.725 2.01 . . . . 3.64 109.445 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.97 125.55 44.45 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.211 1.804 . . . . 4.02 108.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.08 111.84 23.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.685 0.675 . . . . 2.4 109.416 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.46 115.69 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.763 -1.569 . . . . 2.72 106.763 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.18 48.02 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.568 -1.013 . . . . 1.82 110.568 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 107.73 1.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.802 -1.653 . . . . 3.86 107.802 156.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -174.91 -86.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.005 -1.907 . . . . 7.34 108.578 -158.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 120.36 3.99 11.25 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 116.933 -2.037 . . . . 3.17 117.829 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 -58.07 1.01 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.115 1.957 . . . . 5.91 112.02 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -176.55 144.22 0.5 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.89 1.276 . . . . 5.22 112.215 -171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -52.17 2.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.018 0.747 . . . . 3.14 113.018 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -163.89 170.42 16.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.944 1.298 . . . . 3.27 110.954 -169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.29 145.66 30.44 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.575 1.324 . . . . 4.01 114.575 172.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -123.15 99.67 6.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.784 1.633 . . . . 3.02 108.852 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.26 152.28 16.97 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.919 1.247 . . . . 2.28 112.855 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 64.17 20.37 12.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.158 1.783 . . . . 4.51 111.694 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.37 95.97 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.379 1.872 . . . . 9.26 113.002 -150.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -77.06 43.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 119.783 -1.823 . . . . 4.9 112.609 171.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 66.81 123.32 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.418 2.687 . . . . 6.8 112.861 167.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.2 tptp -39.18 -60.1 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.48 1.512 . . . . 1.65 112.464 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 -14.0 72.78 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.499 -1.167 . . . . 1.43 115.192 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -81.21 -22.56 38.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.876 1.838 . . . . 4.02 112.738 170.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.1 mt -66.81 -46.57 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.168 0.895 . . . . 1.42 109.075 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.24 69.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.149 0.98 . . . . 1.38 111.642 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.29 -48.9 79.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.055 0.542 . . . . 1.58 112.438 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -53.44 -56.25 18.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.111 0.564 . . . . 1.86 111.244 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.28 -32.54 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.752 0.705 . . . . 2.18 111.732 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.81 72.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.072 -1.018 . . . . 1.92 113.486 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -70.83 -40.67 72.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.786 -1.102 . . . . 3.69 111.477 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -67.72 -31.73 71.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.314 0.961 . . . . 3.65 112.441 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.3 ttp -51.55 -36.81 46.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.849 0.86 . . . . 4.87 112.148 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -61.41 -55.82 39.49 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 116.103 -1.903 . . . . 4.9 111.604 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.93 -71.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.832 3.021 . . . . 2.13 112.087 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -73.84 89.53 1.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.879 1.672 . . . . 4.15 110.359 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 130.92 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 130.537 3.535 . . . . 8.59 113.38 166.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -135.69 -147.49 0.27 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.327 0.967 . . . . 8.31 111.53 -163.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.59 -38.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.656 1.182 . . . . 11.27 109.872 157.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 129.109 2.964 . . . . 12.1 108.678 160.181 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 117.394 -1.289 . . . . 23.58 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 61.34 -157.25 0.34 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.995 0.918 . . . . 20.92 110.231 -166.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.0 m -159.53 164.38 34.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.613 1.965 . . . . 14.54 107.648 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.65 66.08 1.37 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.621 1.105 . . . . 11.43 111.815 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.9 127.82 2.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.026 1.73 . . . . 10.65 109.894 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.0 154.85 66.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.064 2.509 . . . . 6.39 111.311 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.59 21.9 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.922 1.289 . . . . 7.6 113.449 -167.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.45 129.63 34.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.658 0.783 . . . . 5.9 110.672 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.34 120.85 3.59 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.35 0.976 . . . . 3.55 111.602 -167.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.01 137.13 16.75 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 118.926 -0.93 . . . . 3.21 113.571 -166.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -82.74 55.02 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.479 3.453 . . . . 3.61 111.673 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -98.03 164.91 12.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.053 1.341 . . . . 2.85 110.486 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.5 p -141.08 114.58 8.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.13 -0.981 . . . . 2.74 110.494 156.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.82 150.18 33.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.041 0.936 . . . . 2.53 108.529 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.99 150.0 23.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.238 0.472 . . . . 3.62 110.44 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 p -93.6 153.9 18.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.248 1.419 . . . . 2.11 111.921 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 0.6 OUTLIER -52.91 -24.54 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.437 1.895 . . . . 2.62 113.51 163.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 -23.56 56.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.435 2.294 . . . . 3.17 112.197 172.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.48 13.36 38.57 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 119.838 1.199 . . . . 3.39 114.764 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.401 ' OE1' ' HE2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -108.86 -151.56 0.47 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.66 1.184 . . . . 4.78 109.984 169.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.41 142.24 29.15 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.945 -1.097 . . . . 8.24 110.768 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HE2' ' OE1' ' A' ' 148' ' ' GLU . 69.3 mmtt -126.45 150.5 48.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.282 1.216 . . . . 3.16 114.282 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -123.86 161.26 25.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.153 2.581 . . . . 1.88 105.957 166.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.13 -53.36 10.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.548 1.139 . . . . 3.23 112.602 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -88.63 3.76 49.45 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.113 1.153 . . . . 6.34 114.113 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.18 -11.22 47.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.757 2.023 . . . . 3.53 112.203 163.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -128.54 -21.89 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.591 1.557 . . . . 3.27 114.959 -161.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.37 164.6 20.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.966 1.099 . . . . 3.09 113.966 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 121.28 -32.81 4.58 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.072 1.32 . . . . 1.4 113.831 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -105.15 163.15 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.813 -0.81 . . . . 3.35 108.813 155.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 29.2 m95 -65.33 134.82 54.39 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.311 0.485 . . . . 1.8 112.311 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.19 140.2 48.74 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.724 0.81 . . . . 2.23 110.924 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.73 106.23 7.25 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 105.943 -1.873 . . . . 3.49 105.943 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.15 120.28 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.922 0.889 . . . . 2.14 110.39 -167.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -119.42 131.31 55.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.632 1.573 . . . . 3.39 112.174 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -81.91 131.61 35.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.592 0.757 . . . . 2.93 110.858 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.73 179.66 19.02 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.336 1.446 . . . . 2.37 114.653 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 178.0 141.05 0.09 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 130.178 3.391 . . . . 5.7 105.781 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 m -112.08 57.32 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.982 1.719 . . . . 4.15 111.103 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.64 12.04 2.5 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.783 1.401 . . . . 5.91 114.783 165.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.79 157.28 71.97 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-N 119.977 1.262 . . . . 3.15 112.414 -162.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.41 72.37 6.55 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.324 3.349 . . . . 6.13 113.409 -157.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 73.34 2.61 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.887 2.875 . . . . 5.52 112.802 162.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -53.89 -20.51 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.701 2.0 . . . . 4.29 114.231 166.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 8.9 m -67.26 -83.71 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 116.982 -1.485 . . . . 2.66 109.857 163.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -58.98 -43.63 41.52 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.478 2.786 . . . . 1.62 114.035 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -60.7 -57.69 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.962 1.255 . . . . 3.64 112.752 -165.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -80.24 -31.34 38.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.57 -1.331 . . . . 3.55 112.598 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 tt -59.03 -33.8 71.17 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.619 1.099 . . . . 2.28 111.515 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.81 -44.7 78.12 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.992 0.815 . . . . 3.91 110.751 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -61.3 -19.33 61.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.807 -1.808 . . . . 3.1 112.344 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -33.7 43.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.143 0.883 . . . . 4.0 112.873 166.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.3 -37.84 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.55 1.523 . . . . 1.84 109.778 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 89.8 mm-40 -51.58 -16.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.827 1.651 . . . . 2.92 114.978 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.31 9.25 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.051 1.296 . . . . 2.49 113.299 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 -60.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.537 -0.912 . . . . 2.52 108.537 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.28 -44.44 96.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.727 0.811 . . . . 4.44 112.794 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.43 -5.27 2.37 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.518 2.327 . . . . 2.48 114.129 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.24 -46.91 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.978 2.111 . . . . 1.65 110.982 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -50.86 64.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.436 2.294 . . . . 2.3 110.613 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 25.3 t -70.89 -4.14 22.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.181 1.793 . . . . 2.2 113.79 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 mm -98.94 -32.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.212 -0.93 . . . . 3.12 110.258 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.2 m 70.39 -21.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 128.242 2.617 . . . . 2.34 114.172 159.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.3 m -84.06 -19.33 34.56 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 128.686 2.795 . . . . 2.74 111.001 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.37 158.04 69.62 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.646 1.578 . . . . 3.8 110.716 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.68 125.66 9.65 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.862 2.374 . . . . 2.5 109.611 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -67.49 156.29 37.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.755 1.021 . . . . 4.61 113.755 -171.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 196' ' ' LEU . 1.5 pt? -126.24 147.26 49.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.914 1.286 . . . . 4.15 113.783 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.4 m -119.92 108.18 39.1 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 124.776 1.23 . . . . 1.7 108.824 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.03 144.55 15.01 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.661 2.241 . . . . 1.22 111.749 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 tt -134.6 137.0 43.34 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.812 1.645 . . . . 2.43 110.843 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.06 121.6 36.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.45 2.7 . . . . 3.5 107.99 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.9 119.51 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.061 0.545 . . . . 2.57 110.03 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.4 m -87.4 101.76 13.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.588 -0.893 . . . . 2.66 108.588 164.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.0 pt -79.58 44.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.577 0.703 . . . . 3.03 111.46 172.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -120.33 60.66 7.64 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.804 2.042 . . . . 3.52 111.545 -165.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.81 0.18 8.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.522 3.481 . . . . 2.57 114.346 -163.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -75.49 -34.25 60.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.706 0.802 . . . . 5.87 111.88 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.64 -10.78 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.61 2.448 . . . . 7.05 117.61 -153.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.0 87.74 7.54 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.36 1.891 . . . . 4.77 111.492 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.1 m -65.06 134.08 53.04 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.795 1.238 . . . . 2.67 109.608 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -42.05 27.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.434 1.094 . . . . 3.47 113.196 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -60.23 -44.48 95.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.392 1.877 . . . . 3.61 113.35 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.6 -34.43 72.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.164 0.893 . . . . 1.74 112.606 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.46 -51.92 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.117 -0.697 . . . . 2.38 109.117 165.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -55.68 -29.55 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.208 1.403 . . . . 1.64 113.425 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -66.81 -59.64 3.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.317 0.962 . . . . 3.51 110.735 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -66.8 -36.98 83.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.355 0.502 . . . . 3.56 112.355 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.5 t -46.85 -38.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.659 1.584 . . . . 1.27 113.762 175.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -64.59 -45.16 88.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.025 0.829 . . . . 5.84 111.855 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -68.65 -19.71 64.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.384 1.474 . . . . 3.9 112.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -80.95 -45.08 17.24 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.202 1.001 . . . . 3.51 112.002 167.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.25 147.79 0.51 Allowed Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 114.68 1.363 . . . . 2.3 114.68 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.38 -34.21 16.36 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.05 2.5 . . . . 2.51 113.443 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -77.67 0.1 24.66 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.79 1.033 . . . . 2.92 113.79 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tt -83.92 144.73 29.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.911 -1.118 . . . . 2.17 111.685 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 145' ' ' HIS . 95.5 t -113.79 135.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.537 1.535 . . . . 1.6 111.353 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.11 132.41 10.18 Favored Glycine 0 N--CA 1.472 1.046 0 C-N-CA 124.525 1.06 . . . . 1.45 113.538 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.44 153.0 44.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.243 1.817 . . . . 1.94 113.591 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.3 t -154.89 163.25 40.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.849 2.06 . . . . 2.54 110.787 161.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.57 -175.3 26.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.853 -1.699 . . . . 1.68 108.853 163.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 p -84.36 -168.08 2.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.224 1.012 . . . . 3.56 110.823 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.2 ptt-85 -50.74 -37.91 44.61 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 116.446 -1.74 . . . . 9.43 113.858 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.42 67.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.213 1.824 . . . . 4.35 110.55 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -76.66 -46.15 26.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.366 1.467 . . . . 4.44 110.653 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.73 -44.86 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.221 1.009 . . . . 2.26 111.493 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.47 -48.18 78.76 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.296 -0.878 . . . . 4.22 111.123 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -56.75 -47.91 79.0 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.034 -1.041 . . . . 3.73 113.314 172.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -32.1 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.008 0.822 . . . . 3.08 111.798 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.43 70.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.959 0.904 . . . . 2.59 112.495 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -67.33 -39.35 85.82 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.038 -1.039 . . . . 5.89 112.106 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.34 0.25 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 2.42 110.923 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.0 59.49 5.3 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.01 1.724 . . . . 4.31 111.425 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -50.98 -22.76 2.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 118.224 2.676 . . . . 5.63 118.224 -165.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 244' ' ' TYR 0.275 5.5 p 52.28 -145.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 127.681 2.392 . . . . 3.83 112.682 165.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.547 ' H ' HG22 ' A' ' 243' ' ' VAL . 62.3 t80 -147.9 144.04 27.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.309 1.444 . . . . 5.51 109.279 161.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -166.41 162.0 16.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.813 1.645 . . . . 4.38 110.256 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.7 t -148.13 142.81 16.85 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-O 117.812 -1.089 . . . . 2.7 111.671 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.83 -179.41 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.171 2.58 . . . . 3.69 110.812 162.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.55 175.09 38.15 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.43 1.491 . . . . 3.18 111.692 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.08 117.09 4.98 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.167 2.578 . . . . 5.3 111.626 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.481 ' HE2' ' H ' ' A' ' 251' ' ' ASP . 0.0 OUTLIER -96.95 -49.9 4.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.631 1.572 . . . . 5.39 112.336 167.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.481 ' H ' ' HE2' ' A' ' 250' ' ' LYS . 79.2 m-20 -107.29 -123.77 0.24 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 106.377 -1.712 . . . . 6.23 106.377 161.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.35 31.6 6.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.494 1.517 . . . . 12.48 111.051 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -115.79 -40.14 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.726 2.01 . . . . 13.59 113.514 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.255 13.9 tt0 99.48 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 129.813 3.245 . . . . 17.1 108.583 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 20.7 t0 64.61 -167.81 0.21 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.89 1.676 . . . . 12.91 113.756 172.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.2 t80 58.27 -68.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.727 2.811 . . . . 7.35 117.194 151.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.3 41.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 127.081 2.153 . . . . 4.29 111.474 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.79 131.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.719 2.008 . . . . 3.47 112.684 -166.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.47 143.3 30.33 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.516 1.526 . . . . 4.72 111.776 165.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.1 p80 -108.59 99.28 8.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.036 1.334 . . . . 2.39 110.241 167.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.0 57.61 1.37 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.646 1.179 . . . . 4.75 112.736 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.662 HD11 HE21 ' A' ' 279' ' ' GLN 0.274 5.8 pt 61.04 3.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 119.655 3.205 . . . . 3.47 119.655 155.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.05 136.46 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.96 1.709 . . . . 2.07 112.097 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -126.63 140.58 52.31 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.568 1.947 . . . . 2.77 112.63 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -103.4 130.35 50.71 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.929 1.292 . . . . 3.93 113.07 175.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.7 tp -99.5 130.32 45.74 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.195 0.998 . . . . 2.37 108.624 164.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.9 132.45 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.819 -0.808 . . . . 2.59 108.819 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.34 -175.33 50.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.463 0.554 . . . . 1.34 113.352 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.76 159.4 52.91 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.879 2.386 . . . . 2.46 109.571 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.9 t70 74.72 -41.61 0.47 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 127.832 2.453 . . . . 5.53 112.271 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.55 54.66 3.22 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.926 1.251 . . . . 2.86 115.465 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.63 -62.41 1.58 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 117.196 0.498 . . . . 4.9 110.394 161.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -164.36 -159.54 0.48 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.556 1.542 . . . . 3.63 109.954 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 -63.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.924 0.89 . . . . 2.91 112.779 151.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -165.75 162.09 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.559 1.144 . . . . 2.61 110.074 -162.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.68 155.07 50.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.74 1.015 . . . . 3.59 113.74 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.459 ' CE2' ' HE2' ' A' ' 281' ' ' LYS . 70.4 m-85 -146.4 174.76 11.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.892 1.677 . . . . 2.24 111.478 -168.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.45 133.99 8.07 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.276 1.417 . . . . 2.55 111.204 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.662 HE21 HD11 ' A' ' 262' ' ' ILE . 4.5 mm-40 74.8 -20.13 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.059 2.144 . . . . 4.11 112.055 -171.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.08 173.14 16.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.131 . . . . 5.36 112.383 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 277' ' ' PHE . 51.0 mtpt 75.05 93.92 0.07 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.05 2.54 . . . . 5.22 109.757 -170.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -70.81 164.99 24.1 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.938 2.095 . . . . 7.17 111.21 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.403 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -47.78 -52.78 17.49 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.893 -1.755 . . . . 2.17 113.451 -164.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.72 -24.99 76.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 113.806 0.282 . . . . 1.76 113.806 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.7 -28.11 60.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.216 1.407 . . . . 4.4 110.855 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.1 -52.52 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.053 -1.029 . . . . 1.41 109.719 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.8 -44.95 78.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.364 0.666 . . . . 1.05 111.639 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.96 71.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.496 1.118 . . . . 1.36 113.852 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -63.19 -54.3 39.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.666 1.121 . . . . 1.63 109.686 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.31 -39.34 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.625 -0.672 . . . . 2.21 110.108 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.21 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.656 -1.277 . . . . 1.42 113.722 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.0 m -69.42 -36.17 76.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 1.6 110.956 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -84.9 -26.23 27.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.882 1.273 . . . . 1.98 113.681 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -73.18 -30.32 63.46 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 119.501 -1.999 . . . . 4.51 112.295 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -50.58 -48.68 81.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.656 1.582 . . . . 4.43 115.068 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.66 -18.94 32.44 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.512 2.142 . . . . 1.98 113.458 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -103.52 -14.07 16.34 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.101 1.889 . . . . 3.73 116.101 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 -154.88 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 120.575 1.534 . . . . 6.91 113.875 -166.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -65.34 156.48 32.01 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.119 -1.613 . . . . 8.12 113.481 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -119.42 1.57 11.23 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.949 1.7 . . . . 14.39 113.091 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.48 1.055 1 C-N-CA 131.739 4.015 . . . . 10.93 106.688 -155.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.634 ' N ' ' HG1' ' A' ' 131' ' ' THR . 12.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 116.491 -1.718 . . . . 23.86 107.161 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -75.47 83.19 2.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 121.312 1.869 . . . . 19.94 108.087 162.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 129' ' ' SER . 63.9 p -153.3 167.73 28.37 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.805 1.642 . . . . 18.75 110.324 -166.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.4 175.16 33.51 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 116.124 -0.489 . . . . 14.66 112.518 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.33 151.83 1.35 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.745 2.818 . . . . 11.7 109.809 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -82.27 -167.13 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.345 2.697 . . . . 10.86 112.726 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.06 -132.19 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.296 1.838 . . . . 7.29 109.23 166.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.81 141.28 51.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.243 1.817 . . . . 9.31 108.432 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.48 -41.65 65.99 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 118.904 0.775 . . . . 4.43 111.265 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -145.02 135.63 6.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 108.985 -1.646 . . . . 3.17 108.985 157.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.81 119.59 5.19 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 CA-C-N 121.114 2.457 . . . . 3.85 109.322 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.54 163.01 39.88 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.1 1.148 . . . . 2.67 114.1 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -129.05 148.25 50.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.101 -0.5 . . . . 3.47 109.785 150.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -147.53 138.25 23.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.218 0.533 . . . . 2.87 111.405 168.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.0 m -68.71 155.26 40.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.488 1.515 . . . . 2.3 109.894 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 160.68 22.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.718 1.607 . . . . 2.11 111.441 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -52.54 -19.4 2.25 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.671 1.359 . . . . 2.3 114.671 164.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 m -86.7 -14.37 42.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.908 2.483 . . . . 2.97 112.316 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.48 -17.17 57.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.857 1.218 . . . . 2.69 114.44 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.52 176.27 9.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.348 1.074 . . . . 4.73 110.864 166.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.46 125.71 27.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.676 0.751 . . . . 5.43 111.865 174.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.31 168.33 11.39 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.547 2.339 . . . . 2.93 112.633 -172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 p -134.74 175.53 9.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.7 2.0 . . . . 2.16 109.92 168.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.05 -38.91 87.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.102 1.361 . . . . 3.7 111.914 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.43 -19.1 64.57 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.076 1.88 . . . . 6.13 116.076 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -35.96 70.32 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.564 1.075 . . . . 3.28 112.433 -177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -119.67 -7.75 10.03 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.089 1.144 . . . . 3.13 114.089 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 7.7 tt -66.16 106.51 1.67 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.567 -1.333 . . . . 4.33 110.164 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' N ' ' H ' ' A' ' 270' ' ' ASP . . . 142.69 -24.91 2.29 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.345 1.926 . . . . 2.68 112.093 -155.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.52 -170.3 1.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.032 2.133 . . . . 4.15 109.698 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -93.57 128.14 39.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.281 -1.512 . . . . 2.02 112.119 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.9 124.35 48.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.432 1.093 . . . . 2.83 112.164 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.65 116.68 28.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.971 -1.492 . . . . 3.32 106.971 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.93 104.9 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.74 1.216 . . . . 1.75 108.012 -167.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -120.99 131.73 54.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.739 1.616 . . . . 3.49 112.808 -156.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.45 126.41 40.73 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.719 0.771 . . . . 2.18 112.687 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.96 -173.79 22.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.49 1.519 . . . . 1.85 112.631 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.42 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.973 1.709 . . . . 4.71 113.401 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.3 m 59.45 -93.88 0.04 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.709 1.603 . . . . 3.39 108.307 -164.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -19.86 -38.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 1 C-N-CA 131.933 4.093 . . . . 4.57 118.593 -134.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 30.4 p -85.21 142.71 38.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.448 1.099 . . . . 2.14 109.733 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.52 103.91 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.003 2.469 . . . . 4.81 111.598 -163.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 174' ' ' PRO 0.281 74.6 m-20 89.0 -7.41 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.873 1.669 . . . . 6.46 112.169 134.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -10.05 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.577 -1.192 . . . . 3.24 113.279 160.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.54 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 57.9 m -71.23 -67.52 0.57 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 117.807 -1.092 . . . . 2.06 112.032 162.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 171' ' ' ASP . 57.9 Cg_endo -74.09 -32.26 7.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.359 3.372 . . . . 2.45 116.458 -173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.77 -65.52 0.58 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.024 2.193 . . . . 5.13 115.716 -158.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -78.69 -11.7 59.99 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 119.158 -2.214 . . . . 6.33 113.046 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.29 -39.59 78.22 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.04 1.291 . . . . 2.79 111.415 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.84 -49.7 76.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.666 1.586 . . . . 5.34 109.267 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -26.51 67.88 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.117 -1.614 . . . . 5.07 111.564 173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.8 tpp -66.49 -28.24 68.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.656 -1.278 . . . . 3.27 113.256 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.3 mm -70.94 -45.96 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.755 1.161 . . . . 3.05 107.893 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -54.56 -48.64 71.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.691 -1.147 . . . . 2.49 111.455 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.59 -21.44 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 120.867 1.667 . . . . 2.85 113.453 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.34 -49.77 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.74 1.155 . . . . 2.55 110.035 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.41 -23.22 32.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.903 0.705 . . . . 5.97 112.903 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -60.63 -32.35 71.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.849 0.859 . . . . 3.43 111.665 161.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.79 -38.79 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.288 -0.882 . . . . 2.26 112.887 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.27 -40.42 90.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.188 0.995 . . . . 3.48 111.035 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -64.28 -16.28 61.81 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.778 1.029 . . . . 4.02 113.778 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 46.2 mt -73.13 -21.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.15 1.341 . . . . 4.4 110.608 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.6 m 77.82 -36.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.996 2.118 . . . . 4.02 113.294 160.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.0 p -105.94 7.35 32.04 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.001 1.482 . . . . 4.88 115.001 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 142.43 95.09 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.025 -0.732 . . . . 4.46 109.025 150.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.47 162.77 40.5 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 N-CA-C 108.025 -1.567 . . . . 3.16 108.025 159.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.95 150.89 41.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 123.25 1.5 . . . . 4.36 114.07 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.46 110.44 22.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.09 -1.868 . . . . 3.22 107.088 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 11.2 m -99.44 108.67 51.67 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.838 1.655 . . . . 2.45 109.277 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.51 134.28 1.26 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.496 2.798 . . . . 1.58 112.849 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tp -125.09 107.27 10.61 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.254 -1.339 . . . . 2.43 109.7 -170.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -89.61 116.71 27.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.208 1.003 . . . . 2.47 110.406 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.3 mm -102.15 101.39 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.123 0.969 . . . . 1.38 110.56 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.5 t -86.29 92.71 8.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.429 0.692 . . . . 1.84 111.917 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.3 pt -89.7 12.32 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 115.605 1.705 . . . . 1.63 115.605 -170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.84 69.14 7.71 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.666 -1.235 . . . . 3.92 107.666 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB3' HG23 ' A' ' 228' ' ' THR . 68.7 Cg_endo -82.83 -104.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.27 2.647 . . . . 4.85 110.286 -162.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 59.75 -74.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.247 2.619 . . . . 4.58 112.877 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -68.37 -50.53 52.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.142 1.377 . . . . 6.95 110.559 163.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.06 55.16 2.08 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.54 1.536 . . . . 5.28 110.276 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 m -66.46 159.46 27.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.929 1.692 . . . . 4.26 109.995 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.89 -28.41 61.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.87 1.433 . . . . 4.96 114.87 -171.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -61.67 -45.36 94.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.738 1.608 . . . . 3.52 113.186 168.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.86 98.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.928 -1.107 . . . . 1.58 111.001 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.0 mm -64.22 -31.8 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.565 -0.731 . . . . 2.83 111.731 172.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.17 -34.47 78.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.151 1.342 . . . . 2.23 113.232 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.471 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 10.1 t30 -65.38 -49.37 69.56 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.067 0.848 . . . . 2.86 110.931 168.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -37.11 86.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.263 0.625 . . . . 3.31 112.094 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.94 -52.23 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.862 1.665 . . . . 2.48 112.198 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.1 OUTLIER -73.72 -13.14 60.92 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.355 1.242 . . . . 3.6 114.355 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.6 -25.01 25.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.904 1.282 . . . . 3.81 112.419 169.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -74.37 -58.97 2.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.909 0.777 . . . . 4.63 111.525 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.7 t 178.94 151.51 0.48 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.255 1.022 . . . . 2.14 111.103 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.55 -15.77 50.97 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.898 2.399 . . . . 2.24 113.409 165.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -94.82 -7.23 40.92 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.498 1.296 . . . . 2.36 114.498 174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -91.59 114.64 27.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.519 1.509 . . . . 2.75 110.436 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.84 130.56 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.749 -0.463 . . . . 1.67 109.749 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.08 114.9 4.15 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.05 0.833 . . . . 1.08 111.317 -165.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.402 ' HB3' HD13 ' A' ' 142' ' ' LEU . 9.2 mp -103.77 133.15 49.24 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.492 1.117 . . . . 2.3 111.299 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 205' ' ' PRO . 80.4 m -171.38 128.18 0.68 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.992 2.517 . . . . 2.79 109.072 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.59 -123.92 2.49 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.063 -0.815 . . . . 2.62 111.063 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.5 m -115.52 165.35 13.1 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.954 -1.869 . . . . 4.06 105.954 161.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -57.78 -21.35 41.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.592 0.96 . . . . 9.16 113.592 -162.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 15.1 mp0 -65.66 -45.11 84.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.191 2.196 . . . . 4.14 111.481 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.425 -0.797 . . . . 3.64 111.227 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 t -65.52 -36.65 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.546 1.538 . . . . 1.99 113.235 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.75 -57.75 11.37 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 3.48 109.358 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -48.85 -47.77 42.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.988 -1.006 . . . . 3.08 113.602 -176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.3 m -66.7 -48.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.768 1.167 . . . . 2.42 113.271 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.41 -29.09 70.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.081 0.952 . . . . 2.91 112.35 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -88.02 -39.33 14.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.261 2.224 . . . . 5.84 112.793 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.91 -55.94 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.315 1.046 . . . . 2.34 112.425 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -79.24 58.04 2.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.012 0.925 . . . . 3.66 109.796 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -45.59 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.471 2.308 . . . . 6.15 114.214 -153.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.16 177.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.654 1.581 . . . . 2.74 112.104 -173.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.75 164.98 28.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.428 1.891 . . . . 8.07 111.141 166.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -162.19 163.11 28.52 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.04 1.736 . . . . 4.53 110.695 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -120.6 97.75 48.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 121.056 -1.028 . . . . 4.12 111.46 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.82 142.77 17.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.034 2.489 . . . . 3.56 112.6 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.98 162.09 26.01 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.396 0.998 . . . . 3.04 113.883 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -79.55 145.79 18.71 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.692 2.928 . . . . 4.89 110.274 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -97.35 114.17 25.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.726 0.81 . . . . 5.84 110.72 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -75.53 -18.31 59.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.053 1.131 . . . . 8.29 114.053 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.262 11.4 tp10 121.42 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 1 C-N-CA 131.932 4.093 . . . . 8.85 111.936 167.751 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -75.85 52.44 0.69 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.173 1.789 . . . . 8.75 111.181 168.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.335 4.1 pt-20 54.61 -33.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 132.276 4.231 . . . . 8.64 117.94 -167.283 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.93 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 117.124 2.268 . . . . 6.14 117.124 -157.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -99.31 102.99 14.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.489 1.116 . . . . 5.62 109.95 161.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 mt -132.92 161.73 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.051 1.741 . . . . 5.39 110.57 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 93.3 t -146.43 150.18 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.357 3.063 . . . . 3.05 106.438 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -92.67 145.56 24.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.593 1.157 . . . . 4.39 112.136 167.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.54 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.0 p80 -130.18 72.34 1.48 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.223 . . . . 2.52 111.752 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.3 t -39.7 115.02 0.47 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.131 0.972 . . . . 5.97 109.423 156.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -65.14 144.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.943 1.831 . . . . 4.71 115.943 -155.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 9.4 tp -163.33 144.43 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.56 1.944 . . . . 4.01 109.363 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ptm -158.93 147.89 18.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.713 1.205 . . . . 3.3 112.286 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.96 142.9 27.04 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.881 1.672 . . . . 3.41 112.983 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.57 120.53 40.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.596 1.158 . . . . 2.46 109.868 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 51.6 mm -113.37 139.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.702 1.601 . . . . 3.09 108.793 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.32 175.28 39.26 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.626 1.01 . . . . 2.27 115.626 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.23 128.35 12.05 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.595 2.863 . . . . 3.31 110.83 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.407 ' H ' ' N ' ' A' ' 157' ' ' GLY . 3.0 t70 66.95 3.31 3.04 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.414 2.286 . . . . 5.93 113.377 -162.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.94 -151.13 17.45 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.95 1.262 . . . . 3.56 115.048 162.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 71.27 149.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.601 2.36 . . . . 6.54 112.673 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -100.7 124.25 46.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.696 0.798 . . . . 5.61 110.073 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.63 -43.87 6.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.915 0.886 . . . . 3.65 112.092 -171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.71 173.7 6.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.131 0.973 . . . . 3.45 110.483 -154.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.81 140.56 22.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.092 1.357 . . . . 3.13 112.874 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -116.92 -179.06 3.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.561 1.144 . . . . 2.58 109.568 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.3 -119.58 1.53 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-O 118.973 -0.904 . . . . 2.89 111.32 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -55.53 147.99 16.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.632 0.716 . . . . 3.71 110.344 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 71.05 -160.85 0.14 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.02 1.728 . . . . 5.28 110.461 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 34.7 mttm 64.19 -80.87 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.405 2.282 . . . . 4.16 113.655 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 87.35 158.62 0.07 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 129.215 3.006 . . . . 5.93 111.549 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -41.78 -55.75 2.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 128.448 2.699 . . . . 2.1 113.031 -174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.38 -30.01 71.55 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 116.242 -0.436 . . . . 1.99 113.154 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.53 -43.41 69.67 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.729 0.812 . . . . 4.65 109.543 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.0 mt -62.92 -40.45 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.039 0.936 . . . . 2.09 111.557 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.29 90.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.564 0.745 . . . . 1.57 111.004 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.33 83.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.743 0.646 . . . . 1.6 112.743 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 57.4 m -64.57 -49.06 72.68 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.087 1.355 . . . . 2.24 111.554 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.99 -39.53 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.477 -1.389 . . . . 2.68 110.825 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.56 -19.08 65.23 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.477 0.917 . . . . 1.88 113.477 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.3 m -77.77 -47.64 18.51 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.186 0.994 . . . . 2.41 109.196 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.087 0.955 . . . . 2.42 113.319 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.5 ttp -58.16 -35.72 71.96 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.426 -1.421 . . . . 4.73 113.566 164.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -61.27 -49.91 85.94 Favored Pre-proline 0 N--CA 1.476 0.861 0 CA-C-O 115.755 -2.069 . . . . 5.57 113.555 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.11 -42.01 2.3 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 122.605 1.966 . . . . 3.65 112.531 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -153.48 0.45 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.529 0.937 . . . . 4.09 113.529 -154.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 126.7 28.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.412 1.485 . . . . 7.64 110.51 -175.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 1.0 OUTLIER -163.45 -179.77 6.74 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.404 1.882 . . . . 11.72 110.119 -162.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 29.7 tttm -173.1 158.76 3.77 Favored 'General case' 0 CA--C 1.557 1.229 1 C-N-CA 132.985 4.514 . . . . 9.7 104.891 167.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.466 -0.939 . . . . 8.29 108.466 152.254 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 118.152 -0.928 . . . . 14.98 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -76.48 -178.46 4.66 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.631 0.65 . . . . 14.6 110.201 157.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -94.62 -172.8 2.84 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.452 1.501 . . . . 11.73 110.915 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.91 -126.3 1.9 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.055 0.836 . . . . 9.4 113.709 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.73 143.49 13.42 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.338 1.855 . . . . 10.91 110.699 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.23 157.21 57.76 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.508 2.139 . . . . 6.38 109.974 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.52 -29.56 46.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.91 1.078 . . . . 8.03 113.91 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 mt 68.95 179.48 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.138 2.175 . . . . 7.57 112.048 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.51 -161.13 52.67 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.481 1.045 . . . . 2.86 114.731 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.93 62.27 0.65 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 127.013 2.244 . . . . 3.11 112.982 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.93 111.52 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.973 3.116 . . . . 2.52 111.994 -166.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 3.7 p90 -109.25 172.94 6.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.231 2.213 . . . . 2.48 111.434 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 p -118.21 64.41 0.76 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.078 -1.639 . . . . 2.97 112.392 161.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.405 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 61.9 mt -76.39 135.96 39.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 119.958 -1.714 . . . . 2.31 110.154 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -89.77 136.46 33.02 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.436 1.494 . . . . 1.93 107.258 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 48.3 p -75.56 160.16 30.46 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.034 0.921 . . . . 1.84 111.172 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.85 51.13 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.91 1.078 . . . . 1.67 113.91 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.2 p -83.07 -41.74 18.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.567 1.947 . . . . 3.13 113.344 166.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.7 9.47 4.36 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 125.249 1.405 . . . . 2.36 115.772 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.02 -175.78 2.72 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.754 1.622 . . . . 4.6 110.48 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -140.36 115.73 9.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.305 1.042 . . . . 5.93 111.23 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -116.75 165.92 12.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.597 1.159 . . . . 3.31 112.717 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.8 p -128.94 159.52 35.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.032 1.733 . . . . 2.08 108.704 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -51.09 -43.11 61.02 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.506 1.922 . . . . 4.08 113.794 -171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -11.36 59.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.82 1.785 . . . . 7.41 115.82 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.53 -18.06 42.82 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.427 0.691 . . . . 3.27 112.583 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -101.28 -3.69 28.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 2.55 113.169 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.37 178.88 1.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.601 1.16 . . . . 3.55 110.242 163.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.93 -25.87 3.96 Favored Glycine 0 N--CA 1.476 1.315 0 O-C-N 119.825 -1.797 . . . . 1.52 115.142 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -112.18 176.62 4.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.707 1.254 . . . . 3.14 109.506 154.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -75.96 140.62 42.14 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.237 -0.915 . . . . 1.66 110.55 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.76 135.29 41.77 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.601 0.76 . . . . 2.92 111.525 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.89 114.54 24.82 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.697 -1.223 . . . . 2.75 107.697 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.44 131.26 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.583 1.553 . . . . 1.53 109.3 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -135.43 148.56 49.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.566 1.546 . . . . 4.54 111.823 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -107.69 105.63 15.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.491 1.139 . . . . 2.98 112.047 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.33 177.39 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 127.021 2.248 . . . . 1.97 114.09 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -176.22 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.812 2.045 . . . . 4.15 111.288 -165.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.5 m 79.06 -71.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 3.39 108.255 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.86 21.3 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.778 3.231 . . . . 6.14 116.326 -163.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.11 165.46 43.16 Favored Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 120.315 1.416 . . . . 3.23 109.062 159.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.29 61.54 5.06 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.573 2.182 . . . . 6.85 110.828 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 60.36 11.58 2.98 Favored 'General case' 0 N--CA 1.473 0.678 1 C-N-CA 131.959 4.103 . . . . 5.38 114.024 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.94 -42.77 90.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 121.833 0.825 . . . . 3.21 111.456 -162.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.55 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.282 87.6 m -90.49 -43.89 0.4 Allowed Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 127.5 2.32 . . . . 5.03 114.278 -173.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.59 -22.61 70.47 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.972 1.781 . . . . 3.25 112.944 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.8 -46.6 51.11 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.559 1.544 . . . . 3.44 112.511 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 262' ' ' ILE . 39.2 tt0 -79.7 -30.86 41.16 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.356 0.873 . . . . 3.25 113.356 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.96 -30.48 70.62 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.959 1.254 . . . . 2.67 112.037 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.39 -54.68 40.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.673 0.67 . . . . 3.49 109.635 164.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 176' ' ' GLU . 50.0 mtmt -58.66 -27.9 65.21 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.221 -0.924 . . . . 3.43 113.012 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.4 mtp -64.96 -45.57 85.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.982 -1.074 . . . . 4.05 111.708 167.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.5 mm -61.82 -53.15 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.585 -1.322 . . . . 1.6 110.428 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -61.1 -16.43 43.96 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.413 0.894 . . . . 2.36 113.413 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.2 t -88.53 -44.01 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.739 1.154 . . . . 1.49 111.806 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 196' ' ' LEU . 52.5 t -70.11 -36.0 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.038 0.935 . . . . 2.5 112.9 -170.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.29 -13.71 23.15 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.648 1.579 . . . . 5.29 111.266 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.69 -37.09 73.56 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.907 0.883 . . . . 2.53 111.472 160.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -35.49 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.592 0.633 . . . . 2.44 111.942 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.458 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 8.9 m-20 -58.15 -26.37 62.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.463 1.505 . . . . 2.6 112.024 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -61.98 -26.83 68.45 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.171 -0.956 . . . . 2.54 112.062 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.73 59.4 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.045 -1.659 . . . . 2.58 108.514 167.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 5.1 t -55.22 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 130.754 3.622 . . . . 3.52 114.648 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.61 -24.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 129.84 3.256 . . . . 3.7 111.843 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.41 144.41 98.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.334 0.97 . . . . 3.63 109.356 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.61 156.44 53.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.184 2.589 . . . . 2.64 111.205 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.26 129.49 38.57 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.535 1.934 . . . . 3.88 114.504 -162.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 184' ' ' VAL . 28.6 tp -99.87 103.28 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.502 0.721 . . . . 3.14 110.045 170.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 16.0 m -92.16 127.44 49.21 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.948 1.299 . . . . 1.25 110.19 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 141.85 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.772 2.315 . . . . 1.28 111.991 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.8 tp -132.08 116.98 17.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.357 1.075 . . . . 2.65 111.424 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -93.49 114.88 27.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.522 1.529 . . . . 2.44 108.903 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.72 131.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.173 -1.417 . . . . 2.0 107.173 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.1 t -101.52 138.34 38.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.739 0.7 . . . . 1.74 112.202 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.59 -3.92 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 115.411 1.634 . . . . 1.66 115.411 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.16 82.83 9.32 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 119.956 1.253 . . . . 4.22 109.552 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.16 0.91 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.885 3.057 . . . . 2.16 113.009 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -92.15 -20.88 20.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.712 1.205 . . . . 6.03 111.969 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -102.75 -55.6 2.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.743 1.217 . . . . 7.06 112.706 168.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.63 105.99 14.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.578 1.151 . . . . 5.27 110.557 -166.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 42.0 p -92.17 168.37 11.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.242 1.017 . . . . 4.42 113.275 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -44.13 -39.81 4.54 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.819 1.247 . . . . 3.34 113.949 -171.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -88.91 -27.05 21.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.597 1.959 . . . . 4.62 113.733 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.4 84.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.958 0.799 . . . . 1.97 110.224 164.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.9 -45.05 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 117.677 -1.154 . . . . 2.07 110.622 164.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.22 70.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.842 1.201 . . . . 1.35 112.261 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.62 -43.75 92.73 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.369 0.531 . . . . 3.52 111.25 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -60.81 -43.82 97.67 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.368 -0.832 . . . . 3.08 111.231 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.85 -45.03 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.215 1.806 . . . . 1.29 111.491 170.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -11.48 44.2 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.492 1.517 . . . . 3.65 115.04 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -82.8 -19.51 37.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.98 1.718 . . . . 2.81 113.658 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.33 -54.85 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.892 0.769 . . . . 2.22 112.551 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.2 t -168.82 141.38 2.25 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 120.714 -1.241 . . . . 1.54 110.377 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.05 -20.19 57.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.714 2.276 . . . . 1.85 113.335 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 25.4 ttmt -70.92 -17.47 62.69 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 119.419 1.009 . . . . 2.58 112.884 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.0 tp -74.08 129.42 37.81 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.609 -1.307 . . . . 1.99 111.662 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.7 t -107.97 140.34 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.602 0.761 . . . . 1.88 109.623 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.81 151.03 18.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.603 1.096 . . . . 1.24 113.569 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -147.54 137.71 23.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.44 1.096 . . . . 2.75 113.858 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.0 p -149.86 137.37 19.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.867 2.067 . . . . 2.57 110.072 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.63 -142.03 6.8 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 109.152 -1.579 . . . . 1.82 109.152 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -110.17 -168.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.941 0.87 . . . . 2.96 110.06 161.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -50.68 -43.62 57.55 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.809 1.644 . . . . 6.67 111.432 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.88 -52.17 11.87 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.931 1.692 . . . . 3.5 112.746 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -70.52 -40.65 73.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.317 1.417 . . . . 3.21 114.634 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -53.69 -45.91 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.696 0.798 . . . . 1.91 110.558 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.37 -28.3 34.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.244 . . . . 4.71 111.699 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -50.66 -56.46 11.79 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.541 1.518 . . . . 2.51 111.713 162.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.76 -31.62 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.652 0.66 . . . . 2.53 112.206 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.08 74.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.048 0.939 . . . . 2.32 112.987 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -81.85 -25.99 34.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.062 1.745 . . . . 4.76 112.845 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.52 -107.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.158 1.783 . . . . 2.37 112.43 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -62.62 -49.34 75.6 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.799 0.84 . . . . 4.08 111.638 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 28.3 mtt85 140.0 147.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 132.402 4.281 . . . . 6.16 111.334 166.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.12 138.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.521 1.528 . . . . 2.82 106.914 169.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -106.75 131.4 53.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.821 0.343 . . . . 5.96 111.178 159.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -141.6 162.78 34.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.328 1.451 . . . . 3.37 110.658 171.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.0 t -150.08 124.03 4.53 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 118.551 -0.738 . . . . 4.24 111.347 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.87 141.13 43.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.082 2.521 . . . . 3.1 111.505 -172.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.88 -173.16 18.8 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.256 0.931 . . . . 2.61 114.486 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.16 -178.69 4.59 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.41 3.407 . . . . 4.63 112.951 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -105.28 -86.15 0.47 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.338 -0.986 . . . . 6.34 108.338 150.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 73.54 -39.56 0.44 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.811 2.844 . . . . 5.9 116.173 151.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -88.16 -27.19 22.02 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.332 1.053 . . . . 11.75 113.322 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -154.06 -66.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.333 1.235 . . . . 9.05 114.333 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 163.08 2.45 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 131.154 3.782 . . . . 7.8 113.867 -173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.48 173.75 8.39 Favored 'General case' 0 CA--C 1.556 1.179 0 O-C-N 119.237 -2.164 . . . . 6.85 110.759 159.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -125.2 152.03 45.07 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.128 -1.608 . . . . 5.24 111.599 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -141.46 153.43 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.911 1.284 . . . . 4.02 109.739 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 p -160.95 135.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.54 2.736 . . . . 2.69 104.235 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.95 145.05 52.17 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.542 0.737 . . . . 4.23 109.481 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.55 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 3.6 p80 -152.38 126.27 9.03 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 122.471 1.129 . . . . 2.64 110.5 164.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.9 t -63.74 170.4 3.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 113.639 -1.619 . . . . 3.04 111.022 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 279' ' ' GLN . 12.6 tt -108.95 122.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 122.998 0.519 . . . . 4.08 109.808 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.1 146.02 21.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.525 -1.287 . . . . 2.84 107.525 164.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.4 ttp -119.37 126.13 50.67 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.22 1.008 . . . . 3.12 108.724 157.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -99.9 143.4 30.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.39 1.076 . . . . 2.77 112.047 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.2 124.7 52.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.309 1.444 . . . . 2.25 110.344 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.16 144.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.865 1.666 . . . . 2.66 107.913 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.5 171.64 32.26 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.48 0.562 . . . . 1.46 112.703 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.1 -44.9 6.51 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.783 2.322 . . . . 2.73 110.602 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.51 -1.26 57.95 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.101 1.761 . . . . 6.55 114.829 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -165.44 153.0 22.8 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 120.195 1.361 . . . . 3.65 115.869 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -69.94 -9.23 54.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.469 2.308 . . . . 4.81 115.705 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -166.51 156.74 12.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.022 1.329 . . . . 3.99 111.565 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mt -149.65 -45.95 0.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.985 1.106 . . . . 2.6 113.985 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.9 166.66 32.08 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.898 0.879 . . . . 2.59 112.739 -165.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.64 142.26 21.84 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.789 1.033 . . . . 3.14 113.789 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.73 -154.41 0.58 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.78 1.232 . . . . 2.43 112.463 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.56 143.53 3.73 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.491 1.996 . . . . 2.17 110.502 -165.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.465 ' HB3' HD13 ' A' ' 262' ' ' ILE . 4.7 pt20 -34.3 -35.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 118.667 2.84 . . . . 4.43 118.667 -162.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.46 -10.59 12.13 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.606 -1.309 . . . . 5.44 113.45 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 113.71 7.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 123.027 1.394 . . . . 5.48 112.792 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.13 148.28 44.08 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.079 1.752 . . . . 5.29 108.757 172.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -37.76 -57.99 0.94 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.029 1.732 . . . . 1.79 113.255 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -18.56 75.72 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.559 -1.134 . . . . 1.43 115.437 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -70.64 -42.14 71.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.376 1.588 . . . . 3.86 111.393 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.25 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.084 0.954 . . . . 1.26 109.284 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.019 0.928 . . . . 1.14 112.822 172.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.05 74.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.226 0.921 . . . . 1.3 113.395 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 19.8 m -67.27 -51.79 48.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.213 1.005 . . . . 1.84 110.698 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.7 mt -57.52 -44.44 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 121.219 -0.926 . . . . 2.36 110.702 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.66 -9.73 15.37 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.833 -1.167 . . . . 1.89 113.526 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.7 m -93.1 -57.12 2.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.118 1.367 . . . . 1.65 109.94 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.29 -22.56 62.84 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.086 1.143 . . . . 2.52 114.086 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 60.3 tpp -64.68 -28.2 69.44 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.251 1.02 . . . . 5.06 112.411 170.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -59.73 -53.36 66.3 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 115.955 -1.974 . . . . 5.45 113.357 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.42 -43.74 5.53 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.817 2.345 . . . . 1.93 110.896 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.98 61.91 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.713 0.768 . . . . 2.93 112.783 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 89.99 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.714 2.406 . . . . 9.1 113.474 156.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.9 tttt 61.21 -145.66 0.45 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.345 1.458 . . . . 10.16 111.693 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.72 -10.68 0.2 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.139 1.903 . . . . 13.65 116.139 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 130.46 3.504 . . . . 8.55 108.639 -153.815 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.636 -0.697 . . . . 17.58 110.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -169.45 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.906 2.483 . . . . 17.64 107.656 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -91.6 177.93 6.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.515 0.726 . . . . 13.15 109.336 140.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.26 9.28 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 117.157 1.623 . . . . 10.16 117.157 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -145.01 142.95 19.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.197 1.999 . . . . 12.13 112.454 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.47 170.77 19.3 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.124 2.55 . . . . 7.59 110.044 161.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.58 32.0 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.44 1.896 . . . . 8.83 111.885 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.6 mt -137.68 166.1 24.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 7.66 110.653 -166.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.42 148.06 11.64 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 126.038 1.78 . . . . 3.61 112.401 -168.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.31 84.96 0.38 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.106 -1.941 . . . . 2.91 111.073 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.28 128.38 7.15 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.342 2.694 . . . . 2.75 112.504 -162.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -156.06 166.64 32.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.041 0.924 . . . . 2.45 113.132 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -134.52 150.94 50.82 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.957 -1.089 . . . . 2.98 109.886 162.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.6 mt -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.887 0.875 . . . . 3.03 110.993 162.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -77.24 143.32 39.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.503 1.521 . . . . 1.66 108.295 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.6 t -111.06 154.42 24.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.656 1.182 . . . . 3.07 111.637 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -56.59 -11.1 1.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.729 2.122 . . . . 1.75 116.729 -169.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 37.8 p -94.49 -16.64 23.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.593 2.357 . . . . 2.62 114.126 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.66 -5.37 26.14 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 125.578 1.561 . . . . 2.0 114.972 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.46 172.95 13.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.675 1.238 . . . . 4.74 111.677 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 109.45 5.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.469 1.508 . . . . 5.39 109.484 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -126.03 171.27 10.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.817 1.247 . . . . 4.35 113.253 -164.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.4 p -145.51 170.19 16.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.311 1.844 . . . . 1.99 111.159 -166.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.62 -47.33 73.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.209 1.404 . . . . 4.06 111.839 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -9.59 57.82 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.779 1.4 . . . . 8.13 114.779 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.75 -41.83 13.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.207 1.003 . . . . 2.61 111.468 171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -92.21 -2.37 56.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.873 1.434 . . . . 2.6 114.873 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.62 169.53 0.93 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.574 1.324 . . . . 4.21 114.574 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' H ' ' H ' ' A' ' 270' ' ' ASP . . . 79.4 -34.89 2.0 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.559 1.076 . . . . 1.91 113.688 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -100.9 164.01 12.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.322 1.049 . . . . 3.29 109.727 161.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -90.16 150.29 22.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.054 0.942 . . . . 1.77 113.468 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -129.9 142.83 50.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.053 -1.029 . . . . 2.6 113.276 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.2 mt -116.81 109.59 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 104.669 -2.345 . . . . 2.56 104.669 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mt -112.04 111.57 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.064 1.346 . . . . 1.7 109.114 -163.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.07 142.49 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.549 2.34 . . . . 5.47 112.266 -167.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.53 100.06 6.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.868 1.267 . . . . 2.15 110.736 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -170.57 -173.6 37.93 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.824 -0.547 . . . . 1.73 114.078 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -176.0 162.09 2.52 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.537 1.31 . . . . 5.2 114.537 -153.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 m -71.09 -20.92 62.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 116.46 -1.734 . . . . 4.05 114.739 -172.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -48.09 -52.04 21.99 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.802 1.637 . . . . 5.39 111.812 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 28.0 p -119.75 97.76 49.73 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.799 1.239 . . . . 2.75 108.539 170.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 51.3 3.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.937 3.758 . . . . 4.64 109.397 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -120.37 -88.61 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.395 2.278 . . . . 4.29 107.005 -166.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.2 t -38.9 -46.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.798 1.639 . . . . 2.51 112.959 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 90.9 m -56.0 -63.69 3.04 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.864 1.266 . . . . 1.83 113.744 -172.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.53 -31.38 41.7 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.847 1.698 . . . . 1.39 111.944 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -67.77 -36.03 79.76 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 120.447 1.476 . . . . 2.76 112.882 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.47 -43.29 23.49 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.089 -1.007 . . . . 4.04 113.103 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -40.05 83.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.343 0.974 . . . . 2.62 112.134 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -45.99 -58.21 3.77 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.587 1.555 . . . . 3.32 111.135 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -49.85 -35.99 25.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.197 0.599 . . . . 3.32 111.359 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.5 mtm -86.08 -20.94 27.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.138 1.375 . . . . 2.93 114.184 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.5 mm -70.17 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.011 1.278 . . . . 1.84 108.427 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.82 -22.59 66.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.3 -0.857 . . . . 1.72 112.844 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.6 -40.94 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 121.081 1.764 . . . . 1.44 112.6 167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.6 -18.54 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 120.745 1.611 . . . . 2.54 112.43 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -47.07 26.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.784 1.234 . . . . 3.44 112.229 167.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.63 -39.4 93.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.922 1.689 . . . . 2.53 113.392 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 tt -74.22 -41.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.64 0.978 . . . . 2.28 113.64 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.1 -29.95 69.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.754 2.022 . . . . 2.13 112.296 -171.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -62.43 -30.39 71.2 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.775 1.23 . . . . 2.22 112.06 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.0 mm -96.8 55.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.268 1.427 . . . . 3.11 109.171 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.3 t -57.52 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 129.732 3.213 . . . . 4.24 117.056 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.66 2.45 15.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.973 1.709 . . . . 2.85 111.097 157.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.46 158.2 37.3 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 125.705 1.602 . . . . 2.49 109.236 154.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 168.95 18.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.922 3.748 . . . . 2.24 113.4 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.63 147.37 52.8 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.801 1.64 . . . . 4.25 112.819 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.8 tt -140.0 130.56 25.61 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.663 0.785 . . . . 2.44 111.393 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.7 m -114.02 111.64 47.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 125.409 1.484 . . . . 1.35 110.926 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 143.82 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.507 2.138 . . . . 0.93 111.769 167.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -139.87 118.8 12.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.01 -0.995 . . . . 2.35 110.555 -160.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -98.44 110.03 22.69 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.309 1.044 . . . . 2.38 108.898 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.7 mm -88.23 90.79 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.371 -0.974 . . . . 1.48 108.371 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 228' ' ' THR . 15.7 t -73.02 85.99 1.31 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.692 0.758 . . . . 2.1 109.596 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.488 HG22 HG13 ' A' ' 234' ' ' VAL . 10.4 pt -67.75 -2.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.651 1.58 . . . . 1.96 113.693 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.89 96.73 0.56 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.596 1.958 . . . . 4.04 109.441 152.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -87.01 5.96 5.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.127 3.218 . . . . 2.66 110.906 150.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -72.37 64.69 0.6 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.317 2.247 . . . . 4.51 109.665 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.65 167.76 5.33 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 114.989 1.478 . . . . 8.36 114.989 -155.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.28 67.32 6.07 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.884 1.673 . . . . 8.93 111.142 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.6 p 60.82 -150.17 0.41 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.992 2.117 . . . . 3.6 112.366 166.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -67.7 -28.72 67.91 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.951 -1.093 . . . . 4.01 112.155 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.99 -46.03 82.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.332 1.453 . . . . 3.44 111.485 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.77 61.8 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.421 1.637 . . . . 1.94 115.421 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.71 -37.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 1.96 109.835 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.21 -41.51 75.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.737 0.815 . . . . 1.59 111.465 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -60.45 -22.51 63.54 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.435 1.094 . . . . 4.07 113.51 171.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -40.67 12.4 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.7 1.136 . . . . 2.98 112.212 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.19 -36.42 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.136 0.975 . . . . 2.07 111.342 174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -51.89 -32.95 34.62 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.922 2.089 . . . . 5.06 113.304 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.55 -48.85 9.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.488 0.715 . . . . 3.34 110.213 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.94 -28.89 60.78 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 115.407 1.632 . . . . 3.28 115.407 -162.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.0 t 126.97 145.57 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 129.738 3.215 . . . . 2.14 110.926 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.98 -13.38 34.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.909 2.406 . . . . 1.99 114.601 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.65 -20.51 60.55 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.324 0.966 . . . . 2.62 113.562 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.23 111.23 20.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.771 1.228 . . . . 2.53 108.09 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.49 131.67 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.06 0.544 . . . . 1.83 109.596 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.25 6.18 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 123.632 0.634 . . . . 1.26 113.101 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.53 145.17 49.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.592 1.157 . . . . 2.16 113.145 -170.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 202' ' ' SER . 4.9 t -172.97 -174.27 1.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 128.216 2.606 . . . . 2.64 111.018 167.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -168.49 -62.84 0.03 OUTLIER Glycine 0 N--CA 1.467 0.765 0 CA-C-N 119.435 1.016 . . . . 3.0 112.527 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -162.52 162.63 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.39 1.876 . . . . 3.05 109.7 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -50.52 -39.13 47.96 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.638 1.575 . . . . 8.91 112.08 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.3 mp0 -72.66 -30.32 64.17 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.031 1.732 . . . . 4.57 112.072 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.72 -38.49 25.66 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.059 -1.026 . . . . 3.79 111.068 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 203' ' ' ILE . 2.5 t -53.29 -37.15 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.119 1.768 . . . . 2.05 112.633 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.16 -60.48 3.43 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.54 -1.219 . . . . 2.93 109.93 168.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -42.97 -44.24 4.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.935 1.698 . . . . 2.23 114.411 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.83 -50.84 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.024 0.829 . . . . 2.58 112.551 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.16 65.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.754 0.822 . . . . 2.46 112.629 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -82.0 -41.67 20.39 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.983 2.113 . . . . 5.13 111.533 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.8 79.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.434 0.694 . . . . 1.83 111.107 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.85 20.63 2.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.349 0.66 . . . . 3.12 112.587 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.308 3.5 ppt_? 16.22 68.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 129.744 3.217 . . . . 7.43 116.016 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.31 149.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.468 1.907 . . . . 3.21 109.312 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -109.16 171.14 7.61 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.282 1.039 . . . . 5.37 113.383 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -149.64 179.81 7.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.802 1.641 . . . . 4.32 109.106 165.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -118.16 63.46 4.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.564 -0.71 . . . . 3.09 112.386 -166.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.96 133.7 22.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.594 2.196 . . . . 3.29 110.464 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.79 174.31 21.57 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.905 1.24 . . . . 2.9 114.071 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -82.66 -169.85 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.702 3.602 . . . . 4.21 110.574 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -160.11 155.74 25.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.184 1.394 . . . . 5.57 111.937 168.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.37 -93.49 0.29 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.119 1.367 . . . . 7.06 111.281 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -115.47 -49.04 2.76 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.471 1.032 . . . . 10.75 113.536 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.32 -16.08 31.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 116.411 2.004 . . . . 8.58 116.411 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 250' ' ' LYS 0.289 5.3 mm-40 90.38 28.53 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 129.176 2.99 . . . . 7.63 110.978 -174.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -60.84 25.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 134.276 5.03 . . . . 8.9 115.891 177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.85 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.998 2.119 . . . . 4.73 112.438 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.54 148.22 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.081 1.752 . . . . 4.42 112.007 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.2 t -150.79 131.68 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.363 1.865 . . . . 2.78 106.764 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.06 164.27 15.76 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 127.024 2.13 . . . . 3.17 112.57 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.47 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.2 p80 -152.3 140.95 20.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.007 1.323 . . . . 2.67 114.101 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.5 p -62.76 160.69 13.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.703 1.601 . . . . 3.44 112.318 168.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.68 74.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.84 1.256 . . . . 3.99 109.499 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -143.76 142.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 128.139 2.576 . . . . 3.02 107.421 -172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 19.0 tpt -145.06 137.03 25.71 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.179 0.991 . . . . 3.91 111.954 -163.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -102.59 133.65 47.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.536 1.31 . . . . 2.91 114.536 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.98 120.61 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.691 0.796 . . . . 2.07 109.224 160.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.37 128.5 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 106.043 -1.836 . . . . 2.43 106.043 165.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.67 -154.3 6.6 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.386 0.517 . . . . 1.92 112.087 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -66.52 179.99 1.83 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.461 1.441 . . . . 3.77 109.375 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.55 ' H ' ' H ' ' A' ' 157' ' ' GLY . 27.9 m-20 62.25 -10.26 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 119.017 2.969 . . . . 5.07 119.017 163.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 121.07 18.4 3.85 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 118.679 2.231 . . . . 4.18 118.679 162.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.08 177.21 10.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.543 2.171 . . . . 5.39 116.646 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -60.02 147.04 40.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.32 . . . . 3.87 112.922 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.97 -42.13 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.75 1.018 . . . . 2.63 113.75 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -144.5 151.73 39.58 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.79 1.636 . . . . 2.72 110.017 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -119.55 126.09 50.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.065 1.412 . . . . 4.02 112.845 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.67 -176.73 3.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.331 2.253 . . . . 2.29 110.048 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.38 -171.04 31.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.864 1.697 . . . . 2.41 110.481 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -70.4 91.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.246 0.461 . . . . 6.15 112.246 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.58 -41.75 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.979 1.711 . . . . 6.0 113.36 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 281' ' ' LYS . 8.6 mmpt? -68.0 134.13 50.21 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.451 1.278 . . . . 5.56 114.451 -166.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -67.69 159.35 30.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.144 1.378 . . . . 5.41 109.573 166.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -52.86 -66.97 0.29 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.63 -1.294 . . . . 2.4 112.368 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.11 -5.83 63.1 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 114.755 0.662 . . . . 2.19 114.755 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -76.23 -30.31 57.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.742 1.271 . . . . 4.41 112.109 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.87 -48.86 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 121.085 -1.009 . . . . 1.62 109.04 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.75 82.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.702 1.201 . . . . 1.71 111.641 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.52 80.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.549 1.068 . . . . 1.64 113.496 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 t -64.2 -55.3 22.62 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.787 0.721 . . . . 2.5 109.51 172.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.7 tt -68.72 -30.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 120.503 -1.373 . . . . 2.97 113.667 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.57 63.97 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.647 -1.283 . . . . 1.89 112.717 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 74.0 m -82.18 -43.1 18.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.465 1.106 . . . . 1.98 111.05 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -69.62 -20.35 63.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.743 1.217 . . . . 2.21 113.571 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -18.88 64.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.476 1.111 . . . . 5.41 113.679 166.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -67.28 -48.28 47.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 116.82 -1.562 . . . . 5.26 112.348 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.78 -28.56 9.47 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.125 2.55 . . . . 2.97 113.218 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -127.06 100.45 6.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.158 0.89 . . . . 3.64 111.25 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 82.22 -151.14 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.026 2.131 . . . . 8.36 110.057 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? 66.81 -44.67 0.44 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 130.407 3.483 . . . . 6.8 115.95 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -73.46 -16.63 61.3 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.295 2.238 . . . . 11.71 112.197 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--O 1.253 1.28 0 C-N-CA 129.9 3.28 . . . . 9.62 108.462 176.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 117.906 -1.045 . . . . 18.9 110.057 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -165.57 166.5 18.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 16.17 109.84 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 t -161.09 152.05 18.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.77 1.628 . . . . 13.66 109.646 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.77 -167.74 39.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.935 0.779 . . . . 12.15 111.272 163.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -157.72 153.48 22.84 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.265 1.426 . . . . 9.16 111.259 175.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.77 174.05 12.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.2 2.6 . . . . 7.72 111.679 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.7 mt -114.06 -174.56 2.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.475 1.51 . . . . 7.74 108.025 157.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.04 -146.57 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.718 0.69 . . . . 7.19 110.113 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.65 -130.99 40.52 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.392 -1.483 . . . . 4.74 109.392 -165.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -158.32 92.41 0.12 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.822 -1.544 . . . . 3.54 111.5 170.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.22 150.69 76.89 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 3.34 112.961 -166.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -169.74 174.51 5.71 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.362 2.265 . . . . 2.59 110.873 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.261 11.4 p -141.8 41.87 1.7 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.603 2.075 . . . . 2.64 116.603 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 159.11 20.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.361 1.464 . . . . 2.19 114.723 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.3 m -94.67 155.35 16.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.251 2.22 . . . . 2.24 109.601 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.4 p -106.15 162.22 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.931 1.692 . . . . 1.45 112.597 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -60.17 -9.45 3.32 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.552 1.686 . . . . 1.53 115.552 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 5.29 18.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.825 1.65 . . . . 2.79 113.422 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.73 -8.91 79.1 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.305 -1.275 . . . . 2.84 115.352 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -63.45 140.34 58.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.604 1.702 . . . . 6.11 110.168 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 145.45 29.85 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.797 -0.816 . . . . 7.54 108.797 158.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -132.87 165.16 25.26 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.291 0.636 . . . . 3.19 111.499 167.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 17.3 p -127.37 167.75 15.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.951 1.7 . . . . 2.35 107.12 163.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -45.14 -37.06 4.08 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.631 1.572 . . . . 3.78 112.928 165.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -91.93 -15.49 27.97 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.112 1.153 . . . . 7.3 114.112 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 151' ' ' THR . 4.5 m-20 -81.95 -20.78 37.91 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.657 1.117 . . . . 3.84 111.9 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -18.13 27.08 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.967 1.469 . . . . 3.02 114.967 -171.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.33 -176.13 5.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.087 1.143 . . . . 3.4 114.087 -162.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.03 -8.76 63.28 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.629 1.585 . . . . 1.57 115.611 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.83 -132.28 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.139 1.776 . . . . 3.34 109.845 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.87 141.74 50.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.379 1.471 . . . . 1.74 110.293 165.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.47 146.61 52.33 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.413 0.894 . . . . 2.5 113.413 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.44 120.93 38.3 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.954 1.301 . . . . 2.57 109.178 168.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.2 tt -109.48 126.63 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.25 1.02 . . . . 2.89 110.892 -173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -137.64 127.92 26.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.731 1.613 . . . . 3.7 111.826 -171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 148.26 22.92 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.75 -1.219 . . . . 2.77 111.961 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.88 -170.35 39.92 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-O 122.903 1.28 . . . . 1.85 115.958 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -149.94 -160.82 1.22 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.899 0.88 . . . . 7.44 109.827 166.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 36.8 p -66.88 -76.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.297 1.039 . . . . 3.65 110.467 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -71.74 60.25 0.35 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.415 3.086 . . . . 4.99 115.686 -162.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 5.0 p -169.64 144.21 2.35 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.36 1.064 . . . . 3.04 109.088 -165.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.9 157.7 37.16 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 125.087 3.858 . . . . 7.36 114.28 -142.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -73.76 9.44 1.47 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.801 3.241 . . . . 5.13 113.519 -159.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.24 -20.92 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.287 -1.324 . . . . 3.35 110.241 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.463 ' SG ' ' CE1' ' A' ' 260' ' ' HIS 0.262 42.7 t -48.85 -68.07 0.36 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 129.418 3.087 . . . . 2.39 114.068 173.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 173' ' ' CYS . 74.4 Cg_endo -69.43 -30.1 24.39 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.337 2.024 . . . . 1.42 111.795 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -52.34 -50.85 61.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.909 1.231 . . . . 3.2 111.747 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.601 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 7.8 tp10 -82.6 -25.16 33.48 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.449 1.277 . . . . 4.15 114.449 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -52.15 66.61 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.357 1.435 . . . . 2.75 110.919 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -47.79 82.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.52 1.528 . . . . 5.9 111.764 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 48.9 mtmt -58.25 -41.45 84.21 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.201 -1.562 . . . . 3.44 112.051 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.4 mtm -56.38 -38.92 72.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.365 1.439 . . . . 3.31 110.898 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.6 mt -67.4 -36.72 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 120.403 -1.436 . . . . 2.05 111.325 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 6.6 mm-40 -56.08 -30.02 61.39 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.781 0.719 . . . . 2.93 112.534 168.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.45 -40.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.201 0.91 . . . . 1.51 110.095 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.79 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.358 0.526 . . . . 2.72 109.639 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.11 -52.25 63.86 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.581 1.552 . . . . 4.56 111.778 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 27.6 tt0 -67.02 -13.52 61.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.797 1.639 . . . . 2.51 114.173 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.83 -42.19 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.142 1.377 . . . . 2.33 112.348 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -37.04 76.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.671 0.789 . . . . 2.28 110.027 172.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -64.62 -9.67 21.15 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.122 1.769 . . . . 2.97 114.975 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 35.6 mm -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.555 1.07 . . . . 2.6 110.83 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.4 m 70.48 -25.45 0.16 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.148 2.179 . . . . 2.32 113.718 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.1 p -84.63 18.06 2.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.829 1.251 . . . . 3.09 113.538 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.86 156.61 34.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.912 0.885 . . . . 3.1 110.185 160.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.99 152.35 51.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.299 1.999 . . . . 2.98 108.844 153.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -45.09 137.58 4.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.044 1.738 . . . . 4.45 115.461 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.67 112.85 22.02 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.238 0.542 . . . . 3.23 110.046 163.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.5 m -99.21 107.26 43.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.032 1.733 . . . . 1.34 109.836 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 138.25 10.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.357 2.038 . . . . 1.17 112.66 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.58 104.85 7.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.828 1.251 . . . . 2.56 110.87 -163.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -95.94 130.01 43.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.991 1.317 . . . . 2.65 110.138 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.52 126.71 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.345 0.975 . . . . 1.2 112.686 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 10.6 m -73.68 110.18 7.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.101 1.148 . . . . 2.03 114.101 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -96.23 23.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.835 1.42 . . . . 2.17 114.835 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -117.94 66.32 5.64 Favored Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 124.902 1.281 . . . . 3.66 110.86 169.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.78 66.73 7.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.235 3.29 . . . . 4.25 111.386 -163.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -169.59 -39.47 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.636 1.574 . . . . 4.75 111.144 -160.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.33 15.29 2.59 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.945 1.461 . . . . 8.0 114.945 160.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -48.39 142.41 5.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.735 -0.603 . . . . 7.9 111.278 146.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.8 m -158.62 129.26 6.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.856 1.662 . . . . 3.07 109.511 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -61.55 -35.63 78.31 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.687 0.995 . . . . 3.56 113.687 -171.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -68.26 -40.63 81.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.845 1.202 . . . . 3.74 112.503 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.02 95.39 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.181 -0.95 . . . . 1.94 110.783 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.79 -37.36 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 117.781 -1.104 . . . . 2.24 112.357 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.12 -45.28 79.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 121.038 1.745 . . . . 1.32 111.48 173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.415 ' O ' ' HE3' ' A' ' 218' ' ' LYS . 41.5 m-80 -66.26 -23.43 66.4 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.349 0.87 . . . . 4.59 113.349 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.94 -50.24 10.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.716 1.207 . . . . 3.42 111.263 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.84 -40.54 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.418 1.887 . . . . 1.26 112.069 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.45 -20.82 63.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.69 1.367 . . . . 3.34 114.69 -175.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -72.19 -41.31 67.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.24 0.927 . . . . 3.02 110.708 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.63 -59.71 2.61 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.202 0.601 . . . . 2.61 112.042 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.3 m -173.86 146.66 1.23 Allowed Pre-proline 0 N--CA 1.477 0.911 0 O-C-N 120.401 -1.437 . . . . 2.25 114.61 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.38 -19.4 22.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.593 2.862 . . . . 1.79 114.076 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -87.27 -3.08 59.03 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.506 1.048 . . . . 2.78 113.34 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tt -81.96 149.27 28.26 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.446 -0.784 . . . . 2.03 110.444 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.9 139.91 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.79 0.836 . . . . 2.55 110.881 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.58 128.94 8.16 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.034 1.302 . . . . 0.81 110.893 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.52 136.16 51.08 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.544 1.137 . . . . 2.31 112.555 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.8 p -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.869 2.068 . . . . 3.96 109.869 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -143.92 -82.61 0.06 OUTLIER Glycine 0 N--CA 1.471 0.973 0 CA-C-N 120.292 1.405 . . . . 2.91 113.197 167.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t 172.66 166.68 0.12 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 129.803 3.241 . . . . 2.73 106.868 -172.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.55 -30.2 53.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.931 1.692 . . . . 6.58 112.422 -170.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.62 -46.0 27.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.952 2.501 . . . . 3.38 113.261 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.97 -41.04 62.55 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.989 0.916 . . . . 4.5 111.031 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.63 -33.1 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.852 -1.155 . . . . 2.4 112.295 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.33 -61.09 2.83 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.709 -1.138 . . . . 3.28 109.894 160.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -40.84 -54.88 2.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.626 1.571 . . . . 3.07 114.528 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.87 -44.08 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.419 1.463 . . . . 2.83 113.94 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.21 -26.48 66.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.345 0.975 . . . . 3.19 112.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -79.03 -48.28 14.68 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.45 2.7 . . . . 5.71 112.373 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.79 -60.97 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.825 1.193 . . . . 2.55 112.119 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -76.31 69.7 2.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.226 1.01 . . . . 3.8 109.057 165.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.08 83.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.09 2.156 . . . . 6.3 114.894 -156.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.65 157.33 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.264 1.426 . . . . 3.48 112.887 -166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -105.07 151.59 23.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.141 1.376 . . . . 5.7 111.966 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -168.78 156.55 7.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.001 1.721 . . . . 3.72 110.521 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -106.63 104.82 52.67 Favored Pre-proline 0 N--CA 1.473 0.705 0 O-C-N 121.176 -0.952 . . . . 3.73 109.52 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.53 151.6 33.01 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.359 2.04 . . . . 2.92 110.317 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.86 43.57 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.589 -1.117 . . . . 2.73 111.897 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.68 -23.87 30.67 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.354 2.703 . . . . 4.94 112.673 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.359 13.7 ptpt 66.26 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.288 3.435 . . . . 8.38 118.29 170.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.94 -18.68 4.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.836 0.854 . . . . 5.71 113.238 -163.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -135.5 -60.4 0.75 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.486 0.714 . . . . 10.32 109.746 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -168.6 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.893 1.677 . . . . 13.65 109.172 154.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -85.52 3.72 39.16 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.061 1.874 . . . . 8.59 116.061 -159.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -64.77 -12.07 43.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.196 2.198 . . . . 7.71 115.579 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -71.67 133.48 45.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 116.023 1.86 . . . . 5.6 116.023 -145.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.95 165.28 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 125.947 1.699 . . . . 3.81 109.533 161.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.63 83.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.786 -1.197 . . . . 3.13 109.59 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 105.73 2.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.07 1.348 . . . . 4.79 111.874 -168.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.463 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.9 p80 -86.63 76.08 9.59 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.78 0.8 . . . . 2.49 112.739 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.8 m -43.44 122.47 2.63 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.397 1.879 . . . . 4.51 109.996 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 279' ' ' GLN . 6.7 tt -51.65 99.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.605 1.962 . . . . 5.26 113.144 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.9 mt -140.75 138.99 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 126.532 1.933 . . . . 2.29 108.305 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 21.5 ttm -140.97 144.04 34.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.85 2.46 . . . . 3.57 108.847 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -116.11 154.0 30.75 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.423 -0.798 . . . . 3.25 112.141 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.74 125.86 53.97 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.132 1.773 . . . . 2.85 109.516 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.78 127.48 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 2.63 109.516 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.52 -179.51 40.77 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.907 1.241 . . . . 1.62 112.208 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.36 -37.56 71.46 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.769 2.98 . . . . 2.83 113.461 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.92 -9.45 55.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.496 1.518 . . . . 5.12 114.655 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.4 -22.81 1.6 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 126.063 1.792 . . . . 2.55 117.142 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.79 0.3 11.3 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.734 1.753 . . . . 5.63 115.734 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.6 t80 119.22 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.198 3.799 . . . . 3.48 111.319 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.21 -68.21 0.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.186 -0.946 . . . . 2.69 113.053 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -158.28 177.0 11.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.436 1.094 . . . . 2.8 111.742 -165.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -143.34 150.76 39.62 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.473 -1.392 . . . . 3.44 113.93 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.433 ' CD1' ' HE3' ' A' ' 281' ' ' LYS . 14.9 m-85 -129.79 129.38 43.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.211 1.404 . . . . 2.64 108.679 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.32 153.05 25.02 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.065 0.84 . . . . 3.04 113.446 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 30.7 tp60 66.07 -178.16 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.307 1.843 . . . . 3.99 110.466 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 11.6 m120 -72.19 62.49 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.898 1.279 . . . . 8.1 113.002 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 277' ' ' PHE . 5.6 tppt? -52.05 125.87 16.82 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.728 -1.233 . . . . 4.17 108.151 160.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -64.95 143.75 57.74 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.036 -1.04 . . . . 5.97 108.706 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 4.4 tmtt? -52.7 -43.51 65.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.973 1.101 . . . . 2.27 113.973 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.96 -23.67 66.02 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.167 -0.796 . . . . 1.66 112.934 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.65 -46.04 64.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.449 0.625 . . . . 4.34 110.185 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.1 -49.37 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.071 1.349 . . . . 1.51 109.467 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.97 -47.04 79.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.549 -0.739 . . . . 1.37 112.827 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.04 75.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.531 1.06 . . . . 1.56 112.601 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.5 t -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.618 1.567 . . . . 1.96 111.679 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.35 -44.35 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.256 -0.902 . . . . 2.29 110.058 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.1 45.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.347 0.976 . . . . 1.84 113.104 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 55.5 m -85.61 -42.72 14.1 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 117.472 -1.252 . . . . 2.18 112.232 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -70.37 -23.83 62.85 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.079 1.309 . . . . 2.68 113.461 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -71.95 -33.54 68.29 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.016 1.326 . . . . 3.71 111.5 170.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -52.22 -43.19 89.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 116.926 -1.512 . . . . 6.2 114.138 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.54 -14.77 30.71 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.767 2.978 . . . . 2.64 115.164 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -106.99 -50.53 3.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.359 1.436 . . . . 3.38 113.733 -168.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.45 ' HG3' ' H ' ' A' ' 299' ' ' LYS . 0.0 OUTLIER -127.66 168.4 15.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.371 1.081 . . . . 8.58 113.835 -155.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.45 ' H ' ' HG3' ' A' ' 298' ' ' ARG . 1.0 OUTLIER 76.11 -41.89 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.217 3.407 . . . . 9.47 110.789 -174.034 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -64.7 22.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.465 1.906 . . . . 9.54 115.32 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 131.411 3.884 . . . . 8.43 109.042 -151.651 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.45 -0.786 . . . . 24.74 110.121 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -65.9 163.45 16.98 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.707 0.685 . . . . 21.78 110.217 155.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -107.25 -175.28 2.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.015 1.326 . . . . 16.9 109.506 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.79 14.14 82.86 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.119 1.208 . . . . 14.12 116.119 163.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -62.73 114.98 13.91 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 120.247 2.024 . . . . 18.0 108.78 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -82.28 -156.55 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.102 2.535 . . . . 10.62 110.558 -172.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.91 2.32 0.11 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.255 1.576 . . . . 12.25 115.255 -167.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 -10.04 2.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.39 1.626 . . . . 6.59 115.39 -166.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 143.79 164.96 10.63 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.253 1.406 . . . . 3.63 111.851 -163.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.03 -170.32 27.23 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.228 0.918 . . . . 3.75 113.693 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.82 145.17 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.505 2.803 . . . . 3.78 112.188 -172.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -161.65 170.42 19.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.263 2.225 . . . . 3.31 109.711 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.1 p -146.49 109.33 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.675 -1.266 . . . . 2.75 111.544 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.67 147.15 29.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.074 0.95 . . . . 2.67 111.16 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -78.65 141.55 37.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.373 1.069 . . . . 1.75 108.705 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.9 p -97.28 159.51 14.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.33 111.498 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.45 66.56 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 1.31 112.892 171.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -51.21 35.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.525 1.93 . . . . 2.33 111.729 167.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.497 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . 126.88 7.49 5.07 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.672 1.429 . . . . 1.93 116.672 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -78.77 177.81 8.39 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.699 1.749 . . . . 5.12 111.484 160.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -104.14 133.72 48.59 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.579 -1.326 . . . . 6.02 109.78 159.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.26 159.65 19.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.913 1.285 . . . . 3.62 112.792 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.3 p -141.25 166.5 24.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.206 1.003 . . . . 2.54 111.074 -167.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -29.46 -64.91 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.77 2.828 . . . . 5.84 114.588 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -72.38 -3.84 26.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.689 2.107 . . . . 6.31 116.689 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.44 -37.97 74.44 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.475 1.034 . . . . 5.31 111.849 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.08 -14.22 16.52 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.031 1.332 . . . . 2.86 114.076 -172.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.27 94.17 0.15 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.994 1.718 . . . . 3.87 111.243 -168.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.91 -35.86 0.99 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.96 1.267 . . . . 2.12 112.757 -171.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.09 167.01 10.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 3.55 109.488 167.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -90.27 140.16 29.96 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.231 -0.918 . . . . 1.68 112.603 -167.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.3 mt -112.24 124.03 51.57 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.975 1.31 . . . . 1.99 112.031 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.22 114.93 29.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 106.121 -1.807 . . . . 3.21 106.121 165.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.83 122.85 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.531 -0.731 . . . . 1.84 109.433 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.5 152.68 51.47 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.981 0.912 . . . . 4.09 111.364 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.96 121.05 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.412 1.085 . . . . 2.52 109.149 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -131.35 82.6 0.32 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 124.344 0.973 . . . . 1.94 111.567 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.3 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.716 2.006 . . . . 4.6 113.337 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.5 p 31.27 -113.28 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.722 1.609 . . . . 4.52 110.19 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 55.29 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.348 0.526 0 C-N-CA 129.179 2.992 . . . . 5.51 111.43 171.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.6 p -71.35 107.65 2.96 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 126.468 1.907 . . . . 2.98 106.235 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.59 22.84 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.386 3.391 . . . . 4.08 111.805 -160.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -59.46 1.85 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.651 1.981 . . . . 4.71 110.01 -157.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 m -69.43 -30.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 3.61 112.229 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 10.9 m -56.12 -60.24 9.48 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 125.944 1.698 . . . . 2.0 113.353 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 -19.47 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.509 2.14 . . . . 1.81 114.273 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -65.97 -59.62 3.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.334 1.424 . . . . 4.4 113.22 -169.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.66 -24.14 65.4 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.051 -1.031 . . . . 2.84 111.577 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -46.62 65.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.74 0.816 . . . . 2.81 110.301 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.39 -49.06 78.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.88 0.872 . . . . 3.02 109.462 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -53.74 -41.71 67.37 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.851 -1.156 . . . . 4.1 112.366 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.9 mtm -63.61 -24.12 67.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 117.09 -1.433 . . . . 3.28 113.542 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.55 -56.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 122.163 2.256 . . . . 1.64 108.71 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.33 -13.45 62.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.068 -1.444 . . . . 1.85 112.972 174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.76 -56.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 121.899 2.136 . . . . 1.63 112.574 157.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.37 -43.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.485 1.493 . . . . 2.94 112.491 -163.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.58 -26.32 57.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.027 0.531 . . . . 4.11 111.891 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.77 -55.16 10.61 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.992 0.917 . . . . 3.1 110.781 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.9 tt -72.85 -24.27 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.228 0.825 . . . . 2.3 113.228 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.68 -57.81 11.13 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.01 1.724 . . . . 3.12 111.286 160.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.7 m -58.7 -34.37 71.24 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.261 -0.899 . . . . 3.24 113.04 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.04 -16.04 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.244 1.818 . . . . 3.51 112.762 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.9 m 67.97 -9.25 0.48 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.481 1.912 . . . . 3.36 113.558 163.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.7 m -92.79 -29.39 16.02 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.923 1.689 . . . . 4.25 111.788 -166.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.6 175.29 4.3 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.943 0.897 . . . . 3.5 111.378 167.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.19 -166.55 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.531 2.821 . . . . 2.76 108.111 155.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -73.81 158.18 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.646 1.213 . . . . 3.61 113.399 171.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.39 132.11 17.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.06 -0.973 . . . . 4.15 112.864 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.8 m -105.77 116.15 60.35 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.607 1.963 . . . . 1.14 110.13 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -76.03 135.22 17.0 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.222 2.614 . . . . 0.87 112.04 160.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tp -131.68 102.62 5.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.424 1.49 . . . . 2.79 110.048 -166.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 65.7 t80 -95.84 106.45 18.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.118 1.367 . . . . 2.61 110.311 -167.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.38 105.56 14.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.011 0.91 . . . . 1.4 109.251 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.38 106.84 16.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.937 -1.029 . . . . 2.26 108.951 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.09 22.94 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 121.118 -0.989 . . . . 2.2 112.246 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -113.61 39.59 0.22 Allowed Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 130.559 3.544 . . . . 5.19 114.182 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -79.25 59.57 7.45 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.544 3.496 . . . . 2.18 112.853 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 207' ' ' ARG . 92.8 mt-10 -98.19 -21.8 16.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.085 1.754 . . . . 6.12 113.112 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -172.05 -38.85 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.951 2.1 . . . . 7.94 112.377 -178.102 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.24 113.06 2.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.715 0.689 . . . . 4.71 109.755 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -78.26 169.89 17.52 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.588 0.708 . . . . 2.94 109.348 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.497 ' HE2' ' HA2' ' A' ' 147' ' ' GLY 0.327 0.0 OUTLIER -62.75 -13.86 37.86 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.446 -1.408 . . . . 3.75 113.319 179.045 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -70.77 -35.16 72.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.511 1.925 . . . . 3.09 113.511 166.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.89 74.65 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.933 -1.104 . . . . 1.39 110.376 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.25 -39.05 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.176 0.591 . . . . 1.81 110.745 173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.39 78.42 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.083 -1.01 . . . . 1.0 111.593 169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 30.8 m-80 -59.33 -39.57 83.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.963 -0.541 . . . . 3.81 112.377 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.69 -52.28 61.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.492 0.587 . . . . 3.14 110.687 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.29 -43.08 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.166 1.386 . . . . 1.08 113.843 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -69.38 -11.47 60.85 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.843 1.423 . . . . 3.56 114.843 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.35 -12.66 48.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.634 0.774 . . . . 3.52 112.813 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.85 -51.09 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.355 1.613 . . . . 2.76 115.355 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.7 t -171.25 145.54 1.86 Allowed Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 121.012 1.733 . . . . 1.65 112.557 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 -14.28 36.36 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.009 2.473 . . . . 2.36 114.318 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.77 -15.15 57.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.459 1.027 . . . . 4.38 113.502 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.31 132.98 35.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.573 -0.704 . . . . 2.39 111.956 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.46 142.04 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.493 1.117 . . . . 1.84 108.794 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.14 139.73 15.7 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.123 1.344 . . . . 1.03 111.84 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.37 152.8 48.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.598 1.559 . . . . 1.94 112.467 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.7 m -160.7 160.84 31.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.705 1.602 . . . . 2.6 111.779 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -163.62 -140.38 2.86 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.53 -1.15 . . . . 1.78 110.372 149.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.6 p -111.8 -156.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.507 1.153 . . . . 2.73 110.45 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -30.85 41.89 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.48 1.512 . . . . 11.09 112.338 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -44.78 63.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.99 1.316 . . . . 3.9 110.667 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.42 -49.15 67.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.436 -0.79 . . . . 3.03 112.616 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.9 t -51.85 -42.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.644 0.609 . . . . 2.8 112.644 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -69.58 -40.49 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.048 0.939 . . . . 4.26 111.252 174.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.539 HE22 ' HD2' ' A' ' 239' ' ' ARG . 23.9 mm100 -64.35 -34.35 77.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 116.021 -1.942 . . . . 3.21 115.999 172.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.61 -37.17 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.049 2.204 . . . . 2.9 110.26 169.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.96 4.56 6.36 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.386 1.475 . . . . 4.78 114.198 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.539 ' HD2' HE22 ' A' ' 236' ' ' GLN . 0.0 OUTLIER -122.35 -25.05 4.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.687 1.595 . . . . 8.13 112.626 177.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.8 -77.51 0.12 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.081 0.855 . . . . 4.22 109.829 157.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.62 -120.6 0.07 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.718 0.807 . . . . 4.77 111.672 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -170.64 134.09 1.04 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.773 1.229 . . . . 5.32 111.583 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.5 p -163.93 152.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.655 1.582 . . . . 3.72 109.416 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.15 154.91 48.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.373 1.869 . . . . 6.64 110.669 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.78 144.35 50.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.577 0.751 . . . . 5.79 110.479 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 66.1 m -107.82 90.41 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.186 -0.672 . . . . 4.66 109.186 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.38 138.64 15.88 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.819 2.346 . . . . 3.96 110.41 172.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.69 -172.49 18.1 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.217 1.389 . . . . 4.04 113.512 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.88 169.75 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.345 2.697 . . . . 4.43 110.279 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -118.55 164.13 15.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.554 0.742 . . . . 5.47 110.26 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.55 -169.31 2.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.018 0.927 . . . . 6.71 109.66 160.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -40.49 63.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.909 0.884 . . . . 9.93 112.248 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.06 47.17 1.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.425 1.49 . . . . 7.68 112.516 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 72.96 -20.73 0.27 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.049 2.94 . . . . 7.08 117.077 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.55 124.95 20.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 122.468 2.395 . . . . 6.67 116.048 -164.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.05 88.81 4.6 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.54 1.936 . . . . 5.17 109.942 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.38 101.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.495 -1.298 . . . . 5.93 107.495 166.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.1 t -147.66 131.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.541 1.136 . . . . 3.46 109.626 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -87.09 148.06 25.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.592 1.957 . . . . 5.02 113.152 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 13.3 p80 -125.5 54.05 1.51 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.264 1.95 . . . . 4.09 116.264 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 80.28 -32.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 128.453 2.701 . . . . 5.59 115.526 149.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.38 -38.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 129.071 2.948 . . . . 5.44 113.2 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 45.3 mm -77.98 127.06 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.533 -1.354 . . . . 3.28 113.096 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.2 ttp -98.91 149.0 23.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.814 2.446 . . . . 2.67 111.36 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -102.42 140.35 36.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.551 1.541 . . . . 3.02 113.889 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.75 136.0 46.15 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 154.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.73 143.67 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.804 -1.925 . . . . 2.37 105.804 160.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.56 -130.19 4.39 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 109.243 -1.543 . . . . 2.12 109.243 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.94 -165.55 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.025 1.817 . . . . 2.98 109.046 161.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 70.57 -24.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.2 2.2 . . . . 4.73 116.461 165.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.23 -31.45 5.4 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.116 1.817 . . . . 2.49 114.992 168.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -84.15 72.46 10.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.835 1.254 . . . . 5.07 111.794 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.3 t80 62.84 -168.22 0.2 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.682 1.593 . . . . 4.02 112.614 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.34 -52.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.503 1.921 . . . . 2.62 112.359 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -160.09 154.44 23.64 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.655 1.182 . . . . 2.76 111.81 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -103.03 146.53 28.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.925 1.29 . . . . 6.72 112.766 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -142.94 -179.8 6.57 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.022 0.929 . . . . 2.5 112.04 -174.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.27 -171.88 14.68 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.75 -0.94 . . . . 2.29 110.75 -166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -66.16 96.73 0.35 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.352 0.661 . . . . 4.83 112.116 -163.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.6 p30 176.49 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.088 2.555 . . . . 6.59 109.559 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.97 134.38 47.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.074 0.949 . . . . 5.08 111.064 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -92.23 169.63 10.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.183 1.393 . . . . 5.9 111.346 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -57.99 10.12 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 118.147 -2.845 . . . . 1.88 114.022 -168.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.98 -14.56 65.94 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 122.109 -0.37 . . . . 1.52 113.991 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -84.1 -35.26 23.82 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 124.397 1.079 . . . . 3.83 110.459 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.66 -46.7 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.979 -1.075 . . . . 1.2 109.805 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.17 -47.45 81.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.949 0.9 . . . . 1.18 112.621 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.66 75.67 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.958 -1.089 . . . . 1.38 113.445 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -69.16 -49.45 56.71 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.151 1.381 . . . . 1.8 109.351 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.5 tt -70.77 -35.13 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 121.489 -0.757 . . . . 2.81 112.064 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.35 69.01 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.357 -0.839 . . . . 1.5 113.117 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.8 m -70.67 -51.8 25.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.845 0.858 . . . . 1.69 110.42 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.6 -20.23 64.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.972 0.909 . . . . 2.36 112.711 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 mmm -71.11 -15.11 62.49 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.521 -1.362 . . . . 4.74 114.342 167.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.76 -49.28 60.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 120.707 1.594 . . . . 4.8 113.575 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.47 -50.13 2.84 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.774 1.65 . . . . 2.56 110.513 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -81.7 25.54 0.53 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.657 1.355 . . . . 3.29 114.657 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -60.41 120.41 9.84 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.358 -1.464 . . . . 9.21 113.13 -166.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -19.14 13.48 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.008 1.855 . . . . 6.25 116.008 -171.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER 148.23 135.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.914 4.486 . . . . 11.12 111.031 154.863 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 C--O 1.251 1.165 0 C-N-CA 131.38 3.872 . . . . 8.33 105.82 -158.635 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 118.263 -0.875 . . . . 19.99 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -162.95 175.68 10.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.715 1.606 . . . . 16.13 109.591 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -134.27 155.49 50.11 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.722 1.209 . . . . 13.42 111.514 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.84 134.91 12.48 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.462 1.03 . . . . 10.57 111.903 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -151.18 71.14 8.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.003 0.921 . . . . 8.87 112.73 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.96 -174.75 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.589 2.859 . . . . 6.84 110.851 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.32 173.72 10.54 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.653 1.581 . . . . 6.42 108.33 157.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -39.78 0.18 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.491 0.923 . . . . 7.18 113.491 -165.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.99 -54.74 0.66 Allowed Glycine 0 N--CA 1.472 1.086 0 C-N-CA 125.039 1.304 . . . . 4.02 111.642 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.13 169.61 20.63 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.955 1.264 . . . . 3.12 114.207 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -85.05 156.23 11.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.36 3.374 . . . . 2.56 111.829 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -165.22 166.78 18.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.5 1.92 . . . . 2.79 108.766 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 m -122.37 160.88 24.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.43 1.014 . . . . 2.85 110.715 152.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -142.02 163.9 31.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.936 0.895 . . . . 2.79 110.481 154.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.1 m -99.15 139.07 35.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.508 . . . . 1.6 110.18 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 81.2 p -85.25 159.75 20.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.679 1.192 . . . . 1.43 113.221 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -59.15 -14.19 9.61 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.841 1.256 . . . . 1.78 113.855 165.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 m -95.24 -14.56 23.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.078 . . . . 2.28 111.847 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.16 -17.03 41.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.907 1.718 . . . . 1.78 115.514 169.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.76 164.61 16.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.096 1.448 . . . . 4.96 110.927 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.76 152.28 21.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.95 2.5 . . . . 8.53 111.644 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -139.08 144.68 38.86 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.111 -1.618 . . . . 3.18 112.628 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -112.71 174.43 5.89 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.169 1.788 . . . . 1.85 109.047 162.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -66.14 -30.29 70.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.092 0.86 . . . . 3.7 113.003 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.91 -25.63 61.99 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.432 -0.792 . . . . 6.56 111.85 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.66 -6.2 51.08 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.857 1.263 . . . . 2.97 113.052 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -112.89 -14.73 13.01 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.603 1.705 . . . . 2.12 115.603 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.66 124.33 23.66 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 120.199 1.363 . . . . 3.04 111.931 -169.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 146.95 -19.93 1.6 Allowed Glycine 0 N--CA 1.48 1.59 0 N-CA-C 116.288 1.275 . . . . 1.53 116.288 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -140.96 169.38 17.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.315 1.846 . . . . 3.14 108.491 170.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.24 136.34 47.95 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 2.31 112.099 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.92 169.1 9.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.571 0.748 . . . . 3.27 109.328 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -139.14 120.15 14.52 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.598 -1.63 . . . . 3.93 106.598 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.56 114.74 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.831 0.853 . . . . 1.78 109.727 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.46 125.45 40.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.323 1.449 . . . . 3.49 111.717 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -83.82 79.62 9.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.042 0.925 . . . . 2.52 110.717 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 200' ' ' PHE . . . -110.55 127.8 8.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 125.764 1.65 . . . . 2.56 112.344 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -175.29 -176.45 0.92 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.172 1.789 . . . . 5.33 113.478 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.7 p -80.84 -18.95 45.71 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 118.442 2.756 . . . . 4.64 118.442 -156.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -124.48 117.89 25.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.336 1.426 . . . . 5.74 112.264 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.438 ' CB ' ' H ' ' A' ' 171' ' ' ASP 0.253 2.7 m -142.24 174.23 3.94 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.688 1.366 . . . . 4.92 114.688 -156.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 260' ' ' HIS . 43.0 Cg_endo -87.35 8.0 4.5 Favored 'Trans proline' 0 CA--C 1.554 1.483 1 C-N-CA 125.541 4.161 . . . . 8.95 113.028 148.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.438 ' H ' ' CB ' ' A' ' 169' ' ' CYS . 8.5 t70 85.24 9.56 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.463 3.105 . . . . 4.35 112.567 170.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.63 -14.15 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.073 -1.421 . . . . 2.98 113.526 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -56.43 30.13 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 126.582 1.953 . . . . 1.87 114.043 -170.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.25 -45.74 5.14 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.509 2.139 . . . . 1.45 111.572 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.6 -65.32 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.996 1.11 . . . . 4.37 113.996 -156.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -67.3 -38.1 84.46 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.737 0.78 . . . . 3.82 111.736 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -39.74 93.65 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.177 1.391 . . . . 2.81 111.196 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.19 -46.35 68.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.35 1.06 . . . . 3.14 110.619 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -65.4 -38.76 90.92 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.841 -1.787 . . . . 5.01 110.121 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 28.9 mtt -61.36 -27.82 68.79 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.93 . . . . 3.34 112.11 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.6 -46.38 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 120.289 1.404 . . . . 1.41 108.343 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -61.38 -28.13 69.02 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.114 0.415 . . . . 1.99 112.088 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.98 -41.68 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.011 -1.056 . . . . 1.59 111.532 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -69.96 -24.53 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.849 1.259 . . . . 2.01 111.89 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.8 -67.59 0.48 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.29 2.236 . . . . 3.99 111.61 162.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.46 -45.76 66.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.52 1.528 . . . . 2.14 113.352 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 tt -78.88 -19.52 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.566 0.95 . . . . 1.98 113.566 -174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.95 -48.47 44.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.026 0.93 . . . . 2.95 109.36 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.0 t -60.47 -28.76 68.59 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.111 0.782 . . . . 2.34 113.111 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.3 -20.25 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.008 1.323 . . . . 2.39 112.788 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.1 m 71.2 -25.09 0.17 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 128.72 2.808 . . . . 3.04 113.747 165.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.9 m -78.34 -15.15 59.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.235 3.014 . . . . 3.42 112.527 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.15 155.96 46.65 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.122 0.969 . . . . 3.79 111.989 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.44 -56.05 0.77 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.28 1.987 . . . . 3.6 109.593 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.0 t70 171.61 159.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 129.657 3.183 . . . . 3.84 109.498 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.5 tt -130.96 100.25 5.18 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.879 2.072 . . . . 2.68 108.922 164.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 5.2 m -97.09 114.44 64.7 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.466 1.106 . . . . 1.38 109.667 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.65 151.85 25.45 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.393 1.395 . . . . 0.92 111.731 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.278 3.6 pp -140.87 135.27 31.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.116 1.436 . . . . 2.43 113.523 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 33.4 t80 -112.01 110.72 21.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.025 1.73 . . . . 2.89 108.508 -163.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.31 112.68 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.05 0.94 . . . . 1.49 111.327 -166.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.6 p -85.9 105.69 16.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.08 0.467 . . . . 2.33 112.236 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.9 pt -86.93 28.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.549 1.14 . . . . 1.89 112.548 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -123.7 53.1 5.73 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 127.521 2.329 . . . . 3.71 110.937 -167.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -23.2 11.32 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.46 2.773 . . . . 2.36 116.03 -150.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 16.13 0.64 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.512 1.051 . . . . 4.51 113.482 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -159.79 -41.17 0.05 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.316 1.046 . . . . 6.93 113.626 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -95.1 137.17 34.52 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.722 0.809 . . . . 5.89 109.824 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.8 t -164.31 155.09 15.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.965 -0.561 . . . . 3.53 112.387 -158.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -43.96 -35.66 2.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.477 1.511 . . . . 3.54 114.158 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -70.56 -55.95 7.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.931 1.241 . . . . 2.64 112.569 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.02 97.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.222 -0.924 . . . . 1.77 112.296 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.1 -26.86 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.817 1.247 . . . . 2.08 111.164 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.28 -28.26 69.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.471 1.487 . . . . 1.62 112.054 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.42 -47.52 63.85 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.413 1.006 . . . . 4.58 111.211 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -35.22 80.47 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.004 1.321 . . . . 3.25 111.663 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -63.55 -45.34 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.406 1.482 . . . . 2.12 111.1 167.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -60.2 -31.53 70.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.789 0.836 . . . . 4.95 112.13 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.08 -50.93 28.49 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 5.07 111.586 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -73.23 -61.64 1.75 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.316 0.858 . . . . 2.83 113.316 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.0 p 174.86 144.68 0.21 Allowed Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.846 1.658 . . . . 2.09 110.888 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.68 -13.07 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.884 2.389 . . . . 1.61 113.274 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -85.02 -9.05 58.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.992 1.317 . . . . 2.81 113.295 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.91 127.98 32.91 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.703 -0.851 . . . . 2.08 108.703 168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.42 129.93 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 123.051 0.219 . . . . 1.36 110.524 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.18 142.61 16.1 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 124.403 1.001 . . . . 1.06 111.748 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.7 mt -142.5 139.9 31.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.392 1.077 . . . . 2.61 113.371 -170.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.2 m -147.49 150.73 35.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.297 2.239 . . . . 2.67 111.016 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -140.0 176.83 21.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.438 -1.465 . . . . 1.86 109.438 162.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 231' ' ' ARG . 19.5 m -81.74 173.12 12.61 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.392 -1.336 . . . . 3.97 107.392 169.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 230' ' ' THR . 58.1 mtt-85 -43.02 -36.07 1.46 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.646 2.378 . . . . 7.23 114.597 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.5 mp0 -70.08 -46.62 64.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.642 1.977 . . . . 3.84 110.911 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -75.45 -36.65 60.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 3.42 111.717 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.07 -38.51 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.577 1.151 . . . . 2.3 112.401 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -63.09 -61.76 2.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.871 1.214 . . . . 2.85 110.044 164.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -47.78 -45.38 29.33 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.367 1.247 . . . . 2.53 114.367 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.48 -41.71 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 3.33 112.679 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.1 59.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.497 1.044 . . . . 2.5 112.593 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -84.69 -38.67 19.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.563 2.345 . . . . 4.75 112.18 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.08 -64.5 0.88 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.336 1.054 . . . . 2.29 111.669 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 77.54 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.472 1.129 . . . . 4.09 109.597 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -66.47 81.59 0.09 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.094 1.758 . . . . 6.04 114.212 -151.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.22 157.97 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.058 1.343 . . . . 2.42 112.794 -168.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.43 151.11 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.701 1.2 . . . . 6.37 112.059 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -151.76 167.92 26.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.389 1.476 . . . . 3.01 110.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.6 m -115.88 77.12 6.46 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.713 -0.617 . . . . 3.17 112.644 -166.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.14 134.64 21.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.778 2.319 . . . . 2.32 111.589 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.56 113.46 4.39 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.094 1.331 . . . . 2.43 111.1 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.13 159.63 52.47 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.062 2.508 . . . . 4.45 110.475 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 253' ' ' ASP . 25.6 mmmt -119.09 -173.94 2.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.271 1.952 . . . . 6.92 116.271 -164.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.41 -89.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.985 0.914 . . . . 5.78 111.546 -142.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.66 -26.29 6.62 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.115 1.766 . . . . 10.31 112.038 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 250' ' ' LYS . 0.9 OUTLIER -81.1 136.05 35.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.913 1.233 . . . . 8.11 109.476 157.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.05 -8.81 52.36 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.99 0.916 . . . . 8.48 111.859 162.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.56 84.51 0.85 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.586 1.554 . . . . 5.52 112.774 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.63 107.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.828 0.851 . . . . 7.4 111.606 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -98.5 170.81 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.481 1.512 . . . . 3.67 109.825 -169.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 p -173.48 158.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.54 1.536 . . . . 2.88 108.033 -167.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.28 147.88 46.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.158 2.583 . . . . 3.29 109.713 169.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.447 ' H ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 p80 -127.76 113.64 16.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.794 1.035 . . . . 1.95 113.794 176.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -46.44 138.17 5.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.779 2.432 . . . . 3.16 111.684 163.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 6.6 tp -93.68 77.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 122.896 1.332 . . . . 4.79 112.312 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.22 137.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.763 1.625 . . . . 2.59 107.444 168.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 156.14 45.15 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.83 1.252 . . . . 3.02 111.067 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.56 138.68 51.23 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.655 0.983 . . . . 2.92 113.655 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.78 130.25 45.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.195 1.398 . . . . 2.12 111.223 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 273' ' ' PHE . 0.2 OUTLIER -152.88 171.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.152 2.581 . . . . 3.42 109.04 -177.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 145.6 -97.72 0.19 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 117.572 -1.682 . . . . 3.44 117.124 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.06 -43.18 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 2.55 110.6 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.68 -50.45 63.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.836 2.054 . . . . 7.46 113.043 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 156.3 -158.52 28.73 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.058 0.837 . . . . 2.79 113.086 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.41 -17.87 57.77 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.058 1.503 . . . . 8.06 115.058 -169.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 267' ' ' ILE . 1.7 t80 -164.55 112.47 1.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.793 1.633 . . . . 5.42 111.836 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 61.2 tp -117.3 -56.07 2.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.188 0.995 . . . . 4.3 113.627 -174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.25 171.06 20.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.091 0.956 . . . . 3.73 111.621 -165.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -145.03 140.96 28.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.627 1.171 . . . . 3.13 113.021 -176.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -126.77 134.18 50.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.904 0.882 . . . . 3.25 111.017 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.0 -171.57 44.59 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.312 0.958 . . . . 2.3 112.437 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -71.67 169.54 15.39 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.612 1.338 . . . . 3.74 114.612 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.83 15.26 5.82 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.296 2.239 . . . . 6.37 112.936 170.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.27 113.13 10.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.107 -1.621 . . . . 4.42 109.737 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -56.16 144.38 29.78 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.913 -1.117 . . . . 5.44 110.406 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.47 -48.35 82.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 119.699 -1.876 . . . . 2.06 113.542 -161.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.59 -17.43 74.75 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 114.327 0.491 . . . . 1.87 114.327 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -81.4 -36.13 29.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.348 1.074 . . . . 4.56 110.81 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.7 mt -53.45 -47.42 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 120.71 1.596 . . . . 1.49 110.006 164.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.39 88.28 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.543 0.572 . . . . 1.24 112.543 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.25 85.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.864 -1.147 . . . . 1.48 113.574 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 22.7 t -67.78 -37.14 81.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.281 1.832 . . . . 2.01 110.727 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 9.8 tp -82.78 -33.26 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.939 0.718 . . . . 3.54 112.939 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.12 -22.1 64.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.705 1.138 . . . . 2.06 112.72 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 98.9 m -63.64 -54.92 28.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.158 1.383 . . . . 2.32 110.873 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.03 -21.13 62.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.053 1.341 . . . . 2.54 113.633 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.8 ttp -68.88 -34.3 75.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.191 -1.568 . . . . 3.74 111.9 166.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -52.22 -42.61 87.42 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.586 -1.673 . . . . 5.86 114.145 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.19 -43.99 2.01 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.005 2.47 . . . . 2.18 112.36 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -91.24 72.78 6.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.628 1.204 . . . . 3.26 113.128 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -55.03 118.38 4.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.546 1.939 . . . . 7.47 110.791 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -37.23 -74.57 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.235 1.814 . . . . 7.49 114.55 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 300' ' ' LYS . 9.0 mmpt? -144.32 20.0 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.127 1.771 . . . . 12.11 111.187 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.246 0.911 0 C-N-CA 130.998 3.719 . . . . 8.98 106.274 -139.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.219 -0.896 . . . . 20.07 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.93 152.84 26.52 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.23 0.923 . . . . 16.18 110.46 163.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -167.06 30.15 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.416 1.487 . . . . 13.28 112.551 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.07 21.88 0.99 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 117.87 1.908 . . . . 10.24 117.87 -162.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 120.01 6.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.914 1.857 . . . . 10.49 110.444 162.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -80.53 -175.7 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.508 2.805 . . . . 6.73 110.547 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.69 160.47 34.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.477 1.911 . . . . 6.65 110.312 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.0 116.28 16.54 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.233 -1.025 . . . . 9.3 108.233 167.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.05 -130.86 19.98 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.223 0.916 . . . . 3.04 113.751 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.53 141.72 6.02 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.361 1.458 . . . . 3.21 112.065 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.83 112.52 3.3 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.24 2.627 . . . . 3.67 111.98 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -101.91 165.98 10.89 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.761 1.625 . . . . 2.69 110.838 168.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 p -123.42 23.59 8.93 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.968 -1.083 . . . . 3.08 113.259 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.5 mt -45.01 126.64 6.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.968 2.107 . . . . 2.42 111.685 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.9 m -93.43 146.77 23.51 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.07 -0.715 . . . . 2.25 109.07 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -86.01 150.07 24.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.991 1.316 . . . . 1.32 112.504 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -22.38 1.86 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.825 2.05 . . . . 1.68 113.615 162.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 97.4 m -72.51 -70.74 0.33 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.612 1.965 . . . . 2.12 109.373 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.36 -9.18 0.5 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.018 1.294 . . . . 2.14 115.418 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.86 140.59 58.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.438 1.119 . . . . 5.51 111.824 168.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.83 123.72 22.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.15 -1.426 . . . . 6.28 107.15 155.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 151.08 35.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.082 1.31 . . . . 2.89 109.766 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -139.81 168.2 20.35 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.622 0.647 . . . . 2.16 111.659 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -65.59 -43.46 89.62 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.215 0.82 . . . . 5.13 113.215 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -74.77 -19.49 60.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.012 1.116 . . . . 5.98 114.012 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.69 -19.2 57.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.067 1.347 . . . . 3.11 112.078 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.39 -10.48 35.08 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.056 1.873 . . . . 2.79 116.056 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.21 156.51 33.95 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.243 1.383 . . . . 2.89 113.674 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.5 -4.44 31.11 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.163 1.363 . . . . 1.47 115.413 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.417 HE22 ' CD2' ' A' ' 160' ' ' LEU . 3.9 pp0? -145.15 174.8 10.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.766 1.283 . . . . 3.55 111.535 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.7 108.65 9.87 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.154 1.168 . . . . 1.87 114.154 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.417 ' CD2' HE22 ' A' ' 158' ' ' GLN . 45.5 mt -97.63 110.76 23.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.865 1.266 . . . . 2.74 112.567 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.98 97.64 8.48 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.88 1.672 . . . . 2.79 106.836 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.8 mt -105.8 108.59 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.742 1.217 . . . . 2.32 109.556 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 135.17 53.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.823 1.249 . . . . 5.38 112.678 -163.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -89.12 116.87 27.7 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.135 0.974 . . . . 2.06 111.512 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.71 40.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.516 1.531 . . . . 1.99 113.214 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.61 161.61 9.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 115.91 1.819 . . . . 4.78 115.91 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.436 ' H ' ' NH2' ' A' ' 207' ' ' ARG . 2.4 m -76.38 36.27 0.15 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.407 2.283 . . . . 3.29 111.94 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -118.95 -77.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.972 1.309 . . . . 5.15 109.522 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.6 OUTLIER -82.78 109.24 15.49 Favored Pre-proline 0 C--O 1.256 1.447 0 CA-C-N 120.078 1.308 . . . . 2.9 108.67 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 38.7 Cg_endo -94.04 -1.45 3.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.392 2.061 . . . . 4.13 114.109 -137.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -104.91 -57.82 1.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.403 1.881 . . . . 4.35 111.704 -166.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.51 -27.46 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.501 0.721 . . . . 3.08 112.932 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 76.0 m -69.93 -63.4 1.87 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.001 -0.999 . . . . 2.06 111.074 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.11 -29.26 33.61 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.63 1.618 . . . . 1.5 114.771 -172.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.42 -46.93 78.03 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 120.786 1.63 . . . . 2.9 111.241 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 17.6 mm-40 -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.248 1.019 . . . . 3.03 113.222 173.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.06 -32.55 70.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.444 1.02 . . . . 2.97 112.522 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -67.35 -50.11 61.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.801 -1.095 . . . . 3.12 109.88 168.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 31.9 mtmt -47.94 -44.37 30.0 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.714 1.597 . . . . 3.51 111.611 171.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.4 tpp -67.33 -23.71 65.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 3.23 113.634 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.37 -46.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.743 1.611 . . . . 1.65 110.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.21 -19.43 63.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.594 -0.717 . . . . 2.12 112.169 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.78 -53.26 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.036 1.334 . . . . 1.56 113.325 166.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.99 -42.14 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 120.239 1.381 . . . . 1.98 112.229 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.41 -18.12 62.36 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 118.95 0.796 . . . . 4.6 112.164 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.24 -32.17 43.79 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.891 -1.131 . . . . 3.31 113.008 164.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mt -69.56 -39.2 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.738 1.215 . . . . 2.29 111.998 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -51.4 31.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.849 1.259 . . . . 2.59 110.244 161.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.3 m -66.68 -14.92 63.09 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.47 1.108 . . . . 2.95 113.278 -174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 50.5 mm -62.04 -19.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.562 -1.336 . . . . 2.25 111.848 168.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 58.8 26.99 15.45 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.339 1.456 . . . . 3.91 112.516 164.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -159.4 -6.66 0.07 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 2.95 113.567 -169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.68 167.02 29.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 121.074 -1.016 . . . . 3.22 111.009 167.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.75 -51.22 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.823 2.349 . . . . 4.95 111.615 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.0 t70 175.33 154.17 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.397 3.079 . . . . 3.49 108.495 -168.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.93 119.62 19.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 118.423 -0.799 . . . . 2.32 109.053 153.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.7 m -98.66 105.98 33.93 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 119.631 1.105 . . . . 1.01 110.235 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.32 132.68 8.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.699 2.266 . . . . 0.9 111.058 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.58 101.62 7.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.205 1.402 . . . . 2.48 108.933 -164.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.57 112.66 24.69 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.867 1.267 . . . . 2.54 109.449 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.69 125.1 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 1.51 110.588 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 1.5 t -91.08 133.4 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.755 -1.566 . . . . 1.86 110.04 162.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.6 pt -100.2 -1.71 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.191 0.996 . . . . 2.34 112.734 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -137.28 73.28 50.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.17 1.788 . . . . 4.35 110.562 -162.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.16 -0.36 4.78 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.377 3.385 . . . . 3.69 116.011 -163.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.72 124.21 32.73 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.49 1.916 . . . . 7.0 111.652 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.436 ' NH2' ' H ' ' A' ' 167' ' ' THR . 0.0 OUTLIER 174.26 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.357 2.263 . . . . 9.39 111.871 -163.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -169.95 80.62 0.11 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.734 2.414 . . . . 8.49 110.033 167.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 m 72.91 178.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.181 1.393 . . . . 3.32 109.739 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -24.14 67.1 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.868 -1.77 . . . . 4.82 111.722 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -44.5 63.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.433 2.293 . . . . 4.04 113.678 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.83 -35.98 66.99 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.521 1.51 . . . . 1.72 112.666 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 52.5 mt -73.93 -43.02 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.364 0.665 . . . . 2.02 110.956 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.91 76.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.552 0.741 . . . . 1.18 112.151 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -59.65 -54.99 39.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 3.19 111.607 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -60.45 -22.96 64.06 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.899 -1.126 . . . . 3.37 113.589 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.54 -56.82 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.468 1.507 . . . . 1.49 112.165 167.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 15.1 pttm -65.44 -27.9 68.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.411 0.523 . . . . 3.51 112.411 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.44 -20.57 63.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.327 1.851 . . . . 3.11 113.535 175.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -99.08 -56.77 2.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.12 0.873 . . . . 2.77 112.036 167.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.1 t -179.68 141.65 0.35 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.038 1.735 . . . . 1.85 110.641 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.73 -13.51 39.58 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.225 2.617 . . . . 1.79 113.855 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.98 -24.55 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.765 0.711 . . . . 3.91 112.681 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.32 122.56 22.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.473 -0.767 . . . . 2.12 110.696 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.42 130.39 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.543 0.737 . . . . 1.59 109.831 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.49 115.87 4.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.915 0.769 . . . . 0.81 113.09 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.39 153.11 32.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.841 1.656 . . . . 2.0 112.718 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.6 t -161.27 164.69 30.09 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.085 2.154 . . . . 2.82 107.488 171.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -142.38 -169.67 12.3 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 118.599 0.636 . . . . 2.05 112.316 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -76.68 169.98 17.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.427 1.091 . . . . 2.89 108.499 159.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.83 -28.85 4.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.079 2.152 . . . . 8.18 113.26 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -70.24 -33.65 71.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.59 1.556 . . . . 3.44 112.546 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -80.38 -39.49 28.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.707 1.203 . . . . 4.19 110.66 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.92 -39.5 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.938 1.295 . . . . 2.12 111.274 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.75 -59.57 5.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.741 -1.123 . . . . 3.84 110.206 163.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -48.56 -46.31 38.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.209 1.368 . . . . 3.35 113.786 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.18 -27.27 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.514 0.597 . . . . 2.92 112.589 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.75 35.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.378 1.471 . . . . 2.99 112.944 173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 21.4 ttt85 -80.47 -51.27 9.0 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.806 2.442 . . . . 4.21 110.127 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.94 -72.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 2.47 112.063 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -82.98 -45.29 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.132 0.419 . . . . 3.03 112.132 -169.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 93.21 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 130.011 3.325 . . . . 8.22 111.875 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 p -167.2 154.01 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.02 1.328 . . . . 2.7 109.979 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -116.57 141.44 48.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.888 1.275 . . . . 6.2 112.112 166.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.72 138.28 20.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.171 1.788 . . . . 3.5 111.112 171.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.7 t -101.81 111.27 63.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.393 1.077 . . . . 3.73 111.415 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.26 143.24 11.13 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.961 2.441 . . . . 3.08 111.226 177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -70.31 154.28 52.42 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.215 0.912 . . . . 3.38 114.156 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -100.82 -4.72 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.322 3.348 . . . . 4.92 113.795 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt 103.13 113.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 131.934 4.094 . . . . 5.96 108.048 -153.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.13 -46.41 5.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.821 -0.609 . . . . 8.79 111.555 -166.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -151.64 135.48 16.42 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.656 0.662 . . . . 12.14 112.222 155.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 t70 60.55 -62.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 130.2 3.4 . . . . 8.77 115.144 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -154.31 10.42 0.38 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.975 2.11 . . . . 8.16 112.281 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -78.64 156.59 28.97 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.262 -1.524 . . . . 6.08 112.071 169.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.99 104.57 3.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.946 1.298 . . . . 6.13 112.063 -170.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 5.8 tt -81.69 161.34 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 120.988 -1.07 . . . . 3.99 112.439 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.9 t -144.13 131.35 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 105.714 -1.958 . . . . 3.05 105.714 162.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.56 160.44 14.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.452 1.901 . . . . 4.47 112.195 172.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.473 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 8.4 p80 -151.82 136.03 16.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.029 -1.044 . . . . 2.26 112.518 168.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.8 t -62.06 121.56 13.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.488 0.661 . . . . 4.12 110.093 167.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 9.4 tp -78.79 78.75 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.481 0.658 . . . . 4.73 110.029 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 32.7 mm -134.58 144.1 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.961 2.105 . . . . 2.84 110.462 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.8 ttp -135.65 135.01 39.81 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.375 1.47 . . . . 4.01 110.033 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.69 133.26 41.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 2.8 111.336 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.51 111.88 23.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.505 1.122 . . . . 1.98 108.474 172.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 39.1 mm -109.97 136.34 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.5 1.12 . . . . 2.93 108.173 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.78 171.26 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.721 0.677 . . . . 1.37 113.716 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -60.81 -37.95 74.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.898 3.065 . . . . 3.06 112.897 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.53 -27.36 68.55 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.733 2.013 . . . . 5.2 114.476 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.76 43.45 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 116.989 -2.006 . . . . 2.27 116.735 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -85.67 165.48 16.95 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.799 2.299 . . . . 4.75 113.679 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.88 124.68 33.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.394 1.877 . . . . 3.14 110.542 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.1 mt -115.89 -42.48 3.08 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.717 1.377 . . . . 2.94 114.717 -168.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -162.05 -174.56 4.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.542 1.537 . . . . 2.84 112.484 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.24 141.7 33.98 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.003 0.906 . . . . 3.09 113.295 172.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -108.21 -176.63 3.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.83 2.452 . . . . 2.78 109.68 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 281' ' ' LYS . . . 131.8 -100.39 0.43 Allowed Glycine 0 C--N 1.337 0.587 0 O-C-N 121.253 -0.904 . . . . 2.22 112.011 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -66.83 151.12 48.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.812 -0.816 . . . . 4.04 110.858 167.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 27.1 m120 66.89 36.62 4.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.779 1.231 . . . . 5.72 113.796 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 278' ' ' GLY . 11.4 mmtt -117.1 146.53 43.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.947 1.462 . . . . 4.08 114.947 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.66 145.5 3.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.684 1.994 . . . . 5.66 111.286 -168.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -43.41 -65.59 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.347 -1.471 . . . . 1.93 113.74 -164.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.69 -15.15 75.57 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 114.029 0.371 . . . . 1.49 114.029 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -33.93 12.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.637 1.175 . . . . 4.29 110.496 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.53 -48.03 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.752 1.16 . . . . 1.48 109.051 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.52 -49.3 70.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.281 0.632 . . . . 1.26 111.536 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.83 78.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.515 1.052 . . . . 1.28 113.544 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 32.8 m -65.2 -58.52 5.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.479 1.111 . . . . 2.25 109.38 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 40.1 mt -63.24 -38.16 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 118.981 -0.533 . . . . 2.56 110.369 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.83 62.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.466 1.284 . . . . 1.55 114.466 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.0 m -70.04 -49.12 54.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 1.68 110.15 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -73.41 -26.09 60.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.922 1.289 . . . . 2.12 113.193 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.3 mtp -67.04 -24.5 66.0 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.138 -1.601 . . . . 4.9 112.459 169.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -63.83 -46.91 81.99 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 116.359 -1.782 . . . . 6.01 113.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.39 -44.43 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.06 2.507 . . . . 3.26 113.057 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -91.38 90.18 7.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.18 0.991 . . . . 3.6 112.816 -172.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 79.04 -65.52 0.21 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.635 2.774 . . . . 8.88 111.173 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -173.72 147.41 1.38 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.061 1.134 . . . . 8.71 114.061 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 8.74 35.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.938 2.095 . . . . 15.31 112.929 165.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 126.159 1.784 . . . . 10.72 110.536 -138.751 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 117.917 -1.04 . . . . 18.06 109.939 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -159.72 148.41 17.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.179 0.992 . . . . 15.33 111.091 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t 153.46 155.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 1 C-N-CA 132.032 4.133 . . . . 12.58 108.047 176.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 5.13 20.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.846 1.212 . . . . 10.15 113.179 166.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -146.08 142.31 17.56 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.755 1.277 . . . . 9.61 112.206 -171.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.27 164.06 35.01 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.628 . . . . 6.41 109.834 163.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.6 mt -139.24 76.34 1.56 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.477 1.111 . . . . 8.31 111.16 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.3 mt -141.93 114.98 8.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.473 1.909 . . . . 7.31 106.82 170.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.87 149.31 1.92 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.195 0.902 . . . . 3.79 112.686 -166.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.73 -48.97 0.89 Allowed Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.113 -1.937 . . . . 5.02 115.3 176.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -100.18 133.57 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.417 2.608 . . . . 3.36 111.761 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -159.88 171.62 19.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.798 0.839 . . . . 2.79 108.779 148.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -134.57 128.07 32.52 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.876 -1.14 . . . . 3.05 109.247 151.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -140.85 146.36 37.43 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.616 0.767 . . . . 2.27 110.688 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 m -82.04 136.79 35.19 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.523 1.529 . . . . 1.69 108.443 -178.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.9 p -77.81 160.57 28.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.986 1.314 . . . . 1.42 111.483 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -54.07 -15.43 1.45 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.388 1.475 . . . . 1.38 113.55 166.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 87.1 m -91.67 -40.51 11.25 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.246 2.218 . . . . 2.6 111.427 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.13 -10.46 9.42 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 125.175 1.369 . . . . 2.03 115.275 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -66.97 146.27 54.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.097 0.949 . . . . 4.86 109.103 164.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -90.98 128.55 36.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.906 0.776 . . . . 6.35 111.409 168.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 176.6 5.11 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 3.21 111.802 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.8 p -132.33 177.64 7.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.178 2.191 . . . . 2.31 109.186 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -61.7 -40.24 94.32 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.071 0.549 . . . . 3.4 111.296 174.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -75.63 -7.99 55.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.626 1.713 . . . . 7.14 115.626 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.37 -25.85 64.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 3.09 111.833 163.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.77 -35.82 6.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.294 1.437 . . . . 2.38 113.788 -177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.35 81.62 4.69 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.482 1.113 . . . . 5.1 110.132 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.88 -45.32 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 127.859 2.647 . . . . 1.82 111.039 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -106.66 -170.69 1.76 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.602 2.761 . . . . 3.58 110.912 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -86.89 122.48 30.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.981 -1.074 . . . . 1.41 112.365 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.14 146.73 45.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.594 1.158 . . . . 2.44 112.867 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -140.98 114.74 8.97 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.263 -1.755 . . . . 3.08 106.263 -178.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.3 134.76 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.287 1.035 . . . . 2.28 109.314 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -134.15 146.03 49.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.38 1.872 . . . . 3.7 110.633 172.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -113.32 125.48 54.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.595 1.158 . . . . 2.2 111.09 -177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.53 139.21 10.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.494 1.045 . . . . 1.98 114.822 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -81.01 112.44 18.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.721 1.208 . . . . 4.6 108.815 162.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.0 m 48.53 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.674 2.39 . . . . 5.06 114.558 177.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.27 16.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.402 2.281 . . . . 8.36 111.586 -173.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 25.4 p -69.67 117.73 56.08 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-N 119.046 0.839 . . . . 3.43 109.973 -160.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.79 76.66 3.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.896 3.064 . . . . 4.76 110.871 -160.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.37 -86.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.802 1.641 . . . . 5.34 110.312 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.04 -15.82 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.637 1.975 . . . . 3.37 110.437 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.427 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 19.6 m -47.87 -45.17 61.09 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.104 1.52 . . . . 1.88 115.104 164.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.41 -21.42 30.51 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.591 2.194 . . . . 2.35 113.716 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -71.64 -66.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.808 1.186 . . . . 3.55 108.688 158.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -51.17 -54.43 25.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 115.791 1.774 . . . . 3.44 115.791 -165.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.29 -19.7 61.63 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.68 -1.153 . . . . 2.79 112.702 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -45.86 6.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.341 1.056 . . . . 3.31 111.921 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -60.55 -22.76 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 118.59 -2.569 . . . . 5.2 111.962 167.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -80.8 -32.1 35.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.017 -0.992 . . . . 4.98 113.274 162.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -49.35 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 120.948 1.704 . . . . 3.75 108.673 -176.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 65.2 mt-30 -61.48 -20.74 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 2.07 111.678 -178.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.15 -51.11 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.132 0.973 . . . . 1.56 110.344 174.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.02 -29.07 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.156 1.343 . . . . 2.38 112.914 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.76 -56.92 15.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.526 2.33 . . . . 3.76 110.983 166.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.11 -37.96 78.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.961 1.304 . . . . 2.24 113.39 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.5 mm -59.27 -53.74 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.5 1.12 . . . . 1.88 110.551 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -70.24 -43.54 70.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.249 0.62 . . . . 2.63 110.775 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.1 t -58.05 -41.34 83.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.981 0.913 . . . . 2.5 112.444 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.2 mm -64.32 -16.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 120.628 -1.295 . . . . 3.62 112.85 176.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 68.2 m 69.07 -23.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.921 2.088 . . . . 3.0 114.511 166.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.9 m -81.64 -6.66 59.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.065 2.546 . . . . 3.27 112.213 -178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.62 162.13 37.2 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.441 1.897 . . . . 3.95 111.924 178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.0 -54.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.219 2.612 . . . . 3.77 111.254 168.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.29 171.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.679 2.792 . . . . 4.28 110.862 -176.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 197' ' ' THR . 6.8 tt -143.41 132.54 23.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.936 -1.029 . . . . 2.43 108.877 135.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 196' ' ' LEU . 96.4 m -116.66 100.11 53.23 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.659 1.584 . . . . 1.75 109.428 -177.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.95 155.36 11.39 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.126 2.551 . . . . 1.02 114.513 -174.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.5 tp -136.27 114.1 11.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.932 1.293 . . . . 2.23 111.649 -168.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -92.16 112.58 24.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.954 1.701 . . . . 2.43 109.7 175.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mm -87.82 120.28 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.207 -1.034 . . . . 1.44 108.207 170.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.8 t -85.13 149.49 25.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 119.824 -0.75 . . . . 1.68 110.284 159.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.5 pt -121.05 -8.67 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.064 1.345 . . . . 1.97 113.331 -173.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -115.75 69.03 3.17 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.411 1.084 . . . . 4.17 110.981 -176.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 -31.06 14.08 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.654 2.902 . . . . 2.18 113.11 -170.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.38 42.81 1.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.258 1.423 . . . . 7.39 110.275 175.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.418 HH22 ' CG ' ' A' ' 255' ' ' ASP . 1.1 tpp180 -160.02 -50.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.723 2.409 . . . . 7.34 110.951 -175.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . 0.264 2.8 p30 -115.22 -152.64 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.566 1.147 . . . . 5.84 112.819 173.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -175.6 147.44 0.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.69 -1.256 . . . . 3.2 110.178 -153.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -53.89 -43.3 69.54 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 118.244 -0.884 . . . . 3.41 112.611 -176.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -69.18 -33.71 73.8 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.335 1.425 . . . . 2.74 113.405 175.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.13 -42.1 89.57 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.174 -0.954 . . . . 2.18 110.478 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.95 -47.16 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.337 1.055 . . . . 2.15 110.599 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.32 63.26 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.973 1.309 . . . . 1.48 112.205 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -63.18 -51.47 66.25 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.143 0.577 . . . . 3.31 111.992 177.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -60.12 -42.35 94.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.571 0.623 . . . . 3.34 111.701 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.85 -52.19 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.694 1.597 . . . . 1.44 112.07 174.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -15.42 62.91 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.201 1.556 . . . . 3.39 115.201 -177.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.71 -26.45 66.16 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.036 1.289 . . . . 2.7 111.388 171.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -93.43 -56.64 2.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.429 0.692 . . . . 3.16 110.991 175.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.9 t -169.44 140.75 1.9 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 120.906 -1.121 . . . . 1.94 112.466 -173.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.51 -12.79 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.879 2.386 . . . . 2.05 113.156 171.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -83.33 -13.66 54.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.66 0.784 . . . . 3.25 112.725 173.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -74.78 128.32 35.28 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.329 -1.36 . . . . 2.29 107.329 166.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.13 134.78 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 109.232 -0.655 . . . . 1.48 109.232 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.02 147.27 17.76 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-O 118.834 -0.981 . . . . 1.13 112.49 -178.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.68 145.26 44.55 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.364 1.082 . . . . 2.13 113.306 -171.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -156.72 142.32 17.64 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.036 1.335 . . . . 2.32 111.737 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -158.73 175.19 35.8 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.936 2.684 . . . . 2.54 107.96 165.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.5 t -70.64 176.04 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.757 2.279 . . . . 2.84 110.24 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.6 mtm105 -38.98 -52.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.023 2.529 . . . . 6.12 113.101 -174.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -73.55 -21.48 60.36 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.795 0.838 . . . . 4.59 112.328 -175.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -82.05 -38.55 24.79 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.923 1.289 . . . . 3.47 110.709 171.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.79 -40.87 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.809 0.844 . . . . 2.15 110.98 167.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.39 -52.86 63.67 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.768 -1.587 . . . . 3.79 110.501 170.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -40.11 -55.17 2.16 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 121.457 1.935 . . . . 2.64 115.035 178.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.84 -29.59 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 113.815 1.043 . . . . 3.7 113.815 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.55 71.82 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.696 0.68 . . . . 2.98 111.411 173.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -77.8 -27.81 50.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 128.764 2.825 . . . . 3.98 113.965 -176.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.12 17.45 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.772 1.169 . . . . 2.57 113.465 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.14 -48.03 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.196 1.554 . . . . 4.04 115.196 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 111.25 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 1 C-N-CA 132.462 4.305 . . . . 6.06 110.133 -169.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.4 p -148.89 146.38 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.467 1.507 . . . . 2.65 108.566 165.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -104.03 149.03 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.448 1.099 . . . . 5.86 111.683 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.71 155.38 50.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.313 1.445 . . . . 7.07 110.434 172.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.4 t -122.42 91.16 49.38 Favored Pre-proline 0 CA--C 1.542 0.656 0 O-C-N 121.299 -0.876 . . . . 2.74 111.928 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.93 147.56 21.4 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.762 2.975 . . . . 2.49 112.222 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -130.92 156.61 21.82 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.591 1.567 . . . . 2.26 113.763 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -79.59 -159.35 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.336 3.357 . . . . 3.68 110.194 175.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.26 177.07 9.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.183 2.193 . . . . 4.92 111.301 172.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.25 -70.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.724 -1.584 . . . . 7.33 106.724 154.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -168.02 167.6 12.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.668 1.987 . . . . 9.09 109.922 164.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 77.61 -27.35 0.17 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 129.793 3.237 . . . . 8.57 112.808 172.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -73.64 -32.72 64.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.869 1.268 . . . . 11.58 112.938 162.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.418 ' CG ' HH22 ' A' ' 207' ' ' ARG . 22.8 t0 62.25 165.58 0.1 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.747 2.419 . . . . 6.67 113.614 -170.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -66.62 145.26 55.78 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.619 -1.926 . . . . 5.03 112.013 -177.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.44 168.44 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.8 -1.188 . . . . 4.4 112.917 -167.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.19 139.79 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.683 1.193 . . . . 3.47 110.201 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -88.19 119.77 28.91 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.662 1.22 . . . . 3.63 109.132 160.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.427 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 20.0 p80 -87.55 5.7 37.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.782 1.633 . . . . 3.38 114.058 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m 79.65 -50.11 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.438 3.095 . . . . 3.18 114.022 160.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 3.5 mp 80.29 106.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 129.34 3.056 . . . . 4.0 111.472 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.1 mt -142.49 145.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.657 2.383 . . . . 2.42 105.465 168.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.1 mtt -117.04 132.29 56.73 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.999 0.519 . . . . 4.22 110.787 163.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -99.92 133.53 44.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.71 0.804 . . . . 2.62 112.13 171.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 267' ' ' ILE . 55.6 tp -101.23 121.71 42.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.074 1.35 . . . . 2.15 110.972 177.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 266' ' ' LEU . 1.9 mp -121.37 138.39 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.558 1.543 . . . . 2.12 107.884 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -104.25 -171.38 25.01 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.542 1.544 . . . . 1.46 112.238 177.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.02 147.32 79.77 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.337 2.025 . . . . 2.49 111.806 -170.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.69 -8.85 0.11 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 129.391 3.076 . . . . 6.95 116.218 -178.033 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.97 8.62 6.58 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-O 118.513 -1.159 . . . . 2.7 114.934 -170.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -52.07 129.18 26.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.369 1.085 . . . . 9.2 111.287 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -96.02 135.67 37.48 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.413 -0.804 . . . . 3.77 109.127 168.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 -54.4 2.08 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.664 0.987 . . . . 3.02 113.664 -177.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -164.33 172.24 13.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.619 0.97 . . . . 2.74 113.619 -161.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -149.32 141.17 23.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 122.774 1.273 . . . . 4.18 113.001 166.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.07 141.52 37.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.015 1.326 . . . . 2.68 110.24 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -84.79 -141.73 5.46 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.886 -1.286 . . . . 2.83 109.886 164.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -84.8 -6.68 59.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.033 0.933 . . . . 5.11 111.799 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -77.92 50.0 0.83 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.946 2.098 . . . . 6.36 114.821 -170.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 155.42 18.1 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.356 -1.465 . . . . 7.65 113.398 -171.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -140.22 -164.66 1.75 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 4.85 108.505 167.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 9.9 tmtt? -53.34 -49.73 66.51 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.032 -1.668 . . . . 2.1 113.161 -171.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.27 -42.76 99.19 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.178 -0.79 . . . . 1.86 111.817 -176.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.67 -40.05 73.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.551 0.74 . . . . 4.67 111.921 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.95 -47.66 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.388 0.675 . . . . 1.79 110.227 174.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.92 -53.36 56.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.961 0.904 . . . . 1.5 112.189 176.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.91 74.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.816 0.846 . . . . 1.85 112.587 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -70.49 -60.73 2.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.931 0.492 . . . . 2.24 110.917 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.09 -37.74 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.0 -1.062 . . . . 2.77 111.544 -173.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.38 64.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.494 1.043 . . . . 2.2 113.329 176.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 81.2 m -79.54 -45.58 18.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.16 0.984 . . . . 2.3 110.671 172.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.23 -25.38 66.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.837 1.255 . . . . 1.92 113.829 172.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 52.5 tpp -65.36 -50.43 65.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.277 1.431 . . . . 5.76 111.702 173.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -44.29 -48.63 24.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.187 1.795 . . . . 6.67 115.557 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.32 -18.82 64.71 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.253 2.635 . . . . 2.41 114.135 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.8 -33.78 7.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.773 1.169 . . . . 3.54 113.36 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -156.03 135.31 12.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.851 1.66 . . . . 8.37 112.464 -165.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt 124.82 175.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.469 4.308 . . . . 9.38 111.597 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -133.6 46.4 2.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.274 1.83 . . . . 11.11 108.302 160.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.246 0.888 0 C-N-CA 125.634 1.574 . . . . 11.41 111.663 -157.19 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.021 -0.99 . . . . 24.04 110.159 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -162.56 155.96 20.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.442 1.497 . . . . 19.1 109.812 -177.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t 179.08 166.65 0.96 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.327 2.651 . . . . 17.1 109.132 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.17 158.72 8.79 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.763 1.649 . . . . 13.22 112.667 -178.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -89.58 152.14 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 121.779 -0.836 . . . . 12.17 112.849 173.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -69.94 176.11 7.35 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.708 2.272 . . . . 8.23 109.604 157.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 135' ' ' LEU . 2.1 pt? -126.0 160.39 30.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.895 1.278 . . . . 7.2 112.192 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.48 -124.69 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.911 2.085 . . . . 5.86 108.82 -177.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.82 154.04 10.16 Favored Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.21 1.386 . . . . 2.82 112.315 -168.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.71 111.64 3.33 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.893 -1.504 . . . . 2.91 113.257 -167.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.13 94.09 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 120.742 2.271 . . . . 3.45 110.412 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -140.97 154.89 46.26 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.819 0.848 . . . . 2.63 111.028 168.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.0 p -134.4 111.1 9.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.669 -1.604 . . . . 2.15 106.669 161.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.81 161.3 26.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.374 1.07 . . . . 2.47 109.828 -176.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -87.49 138.51 31.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.26 1.024 . . . . 1.75 109.314 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -82.99 147.79 27.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.999 0.92 . . . . 1.3 110.358 170.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -41.69 -37.65 1.24 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.877 2.471 . . . . 1.45 115.194 173.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m -77.71 -52.91 8.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.174 1.389 . . . . 2.81 112.904 178.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.24 81.36 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.004 0.811 . . . . 3.33 111.895 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 169.69 3.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.247 3.019 . . . . 4.71 106.115 -173.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 54.99 1.63 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.519 1.128 . . . . 6.05 112.17 -159.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 162.7 11.45 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.653 1.981 . . . . 2.8 116.241 -169.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -130.81 178.84 6.35 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.008 2.123 . . . . 2.06 111.101 171.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -63.58 -55.36 24.36 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.218 2.207 . . . . 3.96 111.896 174.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -80.52 7.73 9.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.022 1.119 . . . . 6.98 114.022 -177.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.57 -41.6 88.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.845 . . . . 3.08 111.426 169.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.47 8.0 43.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.112 1.365 . . . . 3.3 113.465 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.33 91.72 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.197 1.399 . . . . 3.5 111.489 175.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.64 -31.02 0.36 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.708 1.623 . . . . 1.56 111.442 -171.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.33 -158.65 0.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 4.07 109.398 167.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -114.03 132.49 55.98 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.362 -0.836 . . . . 1.92 111.852 -169.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.86 132.8 48.81 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.711 1.204 . . . . 2.49 111.33 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.66 109.1 15.26 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.817 -1.549 . . . . 3.62 106.817 175.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.4 mt -110.92 121.38 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.785 1.234 . . . . 1.54 109.751 -168.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -128.65 140.51 51.72 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.571 1.548 . . . . 3.91 110.362 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -99.96 115.33 29.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.891 0.769 . . . . 2.79 111.699 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.05 114.99 1.4 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.034 1.302 . . . . 2.33 115.567 -173.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.428 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 20.0 m-85 -75.39 145.61 41.47 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.287 0.565 . . . . 4.65 110.164 162.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 68.4 p -69.83 159.22 34.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.712 2.005 . . . . 3.25 112.619 -177.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 81.68 -44.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.782 2.833 . . . . 7.47 115.123 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 0.7 OUTLIER -61.82 132.9 93.53 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-N 120.232 1.378 . . . . 3.72 111.846 -167.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -88.0 8.61 4.08 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.908 3.072 . . . . 5.18 114.275 -154.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -142.11 -66.86 0.39 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.054 1.342 . . . . 3.57 111.878 -157.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.87 -34.4 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 118.338 -0.839 . . . . 3.6 113.034 -174.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.523 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.0 m -70.17 -65.04 1.19 Allowed Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.342 -1.313 . . . . 2.25 111.662 169.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.36 -33.76 57.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.895 1.73 . . . . 1.76 114.765 -166.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.45 -47.63 47.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.796 2.089 . . . . 3.43 112.34 -178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.46 -39.11 93.59 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.231 -0.918 . . . . 3.06 111.366 172.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 tp -70.99 -28.84 64.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.583 -1.199 . . . . 2.64 112.131 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -59.07 -55.01 40.52 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.951 1.705 . . . . 3.09 110.261 168.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -46.38 -39.74 10.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.327 1.051 . . . . 6.96 112.207 174.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.46 -45.11 32.65 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.03 1.122 . . . . 3.19 114.03 173.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.33 -38.0 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 119.87 -1.769 . . . . 1.42 109.687 -169.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' ' 283' ' ' LYS . 63.6 mt-30 -64.77 -22.68 67.04 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 117.971 0.351 . . . . 2.25 111.434 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.1 t -85.83 -34.98 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 120.553 -1.342 . . . . 1.54 111.916 173.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -57.57 -41.29 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.873 1.269 . . . . 2.4 110.818 170.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.75 -62.07 2.15 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.912 2.085 . . . . 5.32 112.075 166.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.24 -19.34 20.82 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.477 1.511 . . . . 3.05 115.035 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 tt -97.35 -42.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.643 1.11 . . . . 2.5 113.156 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -66.14 -34.61 78.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.643 0.656 . . . . 2.67 110.887 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.3 t -58.05 -18.77 26.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.519 1.528 . . . . 2.57 112.955 170.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.94 -38.9 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.952 -1.092 . . . . 2.68 111.501 171.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 m 65.22 -27.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.536 2.734 . . . . 2.91 114.668 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 17.8 m -76.54 -34.75 58.51 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 129.325 3.05 . . . . 2.64 110.398 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.28 164.89 58.05 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.517 1.927 . . . . 2.67 110.266 162.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.418 ' HA ' ' HE2' ' A' ' 299' ' ' LYS . 51.8 Cg_endo -71.1 150.73 60.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.821 2.347 . . . . 3.16 113.308 -167.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -69.24 103.74 2.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 124.502 2.096 . . . . 3.3 109.001 162.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.99 113.25 13.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.329 -2.214 . . . . 3.04 106.84 173.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.1 m -95.0 106.02 22.8 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.081 -1.081 . . . . 1.07 108.081 175.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.16 135.28 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.001 1.8 . . . . 0.85 111.366 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 tp -128.78 94.24 3.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.417 -1.719 . . . . 2.62 108.684 -164.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -90.82 113.49 25.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.552 -1.204 . . . . 2.54 109.489 -170.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mt -98.82 115.51 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.526 0.731 . . . . 1.51 109.508 -171.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.9 t -70.5 140.66 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.777 0.798 . . . . 1.89 111.142 157.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 pt -128.4 20.73 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 2.1 110.319 168.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -113.93 50.94 0.53 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 128.78 2.832 . . . . 4.44 112.338 169.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.85 -21.68 43.9 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.02 3.146 . . . . 2.72 112.826 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.13 -6.71 14.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.429 1.892 . . . . 5.03 112.914 -174.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.92 -20.49 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.818 2.155 . . . . 6.81 116.818 -158.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 136.34 48.64 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.907 1.685 . . . . 5.32 108.695 167.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.9 p -91.46 173.16 8.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.871 0.844 . . . . 2.99 112.193 -171.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -57.3 -28.75 63.31 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.009 0.744 . . . . 3.75 113.009 175.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -72.2 -41.69 66.65 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.381 2.272 . . . . 2.76 112.437 174.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.4 96.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.411 0.551 . . . . 1.66 110.328 175.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.92 -49.37 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.798 1.239 . . . . 1.57 110.876 168.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.12 -41.02 67.89 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.536 0.734 . . . . 1.22 112.606 177.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.82 -48.73 80.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.893 0.77 . . . . 4.27 111.412 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -60.87 -46.6 89.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.485 0.584 . . . . 6.16 111.19 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.8 t -50.55 -48.53 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.177 0.991 . . . . 1.23 111.412 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -16.59 62.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.658 1.725 . . . . 3.5 115.658 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.78 -40.12 66.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.381 1.446 . . . . 2.94 110.064 170.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.09 -38.14 21.16 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 114.075 1.139 . . . . 2.86 114.075 -167.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 179.85 140.15 0.31 Allowed Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 120.131 1.332 . . . . 1.57 112.238 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.79 -10.8 25.36 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.252 2.635 . . . . 2.01 113.31 174.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.4 tttp -84.97 -8.71 58.63 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.509 -0.744 . . . . 2.95 112.889 173.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.05 145.17 24.92 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.204 -0.935 . . . . 2.0 111.975 -172.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.98 137.37 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.327 1.051 . . . . 1.82 108.35 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -102.4 142.41 15.58 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 124.388 0.994 . . . . 0.92 111.434 178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.0 152.79 43.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.974 1.71 . . . . 1.84 111.547 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.1 t -159.9 156.76 27.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.275 1.43 . . . . 2.5 111.389 162.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -146.28 156.55 27.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 107.647 -2.181 . . . . 2.43 107.647 163.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.12 165.46 0.22 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 129.787 3.235 . . . . 4.05 110.504 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -41.05 -31.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 116.165 1.913 . . . . 5.46 116.165 174.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.19 -35.56 48.52 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 120.39 1.45 . . . . 4.51 113.117 172.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -73.67 -33.36 64.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.917 1.287 . . . . 4.82 111.635 174.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.49 -42.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.555 1.542 . . . . 2.49 112.167 164.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.43 -59.69 4.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.798 1.181 . . . . 3.06 109.348 166.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -45.89 -46.23 15.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.592 1.331 . . . . 3.06 114.592 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.23 -31.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.199 0.999 . . . . 3.62 113.427 179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.24 -25.94 62.7 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.469 -0.769 . . . . 2.19 112.392 167.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -84.8 -21.45 29.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.327 2.251 . . . . 4.61 111.931 175.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.37 84.24 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.125 1.37 . . . . 2.88 112.741 174.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -126.21 -76.23 0.58 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.566 0.746 . . . . 3.55 110.692 170.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 166.87 152.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 130.2 3.4 . . . . 5.26 106.701 -165.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.9 p -157.59 166.93 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.732 1.213 . . . . 3.11 109.133 166.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -146.24 152.09 38.62 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.418 1.087 . . . . 5.98 111.093 165.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -157.3 146.38 19.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.316 1.846 . . . . 3.43 110.598 -177.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.9 m -107.45 113.07 62.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.361 -0.837 . . . . 3.51 110.389 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.64 152.39 7.55 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.425 2.75 . . . . 3.38 112.437 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.8 169.74 54.34 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.705 1.621 . . . . 3.18 115.279 -175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 -41.32 0.99 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.6 2.867 . . . . 5.53 112.333 -168.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.327 16.7 ptpt 56.23 153.37 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.956 2.947 . . . . 5.96 118.956 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.0 -132.97 0.18 Allowed 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.601 -1.182 . . . . 7.52 108.764 165.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -51.31 -33.48 29.17 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.935 1.698 . . . . 11.71 114.192 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -170.45 -30.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.229 1.412 . . . . 10.62 111.98 167.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.74 159.06 34.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.378 1.071 . . . . 8.62 112.899 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . 0.279 16.2 t70 74.19 28.91 1.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.084 2.554 . . . . 8.49 112.923 -164.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -68.74 58.12 0.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.837 1.255 . . . . 8.0 111.967 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.24 151.55 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.564 -1.335 . . . . 4.3 109.238 161.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.9 m -150.97 132.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.234 0.924 . . . . 4.44 110.751 -170.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.31 125.66 51.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.995 2.118 . . . . 3.68 109.607 172.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.523 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 9.5 p80 -94.87 104.98 16.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.506 0.722 . . . . 2.17 109.556 167.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -80.5 56.63 2.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.146 0.978 . . . . 4.35 113.594 -161.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.287 37.6 pt 39.74 47.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 129.661 3.185 . . . . 3.13 115.846 171.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -79.75 125.9 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.148 0.979 . . . . 3.91 110.177 171.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.26 135.66 19.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.698 0.799 . . . . 3.09 112.459 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.44 148.2 52.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.356 1.462 . . . . 2.98 113.422 -176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 30.7 tp -107.08 138.99 42.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.057 1.343 . . . . 2.36 109.528 170.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.0 mt -130.25 136.07 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.281 -1.007 . . . . 2.38 108.281 172.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.3 168.5 24.32 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.148 0.88 . . . . 1.72 113.35 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 104.28 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.995 3.13 . . . . 2.69 110.137 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 155.22 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.689 3.196 . . . . 6.1 108.768 -158.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.48 7.64 84.34 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.744 -1.587 . . . . 3.47 115.453 165.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 -26.78 62.4 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.322 2.561 . . . . 6.04 115.067 -177.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.7 t80 125.46 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 132.296 4.238 . . . . 4.31 107.38 -161.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.68 -67.92 0.19 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.743 1.61 . . . . 2.84 114.333 167.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -143.98 154.08 42.91 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.663 1.185 . . . . 2.51 111.526 -159.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 143.06 50.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.626 1.17 . . . . 3.97 113.609 -170.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -130.89 -130.0 0.2 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.747 1.219 . . . . 3.44 110.344 -161.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 70.11 -101.24 0.86 Allowed Glycine 0 C--N 1.341 0.836 0 O-C-N 120.857 -1.152 . . . . 2.15 111.982 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -76.1 -5.36 46.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.059 1.133 . . . . 4.02 114.059 175.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -174.47 3.32 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.921 0.782 . . . . 9.07 110.434 165.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm 64.98 64.29 0.65 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.183 0.993 . . . . 5.43 111.299 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -53.65 159.73 1.5 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.28 1.032 . . . . 5.7 110.485 170.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 182' ' ' GLN . 12.5 tmtt? -41.53 -61.24 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.25 -1.531 . . . . 2.73 112.733 -173.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.28 -20.73 78.35 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.922 0.729 . . . . 2.44 114.922 -178.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.77 -39.15 73.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.528 1.131 . . . . 6.31 110.762 173.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 42.2 mt -51.55 -53.32 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.563 1.074 . . . . 2.36 110.165 171.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.77 82.07 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.181 0.992 . . . . 2.23 111.616 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.09 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.262 0.838 . . . . 2.77 113.262 175.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -51.39 37.55 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.654 1.181 . . . . 3.57 110.29 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 13.8 tt -64.82 -34.89 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 120.916 -1.115 . . . . 3.34 112.214 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.38 -32.24 73.51 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.269 0.94 . . . . 3.07 112.36 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.8 m -70.23 -41.86 73.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.062 0.945 . . . . 2.95 110.631 176.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -76.83 -25.62 53.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.921 0.888 . . . . 2.72 113.168 174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 8.6 ttp -70.54 -25.35 63.07 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.387 -1.446 . . . . 4.26 111.145 167.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -56.21 -44.07 99.55 Favored Pre-proline 0 CA--C 1.554 1.133 0 CA-C-O 117.0 -1.476 . . . . 6.37 113.432 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.08 -58.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.823 3.015 . . . . 3.01 111.374 165.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -75.87 54.72 0.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.468 1.507 . . . . 3.81 112.858 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -63.62 116.53 5.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.454 1.501 . . . . 7.91 113.41 -166.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 194' ' ' PRO . 1.2 tmtt? -60.26 -36.3 77.48 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.3 1.963 . . . . 7.59 116.3 -157.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.45 5.01 3.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.765 1.024 . . . . 9.32 113.765 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.065 1.346 . . . . 8.86 109.479 -149.418 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 118.275 -0.869 . . . . 25.53 109.98 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -72.56 176.27 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.279 0.49 . . . . 25.04 110.547 158.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.4 p -137.84 160.31 39.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.301 1.84 . . . . 20.35 110.325 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.19 -167.49 28.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.75 1.643 . . . . 16.58 112.375 -176.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 122.67 145.8 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 131.406 3.883 . . . . 14.02 110.871 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 130.45 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.713 2.276 . . . . 12.63 111.943 169.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.59 -40.82 11.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.766 1.226 . . . . 9.87 112.786 -171.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.15 133.17 2.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.02 1.328 . . . . 6.08 111.113 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -119.76 145.97 17.92 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.571 -1.412 . . . . 3.54 109.571 160.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.14 122.3 25.2 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.991 -1.45 . . . . 2.99 109.689 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 121.79 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.221 2.011 . . . . 3.73 111.935 -166.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 236' ' ' GLN . 2.0 p90 -155.82 154.79 31.89 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.899 2.08 . . . . 3.17 108.205 168.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -128.38 36.27 4.29 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.547 2.054 . . . . 2.52 116.547 -168.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.84 155.1 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.211 0.819 . . . . 2.76 113.211 -147.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 m -79.35 133.72 36.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.143 0.977 . . . . 2.05 109.426 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.0 p -80.71 170.71 15.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.295 1.045 . . . . 1.67 111.895 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -56.47 -20.7 21.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.91 1.684 . . . . 1.83 113.329 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 96.9 m -85.48 -17.66 35.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.455 1.502 . . . . 2.81 111.885 176.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.9 -0.5 55.12 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.737 1.055 . . . . 2.83 115.737 174.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.51 158.95 22.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 6.75 110.954 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.32 138.06 31.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.662 1.585 . . . . 5.53 114.369 -166.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE3' ' CD2' ' A' ' 155' ' ' TYR . 10.1 tmtt? -119.23 108.09 14.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.532 1.933 . . . . 8.19 107.458 169.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.6 m -97.44 132.61 42.98 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.881 -1.525 . . . . 4.93 106.881 177.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.62 -30.64 61.29 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 117.181 2.289 . . . . 4.68 117.181 -143.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -21.3 0.29 Allowed 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.654 1.724 . . . . 7.91 115.654 170.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.34 -24.3 66.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.244 1.818 . . . . 3.29 114.927 -172.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.452 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 17.2 m-30 -110.46 1.29 18.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.375 1.25 . . . . 2.67 114.375 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.53 145.84 55.51 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.358 -0.839 . . . . 4.64 109.788 176.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 103.25 -16.65 53.01 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 124.35 0.976 . . . . 2.86 112.199 -171.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -121.93 -174.62 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.027 1.331 . . . . 3.62 108.814 154.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -89.87 140.32 29.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.749 1.159 . . . . 2.71 113.823 -170.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 125.25 50.77 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.237 -0.914 . . . . 3.37 109.888 173.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.77 108.73 15.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.734 1.614 . . . . 3.19 106.709 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.07 127.29 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 2.18 110.71 -164.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -125.9 158.94 33.87 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.233 2.213 . . . . 5.86 113.727 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.05 63.25 1.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.82 1.648 . . . . 2.12 113.892 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -107.16 174.38 19.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.863 1.697 . . . . 2.05 111.433 169.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 167' ' ' THR . 26.7 t80 -164.28 -163.79 0.79 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.208 1.504 . . . . 5.67 112.128 -175.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 32.1 p -84.08 -139.17 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.038 1.335 . . . . 3.68 109.357 156.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 53.56 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.793 1.637 . . . . 5.28 109.605 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 31.4 p -110.44 98.06 34.61 Favored Pre-proline 0 CA--C 1.565 1.544 0 N-CA-C 106.507 -1.664 . . . . 2.96 106.507 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.18 65.85 8.8 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.935 3.09 . . . . 5.58 108.096 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 172' ' ' VAL . 22.7 p-10 -112.51 -79.13 0.58 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.291 1.836 . . . . 4.0 110.628 -158.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.533 ' H ' ' CG ' ' A' ' 171' ' ' ASP . 49.4 t -78.3 -25.61 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.223 2.209 . . . . 3.04 110.098 168.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 58.5 m -49.4 -46.66 77.93 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 126.733 2.013 . . . . 1.97 113.725 177.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.13 -29.22 0.97 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.694 2.93 . . . . 1.85 113.659 166.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.29 -57.85 11.22 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.508 1.504 . . . . 3.37 112.396 -168.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.48 -35.68 77.88 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.509 -0.744 . . . . 3.66 111.814 177.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -44.58 83.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.168 0.987 . . . . 2.78 110.695 -176.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.84 -60.55 2.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.348 1.459 . . . . 3.67 109.463 172.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -35.03 69.84 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.677 -0.639 . . . . 3.87 110.656 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 184' ' ' VAL . 27.1 tpp -69.89 -24.11 63.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.97 -1.014 . . . . 3.94 113.453 174.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.07 -50.93 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 121.67 2.032 . . . . 2.0 109.007 176.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -65.44 -12.09 49.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.574 -1.203 . . . . 1.95 113.652 172.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.91 -45.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.929 1.695 . . . . 1.46 112.861 159.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 180' ' ' MET . 24.0 t -59.97 -40.87 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.13 1.786 . . . . 2.59 110.746 -178.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.19 -29.51 66.39 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.187 -0.946 . . . . 4.44 113.124 177.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.96 -4.23 19.75 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.67 1.588 . . . . 3.36 112.035 168.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.4 -50.22 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.838 2.055 . . . . 2.48 111.1 169.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.24 -41.51 50.26 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.424 1.489 . . . . 3.39 111.649 177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -66.32 -24.44 66.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.57 1.548 . . . . 3.68 112.76 -177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.39 62.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.081 -1.452 . . . . 5.07 107.081 171.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.18 6.87 0.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.085 2.154 . . . . 4.76 115.537 -165.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 41.5 p -82.4 -2.47 53.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.715 2.006 . . . . 4.83 112.808 162.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 155.59 93.19 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 121.401 -0.812 . . . . 4.45 110.577 152.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.21 -173.25 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.057 2.505 . . . . 3.44 109.033 161.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.11 148.07 47.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.768 -0.582 . . . . 4.28 111.806 178.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -118.86 94.16 4.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.758 1.223 . . . . 3.86 109.175 166.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.6 m -93.98 106.72 23.63 Favored Pre-proline 0 N--CA 1.473 0.675 0 C-N-CA 125.191 1.396 . . . . 1.89 110.531 174.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.33 142.49 30.21 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.981 2.454 . . . . 1.76 113.504 171.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.5 111.69 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.668 1.587 . . . . 3.34 109.13 -169.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.84 116.43 26.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.297 1.039 . . . . 3.08 110.181 -164.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.08 126.47 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.99 0.9 . . . . 1.9 111.178 -171.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.0 t -77.06 99.18 5.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.219 1.008 . . . . 1.83 109.31 166.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.5 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.781 1.632 . . . . 1.94 115.017 -173.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.63 76.43 2.09 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 107.075 -1.454 . . . . 4.53 107.075 171.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.93 -1.05 11.28 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.752 2.968 . . . . 2.47 114.197 -154.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -61.72 -12.17 15.42 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.251 2.221 . . . . 4.97 113.216 -173.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.42 127.07 1.68 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 125.626 1.571 . . . . 7.07 111.518 -172.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -173.04 124.72 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.85 1.26 . . . . 5.14 110.669 163.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.6 m -77.64 111.17 13.12 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 104.903 -2.258 . . . . 3.89 104.903 161.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.21 -30.52 71.42 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.766 -0.583 . . . . 7.71 110.739 -173.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.95 -40.31 95.11 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.398 2.679 . . . . 3.79 111.877 170.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.02 -34.49 73.34 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.956 -1.09 . . . . 2.37 111.778 172.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.95 -35.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.718 -0.614 . . . . 2.95 111.296 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.2 96.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.474 1.034 . . . . 1.83 111.404 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.42 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 8.1 t30 -58.24 -53.46 57.98 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 119.297 -0.382 . . . . 3.71 111.705 170.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -52.69 -48.61 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.937 0.895 . . . . 4.39 112.463 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.27 -47.06 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.129 0.972 . . . . 1.94 111.926 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -70.86 -18.77 62.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.994 1.479 . . . . 3.22 114.994 -179.07 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.09 -29.03 67.88 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.953 1.252 . . . . 4.22 111.334 173.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.98 -51.94 5.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.695 0.798 . . . . 2.65 112.156 177.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.83 151.66 0.84 Allowed Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 120.428 -1.42 . . . . 2.72 113.989 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -68.94 -29.16 28.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.579 2.186 . . . . 3.66 111.943 170.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -1.8 40.65 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.074 1.139 . . . . 3.12 114.074 172.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.0 tp -82.16 138.88 34.61 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.898 -1.127 . . . . 2.49 109.059 167.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -127.16 121.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.785 . . . . 2.15 109.26 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.36 133.3 11.24 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.569 1.08 . . . . 1.23 110.809 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.8 150.84 41.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.25 1.42 . . . . 2.39 112.049 -170.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -164.78 158.16 17.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.979 1.712 . . . . 2.75 109.649 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.05 -80.84 0.03 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 120.297 1.408 . . . . 2.42 113.969 168.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.0 t -170.71 168.3 7.47 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.303 3.041 . . . . 3.41 107.506 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -48.66 -41.82 32.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.996 1.718 . . . . 8.09 111.818 -178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.19 -46.63 88.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.663 1.585 . . . . 3.68 111.524 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -33.71 60.22 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.646 -0.659 . . . . 4.07 112.621 178.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.04 -36.57 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 120.601 -1.312 . . . . 2.05 112.624 166.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.82 -35.61 69.99 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.838 1.654 . . . . 3.7 111.86 167.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' PHE . 25.5 tp60 -55.38 -41.52 72.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.221 -0.895 . . . . 2.99 111.412 172.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.36 -32.7 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.069 1.348 . . . . 3.15 113.111 170.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.08 61.91 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.153 -0.967 . . . . 2.38 111.802 173.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.77 -24.26 28.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.609 2.363 . . . . 6.09 113.22 170.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.7 2.44 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.75 1.22 . . . . 2.19 110.974 173.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -123.44 -58.65 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.121 -0.942 . . . . 2.9 113.23 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 143.88 138.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.661 3.584 . . . . 5.14 111.043 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.76 155.33 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.972 1.709 . . . . 3.35 108.594 168.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -155.62 148.86 24.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.109 1.363 . . . . 6.35 111.049 179.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -175.96 155.07 1.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.005 1.722 . . . . 3.91 111.947 -166.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 m -114.37 111.12 47.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.794 0.837 . . . . 3.19 109.854 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.26 146.27 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.173 1.915 . . . . 3.76 109.704 163.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.18 155.01 29.46 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.698 -1.057 . . . . 3.27 111.687 174.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.93 -50.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.701 2.267 . . . . 4.84 110.283 165.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 252' ' ' GLU 0.25 0.2 OUTLIER 63.36 -28.31 0.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 129.178 2.991 . . . . 9.58 116.871 177.202 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 74.65 -23.63 0.23 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.42 1.888 . . . . 6.09 115.305 150.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 29.5 mt-10 -102.95 -36.73 8.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.97 2.508 . . . . 9.68 112.994 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -160.3 138.86 10.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.392 1.877 . . . . 7.87 106.211 -171.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -80.8 41.37 0.57 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.319 1.448 . . . . 7.51 113.409 -163.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -146.01 152.97 40.23 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.848 1.259 . . . . 6.7 113.237 -177.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -177.31 164.45 2.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.701 2.0 . . . . 5.11 112.44 -155.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 42.2 pt -74.08 156.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.386 -1.446 . . . . 5.4 109.412 163.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -134.65 128.03 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.871 -1.159 . . . . 3.71 107.871 176.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -75.71 52.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.774 1.23 . . . . 4.8 112.222 -174.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.628 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 29.2 p80 -56.76 108.92 0.55 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.671 -1.268 . . . . 2.13 110.085 176.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -58.64 133.7 56.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.909 0.484 . . . . 3.3 109.86 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.99 71.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.382 1.073 . . . . 3.83 110.18 -172.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.2 mt -134.22 131.99 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.23 1.412 . . . . 2.48 110.034 -174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.07 126.79 50.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.411 1.484 . . . . 3.55 111.055 177.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.86 135.92 40.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.855 1.262 . . . . 3.73 112.056 -175.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.11 122.47 44.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.854 1.262 . . . . 3.22 109.473 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.1 mm -126.44 139.09 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.744 2.017 . . . . 3.74 108.698 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.59 174.28 42.88 Favored Glycine 0 CA--C 1.544 1.88 0 N-CA-C 116.486 1.354 . . . . 2.69 116.486 -172.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.58 142.03 43.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.318 3.345 . . . . 3.61 109.834 168.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.282 1.1 m-20 56.9 11.2 0.89 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.175 1.79 . . . . 5.77 113.885 -160.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.54 -160.61 17.22 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 125.472 1.511 . . . . 3.35 113.459 172.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 77.7 152.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.736 2.414 . . . . 5.41 114.064 176.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -92.17 147.64 22.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.568 1.547 . . . . 4.11 112.736 177.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.4 tt -118.49 -62.54 1.52 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.034 0.933 . . . . 4.41 110.806 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -164.96 177.36 7.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.906 1.682 . . . . 3.18 112.072 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.2 148.57 52.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.757 1.265 . . . . 4.14 113.294 178.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.01 177.29 5.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.94 2.096 . . . . 2.83 109.851 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.57 -178.45 40.99 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.108 2.289 . . . . 2.4 110.311 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.62 70.76 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.842 1.793 . . . . 4.47 115.842 -159.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -163.82 -48.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.013 1.725 . . . . 4.87 109.947 -172.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -65.06 116.09 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.126 -0.983 . . . . 5.62 111.818 -176.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -73.24 163.62 27.85 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.049 -1.032 . . . . 5.95 110.461 -175.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -64.64 0.79 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 118.747 -2.47 . . . . 1.67 113.636 -168.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.85 59.58 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.198 0.439 . . . . 1.53 114.198 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.45 -32.81 19.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.999 1.32 . . . . 3.64 110.856 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 -45.87 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.208 -0.932 . . . . 1.36 108.621 164.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.87 70.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.801 -0.619 . . . . 1.41 112.548 174.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.66 83.66 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.255 1.389 . . . . 1.62 113.394 173.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 12.2 m -61.31 -50.72 71.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.433 -0.792 . . . . 2.16 111.258 167.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.8 mt -64.05 -36.3 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.328 -0.858 . . . . 2.43 112.06 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.39 67.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.783 1.629 . . . . 1.81 113.734 174.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 34.7 m -75.95 -54.98 6.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.509 1.124 . . . . 1.92 109.1 171.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -66.26 -18.41 65.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.512 1.925 . . . . 2.77 113.974 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -66.74 -39.43 87.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.628 1.971 . . . . 4.17 111.506 169.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.9 ttt-85 -54.13 -43.27 96.87 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 116.339 -1.791 . . . . 5.63 113.988 -178.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -11.03 12.32 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.085 3.19 . . . . 3.37 115.129 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -130.31 36.19 4.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.871 1.268 . . . . 4.05 112.523 -171.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.45 HH12 ' C ' ' A' ' 301' ' ' SER . 17.4 ttt-85 -55.4 147.28 17.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.082 0.953 . . . . 7.33 110.666 172.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -59.61 164.83 3.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.992 -1.068 . . . . 8.14 112.298 172.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.04 10.53 11.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.105 1.362 . . . . 14.05 113.4 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.45 ' C ' HH12 ' A' ' 298' ' ' ARG . 5.7 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 129.086 2.955 . . . . 10.76 107.953 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.194 -0.908 . . . . 19.9 109.997 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -64.38 152.66 40.78 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.597 0.635 . . . . 16.35 110.088 158.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t 179.09 153.78 0.41 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.378 2.671 . . . . 13.97 108.969 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.22 -179.15 49.71 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.38 -0.688 . . . . 11.52 111.38 162.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -163.4 150.51 10.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.493 1.517 . . . . 11.15 111.394 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.13 176.02 10.63 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.333 2.688 . . . . 8.86 111.095 172.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.23 152.98 45.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.351 1.46 . . . . 7.13 109.267 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.441 HD12 ' HE3' ' A' ' 153' ' ' LYS . 1.0 OUTLIER -122.88 143.52 49.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.745 1.218 . . . . 8.06 108.482 178.148 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.91 -57.52 5.77 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.114 0.864 . . . . 4.45 111.882 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.37 58.81 0.51 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 117.318 -1.823 . . . . 4.06 115.737 -176.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.04 128.44 13.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 120.716 2.258 . . . . 4.05 110.827 -173.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -141.07 160.59 39.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 112.761 0.652 . . . . 3.71 112.761 169.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.5 p -115.17 139.58 49.8 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.289 -1.004 . . . . 4.02 108.289 152.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mt -147.74 151.77 36.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 2.61 111.363 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -99.74 132.8 44.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.93 1.292 . . . . 2.98 110.395 -176.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.0 p -83.43 161.52 21.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.473 1.509 . . . . 1.75 112.882 -175.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -60.19 -21.54 61.85 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.39 1.076 . . . . 1.8 113.248 166.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -84.83 -3.84 58.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.879 2.472 . . . . 2.82 111.45 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.46 -13.82 26.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.711 1.148 . . . . 2.73 114.504 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 156.46 36.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.366 1.066 . . . . 5.89 109.581 165.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -136.52 127.02 26.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.007 1.323 . . . . 6.05 109.244 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 -173.57 4.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.667 1.358 . . . . 3.33 114.667 -172.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 p -131.6 168.37 17.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.404 1.882 . . . . 2.99 109.152 -171.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -60.8 -36.44 79.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.785 0.721 . . . . 3.76 112.339 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.441 ' HE3' HD12 ' A' ' 136' ' ' LEU . 42.0 mmtt -77.31 -3.96 42.62 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.548 1.314 . . . . 8.08 114.548 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -113.25 -23.41 9.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.276 1.83 . . . . 3.55 111.632 176.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -68.24 -14.11 62.74 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.807 -1.808 . . . . 3.33 112.553 154.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.4 tp -66.81 125.45 25.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.971 0.909 . . . . 3.72 112.075 -172.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 152.61 -31.07 0.84 Allowed Glycine 0 N--CA 1.472 1.037 0 C-N-CA 125.138 1.351 . . . . 1.96 113.223 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 174.76 5.74 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.26 1.824 . . . . 2.82 109.722 175.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -74.75 129.11 37.11 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.121 -0.987 . . . . 2.13 109.66 161.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 mt -107.96 138.78 43.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.262 0.625 . . . . 2.31 110.905 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.51 116.47 20.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.407 -1.701 . . . . 3.79 106.407 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mt -124.43 100.27 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.762 1.225 . . . . 1.97 109.069 -161.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -107.97 145.72 33.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.295 1.838 . . . . 4.11 113.061 -174.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -88.57 101.01 13.53 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.326 -0.858 . . . . 2.92 110.338 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.43 153.73 25.13 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 116.857 1.503 . . . . 2.17 116.857 -164.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -160.24 -147.59 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.639 . . . . 5.0 111.321 -171.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.23 -0.35 56.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.684 1.193 . . . . 2.78 113.494 -171.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -138.57 -145.29 0.19 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 124.39 2.043 . . . . 5.37 112.778 -165.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 12.3 m 58.84 -152.92 0.01 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 118.96 -2.338 . . . . 3.81 111.282 -106.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.65 -94.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.543 1.496 . . . . 5.79 108.726 121.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 -26.26 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.517 1.673 . . . . 4.42 115.517 -152.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.65 -16.0 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 114.127 1.158 . . . . 2.57 114.127 -149.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 64.3 m -66.11 -60.74 6.45 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-O 117.347 -1.311 . . . . 2.28 112.15 164.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.56 -26.63 80.85 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.937 1.758 . . . . 2.88 113.654 175.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -65.25 -59.16 4.37 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.013 1.279 . . . . 3.44 111.724 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.63 -20.21 62.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.056 1.298 . . . . 3.38 114.017 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -58.42 -51.11 71.23 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.277 0.944 . . . . 3.7 110.678 162.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -58.78 -49.16 78.71 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.844 0.747 . . . . 4.27 111.091 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -46.68 -55.54 7.58 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.363 -0.836 . . . . 3.93 112.248 175.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 15.7 ptp -67.01 -28.04 67.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.813 -0.613 . . . . 4.21 112.623 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.3 mm -68.71 -58.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.912 1.233 . . . . 1.96 110.772 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.89 -12.33 53.76 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.099 0.777 . . . . 2.6 113.099 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.6 t -75.15 -37.36 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.711 -1.243 . . . . 1.94 113.687 163.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.04 -25.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 120.793 1.633 . . . . 2.53 113.528 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.37 -48.26 68.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.433 1.093 . . . . 3.94 111.756 166.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.82 -40.78 75.69 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.589 1.556 . . . . 2.21 112.477 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.7 tt -76.32 -30.54 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.25 -0.906 . . . . 1.84 113.442 -175.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.419 ' CG ' ' HZ3' ' A' ' 223' ' ' LYS . 60.5 m-20 -69.2 -45.37 70.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.789 0.436 . . . . 2.34 110.288 167.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 58.0 m -60.5 -30.97 70.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.091 -1.006 . . . . 2.72 112.98 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.4 mt -57.21 -25.86 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 117.95 -1.024 . . . . 2.76 112.579 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.6 m 64.09 3.91 1.88 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.284 1.434 . . . . 2.81 113.089 168.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.3 m -125.52 0.93 7.61 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.144 2.178 . . . . 2.66 111.76 -166.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.27 161.87 32.88 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.529 1.532 . . . . 3.01 109.289 166.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.21 -38.36 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.648 1.565 . . . . 3.87 113.389 -165.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.7 t70 166.95 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 129.967 3.307 . . . . 3.81 107.548 -176.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 tt -117.83 114.62 23.53 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 160.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.2 m -97.2 101.4 9.72 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 125.371 1.468 . . . . 1.21 108.887 176.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.27 144.29 16.27 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.156 1.904 . . . . 0.85 110.251 172.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.82 145.19 28.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.183 0.992 . . . . 2.7 113.446 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -116.28 109.51 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.688 1.195 . . . . 3.02 110.029 -159.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.32 99.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.529 1.132 . . . . 1.94 109.418 -174.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.62 139.68 30.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.42 0.688 . . . . 2.06 112.245 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.86 -3.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.777 1.399 . . . . 2.16 114.777 -160.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -115.28 66.34 2.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 128.612 2.765 . . . . 3.73 110.105 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.16 77.07 4.16 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.237 3.291 . . . . 2.85 111.871 -170.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -149.66 -43.64 0.14 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.983 1.313 . . . . 5.15 111.82 175.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.0 ptt85 -56.99 -49.23 76.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.028 1.731 . . . . 8.59 115.411 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -164.02 156.79 17.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.471 1.508 . . . . 4.25 110.325 -167.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.2 p -104.2 173.04 6.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.807 0.813 . . . . 3.18 112.585 -160.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -54.41 -32.49 57.4 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.703 -0.623 . . . . 4.48 112.355 175.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.92 -36.03 72.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.393 1.877 . . . . 4.27 113.222 174.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.95 60.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.324 -0.86 . . . . 1.89 111.349 175.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 -39.86 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.715 1.206 . . . . 1.87 110.762 170.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.52 -50.95 66.63 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.193 0.997 . . . . 1.63 112.691 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -65.98 -43.94 86.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.238 0.458 . . . . 2.91 112.238 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.95 -48.12 82.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.359 1.063 . . . . 2.99 111.424 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.3 t -60.86 -46.59 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.577 1.151 . . . . 1.43 111.605 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -17.97 60.86 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.851 1.426 . . . . 3.4 114.851 -177.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -39.78 95.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.626 1.17 . . . . 3.87 112.012 167.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.53 -55.44 6.95 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.168 0.587 . . . . 3.02 111.589 171.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.4 t -175.52 135.83 0.5 Allowed Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.916 1.286 . . . . 2.13 110.587 169.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.56 -7.44 20.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.19 2.593 . . . . 2.77 113.558 176.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.419 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 36.2 tttp -69.48 -31.25 69.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.621 0.6 . . . . 2.59 112.621 168.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.09 145.08 38.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.685 0.794 . . . . 1.98 109.327 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.6 t -114.04 134.12 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 118.45 0.568 . . . . 1.45 111.763 178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.05 137.62 13.37 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 124.342 0.972 . . . . 1.1 110.706 173.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.71 159.41 24.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.521 1.128 . . . . 2.18 111.43 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.1 m -168.16 165.94 13.04 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.442 2.697 . . . . 2.48 107.451 173.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -154.76 -129.11 1.23 Allowed Glycine 0 N--CA 1.46 0.242 0 N-CA-C 110.439 -1.064 . . . . 1.96 110.439 163.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 76.2 p -106.17 -179.19 3.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.032 1.333 . . . . 3.79 109.048 163.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -33.95 3.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.389 1.476 . . . . 9.1 112.642 170.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -72.35 -42.44 65.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.127 1.371 . . . . 3.66 110.344 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -71.22 -37.36 72.04 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.129 -0.357 . . . . 3.45 111.069 174.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.23 -41.97 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 123.742 0.817 . . . . 1.98 112.618 170.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.95 -55.0 38.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.191 1.396 . . . . 3.33 109.97 173.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -43.12 -55.35 3.93 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.472 1.909 . . . . 2.7 114.814 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.6 m -71.11 -34.89 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.189 1.181 . . . . 2.58 114.189 -176.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.1 -19.76 63.23 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.875 0.87 . . . . 2.28 112.561 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -104.48 -33.76 8.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.38 2.272 . . . . 4.14 112.794 -172.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.01 -66.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.993 0.917 . . . . 2.19 110.552 171.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.1 -145.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.337 -0.616 . . . . 3.47 109.337 161.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.91 133.36 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.348 -1.47 . . . . 5.54 111.491 -174.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.29 154.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.517 1.527 . . . . 2.67 110.383 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -119.0 146.37 45.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.58 0.752 . . . . 6.55 110.642 159.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -155.2 154.68 32.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.272 1.429 . . . . 3.13 110.582 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.3 t -150.22 121.0 3.91 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.863 -0.589 . . . . 3.8 111.41 -176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.61 141.86 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.723 1.615 . . . . 3.47 110.474 172.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.27 177.37 37.89 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.942 -0.863 . . . . 2.89 110.942 164.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.34 162.03 41.28 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.967 2.445 . . . . 4.9 111.43 177.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -81.6 110.52 17.04 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.337 -1.357 . . . . 6.69 107.337 161.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -164.7 -46.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.554 0.742 . . . . 8.2 111.736 -152.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.76 -24.33 65.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.47 1.108 . . . . 14.35 113.767 168.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 161.28 -138.17 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 1 C-N-CA 133.676 4.79 . . . . 9.48 103.316 175.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -98.82 -10.52 22.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.465 1.506 . . . . 7.7 114.052 -174.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -84.6 52.9 2.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.299 1.047 . . . . 8.41 113.627 -175.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -0.15 94.18 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 130.061 3.344 . . . . 4.8 116.315 171.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.22 138.32 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 121.319 -0.863 . . . . 4.37 110.306 175.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -144.03 123.0 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.482 1.513 . . . . 2.91 108.146 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.79 154.24 36.39 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.595 2.358 . . . . 4.08 111.181 171.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.411 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 6.0 p80 -165.34 140.68 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.189 1.395 . . . . 2.19 112.829 173.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.3 p -64.79 102.95 0.64 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.729 0.812 . . . . 3.37 110.313 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.52 91.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.736 2.414 . . . . 3.65 109.042 174.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.4 mt -147.34 144.09 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 127.059 2.143 . . . . 1.98 107.514 -174.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.55 123.95 30.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.009 1.724 . . . . 4.47 111.454 174.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.55 146.0 26.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.224 1.41 . . . . 3.02 111.959 174.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.9 tt -111.29 128.62 56.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.372 1.069 . . . . 1.94 111.209 174.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.89 134.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.777 1.631 . . . . 2.1 107.551 173.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.05 157.45 30.77 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 120.017 -0.324 . . . . 1.81 113.754 -177.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.19 96.05 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.188 2.592 . . . . 4.47 108.228 161.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 t70 176.44 -76.9 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 110.717 -2.947 . . . . 5.53 108.707 -152.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 164.88 -28.66 0.21 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-O 116.762 -2.132 . . . . 2.76 116.513 -173.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -148.21 177.59 9.27 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.202 2.501 . . . . 5.34 114.155 -174.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -75.76 152.5 37.38 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.985 -1.072 . . . . 4.13 113.253 -177.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -124.24 -54.1 1.7 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.549 1.54 . . . . 3.43 111.778 -167.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -154.31 175.41 13.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.728 1.611 . . . . 2.81 110.368 -165.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -152.97 136.09 15.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.577 1.18 . . . . 3.21 114.004 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -132.17 -160.85 1.08 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.058 2.143 . . . . 3.28 110.987 -170.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.68 153.09 26.35 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.53 1.062 . . . . 2.4 110.555 -169.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 97.69 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.313 2.645 . . . . 4.4 109.189 -176.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.35 27.12 0.05 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.512 2.725 . . . . 5.43 113.782 -177.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -79.51 153.77 29.32 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.592 -1.318 . . . . 4.45 112.347 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -143.3 159.78 41.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.807 2.443 . . . . 8.11 109.898 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -67.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 119.17 -2.207 . . . . 2.37 113.958 -149.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.08 -8.14 61.0 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 113.778 0.271 . . . . 2.24 113.778 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -87.14 -31.69 20.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.972 1.309 . . . . 3.98 110.511 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.07 -53.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.578 -1.326 . . . . 1.95 109.647 159.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.76 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.676 0.79 . . . . 1.41 112.609 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.66 -25.17 66.14 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.12 1.156 . . . . 1.95 114.12 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.0 m -73.73 -50.99 18.04 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.417 -0.802 . . . . 2.96 110.627 177.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.58 -31.93 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.301 -0.874 . . . . 2.4 112.377 176.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.41 68.68 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.831 -1.168 . . . . 1.91 113.066 168.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.7 m -73.96 -41.9 61.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 118.556 -0.735 . . . . 2.55 110.405 171.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -63.86 -26.87 68.81 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.591 0.96 . . . . 3.29 113.591 171.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 45.3 ttp -63.98 -21.31 66.44 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.079 0.952 . . . . 4.14 112.625 174.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -67.16 -52.16 31.69 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 116.529 -1.7 . . . . 5.35 112.441 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.07 -55.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.465 2.777 . . . . 3.19 112.023 167.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.45 71.19 9.53 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.539 1.161 . . . . 4.94 110.775 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -48.13 133.67 14.93 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.651 -1.159 . . . . 8.99 111.386 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 166.14 3.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.03 1.332 . . . . 5.88 113.044 -175.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -108.1 -111.19 0.3 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.031 -1.1 . . . . 11.39 108.031 -172.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 116.125 -1.893 . . . . 11.17 111.216 130.354 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 118.185 -0.912 . . . . 18.17 109.968 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.45 168.05 13.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.682 0.674 . . . . 17.86 110.937 164.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.3 t -154.72 145.88 22.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.958 1.703 . . . . 13.9 109.075 173.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.46 -19.28 57.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.972 -0.904 . . . . 13.6 115.108 -169.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -104.05 105.62 49.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 119.49 1.645 . . . . 11.95 111.696 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.15 177.81 8.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.918 2.412 . . . . 9.55 110.368 166.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 155.26 21.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.363 1.865 . . . . 6.61 110.093 175.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -161.47 -14.69 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.248 1.819 . . . . 7.13 113.211 -171.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.92 122.21 25.35 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.082 1.325 . . . . 3.28 113.428 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.81 136.73 15.24 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.62 -1.1 . . . . 3.37 112.577 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.97 172.8 15.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.432 2.755 . . . . 3.33 111.023 176.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -144.63 169.71 17.47 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 123.56 1.648 . . . . 3.4 113.474 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 m -148.28 95.4 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.465 -1.397 . . . . 2.54 109.27 170.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.26 165.69 13.52 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.1 0.875 . . . . 2.68 112.928 -172.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -69.43 144.03 53.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.328 1.451 . . . . 2.96 110.338 164.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.52 139.54 41.88 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.313 1.045 . . . . 1.61 111.038 166.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -48.19 -35.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.731 2.013 . . . . 1.49 114.591 172.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -112.5 10.06 19.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.012 1.725 . . . . 2.94 111.787 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -143.11 -116.09 1.13 Allowed Glycine 0 C--O 1.221 -0.694 0 N-CA-C 108.935 -1.666 . . . . 3.45 108.935 177.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 170.71 -13.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.403 2.281 . . . . 11.39 112.935 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -141.62 123.06 14.96 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.095 0.958 . . . . 4.5 112.305 172.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.596 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 49.5 tptt -140.71 153.59 46.0 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.469 1.908 . . . . 3.41 110.579 171.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 38.8 p -134.26 165.13 25.84 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.646 1.978 . . . . 2.94 109.659 169.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.21 -57.19 5.44 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.557 3.143 . . . . 5.89 113.315 172.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -14.06 60.95 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.326 1.232 . . . . 9.92 114.326 -176.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -76.23 -3.45 36.51 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.879 0.872 . . . . 3.13 112.336 174.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 11.9 m-85 -127.8 14.64 6.94 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.443 1.497 . . . . 3.7 114.326 167.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.59 152.55 25.95 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.111 -1.618 . . . . 4.12 111.166 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 85.42 -1.02 88.58 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 118.428 -1.207 . . . . 1.8 115.935 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.87 166.77 14.47 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.29 1.545 . . . . 2.84 109.97 171.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.19 140.97 43.64 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.851 -0.531 . . . . 2.26 111.072 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.58 151.72 47.57 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.924 1.345 . . . . 2.4 112.659 169.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.9 tt -134.18 98.24 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.931 -2.248 . . . . 2.92 104.931 -171.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.62 136.45 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.038 0.535 . . . . 1.87 109.781 -176.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.64 139.64 49.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.516 1.526 . . . . 6.13 109.727 172.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.49 111.71 24.03 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.322 0.649 . . . . 2.22 110.61 174.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.52 136.79 8.95 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 115.186 0.834 . . . . 1.75 115.186 -174.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -80.56 5.18 16.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.165 0.986 . . . . 4.39 113.35 173.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m 71.52 -15.33 0.44 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.855 2.062 . . . . 4.04 115.316 157.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -133.78 -18.77 2.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.53 1.678 . . . . 6.42 115.53 -162.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 18.2 p -105.28 106.75 57.06 Favored Pre-proline 0 C--O 1.255 1.371 0 CA-C-N 120.354 1.434 . . . . 2.91 108.683 -167.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.72 129.83 19.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.501 2.801 . . . . 5.08 108.371 -173.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -178.24 -146.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 105.446 -2.057 . . . . 5.23 105.446 -157.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.95 -13.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.099 . . . . 5.43 113.855 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.504 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 27.5 m -51.59 -60.45 5.9 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-N 119.915 1.234 . . . . 3.24 113.687 -177.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -62.93 -33.38 75.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.737 2.291 . . . . 2.51 112.239 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.15 -44.76 75.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.269 0.94 . . . . 3.67 111.449 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -80.47 -43.36 20.99 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.055 1.131 . . . . 3.77 114.055 175.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.13 -45.86 86.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.198 0.999 . . . . 3.52 111.889 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -49.06 69.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.426 1.012 . . . . 4.48 109.69 171.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -70.24 -29.41 66.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.293 -1.504 . . . . 4.03 112.697 -176.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -62.12 -39.47 92.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.953 0.901 . . . . 4.65 111.499 162.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.2 mm -70.38 -35.64 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 119.928 -1.732 . . . . 1.42 109.372 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.425 ' C ' ' HE2' ' A' ' 283' ' ' LYS . 73.9 mt-30 -65.58 -16.2 63.47 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 116.804 -1.57 . . . . 2.03 112.961 176.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.66 -32.96 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 120.845 1.657 . . . . 3.2 113.243 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.5 t -61.75 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.472 1.109 . . . . 2.28 111.291 172.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.26 -39.99 74.64 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.169 -0.332 . . . . 3.3 111.448 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.64 -45.05 93.15 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.29 1.436 . . . . 3.14 112.546 176.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 tt -71.65 -36.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.809 -1.182 . . . . 2.48 113.247 -177.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.88 -35.13 72.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.312 1.045 . . . . 2.51 111.873 173.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t -67.21 -20.37 65.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.391 . . . . 2.07 112.885 172.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 80.6 mt -81.55 -36.61 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 120.852 -1.155 . . . . 2.4 110.967 166.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m 74.09 -35.82 0.32 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.36 2.264 . . . . 3.08 113.739 166.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 74.5 p -80.27 -18.99 47.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.693 1.597 . . . . 3.78 113.107 177.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.3 mp -71.39 161.59 77.56 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.573 1.549 . . . . 2.76 111.32 170.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.03 145.52 28.12 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.431 2.087 . . . . 2.85 112.66 -170.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.49 134.38 37.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.612 1.565 . . . . 5.32 111.585 -159.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.6 tt -130.83 130.98 44.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.86 0.689 . . . . 2.57 112.86 -169.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.9 m -111.07 111.53 55.99 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.331 1.853 . . . . 1.48 109.985 175.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.11 134.82 4.44 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.835 2.357 . . . . 1.15 111.053 176.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.3 91.08 3.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.51 1.148 . . . . 2.24 110.274 -163.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -78.71 119.63 22.22 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.856 -1.065 . . . . 2.51 109.811 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 67.5 mt -95.31 110.56 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.795 -1.187 . . . . 1.53 107.795 174.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.46 130.49 36.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.513 0.673 . . . . 1.85 109.783 173.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.34 18.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 3.17 113.789 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -115.4 68.66 2.68 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.195 0.998 . . . . 4.82 112.456 172.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.91 -4.67 15.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.753 2.969 . . . . 3.38 114.11 -176.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -71.56 -5.27 32.07 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.397 0.999 . . . . 7.7 111.832 171.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.63 -12.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.769 2.137 . . . . 6.22 116.769 168.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -70.05 84.64 0.52 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 121.042 1.746 . . . . 5.41 111.62 176.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.1 m -79.09 146.55 33.18 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.99 1.716 . . . . 3.19 108.403 175.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.97 -54.57 3.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 3.57 113.032 -175.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -68.36 -31.95 71.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.233 2.213 . . . . 2.97 113.173 179.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -40.43 76.74 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.944 -1.098 . . . . 1.84 110.954 177.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.08 -38.3 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.876 0.47 . . . . 2.35 110.163 171.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.94 78.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.425 0.69 . . . . 1.35 111.852 176.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.29 -48.91 77.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.113 -0.47 . . . . 4.21 111.871 176.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -54.04 -54.87 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.327 1.051 . . . . 4.17 111.101 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.19 -43.65 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.815 1.246 . . . . 1.26 111.89 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -25.85 64.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.892 1.277 . . . . 3.01 113.588 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -96.27 -14.88 22.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.269 1.027 . . . . 3.42 113.387 -175.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -79.15 -50.8 10.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.57 0.623 . . . . 2.61 110.331 161.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.2 p -172.36 150.07 2.21 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.04 0.936 . . . . 2.01 112.687 162.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.75 -9.84 27.36 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.196 2.597 . . . . 1.63 114.224 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -83.9 -16.2 45.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.364 1.065 . . . . 3.16 113.865 172.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -81.44 154.45 26.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.831 0.742 . . . . 2.09 111.647 -171.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.2 138.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.836 1.254 . . . . 1.35 110.484 -174.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.72 130.31 9.02 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.442 1.02 . . . . 0.76 112.842 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.33 141.42 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.493 2.317 . . . . 2.12 109.677 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.7 m -154.89 164.82 38.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.322 2.249 . . . . 3.04 108.04 174.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -165.76 -167.44 26.39 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 115.777 1.071 . . . . 2.74 115.777 166.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.5 t -77.35 176.79 8.5 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.919 1.688 . . . . 3.37 109.708 168.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -55.25 -26.94 42.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.054 1.341 . . . . 7.63 113.506 -177.246 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 57.2 mp0 -66.58 -41.12 89.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.696 1.998 . . . . 3.66 111.981 172.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -78.41 -41.2 33.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.145 0.978 . . . . 5.02 111.477 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.05 -41.42 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 2.46 111.461 168.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.47 -58.91 5.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.679 -1.153 . . . . 3.64 110.583 164.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -42.13 -48.87 4.84 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.632 1.56 . . . . 3.92 114.618 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -70.79 -35.83 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.898 0.772 . . . . 3.05 112.91 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -77.28 -19.13 56.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.877 1.271 . . . . 2.48 113.397 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -90.84 -35.43 14.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.223 2.609 . . . . 5.3 111.236 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.38 9.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.85 1.26 . . . . 2.52 111.877 166.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -117.59 112.46 20.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.652 1.181 . . . . 4.29 110.124 178.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -70.28 67.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.726 1.38 . . . . 8.59 114.726 -173.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.74 135.54 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.99 1.316 . . . . 2.46 110.08 166.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -104.25 111.2 23.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.848 0.859 . . . . 5.53 109.842 171.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.39 158.11 43.3 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.413 0.894 . . . . 4.64 113.413 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.0 t -105.77 120.08 50.36 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 118.899 -0.572 . . . . 5.1 111.555 163.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.74 162.8 41.31 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.954 1.769 . . . . 4.85 109.854 165.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.69 16.48 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.041 -1.422 . . . . 5.28 111.194 176.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.79 -43.73 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.399 2.066 . . . . 6.62 111.833 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt 67.42 110.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.428 2.691 . . . . 6.83 114.24 -174.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.27 39.39 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.725 1.61 . . . . 6.39 111.214 176.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 69.85 -49.76 0.63 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 130.094 3.358 . . . . 11.63 113.036 -178.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -79.99 46.26 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.948 2.099 . . . . 8.78 113.558 -173.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 66.54 -21.29 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 129.16 2.984 . . . . 8.74 118.08 170.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -74.35 144.48 44.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.638 2.017 . . . . 8.81 111.463 170.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.24 122.06 5.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.558 1.171 . . . . 9.07 113.332 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.03 76.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.753 -1.217 . . . . 7.2 112.303 170.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.08 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.421 1.488 . . . . 5.19 110.165 160.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.25 151.35 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.473 2.309 . . . . 4.36 111.643 -172.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.504 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 2.0 t-80 -113.69 84.02 1.95 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.981 0.913 . . . . 5.12 112.138 -159.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.7 -28.52 69.95 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 119.145 3.017 . . . . 5.12 119.145 -162.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.295 0.2 OUTLIER 49.89 19.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 117.13 2.27 . . . . 4.7 117.13 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.12 128.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 119.861 -1.774 . . . . 3.19 113.106 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -120.83 145.09 47.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.587 1.955 . . . . 3.61 110.632 165.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.45 134.84 47.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.356 1.462 . . . . 3.76 112.601 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.4 tp -96.55 136.89 36.43 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.554 0.741 . . . . 2.14 111.037 171.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.58 133.75 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.314 1.845 . . . . 2.68 107.761 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.75 -176.42 38.31 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.689 0.661 . . . . 1.72 113.204 -176.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.38 -35.02 64.04 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.458 2.772 . . . . 3.49 112.163 169.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.43 -3.58 4.49 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 127.843 2.457 . . . . 6.01 113.826 167.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.04 -137.09 18.77 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.484 1.516 . . . . 2.54 112.874 174.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 40.88 -104.18 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.948 2.499 . . . . 6.08 113.537 178.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.31 161.2 33.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.316 1.847 . . . . 4.77 109.924 167.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.86 -57.22 2.26 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.812 0.845 . . . . 2.95 109.039 174.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -155.91 -167.19 2.4 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.235 1.814 . . . . 3.33 111.081 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -150.32 149.01 29.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.404 1.081 . . . . 3.25 111.69 -173.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -140.63 -165.64 1.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.509 1.124 . . . . 4.09 111.979 -173.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.7 -127.35 3.01 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.515 2.007 . . . . 2.4 110.999 -173.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -52.55 141.77 19.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.785 2.034 . . . . 4.16 113.228 -175.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.8 t30 69.4 -50.83 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.292 2.237 . . . . 6.29 112.129 -172.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.42 -44.05 97.81 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.515 1.126 . . . . 6.14 111.068 -176.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 51.41 -139.56 0.95 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.776 1.631 . . . . 7.84 110.524 156.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 182' ' ' GLN . 5.2 tmtt? -65.91 -52.33 50.87 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 119.813 -1.804 . . . . 2.71 112.017 174.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.38 -54.49 10.63 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 123.843 0.735 . . . . 3.07 113.649 -159.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.9 -31.1 68.72 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.886 0.843 . . . . 5.81 111.269 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.79 -49.51 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.763 0.71 . . . . 3.42 109.813 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.08 74.62 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.172 0.896 . . . . 1.87 112.809 174.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.69 85.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.486 1.114 . . . . 2.29 113.661 176.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.2 p -64.14 -43.64 94.6 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.301 -0.874 . . . . 3.03 111.564 172.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.76 -37.99 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 O-C-N 121.263 -0.898 . . . . 3.06 111.158 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.7 -24.27 65.51 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.219 1.372 . . . . 1.64 113.434 170.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 50.2 m -78.99 -54.44 6.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.641 1.176 . . . . 2.42 110.02 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.5 -21.75 64.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.377 1.471 . . . . 2.39 113.696 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 ttp -53.15 -41.74 65.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.925 1.69 . . . . 4.21 111.612 161.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -58.71 -43.32 97.69 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 116.306 -1.807 . . . . 5.74 114.12 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.42 -8.95 22.5 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.436 2.757 . . . . 2.76 115.274 170.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.14 40.52 1.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 120.49 1.495 . . . . 3.73 112.703 -174.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -77.18 92.0 3.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.779 -1.201 . . . . 9.76 112.237 -166.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -49.51 -40.82 39.11 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.414 2.005 . . . . 8.0 116.414 -163.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -137.95 -37.1 0.59 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.726 1.38 . . . . 11.6 114.726 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.069 0 C-N-CA 128.608 2.763 . . . . 7.34 110.399 174.038 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 118.277 -0.868 . . . . 16.48 109.989 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -67.0 163.53 19.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.728 0.695 . . . . 15.71 111.152 168.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.4 -2.37 22.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.636 1.575 . . . . 10.95 114.434 -170.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.35 -1.63 33.9 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.635 1.414 . . . . 11.67 116.635 167.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.75 119.49 63.84 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 119.351 1.575 . . . . 10.74 112.305 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.97 154.29 47.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.595 2.197 . . . . 10.76 110.56 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.8 mt -142.77 162.17 36.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.205 1.802 . . . . 7.33 108.994 175.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.26 -14.15 21.55 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.771 0.828 . . . . 10.05 113.101 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.67 -161.67 11.49 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.68 1.61 . . . . 4.92 112.441 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.51 -32.96 6.07 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.726 -1.597 . . . . 4.74 115.03 178.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -104.79 65.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.207 3.271 . . . . 3.08 110.032 167.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.08 141.73 31.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.077 0.942 . . . . 3.17 110.952 176.065 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.4 p -140.99 151.72 44.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.706 1.603 . . . . 2.97 110.042 164.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -151.98 147.75 26.91 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 2.38 111.609 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -69.4 125.0 25.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.872 2.069 . . . . 1.72 109.361 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -89.8 140.44 29.6 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.881 1.272 . . . . 1.88 109.428 174.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -62.51 -11.06 14.04 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.371 1.619 . . . . 1.83 115.371 -169.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 p -58.41 -27.75 64.59 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 128.378 2.671 . . . . 2.46 113.526 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.61 41.25 3.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 2.96 111.651 -167.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.24 -171.05 3.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.164 1.785 . . . . 4.85 108.681 -178.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -160.08 98.57 1.32 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.838 1.654 . . . . 4.86 112.772 -169.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.57 168.57 17.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.668 1.187 . . . . 3.22 113.573 -178.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -126.94 167.32 16.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.627 1.571 . . . . 2.5 113.407 -178.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -42.75 -27.72 0.19 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.606 2.762 . . . . 3.99 113.777 165.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.91 1.19 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.169 1.388 . . . . 5.6 114.173 -171.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.94 -51.28 34.18 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.859 -0.793 . . . . 3.46 108.859 156.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -78.15 4.05 13.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.684 1.365 . . . . 2.52 114.684 -173.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.16 49.53 0.97 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.996 1.318 . . . . 3.29 111.632 177.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.09 -39.39 0.1 OUTLIER Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.832 1.682 . . . . 1.84 114.234 -176.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -117.71 -167.12 1.28 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.871 1.268 . . . . 2.71 111.828 -179.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -95.84 145.82 25.05 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.597 1.159 . . . . 1.62 110.503 169.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.22 138.74 43.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.774 1.273 . . . . 2.85 113.066 -176.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.74 119.58 37.73 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.152 -1.796 . . . . 3.28 106.152 166.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.42 109.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.872 0.869 . . . . 2.58 111.212 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.12 145.41 27.18 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.763 1.225 . . . . 7.82 111.922 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.49 104.69 12.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.9 0.88 . . . . 2.26 111.146 172.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.44 153.02 18.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.739 1.161 . . . . 2.08 114.259 -173.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.597 ' H ' ' CD2' ' A' ' 260' ' ' HIS . 22.4 t80 -117.58 141.03 48.84 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.568 -0.901 . . . . 4.41 108.568 154.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.2 m -72.45 -36.26 68.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.076 1.75 . . . . 3.26 113.936 -168.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -92.43 -4.94 52.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.231 1.378 . . . . 5.25 112.99 -170.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.446 ' SG ' ' CD2' ' A' ' 260' ' ' HIS . 22.5 p -91.69 151.82 42.71 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 120.89 1.677 . . . . 2.8 112.812 -168.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.46 95.65 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.584 2.856 . . . . 6.04 112.458 -161.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 84.49 -12.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.289 2.636 . . . . 4.3 111.738 148.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.4 m -56.97 -20.26 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.601 1.56 . . . . 4.15 114.347 174.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.476 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 68.3 m -83.89 -69.88 0.14 Allowed Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 125.41 1.484 . . . . 1.98 112.216 167.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.36 -32.66 71.96 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.247 2.631 . . . . 1.71 114.511 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -54.68 -58.84 5.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.795 1.18 . . . . 3.24 111.514 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 6.6 tp10 -81.1 -22.63 39.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.869 0.692 . . . . 3.99 112.869 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.16 -26.76 64.07 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.659 -1.276 . . . . 2.55 113.202 175.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.86 -70.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.931 1.242 . . . . 3.91 109.522 169.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 32.1 mtmt -50.69 -40.53 54.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.199 1.4 . . . . 3.35 112.723 178.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.2 mmm -67.25 -37.75 84.02 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.368 0.877 . . . . 4.21 113.368 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.94 -30.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.878 1.672 . . . . 1.53 110.983 -178.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.453 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 64.0 mt-30 -58.91 -19.72 45.01 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.174 0.805 . . . . 2.02 113.174 172.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.55 -31.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.303 -1.498 . . . . 1.55 111.137 175.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.65 -45.23 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.069 0.947 . . . . 2.46 108.741 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -49.86 -58.3 5.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 5.15 111.828 168.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -58.06 -47.17 83.98 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.508 0.929 . . . . 2.64 113.508 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.5 tt -76.96 -36.57 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 120.377 -1.452 . . . . 2.03 113.627 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -63.5 -42.22 98.52 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.831 -0.803 . . . . 2.79 108.831 171.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -70.24 -19.72 63.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.613 1.165 . . . . 2.45 114.104 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.6 mt -74.72 -34.86 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.319 -0.863 . . . . 2.66 110.599 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.2 m 69.27 -29.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 128.895 2.878 . . . . 2.9 114.642 164.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 47.8 m -69.61 -34.75 74.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 128.922 2.889 . . . . 3.03 110.896 178.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.14 170.7 11.66 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.025 1.73 . . . . 2.82 110.861 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.62 171.41 18.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.351 2.034 . . . . 2.71 109.337 179.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.16 147.68 51.01 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 118.612 -1.235 . . . . 3.32 109.797 163.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -105.69 129.03 54.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.772 -1.558 . . . . 3.84 110.801 153.131 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 m -99.1 102.29 15.16 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.008 -1.108 . . . . 1.28 108.008 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.63 142.78 23.45 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.395 2.063 . . . . 1.0 111.7 175.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.1 135.91 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.39 1.091 . . . . 2.45 112.979 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -113.35 113.74 25.66 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.948 1.299 . . . . 2.41 109.085 -168.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 64.3 mt -91.67 114.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.565 -0.531 . . . . 1.34 109.565 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.2 t -78.17 115.72 18.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.913 -0.585 . . . . 1.61 110.138 166.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 pt -79.06 -6.72 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.853 1.057 . . . . 2.08 113.853 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.3 97.53 19.3 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.065 0.946 . . . . 4.2 111.217 178.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.6 -8.27 8.39 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.194 2.596 . . . . 2.84 112.233 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -79.68 -38.14 34.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.644 0.778 . . . . 6.69 112.629 -166.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -7.05 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 116.338 1.977 . . . . 7.37 116.338 -178.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.7 -177.28 3.66 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.155 -1.59 . . . . 4.54 110.435 156.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -158.51 158.27 33.71 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.377 -1.452 . . . . 3.14 112.097 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.9 tmpt? -51.66 -39.36 58.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.36 1.064 . . . . 4.46 111.855 175.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.15 -37.88 86.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.875 1.065 . . . . 3.15 113.875 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.62 43.89 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.555 -0.715 . . . . 2.51 110.69 176.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.0 mt -51.72 -51.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.669 1.588 . . . . 2.15 110.87 174.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.18 -38.46 62.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.126 1.37 . . . . 1.49 113.441 -178.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -73.94 -53.32 10.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.261 0.624 . . . . 3.38 111.497 173.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.11 -40.71 46.72 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.787 1.235 . . . . 3.5 112.198 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' A' ' 226' ' ' GLY . 35.7 t -57.36 -57.61 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.018 2.127 . . . . 1.58 112.592 176.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -73.24 -19.29 61.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.636 1.347 . . . . 3.72 114.636 -177.402 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.45 -26.76 68.09 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.753 0.821 . . . . 3.65 112.176 167.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -84.85 -50.96 7.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.314 0.646 . . . . 2.89 111.43 168.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.9 t -176.44 144.05 0.64 Allowed Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.758 1.223 . . . . 1.61 112.109 176.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.58 -15.74 30.55 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.979 2.453 . . . . 2.27 113.625 172.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -78.94 -11.78 60.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.261 0.937 . . . . 2.37 112.388 170.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 137.99 36.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.052 1.341 . . . . 2.05 108.461 173.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 14.9 p -118.3 132.05 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.311 0.644 . . . . 2.91 110.664 173.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -90.32 127.99 9.04 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.121 0.867 . . . . 0.85 112.603 -173.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -118.32 135.27 54.41 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.086 1.754 . . . . 1.99 112.168 -173.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -162.64 168.06 22.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.274 1.429 . . . . 3.2 110.417 159.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.65 -160.07 9.74 Favored Glycine 0 N--CA 1.468 0.771 0 O-C-N 120.744 -1.222 . . . . 2.43 111.563 -175.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 160.97 31.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.928 1.346 . . . . 4.58 109.85 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -38.39 -43.05 0.78 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.818 2.847 . . . . 5.33 112.519 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -74.43 -26.45 60.07 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.616 1.967 . . . . 3.93 113.384 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -83.2 -41.56 18.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.9 -1.125 . . . . 3.68 111.038 172.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.64 -36.43 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.778 1.631 . . . . 2.3 110.927 172.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -56.36 -64.58 0.82 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 116.998 -1.477 . . . . 3.77 108.914 159.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -44.15 -44.12 7.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.359 1.436 . . . . 3.39 113.724 -173.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.7 -37.41 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 114.309 1.226 . . . . 3.15 114.309 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.48 -18.23 58.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.811 1.187 . . . . 2.15 112.815 175.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -80.1 -48.49 13.15 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 129.844 3.258 . . . . 3.9 110.889 172.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.81 0.35 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.166 0.987 . . . . 2.31 110.94 176.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.45 89.15 7.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.315 -1.735 . . . . 3.31 106.315 177.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.98 58.29 1.16 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 115.778 1.77 . . . . 7.28 115.778 -154.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.68 161.59 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.044 2.138 . . . . 4.15 114.149 -173.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -110.44 153.09 25.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.427 1.891 . . . . 5.57 112.476 172.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -158.73 155.91 28.88 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.063 2.145 . . . . 2.97 110.55 175.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.7 t -113.9 88.8 14.93 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.306 1.442 . . . . 2.98 112.992 -174.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.89 127.07 8.39 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.372 2.714 . . . . 2.53 111.52 176.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -126.65 76.18 0.4 Allowed Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.348 -1.251 . . . . 2.63 111.767 173.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.72 150.8 24.48 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.292 2.661 . . . . 6.87 112.799 -172.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 67.2 45.68 1.63 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.995 2.118 . . . . 5.84 113.611 175.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -112.29 150.46 30.94 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.508 1.523 . . . . 7.37 111.077 170.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 57.11 -68.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.812 2.845 . . . . 10.69 110.505 -157.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -157.03 -77.74 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 7.68 109.429 154.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -132.85 38.85 3.36 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.075 1.509 . . . . 7.45 115.075 -162.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -160.46 149.95 17.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.355 1.062 . . . . 6.56 110.39 149.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -176.83 172.58 2.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.885 1.439 . . . . 4.98 114.885 -152.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 32.6 pt -66.01 145.98 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.795 2.438 . . . . 5.03 113.557 -175.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -153.6 45.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 128.223 2.609 . . . . 3.09 107.079 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.78 125.48 32.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.113 -0.949 . . . . 5.84 111.242 -145.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 166' ' ' PHE . 16.3 p80 -106.36 150.23 26.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.687 0.995 . . . . 1.8 113.687 -157.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.6 m -53.87 133.76 42.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.062 0.945 . . . . 3.65 109.574 171.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.93 63.14 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.586 1.184 . . . . 3.08 109.674 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.0 mm -136.07 143.32 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.707 1.603 . . . . 5.07 109.919 -178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.6 ptm -125.19 154.2 41.92 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.84 110.93 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.83 153.31 19.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.223 0.609 . . . . 4.62 111.81 171.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.03 110.33 22.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.622 1.169 . . . . 3.07 108.359 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.83 136.6 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.49 1.516 . . . . 2.39 107.583 173.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.58 -163.51 39.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.304 -0.719 . . . . 1.66 111.304 170.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.29 -160.49 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.026 1.817 . . . . 2.92 108.092 146.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 t0 76.82 -41.08 0.39 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.538 1.935 . . . . 5.43 112.162 174.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 127.89 14.85 2.45 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-O 117.586 -1.675 . . . . 2.62 116.899 165.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -147.05 171.17 15.7 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.251 2.026 . . . . 5.68 112.38 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -81.36 136.86 35.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.117 1.367 . . . . 3.53 112.49 173.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.23 -21.4 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.78 0.832 . . . . 3.25 112.735 177.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.39 173.84 8.48 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.569 1.548 . . . . 3.39 110.976 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -140.67 156.1 46.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.218 . . . . 3.74 112.698 172.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -145.2 162.36 37.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.841 1.256 . . . . 2.82 112.754 -163.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.11 -150.21 22.43 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.763 1.649 . . . . 3.16 111.282 177.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -61.32 117.49 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.286 0.634 . . . . 4.69 111.92 -170.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 114.13 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 132.461 4.305 . . . . 4.89 111.784 177.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -73.75 94.72 2.27 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 120.013 1.279 . . . . 4.64 110.524 169.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -80.07 71.75 6.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.186 1.795 . . . . 6.98 112.14 -165.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 182' ' ' GLN . 11.9 tmtt? 33.36 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 1 C-N-CA 139.489 7.116 . . . . 1.94 117.858 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.1 -32.77 31.06 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 121.297 -0.877 . . . . 1.53 113.879 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -22.92 52.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.068 -0.967 . . . . 3.77 111.673 167.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 10.6 mt -55.01 -52.11 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.915 1.689 . . . . 1.67 110.426 164.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.43 75.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.055 0.542 . . . . 1.39 112.27 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.1 -31.27 68.76 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.765 1.024 . . . . 1.7 113.765 174.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 46.9 m -70.39 -47.07 62.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.651 1.18 . . . . 2.29 109.891 177.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.25 -32.55 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 121.073 -1.017 . . . . 2.7 111.56 173.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.25 -27.72 68.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.59 -1.319 . . . . 1.56 113.176 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.6 m -70.26 -37.07 74.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.685 0.794 . . . . 1.68 110.953 175.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -78.77 -19.87 51.22 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.763 1.023 . . . . 2.6 113.763 171.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 38.2 mmt -70.8 -23.05 62.3 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.486 -1.384 . . . . 4.94 112.383 162.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -56.88 -47.03 99.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-O 117.22 -1.372 . . . . 5.04 112.589 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.74 -57.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.919 2.413 . . . . 3.07 111.747 166.023 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -101.91 54.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.288 1.035 . . . . 4.45 112.765 -167.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -58.33 103.23 0.14 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.74 1.216 . . . . 8.47 111.904 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 tttp 55.93 -89.65 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.1 1.36 . . . . 7.13 112.622 -177.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 -15.26 14.51 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.812 1.645 . . . . 9.07 115.001 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.487 1.419 1 C-N-CA 133.3 4.64 . . . . 9.79 110.445 -167.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 118.416 -0.802 . . . . 14.92 110.234 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -150.12 -155.44 0.63 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.597 1.559 . . . . 14.59 108.227 173.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -66.27 151.05 47.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.922 1.237 . . . . 11.09 111.173 172.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.59 -158.13 29.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.662 -0.975 . . . . 8.61 110.662 159.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -55.48 117.8 16.47 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.053 0.941 . . . . 10.46 110.558 169.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.04 172.48 15.86 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.644 2.229 . . . . 6.55 110.29 170.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' A' ' 135' ' ' LEU . 1.7 pt? -74.78 -163.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.409 1.484 . . . . 7.23 113.392 174.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -178.96 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.287 1.435 . . . . 8.2 112.987 174.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.75 -13.09 30.76 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.116 1.207 . . . . 4.37 116.116 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.54 129.77 1.19 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.327 1.918 . . . . 3.22 111.326 173.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.24 159.3 40.65 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.572 2.181 . . . . 3.07 109.722 170.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -132.73 -178.97 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 2.49 114.186 -173.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 m -161.22 62.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.228 1.411 . . . . 2.9 112.82 176.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.88 157.99 17.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.536 1.134 . . . . 1.92 110.738 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.6 m -97.24 142.22 29.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.454 0.701 . . . . 1.69 110.723 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.8 p -95.1 164.13 13.0 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.236 1.414 . . . . 1.64 113.995 -176.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -63.35 -2.06 1.34 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.281 1.432 . . . . 2.33 114.093 158.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -27.95 29.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.131 1.372 . . . . 2.21 110.525 166.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.56 19.26 11.44 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.931 1.729 . . . . 2.3 114.311 176.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.97 159.26 42.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.976 1.31 . . . . 4.58 109.793 -168.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -99.37 106.55 18.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.993 1.317 . . . . 4.89 111.749 -167.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.48 157.96 16.68 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.246 -0.909 . . . . 4.11 113.22 -176.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.1 p -125.02 163.27 22.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 2.02 111.133 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -55.85 -35.63 66.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.637 0.775 . . . . 3.99 111.539 165.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -76.66 -17.54 59.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 116.419 -1.753 . . . . 5.7 115.185 176.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.31 -44.93 34.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.494 1.043 . . . . 2.57 108.926 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.6 -11.18 59.88 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.637 1.347 . . . . 2.46 114.637 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.435 HD11 ' H ' ' A' ' 270' ' ' ASP . 55.4 tp -66.99 95.86 0.4 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.731 1.15 . . . . 2.91 111.925 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 178.33 -20.03 0.04 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.401 1.477 . . . . 1.65 114.699 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -153.06 166.04 33.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.734 1.614 . . . . 2.96 109.657 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -64.33 127.77 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.568 0.951 . . . . 1.8 113.568 -168.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.6 mt -113.09 126.25 55.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.814 1.246 . . . . 2.15 110.332 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.73 109.69 17.47 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.937 -1.505 . . . . 3.32 106.937 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.32 108.31 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.25 1.82 . . . . 1.52 109.094 -169.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -110.09 149.79 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.688 1.195 . . . . 3.63 111.811 -175.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -116.61 111.22 19.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.209 1.003 . . . . 2.49 112.787 -175.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.84 145.26 17.25 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.845 1.212 . . . . 1.79 113.626 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -84.58 0.07 51.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.961 1.467 . . . . 4.28 114.961 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.86 -63.94 0.34 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 127.097 2.159 . . . . 3.89 112.625 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -53.9 -31.61 50.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.136 2.174 . . . . 4.99 112.16 -173.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.2 p -112.73 97.0 39.6 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.353 1.061 . . . . 2.13 111.007 -171.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.92 107.05 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.3 2.667 . . . . 4.98 108.721 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -164.15 -97.45 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.85 2.06 . . . . 4.32 107.483 -176.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 t -43.94 -38.62 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.012 1.325 . . . . 2.76 113.428 163.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.541 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 60.3 m -58.51 -60.89 8.84 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-O 117.479 -1.248 . . . . 1.6 113.287 -178.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -20.23 67.13 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.163 2.576 . . . . 1.71 114.791 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.25 -74.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.66 2.027 . . . . 4.01 111.067 169.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.76 -24.18 67.66 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.456 1.025 . . . . 3.23 112.361 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.72 -50.14 72.28 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.289 -1.507 . . . . 2.38 111.111 167.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.33 -38.81 92.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.463 1.483 . . . . 3.96 110.631 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.442 ' N ' ' HZ3' ' A' ' 179' ' ' LYS . 1.6 mmpm? -56.05 -45.61 79.19 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.927 -1.108 . . . . 4.33 112.636 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.8 -36.96 59.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.099 0.863 . . . . 3.41 113.322 177.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.81 -57.1 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 120.115 1.325 . . . . 1.72 110.458 -176.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.71 -13.23 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.964 1.468 . . . . 3.11 114.964 178.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.41 -37.37 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.713 1.605 . . . . 1.88 112.615 178.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.37 -29.25 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.101 1.319 . . . . 2.6 110.469 174.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -80.47 -26.57 38.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.804 0.842 . . . . 3.5 113.02 171.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.32 -26.5 63.8 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.081 -1.012 . . . . 2.54 111.814 168.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.21 -50.27 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.163 1.785 . . . . 2.09 110.951 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.28 -45.81 89.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.937 1.695 . . . . 3.44 111.882 -178.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.0 t -70.19 -7.32 40.92 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.042 0.937 . . . . 2.26 113.308 176.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.3 mt -97.32 -34.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 117.974 -1.012 . . . . 2.55 111.455 169.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.9 m 67.42 -23.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 128.62 2.768 . . . . 3.09 114.607 166.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 27.8 m -69.61 -36.77 76.49 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.943 2.497 . . . . 2.85 109.823 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -66.44 155.88 87.21 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.035 0.934 . . . . 2.51 111.255 169.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 294' ' ' MET . 66.4 Cg_endo -71.7 147.23 50.42 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.265 3.31 . . . . 2.36 110.811 170.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.1 126.24 30.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.225 1.81 . . . . 4.23 111.427 -165.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.5 tt -97.22 125.45 41.77 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.292 -0.88 . . . . 2.58 110.152 -169.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 98.0 m -103.23 106.53 51.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 125.325 1.45 . . . . 1.09 110.626 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.01 136.31 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.576 2.184 . . . . 0.95 113.113 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.86 105.06 13.41 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.356 1.863 . . . . 2.55 109.804 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -76.53 106.71 8.33 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.321 -1.363 . . . . 2.86 107.321 157.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.9 mt -91.26 121.59 41.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.309 -0.997 . . . . 1.35 108.309 169.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 102.0 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.076 -1.42 . . . . 2.45 109.232 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.9 pt -78.41 60.79 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 122.617 1.199 . . . . 2.3 110.808 171.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -145.57 71.35 14.07 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.235 1.414 . . . . 3.74 110.002 -163.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -89.66 68.26 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.047 2.498 . . . . 4.19 112.038 -167.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . 0.286 0.3 OUTLIER -105.78 -73.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.416 -1.278 . . . . 6.95 109.196 155.568 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.262 15.0 mmm-85 140.88 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 1 C-N-CA 131.988 4.115 . . . . 15.38 113.319 156.125 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.8 158.27 3.77 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.861 2.065 . . . . 4.94 112.951 168.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.5 m -77.37 144.53 37.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.951 1.7 . . . . 4.15 110.443 -173.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -52.59 12.55 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.515 1.126 . . . . 6.25 112.248 176.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -63.48 -37.31 86.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.866 1.666 . . . . 5.55 113.45 176.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.78 -43.45 62.79 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.118 -0.989 . . . . 2.09 112.291 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.27 -40.64 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.331 0.652 . . . . 3.1 109.902 167.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.12 75.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.497 -1.239 . . . . 1.74 112.465 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.14 -48.21 81.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.425 1.466 . . . . 4.49 112.0 173.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -59.18 -44.75 92.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.896 0.879 . . . . 4.17 111.149 175.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.92 -53.16 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.474 0.709 . . . . 1.54 111.325 177.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -25.0 64.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 3.99 114.913 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.14 -19.57 64.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.425 1.011 . . . . 3.38 113.25 175.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.54 -42.14 5.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.731 0.812 . . . . 2.94 111.604 167.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.5 m 174.42 142.76 0.19 Allowed Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.591 1.956 . . . . 2.87 112.514 164.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -66.25 -8.73 21.3 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.754 2.303 . . . . 3.25 112.258 168.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -66.3 -21.55 66.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.923 1.689 . . . . 2.8 113.053 168.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.03 164.32 25.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.517 1.053 . . . . 2.64 111.976 176.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.96 138.19 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.616 -0.72 . . . . 2.68 110.269 155.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.81 139.16 14.28 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 109.9 -1.28 . . . . 0.95 109.9 170.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 23.9 mt -140.53 104.87 4.84 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.551 1.141 . . . . 2.29 113.4 -169.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.7 p -99.9 145.45 27.78 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.264 1.826 . . . . 2.31 110.586 171.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.31 178.63 17.15 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.526 1.06 . . . . 2.26 111.444 160.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -83.27 179.91 7.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.26 -1.385 . . . . 2.69 107.26 148.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -53.37 -24.29 11.86 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.197 1.399 . . . . 6.98 112.307 -177.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -64.37 -62.66 1.46 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.763 2.025 . . . . 3.09 111.028 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -74.34 -25.67 59.68 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.027 -1.046 . . . . 3.68 112.224 178.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -34.33 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 117.715 -1.136 . . . . 1.71 111.914 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.06 -62.45 1.81 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.073 1.306 . . . . 2.93 108.257 162.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -36.06 -59.78 0.59 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.271 1.429 . . . . 2.66 113.723 -178.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.09 -42.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.111 1.152 . . . . 2.69 114.111 -172.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.02 -20.1 61.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.07 0.85 . . . . 2.67 113.047 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -84.55 -49.2 8.81 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 128.432 2.693 . . . . 3.78 111.974 171.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.98 83.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.961 0.8 . . . . 2.0 111.961 178.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -111.06 70.66 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.584 -1.265 . . . . 3.22 107.584 175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -49.66 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.275 1.83 . . . . 5.78 114.124 -158.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.38 151.73 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.791 1.236 . . . . 3.27 111.557 -174.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -109.13 155.14 21.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.218 1.407 . . . . 8.72 113.023 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -169.36 153.97 5.55 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.651 1.98 . . . . 3.74 109.976 -165.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.9 m -112.17 93.78 23.34 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.335 1.054 . . . . 3.41 110.994 -171.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.21 131.22 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.608 2.205 . . . . 2.98 112.038 -176.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.54 -169.55 25.61 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.448 1.499 . . . . 3.08 112.888 173.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -85.33 168.5 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.897 3.064 . . . . 4.16 111.666 -179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -98.81 86.42 3.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.189 0.996 . . . . 6.48 109.081 166.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -147.95 -5.14 0.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.477 1.511 . . . . 5.35 112.612 -160.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -99.8 80.19 2.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 11.2 109.563 -171.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.5 t70 73.23 -25.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 129.231 3.013 . . . . 7.89 113.451 -178.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 163.15 -17.49 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 1 C-N-CA 132.52 4.328 . . . . 7.87 110.943 178.281 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -86.48 177.02 7.54 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.593 1.557 . . . . 6.09 113.113 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.65 164.19 28.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.312 1.845 . . . . 6.48 112.779 -177.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.7 pt -125.43 141.45 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.516 -0.74 . . . . 4.12 111.559 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 54.5 t -139.59 108.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.785 -1.561 . . . . 3.33 106.785 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.4 149.56 45.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.76 0.824 . . . . 3.29 110.785 175.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.541 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 25.7 p80 -145.12 133.03 21.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.206 1.002 . . . . 1.73 112.561 -164.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.7 t -79.84 161.52 25.58 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.295 1.22 . . . . 4.02 114.295 -170.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.76 68.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.102 2.161 . . . . 3.84 111.548 176.557 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.43 143.42 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.119 1.367 . . . . 2.52 111.132 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.6 ttp -143.34 122.69 13.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.041 1.336 . . . . 2.6 111.892 -176.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.29 144.09 28.31 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.726 -1.234 . . . . 3.75 113.233 -176.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.24 117.64 33.09 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.645 1.178 . . . . 2.31 110.698 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.53 138.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.696 1.598 . . . . 1.91 107.153 172.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.28 173.0 21.85 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.706 0.669 . . . . 1.5 113.907 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 97.2 0.75 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.991 1.794 . . . . 3.12 109.117 158.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 156' ' ' LEU . 15.9 t70 -176.7 -79.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.103 -2.317 . . . . 5.92 110.364 -153.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 152.73 -24.79 0.83 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.558 1.075 . . . . 3.42 114.432 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.08 -164.4 2.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.565 1.183 . . . . 4.82 113.324 -177.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -92.5 146.75 23.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.023 -1.048 . . . . 5.2 112.351 -169.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.5 mt -131.24 -17.92 2.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.848 1.259 . . . . 4.06 114.145 -169.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -161.64 165.59 28.05 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.142 2.177 . . . . 2.27 109.366 -177.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -140.8 122.12 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 122.558 1.171 . . . . 3.24 111.434 158.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -83.19 178.27 8.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.096 1.358 . . . . 2.68 110.441 175.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.2 163.3 9.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 124.058 0.837 . . . . 2.61 112.719 -178.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.464 ' CD ' ' H ' ' A' ' 280' ' ' ASN . 0.2 OUTLIER 70.0 165.03 0.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.22 1.808 . . . . 6.15 110.253 -165.015 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 279' ' ' GLN . 28.1 t-20 -55.09 -17.86 4.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.06 1.744 . . . . 7.83 114.764 -175.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 38.7 mttm 43.82 -108.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.668 1.587 . . . . 4.45 112.224 174.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 163.52 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.565 3.546 . . . . 5.1 109.725 175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -42.93 -60.07 1.75 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.623 1.969 . . . . 2.64 112.487 -176.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.72 -12.36 83.88 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.765 -1.019 . . . . 1.72 115.175 -178.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -49.24 24.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.949 1.375 . . . . 4.96 110.306 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.25 -45.72 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.271 0.628 . . . . 1.68 110.639 -178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.31 -44.79 95.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.148 0.979 . . . . 1.1 113.074 174.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.84 71.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.988 0.915 . . . . 1.39 113.262 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 58.5 m -61.12 -50.17 74.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.016 1.326 . . . . 1.9 110.17 172.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.86 -39.32 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 120.667 -1.271 . . . . 2.42 111.131 173.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.11 -15.17 62.1 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.924 -1.11 . . . . 1.4 113.538 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 99.8 m -73.8 -55.79 5.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.066 0.848 . . . . 1.88 109.278 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -60.7 -26.06 66.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.63 1.172 . . . . 2.33 113.459 177.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 194' ' ' PRO . 17.2 tpp -60.29 -21.83 62.42 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 114.247 1.203 . . . . 5.03 114.247 172.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -79.6 -46.59 1.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 117.139 -1.41 . . . . 4.57 113.123 -178.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.09 -46.97 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.637 2.225 . . . . 2.06 113.261 172.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.11 35.56 2.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.755 1.222 . . . . 3.09 111.594 -170.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -58.66 145.88 38.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.71 1.204 . . . . 8.27 112.81 -172.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.99 72.24 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.764 1.394 . . . . 7.1 114.764 -173.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -179.57 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 128.459 2.704 . . . . 11.58 111.232 148.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p . . . . . 0 C--O 1.257 1.452 0 CA-C-O 115.896 -2.002 . . . . 7.21 110.254 130.539 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 117.976 -1.011 . . . . 17.3 109.844 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -67.17 142.9 56.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.767 0.712 . . . . 18.22 110.666 172.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.6 t 152.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 1 C-N-CA 131.842 4.057 . . . . 12.17 107.509 -177.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.19 145.15 4.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.256 1.408 . . . . 9.81 113.487 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -175.24 141.5 0.66 Allowed Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.318 1.847 . . . . 10.74 111.012 177.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.8 161.03 30.69 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.89 2.393 . . . . 6.93 110.243 167.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.57 139.31 4.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.679 1.992 . . . . 7.36 109.605 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tp -169.75 -162.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.36 1.864 . . . . 5.87 109.766 -174.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.52 170.81 37.59 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.307 1.432 . . . . 3.19 113.2 -175.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.77 93.79 0.75 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.756 -1.58 . . . . 3.44 111.13 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.65 68.32 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.52 2.813 . . . . 3.49 112.628 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 142' ' ' LEU . 4.7 p90 -103.22 169.62 8.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.963 1.705 . . . . 2.78 112.698 -176.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.7 p -140.32 31.38 1.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.151 0.98 . . . . 3.22 113.249 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.446 HD23 ' CD1' ' A' ' 140' ' ' PHE . 4.5 mm? -52.26 137.86 27.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.743 1.617 . . . . 3.55 111.662 -172.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -88.82 143.83 26.63 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.001 -0.741 . . . . 1.86 109.001 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -95.15 155.0 16.92 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.074 1.35 . . . . 1.71 112.092 -174.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -12.83 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.707 2.003 . . . . 2.07 114.856 162.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.7 m -99.07 -15.78 18.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.184 2.194 . . . . 2.36 111.768 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.79 61.13 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.725 1.631 . . . . 2.2 114.898 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.59 178.7 7.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.814 1.307 . . . . 5.64 110.855 164.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.72 147.11 50.74 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.387 -0.821 . . . . 5.22 111.464 171.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -121.06 168.11 11.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.302 1.041 . . . . 3.27 113.124 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -135.93 160.67 37.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.707 2.003 . . . . 2.04 109.978 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -51.6 -41.66 61.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.726 1.61 . . . . 3.76 112.266 173.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -61.6 -30.88 70.97 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.391 1.076 . . . . 6.5 113.384 176.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.55 -24.32 63.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.056 0.942 . . . . 2.84 112.095 -166.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -94.1 -13.17 27.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.869 1.268 . . . . 2.42 113.361 -178.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.11 131.49 51.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.546 1.539 . . . . 3.32 110.613 -178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 269' ' ' PRO . . . 90.07 -5.43 83.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.87 0.748 . . . . 2.01 113.666 -172.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.3 156.02 33.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.254 2.222 . . . . 3.18 107.285 165.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -83.27 141.83 31.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.025 -1.047 . . . . 1.74 111.332 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.92 139.88 41.89 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.735 -1.228 . . . . 4.04 111.774 -175.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.8 113.47 25.58 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.803 1.241 . . . . 2.58 108.076 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.07 128.06 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.917 1.235 . . . . 3.35 111.124 177.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.62 138.03 54.62 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.773 1.229 . . . . 3.93 112.64 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -94.47 104.75 16.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.493 0.717 . . . . 1.89 109.969 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -127.15 171.45 18.72 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.681 1.134 . . . . 1.68 115.115 -166.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.0 t80 179.88 146.67 0.23 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 128.376 2.67 . . . . 5.52 110.643 167.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 t -88.11 21.29 2.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.887 2.075 . . . . 5.11 114.158 -175.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -28.11 38.27 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.577 -1.327 . . . . 8.78 110.448 157.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.6 p -152.74 93.87 3.21 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.063 -2.569 . . . . 2.7 104.063 -160.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -86.56 17.69 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 125.089 3.859 . . . . 5.33 110.758 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -99.63 -58.71 1.86 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.395 1.878 . . . . 3.7 110.624 172.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.07 2.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 3.12 113.041 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.63 -68.94 0.22 Allowed Pre-proline 0 CA--C 1.573 1.86 0 C-N-CA 123.455 0.702 . . . . 1.98 110.117 157.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.98 -23.78 24.85 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.17 2.58 . . . . 2.3 115.437 -176.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 12.79 0.19 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 122.968 2.622 . . . . 3.31 112.541 178.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -135.9 -33.24 0.85 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 119.539 -1.976 . . . . 4.57 113.121 143.795 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.4 -24.79 61.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.6 1.091 . . . . 2.83 112.883 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.401 ' CD ' HE21 ' A' ' 182' ' ' GLN . 0.7 OUTLIER -62.75 -67.22 0.44 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.032 1.287 . . . . 3.72 109.211 167.581 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -58.16 -28.21 64.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.71 1.604 . . . . 3.54 113.934 -176.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.461 ' O ' HG22 ' A' ' 183' ' ' VAL . 69.2 mmm -73.66 -44.31 57.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.472 1.909 . . . . 4.63 112.142 168.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 181' ' ' ILE . 1.3 mm -64.19 -35.62 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 120.406 1.457 . . . . 1.88 109.893 -174.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.401 HE21 ' CD ' ' A' ' 178' ' ' GLU . 75.0 mt-30 -51.83 -27.08 11.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 116.966 -1.492 . . . . 2.25 114.075 172.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 180' ' ' MET . 23.1 m -87.59 -18.65 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 121.412 1.914 . . . . 2.5 113.518 173.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.34 -50.6 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.789 1.177 . . . . 2.0 109.255 -175.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.39 -28.12 65.9 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.574 0.75 . . . . 4.36 111.405 175.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.34 -52.15 24.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.028 0.931 . . . . 2.55 112.757 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 tt -69.33 -31.89 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.09 -1.006 . . . . 2.13 112.063 -174.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.2 -51.92 67.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.937 1.695 . . . . 2.95 111.252 166.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 35.3 t -64.9 -16.73 63.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.42 0.896 . . . . 2.47 113.42 176.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 74.6 mt -83.93 -37.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 118.281 -0.866 . . . . 2.62 111.023 168.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.3 m 71.36 -34.95 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 129.34 3.056 . . . . 3.09 114.08 166.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.5 m -69.59 -27.95 65.54 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 130.18 3.392 . . . . 3.03 111.124 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.73 172.04 8.2 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.894 1.678 . . . . 3.48 111.08 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 122.9 9.45 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.097 1.865 . . . . 3.88 111.256 -176.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -82.62 140.13 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.595 0.559 . . . . 4.15 111.939 176.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.36 132.49 28.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.567 1.547 . . . . 2.82 114.571 -172.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 86.4 m -91.36 122.9 65.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.161 -0.923 . . . . 1.49 110.882 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.33 135.71 10.87 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.895 2.397 . . . . 0.99 113.037 168.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.27 104.28 8.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.696 2.398 . . . . 3.26 109.168 -170.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -82.17 110.52 17.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.582 -1.266 . . . . 2.37 107.582 169.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 tt -100.7 124.15 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.099 -0.704 . . . . 2.28 109.099 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -91.17 141.23 29.03 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.093 0.473 . . . . 2.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 pt -106.73 13.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.828 1.251 . . . . 2.17 112.624 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -124.98 65.29 46.72 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 126.279 1.831 . . . . 3.59 111.067 -172.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.61 71.05 3.18 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.095 2.53 . . . . 2.18 113.582 -157.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -155.3 -92.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.89 1.276 . . . . 7.41 109.22 174.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.61 65.87 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.074 1.139 . . . . 6.98 114.074 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.68 62.3 5.45 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.539 1.536 . . . . 5.46 110.417 167.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.9 t -71.05 161.36 31.27 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.74 1.216 . . . . 2.85 111.183 178.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -29.09 54.29 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.274 0.842 . . . . 3.97 113.274 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -63.81 -52.02 62.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.659 1.184 . . . . 2.87 111.9 171.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.05 93.45 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.823 0.849 . . . . 1.68 111.598 -178.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 82.8 mt -59.54 -40.57 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.718 0.807 . . . . 1.74 111.022 170.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.24 -18.59 64.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.846 -1.159 . . . . 1.89 113.539 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.83 -62.66 1.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.843 1.201 . . . . 3.46 109.867 164.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -61.98 -36.91 82.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.254 1.021 . . . . 3.22 112.974 -169.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.95 -34.09 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.315 1.046 . . . . 1.45 112.942 178.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.97 -32.71 73.32 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.369 0.877 . . . . 5.14 113.369 178.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.21 -16.78 63.69 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.215 1.006 . . . . 4.63 112.535 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -84.3 -62.26 1.6 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.079 0.77 . . . . 2.8 113.079 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.6 t -175.94 150.82 1.13 Allowed Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.701 1.2 . . . . 1.82 110.784 -168.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.23 -24.27 51.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.671 2.247 . . . . 2.68 112.995 174.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -82.29 -3.55 55.49 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.409 1.004 . . . . 2.43 113.452 178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.24 142.75 29.18 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.008 1.277 . . . . 2.1 112.653 -176.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.86 135.76 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.536 1.534 . . . . 1.68 108.975 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.1 136.04 12.06 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 124.317 0.961 . . . . 1.21 114.097 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.72 139.63 49.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.096 1.758 . . . . 2.7 113.521 -171.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.4 t -154.28 166.46 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.428 2.291 . . . . 2.74 109.842 175.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -153.54 -90.28 0.08 OUTLIER Glycine 0 N--CA 1.474 1.171 0 O-C-N 120.865 -1.147 . . . . 2.95 114.955 171.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -167.54 164.8 14.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.616 2.767 . . . . 3.2 108.097 -173.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.456 HH21 ' CG ' ' A' ' 253' ' ' ASP . 5.5 mtt-85 -41.39 -49.03 3.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.977 1.711 . . . . 7.01 110.573 172.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 3.6 mp0 -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.335 2.254 . . . . 4.53 113.738 -176.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.94 -45.47 6.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.76 1.624 . . . . 3.28 110.932 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -19.83 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.278 1.431 . . . . 2.2 113.206 169.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -51.47 -60.34 3.25 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.081 -1.012 . . . . 3.78 110.911 161.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -57.4 -42.52 82.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.272 1.029 . . . . 3.33 111.621 -175.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.85 -50.23 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.198 1.799 . . . . 3.61 112.241 175.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -76.07 -53.48 8.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.436 1.094 . . . . 2.25 111.985 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -54.19 -29.07 44.58 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.365 2.666 . . . . 5.36 114.697 -175.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.53 -66.41 0.61 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.918 0.781 . . . . 2.41 111.513 171.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -92.01 12.56 21.45 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 121.067 -1.02 . . . . 3.78 112.639 -167.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 61.55 -58.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.337 3.055 . . . . 6.46 113.813 -161.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.12 174.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.41 1.884 . . . . 3.02 111.181 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -153.15 154.59 35.08 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.942 -1.099 . . . . 5.48 111.606 166.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -173.88 -178.55 1.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.925 2.49 . . . . 3.21 109.931 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m -157.2 140.42 11.07 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 120.904 -1.122 . . . . 2.93 111.522 166.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.94 176.05 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.926 2.417 . . . . 3.08 111.809 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.99 171.01 54.66 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 115.178 -0.919 . . . . 2.7 112.225 171.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.89 18.84 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.514 3.476 . . . . 4.39 113.823 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 61.15 5.96 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.919 1.688 . . . . 5.84 112.084 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -36.66 115.14 0.35 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.941 2.096 . . . . 9.62 112.003 164.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 179.15 -55.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.395 2.278 . . . . 11.98 109.241 -164.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.456 ' CG ' HH21 ' A' ' 231' ' ' ARG . 27.4 t70 -172.16 48.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.15 1.78 . . . . 17.2 112.176 175.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.93 -8.75 0.22 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.353 1.861 . . . . 16.21 115.436 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 17.3 t70 -82.09 -171.46 3.41 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.249 1.82 . . . . 9.35 114.916 -169.161 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.464 ' H ' ' CG ' ' A' ' 255' ' ' ASP . 73.6 m-85 83.35 138.39 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.305 3.842 . . . . 7.54 112.512 178.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.5 mt 77.47 -67.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 126.769 2.028 . . . . 4.62 112.165 167.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.301 29.2 m 43.1 81.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.261 2.224 . . . . 3.44 115.027 -173.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -64.17 109.73 1.95 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.489 1.916 . . . . 5.0 111.509 173.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -94.18 124.04 37.95 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -167.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.8 t -64.17 18.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 119.124 3.009 . . . . 3.29 119.124 -165.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.299 24.3 pt 54.27 33.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 118.117 2.636 . . . . 3.39 118.117 164.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.52 134.5 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.766 1.226 . . . . 3.53 112.556 173.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 52.5 tpp -103.62 129.18 50.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.022 2.529 . . . . 3.8 110.683 168.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -110.09 139.92 44.7 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.645 0.736 . . . . 3.6 112.797 170.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 122.87 43.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.149 1.38 . . . . 2.93 108.701 170.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.8 mt -107.0 131.64 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.151 0.981 . . . . 2.27 109.041 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.09 -171.28 35.32 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.509 1.052 . . . . 1.51 113.171 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.411 ' HA ' ' H ' ' A' ' 157' ' ' GLY . 57.6 Cg_endo -61.21 -27.34 83.53 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.136 1.891 . . . . 3.07 112.391 169.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.3 -11.86 1.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 131.09 3.756 . . . . 6.43 116.07 175.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.87 -60.7 2.02 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.095 -1.392 . . . . 3.01 115.365 168.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.16 -51.43 7.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.281 1.541 . . . . 6.08 114.3 -169.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -170.31 176.99 4.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.57 1.948 . . . . 4.09 110.745 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.2 tt -146.13 -38.83 0.23 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.749 1.22 . . . . 3.46 112.758 -178.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -152.71 173.81 14.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.971 1.309 . . . . 3.96 111.117 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.0 152.67 23.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.112 1.523 . . . . 3.95 115.112 174.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.26 138.26 44.91 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.546 1.138 . . . . 2.68 111.303 179.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.27 140.82 15.27 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.113 -1.595 . . . . 2.45 109.113 163.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 176' ' ' GLU . 1.7 tm0? -38.02 -42.05 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.131 2.572 . . . . 5.74 116.654 -169.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.95 3.9 1.79 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.491 1.116 . . . . 6.72 114.002 -175.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.47 159.87 5.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.639 -1.288 . . . . 4.73 113.236 169.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -122.99 144.17 49.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.359 2.264 . . . . 5.82 108.906 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -35.03 -58.24 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.321 2.248 . . . . 2.42 113.715 -171.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.44 -20.0 73.18 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.598 -1.112 . . . . 1.63 114.536 -169.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.71 -41.23 88.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.713 1.256 . . . . 3.81 111.21 172.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.69 -46.1 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.984 0.914 . . . . 1.98 109.543 -174.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.52 80.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.586 1.155 . . . . 1.53 111.897 171.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.18 79.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.296 0.85 . . . . 1.53 113.296 177.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -67.41 -51.45 51.63 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.619 0.645 . . . . 2.29 110.426 176.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.07 -31.3 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.653 -1.279 . . . . 3.21 113.176 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.24 51.03 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.723 -1.236 . . . . 2.33 113.967 170.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.2 m -91.14 -50.41 5.86 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.772 1.229 . . . . 1.98 109.657 168.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -61.41 -26.9 68.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.856 1.263 . . . . 2.26 113.521 174.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 56.7 ttp -54.92 -27.97 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.238 -1.539 . . . . 5.02 113.238 168.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -71.0 -49.49 12.9 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.311 -1.804 . . . . 5.25 112.293 -175.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.62 -53.78 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.777 2.318 . . . . 2.13 111.229 166.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -83.78 45.61 1.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.771 1.628 . . . . 4.09 112.417 -174.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -52.02 128.64 25.04 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.425 1.49 . . . . 9.9 109.923 -177.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 132.94 53.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.267 1.21 . . . . 7.18 114.267 -156.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 26.37 1.08 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 115.411 1.634 . . . . 13.11 115.411 -163.218 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 128.785 2.834 . . . . 11.45 110.768 -155.902 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 118.487 -0.768 . . . . 24.35 110.362 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.13 -179.59 8.15 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.241 1.382 . . . . 20.3 114.115 -171.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m 148.68 128.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 1 C-N-CA 132.32 4.248 . . . . 16.3 108.841 171.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.4 23.49 73.33 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.643 1.116 . . . . 12.22 115.863 170.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 161.11 63.89 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 119.058 1.429 . . . . 11.6 111.21 177.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.22 171.61 15.68 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.435 2.756 . . . . 6.71 110.888 172.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.19 83.24 1.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.628 1.571 . . . . 10.22 108.486 -173.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.8 -29.19 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.547 2.054 . . . . 5.62 116.547 -173.391 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.43 -167.85 31.44 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.858 1.218 . . . . 3.03 111.688 -171.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.89 -74.69 0.24 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.57 1.081 . . . . 4.31 113.636 178.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -95.41 87.52 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.424 2.749 . . . . 3.17 109.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.28 157.55 16.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.035 -0.728 . . . . 2.69 109.035 157.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 233' ' ' GLU . 93.8 p -131.32 66.02 1.55 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 123.046 1.403 . . . . 2.96 111.509 -176.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.8 mt -101.53 148.62 25.0 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.895 -1.048 . . . . 2.63 112.504 -171.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 33.7 m -68.2 131.01 44.63 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.108 1.363 . . . . 2.38 108.346 172.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 150' ' ' LYS . 11.8 p -78.89 137.7 37.78 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.801 -0.814 . . . . 1.54 108.801 163.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -21.9 9.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.506 1.298 . . . . 2.16 114.506 175.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -112.62 24.93 11.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.485 1.914 . . . . 2.66 110.865 -177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 210' ' ' LYS . . . 170.53 -129.84 1.88 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.15 1.833 . . . . 3.32 110.87 -176.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 4.6 mp0 -156.95 -1.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.158 1.54 . . . . 10.12 115.158 -162.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -146.81 128.38 15.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.625 -1.297 . . . . 5.3 114.363 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -152.24 136.67 16.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.44 1.896 . . . . 4.06 110.433 175.698 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -115.61 175.6 5.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.691 1.996 . . . . 2.03 109.634 160.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.4 -48.62 55.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.749 1.22 . . . . 4.24 110.87 -178.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -72.67 -12.29 60.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.304 1.224 . . . . 7.23 114.304 -178.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 150' ' ' LYS . 13.1 m-20 -66.62 -10.91 50.67 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.121 1.369 . . . . 2.71 113.049 165.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -113.68 -8.05 13.28 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.467 1.507 . . . . 2.66 114.069 173.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.1 mt -74.03 167.69 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.755 0.788 . . . . 4.24 112.619 -170.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.53 -14.07 43.19 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 118.494 -1.17 . . . . 1.72 113.652 -164.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.88 167.06 18.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.386 1.474 . . . . 3.78 110.591 165.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -83.96 152.55 24.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.031 1.333 . . . . 1.57 112.824 -172.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.58 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.456 0.91 . . . . 2.37 113.456 171.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.97 116.54 29.01 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 106.958 -1.497 . . . . 2.86 106.958 152.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.2 tt -99.24 128.58 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.491 -0.559 . . . . 2.81 109.491 167.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -131.83 134.75 46.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.551 1.141 . . . . 3.65 111.697 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -93.72 87.08 5.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.489 1.137 . . . . 2.21 110.481 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.7 126.29 3.88 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.152 -1.579 . . . . 2.31 109.152 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -109.08 128.56 55.09 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 117.921 0.861 . . . . 7.41 112.169 -163.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.1 t -57.84 -24.01 55.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.114 2.166 . . . . 4.16 115.573 -166.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -69.25 -24.53 64.0 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.023 1.283 . . . . 6.34 113.642 -178.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 29.5 p -129.16 91.81 41.03 Favored Pre-proline 0 CA--C 1.562 1.416 0 CA-C-N 119.38 0.991 . . . . 2.93 109.863 -171.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.24 119.25 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.431 2.754 . . . . 6.29 106.593 159.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.486 ' H ' ' HD2' ' A' ' 174' ' ' PRO . 7.0 t70 177.71 -107.49 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.291 1.836 . . . . 3.8 106.672 -152.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.28 -32.67 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.423 1.465 . . . . 2.54 112.43 169.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.73 -59.25 6.53 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 116.699 -1.619 . . . . 1.74 114.286 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 171' ' ' ASP . 16.4 Cg_endo -55.04 -29.62 66.04 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.458 2.772 . . . . 1.6 114.121 -179.05 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.0 -52.41 42.96 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.506 1.957 . . . . 2.83 112.038 176.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -60.63 -33.23 72.48 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.628 1.171 . . . . 3.34 112.873 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.42 -56.29 5.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.361 1.464 . . . . 2.9 111.467 178.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 -31.47 69.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.459 1.482 . . . . 4.71 111.584 175.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -59.1 -46.47 88.22 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.992 -1.067 . . . . 6.78 111.794 166.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 74.8 mtm -65.05 -43.88 90.86 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 117.666 -1.159 . . . . 3.8 112.743 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.66 -59.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.264 1.426 . . . . 2.75 110.49 -177.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 182' ' ' GLN . 10.2 pt20 -71.21 -13.23 61.85 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.696 1.598 . . . . 1.93 113.213 -175.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -88.19 -42.41 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.182 1.355 . . . . 1.42 110.652 172.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 81.0 t -69.98 -36.14 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.95 0.5 . . . . 2.27 110.159 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -54.61 -56.76 15.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.596 1.958 . . . . 4.51 111.678 168.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.57 -5.32 1.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.066 2.147 . . . . 2.33 114.303 175.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.0 mt -113.74 -53.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.089 1.755 . . . . 1.61 111.998 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.9 -40.02 75.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.738 1.215 . . . . 2.68 110.521 173.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 t -70.66 -6.27 35.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.39 1.255 . . . . 2.02 114.39 173.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.03 -35.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.055 -1.028 . . . . 3.45 110.939 170.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 m 69.93 -30.07 0.19 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 128.16 2.584 . . . . 3.12 114.173 164.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -70.67 -22.9 62.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.219 2.607 . . . . 3.14 110.581 171.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 54.6 mt -87.03 129.85 50.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.612 -1.255 . . . . 3.26 107.612 165.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.02 160.56 30.18 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.737 2.958 . . . . 2.3 110.366 -176.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -48.7 138.63 10.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.079 1.511 . . . . 3.46 115.079 -164.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.2 tp -116.15 86.7 2.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.456 1.103 . . . . 3.49 109.236 170.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.4 m -78.33 126.4 83.3 Favored Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.603 -0.685 . . . . 1.61 110.837 -176.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.26 139.45 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.636 2.224 . . . . 1.2 112.949 172.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.79 112.71 10.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.079 0.952 . . . . 2.08 112.201 -166.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -96.1 109.79 22.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.244 1.418 . . . . 2.44 110.048 -177.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 27.3 mm -94.83 110.21 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.34 0.656 . . . . 1.82 110.384 177.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.06 103.05 13.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.567 -1.271 . . . . 2.54 107.567 170.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.4 pt -72.34 -3.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.994 -1.066 . . . . 3.11 113.718 176.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.08 95.08 2.08 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.521 1.928 . . . . 4.24 111.454 170.011 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.6 -20.71 23.02 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.686 2.257 . . . . 2.42 111.397 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -60.08 93.09 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.512 1.125 . . . . 5.38 111.628 169.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -169.79 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.952 1.701 . . . . 8.87 114.116 154.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -176.29 179.51 1.22 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.412 1.46 . . . . 7.07 113.044 -156.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.8 m -79.93 148.27 31.31 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.722 2.009 . . . . 4.09 109.338 174.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 147' ' ' GLY 0.25 1.7 pptp? -55.48 -34.63 64.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.919 1.451 . . . . 3.34 114.919 -172.778 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -52.08 -36.23 50.06 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.176 1.79 . . . . 3.99 113.867 170.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.05 -15.32 56.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.473 -1.392 . . . . 2.14 113.42 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 67.4 mt -85.17 -38.06 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.611 1.164 . . . . 2.12 109.909 164.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.96 56.66 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.398 0.679 . . . . 1.58 111.176 172.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -61.05 -27.5 68.39 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.973 1.472 . . . . 4.18 114.973 176.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -72.77 -45.51 58.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.886 1.221 . . . . 3.04 111.019 170.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 224' ' ' LEU . 15.5 t -70.99 -41.06 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.661 1.584 . . . . 2.24 113.678 -173.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.332 1.234 . . . . 2.93 114.332 -169.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.13 -43.01 96.57 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.938 -0.764 . . . . 3.15 108.938 172.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -77.37 30.07 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.334 1.454 . . . . 2.85 112.464 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.6 t 102.74 136.18 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 131.134 3.774 . . . . 1.81 111.658 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -67.86 -15.03 43.14 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.303 2.002 . . . . 2.06 112.378 168.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -78.37 -10.78 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.462 0.705 . . . . 3.08 112.701 168.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 217' ' ' VAL . 1.5 tt -80.12 133.92 36.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.921 1.237 . . . . 2.23 108.84 174.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.3 134.49 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.064 -0.971 . . . . 2.11 110.243 -176.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.99 134.2 12.06 Favored Glycine 0 N--CA 1.465 0.633 0 C-N-CA 124.401 1.0 . . . . 1.18 111.774 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.54 139.99 50.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.414 1.486 . . . . 2.36 112.186 -172.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 82.5 p -141.01 147.16 38.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.672 1.989 . . . . 2.54 109.57 172.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.68 169.24 20.22 Favored Glycine 0 N--CA 1.464 0.539 0 C-N-CA 123.895 0.76 . . . . 3.39 111.938 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.6 t -76.5 174.1 10.71 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.79 -0.818 . . . . 4.21 108.79 161.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 231' ' ' ARG . 63.7 mtt85 -58.88 -25.84 63.72 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.551 1.54 . . . . 6.05 113.993 -171.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.33 -12.83 58.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.357 1.243 . . . . 9.34 114.357 171.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 141' ' ' SER . 64.4 mm-40 -100.76 -31.63 11.09 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.967 1.307 . . . . 5.88 112.178 172.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.26 -45.28 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.759 0.824 . . . . 2.86 110.247 153.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -57.28 -59.41 5.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 117.489 -1.243 . . . . 4.64 111.681 166.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -44.66 -53.86 6.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.752 1.614 . . . . 3.97 113.388 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.55 -27.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.898 1.226 . . . . 2.66 112.654 -176.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.45 -22.75 57.05 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.116 0.784 . . . . 2.68 113.116 170.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -91.56 -37.42 13.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.531 1.932 . . . . 4.42 112.132 -176.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.83 -87.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.832 2.053 . . . . 2.65 111.538 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -83.23 -31.62 26.92 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.196 0.998 . . . . 3.61 113.561 -170.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 89.84 150.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.878 2.871 . . . . 7.68 112.771 168.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.8 146.72 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.717 1.607 . . . . 2.65 110.161 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.46 151.47 40.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.369 1.068 . . . . 5.77 111.006 162.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -157.54 125.86 5.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.262 1.825 . . . . 3.79 109.051 -171.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.8 m -82.92 123.87 77.41 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 120.631 -1.293 . . . . 2.94 111.555 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.33 141.21 14.17 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.953 2.436 . . . . 3.4 111.25 177.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.41 55.98 0.36 Allowed Glycine 0 CA--C 1.537 1.469 0 CA-C-O 117.227 -1.874 . . . . 2.6 116.031 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.22 154.23 74.85 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.06 3.173 . . . . 6.08 113.27 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -160.08 -176.81 5.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.537 1.535 . . . . 5.75 112.451 -167.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 60.49 12.77 3.72 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.611 2.078 . . . . 7.23 116.611 159.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -34.17 0.28 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.286 2.634 . . . . 10.77 114.209 179.048 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.27 4.78 8.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.156 1.782 . . . . 10.43 113.105 170.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 77.39 -35.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.92 3.288 . . . . 11.2 113.636 177.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -30.02 134.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.515 2.326 . . . . 5.57 116.262 -168.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.85 138.79 17.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.563 1.173 . . . . 7.1 111.957 162.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 25.2 pt -70.19 58.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.149 1.78 . . . . 5.38 112.547 175.119 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.8 t -23.44 117.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 129.372 3.069 . . . . 2.59 114.628 -175.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 149.87 17.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.48 1.512 . . . . 3.65 111.84 174.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -146.11 112.12 5.7 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.966 0.728 . . . . 1.59 112.966 -175.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.9 p -60.65 135.93 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.623 0.769 . . . . 3.03 111.023 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 262' ' ' ILE . 0.5 OUTLIER -79.14 54.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.707 1.603 . . . . 3.38 113.084 -170.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.6 mt -110.01 136.72 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.134 1.773 . . . . 2.08 110.55 -174.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 41.1 ttm -141.17 145.02 35.14 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.092 1.357 . . . . 3.8 108.823 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -129.04 161.98 28.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.208 1.403 . . . . 3.89 114.076 -175.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.27 133.16 45.09 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.784 1.634 . . . . 2.08 110.695 172.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.9 141.2 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.267 1.027 . . . . 2.42 109.549 164.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.43 147.71 20.85 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.967 0.794 . . . . 1.48 112.303 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.55 85.95 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.262 1.975 . . . . 3.18 113.489 -173.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . 0.381 3.6 t70 129.33 -0.86 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.962 1 C-N-CA 134.821 5.248 . . . . 6.68 114.72 173.634 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -155.87 145.97 13.28 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.384 0.993 . . . . 3.19 115.284 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.88 128.23 35.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.315 1.446 . . . . 7.02 113.468 -173.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 74.5 t80 74.93 132.78 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.924 2.49 . . . . 3.64 115.885 166.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 51.6 mt -143.98 -37.55 0.32 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.794 1.776 . . . . 2.93 115.794 171.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -155.58 171.2 20.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.749 1.62 . . . . 2.53 111.48 -166.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -136.04 158.9 43.29 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.229 1.566 . . . . 4.93 115.229 176.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -140.63 -145.35 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.322 3.049 . . . . 2.92 109.909 -171.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 100.21 177.67 30.29 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.696 1.617 . . . . 3.03 109.892 -161.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -54.46 -33.11 59.01 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.398 1.259 . . . . 5.01 114.398 -170.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.7 65.03 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.972 -1.08 . . . . 5.55 113.549 -178.133 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -94.5 100.96 12.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.515 -1.366 . . . . 5.38 108.618 160.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -74.9 178.16 5.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.635 1.207 . . . . 5.97 109.121 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -55.71 -44.04 77.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.92 1.082 . . . . 1.61 113.92 -164.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.13 -36.41 71.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.159 0.436 . . . . 1.64 112.619 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.9 -35.81 74.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.874 0.87 . . . . 3.78 111.766 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 40.9 mt -61.07 -55.67 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.834 -0.603 . . . . 1.54 109.851 171.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.32 -49.25 72.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.138 0.575 . . . . 1.09 111.581 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.09 95.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.03 1.122 . . . . 1.37 114.03 176.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 50.1 m -64.46 -50.61 66.82 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.669 0.668 . . . . 1.75 110.75 177.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.6 -37.75 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 118.782 -0.628 . . . . 2.05 109.886 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.99 -33.29 75.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.279 1.399 . . . . 1.48 112.896 175.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -66.7 -50.03 64.16 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.827 1.251 . . . . 1.61 110.467 175.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -70.83 -21.0 62.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.658 1.183 . . . . 2.34 113.885 174.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.7 ttp -81.7 -31.53 32.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.358 -1.464 . . . . 4.18 112.992 173.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.7 -27.81 3.93 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 116.429 2.011 . . . . 6.09 116.429 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.92 -39.03 2.53 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 CA-C-N 123.471 2.276 . . . . 2.23 112.964 163.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.45 -173.48 1.14 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.19 2.293 . . . . 3.4 117.19 -169.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -64.7 -35.0 79.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.687 2.395 . . . . 10.57 116.249 -163.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -147.21 145.65 29.55 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.406 1.883 . . . . 7.83 108.273 -179.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 36.6 pttt 174.15 171.04 0.21 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.603 1.161 . . . . 10.12 112.403 -146.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.249 1.074 0 C-N-CA 129.803 3.241 . . . . 10.32 108.46 173.603 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.192 -0.909 . . . . 19.88 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -161.18 -179.26 7.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.995 1.718 . . . . 19.08 109.157 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.1 t -78.46 160.25 27.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.531 0.732 . . . . 14.91 110.408 170.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.37 165.26 24.9 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.742 0.687 . . . . 11.31 111.419 163.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -121.61 141.35 33.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.513 1.525 . . . . 11.62 108.467 163.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.64 150.81 87.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.024 1.816 . . . . 7.97 110.208 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -77.28 137.1 38.59 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.146 0.498 . . . . 6.16 111.613 178.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -133.33 142.21 48.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.262 1.425 . . . . 6.99 107.891 170.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 161.4 153.23 6.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.041 0.829 . . . . 3.18 112.018 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.74 72.27 0.45 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.651 -1.639 . . . . 2.9 109.443 174.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.05 90.95 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.146 2.564 . . . . 2.4 111.282 -164.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -85.54 171.99 11.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.455 1.102 . . . . 3.0 110.062 163.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 m -140.81 25.31 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 120.307 -1.496 . . . . 2.7 114.701 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -178.92 7.11 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.005 1.722 . . . . 2.86 115.01 -172.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 148' ' ' GLU . 55.1 m -86.44 144.32 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.822 1.249 . . . . 2.12 111.912 -169.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 140.6 29.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.6 1.16 . . . . 2.06 107.882 164.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -53.46 -19.13 3.26 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.538 1.135 . . . . 2.32 113.728 168.156 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.0 t -122.18 15.44 10.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.683 2.393 . . . . 3.62 111.006 -175.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.63 -126.72 1.13 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.781 -0.928 . . . . 2.66 110.781 -177.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 143' ' ' THR . 2.2 tt0 -167.98 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.825 1.046 . . . . 9.97 113.825 -171.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.27 132.0 29.04 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.053 2.141 . . . . 7.02 111.558 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.21 147.91 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.009 1.723 . . . . 3.75 110.233 -170.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -140.98 -179.65 6.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.51 1.524 . . . . 2.22 109.106 178.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -64.51 -49.38 71.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.966 1.306 . . . . 4.5 114.239 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -71.01 -4.12 23.18 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.524 1.676 . . . . 7.6 115.524 -178.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.88 -24.29 63.39 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.65 0.78 . . . . 3.17 112.67 168.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.56 -12.99 13.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.602 1.334 . . . . 2.14 114.602 -176.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.18 122.92 26.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.235 1.014 . . . . 3.69 112.047 -158.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 126.62 -25.02 5.43 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.51 1.052 . . . . 2.09 113.631 -173.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -103.16 176.15 5.24 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.547 -0.908 . . . . 2.99 108.547 150.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -91.84 144.94 24.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.113 0.783 . . . . 2.3 113.113 -164.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.47 137.84 52.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.4 1.08 . . . . 2.66 111.148 -178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.15 120.25 29.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.811 2.044 . . . . 3.01 105.999 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.59 132.86 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.967 0.507 . . . . 1.59 110.809 -167.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -135.17 150.36 50.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.375 1.47 . . . . 4.13 111.767 -176.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CZ ' HG22 ' A' ' 243' ' ' VAL . 70.8 m-85 -102.85 113.36 26.72 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.306 1.051 . . . . 1.81 112.575 -178.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.62 179.61 18.51 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 127.448 2.451 . . . . 2.07 112.824 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.463 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 52.2 t80 -171.33 5.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.519 1.128 . . . . 4.12 111.712 -171.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 37.8 p 30.68 -116.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 116.92 -1.514 . . . . 3.18 110.502 -153.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 47.27 -94.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.966 2.106 . . . . 4.79 110.011 -170.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 6.3 p -67.3 111.19 6.6 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 128.01 2.524 . . . . 2.26 106.854 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -97.05 15.85 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.269 3.312 . . . . 4.58 112.769 -158.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -105.22 -53.93 2.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.698 2.399 . . . . 3.75 111.99 -175.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' A' ' 260' ' ' HIS . 10.6 m -73.63 -15.03 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.648 1.179 . . . . 3.42 113.213 173.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.495 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 20.8 m -72.16 -48.1 10.53 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 117.588 -1.196 . . . . 2.32 113.526 171.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.96 -25.26 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.874 2.382 . . . . 1.65 115.244 176.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -54.39 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 122.013 2.188 . . . . 2.64 114.354 -166.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.38 -46.01 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.396 1.453 . . . . 4.09 111.864 173.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 50.2 tp -54.0 -50.78 65.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.029 1.732 . . . . 2.58 111.439 -172.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.47 -51.67 68.87 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.262 2.225 . . . . 3.9 111.202 -177.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -59.58 -43.66 93.58 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.175 -0.953 . . . . 3.79 110.424 178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 31.2 mtt -69.58 -28.51 66.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.983 1.313 . . . . 4.01 112.587 -177.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 mm -56.94 -53.35 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 120.076 1.307 . . . . 1.73 109.138 170.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.93 -23.79 66.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.877 -0.514 . . . . 2.02 110.582 -166.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.51 -33.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.032 0.933 . . . . 1.56 112.229 173.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 187' ' ' ILE . 33.3 m -81.84 -24.32 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 120.005 1.275 . . . . 2.73 113.081 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -74.53 -32.79 62.58 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.433 -0.792 . . . . 4.23 110.809 170.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.53 -43.65 72.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.207 1.403 . . . . 2.23 112.417 172.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 184' ' ' VAL . 6.7 tt -70.26 -37.53 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.427 1.012 . . . . 2.42 112.191 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.35 -52.96 63.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.141 1.776 . . . . 2.72 110.827 169.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.8 t -62.93 -26.01 68.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.105 1.362 . . . . 2.19 113.076 178.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 64.7 mt -77.65 -35.65 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 120.661 -1.275 . . . . 2.21 111.498 169.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.3 m 67.41 -30.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 129.663 3.185 . . . . 3.11 114.133 171.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.0 m -72.37 -40.39 67.33 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.818 2.847 . . . . 2.4 110.759 -175.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.35 166.04 48.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.672 1.989 . . . . 3.06 111.516 178.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.73 149.05 92.5 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.08 2.52 . . . . 3.54 112.758 -171.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -82.08 135.19 35.35 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.059 1.744 . . . . 3.41 110.78 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.95 109.65 6.01 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.484 0.92 . . . . 2.75 113.484 -158.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 100.0 m -93.48 113.58 60.6 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.016 1.327 . . . . 1.3 111.103 172.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.09 140.38 9.92 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.537 2.158 . . . . 0.95 111.429 166.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.49 94.88 2.79 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.479 -1.237 . . . . 2.23 111.04 -161.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -78.45 123.68 27.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.286 1.434 . . . . 2.27 109.479 -178.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 34.0 mt -107.21 123.1 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.959 -0.756 . . . . 1.36 108.959 178.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.4 t -93.47 141.79 28.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.969 0.414 . . . . 1.9 111.268 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.4 pt -109.82 20.39 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.728 1.211 . . . . 2.28 112.598 164.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.88 125.49 32.01 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.913 0.779 . . . . 4.37 109.775 155.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -120.32 11.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 125.322 4.014 . . . . 2.61 113.02 167.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -106.08 -26.78 11.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.313 1.445 . . . . 5.91 112.003 -164.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 -19.44 1.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.121 1.156 . . . . 6.61 114.121 159.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.38 78.33 7.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.088 0.955 . . . . 5.26 109.818 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.0 p -76.47 172.67 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.555 1.142 . . . . 2.98 112.673 -171.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -43.97 -57.14 3.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.348 1.059 . . . . 3.7 112.682 174.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 1.3 pm0 -76.48 -26.73 55.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.933 1.693 . . . . 3.52 114.222 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.97 -42.95 69.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.058 1.299 . . . . 1.46 112.363 172.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 81.8 mt -57.81 -47.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.32 1.048 . . . . 1.76 109.538 168.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.85 69.28 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.688 -0.672 . . . . 1.13 112.105 175.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -61.15 -54.35 45.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 3.61 111.324 175.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -56.93 -44.16 82.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.862 0.865 . . . . 2.8 111.431 -178.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.75 -46.36 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.275 1.43 . . . . 1.48 112.754 175.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.25 0.1 OUTLIER -69.09 -12.82 62.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.859 1.429 . . . . 3.2 114.859 -177.377 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.56 -19.45 63.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.921 0.782 . . . . 2.75 112.099 172.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.57 -52.98 3.09 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.863 0.69 . . . . 3.06 112.863 -177.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -177.75 140.23 0.42 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.991 1.316 . . . . 1.69 111.75 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.68 -11.19 29.26 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.318 2.679 . . . . 1.56 113.632 177.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -69.08 -18.31 63.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.447 0.906 . . . . 2.82 113.447 168.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.42 131.43 34.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.138 0.881 . . . . 2.31 111.315 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.8 t -113.63 137.11 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.181 0.592 . . . . 1.45 109.888 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.442 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -110.9 147.01 17.67 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.432 1.015 . . . . 0.96 112.781 -171.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 70.6 mt -135.51 148.85 49.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.967 1.707 . . . . 2.65 111.555 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -164.11 153.24 13.76 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.206 1.802 . . . . 3.01 111.293 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.37 178.49 26.86 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.005 0.812 . . . . 2.63 113.472 176.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 166.31 9.49 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 122.705 1.241 . . . . 3.04 108.457 169.357 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.44 -21.15 59.6 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.521 1.128 . . . . 6.46 113.774 -177.25 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -66.52 -35.14 79.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.705 1.602 . . . . 3.79 112.154 167.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -83.54 -36.89 23.68 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.195 1.398 . . . . 3.76 112.203 175.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 90.8 t -52.3 -48.38 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.659 -0.651 . . . . 2.2 110.317 161.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -60.32 -41.23 93.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.034 0.834 . . . . 4.69 111.984 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -59.1 -53.43 58.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.533 1.061 . . . . 2.2 113.094 174.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.67 -34.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.887 1.221 . . . . 3.27 112.083 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.58 68.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.137 0.975 . . . . 2.23 111.643 171.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -59.09 -37.43 77.11 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.558 1.543 . . . . 4.48 112.027 176.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.28 -75.47 0.11 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.574 1.079 . . . . 2.14 113.305 171.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -90.86 -4.81 56.29 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.824 1.787 . . . . 2.52 115.824 -164.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 73.83 52.59 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.626 1.571 . . . . 6.33 111.782 174.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 164' ' ' PHE . 13.5 t -66.43 144.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.307 1.843 . . . . 3.33 109.365 169.006 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -135.83 152.48 51.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.542 1.537 . . . . 5.29 110.251 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -163.54 140.62 7.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.412 1.085 . . . . 3.29 113.085 -172.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.2 m -115.56 106.74 49.99 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.237 1.015 . . . . 2.88 110.273 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.29 130.67 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.079 1.853 . . . . 2.74 112.594 -174.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.58 34.22 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 110.808 -0.917 . . . . 2.45 110.808 163.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.65 163.55 34.67 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.261 1.974 . . . . 3.98 110.965 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.473 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 23.3 ttmt -101.66 109.46 21.25 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.34 -0.615 . . . . 5.92 109.34 162.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.14 49.23 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.654 1.982 . . . . 6.5 108.933 -177.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -172.72 -165.77 0.33 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 130.01 3.324 . . . . 11.02 107.047 -172.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -82.5 63.59 6.73 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.301 1.409 . . . . 9.35 112.804 -165.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 74.02 -42.69 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.336 3.054 . . . . 7.33 116.139 168.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.49 44.7 0.98 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.071 1.878 . . . . 6.75 116.071 -162.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.473 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 2.7 p90 -39.87 132.52 1.74 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.897 1.679 . . . . 4.28 114.877 178.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 45.2 pt -100.38 149.08 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.352 1.061 . . . . 4.02 111.841 -178.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.5 t -135.72 131.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.351 2.261 . . . . 2.81 106.432 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.19 121.13 11.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.827 0.851 . . . . 4.09 109.815 174.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.524 ' CE1' HG23 ' A' ' 172' ' ' VAL . 11.0 p80 -103.01 91.3 4.06 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.469 -0.937 . . . . 2.04 108.469 174.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.24 136.04 53.2 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.028 0.83 . . . . 3.19 112.197 -155.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.96 68.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.961 1.304 . . . . 3.36 111.423 -166.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.45 138.69 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 127.136 2.175 . . . . 2.36 108.994 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.94 149.28 36.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.657 1.583 . . . . 3.33 109.839 -177.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.6 165.62 30.4 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 114.043 1.127 . . . . 6.4 114.043 -168.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.13 141.48 47.95 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.082 1.753 . . . . 2.61 112.26 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.37 143.52 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.369 1.868 . . . . 3.12 107.866 166.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.67 -155.32 30.56 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.283 0.944 . . . . 1.64 114.207 -173.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -83.04 153.07 14.43 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.799 2.999 . . . . 3.45 109.893 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.1 t0 58.85 15.87 4.15 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.677 1.191 . . . . 6.38 114.067 175.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 112.17 -129.88 9.3 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.074 -1.61 . . . . 3.01 109.074 -169.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 71.38 138.47 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.33 1.852 . . . . 8.03 112.976 175.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -142.75 120.02 11.55 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.732 -1.23 . . . . 3.42 109.013 -177.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.68 -51.2 1.25 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.24 1.2 . . . . 2.98 114.24 -173.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -105.59 126.61 52.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.715 0.806 . . . . 3.84 110.339 -163.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -136.62 118.77 15.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.669 0.788 . . . . 6.1 111.675 -175.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -157.02 -140.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.524 1.93 . . . . 4.02 111.504 -163.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 97.95 170.41 32.45 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.256 1.408 . . . . 1.9 111.141 -155.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 281' ' ' LYS . 67.8 mm-40 85.95 171.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.523 2.729 . . . . 4.48 111.389 -172.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -48.78 106.99 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.711 1.604 . . . . 8.74 112.582 176.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 279' ' ' GLN . 0.0 OUTLIER -115.86 140.57 49.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.045 0.938 . . . . 6.61 113.2 -167.497 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.67 143.02 29.48 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.723 -1.236 . . . . 4.83 109.912 173.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.39 -51.02 61.21 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.71 -1.244 . . . . 2.12 112.511 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.36 -23.56 76.36 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.704 -1.053 . . . . 1.59 114.83 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -65.32 -49.48 69.29 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.825 1.312 . . . . 4.33 110.036 178.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.91 -45.87 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.417 1.087 . . . . 1.73 111.353 177.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.13 -47.82 83.87 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.167 -0.444 . . . . 1.37 111.44 176.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.37 83.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.286 1.435 . . . . 1.71 114.124 -178.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.6 m -58.88 -56.57 20.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.345 0.658 . . . . 2.5 110.193 171.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.42 -34.81 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 121.674 -0.641 . . . . 2.51 111.546 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.14 66.54 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.681 1.192 . . . . 1.91 113.73 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.6 m -68.67 -48.45 63.94 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.179 -0.675 . . . . 2.17 109.179 170.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -70.19 -19.54 63.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.581 1.552 . . . . 2.32 113.073 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 28.6 mtt -66.71 -29.53 69.54 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.434 -1.416 . . . . 5.52 112.67 167.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -56.23 -51.04 83.94 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.632 -1.651 . . . . 4.85 113.75 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.04 -36.33 22.5 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.039 2.492 . . . . 2.16 114.046 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -113.74 -24.22 9.28 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.482 1.66 . . . . 3.44 115.482 -167.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . 0.262 47.7 ptt85 31.27 -125.32 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.137 2.575 . . . . 7.2 115.006 177.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -108.84 167.9 9.74 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.378 1.471 . . . . 6.62 111.25 170.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -54.82 -21.47 11.37 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.549 2.426 . . . . 11.29 117.549 -167.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.778 0 C-N-CA 126.142 1.777 . . . . 10.88 109.876 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_